17003041-302	<protein-id="O76090,O88870,Q21973,Q6UY87,Q8WMR7">Bestrophin-1</protein-id> enables Ca2+-activated <compound-id="312">Cl</compound-id>-conductance in epithelia.	Cl__Bestrophin-1__interaction
17003041-304	Calcium-dependent <compound-id="312">Cl</compound-id> (-) currents were activated by <compound-id="5957">ATP</compound-id> in HEK293 cells expressing <protein-id="O76090,Q6UY87,Q8WMR7">BEST1</protein-id>.	ATP__BEST1__no_interaction	Cl__BEST1__interaction
17321121-703	The absorption spectrum of the <protein-id="P80509,P80510">hydrogenase</protein-id> enzyme showed an absorption peak at 425nm indicating that the enzyme had iron-<compound-id="402">sulfur</compound-id> clusters.	sulfur__hydrogenase__interaction
17403602-1067	When Vitreoscilla were grown in medium containing 60mM <compound-id="23668193">sodium nitrite</compound-id> under both normal and limited aeration conditions, the levels of Vitreoscilla <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> (VHb) were decreased by greater than 90%, while the levels of the terminal respiratory oxidase, cytochrome bo, were increased 350% under normal aeration and 7-23% under limited aeration.	sodium nitrite__hemoglobin__interaction
17590240-1233	<compound-id="65064">Epigallocatechin gallate (EGCG</compound-id>) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-<protein-id="P00520,P00522">Abl</protein-id>/<protein-id="O00213">FE65</protein-id> nuclear translocation and <protein-id="P18266,P49841,Q5YJC2,Q9WV60">GSK3 beta</protein-id> activation.	Epigallocatechin gallate (EGCG__GSK3 beta__interaction	Epigallocatechin gallate (EGCG__Abl__interaction	Epigallocatechin gallate (EGCG__FE65__interaction
17590240-1234	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (<protein-id="P12023">APP-C99</protein-id>) to investigate the protection mechanism of <compound-id="65064">epigallocatechin gallate (EGCG</compound-id>), the main constituent of <compound-id="4630">green tea</compound-id>.	green tea__APP-C99__interaction	epigallocatechin gallate (EGCG__APP-C99__interaction
17616381-938	The <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">protease</protein-id> was purified to homogeneity using <compound-id="223">ammonium</compound-id> <compound-id="1117">sulfate</compound-id> precipitation, and ion exchange chromatography with a fold purification of 1.8 and a recovery of 49%.	sulfate__protease__interaction	ammonium__protease__interaction
17629591-228	In addition, we demonstrated that Hsp20, <protein-id="O35878,Q16082,Q99PR8">HspB2</protein-id> and <protein-id="Q5EAC9,Q5RAB0,Q6SJQ8,Q8MJ36,Q9EPX0,Q9JK92,Q9UJY1">HspB8</protein-id> induced <protein-id="P41693">interleukin-6</protein-id> production in cultured pericytes and astrocytes, which could be antagonized by <compound-id="5743">dexamethasone</compound-id>, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	dexamethasone__HspB2__interaction	dexamethasone__interleukin-6__interaction	dexamethasone__HspB8__interaction
17692997-193	Furthermore, <compound-id="19001,439196,446094">dithiothreitol</compound-id> was found to be capable of significantly preventing the inhibitory effect of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> on Abeta oligomer formation.	dithiothreitol__insulin__interaction
17719144-1171	The scavenger receptor, <protein-id="P21988,P21989,P21990,P21991,P21992">class B</protein-id>, type I (<protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id>) is critical in maintaining the homeostasis of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and <compound-id="2116,14985">alpha-tocopherol</compound-id>.	alpha-tocopherol__class B__interaction	alpha-tocopherol__SR-BI__interaction	cholesterol__SR-BI__interaction	cholesterol__class B__interaction
17719144-1172	<protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> binds <protein-id="P81182">high-density lipoproteins</protein-id> (HDL) and mediates the selective transfer of cholesteryl esters and <compound-id="2116,14985">alpha-tocopherol</compound-id> from circulating HDL to cells.	alpha-tocopherol__high-density lipoproteins__interaction	alpha-tocopherol__SR-BI__interaction
17719144-1173	Thus, <protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> influences neural and cognitive processes, a finding that highlights the contribution of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and <compound-id="2116,14985">alpha-tocopherol</compound-id> homeostasis in proper cognitive function.	cholesterol__SR-BI__no_interaction	alpha-tocopherol__SR-BI__no_interaction
17768029-984	<compound-id="5781">Alloxan</compound-id> is believed to confer its diabetogenic effect by inhibiting pancreatic <protein-id="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0">glucokinase</protein-id> activity, leading to pancreatic beta-cell death.	Alloxan__glucokinase__interaction
17882129-602	<compound-id="2116,14985">Alpha-tocopherol</compound-id> supplementation prevents the exercise-induced reduction of serum paraoxonase 1/<protein-id="P22862">arylesterase</protein-id> activities in healthy individuals.	Alpha-tocopherol__arylesterase__interaction
17888544-779	Although ApoE4 has been repeatedly associated with altered sphingomyelin and <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels in tissue culture and rodent models, there has not been a direct quantification of sphingomyelin or sterol levels in the brains of patients with different forms of <protein-id="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8">ApoE</protein-id>.	cholesterol__ApoE__no_interaction
17888546-781	<protein-id="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8">ApoE</protein-id> modified the association between <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and cognitive decline, and the association between the ratio of <compound-id="99470,123976,50990021">27-hydroxycholesterol</compound-id> to <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and cognitive functioning.	27-hydroxycholesterol__ApoE__interaction	cholesterol__ApoE__interaction
17890844-955	Here we show that during growth in media containing <compound-id="206,5793,64689,79025">glucose</compound-id> and in complex medium without <compound-id="206,5793,64689,79025">glucose</compound-id> RamB activates expression of the <protein-id="P0AFG8,P0AFG9,P45119,P57301,Q10504,Q59637,Q89AR0,Q8K9T9">aceE</protein-id> gene, encoding the E1p subunit of the pyruvate dehydrogenase complex.	glucose__aceE__no_interaction
17925795-1037	The mood stabilizers <compound-id="28486,3028194">lithium</compound-id> and <compound-id="3121">valproate</compound-id> selectively activate the promoter IV of <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id> in neurons.	lithium__brain-derived neurotrophic factor__interaction	valproate__brain-derived neurotrophic factor__interaction
17925795-1038	Treatment of cultured rat cortical neurons with therapeutic concentrations of <compound-id="433294">LiCl</compound-id> or VPA selectively increased the levels of exon IV (formerly rat exon III)-containing <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> mRNA, and the activity of <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> promoter IV.	LiCl__BDNF__interaction
17925795-1039	We showed that <compound-id="28486,3028194">lithium</compound-id>-induced activation of promoter IV was mimicked by pharmacological inhibition of <protein-id="P51136,P83101">GSK-3</protein-id> or short interfering RNA (siRNA)-mediated gene silencing of <protein-id="P18265,P49840">GSK-3alpha</protein-id> or <protein-id="P18266,P49841,Q5YJC2,Q9WV60">GSK-3beta</protein-id> isoforms.	lithium__GSK-3alpha__interaction	lithium__GSK-3beta__interaction	lithium__GSK-3__interaction
17925795-1040	Furthermore, treatment with other HDAC inhibitors, <compound-id="264">sodium butyrate</compound-id> and <compound-id="444732">trichostatin A</compound-id>, or transfection with an HDAC1-specific siRNA also activated <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> promoter IV.	sodium butyrate__BDNF__no_interaction	trichostatin A__BDNF__no_interaction
17925795-1041	Our study demonstrates for the first time that <protein-id="P51136,P83101">GSK-3</protein-id> and HDAC are respective initial targets for <compound-id="28486,3028194">lithium</compound-id> and VPA to activate <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> promoter IV, and that this <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> induction involves a novel responsive region in promoter IV of the <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> gene.	lithium__GSK-3__interaction	lithium__BDNF__no_interaction
17941873-845	Addition of biphasic <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> aspart 30 to optimized <compound-id="4091">metformin</compound-id> and <compound-id="4829">pioglitazone</compound-id> treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> plus Oral ageNts).	pioglitazone__insulin__no_interaction	metformin__insulin__no_interaction	pioglitazone__Insulin__no_interaction	metformin__Insulin__no_interaction
17941873-846	Efficacy and safety of biphasic <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> aspart) added to an optimized treatment of <compound-id="4091">metformin</compound-id> and <compound-id="4829">pioglitazone</compound-id> (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	pioglitazone__insulin__no_interaction	metformin__insulin__no_interaction
17943458-544	<compound-id="65065">N-acetylaspartic acid</compound-id> (NAA) is converted into <compound-id="5960">aspartate</compound-id> and <compound-id="53627460">acetate</compound-id> by <protein-id="P45381,P46446,Q60HH2,Q8R3P0,Q9R1T5">aspartoacylase</protein-id>.	N-acetylaspartic acid__aspartoacylase__interaction	aspartate__aspartoacylase__interaction	acetate__aspartoacylase__interaction
17950491-1121	In addition, treatment with <compound-id="77999">rosiglitazone</compound-id> increased interleukin-4 (<protein-id="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58">IL-4</protein-id>) mRNA and reversed the age-related decrease in hippocampal <protein-id="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58">IL-4</protein-id> concentration.	rosiglitazone__IL-4__interaction
17965987-545	Serum <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> levels were increased and plasma levels of <compound-id="1738">HVA</compound-id> and <compound-id="10805">MHPG</compound-id> were decreased according to the recovery from the active phase of the disease.	HVA__BDNF__no_interaction	MHPG__BDNF__no_interaction
17965987-546	These results suggest that dysfunctions of catecholaminergic neurons and <protein-id="P18280,P20181,P20783,P25433,P25434,P25435,Q9TST2">neurotrophic factors</protein-id> might exist in Sydenham's chorea, and the decreasing catecholamine activities in response to <compound-id="5073">risperidone</compound-id> might be associated with the improvement of the disease.	risperidone__neurotrophic factors__no_interaction
17968352-734	Based on these validities we identified alterations in the <protein-id="O76024,P56695">Wolframin</protein-id> gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with <compound-id="2771,146570">citalopram</compound-id>.	citalopram__Wolframin__interaction
17968676-958	<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">Cyclooxygenase-2</protein-id> (<protein-id="P00411,P24894,P35355,Q05769,Q8HEC3,Q8SEM9">Cox-2</protein-id>) is a key enzyme in the conversion of <compound-id="444899">arachidonic acid</compound-id> to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	arachidonic acid__Cyclooxygenase-2__interaction	arachidonic acid__Cox-2__interaction
17976762-900	Other potential treatments discussed for possible use with long-acting <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> overdoses include incision and drainage of the injection site, <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id>, and <compound-id="383414,448601">octreotide</compound-id>.	octreotide__insulin__no_interaction	octreotide__glucagon__no_interaction
18037312-321	<compound-id="23973">Cadmium</compound-id> inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient increased bronchial reactivity, and (4) a significant increase in <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id> activity in the BALF.	Cadmium__MMP-9__interaction
18042181-811	To assess whether follicle-stimulating hormone (FSH) and <protein-id="P03969,P09038,P12226,P13109,P15655,P20003,P48798,P48799,P48800,Q60487">basic fibroblast growth factor</protein-id> (bFGF) modulate <compound-id="124886">GSH</compound-id> production in Sertoli cells by regulating the expression of <protein-id="P48506">GCLC</protein-id>, <protein-id="P48507,Q2T9Y6">GCLM</protein-id> and/or GR, we performed in vitro studies using rat Sertoli cells in primary culture.	GSH__GCLM__interaction	GSH__basic fibroblast growth factor__interaction	GSH__GCLC__interaction
18042181-812	In conclusion, our results show that FSH and bFGF increase <compound-id="124886">GSH</compound-id> levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating <protein-id="P48507,Q2T9Y6">GCLM</protein-id> and GR expression respectively.	GSH__GCLM__interaction
18061671-207	Compared to the control, both the stresses individually and in combination led to in reductions in growth, photosynthetic pigments, <compound-id="54670067,54690394">ascorbic acid</compound-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>) activity and yield, whereas a reverse trend was observed for flavonoids, thiols and <compound-id="614,8988,145742">proline</compound-id> contents, <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) and <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="P59097,P79076,Q5B2E9,Q5G234,Q6QWR1,Q6UG02,Q75ZP8,Q8J136,Q8J2V8">POD</protein-id>) activities, and <protein-id="P22079,P80025">LPO</protein-id>.	ascorbic acid__peroxidase__no_interaction	proline__peroxidase__no_interaction	proline__CAT__no_interaction	ascorbic acid__catalase__no_interaction	proline__SOD__no_interaction	ascorbic acid__POD__no_interaction	ascorbic acid__CAT__no_interaction	ascorbic acid__SOD__no_interaction	proline__LPO__no_interaction	proline__superoxide dismutase__no_interaction	proline__POD__no_interaction	proline__catalase__no_interaction	ascorbic acid__LPO__no_interaction	ascorbic acid__superoxide dismutase__no_interaction
18068270-465	Selenium and <compound-id="5359268">aluminum</compound-id> levels were not associated to <protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</protein-id> Abeta42.	aluminum__CSF__no_interaction
18068270-466	In vitro, the degradation of synthetic Abeta substrate added to <protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</protein-id> was markedly accelerated by low levels (2microM) of exogenous zinc and <compound-id="23978">copper</compound-id>.	copper__CSF__interaction
18068871-859	<protein-id="O12976,P49768,P49769,P79802,P97887,Q4JIM4,Q5R780,Q6RH31,Q8HXW5,Q9W6T7,Q9XT97">Presenilin-1</protein-id> mutation impairs cholinergic modulation of synaptic plasticity and suppresses <compound-id="22880">NMDA</compound-id> currents in hippocampus slices.	NMDA__Presenilin-1__interaction
18068871-860	Similarly, mutant <protein-id="P49768,P79802,Q8HXW5,Q9W6T7">PS1</protein-id> impairs the ability of the cholinesterase inhibitor <compound-id="192706,9905831,10337156">phenserine</compound-id> to enhance LTP.	phenserine__PS1__no_interaction
18077014-827	It was found that the expression of <protein-id="P21673,P48026,P49431,Q01612,Q28999,Q3T0Q0,Q8AXL1,Q9JHW6">SSAT</protein-id> and <protein-id="O22616,P00860,P07805,P08432,P09057,P11926,P14019,P27116,P27117,P27118,P27119,P27121,P40807,P40808,P41931,P43099,P49725,P50134,P78599,Q5RFB7,Q8S3N2,Q92445,Q9BQT8,Q9UQW9">ODC</protein-id> were upregulated after reperfusion and the concentrations of <compound-id="1102">spermidine</compound-id> and <compound-id="1103">spermine</compound-id> were significantly decreased, while <compound-id="1045">putrescine</compound-id> concentration was significantly increased.	spermine__ODC__no_interaction	putrescine__SSAT__no_interaction	spermine__SSAT__no_interaction	putrescine__ODC__no_interaction	spermidine__SSAT__no_interaction	spermidine__ODC__no_interaction
18079026-797	In the present study, we investigated the effects of <compound-id="5002">quetiapine</compound-id> on memory impairment and pathological changes in an amyloid precursor protein (<protein-id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</protein-id>)/<protein-id="O12976,P49768,P49769,P79802,P97887,Q4JIM4,Q5R780,Q6RH31,Q8HXW5,Q9W6T7,Q9XT97">presenilin-1</protein-id> (<protein-id="P49768,P49769,P79802,P84566,P97887,Q5R780,Q6RH31,Q8HXW5,Q9XT97">PS-1</protein-id>) double transgenic mouse model of Alzheimer's disease (AD).	quetiapine__presenilin-1__interaction	quetiapine__PS-1__interaction	quetiapine__APP__interaction
18079026-798	<compound-id="5002">Quetiapine</compound-id> also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of <protein-id="P05067,P08592,P12023,P53601,P79307,Q5IS80,Q95241">C99</protein-id> (an <protein-id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</protein-id> C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	Quetiapine__C99__interaction	Quetiapine__APP__interaction
18079026-799	Furthermore, <compound-id="5002">quetiapine</compound-id> attenuated anxiety-like behavior, up-regulated cerebral <protein-id="P10417,P49950">Bcl-2</protein-id> protein, and decreased cerebral nitrotyrosine in the transgenic mice.	quetiapine__Bcl-2__interaction
18162361-61	<compound-id="446157">Rosuvastatin</compound-id> rapidly phosphorylated <protein-id="P31750,Q8INB9">Akt</protein-id> and endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>) in human endothelial cells.	Rosuvastatin__nitric oxide synthase__interaction	Rosuvastatin__eNOS__interaction	Rosuvastatin__Akt__interaction
18162361-62	Our findings indicate that <compound-id="446157">rosuvastatin</compound-id> protects endothelial cells from death with phosphorylation of <protein-id="P31750,Q8INB9">Akt</protein-id> and <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>.	rosuvastatin__eNOS__interaction	rosuvastatin__Akt__interaction
18164165-377	<protein-id="O50258">Superoxide dismutase</protein-id> and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> antioxidant enzyme activities and <compound-id="10964">malondialdehyde</compound-id> levels were found to be increased; however, <compound-id="5280489">beta-carotene</compound-id>, <compound-id="445354">retinol</compound-id>, <compound-id="54670067">vitamin C</compound-id>, <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id>, <compound-id="124886">reduced glutathione</compound-id>, and albumin levels were observed to be significantly decreased.	retinol__Superoxide dismutase__no_interaction	vitamin C__Superoxide dismutase__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction	reduced glutathione__Superoxide dismutase__no_interaction	vitamin E__glutathione peroxidase__no_interaction	vitamin E__Superoxide dismutase__no_interaction	vitamin C__glutathione peroxidase__no_interaction	retinol__glutathione peroxidase__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction	malondialdehyde__Superoxide dismutase__no_interaction	beta-carotene__Superoxide dismutase__no_interaction	beta-carotene__glutathione peroxidase__no_interaction
18172601-392	Structure-function studies of nitrated <protein-id="O46674,O55143,P11507,P11607,P16615,P20647,Q00779,Q03669">SERCA2</protein-id> in aging heart and skeletal muscle demonstrate stoichiometric nitration of vicinal tyrosines, Tyr (294) and Tyr (295), on the lumenal side of the membrane-spanning helix, <compound-id="16682741">M4</compound-id>, which correlates with partial inhibition of Ca(2+)-ATPase activity suggesting a possible regulatory function in down-regulating mitochondrial energy production and the associated generation of reactive <compound-id="977">oxygen</compound-id>/<compound-id="947,123329">nitrogen</compound-id> species.	M4__SERCA2__no_interaction	oxygen__SERCA2__no_interaction	nitrogen__SERCA2__no_interaction
18177531-936	<compound-id="281">Carbon monoxide</compound-id> is an endogenous vasodilator gas produced by the enzyme <protein-id="O19998,O73688,O78497,P51271,P71119">heme oxygenase</protein-id> (HO).	Carbon monoxide__heme oxygenase__interaction
18179560-930	The long pentraxin 3 (<protein-id="O75364,P26022">PTX3</protein-id>) is a multifunctional soluble pattern recognition receptor, involved in several processes ranging from innate resistance and inflammation to clearance of apoptotic cells and organization of <compound-id="24759,453618,3084050,24728612">hyaluronic acid</compound-id>-rich extracellular matrices.	hyaluronic acid__PTX3__interaction
18180755-369	The <protein-id="P0C1J7,Q13451,Q5RF88,Q95L05,Q9XSH5,Q9XSI2,Q9XT11">FKBP5</protein-id> gene product forms part of a complex with the <protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptor</protein-id> and can modulate <compound-id="5754">cortisol</compound-id>-binding affinity.	cortisol__FKBP5__interaction	cortisol__glucocorticoid receptor__interaction
18190985-361	Several studies have shown that <protein-id="P05463">epsilon</protein-id> 2 carriers have lower low-density lipoprotein and apo B levels and higher <protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and apo A-I levels than <protein-id="P05463">epsilon</protein-id> 3 carriers.	cholesterol__high-density lipoprotein__interaction	cholesterol__epsilon__interaction
18191451-670	Toxicity and characterization of <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</protein-id>-inhibition induced by <compound-id="5936">diisopropyl fluorophosphate</compound-id> in Artemia salina larvae.	diisopropyl fluorophosphate__cholinesterase__interaction
18195714-756	<compound-id="11970143">Lipopolysaccharide</compound-id>-induced depressive-like behavior is mediated by <protein-id="P14902,P28776">indoleamine 2,3-dioxygenase</protein-id> activation in mice.	Lipopolysaccharide__indoleamine 2,3-dioxygenase__interaction
18195714-757	We report that peripheral administration of <compound-id="11970143">lipopolysaccharide</compound-id> (LPS) activates <protein-id="P14902,P28776">IDO</protein-id> and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests.	lipopolysaccharide__IDO__interaction
18195714-758	Administration of L-<compound-id="846">kynurenine</compound-id>, a metabolite of <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> that is generated by <protein-id="P14902,P28776">IDO</protein-id>, to naive mice dose dependently induces depressive-like behavior.	kynurenine__IDO__interaction	tryptophan__IDO__interaction
18198986-243	Serum adipocyte <protein-id="O42494,O45035,O76821,P80547,Q17284,Q8MUC1,Q9U5P1">fatty acid binding protein</protein-id> levels in patients with type 2 diabetes mellitus and obesity: the influence of <compound-id="3339">fenofibrate</compound-id> treatment.	fenofibrate__fatty acid binding protein__interaction
18198986-245	Serum <protein-id="P80565">FABP</protein-id> levels were 2.5-fold higher in T2DM group relative to C and were not affected by <compound-id="3339">fenofibrate</compound-id> treatment (C: 20.6+/-2.1 microg/l, T2DM before F: 55.6+/-5.7 microg/l, T2DM after F: 54.2+/-5.4 microg/l, p 0.0001 for C vs. T2DM before F).	fenofibrate__FABP__no_interaction
18198986-246	<protein-id="P80565">FABP</protein-id> levels positively correlated with BMI, triglyceride levels, blood <compound-id="206,5793,64689,79025">glucose</compound-id>, glycated <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id>, atherogenic index and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> levels.	glucose__hemoglobin__no_interaction	glucose__FABP__interaction	glucose__insulin__no_interaction
18198997-256	<compound-id="264">Butyrate</compound-id> enemas upregulate <protein-id="P0A9M0">Muc</protein-id> genes expression but decrease adherent mucus thickness in mice colon.	Butyrate__Muc__interaction
18198997-257	We demonstrated that <compound-id="264">butyrate</compound-id> stimulated the gene expression of both secreted (<protein-id="Q62635">Muc2</protein-id>) and membrane-linked (<protein-id="Q02496">Muc1</protein-id>, Muc3, Muc4) mucins.	butyrate__Muc2__interaction	butyrate__Muc1__interaction
18198997-258	<compound-id="264">Butyrate</compound-id> especially induced a 6-fold increase in <protein-id="Q62635">Muc2</protein-id> gene expression in proximal colon.	Butyrate__Muc2__interaction
18198997-259	However, <compound-id="264">butyrate</compound-id> enemas did not modify the number of epithelial cells containing the protein <protein-id="Q62635">Muc2</protein-id>, and caused a 2-fold decrease in the thickness of adherent mucus layer.	butyrate__Muc2__no_interaction
18204887-141	We examined the association of <protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id> C677T and A1298C, and changes in plasma <compound-id="778">homocysteine</compound-id> in 352 Tunisian patients with angiographically-demonstrated CAD, and 390 age and gender-matched healthy subjects.	homocysteine__MTHFR__no_interaction
18205042-213	However, we also observed that <compound-id="2812">clotrimazol</compound-id> (1alpha-hydroxylase inhibitor) enhanced 25(OH)D(3)-induced <protein-id="Q07973">CYP24</protein-id> expression in breast cancer cells.	clotrimazol__CYP24__interaction
18207583-646	Expression of senescence-associated <protein-id="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6">beta-galactosidase</protein-id> (SA-beta-<protein-id="P10683,P11886,P47212">Gal</protein-id>) by human skin fibroblasts, effect of advanced glycation end-products and <compound-id="840,17106,19466,94270,439554">fucose</compound-id> or rhamnose-rich polysaccharides.	fucose__Gal__interaction	fucose__beta-galactosidase__interaction
18221806-436	Short-term withdrawal of <compound-id="54454,4677798">simvastatin</compound-id> induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id>.	simvastatin__nitric oxide synthase__interaction
18222028-559	It has been shown that the removal efficiency of <protein-id="P14678">COD</protein-id> increased with the increasing applied current density and increasing PAC and <compound-id="923,373840">Na</compound-id> (2)SO(4) dosage and the most effective removal capacity was achieved at the pH 7.	Na__COD__interaction
18222543-918	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against <compound-id="6001">DMBA</compound-id>-induced changes in levels of some [<protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx), and <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR) activities and total <compound-id="124886">glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), malonedialdehyde (MDA)] parameters in rat lung and kidney were investigated.	glutathione__CAT__no_interaction	DMBA__glutathione peroxidase__interaction	GSH__SOD__no_interaction	GSH__glutathione peroxidase__no_interaction	glutathione__SOD__no_interaction	DMBA__glutathione reductase__interaction	glutathione__glutathione peroxidase__no_interaction	GSH__superoxide dismutase__no_interaction	DMBA__SOD__interaction	DMBA__superoxide dismutase__interaction	DMBA__catalase__interaction	GSH__CAT__no_interaction	glutathione__superoxide dismutase__no_interaction	glutathione__glutathione reductase__no_interaction	GSH__catalase__no_interaction	GSH__glutathione reductase__no_interaction	DMBA__CAT__interaction	glutathione__catalase__no_interaction
18226951-1110	Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased <compound-id="6047">l-dopa</compound-id> synthesis, limitations in <compound-id="6047">l-dopa</compound-id> decarboxylation or increased <protein-id="O50163,O67222,O83772,P0A817,P0A818,P0A819,P0A820,P24752,P43762,P47293,P50307,P54419,P56460,P56878,P57486,P57897,P61945,P61946,P66764,P66765,P66766,P66767,P72871,P77899,P78003,Q1QCH2,Q21NJ5,Q21RM4,Q28UI9,Q2A1N2,Q2FFV6,Q2GBP1,Q2IM98,Q2IZR2,Q2JIN3,Q2JV74,Q2NRD1,Q2NZF1,Q2RK28,Q2RYY4,Q2SLT3,Q2SS11,Q2T267,Q2VYQ2,Q2Y5Z1,Q2YTK1,Q30PN0,Q311V1,Q31CL7,Q31EL0,Q31KC6,Q31WK4,Q32C11,Q38YF8,Q39BZ1,Q39W48,Q3A388,Q3AFS4,Q3AME2,Q3AQC3,Q3AWE6,Q3B531,Q3BXB7,Q3IDQ1,Q3IW86,Q3J7R5,Q3JX94,Q3K1M7,Q3K5E8,Q3MF32,Q3SFY2,Q3YXS9,Q3Z943,Q3ZZN7,Q46H57,Q476V0,Q47JN4,Q47R14,Q486L6,Q48CH3,Q48SU7,Q493F2,Q49YL6,Q4A5F4,Q4FNN1,Q4FTH7,Q4JVH7,Q4K4I7,Q4L7C7,Q4QLC5,Q4UR08,Q4ZM01,Q57K26,Q5E7R2,Q5FAC0,Q5FIN8,Q5FSK6,Q5GW76,Q5HEY9,Q5HNB8,Q5KW02,Q5LJ26,Q5LLL2,Q5LZI0,Q5M434,Q5N1I9,Q5NIC7,Q5NQV7,Q5P2V5,Q5PJJ2,Q5QVM7,Q5SHT8,Q5WDZ8,Q5WV18,Q5X3N0,Q5XBJ6,Q5YTN0,Q5ZTY6,Q60CG7,Q62EZ1,Q632S5,Q63YH5,Q650L4,Q65FV8,Q65UT4,Q661P3,Q666P5,Q67T90,Q6A8H3,Q6AF79,Q6AQ43,Q6D081,Q6F1M6,Q6FAQ6,Q6G8E3,Q6GFR6,Q6HCB4,Q6LMM8,Q6MPK2,Q6MTB6,Q71Z03,Q729A3,Q72I53,Q72SM5,Q72YV6,Q73JR4,Q741G5,Q74KS4,Q7M7Z2,Q7MHK6,Q7MTQ0,Q7N119,Q7NHG0,Q7NZF9,Q7U051,Q7U4S6,Q7URU7,Q7V2Y8,Q7V5A2,Q7VDM7,Q7VFY5,Q7VNG7,Q7VRG5,Q7VUL5,Q7W200,Q7WQX8,Q7WYG5,Q7WYN1,Q816Q8,Q81KI0,Q827Q0,Q82WL2,Q837P9,Q83A78,Q83GE4,Q83HT7,Q84FD3,Q87AY6,Q87LK6,Q88AK7,Q88D60,Q88XB8,Q898W7,Q89HP5,Q8A2T6,Q8CNT5,Q8CXS7,Q8D2N8,Q8DCA3,Q8DK88,Q8DQH0,Q8DT23,Q8E0A3,Q8E5Y0,Q8EIB4,Q8EP05,Q8FT48,Q8G3H4,Q8K715,Q8K9E5,Q8KEG7,Q8NVZ9,Q8P0G6,Q8PCH3,Q8PP75,Q8RCE4,Q8RGE5,Q8Y347,Q8Y6M0,Q8ZHG7,Q92AZ5,Q938W7,Q97F85,Q97RN9,Q98A80,Q98PM0,Q99Z77,Q9CCQ4,Q9CEE0,Q9I5Z0,Q9JVV6,Q9JY09,Q9K5E4,Q9K7Q9,Q9KUP3,Q9L0Y3,Q9PGB0,Q9RL99,Q9RWM6,Q9X1Y8,Q9X4Q2,Q9ZMN5">MAT</protein-id>/<protein-id="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2">COMT</protein-id> activity, or some combination of these.	l-dopa__MAT__no_interaction	l-dopa__COMT__no_interaction
18227836-349	To test this hypothesis, we investigated whether disruption of the <protein-id="P01175,P01176,P01177,P01178,P01179,P13389,P32005,P35454,P69043,P69044,P69056,P69057,P69058">oxytocin</protein-id> gene (<protein-id="P01179,P35454,Q5QQ53,Q7KVA1">Oxt</protein-id>-/-) made mice more susceptible to the psychosis-related effects of <compound-id="3007,5826,32893">amphetamine</compound-id> (<compound-id="6083">Amp</compound-id>), <compound-id="6005">apomorphine</compound-id> (Apo) and <compound-id="6468">phencyclidine</compound-id> (PCP).	apomorphine__Oxt__interaction	Amp__oxytocin__interaction	apomorphine__oxytocin__interaction	amphetamine__oxytocin__interaction	amphetamine__Oxt__interaction	phencyclidine__Oxt__interaction	phencyclidine__oxytocin__interaction	Amp__Oxt__interaction
18227838-352	The mood stabilizers <compound-id="28486,3028194">lithium</compound-id> and <compound-id="3121">valproate</compound-id> activate the <protein-id="P29323">ERK</protein-id> pathway in prefrontal cortex and hippocampus and potentiate <protein-id="P29323">ERK</protein-id> pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	lithium__ERK__interaction	valproate__ERK__interaction
18227970-442	In the root soluble fraction, the suicide inhibitor alpha-<compound-id="137670">difluoromethyl</compound-id>-<compound-id="866,5962">lysine</compound-id> suppressed the activity of <protein-id="P05033">lysine decarboxylase</protein-id> and of <protein-id="O22616,P00860,P07805,P08432,P09057,P11926,P14019,P27116,P27117,P27118,P27119,P27121,P41931,P44317,P49725,P50134,P78599,Q8S3N2,Q92445,Q9UQW9">ornithine decarboxylase</protein-id> to the same extent, but had no effect on <protein-id="O81160,O82475,P21885,P22220,P49726,Q39827,Q43075,Q819L4,Q81MS2,Q96412,Q96A70,Q9K9K5,Q9SNN0">arginine decarboxylase</protein-id> activity.	difluoromethyl__arginine decarboxylase__no_interaction	lysine__arginine decarboxylase__no_interaction	difluoromethyl__ornithine decarboxylase__interaction	lysine__ornithine decarboxylase__interaction	difluoromethyl__lysine decarboxylase__interaction	lysine__lysine decarboxylase__interaction
18228136-547	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or <compound-id="10903">2ME</compound-id> treatment groups, based on significance of results 4 genes were selected: <protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id>, <protein-id="P10417,P49950">Bcl2</protein-id>, <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">P53</protein-id> and <protein-id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">Cyclin</protein-id> D1.	2ME__Cyclin__no_interaction	2ME__P53__no_interaction	2ME__MDR1__no_interaction	2ME__Bcl2__no_interaction
18228136-548	The array and western blotting showed that <protein-id="P10417,P49950">Bcl2</protein-id> and <protein-id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">Cyclin</protein-id> D1 expression were down regulated; <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">P53</protein-id> expression was not affected while <protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id> was over expressed by combination of <compound-id="10903">2ME</compound-id> with Dox.	2ME__Cyclin__interaction	2ME__MDR1__interaction	2ME__P53__no_interaction	2ME__Bcl2__interaction
18228136-549	In conclusion, <compound-id="10903">2ME</compound-id> chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of <protein-id="P10417,P49950">Bcl2</protein-id> and <protein-id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">Cyclin</protein-id> D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	2ME__Cyclin__interaction	2ME__Bcl2__interaction
18230627-837	Randomised trials have demonstrated that the efficacy of anti-tumour necrosis factor (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>) agents is significantly increased by concomitant <compound-id="126941">methotrexate</compound-id> (MTX) in rheumatoid arthritis (RA).	methotrexate__TNF__interaction
18243311-231	Neither <protein-id="P52914">apyrase</protein-id> nor <compound-id="5957">ATP</compound-id> altered production of reactive <compound-id="977">oxygen</compound-id> intermediates (ROI) or reactive <compound-id="947,123329">nitrogen</compound-id> intermediates (RNI) by bovine monocytes.	nitrogen__apyrase__no_interaction	oxygen__apyrase__no_interaction	ATP__apyrase__no_interaction
18243368-1130	In this systematic review, we have analyzed the results of 52 clinical trials, including 72 intervention groups and 6290 patients, on <compound-id="5280795">vitamin D</compound-id> supplementation in order to evaluate the experimental evidence and the effects of age and chronic immobility on responses of parathyroid hormone (<protein-id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</protein-id>).	vitamin D__PTH__interaction
18243368-1131	The <compound-id="5280795">vitamin D</compound-id> supplementation of the chronically immobile patients resulted in a smaller decrease in <protein-id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</protein-id> 0.001).	vitamin D__PTH__interaction
18243368-1132	Our results also suggest that <protein-id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</protein-id> decreases quite linearly during <compound-id="5280795">vitamin D</compound-id> supplementation at any given 25-OHD level.	vitamin D__PTH__interaction
18248398-140	<protein-id="O02750,O93416,Q28603,Q95189,Q95234">Leptin</protein-id> did not show any effect in long photoperiod but decreased proliferation by stimulating <compound-id="896">melatonin</compound-id> in short photoperiod.	melatonin__Leptin__interaction
18249383-1046	To compare the changes in body composition and in <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> levels in postmenopausal women receiving hormone therapy (HT) or <compound-id="444008">tibolone</compound-id>.	tibolone__leptin__no_interaction
18249399-1054	Common 677C--&gt;T mutation of the <protein-id="O54235,O67422,P0AEZ1,P0AEZ2,P11003,P45208,P57154,P71319,Q89B13,Q8KA62">5,10-methylenetetrahydrofolate reductase</protein-id> gene affects follicular <compound-id="5757">estradiol</compound-id> synthesis.	estradiol__5,10-methylenetetrahydrofolate reductase__interaction
18253022-733	Surprisingly, a deletion of the <protein-id="Q00934">pilR</protein-id> gene affected not only insoluble <compound-id="29936">Fe(III</compound-id>) reduction, which requires pili, but also soluble <compound-id="29936">Fe(III</compound-id>) reduction, which, in contrast, does not require pili.	Fe(III__pilR__interaction
18253697-765	Furthermore, the suppressive effects of P on <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> release and caspase-9 and caspase-3 activation in serum-deprived MC3T3-E1 cells were also reversed by <compound-id="55245">RU486</compound-id>.	RU486__cytochrome c__interaction
18256928-624	Therapeutic <compound-id="4091">metformin</compound-id>/<protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id> activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	metformin__AMPK__no_interaction
18256928-625	However, when ERalpha negative MDA-MB-435 cells were treated with <compound-id="4091">metformin</compound-id>, they demonstrated increased expression of vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>) in an <protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id> dependent manner; while the ERalpha positive MCF-7 cells did not.	metformin__AMPK__interaction	metformin__VEGF__interaction
18256928-626	The <compound-id="4091">metformin</compound-id>-treated group showed increased <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> expression, intratumoral microvascular density and reduced necrosis.	metformin__VEGF__interaction
18256928-627	<compound-id="4091">Metformin</compound-id> treatment was sufficient, however, to reduce systemic <protein-id="Q95222">IGF-1</protein-id> and the proliferation rate of tumor cells in vascularized regions.	Metformin__IGF-1__interaction
18260130-109	<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id>, <protein-id="P10147,P10855,P50229,Q5I1Z0,Q8HYQ3,Q8SQA6">MIP-1alpha</protein-id>, <protein-id="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5">IL-8</protein-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, <protein-id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</protein-id>, <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, <protein-id="O18999,O77482,P18510,P25085,P25086,P26890,Q29056,Q866R8,Q9BEH0,Q9GMZ4">IL-1ra</protein-id>, and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> were measured from monocyte/macrophage cultures at different stages of activation and differentiation seeded onto polyethylene, <compound-id="12254">polyurethane</compound-id>, expanded polytetrafluoroethylene, <compound-id="6658">polymethyl methacrylate</compound-id>, and a hydrogel copolymer of <compound-id="13360">2-hydroxyethyl methacrylate</compound-id>, <compound-id="6917">1-vinyl-2-pyrrolidinone</compound-id>, and polyethylene glycol acrylate in tissue culture <compound-id="7501">polystyrene</compound-id> (TCPS) plates.	polymethyl methacrylate__TNF-alpha__no_interaction	1-vinyl-2-pyrrolidinone__IL-10__no_interaction	polyurethane__VEGF__no_interaction	polyurethane__IL-6__no_interaction	polymethyl methacrylate__MCP-1__no_interaction	polystyrene__IL-1ra__no_interaction	1-vinyl-2-pyrrolidinone__TNF-alpha__no_interaction	2-hydroxyethyl methacrylate__MIP-1alpha__no_interaction	2-hydroxyethyl methacrylate__MCP-1__no_interaction	polystyrene__MCP-1__no_interaction	polymethyl methacrylate__IL-1ra__no_interaction	polystyrene__IL-6__no_interaction	polystyrene__VEGF__no_interaction	polyurethane__MCP-1__no_interaction	1-vinyl-2-pyrrolidinone__IL-1beta__no_interaction	polyurethane__IL-10__no_interaction	polyurethane__IL-8__no_interaction	polystyrene__TNF-alpha__no_interaction	1-vinyl-2-pyrrolidinone__VEGF__no_interaction	polystyrene__IL-10__no_interaction	polymethyl methacrylate__IL-1beta__no_interaction	polymethyl methacrylate__IL-6__no_interaction	polymethyl methacrylate__MIP-1alpha__no_interaction	1-vinyl-2-pyrrolidinone__MIP-1alpha__no_interaction	1-vinyl-2-pyrrolidinone__IL-1ra__no_interaction	polyurethane__IL-1ra__no_interaction	polymethyl methacrylate__VEGF__no_interaction	polyurethane__TNF-alpha__no_interaction	2-hydroxyethyl methacrylate__IL-1beta__no_interaction	polyurethane__MIP-1alpha__no_interaction	2-hydroxyethyl methacrylate__VEGF__no_interaction	polymethyl methacrylate__IL-10__no_interaction	1-vinyl-2-pyrrolidinone__IL-8__no_interaction	2-hydroxyethyl methacrylate__IL-6__no_interaction	polyurethane__IL-1beta__no_interaction	2-hydroxyethyl methacrylate__TNF-alpha__no_interaction	polymethyl methacrylate__IL-8__no_interaction	1-vinyl-2-pyrrolidinone__MCP-1__no_interaction	2-hydroxyethyl methacrylate__IL-8__no_interaction	1-vinyl-2-pyrrolidinone__IL-6__no_interaction	polystyrene__IL-1beta__no_interaction	2-hydroxyethyl methacrylate__IL-1ra__no_interaction	polystyrene__IL-8__no_interaction	polystyrene__MIP-1alpha__no_interaction	2-hydroxyethyl methacrylate__IL-10__no_interaction
18262559-301	Systemic administration of <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> vesicle elevates tumor tissue <compound-id="977">oxygen</compound-id> tension and modifies tumor response to irradiation.	oxygen__hemoglobin__interaction
18262738-416	The participation of <protein-id="Q05608,Q9RI12">protein kinase A</protein-id> (PKA), <protein-id="P13678,Q25378">protein kinase C</protein-id> (<protein-id="P05130,P13677,P13678,P34722">PKC</protein-id>) and protein tyrosine kinase (PTK) in capacitation induced by <compound-id="5460609">ONOO</compound-id> (-) was evaluated by incubation with specific inhibitors (50 microM H-89, 0.1 microM <compound-id="2396">bisindolylmaleimide I</compound-id>, and 3 microM <compound-id="5280961">genistein</compound-id>, respectively).	bisindolylmaleimide I__PKC__interaction	bisindolylmaleimide I__protein kinase A__interaction	ONOO__protein kinase A__interaction	ONOO__protein kinase C__interaction	genistein__protein kinase A__interaction	genistein__protein kinase C__interaction	ONOO__PKC__interaction	genistein__PKC__interaction	bisindolylmaleimide I__protein kinase C__interaction
18266054-1214	At the time, <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> activity was significantly inhibited and gamma-glutamyl <compound-id="594,5862,5360637">cysteine</compound-id> increased by ACA exposure.	cysteine__glutathione reductase__no_interaction
18268501-1260	The effect of the polymorphism is non-conservative and results in a <compound-id="738,5961">glutamine</compound-id> to <compound-id="232,4367,6322">arginine</compound-id> change (Gln460Arg), which is likely to affect <protein-id="Q99572">P2RX7</protein-id> dimerization and protein-protein interactions.	arginine__P2RX7__interaction	glutamine__P2RX7__interaction
18270841-348	Increased <compound-id="16129681,16129706">somatostatin</compound-id> tone and decreased <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> concentrations may also contribute to reduced GH levels.	somatostatin__ghrelin__no_interaction
18272254-1258	Inhibition of LTP by beta-amyloid is prevented by activation of <protein-id="O70431,P04274,P07550,P10608,P18762,P54833,Q28044,Q28509,Q28997,Q4KWL2,Q8UUY8,Q9TST5">beta2 adrenoceptors</protein-id> and stimulation of the <compound-id="6076">cAMP</compound-id>/PKA signalling pathway.	cAMP__beta2 adrenoceptors__no_interaction
18274872-320	) <compound-id="977,5359597">O2</compound-id> (-) and <compound-id="784">H2O2</compound-id> in H. plumaeforme was respectively related to the low activity of <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> and the decreased activity of <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>.	O2__SOD__interaction	H2O2__CAT__interaction	H2O2__SOD__interaction	O2__CAT__interaction
18279956-684	A novel oligodeoxynuleotides containing 11 <compound-id="6804">CpG</compound-id> motifs was synthesized and inserted into the VR1020 plasmid containing pig <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>) gene (VPIL6) to construct recombinant plasmid, VPIL6C.	CpG__interleukin-6__no_interaction	CpG__IL-6__no_interaction
18280595-101	Furthermore, it has also been reported that <compound-id="1548943">capsaicin</compound-id>-treated pigs significantly increase mean arterial blood pressure compared with controls and that the decrease in <protein-id="P10286,P30880,P30881,P31888,P80511">CGRP</protein-id> synthesis and release contributes to the elevated blood pressure.	capsaicin__CGRP__interaction
18283487-569	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the <compound-id="5957">ATP</compound-id>-dependent and-coupled transport of <compound-id="923,373840">Na</compound-id> (+) and K(+) across the plasma membrane of a living cell in which such a process (<protein-id="P13607,P17326,P28774,P35317">sodium pump</protein-id>) is detected.	ATP__sodium pump__interaction	Na__sodium pump__interaction
18286621-29	Affinity electrophoresis analysis provided evidence that carboxymethylated <compound-id="4125253,5460037">dextran</compound-id> polymers grafted with high amounts of <compound-id="10391">benzylamide</compound-id> groups (named DMCB) interact with <protein-id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</protein-id>.	benzylamide__BMP-2__interaction	dextran__BMP-2__interaction
18286621-30	A screening study provided evidence that the potentiating effects of the <compound-id="4125253,5460037">dextran</compound-id> derivatives on the <protein-id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</protein-id>-induced <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> activity improved with their <compound-id="10391">benzylamide</compound-id> groups content and, therefore, with their affinity for the growth factor.	benzylamide__alkaline phosphatase__interaction	dextran__BMP-2__interaction	dextran__alkaline phosphatase__interaction	benzylamide__BMP-2__interaction
18294936-104	Since <compound-id="40400,644073,5311033,6321408,24838065">buprenorphine</compound-id> is metabolized through <protein-id="P08684">cytochrome P450 3A4</protein-id>, we genotyped six genetic polymorphisms previously described in poor metabolizers but could not confirm these pharmacogenetic bases in this case.	buprenorphine__cytochrome P450 3A4__interaction
18295378-334	Mitochondrial dysfunction was associated with higher levels of reactive <compound-id="977">oxygen</compound-id> species, an altered Bcl-xL/<protein-id="P27297,Q07813,Q63690">Bax</protein-id> ratio and reduction of <protein-id="P11353,P36551,P36552,Q9UTE2,Q9V3D2">COX</protein-id> IV activity.	oxygen__COX__no_interaction	oxygen__Bax__no_interaction
18298568-1058	Peripheral venous levels of <compound-id="6013">testosterone</compound-id>, <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id>, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), <compound-id="10964">malondialdehyde</compound-id> and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	testosterone__prolactin__no_interaction	malondialdehyde__prolactin__no_interaction
18298570-1059	Our results showed that <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> abolished the effect of the oxidant, protecting spermatozoa against reactive <compound-id="977">oxygen</compound-id> species, and improving both sperm motility and chromatin status during incubation.	oxygen__catalase__interaction
18298659-1127	Intranasal and intravenous administration of live Cpn and Aa, respectively induced an accumulation of activated mast cells in the aortic sinus of apolipoprotein E-deficient mice, however, with varying responses in the systemic levels of <compound-id="11970143">lipopolysaccharide</compound-id> (LPS) and <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>.	lipopolysaccharide__TNF-alpha__no_interaction
18304632-1001	<protein-id="P00448,P66828,P66829,Q8Z2V9,Q9RUV2">MnSOD</protein-id> and two additional <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> isozymes were induced by <compound-id="91739">quinclorac</compound-id> or <compound-id="54960">bensulfuron-methyl</compound-id> in S. maltophilia WZ2, but not in E. coli K12.	quinclorac__MnSOD__interaction	quinclorac__catalase__interaction	bensulfuron-methyl__MnSOD__interaction	bensulfuron-methyl__catalase__interaction
18304632-1002	Results indicate that <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> has a much weakly role in the defense against <compound-id="91739">quinclorac</compound-id> or <compound-id="54960">bensulfuron-methyl</compound-id> induced oxidative stress, whereas <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> could be critical.	quinclorac__catalase__interaction	bensulfuron-methyl__SOD__interaction	bensulfuron-methyl__catalase__interaction	quinclorac__SOD__interaction
18304748-1077	Moreover, <protein-id="Q99JR5">TARPs</protein-id> (except gamma4) reduce the ion channel block by the synthetic <compound-id="119582,5311197">Joro spider toxin</compound-id> analog <compound-id="129695">1-naphthylacetyl spermine</compound-id> (NASP).	1-naphthylacetyl spermine__TARPs__interaction	Joro spider toxin__TARPs__no_interaction
18306310-763	SMC cultured on P(100/0) films modified by covalently attached <protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id> or fibrin layers proliferated at a rate comparable to that observed on control tissue culture <compound-id="7501">polystyrene</compound-id>.	polystyrene__fibronectin__no_interaction
18306310-764	However, prewetting P(70/30) with a <compound-id="1061,167704,644102">phosphate</compound-id> buffer prior to aminolysis significantly improved cell numbers following immobilization of <protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id>.	phosphate__fibronectin__no_interaction
18308488-862	The dose of <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> (2.5 microg/kg) was chosen to mimic the <compound-id="5754">cortisol</compound-id> concentrations seen during mixing of unfamiliar sows.	cortisol__ACTH__no_interaction
18311594-236	Our data suggest HumDN1 genotypes are related to total <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels in Han Chinese MI patients, but <protein-id="O18998,O42446,P00639,P11936,P11937,P21704,P24855,P49183,Q4AEE3,Q767J3,Q9YGI5">deoxyribonuclease I</protein-id> gene polymorphisms are not associated with susceptibility to MI in Han Chinese.	cholesterol__deoxyribonuclease I__no_interaction
18314895-1018	Specifically, <compound-id="8172">TEG</compound-id> was shown to alter S. mutans gene expression levels of <protein-id="P08987">gtfB</protein-id>, a known virulence factor, and yfiV, a putative <protein-id="Q9CJ45">transcriptional regulator</protein-id> of cell-surface fatty acid genes.	TEG__transcriptional regulator__interaction	TEG__gtfB__interaction
18314898-1022	Degradation analysis over 8 weeks in the presence of 10 mg/L <protein-id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7">lysozyme</protein-id> showed a 50% decrease in total weight and an 80% decrease in <compound-id="36797">PLGA</compound-id> molecular weight.	PLGA__lysozyme__interaction
18317936-346	Fluo-3 staining used in flow cytometry and video microscopy revealed an oxysterol-induced <compound-id="271">Ca(2</compound-id>+) influx, varying according to the oxysterol studied, leading to the activation of the MEK/<protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 pathway as demonstrated by Western blot analysis.	Ca(2__ERK1__interaction
18327670-82	To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic "flare reaction" detected by positron emission tomography (PET) with 2-[(18)F]-fluoro-<compound-id="108223">2-deoxyglucose</compound-id> (FDG), induced by an <compound-id="5757">estradiol</compound-id> challenge, or by <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen-receptor</protein-id> (ER) status, determined by PET with the estrogen analog 16alpha-[(18)F]fluoroestradiol-17beta (FES).	2-deoxyglucose__estrogen-receptor__no_interaction	estradiol__estrogen-receptor__no_interaction
18328561-582	Depletion of <compound-id="124886">GSH</compound-id> levels was accompanied by the induction of <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR) after 24h exposure with each of the four carbamates to CHO-K1 cells.	GSH__glutathione reductase__interaction
18330498-512	<compound-id="2719">Chloroquine</compound-id> and <compound-id="312145">wortmannin</compound-id> inhibited the upregulation induced by <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> stimulation and amino acid deprivation but not that induced by osmotic shock.	Chloroquine__insulin__interaction	wortmannin__insulin__interaction
18330498-513	Moreover, <compound-id="4713">PD98059</compound-id> and <compound-id="8515">SP600125</compound-id> inhibited only amino acid deprivation-induced upregulation and <compound-id="5353940">SB202190</compound-id> inhibited only <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-induced upregulation.	SB202190__insulin__interaction	SP600125__insulin__no_interaction	PD98059__insulin__no_interaction
18331557-1201	The role of phosphorylated <protein-id="P31750,Q8INB9">Akt</protein-id> (p-<protein-id="P31750,Q8INB9">Akt</protein-id>) in oral carcinogenesis induced by <compound-id="942,89594,157672">nicotine</compound-id> and alkaline environments was investigated.	nicotine__Akt__interaction
18336537-456	Sera from a population sample of infants with cryptorchidism (n = 43), hypospadias (n = 41) and controls (n = 113) were analyzed for inhibin B, anti-Mllerian hormone (<protein-id="P03971,P03972,P27106,P49000,P79295">AMH</protein-id>), <compound-id="6013">testosterone</compound-id>, luteinizing hormone (LH), follicle stimulating hormone (FSH) and sex hormone binding globulin (<protein-id="P04278,P08689,P15196,P97497,Q62588">SHBG</protein-id>).	testosterone__AMH__no_interaction	testosterone__SHBG__no_interaction
18340529-389	Myeloperoxidase (<protein-id="P05164,P11247">MPO</protein-id>) is an endogenous oxidant enzyme that generates reactive <compound-id="977">oxygen</compound-id> species (ROS).	oxygen__MPO__interaction
18343629-1064	In present study, we investigated the combined effect of <compound-id="3220">emodin</compound-id> and <compound-id="64982">baicalin</compound-id> on pancreatic damage and pancreatitis associated lung injury, as well as tissue <protein-id="O00206,P58727,Q2V898,Q68Y56,Q8SPE8,Q8SPE9,Q9GL65,Q9MYW3,Q9TSP2,Q9TTN0,Q9WV82">TLR4</protein-id> expression in the setting of AP.	emodin__TLR4__no_interaction	baicalin__TLR4__no_interaction
18343629-1065	The results showed that combination of <compound-id="3220">emodin</compound-id> and <compound-id="64982">baicalin</compound-id> significantly reduced serum amylase, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha and <protein-id="P41693">interleukin-6</protein-id>, attenuated pancreatic and pulmonary damage, also suppressed <protein-id="O00206,P58727,Q2V898,Q68Y56,Q8SPE8,Q8SPE9,Q9GL65,Q9MYW3,Q9TSP2,Q9TTN0,Q9WV82">TLR4</protein-id> expression in pancreas and lung.	baicalin__TLR4__interaction	emodin__TLR4__interaction	emodin__tumor necrosis factor__interaction	baicalin__interleukin-6__interaction	emodin__interleukin-6__interaction	baicalin__tumor necrosis factor__interaction
18346857-498	Results showed that a moderate dose of <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> (250 microg/kg body weight/day) injected during the re-feeding period: (i) promoted the recovery of the regressed ovary as evidenced by an increase in ovary weight and recovery of yellow hierarchical follicles; (ii) elevated the plasma <compound-id="5757">17beta-estradiol</compound-id> (E(2)) level; (iii) increased the mRNA levels of ovary follicle-stimulating hormone receptor (<protein-id="P23945,P32212,P35376,P35379,P47799,P49059,P79763,Q5GJ04,Q6R6L8,Q6YNB6,Q7ZTV5,Q8R428,Q95179">FSHR</protein-id>), <protein-id="O02721,P16235,P16582,P22888,P30730,Q28005,Q28585,Q90674">luteinizing hormone receptor</protein-id> (<protein-id="P16070,P22888,Q28585">LHR</protein-id>) and <protein-id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">estrogen receptor-beta</protein-id> (<protein-id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ER-beta</protein-id>).	17beta-estradiol__LHR__no_interaction	17beta-estradiol__estrogen receptor-beta__no_interaction	17beta-estradiol__luteinizing hormone receptor__no_interaction	17beta-estradiol__ER-beta__no_interaction	17beta-estradiol__FSHR__no_interaction	17beta-estradiol__leptin__interaction
18357521-771	The anti-neoplastic drug <compound-id="4666,36314,441276">taxol</compound-id> binds to <protein-id="O04386,O42786,O44388,O59837,P02554,P02556,P02557,P04107,P05219,P05220,P05304,P08562,P10875,P10876,P10878,P11482,P11833,P11857,P12457,P14140,P14643,P16040,P17938,P18699,P18700,P20365,P20802,P21148,P22012,P22852,P24637,P28551,P30668,P32256,P33127,P34108,P35394,P41352,P41385,P41386,P41387,P41388,P41741,P41742,P41799,P53373,P53374,P53375,P53376,P79008,P93176,Q00264,Q04709,Q08115,Q24829,Q27380,Q2U2U3,Q39445,Q3KVN1,Q4HZS8,Q4P235,Q4R9N3,Q4WA70,Q52NY7,Q5UBX3,Q6QDC9,Q7KQL5,Q86ZP5,Q8SS99,Q8WZE0,Q91240,Q92268,Q96TU8,Q9GSR5,Q9HFQ3,Q9LKI8,Q9N2N6,Q9UV72">beta-tubulin</protein-id> to prevent tumor cell division, promoting cell death.	taxol__beta-tubulin__interaction
18357521-772	In the current study, we knocked down <protein-id="P10417,P49950">Bcl-2</protein-id> expression using cognate siRNA during low-dose <compound-id="4666,36314,441276">taxol</compound-id> treatment to induce apoptosis in two human glioblastoma U138MG and U251MG cell lines.	taxol__Bcl-2__interaction
18357521-773	The cells were treated with either 100 nM <compound-id="4666,36314,441276">taxol</compound-id> or 100 nM Bcl-2 siRNA or both for 72 h. Immunofluorescent stainings for calpain and active caspase-3 showed increases in expression and co-localization of these <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</protein-id> in apoptotic cells.	taxol__proteases__interaction
18357521-774	Our current study demonstrated that Bcl-2 siRNA significantly augmented <compound-id="4666,36314,441276">taxol</compound-id> mediated apoptosis in different human glioblastoma cells through induction of <protein-id="P27730">calpain</protein-id> and caspase proteolytic activities.	taxol__calpain__interaction
18357522-775	Based on these findings, altered expression of <protein-id="P04116,P23289,P23294,P47789,P47790,P60201,Q04004,Q08868,Q8HXW7">PLP1</protein-id> in most areas of the striatum suggests that widespread changes to the myelin structure could be associated with the adaptive changes following chronic <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id> abuse.	cocaine__PLP1__interaction
18359113-478	No correlation was detected between serum <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> level and <compound-id="5280795">vitamin D</compound-id>-25(OH)D3, which was under normal range in 60% of the patients.	vitamin D__leptin__no_interaction
18359113-479	The higher <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> levels in women was accompanied by higher serum levels of <compound-id="206,5793,64689,79025">glucose</compound-id>, albumin, Ca, <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, <compound-id="923,373840">Na</compound-id> and FT4.	cholesterol__leptin__no_interaction	Na__leptin__no_interaction	glucose__leptin__no_interaction
18359113-480	Comparison of 50 patients with the lowest <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> levels (mean of 3.4ng/ml) to 50 patients with highest <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> levels (mean of 34ng/ml), did not indicate differences in both <compound-id="5283731">25(OH)D3</compound-id> and ICTP between these two populations in spite of the highly significant difference in <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> levels.	25(OH)D3__leptin__no_interaction
18363836-902	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus <protein-id="P08163">glycoprotein</protein-id> (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after <compound-id="5287620">Brefeldin A</compound-id> treatment and inhibition of cargo concentration of the neuronal glutamate transporter <protein-id="P31597,P43005,P51906,P51907,Q95135">excitatory amino-acid carrier 1</protein-id> (<protein-id="P31597,P43005,Q95135">EAAC1</protein-id>) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of <protein-id="P62821,Q4UB16,Q6NYB7,Q9TVU5">Rab1</protein-id>.	Brefeldin A__excitatory amino-acid carrier 1__no_interaction	Brefeldin A__glycoprotein__no_interaction	Brefeldin A__Rab1__no_interaction	Brefeldin A__EAAC1__no_interaction
18367388-537	<compound-id="445154">Resveratrol</compound-id> did not attenuate GA-induced generation of <compound-id="784">hydrogen peroxide</compound-id>, but it did block GA-induced phosphorylation of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">connexin 43</protein-id> (<protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id>), a key modulator of GJIC.	hydrogen peroxide__Cx43__no_interaction	Resveratrol__Cx43__interaction	hydrogen peroxide__connexin 43__no_interaction	Resveratrol__connexin 43__interaction
18367388-538	Furthermore, <compound-id="445154">resveratrol</compound-id> down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (<protein-id="P29323">ERK</protein-id>)1/2, one of the critical regulators of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id>.	resveratrol__ERK__interaction	resveratrol__Cx43__interaction
18368465-1220	<compound-id="3009">DFMO</compound-id> accumulated cells in S phase of the cell cycle and reduced <protein-id="P20248,P30274,P37881,P43449,P51943,Q92161">cyclin A</protein-id> expression.	DFMO__cyclin A__interaction
18368485-1240	Indeed, treatment of cells with 1 muM <compound-id="444795">all-trans retinoic acid</compound-id> (<compound-id="444795">ATRA</compound-id>) or 1 muM 13-cis <compound-id="444795">retinoic acid</compound-id> (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary <protein-id="P01538,P01543,P01544,P01545,P08772,P08943,P09617,P09618,P21742,P32032,Q05806,Q42596,Q42597,Q42838,Q8H0Q5,Q8VZK8,Q9C8D6,Q9SBK8">acidic protein</protein-id> (<protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id>) and down regulation of telomerase activity.	all-trans retinoic acid__acidic protein__interaction	retinoic acid__GFAP__interaction	all-trans retinoic acid__GFAP__interaction	ATRA__acidic protein__interaction	retinoic acid__acidic protein__interaction	ATRA__GFAP__interaction
18368485-1241	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>), and production of <compound-id="145068">nitric oxide</compound-id> (NO) so as to increase sensitivity to <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> for apoptosis.	nitric oxide__nitric oxide synthase__no_interaction	nitric oxide__IFN-gamma__no_interaction	nitric oxide__iNOS__no_interaction
18371961-849	Because <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</protein-id> binds <compound-id="445141,6323481,44147587">phosphatidylserine</compound-id>, this study is using this feature to select functional spermatozoa.	phosphatidylserine__annexin V__interaction
18373731-672	<compound-id="65137">Cyclo(His-Pro</compound-id>) promotes cytoprotection by activating <protein-id="O54968,Q60795">Nrf2</protein-id>-mediated up-regulation of antioxidant defence.	Cyclo(His-Pro__Nrf2__interaction
18373731-674	Here, we addressed this issue and found that <compound-id="65137">cyclo(His-Pro</compound-id>) triggered nuclear accumulation of <protein-id="O54968,Q16236,Q60795">NF-E2-related factor-2</protein-id> (<protein-id="O54968,Q60795">Nrf2</protein-id>), a transcription factor that up-regulates antioxidant-/electrophile-responsive element (ARE-EpRE)-related genes, in PC12 cells.	cyclo(His-Pro__NF-E2-related factor-2__interaction	cyclo(His-Pro__Nrf2__interaction
18374997-195	In women, <protein-id="P20918,Q01177">Plg</protein-id> levels were higher in individuals with diagnosed ischemic heart disease (IHD) and increased with triglycerides (TG) and <compound-id="206,5793,64689,79025">glucose</compound-id> level.	glucose__Plg__interaction
18375536-500	To investigate overnight variations in absolute values and patterns of cytokines including <protein-id="P41693">interleukin 6</protein-id> (<protein-id="O35736,P05231,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL6</protein-id>) and tumour necrosis factor alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id>) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood <compound-id="5754">cortisol</compound-id>.	cortisol__IL6__interaction	cortisol__TNFalpha__interaction	cortisol__interleukin 6__interaction
18378405-1044	Using a cell culture model of synaptic NMDA receptor-dependent synaptic potentiation, we find that this is mediated exclusively by NR2B-containing <protein-id="P35439,Q9R1M7">N-methyl-D-aspartate receptors</protein-id>, as implicated by NR2B-specific antagonists and the use of selective vs. non-selective doses of the NR2A-preferring antagonist <compound-id="4463">NVP</compound-id>-AAM077.	NVP__N-methyl-D-aspartate receptors__no_interaction
18379782-593	<compound-id="30623,71384">Dexrazoxane</compound-id> protects against doxorubicin-induced cardiomyopathy: upregulation of <protein-id="P31750,Q8INB9">Akt</protein-id> and Erk phosphorylation in a rat model.	Dexrazoxane__Akt__no_interaction
18380536-252	Intracellular oxidative status was assessed by analysis of <compound-id="124886">GSH</compound-id>/<compound-id="65359">GSSG</compound-id> levels and time course of ROS production and <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR) activity.	GSH__glutathione reductase__no_interaction	GSSG__glutathione reductase__no_interaction
18380539-1099	A recently discussed cardiovascular risk factor, <compound-id="123831">asymmetric dimethylarginine</compound-id> (<compound-id="123831">ADMA</compound-id>), is known to act as an endogenous inhibitor of endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id>.	ADMA__nitric oxide synthase__interaction	asymmetric dimethylarginine__nitric oxide synthase__interaction
18380542-1100	The net exercise-induced increase in 6-keto-<protein-id="P49763,Q9XS47">PGF</protein-id> (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma <compound-id="612">lactate</compound-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> or <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> concentrations).	lactate__TNF-alpha__no_interaction	lactate__IL-6__no_interaction	lactate__PGF__no_interaction
18380545-1104	Adenosine A(3) receptor agonist N(6)-(3-iodobenzyl) adenosine-5 '-N-methyluronamide (<compound-id="123683">IB-MECA</compound-id>) has been tested from the point of view of potentiating the effects of <protein-id="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4">hematopoietic growth factors</protein-id> interleukin-3 (<protein-id="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4">IL-3</protein-id>), <protein-id="P20826,P21581,P21583,P79169,P79368,Q06220,Q09108,Q28132,Q29030,Q90314,Q95M19,Q95MD2,Q95N18">stem cell factor</protein-id> (<protein-id="P20826,P21581,P21583,P79169,P79368,Q06220,Q09108,Q28132,Q29030,Q90314,Q95M19,Q95MD2,Q95N18">SCF</protein-id>), <protein-id="P48750">granulocyte-macrophage colony-stimulating factor</protein-id> (<protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">GM-CSF</protein-id>), and <protein-id="P35834,Q28746">granulocyte colony-stimulating factor</protein-id> (<protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id>) on the growth of hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC) in suspension of normal mouse bone marrow cells in vitro.	IB-MECA__granulocyte-macrophage colony-stimulating factor__interaction	IB-MECA__hematopoietic growth factors__interaction	IB-MECA__G-CSF__interaction	IB-MECA__granulocyte colony-stimulating factor__interaction	IB-MECA__IL-3__interaction	IB-MECA__SCF__interaction	IB-MECA__stem cell factor__interaction	IB-MECA__GM-CSF__interaction
18380545-1105	Significant elevation of numbers of GM-CFC evoked by the combinations of <compound-id="123683">IB-MECA</compound-id> with <protein-id="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4">IL-3</protein-id>, <protein-id="P20826,P21581,P21583,P79169,P79368,Q06220,Q09108,Q28132,Q29030,Q90314,Q95M19,Q95MD2,Q95N18">SCF</protein-id>, or GM-CSF as compared with these growth factors alone has been noted.	IB-MECA__SCF__no_interaction	IB-MECA__IL-3__no_interaction
18380545-1106	Combination of <compound-id="123683">IB-MECA</compound-id> with <protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id> did not induce significantly higher numbers of GM-CFC in comparison with <protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id> alone.	IB-MECA__G-CSF__no_interaction
18380545-1107	Joint action of three drugs, namely of <compound-id="123683">IB-MECA</compound-id>+ <protein-id="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4">IL-3</protein-id>+ <protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">GM-CSF</protein-id>, produced significantly higher numbers of GM-CFC in comparison with the combinations of <compound-id="123683">IB-MECA</compound-id>+ <protein-id="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4">IL-3</protein-id>, <compound-id="123683">IB-MECA</compound-id>+ <protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">GM-CSF</protein-id>, or <protein-id="P01586,P04823,P06740,P08700,P25140,P49875,P51445,Q06435,Q28334,Q28809,Q9BDX4">IL-3</protein-id>+ <protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">GM-CSF</protein-id>.	IB-MECA__GM-CSF__no_interaction	IB-MECA__IL-3__no_interaction
18381637-476	Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-like growth factor-1 (<protein-id="Q95222">IGF-1</protein-id>), transforming growth factor-beta1 (<protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</protein-id>), or a combination of both growth factors were mixed with OPF, a <compound-id="16212859">poly(ethylene glycol)-diacrylate</compound-id> crosslinker and the radical initiators ammonium persulfate and <compound-id="8037">N,N,N',N'-tetramethylethylenediamine</compound-id>, and then crosslinked at 37 degrees C for 8 min to form hydrogel composites.	N,N,N',N'-tetramethylethylenediamine__TGF-beta1__interaction	N,N,N',N'-tetramethylethylenediamine__IGF-1__interaction	poly(ethylene glycol)-diacrylate__TGF-beta1__no_interaction	N,N,N',N'-tetramethylethylenediamine__insulin__interaction	poly(ethylene glycol)-diacrylate__IGF-1__no_interaction	poly(ethylene glycol)-diacrylate__insulin__no_interaction
18381638-477	<protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">Fibronectin</protein-id> modulates osteoblast behavior on <compound-id="3081502">Nitinol</compound-id>.	Nitinol__Fibronectin__interaction
18384163-783	Real-time RT-PCR showed that the expression of osteoblast marker genes such as <protein-id="Q08775,Q13950,Q9XSB7,Q9Z2J9">CBFalpha1</protein-id> and <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> was increased in <compound-id="24759,453618,3084050,24728612">hyaluronic acid</compound-id>-based hydrogel, and the expression level was dependent on the molecular weight of <compound-id="24759,453618,3084050,24728612">hyaluronic acid</compound-id>, <compound-id="104802">RGD peptide</compound-id>, and <protein-id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</protein-id>.	RGD peptide__alkaline phosphatase__interaction	RGD peptide__BMP-2__no_interaction	hyaluronic acid__alkaline phosphatase__interaction	RGD peptide__CBFalpha1__interaction	hyaluronic acid__BMP-2__no_interaction	hyaluronic acid__CBFalpha1__interaction
18386138-732	Treatment of H9c2 cell with low concentrations of Dox causes alterations in fibrous <protein-id="Q04765,Q04766">structural proteins</protein-id> including the nuclear lamina and sarcomeric cardiac myosin, as well as mitochondrial depolarization and fragmentation, membrane blebbing with cell shape changes, and <compound-id="445141,6323481,44147587">phosphatidylserine</compound-id> externalization.	phosphatidylserine__structural proteins__no_interaction
18387753-460	We monitored <protein-id="P28246,P45123">bcr</protein-id>-<protein-id="P00520,P00522">abl</protein-id> transcript levels by quantitative real time PCR in 50 tunisian patients treated with <compound-id="5291">imatinib</compound-id> for chronic myeloid leukemia in chronic phase for a median of 29 months (3-60) after they started <compound-id="5291">imatinib</compound-id>.	imatinib__abl__no_interaction	imatinib__bcr__no_interaction
18389169-121	The non-covalent interaction of <compound-id="5483782,6085493">brilliant red</compound-id> (BR) with <protein-id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7">lysozyme</protein-id> was investigated by the UV spectrometry, circular dichroism (CD) and isothermal titration calorimetry (ITC).	brilliant red__lysozyme__interaction
18390571-968	Recent studies suggest that crystals of <compound-id="1175">monosodium urate</compound-id> (MSU), deposited in joints of patients with acute gouty arthritis, activate the NACHT domain, <compound-id="857,6106,439524">leucine</compound-id>-rich repeat and <protein-id="O15553,Q9JJ25,Q9JJ26">pyrin</protein-id> domain-containing protein (NALP)3 inflammasome.	leucine__pyrin__no_interaction	monosodium urate__pyrin__interaction
18393628-298	<compound-id="942,89594,157672">Nicotine</compound-id>, <compound-id="9308">muscarine</compound-id>, and <compound-id="2730">chlorpyrifos</compound-id> induced the phosphorylation of <protein-id="P21708,P27361,P28869,P42525,Q63844">extracellular signal-regulated kinases 1</protein-id> and 2.	muscarine__extracellular signal-regulated kinases 1__interaction	chlorpyrifos__extracellular signal-regulated kinases 1__interaction	Nicotine__extracellular signal-regulated kinases 1__interaction
18393672-326	Adult bone marrow (BM)-derived <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-producing cells (IPCs) are capable of regulating blood <compound-id="206,5793,64689,79025">glucose</compound-id> levels in chemically induced hyperglycemic mice.	glucose__insulin__interaction
18393672-328	Treatment with <compound-id="3032771">benfotiamine</compound-id> activated glucose metabolism in INS-1 cells in high-<compound-id="206,5793,64689,79025">glucose</compound-id> culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>.	benfotiamine__insulin__interaction	glucose__insulin__no_interaction
18393672-329	<compound-id="3032771">Benfotiamine</compound-id> was not shown to induce the glucose receptor <protein-id="P12336,P14246">Glut-2</protein-id>, however it was shown to activate <protein-id="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0">glucokinase</protein-id>, the enzyme responsible for conversion of glucose to <compound-id="5958,439284,439427,439958">glucose-6-phosphate</compound-id>.	glucose-6-phosphate__glucokinase__interaction	glucose-6-phosphate__Glut-2__interaction	Benfotiamine__glucokinase__no_interaction	Benfotiamine__Glut-2__no_interaction
18393672-330	However, in cells where the pentose phosphate pathway was blocked by <compound-id="8682">oxythiamine</compound-id> treatment, there was a clear downregulation of <protein-id="P12336,P14246">Glut-2</protein-id>, <protein-id="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0">glucokinase</protein-id>, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, and <protein-id="O01360,O13507,O27090,O28542,O32755,O34425,O42259,O52631,O57479,O57672,O59494,O59841,O67161,O83816,O96423,P00355,P00356,P00357,P00361,P00362,P04406,P04797,P08439,P09124,P09316,P09317,P0A1P0,P0A1P1,P0C0G6,P0C0G7,P10096,P10097,P10618,P15115,P16858,P17244,P17721,P19089,P19314,P19315,P20287,P20445,P22512,P22513,P23722,P24163,P24164,P24166,P24746,P24748,P24749,P24750,P24751,P24753,P25861,P26518,P26519,P26520,P26521,P26988,P27726,P28844,P29272,P29497,P32637,P32638,P34783,P35143,P39460,P44304,P46406,P46713,P46795,P46796,P47543,P48812,P51009,P51469,P51640,P52694,P52987,P53429,P53430,P54117,P54118,P54226,P55070,P55071,P55971,P56649,P57384,P58839,P61879,P61880,P64178,P64179,P68777,P70685,P75358,P80447,P80534,P83601,P87197,P94915,Q00301,Q00584,Q00640,Q01558,Q01597,Q01651,Q01982,Q05025,Q07234,Q12552,Q1DTF9,Q27652,Q27890,Q28259,Q28554,Q2NEN0,Q3IUT3,Q46450,Q48335,Q4J940,Q4KYY3,Q58546,Q59199,Q59309,Q59800,Q59906,Q5JHB5,Q5R2J2,Q5RAB4,Q5V061,Q5XDW3,Q6BMK0,Q6CCU7,Q6L125,Q6M0E6,Q757I2,Q89AK1,Q8J1H3,Q8K8M9,Q8NK47,Q8PTD3,Q8TFJ2,Q8WZN0,Q8X1X3,Q8ZWK7,Q92211,Q92243,Q92263,Q94469,Q96US8,Q971K2,Q97BJ8,Q9HFX1,Q9HGY7,Q9HJ69,Q9HSS7,Q9N2D5,Q9N655,Q9P8C0,Q9PJN6,Q9UR38,Q9UVC0,Q9UW96,Q9V1P1,Q9Y796,Q9Y8E9,Q9YFS9,Q9Z518,Q9Z7T0,Q9ZKT0">GAPDH</protein-id>.	oxythiamine__GAPDH__interaction	oxythiamine__glucokinase__interaction	oxythiamine__insulin__interaction	oxythiamine__Glut-2__interaction
18394828-1061	) and two <compound-id="977">oxygen</compound-id> tensions (5 and 20%) were compared for their ability to sustain blastocyst survival and <protein-id="O46633,P28171,P28172,Q95187">IFNT</protein-id> production from days 8 to 11 post-insemination.	oxygen__IFNT__interaction
18394828-1062	In conclusion, culturing blastocysts of cattle in a 5% <compound-id="977">oxygen</compound-id> environment with M199 containing serum sustains embryo viability and permits constitutive and inducible <protein-id="O46633,P28171,P28172,Q95187">IFNT</protein-id> production.	oxygen__IFNT__interaction
18394828-1063	Incubation in 20% <compound-id="977">oxygen</compound-id> increases <protein-id="O46633,P28171,P28172,Q95187">IFNT</protein-id> production.	oxygen__IFNT__interaction
18395421-172	Histologic examination investigated deposition of extracellular matrix (<protein-id="Q13201">ECM</protein-id>) including collagen, <protein-id="P11547">elastin</protein-id>, <compound-id="24759,453618,3084050,24728612">hyaluronic acid</compound-id> (HA), <protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id>, and decorin in the lamina propria of the scarred vocal folds.	hyaluronic acid__fibronectin__no_interaction	hyaluronic acid__elastin__no_interaction	hyaluronic acid__ECM__no_interaction
18396353-715	A series of novel bis-pyridinium oximes connected by bis-<compound-id="10869">methoxymethyl benzene</compound-id>, 1,4-bis-methoxymethyl (cis)-but-2-ene and 1,4-bis-methoxymethyl but-2-yne linkers were synthesized and their in vitro reactivation efficacy was evaluated against <compound-id="5936">diisopropyl phosphorofluoridate</compound-id> (DFP) inhibited <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (<protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>) and compared with the established antidote 2-PAM and <compound-id="107688">obidoxime</compound-id>.	methoxymethyl benzene__acetylcholinesterase__no_interaction	methoxymethyl benzene__AChE__no_interaction	diisopropyl phosphorofluoridate__AChE__no_interaction	obidoxime__acetylcholinesterase__no_interaction	obidoxime__AChE__no_interaction	diisopropyl phosphorofluoridate__acetylcholinesterase__no_interaction
18396355-716	In-vitro regeneration of <compound-id="7871">sarin</compound-id> inhibited electric eel <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> by bis-pyridinium oximes bearing <compound-id="7237">xylene</compound-id> linker.	sarin__acetylcholinesterase__interaction	xylene__acetylcholinesterase__no_interaction
18396355-717	A series of bis-pyridinium oximes connected by <compound-id="7237">xylene</compound-id> linker were synthesized and their in-vitro reactivation potential was evaluated against <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (<protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>) inhibited by nerve agent, <compound-id="7871">sarin</compound-id>.	xylene__acetylcholinesterase__no_interaction	sarin__acetylcholinesterase__interaction	xylene__AChE__no_interaction	sarin__AChE__interaction
18396355-718	Among the synthesized compounds, alpha,alpha'xylene-bis-[3,3'-(hydroxyiminomethyl) pyridinium] dibromide (3b) was found to be most potent reactivator for <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> inhibited by <compound-id="7871">sarin</compound-id>.	sarin__AChE__interaction
18396356-720	Of the compounds synthesized, <compound-id="398803">compound 2a</compound-id>, which has a primary amide at warhead region of the inhibitor most potently inhibited mu-<protein-id="P27730">calpain</protein-id> with an IC(50) value of 2.81+/-1.26 microM, which is ca.	compound 2a__calpain__interaction
18397836-365	Recent studies have focused on possible functional disorders of the enteric nervous system within the abomasal wall, since cattle with abomasal displacement have an increased activity of neuronal <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id>, as well as decreased <compound-id="187">acetylcholine</compound-id> sensitivity.	acetylcholine__nitric oxide synthase__no_interaction
18397960-447	Earlier publications have suggested a possible role for the efflux transporter <protein-id="Q9UNQ0">breast cancer resistance protein</protein-id> (<protein-id="Q9UNQ0">BCRP</protein-id>) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as <compound-id="3899">leflunomide</compound-id> and its metabolite <compound-id="54684141">A771726</compound-id> (<compound-id="54684141">teriflunomide</compound-id>).	teriflunomide__BCRP__interaction	leflunomide__BCRP__interaction	A771726__breast cancer resistance protein__interaction	leflunomide__breast cancer resistance protein__interaction	teriflunomide__breast cancer resistance protein__interaction	A771726__BCRP__interaction
18398609-866	Inhibition of <protein-id="P0ABF6,P0ABF7,P19079,P32320,P44325,P47298,P47718,P56389,P75051,Q06549,Q322V3,Q32EM3,Q3IBX5,Q3Z062,Q4QK60,Q57MF5,Q5E4R6,Q5PE68,Q65RG8,Q66C79,Q6D3B4,Q6LRI0,Q7MK48,Q7N6K3,Q7VMJ6,Q87Q52,Q8DA31,Q8EDG1,Q8FFV3,Q8X648,Q8Z5A8,Q8ZG08,Q8ZNM0,Q9CP11,Q9KD53,Q9KSM5,Q9S3M0">cytidine deaminase</protein-id> by <compound-id="100016,328839,16760709,46783268">zebularine</compound-id> enhances the antineoplastic action of <compound-id="451668">5-aza-2'-deoxycytidine</compound-id>.	5-aza-2'-deoxycytidine__cytidine deaminase__interaction	zebularine__cytidine deaminase__interaction
18398611-867	An individual's response to <compound-id="657237">fludarabine</compound-id> may be influenced by the amount of <protein-id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</protein-id> (+) and CD8(+) T-lymphocyte suppression.	fludarabine__CD4__interaction
18398624-876	We hypothesise that <compound-id="24325">arginine aspartate</compound-id> acts as a chemical or pharmacological chaperone, and suggest amino acid supplementation as a possible therapy in <protein-id="P08559,P29804,P49823,Q5R490,Q8HXW9">PDHA1</protein-id> mutations with mild phenotypes.	arginine aspartate__PDHA1__no_interaction
18400050-469	mRNA expressions of matrix metallopeptidase-9, inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> and pro-inflammatory cytokines interleukin-1 beta and tumour necrosis factor-alpha in EAN sciatic nerves were greatly decreased by administration of <compound-id="54675783">minocycline</compound-id> as well.	minocycline__nitric oxide synthase__interaction
18400404-699	Then the review evaluates the involvement of <protein-id="O70503,Q4R5G7,Q53GQ0,Q5E9H7,Q6P7R8">KARs</protein-id> activated by the endogenous agonist <compound-id="611,23327,33032">glutamate</compound-id> in the generation and propagation of epileptiform activity.	glutamate__KARs__interaction
18403016-272	<protein-id="O68838,P0A6W9,P0A6X0,P32477,P57485,P58994,P61379,Q09768,Q20117,Q57KV3,Q5E7F8,Q5LYY5,Q5M3J8,Q5PF10,Q65RX0,Q66E64,Q6ANW2,Q6D1T4,Q6LMV1,Q71VZ1,Q72RD4,Q7MHS5,Q7N7A4,Q7W3F2,Q7WES2,Q82ZG8,Q87LS2,Q88AR1,Q88R90,Q88UW5,Q89AD8,Q8D2V5,Q8DC38,Q8DW15,Q8DXM9,Q8E399,Q8EBF9,Q8F4D5,Q8X0X0,Q8X900,Q8XK30,Q8Y3R3,Q8Z4D6,Q8ZBU2,Q926X7,Q97IV1,Q9CM00,Q9HF78,Q9HTY6,Q9KUG5,Q9NFN6,Q9W3K5">Glutamate cysteine ligase</protein-id> (<protein-id="P28676,Q8NEA9,Q96IK5">GCL</protein-id>), synthesizing <compound-id="123938">gamma-glutamylcysteine</compound-id> from <compound-id="611,23327,33032">glutamate</compound-id> and <compound-id="594,5862,5360637">cysteine</compound-id>, is the rate-limiting enzyme in <compound-id="124886">glutathione</compound-id> (<compound-id="124886">GSH</compound-id>) biosynthesis.	cysteine__GCL__interaction	GSH__GCL__interaction	glutamate__Glutamate cysteine ligase__interaction	gamma-glutamylcysteine__GCL__interaction	gamma-glutamylcysteine__Glutamate cysteine ligase__interaction	glutamate__GCL__interaction	cysteine__Glutamate cysteine ligase__interaction	glutathione__Glutamate cysteine ligase__interaction	glutathione__GCL__interaction	GSH__Glutamate cysteine ligase__interaction
18403053-226	We observed that <compound-id="3870,3034764,6610292">lactacystin</compound-id> inhibited the proteasome activities and increased the level and insolubility of different <protein-id="P10637,P16525,P19332,P58384">tau</protein-id> species, including phosphorylated <protein-id="P10637,P16525,P19332,P58384">tau</protein-id>.	lactacystin__tau__interaction
18404246-532	Serine and cysteine <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</protein-id> proved to be suitable tools for the production of amino acids and peptides conjugated to <compound-id="2151">4-aminoantipyrine</compound-id>, whereas metalloproteases do not seem to be very qualified for accepting this nucleophile.	4-aminoantipyrine__proteases__interaction
18405417-151	Role of serotonin <protein-id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</protein-id> receptors in the antidepressant-like effect and the antinociceptive effect of <compound-id="5656">venlafaxine</compound-id> in mice.	venlafaxine__5-HT1A__interaction
18405417-152	The present study was undertaken to evaluate the potential role of <protein-id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</protein-id> receptors in the antidepressant-like effect and antinociceptive effect of <compound-id="5656">venlafaxine</compound-id>.	venlafaxine__5-HT1A__interaction
18405417-154	These findings show that <protein-id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</protein-id> receptors play differing roles in modulating the antidepressant-like and antinociceptive effects of <compound-id="5656">venlafaxine</compound-id> in the models investigated.	venlafaxine__5-HT1A__interaction
18405417-155	In contrast, the antinociceptive effect of <compound-id="5656">venlafaxine</compound-id> is probably potentiated due to the blockade of somatodendritic <protein-id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</protein-id> receptors in the same raphe nuclei, facilitating the descending monoaminergic pain control system.	venlafaxine__5-HT1A__interaction
18407279-655	Moreover, <protein-id="P05804">beta-glucuronidase</protein-id> hydrolysis of <compound-id="64982">baicalin</compound-id> sequentially yielded glucuronic acid and <compound-id="5281605">baicalein</compound-id> as confirmed by co-TLC with authentic samples.	baicalein__beta-glucuronidase__interaction	baicalin__beta-glucuronidase__interaction
18407527-68	The effect of this diet alone or after 2 weeks of treatment with <compound-id="77999">rosiglitazone</compound-id> or <compound-id="3476">glimepiride</compound-id> on glucose homeostasis, lipid profile, and levels of resistin and <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> was studied.	rosiglitazone__leptin__interaction	glimepiride__leptin__interaction
18407527-71	<compound-id="77999">Rosiglitazone</compound-id> corrected the altered parameters measured, except for liver <compound-id="2724387">TGs</compound-id> ; similarly, <compound-id="3476">glimepiride</compound-id> reinstated the inverted parameters but raised <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> level and, consequently, the HOMA index.	glimepiride__insulin__interaction	Rosiglitazone__insulin__no_interaction	TGs__insulin__no_interaction
18409068-1012	<compound-id="10302451">AZD0530</compound-id> inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of <protein-id="Q00944,Q05397">FAK</protein-id> and <protein-id="P49023,P49024,Q5R7I1,Q66H76,Q8VI36">paxillin</protein-id> in a dose-dependent manner in a Calu-6 xenograft model.	AZD0530__FAK__interaction	AZD0530__paxillin__interaction
18409071-995	Activation of ErbB3, <protein-id="P00533,P13387,P55245">EGFR</protein-id> and Erk is essential for growth of human breast cancer cell lines with acquired resistance to <compound-id="104741">fulvestrant</compound-id>.	fulvestrant__EGFR__no_interaction
18409071-997	Treatment with the EGFR inhibitor <compound-id="123631">gefitinib</compound-id> preferentially inhibited growth and reduced the S phase fraction in the resistant cell lines concomitant with inhibition of Erk and unaltered <protein-id="P31750,Q8INB9">Akt</protein-id> activation.	gefitinib__Akt__no_interaction
18410309-540	<compound-id="896">Melatonin</compound-id> protects from hepatic reperfusion injury through inhibition of IKK and <protein-id="P92208,Q966Y3">JNK</protein-id> pathways and modification of cell proliferation.	Melatonin__JNK__interaction
18410309-541	<compound-id="896">Melatonin</compound-id> significantly improved animal survival and decreased transaminase levels, the indices for necrosis, liver damage, leukocyte infiltration, and <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> expression.	Melatonin__iNOS__interaction
18410309-542	At the same time, <compound-id="896">melatonin</compound-id> reduced the expression of both <protein-id="O01377,O02115,O10308,O16852,O27367,O29912,O58398,O73947,O82134,O82797,P04961,P11038,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00265,Q00268,Q03392,Q43124,Q43266,Q57697,Q6B6N4,Q6KZF1,Q6LWJ8,Q74MV1,Q7T6Y0,Q8PX25,Q8TUF7,Q8TWK3,Q979S2,Q9DDF1,Q9DEA3,Q9HJQ0,Q9HN45,Q9M7Q7,Q9MAY3,Q9P9H8,Q9PTP1,Q9UWR9,Q9UYX8,Q9W644">PCNA</protein-id> 0.05).	melatonin__PCNA__interaction
18410309-543	<compound-id="896">Melatonin</compound-id> is hepatoprotective most likely via mechanisms including inhibition of IKK and <protein-id="P92208,Q966Y3">JNK</protein-id> pathways and regulation of cell proliferation.	Melatonin__JNK__interaction
18410522-611	Here, we report that the citrus <compound-id="5280805">bioflavonoid</compound-id> <compound-id="5280445">luteolin</compound-id> reduces amyloid-beta (Abeta) peptide generation in both human 'Swedish' mutant <protein-id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</protein-id> transgene-bearing neuron-like cells and primary neurons.	luteolin__APP__no_interaction	bioflavonoid__APP__no_interaction
18410522-612	We also find that <compound-id="5280445">luteolin</compound-id> induces changes consistent with <protein-id="P51136,P83101">GSK-3</protein-id> inhibition that (i) decrease amyloidogenic gamma-secretase <protein-id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</protein-id> processing, and (ii) promote <protein-id="O12976,P49768,P49769,P79802,P97887,Q4JIM4,Q5R780,Q6RH31,Q8HXW5,Q9W6T7,Q9XT97">presenilin-1</protein-id> (<protein-id="P49768,P79802,Q8HXW5,Q9W6T7">PS1</protein-id>) carboxyl-terminal fragment (CTF) phosphorylation.	luteolin__APP__interaction	luteolin__presenilin-1__interaction	luteolin__PS1__interaction	luteolin__GSK-3__interaction
18410522-613	As validation of these findings in vivo, we find that <compound-id="5280445">luteolin</compound-id>, when applied to the Tg2576 mouse model of AD, decreases soluble Abeta levels, reduces <protein-id="P51136,P83101">GSK-3</protein-id> activity, and disrupts <protein-id="P49768,P79802,Q8HXW5,Q9W6T7">PS1</protein-id>-<protein-id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</protein-id> association.	luteolin__APP__interaction	luteolin__PS1__interaction	luteolin__GSK-3__interaction
18410527-619	Since <compound-id="5280353,5315455,5353439,6183357">biliverdin</compound-id> and <compound-id="5280352">bilirubin</compound-id> are downstream products of <compound-id="4971">heme</compound-id> degradation by <protein-id="O19998,O73688,O78497,P51271,P71119">heme oxygenase</protein-id> (HO), it has been suggested that HO-activity protects against curcumin-induced apoptosis.	bilirubin__heme oxygenase__interaction	heme__heme oxygenase__interaction	biliverdin__heme oxygenase__interaction
18410529-629	Here, we examine the effect of resistin on <compound-id="206,5793,64689,79025">glucose</compound-id> uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by <protein-id="P23586">glucose transporter</protein-id> (GLUT)-1.	glucose__glucose transporter__no_interaction
18410529-630	<protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id> and 2 activation stimulated <protein-id="P79365">GLUT-1</protein-id> synthesis and resulted in increase of placental <compound-id="206,5793,64689,79025">glucose</compound-id> uptake.	glucose__GLUT-1__interaction	glucose__ERK1__interaction
18410529-631	High resistin levels (50-100 ng/ml) seem able to affect <compound-id="206,5793,64689,79025">glucose</compound-id>-uptake, presumably by decreasing the cell surface <protein-id="P23586">glucose transporter</protein-id>.	glucose__glucose transporter__interaction
18410530-134	<compound-id="6804">CpG</compound-id> methylation as well as histone H3 methylation of lysines 9 and 27 contribute independently to <protein-id="O48920,P34727,P34728,P51823,Q94650">ARF</protein-id> gene silencing in adenocarcinoma cell lines and can be reversed by <compound-id="451668">5-aza-2'-deoxycytidine</compound-id>.	CpG__ARF__interaction	5-aza-2'-deoxycytidine__ARF__interaction
18410982-929	<compound-id="79101">Gly-Pro</compound-id>-, <compound-id="79101">Gly-Pro</compound-id>-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)-hydrazides are synthesized by <compound-id="3520">guanidinium</compound-id>/uronium type condensing reagent and used as fluorogenic substrates to localize <protein-id="P14740,P22411,P27487,P28843,P81425,Q9N2I7">dipeptidyl peptidase IV</protein-id> and <protein-id="O14773,O89023,Q5IS74,Q5RFL1,Q60HH1,Q71JP6,Q9EQV6,Q9XSB8">tripeptidyl peptidase I</protein-id> activities in mammalian tissue sections.	Gly-Pro__dipeptidyl peptidase IV__interaction	guanidinium__dipeptidyl peptidase IV__interaction	Gly-Pro__tripeptidyl peptidase I__interaction	guanidinium__tripeptidyl peptidase I__interaction
18413191-1010	However, increased blood <compound-id="206,5793,64689,79025">glucose</compound-id> (200 mg/dl) significantly impaired the inhibitory effect of ASA (84% for <protein-id="P08514,P53711,Q9QUM0">GPIIb</protein-id>.005; 48% for P-selectin, P=NS).	glucose__GPIIb__no_interaction
18413206-1026	The expressions of <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id> mRNA in renal tissues were markedly up-regulated in untreated diabetic rats, and these could be notably reduced by <compound-id="77999">rosiglitazone</compound-id> treatment.	rosiglitazone__MCP-1__interaction
18413206-1027	In conclusion, <compound-id="77999">rosiglitazone</compound-id> may have a potential therapeutic target in DN, which may be partly attributed to lowering of the expression of <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id> in the local kidney and the urinary excretion of <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id>.	rosiglitazone__MCP-1__interaction
18414844-751	The homomeric <protein-id="P13900,P16604">P2X</protein-id> (7) receptor is extraordinary in that in addition to distinctive localization and biological functions it exhibits several hallmark properties, for example, the receptor is potently inhibited by divalent cations such as calcium, <compound-id="5462224">magnesium</compound-id>, zinc and <compound-id="23978">copper</compound-id>.	copper__P2X__interaction	magnesium__P2X__interaction
18414894-793	Replacement doses of <compound-id="5754">hydrocortisone</compound-id> (HC) (10 mg/m2/day) failed to produce a feedback inhibition of <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>), and <compound-id="6013">testosterone</compound-id> levels remained high.	testosterone__adrenocorticotropic hormone__no_interaction	hydrocortisone__ACTH__no_interaction	testosterone__ACTH__no_interaction	hydrocortisone__adrenocorticotropic hormone__no_interaction
18414974-853	<compound-id="23973">Cadmium</compound-id> exposure diminished the activities of enzymatic antioxidants, <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>), <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx) and glucose-6-phosphate dehydrogenase (<protein-id="O00091,O24357,O51581,O54537,O55044,O68282,O83491,O84188,P05370,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11410,P11411,P11412,P11413,P12646,P15588,P21907,P29686,P37830,P37986,P41571,P41764,P44311,P48826,P48828,P48848,P48992,P54547,P54996,P56110,P57405,P73411,P77809,P80619,P97324,Q00612,Q23711,Q24625,Q25019,Q25537,Q27464,Q27638,Q29492,Q42919,Q43793,Q43839,Q7YS37,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">G6PD</protein-id>) as well as non-enzymatic antioxidant, <compound-id="124886">reduced glutathione</compound-id> (<compound-id="124886">GSH</compound-id>) and total thiols.	GSH__GST__no_interaction	reduced glutathione__GST__no_interaction	Cadmium__catalase__interaction	GSH__superoxide dismutase__no_interaction	reduced glutathione__glutathione-S-transferase__no_interaction	reduced glutathione__CAT__no_interaction	reduced glutathione__catalase__no_interaction	reduced glutathione__SOD__no_interaction	GSH__CAT__no_interaction	Cadmium__GST__interaction	GSH__glutathione reductase__no_interaction	Cadmium__G6PD__interaction	GSH__SOD__no_interaction	Cadmium__SOD__interaction	GSH__glutathione peroxidase__no_interaction	reduced glutathione__G6PD__no_interaction	reduced glutathione__superoxide dismutase__no_interaction	Cadmium__superoxide dismutase__interaction	reduced glutathione__glutathione peroxidase__no_interaction	Cadmium__glutathione reductase__interaction	Cadmium__glutathione peroxidase__interaction	GSH__glutathione-S-transferase__no_interaction	Cadmium__glutathione-S-transferase__interaction	reduced glutathione__glutathione reductase__no_interaction	Cadmium__CAT__interaction	GSH__catalase__no_interaction	GSH__G6PD__no_interaction
18414974-854	On the other hand, the levels of <compound-id="975,65359">oxidized glutathione</compound-id> (<compound-id="65359">GSSG</compound-id>), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of <compound-id="5359597">superoxide</compound-id> radicals and activities of <protein-id="O08469">cytochrome P450</protein-id> enzymes (<protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id> P450s) have been found to increase due to <compound-id="23973">cadmium</compound-id> intoxication.	GSSG__CYP__no_interaction	cadmium__CYP__interaction	GSSG__cytochrome P450__no_interaction	oxidized glutathione__cytochrome P450__no_interaction	cadmium__cytochrome P450__interaction	superoxide__CYP__no_interaction	oxidized glutathione__CYP__no_interaction	superoxide__cytochrome P450__no_interaction
18415015-878	This paper describes (1) the preparation of the intact oligosaccharides from <protein-id="P48648">GM1</protein-id> (II(3)NeuAcGgOse(4) Cer) and GbOse(4) Cer as examples to show the use of CGase to prepare intact <compound-id="871">glycan</compound-id> chains from GSLs, and (2) the specificity and detergent requirements of Rhodococcal EGCases for the release of <compound-id="871">glycan</compound-id> chains from different GSLs.	glycan__GM1__no_interaction
18415121-949	The discovery of the <protein-id="P26677,P26678,P61012,P61013,P61015">PLN</protein-id>/<protein-id="O00165,O35387">HAX-1</protein-id> interaction therefore unveils an important new link between <compound-id="271">Ca(2</compound-id>+) homeostasis and cell survival, with significant therapeutic potential.	Ca(2__HAX-1__interaction	Ca(2__PLN__interaction
18418358-391	<compound-id="25081457">UFP-101</compound-id> alone evoked effects similar to low N/<protein-id="Q13519">OFQ</protein-id> doses, suggesting tonic inhibitory control over forelimb movement by endogenous N/<protein-id="Q13519">OFQ</protein-id>.	UFP-101__OFQ__no_interaction
18418709-605	Treating MCF-7 cells with <compound-id="16070039">AVE</compound-id>-1642 Qdots, but not unconjugated Qdots alone, downregulated <protein-id="P08069,Q05688,Q29000">IGF1R</protein-id> levels and rendered cells refractory to <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> stimulation.	AVE__IGF1R__interaction	AVE__IGF-I__interaction
18418709-606	Our data suggest that <compound-id="16070039">AVE</compound-id>-1642 Qdots can be used to detect <protein-id="P08069,Q05688,Q29000">IGF1R</protein-id> expression and measure changes in cell surface receptor levels.	AVE__IGF1R__interaction
18420260-309	Although previous studies indicated reduced levels of <compound-id="906,444885,445063">sialic acid</compound-id> residues during apoptosis, elevated Sambucus nigra <protein-id="P02872,P05046,P11218,P11219,P30617,P42088,P49329,P82859,P82953">agglutinin</protein-id> (SNA) reactivity might be due to the degradation of high molecular weight <protein-id="P08163">glycoproteins</protein-id> (probably including cadherin) that masked the SNA-binding residues of the plasma membrane prior to apoptosis.	sialic acid__glycoproteins__no_interaction	sialic acid__agglutinin__no_interaction
18423787-1115	We detected a marked decrease in target mRNA, an accumulation of short interfering RNAs (siRNAs), and a decrease in <compound-id="5280343">quercetin content</compound-id> relative to <compound-id="5280863">kaempferol</compound-id> in leaf tissues, indicating that sequence-specific mRNA degradation of the <protein-id="Q9SD85">F3'H</protein-id> gene was induced.	kaempferol__F3'H__interaction	quercetin content__F3'H__interaction
18423943-93	Polyhydroxy phenolic compounds, such as flavonoids, <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id>, <compound-id="5281792">rosmarinic acid</compound-id> and <compound-id="2236">aristolochic acid</compound-id>, are able to inhibit <protein-id="P0C1C0,Q01172,Q6CZT4">PLA</protein-id> (2) from different sources.	rosmarinic acid__PLA__interaction	vitamin E__PLA__interaction	aristolochic acid__PLA__interaction
18425600-1102	Analysis of the protein domain features indicated typical conserved <compound-id="594,5862,5360637">cysteine</compound-id> residues containing a single <protein-id="P09837">whey acidic protein</protein-id> (<protein-id="O46655,P01173,P01174,P09412,P09837,Q9N0L8">WAP</protein-id>) domain at the C-terminus.	cysteine__WAP__no_interaction	cysteine__whey acidic protein__no_interaction
18427801-1197	Cross-linked <protein-id="P13900,P16604">P2X</protein-id> (1/2) heteromers showed strongly reduced or absent function that was selectively recovered upon treatment with <compound-id="439196,439352,446094">DTT</compound-id>.	DTT__P2X__interaction
18431601-998	Permeabilization of K. marxianus cells in relation to <protein-id="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6">beta-galactosidase</protein-id> activity was carried out using cetyltrimethyl <compound-id="25514">ammonium bromide</compound-id> (<compound-id="2681">CTAB</compound-id>) to avoid the problem of enzyme extraction.	CTAB__beta-galactosidase__interaction	ammonium bromide__beta-galactosidase__interaction
18431759-1114	Although the levels of <protein-id="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58">IL-4</protein-id>, <protein-id="P20109,P35225,P42203,P61126,Q5I6E4,Q864V6,Q865W5,Q865X3,Q95J68,Q9N0W9,Q9XSV9">IL-13</protein-id>, <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id>, and <protein-id="O46678,O55235,P09340,P09341">GRO</protein-id>/KC were affected by polymer implantation, but not dependent on a specific polymer, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> and <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id> were significantly greater in those animals implanted with <compound-id="5327147">PEU</compound-id> and SR, materials that do not promote fusion.	PEU__GRO__no_interaction	PEU__IL-4__no_interaction	PEU__IL-13__no_interaction	PEU__TNFalpha__no_interaction	PEU__IL-10__no_interaction	PEU__IL-6__no_interaction
18431773-1123	Incorporation of <compound-id="6035">bromodeoxyuridine</compound-id> into newly synthesized DNA and the concentration of <protein-id="O46037,P12003,P18206,P19826,P26234,Q04615,Q17162,Q64727">vinculin</protein-id>, <protein-id="O18840,O42161,O93400,P15475,P29751,P48975,P60706,P60707,P60708,P60709,P60710,P60711,P60712,P60713,P68143,P79818,P83750,P83751,P84336,P84856,Q0PGG4,Q4L0Y2,Q5R1X3,Q711N9,Q71FK5,Q76N69,Q91ZK5,Q9Y702">beta-actin</protein-id>, osteopontin, and <protein-id="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9">osteocalcin</protein-id> in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture <compound-id="7501">polystyrene</compound-id>, which indicated good biocompatibility of the scaffolds.	polystyrene__osteocalcin__no_interaction	bromodeoxyuridine__vinculin__no_interaction	polystyrene__vinculin__no_interaction	bromodeoxyuridine__beta-actin__no_interaction	bromodeoxyuridine__osteocalcin__no_interaction	polystyrene__beta-actin__no_interaction
18431776-1124	To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long-term (about three months) release of bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) from microsphere scaffolds fabricated by using two different polymers, <compound-id="107801">poly(3-hydroxybutyrate-co-3-hydroxyvalerate</compound-id>) (PHBV, 8% PHV), <compound-id="23111554">poly(lactide-co-glycolide</compound-id>) acid (<compound-id="36797">PLGA</compound-id>, 5050) and a blend of <compound-id="36797">PLGA</compound-id> and PHBV.	PLGA__BSA__interaction	poly(3-hydroxybutyrate-co-3-hydroxyvalerate__serum albumin__interaction	PLGA__serum albumin__interaction	poly(lactide-co-glycolide__BSA__interaction	poly(3-hydroxybutyrate-co-3-hydroxyvalerate__BSA__interaction	poly(lactide-co-glycolide__serum albumin__interaction
18433938-1194	Prediction of <protein-id="O62743,O97878,O97879,O97880,O97881,O97882,O97883,O97962,O97975,P51681,P56439,P56440,P56493,P60574,P61755,P61756,P61757,P61813,P61814,P61815,P68269,P68270,Q1ZY22,Q2HJ17,Q5ECR9,Q6WN98,Q71UI8,Q8HZT9,Q95NC0,Q95NC1,Q95NC2,Q95NC3,Q95NC4,Q95NC5,Q95NC6,Q95NC7,Q95NC8,Q95NC9,Q95ND0,Q95ND1,Q95ND2,Q95NE8,Q9BGN6,Q9TV42,Q9TV43,Q9TV45,Q9TV47,Q9TV48,Q9TV49,Q9XT76">CCR5</protein-id> receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-<compound-id="5376415">piperidinyl</compound-id> amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.	piperidinyl__CCR5__interaction
18433938-1195	Quantitative structure-activity relationship (QSAR) models were developed to predict for <protein-id="O62743,O97878,O97879,O97880,O97881,O97882,O97883,O97962,O97975,P51681,P56439,P56440,P56493,P60574,P61755,P61756,P61757,P61813,P61814,P61815,P68269,P68270,Q1ZY22,Q2HJ17,Q5ECR9,Q6WN98,Q71UI8,Q8HZT9,Q95NC0,Q95NC1,Q95NC2,Q95NC3,Q95NC4,Q95NC5,Q95NC6,Q95NC7,Q95NC8,Q95NC9,Q95ND0,Q95ND1,Q95ND2,Q95NE8,Q9BGN6,Q9TV42,Q9TV43,Q9TV45,Q9TV47,Q9TV48,Q9TV49,Q9XT76">CCR5</protein-id> binding affinity of substituted 1-(3,3-diphenylpropyl)-<compound-id="5376415">piperidinyl</compound-id> amides and ureas using linear free energy relationship (LFER).	piperidinyl__CCR5__interaction
18434046-291	It is suggested that <compound-id="119">GABA</compound-id> acting through the <protein-id="P26714,Q08832,Q9BLY8">GABA(A) receptor</protein-id> mechanism on the expression of <protein-id="P27429">GnRH</protein-id> gene and <protein-id="O18821,P30968,P30969,P32236,P32237,P49922,Q01776,Q19PY9,Q8CH60,Q8SPZ1,Q9MZI6,Q9TTI8">GnRH-R</protein-id> gene in the hypothalamus may be involved in two processes: the biosynthesis of <protein-id="P27429">GnRH</protein-id> and the release of this neurohormone in the hypothalamus.	GABA__GnRH-R__interaction	GABA__GnRH__interaction	GABA__GABA(A) receptor__interaction
18435693-994	TT-induced increases in <compound-id="5754">cortisol</compound-id>, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> and <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> were reduced only after 3-h <protein-id="Q9UIJ5">REC</protein-id>.	cortisol__REC__no_interaction	cortisol__adrenocorticotropic hormone__no_interaction	cortisol__prolactin__no_interaction
18436224-84	<compound-id="5280343">Quercetin</compound-id> inhibits vascular <compound-id="5359597">superoxide</compound-id> production induced by <protein-id="P05305,Q28469">endothelin-1</protein-id> : Role of NADPH oxidase, uncoupled <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id> and <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id>.	Quercetin__PKC__no_interaction	Quercetin__eNOS__no_interaction	superoxide__PKC__no_interaction	superoxide__eNOS__no_interaction	superoxide__endothelin-1__interaction	Quercetin__endothelin-1__interaction
18436224-85	We have investigated the effects of <compound-id="5280343">quercetin</compound-id> and its methylated metabolite <compound-id="5281654">isorhamnetin</compound-id> (1-10microM) on endothelial dysfunction and <compound-id="5359597">superoxide</compound-id> (O(2*)(-)) production induced by <protein-id="P05305,Q28469">endothelin-1</protein-id> (<protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id>, 10nM).	superoxide__ET-1__interaction	isorhamnetin__ET-1__interaction	superoxide__endothelin-1__interaction	quercetin__ET-1__interaction	quercetin__endothelin-1__interaction	isorhamnetin__endothelin-1__interaction
18436224-86	<protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id> increased the contractile response induced by phenylephrine and reduced the relaxant responses to <compound-id="187">acetylcholine</compound-id> in phenylephrine contracted intact aorta, and these effects were prevented by co-incubation with <compound-id="5280343">quercetin</compound-id>, <compound-id="5281654">isorhamnetin</compound-id> or <compound-id="2703,411938">chelerythrine</compound-id> (protein kinase C (PKC) inhibitor).	acetylcholine__ET-1__interaction	isorhamnetin__ET-1__interaction	quercetin__ET-1__interaction	chelerythrine__ET-1__interaction
18436224-87	Furthermore, <protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id> increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit <protein-id="O10300,P08567,P26642,P34051,Q12802,Q91375,Q9SZB9,Q9Y240">p47</protein-id> (phox) without affecting <protein-id="O75935,P03304,P11691,P15961,P16342,P17593,P17594,P19751,P23169,P24102,P50629,P50630,P50631,P50632,P50633,P50634,P82796,Q05903,Q66198,Q8V439,Q8V6W7,Q91A29,Q9PYA3">p22</protein-id> (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by <compound-id="1959,11957499">calcium ionophore A23187</compound-id>.	calcium ionophore A23187__p47__no_interaction	calcium ionophore A23187__ET-1__no_interaction	calcium ionophore A23187__p22__no_interaction
18436224-88	Moreover, <compound-id="2214">apocynin</compound-id>, endothelium denudation and <compound-id="4367,440005">N(G)-nitro-l-arginine</compound-id> methylester (l-NAME, nitric oxide synthase inhibitor) suppressed the <protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id>-induced increase in A23187-stimulated O(2*)(-) generation.	N(G)-nitro-l-arginine__ET-1__interaction	apocynin__ET-1__interaction
18436224-89	Moreover, <compound-id="5280343">quercetin</compound-id> but not <compound-id="5281654">isorhamnetin</compound-id>, inhibited the increased <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> activity induced by <protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id>.	isorhamnetin__PKC__no_interaction	quercetin__PKC__interaction	isorhamnetin__ET-1__no_interaction	quercetin__ET-1__interaction
18436224-90	Taken together these results indicate that <protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id>-induced NADPH oxidase up-regulation and <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id> uncoupling via <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> leading to endothelial dysfunction and these effects were prevented by <compound-id="5280343">quercetin</compound-id> and <compound-id="5281654">isorhamnetin</compound-id>.	isorhamnetin__ET-1__interaction	isorhamnetin__eNOS__interaction	isorhamnetin__PKC__interaction	quercetin__eNOS__interaction	quercetin__ET-1__interaction	quercetin__PKC__interaction
18436227-91	We hypothesized that variants in <protein-id="Q8NBP7">PCSK9</protein-id> that lower LDL <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD).	cholesterol__PCSK9__interaction
18436346-156	A series of 2-aryl-naphtho[1,2-d] <compound-id="9255">oxazole</compound-id> derivatives have been synthesized and evaluated for <protein-id="O13016,P18031,P20417,P35821">PTP-1B</protein-id> inhibitory activity.	oxazole__PTP-1B__interaction
18436348-931	A new series of <compound-id="6735">indanone</compound-id> and aurone derivatives have been synthesized and tested for in vitro <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> inhibitory activity by modified Ellman method.	indanone__AChE__interaction
18436399-180	<compound-id="56842239">Polyunsaturated fatty acids</compound-id> differentially alter <protein-id="P49763,Q9XS47">PGF</protein-id> (2alpha) and <protein-id="Q29458">PGE</protein-id> (2) release from bovine trophoblast and endometrial tissues during short-term culture.	Polyunsaturated fatty acids__PGF__interaction	Polyunsaturated fatty acids__PGE__interaction
18436399-181	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), <compound-id="6433873">docosahexaenoic acids</compound-id> (22:6omega3; DHA) or <compound-id="5280450">linoleic acid</compound-id> (C18 :2omega6; <compound-id="96">LIN</compound-id>) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (<protein-id="P49763,Q9XS47">PGF</protein-id> (2alpha)) and prostaglandin E(2) (<protein-id="Q29458">PGE</protein-id> (2)) release during short-term culture.	LIN__PGE__interaction	LIN__PGF__interaction	docosahexaenoic acids__PGE__interaction	linoleic acid__PGE__interaction	linoleic acid__PGF__interaction	docosahexaenoic acids__PGF__interaction
18437529-872	<protein-id="O25121,O67036,O83796,O84335,P0A554,P0A555,P26242,P45205,P54523,P57536,P57848,P73067,P77488,Q0S1H1,Q0SS05,Q0TKM1,Q0TPD8,Q0VMI4,Q11KE0,Q11NY7,Q12CQ9,Q13RX1,Q18B68,Q1BLY7,Q1C4I9,Q1CL87,Q1CUF6,Q1D3G4,Q1GCG4,Q1GQK9,Q1GZD7,Q1IZP0,Q1LK34,Q1LTI9,Q1MKN4,Q1MRB3,Q1QE74,Q1QQ40,Q1R1E5,Q1RFC0,Q21A74,Q21F93,Q21UG7,Q24V05,Q253R7,Q2A3D3,Q2GC13,Q2IPZ2,Q2IRL7,Q2JDD9,Q2JK64,Q2JTX2,Q2KBR2,Q2KZ15,Q2LUA7,Q2NV94,Q2P472,Q2RIB9,Q2SA08,Q2T7N5,Q2W367,Q2YCH7,Q2YMF0,Q30TC5,Q30Z99,Q31AZ2,Q325I1,Q32JH8,Q393P4,Q3A3Z6,Q3AAN0,Q3AJP8,Q3AXZ4,Q3B5P3,Q3BRW8,Q3II09,Q3JAD1,Q3JKA3,Q3K660,Q3KM28,Q3M4F6,Q3SKF1,Q3SUZ1,Q3Z4Y9,Q3Z8G9,Q3ZXC2,Q46L36,Q474C2,Q47BJ0,Q47NL9,Q487D3,Q48NX0,Q493G7,Q4FN07,Q4FV64,Q4JVB5,Q4K5A5,Q4QKG6,Q4UW29,Q4ZYU8,Q50000,Q57ET1,Q57SE2,Q5E6Z0,Q5FAI2,Q5FUB1,Q5H1A0,Q5HWF0,Q5L6H4,Q5LH44,Q5LX42,Q5NG39,Q5P228,Q5PFR6,Q5QVE8,Q5SMD7,Q5WF63,Q5YTA2,Q60AN1,Q62DU1,Q635A7,Q63JF4,Q64Y02,Q65HJ2,Q65TP4,Q66DV4,Q67NB6,Q6A8V3,Q6AFD5,Q6AJQ1,Q6D844,Q6F7N5,Q6G0D4,Q6G4D1,Q6HDY8,Q6LU07,Q6MDK6,Q6NB76,Q6NGV3,Q71ZV7,Q72CD3,Q72H81,Q72U01,Q731B7,Q73LF4,Q73W57,Q75TB7,Q7M7Z0,Q7MN49,Q7MSZ3,Q7N0J7,Q7NP63,Q7NUK5,Q7U6P6,Q7UWB7,Q7V1G6,Q7V7Q3,Q7VC14,Q7VIJ7,Q7VNP7,Q7VRH9,Q7VV87,Q7W7Q0,Q7WL37,Q818R9,Q81M54,Q823V1,Q82VD3,Q83G46,Q83I20,Q83SG2,Q87C03,Q87RU0,Q889Q1,Q88QG7,Q894H0,Q89RW1,Q8A0C2,Q8D357,Q8DFA3,Q8DL74,Q8EGR9,Q8EWX7,Q8F153,Q8FKB9,Q8FPI2,Q8G292,Q8GAA0,Q8K9A1,Q8KFI9,Q8NPB2,Q8P815,Q8PJG7,Q8R639,Q8RAC5,Q8UHD7,Q8XE76,Q8XJE1,Q8XX95,Q8Y7C1,Q8YFM2,Q8YZ80,Q8Z8X3,Q8ZC45,Q8ZRD1,Q92BZ0,Q92RJ1,Q97HD5,Q985Y3,Q9A6M5,Q9JW13,Q9JXV7,Q9K971,Q9KGU7,Q9KTL3,Q9PB95,Q9PIH8,Q9PK62,Q9R6S7,Q9RBN6,Q9RUB5,Q9X291,Q9Z6J9,Q9ZM94">1-Deoxy-D-xylulose-5-phosphate synthase</protein-id> (DXS) catalyses the first committed step of the 2C-methyl-<compound-id="192838,3262721">D-erythritol-4-phosphate</compound-id> (<compound-id="7728">MEP</compound-id>) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	MEP__1-Deoxy-D-xylulose-5-phosphate synthase__interaction	D-erythritol-4-phosphate__1-Deoxy-D-xylulose-5-phosphate synthase__interaction
18437557-896	To get insight into the underlying mechanisms, we compared the ability of recombinant wild type and variant (D327N) <protein-id="P04278,P08689,P15196,P97497,Q62588">SHBG</protein-id> to influence <compound-id="5757">estradiol</compound-id> effects in MCF-7 breast cancer cells.	estradiol__SHBG__interaction
18437557-897	D327N <protein-id="P04278,P08689,P15196,P97497,Q62588">SHBG</protein-id> was more effective than wild type protein in inhibiting <compound-id="5757">estradiol</compound-id>-induced cell proliferation and anti-apoptosis.	estradiol__SHBG__interaction
18437699-978	Our results suggest that <compound-id="934">Ni(II</compound-id>)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by <protein-id="O54968,Q60795">Nrf2</protein-id> but are not likely influenced by changes in whole-cell <protein-id="O14463,P29445,Q8KEA4">Trx1</protein-id> levels.	Ni(II__Trx1__no_interaction	Ni(II__Nrf2__interaction
18439591-271	To test the hypothesis that increasing <compound-id="12594">DHEAS</compound-id> levels is associated with improved <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance in patients with polycystic ovary syndrome (PCOS).	DHEAS__insulin__interaction
18440842-362	Packed cell volume, total protein, <compound-id="588">creatinine</compound-id>, blood <compound-id="1176,265993">urea</compound-id> <compound-id="947,123329">nitrogen</compound-id>, and <protein-id="P07846,P27867,Q00796,Q02912,Q06004,Q29318,Q4R639,Q58D31,Q59787,Q64442,Q9Z9U1">sorbitol dehydrogenase</protein-id> concentrations decreased while foals were on PN, while serum <compound-id="312">chloride</compound-id> concentration increased.	urea__sorbitol dehydrogenase__no_interaction	chloride__sorbitol dehydrogenase__no_interaction	nitrogen__sorbitol dehydrogenase__no_interaction	creatinine__sorbitol dehydrogenase__no_interaction
18442069-1161	The gene expressions of <protein-id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</protein-id> and <protein-id="O18963,P05181,P08682,P33266,P51581,P79383,Q6GUQ4">CYP2E1</protein-id> in the placenta increased significantly in <compound-id="942,89594,157672">nicotine</compound-id>-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.	nicotine__CYP2E1__interaction	nicotine__CYP1A1__interaction
18442069-1162	In <compound-id="942,89594,157672">nicotine</compound-id> group, there was a decrease of <protein-id="P21447">mdr1a</protein-id> expression on GD 15, GD 18, and GD 21, with the most significant decrease on GD 15.	nicotine__mdr1a__interaction
18442070-1163	The present study was designed to understand the effects of sublethal concentrations of <compound-id="3039">dichlorvos</compound-id> (DIC) on hematological constituent [red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id>, mean corpuscular <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> concentration, platelet counts, <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> and hematocrite levels] and serum damage marker enzymes (<protein-id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</protein-id>, alanin aminotransferase, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id>, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	dichlorvos__aspartate aminotransferase__interaction	dichlorvos__alkaline phosphatase__interaction	dichlorvos__hemoglobin__interaction
18442075-634	<compound-id="896">Melatonin</compound-id> altered <compound-id="7516">PHZ</compound-id>-induced responses significantly to a greater degree than <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> as evidenced by <protein-id="P22079,P80025">LPO</protein-id> status, <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> activity, and <compound-id="5464076">ABTS radical cation</compound-id> scavenging activity of antioxidants.	vitamin E__SOD__no_interaction	Melatonin__SOD__no_interaction	Melatonin__LPO__no_interaction	PHZ__SOD__no_interaction	ABTS radical cation__LPO__no_interaction	ABTS radical cation__SOD__no_interaction	PHZ__LPO__no_interaction	vitamin E__LPO__no_interaction
18443829-973	The hydrolysis reaction of <compound-id="75834">p-nitrophenyl butyrate</compound-id> catalyzed by <protein-id="Q7M4U7">lipases</protein-id> was followed with in situ UV/vis diode array spectrophotometry.	p-nitrophenyl butyrate__lipases__interaction
18443829-974	Five enzymes-Candida antarctica <protein-id="Q7M4U7">lipase</protein-id> B and Fusarium solani pisi cutinase wild-type and three single-mutation variants-were tested as catalysts in homogeneous conditions and immobilized on zeolite <compound-id="445523">NaY</compound-id>, on a <compound-id="6581">polyacrylate</compound-id> support and as cross-linked aggregates.	polyacrylate__lipase__no_interaction	NaY__lipase__no_interaction
18443843-1157	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (<protein-id="P22079,P80025">LPO</protein-id>), activities of <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx), <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>), different ATPases and <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (<protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>) in erythrocytes, serum <compound-id="206,5793,64689,79025">glucose</compound-id>, and levels of <compound-id="124886">glutathione</compound-id> (<compound-id="124886">GSH</compound-id>) and glycosylated <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> (GHb) in blood.	GSH__GST__no_interaction	glutathione__GST__no_interaction	glucose__catalase__no_interaction	GSH__superoxide dismutase__no_interaction	GSH__hemoglobin__no_interaction	GSH__SOD__no_interaction	glutathione__AChE__no_interaction	GSH__LPO__no_interaction	glucose__glutathione-S-transferase__no_interaction	glucose__acetylcholinesterase__no_interaction	glutathione__SOD__no_interaction	glucose__superoxide dismutase__no_interaction	glucose__glutathione peroxidase__no_interaction	glutathione__catalase__no_interaction	glutathione__acetylcholinesterase__no_interaction	glucose__hemoglobin__no_interaction	GSH__glutathione peroxidase__no_interaction	glutathione__LPO__no_interaction	glucose__AChE__no_interaction	GSH__glutathione-S-transferase__no_interaction	glutathione__superoxide dismutase__no_interaction	glutathione__glutathione peroxidase__no_interaction	glucose__SOD__no_interaction	glucose__LPO__no_interaction	GSH__acetylcholinesterase__no_interaction	GSH__AChE__no_interaction	glutathione__glutathione-S-transferase__no_interaction	glutathione__hemoglobin__no_interaction	GSH__catalase__no_interaction	glucose__GST__no_interaction
18443843-1158	<protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">Catalase</protein-id> was decreased with <compound-id="3224">endosulfan</compound-id> and the coexposure, but not with arsenic, whereas <compound-id="124886">GSH</compound-id> was decreased with arsenic and <compound-id="3224">endosulfan</compound-id>, but not with the coexposure.	endosulfan__Catalase__no_interaction	GSH__Catalase__no_interaction
18443843-1159	<protein-id="P13607,P17326,P28774,P35317">Na+-K+-ATPase</protein-id> activity was decreased in the <compound-id="3224">endosulfan</compound-id>-treated and the coexposed birds.	endosulfan__Na+-K+-ATPase__interaction
18443897-1003	mRNA and protein levels of <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="P25446,Q63199">Fas</protein-id>, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by <compound-id="10918">L-carnitine</compound-id> treatment.	L-carnitine__TNF-alpha__interaction	L-carnitine__Fas__interaction
18443897-1004	In addition, <compound-id="10918">L-carnitine</compound-id> treatment regulated mitochondria-dependent apoptosis pathways by inducing the up-regulation of caspase-9 and caspase-3 and the down-regulation of <protein-id="P10417,P49950">Bcl-2</protein-id> in hepa1c1c 7 cells.	L-carnitine__Bcl-2__interaction
18443897-1005	Taken together, the findings of this study have demonstrated that <compound-id="10918">L-carnitine</compound-id> could induce apoptosis in hepa1c1c7 cells by regulating <protein-id="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8">Fas ligands</protein-id> and inhibiting the expression of <protein-id="P10417,P49950">Bcl-2</protein-id>.	L-carnitine__Fas ligands__interaction	L-carnitine__Bcl-2__interaction
18445079-363	<compound-id="84098">Merlin</compound-id> is known to bind <protein-id="P49023,P49024,Q5R7I1,Q66H76,Q8VI36">paxillin</protein-id>, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix.	Merlin__paxillin__interaction
18445307-585	Furthermore, free radical overproduction and oxidative stress were associated with a significant decrease in hepatic <compound-id="124886">glutathione</compound-id> levels in septic mice, and with an excessive NO production attributed to the induction of the inducible isoform of NO synthase (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>).	glutathione__iNOS__no_interaction
18445307-586	In fact, hepatic <compound-id="124886">glutathione</compound-id> levels were significantly increased in the group of mice receiving the probiotic, and the increased <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> expression both in the colon and lungs was down-regulated in those mice treated with L. fermentum.	glutathione__iNOS__no_interaction
18448193-1146	Furthermore, supplementation of specific inhibitors of <protein-id="O03979,O04058,O93967,P10248,P10731,P11544,P14166,P14717,P14925,P19021,P26600,P35511,P35512,P45726,P45727,P45730,P45731,P45735,P52777,P83388,P91268,P97467,Q42609,Q43210,Q9P2V4,Q9PSN0">PAL</protein-id>, <protein-id="O24312,O81928,P37114,P37115,P48522,P92994,Q04468,Q42797,Q43033,Q43054,Q43067,Q43240,Q96423,Q9AR74">C4H</protein-id> and <protein-id="O11451,O11452,O11453,O24540,O54075,O69140,P17814,P41636,P42516,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184">4CL</protein-id> in elicited cell cultures led to suppressed accumulation of <compound-id="135">p-hydroxybenzoic acid</compound-id>, which opens up interesting questions regarding the probable route of the biosynthesis of this phenolic acid in C. nucifera.	p-hydroxybenzoic acid__PAL__no_interaction	p-hydroxybenzoic acid__4CL__no_interaction	p-hydroxybenzoic acid__C4H__no_interaction
18449471-648	<compound-id="5291">Imatinib</compound-id> is transported by P-<protein-id="P08163">glycoprotein</protein-id> (P-gp) and <protein-id="Q9UNQ0">Breast Cancer Resistance Protein</protein-id> (<protein-id="Q9UNQ0">BCRP</protein-id>), however, the exact impact of these transporters on absorption, distribution, metabolism and excretion (ADME) of <compound-id="5291">imatinib</compound-id> is not fully understood due to incomplete data.	imatinib__BCRP__interaction	imatinib__Breast Cancer Resistance Protein__interaction	Imatinib__glycoprotein__interaction	Imatinib__BCRP__interaction	Imatinib__Breast Cancer Resistance Protein__interaction	imatinib__glycoprotein__interaction
18449471-650	In conclusion, P-gp and <protein-id="Q9UNQ0">BCRP</protein-id> have only a modest effect on the ADME of <compound-id="5291">imatinib</compound-id> in comparison to metabolic elimination.	imatinib__BCRP__interaction
18449471-651	The considerable drug-drug interaction observed with <compound-id="119373">elacridar</compound-id> or <compound-id="4679">pantoprazole</compound-id> is only partly mediated by inhibition of P-gp and <protein-id="Q9UNQ0">BCRP</protein-id> and far more by the inhibition of other elimination pathways.	pantoprazole__BCRP__interaction	elacridar__BCRP__interaction
18449536-687	There is clear evidence for <protein-id="O95069">TREK</protein-id>-1 and <protein-id="O14649">TASK</protein-id>-1 in the heart and these channels are likely to regulate cardiac action potential duration through their regulation by stretch, <compound-id="56842239">polyunsaturated fatty acids</compound-id>, pH, and neurotransmitters.	polyunsaturated fatty acids__TASK__interaction	polyunsaturated fatty acids__TREK__interaction
18449536-688	<protein-id="O95069">TREK</protein-id>-1 may also have a critical role in mediating the vasodilator response of resistance arteries to <compound-id="56842239">polyunsaturated fatty acids</compound-id>, thus contributing to their protective effect on the cardiovascular system.	polyunsaturated fatty acids__TREK__interaction
18449944-953	Alumina ceramic particles, in comparison with <compound-id="23963">titanium</compound-id> particles, hardly affect the expression of <protein-id="Q9Y6Q6">RANK</protein-id>-, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>-, and <protein-id="O00300">OPG</protein-id>-mRNA in the THP-1 human monocytic cell line.	titanium__TNF-alpha__interaction	titanium__RANK__interaction	titanium__OPG__interaction
18450412-1248	<compound-id="5326739">Indirubin-3-oxime</compound-id>-induced growth inhibition was associated with induction of Cdk inhibitor p21, inhibition of <protein-id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</protein-id> D1 and activation of caspase-3.	Indirubin-3-oxime__cyclin__interaction
18452177-145	Three proteins, porcine <protein-id="P10766,P20391,P20392,P33092,P34005,P34006,P34747,P37885,P55755">somatotropin</protein-id>, bovine <protein-id="P21847,P83517">serum albumin</protein-id>, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, <compound-id="3715">indomethacin</compound-id> and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	indomethacin__serum albumin__no_interaction	indomethacin__somatotropin__no_interaction
18454352-1155	The recombinant protein exhibited high <protein-id="O03979,O04058,O93967,P10248,P10731,P11544,P14166,P14717,P14925,P19021,P26600,P35511,P35512,P45726,P45727,P45730,P45731,P45735,P52777,P83388,P91268,P97467,Q42609,Q43210,Q9P2V4,Q9PSN0">PAL</protein-id> activity and could catalyze the conversion of L:-Phe to <compound-id="444539">trans-cinnamic acid</compound-id>.	trans-cinnamic acid__PAL__no_interaction
18456422-1170	Only the <protein-id="P80298,P80545,P81173">beta-lactamases</protein-id> of pI 5.4 and superior to 7.6 hydrolyze the <compound-id="5479527,5742673,6540461">cefotaxime</compound-id>.	cefotaxime__beta-lactamases__interaction
18457934-815	To investigate this relationship, we used actively growing young Sprague-Dawley rats and <compound-id="6918502">CKD-732</compound-id>, one of the angiogenesis inhibitor (AI) to reveal the relationship of angiogenesis in the effect of <protein-id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</protein-id>.	CKD-732__PTH__no_interaction
18458677-190	Functional polymorphisms in the <protein-id="P41693">interleukin-6</protein-id> and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and <compound-id="37542">ribavirin</compound-id> treatment.	ribavirin__interleukin-6__interaction
18458952-1204	An alpha-numeric code for representing N-linked <compound-id="871">glycan</compound-id> structures in secreted <protein-id="P08163">glycoproteins</protein-id>.	glycan__glycoproteins__interaction
18458952-1205	Towards this end, we propose a fixed-length alpha-numeric code for representing N-linked <compound-id="871">glycan</compound-id> structures commonly found in secreted <protein-id="P08163">glycoproteins</protein-id> from mammalian cell cultures.	glycan__glycoproteins__interaction
18458994-119	There was a significant increase in <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome-c</protein-id> oxidase activity at 2.5 mg/L, which might indicate <compound-id="91590">irgarol</compound-id>'s disruption of the mitochondrial membrane and subsequently <compound-id="5957">ATP</compound-id> synthesis.	irgarol__cytochrome-c__interaction	ATP__cytochrome-c__interaction
18459128-282	Treatment of A549, which express wild-type <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id>, and H1299, which are <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id>-deficient, human lung cancer cells with <compound-id="2353">berberine</compound-id> resulted in inhibition of cell proliferation and an increase in apoptotic cell death ; however, A549 cells were more sensitive to the <compound-id="2353">berberine</compound-id>-induced cytotoxic effects than H1299 cells.	berberine__p53__no_interaction
18459941-785	Furthermore <compound-id="60823">atorvastatin</compound-id> treatment markedly decreased the levels of <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> and <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id>, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id>.	atorvastatin__IL-10__interaction	atorvastatin__MCP-1__interaction	atorvastatin__IL-6__interaction	atorvastatin__TNF-alpha__interaction
18459941-787	Our study suggests that the modulation of the balance between pro- and anti-inflammatory cytokines towards the anti-inflammatory cytokine <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> is one salutary mechanism underlying how <compound-id="60823">atorvastatin</compound-id> influences post-MI remodelling and thus improves LV function.	atorvastatin__IL-10__no_interaction
18459944-788	In addition, <compound-id="10069117">AUDA</compound-id> treatment attenuated macrophage infiltration and inhibited urinary excretion of <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id> (<protein-id="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">monocyte chemoattractant protein-1</protein-id>) and kidney cortex <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id> gene expression.	AUDA__MCP-1__interaction	AUDA__monocyte chemoattractant protein-1__interaction
18462831-74	Exogenous <compound-id="1102">spermidine</compound-id>, arsenic and <compound-id="10932">beta-aminobutyric acid</compound-id> modulate tobacco resistance to tobacco mosaic virus, and affect local and systemic glucosylsalicylic acid levels and <protein-id="O81160,O82475,P21885,P22220,P49726,Q39827,Q43075,Q819L4,Q81MS2,Q96412,Q96A70,Q9K9K5,Q9SNN0">arginine decarboxylase</protein-id> gene expression in tobacco leaves.	beta-aminobutyric acid__arginine decarboxylase__interaction	spermidine__arginine decarboxylase__interaction
18462831-75	Moreover, this phenotypic response was correlated with changes in the endogenous concentration of the SAR-related molecule <compound-id="338">salicylic acid</compound-id> and in transcript levels of some pathogenesis/stress-related genes (<protein-id="P83834">pathogenesis-related proteins</protein-id> PR-1a and <protein-id="P33157,P51525">PR-2</protein-id> and <protein-id="O81160,O82475,P21885,P22220,P49726,Q39827,Q43075,Q819L4,Q81MS2,Q96412,Q96A70,Q9K9K5,Q9SNN0">arginine decarboxylase</protein-id> (<protein-id="O81160,O82475,P21170,P22220,P23670,P28629,P49726,P60658,P60659,P81336,Q39827,Q43075,Q7MK24,Q7N121,Q7NE10,Q7NSA6,Q7NU27,Q7TUJ9,Q7U3S0,Q7UTS2,Q7V3M9,Q7VEG4,Q83Q93,Q87F25,Q87JS8,Q87VU3,Q88QC7,Q8A2B1,Q8BVM4,Q8DA54,Q8DHY6,Q8EFU5,Q8FE34,Q8P448,Q8PFQ5,Q8XCX9,Q8XR10,Q8YRP3,Q8ZHG8,Q96412,Q96A70,Q9CL60,Q9EYI7,Q9HUX1,Q9JT25,Q9K0U3,Q9KLD1,Q9PH02,Q9RPK1,Q9RXR4,Q9SNN0">ADC</protein-id>)).	salicylic acid__arginine decarboxylase__no_interaction	salicylic acid__pathogenesis-related proteins__no_interaction	salicylic acid__ADC__no_interaction	salicylic acid__PR-2__no_interaction
18462962-149	She had a mutation in <protein-id="Q9BZ23">PANK2</protein-id> gene consisting of an aminoacid change of <compound-id="602,4580,5950,71080">Alanine</compound-id> to <compound-id="6287">Valine</compound-id> in exon 5 (A382V).	Valine__PANK2__interaction	Alanine__PANK2__interaction
18466349-969	Decreased hepatic <protein-id="P02753,P06912,P18902,P27485,P41263,P61641,Q28369">RBP4</protein-id> secretion is correlated with reduced hepatic <compound-id="206,5793,64689,79025">glucose</compound-id> production but is not associated with <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance in patients with liver cirrhosis.	glucose__RBP4__interaction	glucose__insulin__no_interaction
18466352-971	<compound-id="6442177">RAD001</compound-id>-induced growth suppression was associated with inactivation of downstream targets of <protein-id="P42345,P42346,Q9JLN9">mTOR</protein-id>, reduction in <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> expression and microvessel density, inhibition of cell proliferation, up-regulation of <protein-id="O11451,O11452,O11453,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P06934,P16342,P19751,P25880,P25881,P25882,P25884,P25989,P26660,P26661,P26662,P26663,P26664,P27958,P29833,P29846,P29996,P29997,P40305,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184,P69618,P69619,Q00269,Q43735,Q5I2N3,Q66198,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q81835,Q81842,Q8V439,Q8V6W7,Q913D4,Q91A29,Q91DH7,Q91DH8,Q91DH9,Q99IB8,Q9DHD6,Q9E925,Q9PYA3,Q9QAX1,Q9WMX2">p27</protein-id> (Kip1) and down-regulation of <protein-id="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">p21</protein-id> (<protein-id="O42923,P39689">Cip1</protein-id>/<protein-id="P39689">Waf1</protein-id>), <protein-id="O05982">Cdk</protein-id>-6, <protein-id="O05982">Cdk</protein-id>-2, <protein-id="O05982">Cdk</protein-id>-4, cdc-25C, <protein-id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</protein-id> B1 and <protein-id="P01109,P06646,P49709,P52160,Q17103">c-Myc</protein-id>.	RAD001__Cip1__interaction	RAD001__p27__interaction	RAD001__VEGF__interaction	RAD001__Cdk__interaction	RAD001__c-Myc__interaction	RAD001__Waf1__interaction	RAD001__p21__interaction	RAD001__cyclin__interaction	RAD001__mTOR__interaction
18467006-128	A series of <compound-id="7370">benzenesulfonamide</compound-id>-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles have been synthesized and evaluated for their <protein-id="P36897">ALK5</protein-id> inhibitory activity in cell-based luciferase reporter assays.	benzenesulfonamide__ALK5__interaction
18468607-1101	Genetic variation in <protein-id="P11597,P22687,P25914,P47896">CETP</protein-id> (<protein-id="P25914">cholesteryl ester transfer protein</protein-id>) has been clearly associated with HDL <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels but its association with cardiovascular disease and related phenotypes has been more controversial, possibly due to variability of polymorphisms and their frequencies across different ethnic populations.	cholesterol__CETP__interaction	cholesterol__cholesteryl ester transfer protein__interaction
18470629-1072	However, <compound-id="5353758">methomyl</compound-id> exhibited more potency in reducing <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> activity than <compound-id="16248">methiocarb</compound-id>.	methomyl__AChE__interaction	methiocarb__AChE__interaction
18470874-1230	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-<compound-id="6029">uridine</compound-id> incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, <protein-id="P17480">UBF</protein-id> and <protein-id="P06748,P07222,P13084,P16039,Q3T160,Q61937">nucleophosmin</protein-id>, <protein-id="P51472">B23</protein-id>).	uridine__nucleophosmin__no_interaction	uridine__UBF__no_interaction	uridine__B23__no_interaction
18471929-584	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>) and lignin-forming <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="P07003,P37063,P92983,Q54970">POX</protein-id>) were found to be increased by <compound-id="614,8988,145742">proline</compound-id> and <compound-id="248">betaine</compound-id> under salt stress.	betaine__peroxidase__interaction	proline__POX__interaction	proline__peroxidase__interaction	proline__CAT__interaction	betaine__CAT__interaction	proline__catalase__interaction	betaine__catalase__interaction	betaine__POX__interaction
18472163-737	Significant <protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id> activity changes, sensitivity of isozyme patterns (Mr of 60, 64, and 85kDa) and increased variation in <protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id> plasticity during acute exposure to <compound-id="23973">cadmium</compound-id> point to its possible aplication as an exposure biomarker.	cadmium__ALP__interaction
18472187-928	To decrease the level of androgen <compound-id="6013">testosterone</compound-id> in the prostate, we are interested in developing inhibitors of <protein-id="P42330,Q5R7C9">17beta-hydroxysteroid dehydrogenase type 5</protein-id> (<protein-id="P42330,P70694,Q5R7C9">17beta-HSD5</protein-id>).	testosterone__17beta-HSD5__interaction	testosterone__17beta-hydroxysteroid dehydrogenase type 5__interaction
18472342-221	A role for <compound-id="24316">guanosine 3',5'-cyclic monophosphate</compound-id> (<compound-id="24316">cGMP</compound-id>) and the <protein-id="P00513,P25848">protein kinase</protein-id> G (PKG) pathway in synaptic long-term depression (LTD) in the hippocampal CA1 region has been proposed, based on observations in vitro, where, for example, increases of [<compound-id="24316">cGMP</compound-id>] result in short-term depression (STD) coupled with a reduction in presynaptic <compound-id="611,23327,33032">glutamate</compound-id> release.	glutamate__protein kinase__no_interaction	guanosine 3',5'-cyclic monophosphate__protein kinase__no_interaction	cGMP__protein kinase__no_interaction
18472342-222	Application of an inhibitor of soluble guanylate <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</protein-id> prevented LTD induced by low-frequency stimulation (<protein-id="P59082">LFS</protein-id>), and impaired <protein-id="P59082">LFS</protein-id>-<protein-id="P50234,P52842,Q06520">STD</protein-id> elicited in the presence of <compound-id="5722">Zaprinast</compound-id>.	Zaprinast__cyclase__no_interaction	Zaprinast__STD__no_interaction	Zaprinast__LFS__no_interaction
18473163-133	<protein-id="O60502,P44955,P49010,P58067,P75949,P96155,P96157,Q04786,Q0TR53,Q2KXM7,Q2P4L0,Q2Y863,Q31G32,Q31ZG4,Q32EW7,Q3BVU6,Q3J953,Q3SKU2,Q3Z310,Q4QLU8,Q4USG7,Q57QE6,Q5FA94,Q5H1Q0,Q5P081,Q5PGT0,Q5QUZ5,Q606N2,Q65VK7,Q669N5,Q6D674,Q6LJ30,Q7N397,Q7NWB7,Q7UCW4,Q7VNI8,Q7VWV8,Q7W9J5,Q7WH65,Q82SJ8,Q87BR5,Q89ZI2,Q8EEW2,Q8FIN2,Q8PB42,Q8PMU1,Q8VIJ5,Q8XL08,Q8Z7I6,Q8ZFS3,Q8ZQ06,Q9CPH0,Q9EQQ9,Q9HZK0,Q9JVT3,Q9K0Q4,Q9KU37,Q9PAZ0">beta-Hexosaminidases</protein-id> (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound <compound-id="24139">N-acetylglucosamine</compound-id> and <compound-id="899,35717,84265,439174">N-acetylgalactosamine</compound-id> residues from a number of glycoconjugates.	N-acetylgalactosamine__beta-Hexosaminidases__interaction	N-acetylglucosamine__beta-Hexosaminidases__interaction
18473182-143	Overexpression of <protein-id="O18963,P05181,P08682,P33266,P51581,P79383,Q6GUQ4">CYP2E1</protein-id> induces HepG2 cells death by the AMP kinase activator <compound-id="16078949">5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside</compound-id> (AICAR).	5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside__CYP2E1__interaction
18474445-915	Distribution of the <protein-id="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90">androgen receptor</protein-id> in the diencephalon and the pituitary gland in goats: Co-localisation with corticotrophin releasing hormone, <compound-id="8230,644077,44285245">arginine vasopressin</compound-id> and corticotrophs.	arginine vasopressin__androgen receptor__no_interaction
18475288-1020	<compound-id="2375">Bicalutamide</compound-id> induced apoptosis in androgen-dependent PWR-1E cells via a caspase-dependent and <protein-id="P27730">calpain</protein-id>-independent mechanism.	Bicalutamide__calpain__no_interaction
18475288-1021	In androgen-independent PC-3 cells, <compound-id="2375">bicalutamide</compound-id> also induced apoptosis by mechanisms that were partially inhibited by pan-caspase inhibition but were partially <protein-id="P27730">calpain</protein-id> dependent.	bicalutamide__calpain__interaction
18477686-347	A differential regulation of the two <compound-id="119">GABA</compound-id> synthesizing enzymes (<protein-id="P48321,Q05329,Q4PRC2">GAD65</protein-id> and <protein-id="P14748,P48319,Q5IS68,Q99259">GAD67</protein-id>) parallels GABAergic neuron differentiation.	GABA__GAD67__interaction	GABA__GAD65__interaction
18479249-96	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-<protein-id="Q08398">alpha1</protein-id> and <protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</protein-id>, protein expression of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> and <protein-id="P24557,P36423,P47787,P49430,Q2KIG5">TXS</protein-id>, and production of <compound-id="5280497">TXA2</compound-id> in liver perfusates were significantly decreased in UDCA-treated BDL rats.	TXA2__iNOS__no_interaction	TXA2__alpha1__no_interaction	TXA2__TGF-beta1__no_interaction	TXA2__TXS__no_interaction
18479249-97	The increased levels of hepatic <compound-id="124886">GSH</compound-id> and <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> activity and decreased levels of TBARS and nitrite were also observed in UDCA-treated BDL rats.	GSH__SOD__no_interaction
18479251-501	The production of rhG-<protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</protein-id> was induced by switching from growth on <compound-id="753">glycerol</compound-id> to growth on <compound-id="887,19314">methanol</compound-id>.	glycerol__CSF__no_interaction	methanol__CSF__interaction
18479251-502	In the induction phase, the <compound-id="887,19314">methanol</compound-id> feed rate had a significant effect on the specific expression rate of rhG-<protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</protein-id>.	methanol__CSF__interaction
18479251-503	Under this condition, a maximum concentration of 300 mg/l of rhG-<protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</protein-id> and the expression yield of 0.6 mg of rhG-<protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</protein-id>/g of <compound-id="887,19314">methanol</compound-id> were attained.	methanol__CSF__interaction
18479251-504	Among seven additives tested, <compound-id="443314">Tween 20</compound-id>, Tween 80 and <compound-id="248">betaine</compound-id> exhibited the best results in respect of preventing the formation of rhG-<protein-id="O62757,P01587,P04141,P11052,P28773,P48749,P48750,P51748,Q0MUT8,Q29118,Q60481">CSF</protein-id> protein aggregates.	Tween 20__CSF__interaction	betaine__CSF__interaction
18479686-323	<compound-id="150311">Ezetimibe</compound-id> potently reduces vascular inflammation and arteriosclerosis in <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>-deficient ApoE ko mice.	Ezetimibe__eNOS__no_interaction
18479686-324	Hypercholesterolemia is associated with decreased vascular <compound-id="145068">nitric oxide</compound-id> bioavailability and deletion of endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>) markedly accelerates atherosclerosis development in apolipoprotein E knockout (apoE ko) mice.	nitric oxide__eNOS__no_interaction	nitric oxide__nitric oxide synthase__no_interaction
18479896-454	<compound-id="445580">Docosahexaenoic acid</compound-id> induces apoptosis in colorectal carcinoma cells by modulating the <protein-id="P42347,P42348,P54673,P54674,P54675,P54676">PI3 kinase</protein-id> and <protein-id="O62618">p38 MAPK</protein-id> pathways.	Docosahexaenoic acid__PI3 kinase__interaction	Docosahexaenoic acid__p38 MAPK__interaction
18479896-455	The protein inhibitors <compound-id="312145">wortmannin</compound-id> (<compound-id="16738692">phosphoinositide</compound-id> 3 kinase inhibitor), <compound-id="4713">PD 98059</compound-id> (MEK inhibitor) and <compound-id="176155">SB 203580</compound-id> (p38 inhibitor) as well as silencing RNA [small interfering RNA (siRNA)] of the <protein-id="O62618">p38 MAPK</protein-id> protein, were used to investigate cross-talk between signalling pathways.	SB 203580__p38 MAPK__no_interaction	phosphoinositide__p38 MAPK__no_interaction	wortmannin__p38 MAPK__no_interaction	PD 98059__p38 MAPK__no_interaction
18479897-371	Feeding long-chain n-3 <compound-id="56842239">polyunsaturated fatty acids</compound-id> during gestation increases intestinal <compound-id="206,5793,64689,79025">glucose</compound-id> absorption potentially via the acute activation of <protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id>.	glucose__AMPK__interaction	polyunsaturated fatty acids__AMPK__interaction
18479897-373	Furthermore, adding <compound-id="445580">docosahexaenoic acid</compound-id> (DHA) or an <protein-id="O24006">AMP</protein-id>-activated <protein-id="P00513,P25848">protein kinase</protein-id> (<protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id>.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	docosahexaenoic acid__AMPK__no_interaction	docosahexaenoic acid__protein kinase__no_interaction	docosahexaenoic acid__AMP__no_interaction
18479950-485	Prior to <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> supplementation, exercise induced a significant decrease in <protein-id="P27169,P27170">PON1</protein-id> activity, <compound-id="23644574">EMF</compound-id>, <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> concentration and a significant increase in MDA concentration at t+1d.	vitamin E__PON1__no_interaction	EMF__PON1__no_interaction
18479950-486	After a 10 week <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> supplementation period, these exercise-induced changes in <protein-id="P27169,P27170">PON1</protein-id> activity, <compound-id="23644574">EMF</compound-id> and MDA concentration were still significant in the control group, but not in the supplemented group.	EMF__PON1__no_interaction	vitamin E__PON1__interaction
18481266-77	In adulthood, <compound-id="6013">testosterone</compound-id> secreted by the testes is converted into estrogens by the preoptic <protein-id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</protein-id>.	testosterone__aromatase__interaction
18481276-83	The model was used to investigate how on-treatment <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id> related to baseline <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id> and estimated treatment effects with <compound-id="446157">rosuvastatin</compound-id>.	rosuvastatin__CRP__interaction
18481313-107	Hepatocyte growth factor, keratinocyte growth factor or <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> prevented the effect of <compound-id="702">ethanol</compound-id> on cell permeability, but not on <protein-id="Q29458">PGE</protein-id> (2) release.	ethanol__insulin__interaction	ethanol__PGE__no_interaction
18481313-108	<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">Cyclooxygenase-2</protein-id> stimulated <protein-id="Q29458">PGE</protein-id> (2) release mediated the reversible effect of <compound-id="702">ethanol</compound-id> on tight junctions and, meanwhile, contributed to cell survival.	ethanol__Cyclooxygenase-2__interaction	ethanol__PGE__no_interaction
18482727-966	Interestingly, <compound-id="60823">atorvastatin</compound-id> inhibited the expression of ICAM and <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id>, followed by the suppression of macrophage recruitment into the aortic wall at 1 week after operation.	atorvastatin__MCP-1__interaction
18482727-967	In addition, synthesis of collagen and <protein-id="P11547">elastin</protein-id> in the vascular wall were significantly increased by <compound-id="60823">atorvastatin</compound-id>.	atorvastatin__elastin__interaction
18484100-516	Organic cations (<compound-id="72886">OCs</compound-id>) are primarily excreted via vectorial transport by various renal organic cation transporters (<protein-id="O75051">OCTs</protein-id>).	OCs__OCTs__interaction
18484100-517	In a rat ARF model, induction of ARF by <compound-id="24933">uranyl nitrate</compound-id> (UN) treatment significantly decreased the levels of <protein-id="Q00196">Oct2</protein-id> (slc22a2) mRNA and protein in the kidney medulla.	uranyl nitrate__Oct2__interaction
18484622-1118	In all final products, <compound-id="679">dimethylsulfoxide</compound-id> used to prepare the <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>/lipid mixture was below 20 ppm.	dimethylsulfoxide__insulin__interaction
18485500-951	Platelet reactivity and <compound-id="2806,60606">clopidogrel</compound-id> resistance are associated with the H2 haplotype of the <protein-id="Q95KC3,Q9CPV9,Q9EPX4,Q9H244">P2Y12</protein-id>-<protein-id="P02783">ADP</protein-id> receptor gene.	clopidogrel__ADP__interaction	clopidogrel__P2Y12__interaction
18486150-336	<compound-id="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938">Cyclosporin A</compound-id> up-regulates and activates <protein-id="P13678,Q25378">protein kinase C</protein-id>-zeta in EBV-infected and EBV-transformed human B-cells.	Cyclosporin A__protein kinase C__interaction
18486150-337	We have proposed that <compound-id="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938">cyclosporin A</compound-id> (CsA), despite being a <protein-id="O88480,Q9Y6J0">calcineurin inhibitor</protein-id>, will activate <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	cyclosporin A__calcineurin inhibitor__interaction	cyclosporin A__PKC__interaction
18486994-189	Our results showed 2a, 2d and 2g as the most active compounds that inhibited the HIV-1 reverse <protein-id="O55528,O89344,P03523,P06447,P06829,P11205,P11213,P12576,P12577,P13179,P13615,P16289,P16379,P20894,P24658,P26676,P28887,P30929,P31332,P31352,P35262,P35341,P35946,P35975,P41357,Q03396,Q05318,Q06996,Q5XX01,Q66802,Q6V1Q2,Q88434,Q8JPX5,Q91DD4,Q997F0,Q9DUD8">transcriptase</protein-id> catalytic activity with cytotoxicity lower than <compound-id="35370">AZT</compound-id> and SI higher than DDC and DDI.	AZT__transcriptase__interaction
18487053-332	<compound-id="445154">Resveratrol</compound-id> (4,3',5'-trihydroxystilbene) is a naturally occurring antioxidant that inhibits <protein-id="O62664,O97554,P05979,P22437,P23219,Q63921">cyclooxygenase-1</protein-id> (<protein-id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</protein-id>), <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</protein-id> (<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>) and the transcription factor NF-kappaB.	Resveratrol__cyclooxygenase-2__interaction	Resveratrol__cyclooxygenase-1__interaction	Resveratrol__COX-1__interaction	Resveratrol__COX-2__interaction
18489490-99	After <compound-id="22880">NMDA</compound-id> stimulation of SV-FHAS and neoplastic astrocytes, real-time polymerase chain reaction showed an increase of the CPE, containing <protein-id="O73691,O73692,O73693,O73694,P08046,P08154,P18146,P26632,Q29W20">EGR-1</protein-id> splice variant only in astrocytoma cells.	NMDA__EGR-1__no_interaction
18489909-317	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of <compound-id="5280343">quercetin</compound-id> and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (<protein-id="P19320,P29533,P29534,Q28260">VCAM-1</protein-id>), intercellular adhesion molecule-1 (<protein-id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</protein-id>) and <protein-id="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">monocyte chemoattractant protein-1</protein-id> (<protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id>) in human umbilical artery smooth muscle cells (HUASMC) activated by <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id>).	quercetin__TNFalpha__interaction	quercetin__monocyte chemoattractant protein-1__interaction	quercetin__tumor necrosis factor__interaction	quercetin__ICAM-1__interaction	quercetin__MCP-1__interaction	quercetin__VCAM-1__interaction
18489909-318	<compound-id="5280343">Quercetin</compound-id> was able to reduce <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id>-induced upregulation of <protein-id="P19320,P29533,P29534,Q28260">VCAM-1</protein-id>, <protein-id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</protein-id> and <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id> at both the protein and transcript (mRNA) level in HUASMC.	Quercetin__TNFalpha__interaction	Quercetin__ICAM-1__interaction	Quercetin__MCP-1__interaction	Quercetin__VCAM-1__interaction
18489909-319	However the quercetin metabolites, <compound-id="5280362">quercetin 3'-sulfate</compound-id>, quercetin 3-glucuronide and 3'-methylquercetin 3-glucuronide, had no effect on <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id>-induced up regulation of adhesion molecule or chemokine expression, at either concentration tested.	quercetin 3'-sulfate__TNFalpha__no_interaction
18490188-482	In its active form, <compound-id="1132">thiamin pyrophosphate</compound-id> (TPP), it is a co-enzyme for several enzymes, including <protein-id="O06811,O67642,O83571,P29277,P29401,P34736,P40142,P43757,P45694,P46708,P47312,P50137,P51010,P56900,P57195,P58333,P59956,P66962,P66963,P75611,P84540,P99161,Q12630,Q52723,Q5HG77,Q5HPJ9,Q5R1W6,Q5R4C1,Q60HC7,Q6B855,Q6G9L6,Q6GH64,Q89AY2,Q8CPC7,Q8KA26,Q9KAD7">transketolase</protein-id>.	thiamin pyrophosphate__transketolase__interaction
18492032-354	Coexpression pattern with <protein-id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</protein-id> provides an indication that <compound-id="5280453">calcitriol</compound-id> could be the modulator of these adaptive responses to involution and dietary P restriction.	calcitriol__VDR__interaction
18492301-527	Dietary chia seed (Salvia hispanica L.) rich in <compound-id="5280934">alpha-linolenic acid</compound-id> improves adiposity and normalises hypertriacylglycerolaemia and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance in dyslipaemic rats.	alpha-linolenic acid__insulin__interaction
18492301-528	The present study investigates the benefits of the dietary intake of chia seed (Salvia hispanica L.) rich in <compound-id="5280934">alpha-linolenic acid</compound-id> and fibre upon dyslipidaemia and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance (IR), induced by intake of a <compound-id="5988">sucrose</compound-id>-rich (62.5 %) diet (SRD).	alpha-linolenic acid__insulin__interaction	sucrose__insulin__interaction
18492302-529	Pigs fed the high-<compound-id="866,5962">lysine</compound-id> diet moreover had an increased concentration of <compound-id="440121">trimethyllysine</compound-id> (TML), a reduced mRNA abundance of <protein-id="Q0VC74,Q5F4B3,Q91ZE0,Q91ZW6,Q96UB1,Q9NVH6">TML dioxygenase</protein-id> and reduced concentrations of <compound-id="134">gamma-butyrobetaine</compound-id> (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	lysine__TML dioxygenase__no_interaction	trimethyllysine__TML dioxygenase__no_interaction	gamma-butyrobetaine__TML dioxygenase__no_interaction
18494609-496	The cells exposed to 10 microM (<compound-id="5280893">15S)-HPETE</compound-id> for 3 h or to 40 microM (<compound-id="5280724">15S)-HETE</compound-id> for 6 h showed increased expression of <protein-id="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8">Fas ligand</protein-id> and <protein-id="P46310,Q13158">FADD</protein-id> (<protein-id="P25446,Q63199">Fas</protein-id>-associated death domain), caspase 8 activation, Bid (<protein-id="P55957,P70444,Q4JHS0,Q8JGM8,Q9JLT6">BH3-interacting domain death agonist</protein-id>) cleavage, decrease in mitochondrial membrane potential, <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> release, caspase 3 activation, <protein-id="P09874,P11103,P18493,P26446,P27008,Q7EYV7,Q9R152,Q9ZP54,Q9ZSV1">PARP-1</protein-id> [poly(<protein-id="P02783">ADP</protein-id>-ribose) polymerase-1] cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	15S)-HPETE__FADD__interaction	15S)-HPETE__Fas__interaction	15S)-HETE__BH3-interacting domain death agonist__interaction	15S)-HETE__Fas__interaction	15S)-HETE__ADP__interaction	15S)-HETE__cytochrome c__interaction	15S)-HETE__Fas ligand__interaction	15S)-HPETE__Fas ligand__interaction	15S)-HETE__FADD__interaction	15S)-HPETE__ADP__interaction	15S)-HETE__PARP-1__interaction	15S)-HPETE__cytochrome c__interaction	15S)-HPETE__BH3-interacting domain death agonist__interaction	15S)-HPETE__PARP-1__interaction
18495128-1028	<compound-id="1651,23190">3-Deazaadenosine</compound-id> inhibits vasa vasorum neovascularization in aortas of <protein-id="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8">ApoE</protein-id> (-/-)/LDL(-/-) double knockout mice.	3-Deazaadenosine__ApoE__no_interaction
18495129-1029	<compound-id="145858">Anthocyanin</compound-id> attenuates <protein-id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</protein-id>-mediated endothelial cell activation and apoptosis by inhibiting <protein-id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</protein-id>-induced <protein-id="O42781,P27638,Q00859">MAPK</protein-id> activation.	Anthocyanin__MAPK__interaction	Anthocyanin__CD40__interaction
18495129-1030	Treatment of ECs with anthocyanins cyanidin-3-O-beta-glucoside (Cy-3-g) and <compound-id="53398755">peonidin-3-O-beta-glucoside</compound-id> (Pn-3-g) prevents <protein-id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</protein-id>-induced endothelial activation by inhibiting production of proinflammatory cytokines and matrix metalloproteinases (MMPs).	peonidin-3-O-beta-glucoside__CD40__interaction
18495129-1031	Collectively, our findings suggested that the inhibition of <protein-id="P92208,Q966Y3">JNK</protein-id> and <protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</protein-id> activation interrupts <protein-id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</protein-id> induced endothelial cell activation and apoptosis, which thereby may represent a mechanism that would explain the anti-inflammatory response of <compound-id="145858">anthocyanin</compound-id> and its athero-protective function.	anthocyanin__p38__interaction	anthocyanin__JNK__interaction	anthocyanin__CD40__interaction
18495357-1187	Postsynaptic action of <compound-id="5957">ATP</compound-id> is mediated through metabotropic P2Y and ionotropic <protein-id="P13900,P16604">P2X</protein-id> receptors abundantly expressed in neural cells.	ATP__P2X__interaction
18495456-706	However, the <protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id> C677T genotype, alone or together with a diet, influenced <compound-id="248">betaine</compound-id> (P=.03) and phosphatidylcholine (P=.03).	betaine__MTHFR__interaction
18495456-707	In addition, the <protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id> C677T genotype appears to influence the direction and use of <compound-id="305">choline</compound-id> moieties in this group of women.	choline__MTHFR__interaction
18495458-1236	<compound-id="1203,72276,182232">Epicatechin</compound-id>-induced survival was a rapid event that was accompanied by early and sustained activation of major survival signaling proteins, such as AKT/phosphatidylinositol 3-kinase and extracellular-regulated kinase (activated from 5 min to 18 h), as well as <protein-id="P13678,Q25378">protein kinase C</protein-id> (<protein-id="P05130,P13677,P13678,P34722">PKC</protein-id>)-alpha (30 min to 18 h), in concert with unaltered c-<protein-id="P05627,P17325,P18289">jun</protein-id> N-amino terminal kinase levels and early inactivation of key death-related signals like <protein-id="P10829">PKC-delta</protein-id> (5 min to 18 h).	Epicatechin__jun__interaction	Epicatechin__PKC__interaction	Epicatechin__PKC-delta__interaction	Epicatechin__protein kinase C__interaction
18495460-1238	Phospholipidosis and down-regulation of the <protein-id="P19957">PI3</protein-id>-K/<protein-id="P22221,Q42736">PDK</protein-id>-1/<protein-id="P31750,Q8INB9">Akt</protein-id> signalling pathway are <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> inhibitable events associated with 7-ketocholesterol-induced apoptosis.	vitamin E__PI3__interaction	vitamin E__Akt__interaction	vitamin E__PDK__interaction
18495461-1165	Lack of <compound-id="445354">vitamin A</compound-id> significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell "cup" area relative to controls; decreased <protein-id="Q02817">MUC2</protein-id> mRNA expression in the jejunum, ileum and colon of VAD rats and increased <protein-id="Q02505">MUC3</protein-id> mRNA expression in the ileum and colon of these rats.	vitamin A__MUC2__interaction	vitamin A__MUC3__interaction
18495461-1166	In addition, <compound-id="445354">vitamin A</compound-id> deficiency down-regulated <protein-id="P17722,P37364,P80154,P80407,P81462,Q10745">defensin</protein-id> 6 mRNA expression while up-regulating toll-like receptors 2 and 5 mRNA expressions.	vitamin A__defensin__interaction
18495463-1243	<compound-id="969516">Curcumin</compound-id>, <compound-id="5324476">demethoxycurcumin</compound-id> and <compound-id="5315472">bisdemethoxycurcumin</compound-id> differentially inhibit cancer cell invasion through the down-regulation of MMPs and <protein-id="P00749,P04185,P06869,P15120,P16227,P29598,Q05589">uPA</protein-id>.	Curcumin__uPA__interaction	bisdemethoxycurcumin__uPA__interaction	demethoxycurcumin__uPA__interaction
18496518-35	<protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">Glucocorticoid receptor</protein-id> antagonism augments <compound-id="3386">fluoxetine</compound-id>-induced downregulation of the 5-HT transporter.	fluoxetine__Glucocorticoid receptor__interaction
18496518-37	In contrast, chronic <compound-id="3386">fluoxetine</compound-id> markedly decreased 5-<protein-id="P31645">HTT</protein-id> levels in all regions.	fluoxetine__HTT__interaction
18496518-38	This downregulation of 5-<protein-id="P31645">HTT</protein-id> by <compound-id="3386">fluoxetine</compound-id> and its enhancement by Org 34850 can explain our recent observation that GR antagonists augment the SSRI-induced increase in extracellular <compound-id="5202">5-HT</compound-id>.	5-HT__HTT__interaction	fluoxetine__HTT__interaction
18496650-691	Moreover, intestinal, colonic and caecal TBARS, LOOH, CD and also the antioxidants <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx), <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR) and <compound-id="124886">reduced glutathione</compound-id> (<compound-id="124886">GSH</compound-id>) were significantly diminished in DMH 0.05) elevated on simultaneous <compound-id="5281670">morin</compound-id> supplementation.	GSH__GST__no_interaction	morin__GST__interaction	morin__CAT__interaction	GSH__superoxide dismutase__no_interaction	morin__glutathione reductase__interaction	GSH__SOD__no_interaction	reduced glutathione__CAT__no_interaction	GSH__glutathione S-transferase__no_interaction	reduced glutathione__catalase__no_interaction	reduced glutathione__SOD__no_interaction	reduced glutathione__GST__no_interaction	GSH__CAT__no_interaction	GSH__glutathione reductase__no_interaction	morin__catalase__interaction	reduced glutathione__glutathione S-transferase__no_interaction	morin__glutathione S-transferase__interaction	GSH__glutathione peroxidase__no_interaction	reduced glutathione__superoxide dismutase__no_interaction	morin__superoxide dismutase__interaction	reduced glutathione__glutathione peroxidase__no_interaction	morin__glutathione peroxidase__interaction	reduced glutathione__glutathione reductase__no_interaction	morin__SOD__interaction	GSH__catalase__no_interaction
18496767-753	Using in vitro binding assays we have demonstrated that <protein-id="O70494,Q02447,Q90WR8">transcription factors Sp3</protein-id>, ZBP-89 and NF-Y are capable of binding to the <protein-id="P35713">SOX18</protein-id> promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by <compound-id="29051,163659,230076,6326719">mithramycin A</compound-id>.	mithramycin A__SOX18__interaction	mithramycin A__transcription factors Sp3__interaction
18496861-830	Treatment with <protein-id="P15316,P26831,P49370,P49371,Q08169,Q53591,Q54699,Q54873,Q59634,Q59801,Q9U6V9">hyaluronidase</protein-id> indicates that the dimensions of the small fibrils may be dependent upon the presence of <compound-id="24759">hyaluronan</compound-id> within the matrix.	hyaluronan__hyaluronidase__no_interaction
18496865-833	<compound-id="8925">Tetraglyme</compound-id> coatings reduce <protein-id="P22775,P81070">fibrinogen</protein-id> and <protein-id="Q62935">von Willebrand factor</protein-id> adsorption and platelet adhesion under both static and flow conditions.	Tetraglyme__fibrinogen__interaction	Tetraglyme__von Willebrand factor__interaction
18496865-834	Previous studies have showed that radio-frequency plasma deposited <compound-id="8925">tetraglyme</compound-id> coatings greatly reduced <protein-id="P22775,P81070">fibrinogen</protein-id> adsorption (Gamma(Fg)) from highly diluted plasmas (0.1 and 1%) and subsequent platelet adhesion under static conditions.	tetraglyme__fibrinogen__interaction
18497703-873	Effects of inhibition of <protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id>, <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>, and <protein-id="O19132,O61309,P29475,P29476,Q9Z0J4">nNOS</protein-id> by N-nitro-<compound-id="92932,550788">L-arginine methyl ester</compound-id> (L-NAME), <compound-id="2146">aminoguanidine</compound-id>, and <compound-id="1893">7-nitroindazole</compound-id>, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	7-nitroindazole__NOS__interaction	aminoguanidine__iNOS__interaction	L-arginine methyl ester__NOS__interaction	L-arginine methyl ester__nNOS__interaction	aminoguanidine__nNOS__interaction	aminoguanidine__NOS__interaction	L-arginine methyl ester__iNOS__interaction	7-nitroindazole__nNOS__interaction	7-nitroindazole__iNOS__interaction
18497707-589	Differential gene expression of <protein-id="P51617,Q62406">interleukin-1 receptor associated kinase-1</protein-id> and interleukin-1 receptor associated kinase-M in peripheral blood mononuclear cells of young and aged rats following preconditioning with <compound-id="44268108">endotoxin</compound-id>.	endotoxin__interleukin-1 receptor associated kinase-1__interaction
18497707-590	The IL-1 receptor-associated kinase 1 (<protein-id="P51617,Q62406">IRAK-1</protein-id>) and <protein-id="Q8K4B2,Q9Y616">IRAK-M</protein-id> are key signaling molecules in cellular responses to <compound-id="44268108">endotoxin</compound-id> initiated through the Toll-like receptors (<protein-id="P23799">TLRs</protein-id>).	endotoxin__IRAK-M__interaction	endotoxin__TLRs__interaction	endotoxin__IRAK-1__interaction
18497707-591	The aim of this study was to evaluate the effect of age on the modulation of <protein-id="P23799">TLRs</protein-id> and <protein-id="P51617,Q62406">IRAK-1</protein-id> and <protein-id="Q8K4B2,Q9Y616">IRAK-M</protein-id> in peripheral blood mononuclear cells (PBMCs) exposed in vitro to <compound-id="44268108">endotoxin</compound-id> under conditions that could induce <compound-id="44268108">endotoxin</compound-id> tolerance.	endotoxin__IRAK-M__interaction	endotoxin__IRAK-1__interaction	endotoxin__TLRs__interaction
18497709-959	We also previously demonstrated that <compound-id="738,5961">glutamine</compound-id> (GLN) significantly induced <protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id> in the lower intestinal tract.	glutamine__HO-1__interaction
18497709-961	<compound-id="738,5961">Glutamine</compound-id> treatment before <compound-id="5047209,46173182">HS</compound-id> (MAP of 30 mmHg for 60 min) significantly ameliorated <compound-id="5047209,46173182">HS</compound-id>-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> and <protein-id="P10417,P49950">Bcl-2</protein-id>.	Glutamine__IL-10__interaction	Glutamine__TNF-alpha__interaction	HS__IL-10__interaction	Glutamine__iNOS__interaction	HS__iNOS__interaction	Glutamine__Bcl-2__interaction	HS__Bcl-2__interaction	HS__TNF-alpha__interaction
18497709-964	<compound-id="738,5961">Glutamine</compound-id> treatment may thus protect mucosal cells from HS-induced oxidative damage via the anti-inflammatory and antiapoptotic properties of <protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id>.	Glutamine__HO-1__interaction
18498083-305	In this work, we identified a high affinity and potency metallocene-containing <compound-id="67516">triazole</compound-id> peptide conjugate that suppresses the interactions of HIV-1 envelope <protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</protein-id> at both its <protein-id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</protein-id> and co-receptor binding sites.	triazole__CD4__interaction	triazole__gp120__interaction
18498083-306	Surface plasmon resonance interaction analysis revealed that, compared to a previously reported phenyl-containing <compound-id="67516">triazole</compound-id> conjugate <compound-id="25085904">HNG-105</compound-id> (105), peptide 156 had a higher direct binding affinity for several subtypes of HIV-1 gp120 due mainly to the decreased dissociation rate of the conjugate-<protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</protein-id> complex.	HNG-105__gp120__no_interaction	triazole__gp120__no_interaction
18498083-307	The ferrocene <compound-id="67516">triazole</compound-id> conjugate bound to <protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</protein-id> of both clade A (92UG037-08) and clade B (YU-2 and SF162) virus subtypes with nanomolar KD in direct binding and inhibited the binding of <protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</protein-id> to soluble <protein-id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</protein-id> and to antibodies that bind to HIV-1YU-2 gp120 at both the <protein-id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</protein-id> binding site and <protein-id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</protein-id>-induced binding sites.	triazole__CD4__no_interaction	triazole__gp120__interaction
18498357-470	Screening of risk factors for thromboembolism revealed that all patients carried a <protein-id="P42898,Q5I598,Q60HE5,Q9WU20">methylenetetrahydrofolate reductase</protein-id> 677C--&gt;T (<protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id>) mutation in a gene involved in folate metabolism, and either borderline or elevated <compound-id="778">homocysteine</compound-id> levels.	homocysteine__methylenetetrahydrofolate reductase__no_interaction	homocysteine__MTHFR__no_interaction
18498673-382	Circulating <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> was negatively correlated with mRNA expression of adiponectin, <protein-id="O02671,O15243,P48357,Q9MYL0">LEPR</protein-id> and <protein-id="O46647,P06858,P11151,P11152,P11153,P11602,P49060,P49923,P55031,Q06000,Q29524">LPL</protein-id>, whereas <compound-id="853,5819">thyroxine</compound-id> was positively correlated with levels of <protein-id="Q865B6,Q865B7,Q9UBK2">PPARGC1A</protein-id>.	thyroxine__LPL__no_interaction	thyroxine__leptin__no_interaction	thyroxine__PPARGC1A__interaction	thyroxine__LEPR__no_interaction
18500430-564	In the absence of exogenous <compound-id="271">Ca(2</compound-id>+) and Mg(2+) and in the presence of <compound-id="6207">EGTA</compound-id>, which favours the release of endogenous <compound-id="271">Ca(2</compound-id>+), the polyamine <compound-id="1103">spermine</compound-id> is able to stimulate the activity of pyruvate dehydrogenase complex (<protein-id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</protein-id>) of energized rat liver mitochondria (RLM).	spermine__PDC__interaction	Ca(2__PDC__no_interaction	EGTA__PDC__no_interaction
18500430-565	At concentrations higher than 0.5 mM, <compound-id="1103">spermine</compound-id> still stimulates <protein-id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</protein-id>, when compared with the control, but shows a slight dose-dependent decrease.	spermine__PDC__interaction
18500430-566	Changes in <protein-id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</protein-id> stimulation are very close to the phosphorylation level of the E(1alpha) subunit of <protein-id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</protein-id>, which regulates the activity of the complex, but it is also the target of <compound-id="1103">spermine</compound-id>.	spermine__PDC__interaction
18500430-567	These results provide the first evidence that, when transported in RLM, <compound-id="1103">spermine</compound-id> can interact in various ways with <protein-id="O77560,P06672,P19632,P20941,P28516,P34734,P41686,P51845,P51846,P51847,P51848,P51849,P51850,P51851,Q05326,Q05327,Q6FJA3,Q9XS39">PDC</protein-id>, showing dose-dependent behaviour.	spermine__PDC__interaction
18500522-58	This study assessed relationships between <protein-id="Q9P121">hNT</protein-id> levels and <compound-id="657237">fludarabine</compound-id> uptake and cytotoxicity in cultures of human renal proximal tubule cells (hRPTCs) that produce multiple transporter types.	fludarabine__hNT__interaction
18502597-1034	Multiple metabolic and neuroendocrine mechanisms are responsible for the CR-mediated anti-inflammatory effects, including reduced adiposity and secretion of pro-inflammatory adipokines, enhanced glucocorticoid production, reduced plasma <compound-id="206,5793,64689,79025">glucose</compound-id> and advanced glycation end-product concentrations, increased parasympathetic tone, and increased <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> production.	glucose__ghrelin__interaction
18503570-926	From the known regulatory mechanisms of Arc expression, HFD reduced <protein-id="P35439,Q9R1M7">N-methyl-D-aspartate receptor</protein-id> (NMDAR) activity, as seen by decreases in <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of <protein-id="P35436,Q00959,Q12879,Q5IS45">NMDAR2A</protein-id> and levels of <protein-id="Q05586,Q5R1P0">NMDAR1</protein-id>.	tyrosine__NMDAR2A__interaction	tyrosine__N-methyl-D-aspartate receptor__interaction	tyrosine__NMDAR1__no_interaction
18503570-927	Additionally, we demonstrated that <compound-id="99470,123976,50990021">27-hydroxycholesterol</compound-id>, a <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> metabolite that enters the brain from the blood, decreases Arc levels as well as NMDAR and <protein-id="P05480,Q9WUD9">Src</protein-id> kinase activities in rat primary hippocampal neurons.	cholesterol__Src__no_interaction	27-hydroxycholesterol__Src__interaction
18505747-21	<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">Cyclooxygenase-2</protein-id>, an inducible enzyme important in inflammation, catalyzes the production of prostanoids from <compound-id="444899">arachidonic acid</compound-id>.	arachidonic acid__Cyclooxygenase-2__interaction
18506596-495	cDNA probes have been developed for subsequent use in monitoring the <compound-id="23973">cadmium</compound-id> exposure of the clam Ruditapes decussatus and the cockle Cerastoderma glaucum using <protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</protein-id> (MT) gene expression in different tissues of these species.	cadmium__metallothionein__no_interaction
18506630-727	Purified <protein-id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">lignin peroxidase</protein-id> was able to oxidize a variety of substrates including <compound-id="27854">Mn2</compound-id>+, <compound-id="1148,6305,9060,5460840">tryptophan</compound-id>, <compound-id="3862">mimosine</compound-id>, <compound-id="6047">L-Dopa</compound-id>, <compound-id="785">hydroquinone</compound-id>, xylidine, <compound-id="1031">n-propanol</compound-id>, <compound-id="7118">veratryl alcohol</compound-id>, and ten textile dyes of various groups indicating as a versatile <protein-id="P15984,P16147,P84714">peroxidase</protein-id>.	n-propanol__lignin peroxidase__interaction	hydroquinone__peroxidase__no_interaction	hydroquinone__lignin peroxidase__interaction	Mn2__lignin peroxidase__interaction	veratryl alcohol__peroxidase__no_interaction	Mn2__peroxidase__no_interaction	L-Dopa__peroxidase__no_interaction	mimosine__lignin peroxidase__interaction	tryptophan__peroxidase__no_interaction	L-Dopa__lignin peroxidase__interaction	veratryl alcohol__lignin peroxidase__interaction	mimosine__peroxidase__no_interaction	n-propanol__peroxidase__no_interaction	tryptophan__lignin peroxidase__interaction
18506630-728	<compound-id="1148,6305,9060,5460840">Tryptophan</compound-id> stabilizes the <protein-id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">lignin peroxidase</protein-id> activity during decolorization of dyes.	Tryptophan__lignin peroxidase__interaction
18506631-523	To achieve enzymatic production of <compound-id="5281">calcium-stearate</compound-id> at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable <protein-id="Q7M4U7">lipase</protein-id> was selected and reaction conditions were optimized using calcium <compound-id="961">hydroxide</compound-id> and hydrogenated beef tallow as substrates.	hydroxide__lipase__interaction	calcium-stearate__lipase__interaction
18506631-524	Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into <compound-id="5281">calcium-stearate</compound-id> by using commercial <protein-id="Q7M4U7">lipase</protein-id> SDL 451.	calcium-stearate__lipase__interaction
18506760-597	<compound-id="2662">Celecoxib</compound-id> could selectively inhibited <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> expression and <compound-id="5280360">PGE2</compound-id> production.	Celecoxib__COX-2__interaction	PGE2__COX-2__no_interaction
18506760-598	<compound-id="2662">Celecoxib</compound-id> also inhibited p(473Ser) <protein-id="P31750,Q8INB9">Akt</protein-id>, <protein-id="P09560,P11345,Q80VX4,Q8C0C0">raf</protein-id> and <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> expression, and induced apoptosis by release of <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> and activation of caspase 9, 3, and 6, which were more remarkably in HBx positive cells than in control cells.	Celecoxib__cytochrome c__interaction	Celecoxib__Akt__interaction	Celecoxib__raf__interaction	Celecoxib__p53__interaction
18506817-653	It has been proposed as a substrate of P-<protein-id="P08163">glycoprotein</protein-id> (P-gp), an efflux transporter, that may contribute to limit <compound-id="5362440">indinavir</compound-id> bioavailability.	indinavir__glycoprotein__interaction
18508255-264	We found that ZPDC <protein-id="P08163">glycoprotein</protein-id> has significant scavenging effect on the production of intracellular <compound-id="784">H2O2</compound-id> without cytotoxicity in G/GO-or HX/XO-treated in Chang liver cells.	H2O2__glycoprotein__interaction
18509327-948	However, the simultaneous presence of the <protein-id="P08684">CYP3A4</protein-id> *1B and <protein-id="P20815">CYP3A5</protein-id> *1A alleles was associated with a 64% increase in <compound-id="148124">docetaxel</compound-id> clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	docetaxel__CYP3A4__interaction	docetaxel__CYP3A5__interaction
18509591-45	It was found that <compound-id="1123">taurine</compound-id> administration produced lower levels of <protein-id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</protein-id> and alkaline aminotransferase than that of the untreated group.	taurine__aspartate aminotransferase__interaction
18509591-46	In addition, the levels of hepatic total protein, <compound-id="124886">glutathione</compound-id> and <protein-id="O50258">superoxide dismutase</protein-id> were higher in the <compound-id="1123">taurine</compound-id> treated groups than those in the untreated control or the <compound-id="1123">taurine</compound-id> depleted groups, while hepatic <compound-id="10964">malondialdehyde</compound-id> content exhibited the negative effect.	taurine__superoxide dismutase__interaction	malondialdehyde__superoxide dismutase__interaction	glutathione__superoxide dismutase__no_interaction
18509591-47	Moreover, the concentrations of hepatic <compound-id="825,5810,69248,440015">hydroxyproline</compound-id>, serum <compound-id="24759,453618,3084050,24728612">hyaluronic acid</compound-id>, interleukin-2, <protein-id="P41693">interleukin-6</protein-id>, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha and <compound-id="44342165">laminin</compound-id> were all decreased in the <compound-id="1123">taurine</compound-id> treated groups.	laminin__interleukin-6__no_interaction	hyaluronic acid__interleukin-6__no_interaction	taurine__tumor necrosis factor__interaction	hydroxyproline__interleukin-6__no_interaction	taurine__interleukin-6__interaction	laminin__tumor necrosis factor__no_interaction	hydroxyproline__tumor necrosis factor__no_interaction	hyaluronic acid__tumor necrosis factor__no_interaction
18509644-1152	Pharmacological (<compound-id="5287969">flavopiridol</compound-id>) and molecular (shRNA) transcription inhibitor were used to impede formation of <protein-id="P08581,Q07DV8,Q07DY1,Q07DZ1,Q07E01,Q07E24,Q07E37,Q07E48,Q09YH7,Q09YI9,Q09YK0,Q09YL1,Q09YN5,Q108U6,Q2IBA6,Q2IBC0,Q2IBD8,Q2IBF2,Q2IBG7,Q2QL89,Q2QLA9,Q2QLC0,Q2QLE0,Q2QLF1,Q2QLG5,Q2QLH6,Q42662,Q75ZY9">MET</protein-id> transcripts.	flavopiridol__MET__interaction
18509748-1206	Effect of small interference RNA targeting <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id> mediated by rAAV combined <compound-id="54690394">L:-ascorbate</compound-id> on pancreatic tumors in athymic mice.	L: -ascorbate__HIF-1alpha__interaction
18509748-1207	Moreover, rAAV-siHIF and <compound-id="54690394">L:-ascorbate</compound-id> could all inhibit the secretion of vascular <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>.	L: -ascorbate__VEGF__interaction
18509748-1208	These results suggest that rAAV-siHIF and <compound-id="54690394">L:-ascorbate</compound-id> can inhibit the growth of nude mice xenograft tumor and <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id> could be a target of pancreatic cancer genetic and pharmacological therapy.	L: -ascorbate__HIF-1alpha__no_interaction
18511076-738	Changes in <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> serum levels in patients with major depression disorder (MDD) after 6 months treatment with <compound-id="68617">sertraline</compound-id>, <compound-id="146570">escitalopram</compound-id>, or <compound-id="5656">venlafaxine</compound-id>.	venlafaxine__BDNF__interaction	sertraline__BDNF__interaction	escitalopram__BDNF__interaction
18511076-739	We assessed serum <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> levels in 21 patients with major depressive episode treated with <compound-id="68617">sertraline</compound-id>, <compound-id="146570">escitalopram</compound-id>, or <compound-id="5656">venlafaxine</compound-id> and 20 healthy controls.	venlafaxine__BDNF__interaction	sertraline__BDNF__interaction	escitalopram__BDNF__interaction
18511076-740	<compound-id="68617">Sertraline</compound-id> increased <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> levels after 5 weeks and 6 months of treatment.	Sertraline__BDNF__interaction
18511076-741	<compound-id="5656">Venlafaxine</compound-id> increased <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> levels only after 6 months.	Venlafaxine__BDNF__interaction
18511076-742	<compound-id="146570">Escitalopram</compound-id> did not affect <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> levels at either time point.	Escitalopram__BDNF__no_interaction
18513727-1142	The increase of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> was accompanied by a marked posttranslational down-regulation of liver <protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> expression.	cholesterol__SR-BI__interaction
18513727-1143	Taken together, a diet-induced increase of plasma and hepatic <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels leads to a posttranscriptional down-regulation of <protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> in mouse liver via a mechanism likely involving <protein-id="Q3T0X8,Q5RCF7,Q5T2W1,Q865P3">PDZK1</protein-id>.	cholesterol__PDZK1__interaction	cholesterol__SR-BI__interaction
18513857-1213	A 5.5 kilobase-pair (kbp) <protein-id="Q09750">Pst1</protein-id>-Kpn1 fragment containing gene(s) encoding for <compound-id="5281576">zearalenone</compound-id> degradation was cloned.	zearalenone__Pst1__interaction
18514659-430	However, <compound-id="5280497">TXA(2</compound-id>) formation remains elevated in patients with cardiovascular disease on doses of <compound-id="2244">aspirin</compound-id> that fully suppress platelet <protein-id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</protein-id>, suggesting other tissue sources for <compound-id="5280497">TXA(2</compound-id>) formation.	aspirin__COX-1__interaction	TXA(2__COX-1__no_interaction
18514900-1098	) production increased; <protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</protein-id> (MT) and <compound-id="124886">glutathione</compound-id> levels increased in most cases, and <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (<protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>) activity decreased in summer.	glutathione__metallothionein__no_interaction	glutathione__AChE__no_interaction	glutathione__acetylcholinesterase__no_interaction
18515453-577	From these findings, it is suggested that <compound-id="3116">distigmine bromide</compound-id> may produce centrally mediated behavioural signs by increasing the ACh levels in the brain, resulting from its <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> and BuChE inhibitions.	distigmine bromide__AChE__interaction
18515457-594	Using DBA/2OlaHsd mice, we investigated the effects of chronic social defeat and concomitant treatment with <compound-id="9821250">R121919</compound-id>/<compound-id="720051">NBI</compound-id> 30775 on 1) the behavioural profile in the modified hole board test and 2) in-situ hybridization analysis-based expression of arginine vasopressin (<protein-id="P01180,P01181,P01182,P01183,P01184,P01185,P10769,P31414,P81768">AVP</protein-id>) and <protein-id="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1">CRH</protein-id> mRNA in both the hypothalamic paraventricular nucleus and supraoptic nucleus.	NBI__AVP__interaction	NBI__CRH__interaction	R121919__CRH__interaction	R121919__AVP__interaction
18515973-10	<compound-id="91474">7-Ketocholesterol</compound-id> also enhanced <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> release from VSMC.	7-Ketocholesterol__IL-6__interaction
18515973-11	<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> release by <compound-id="91474">7-ketocholesterol</compound-id>, although significant, was not as remarkable as that induced by <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>.	7-ketocholesterol__IL-6__interaction	7-ketocholesterol__TNF-alpha__no_interaction
18515973-12	These data suggest that <compound-id="91474">7-ketocholesterol</compound-id> upregulates <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> via mechanisms distinct from <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> and contributes to the intra- and extracellular <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> deposits within the vasculature.	7-ketocholesterol__IL-6__interaction	7-ketocholesterol__TNF-alpha__no_interaction
18515973-3	<compound-id="91474">7-Ketocholesterol</compound-id> upregulates <protein-id="P41693">interleukin-6</protein-id> via mechanisms that are distinct from those of <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha, in vascular smooth muscle cells.	7-Ketocholesterol__interleukin-6__interaction	7-Ketocholesterol__tumor necrosis factor__no_interaction
18515973-4	Among the 7 IL examined, only <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> transcript was increased by <compound-id="91474">7-ketocholesterol</compound-id> treatment in human aorta smooth muscle cells.	7-ketocholesterol__IL-6__interaction
18515973-5	<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> transcripts increased up to 24 h after treatment with <compound-id="91474">7-ketocholesterol</compound-id>, and this effect was profoundly repressed by treatment with p38 MAPK inhibitors and to a lesser extent JNK inhibitors.	7-ketocholesterol__IL-6__interaction
18515973-6	<compound-id="107722">7alpha-Hydroxycholesterol</compound-id>, <compound-id="99470,123976,50990021">27-hydroxycholesterol</compound-id> or <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, however, did not induce <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> expression.	7alpha-Hydroxycholesterol__IL-6__no_interaction	cholesterol__IL-6__no_interaction	27-hydroxycholesterol__IL-6__no_interaction
18515973-7	Mechanisms of <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> induction by <compound-id="91474">7-ketocholesterol</compound-id> were investigated in comparison with <protein-id="Q8JFG3">tumor necrosis factor</protein-id> (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>)-alpha.	7-ketocholesterol__IL-6__interaction	7-ketocholesterol__TNF__no_interaction	7-ketocholesterol__tumor necrosis factor__no_interaction
18515973-8	Whereas <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> activated <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> promoter, which was impaired by p38 MAPK inhibitors or by mutation in the NF-kappaB-binding site within the promoter region, <compound-id="91474">7-ketocholesterol</compound-id> did not affect <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> promoter activity.	7-ketocholesterol__TNF-alpha__no_interaction	7-ketocholesterol__IL-6__no_interaction
18515973-9	<compound-id="91474">7-ketocholesterol</compound-id> significantly increased the amount of intracellular <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> protein in the presence of <compound-id="5287620">brefeldin A</compound-id>.	7-ketocholesterol__IL-6__interaction	brefeldin A__IL-6__interaction
18521540-51	<compound-id="216325">AGI-1067</compound-id> is a novel, phenolic antioxidant, and vascular protectant which dose-dependently inhibits <protein-id="P0C1A8,P0C1A9">PEA</protein-id> biomarkers in vitro.	AGI-1067__PEA__interaction
18521605-224	<compound-id="3637">Hydralazine</compound-id> inhibits human cervical cancer cell growth in vitro in association with <protein-id="P25054">APC</protein-id> demethylation and re-expression.	Hydralazine__APC__interaction
18521605-225	Clinically, it has been approved that DNA methylation inhibitors, such as <compound-id="451668">5-aza-2'-deoxycytidine</compound-id> (<compound-id="451668">5-Aza-dC</compound-id>), can reverse <protein-id="P25054">APC</protein-id> promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.	5-aza-2'-deoxycytidine__APC__interaction	5-Aza-dC__APC__interaction
18521740-1013	The androgen metabolite <compound-id="242332">5alpha- androstane-3beta,17beta-diol</compound-id> (3betaAdiol) induces breast cancer growth via <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> : implications for aromatase inhibitor resistance.	5alpha-androstane-3beta,17beta-diol__estrogen receptor__interaction
18521740-1015	Lastly, we found that the downstream metabolite of <compound-id="10635">5alpha-dihydrotestosterone</compound-id>, <compound-id="242332">5alpha- androstane-3beta,17beta-diol</compound-id> (3betaAdiol), is estrogenic in breast cancer cells, and induces growth and ER-signaling via activation of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id>.	5alpha-dihydrotestosterone__ERalpha__interaction	5alpha-androstane-3beta,17beta-diol__ERalpha__interaction
18521741-219	Here we demonstrate that an AR ligand, <compound-id="15,10635">5-alpha-dihydrotestosterone</compound-id> (<compound-id="10635">DHT</compound-id>), inhibits MCF-7 breast cancer cell growth induced by <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> like growth factor 1 (<protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id>).	5-alpha-dihydrotestosterone__IGF-I__interaction	DHT__insulin__interaction	5-alpha-dihydrotestosterone__insulin__interaction	DHT__IGF-I__interaction
18521748-1184	Here, we constructed variants to test whether any of these motifs may explain why <protein-id="O94759">TRPM2</protein-id>-DeltaN does not respond to stimulation with either ADP ribose or <compound-id="784">hydrogen peroxide</compound-id>.	hydrogen peroxide__TRPM2__no_interaction
18521846-1089	We found that <compound-id="66414">2-methoxyestradiol</compound-id> induced the activation of <protein-id="P92208,Q966Y3">JNK</protein-id>, <protein-id="P29323">ERK</protein-id>, and <protein-id="O62618">p38 MAPKs</protein-id>.	2-methoxyestradiol__ERK__interaction	2-methoxyestradiol__p38 MAPKs__interaction	2-methoxyestradiol__JNK__interaction
18521846-1090	<compound-id="66414">2-methoxyestradiol</compound-id>-induced <protein-id="P92208,Q966Y3">JNK</protein-id> activation was associated with the induction of apoptosis through the mitochondrial pathways as a result of increased phosphorylation (inactivation) of the anti-apoptotic <protein-id="P10417,P49950">Bcl-2</protein-id> and Bcl-xL proteins.	2-methoxyestradiol__Bcl-2__interaction	2-methoxyestradiol__JNK__interaction
18521846-1091	In comparison, <compound-id="66414">2-methoxyestradiol</compound-id>-induced activation of <protein-id="P29323">ERK</protein-id> and <protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</protein-id> in these cells was found to have a protective effect against 2-MeO-E(2)-induced apoptosis.	2-methoxyestradiol__ERK__interaction	2-methoxyestradiol__p38__interaction
18521846-1093	Mechanistically, inhibition of <protein-id="P29323">ERK</protein-id> and <protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</protein-id> activity was associated with activation of various caspases and <protein-id="O50017,P08469,P14043,P31669,P35875,P55057,Q08824,Q11208">PARP</protein-id> cleavage, and it also stabilized the pro-apoptotic <protein-id="P27297">proteins Bax</protein-id> and <protein-id="O54918,O88498">Bim</protein-id>, thereby preventing them from degradation during <compound-id="66414">2-methoxyestradiol</compound-id> treatment.	2-methoxyestradiol__ERK__no_interaction	2-methoxyestradiol__proteins Bax__no_interaction	2-methoxyestradiol__PARP__no_interaction	2-methoxyestradiol__Bim__no_interaction	2-methoxyestradiol__p38__no_interaction
18521859-1108	Accumulating evidence suggests that <compound-id="53477912">phosphatidylinositol</compound-id> (PI) pathways have been involved in the secretion of <compound-id="681">dopamine</compound-id> (DA) and the regulation of <protein-id="P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DA transporter</protein-id>, which is a target of <compound-id="1206,10836,36604">methamphetamine</compound-id> (METH).	dopamine__DA transporter__no_interaction	methamphetamine__DA transporter__interaction	phosphatidylinositol__DA transporter__interaction
18522674-789	<compound-id="2662">Celecoxib</compound-id> caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (<protein-id="Q29458">PGE</protein-id> (2)) concentrations, accompanied by a compensatory increase in <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> mRNA expression.	Celecoxib__COX-2__interaction	Celecoxib__PGE__interaction
18522674-790	However, <compound-id="2662">celecoxib</compound-id> had no effect on <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric-oxide synthase</protein-id>.	celecoxib__COX-2__no_interaction	celecoxib__nitric-oxide synthase__no_interaction
18522674-791	These data indicate that <compound-id="2662">celecoxib</compound-id> reduces intratesticular activity of <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> (as indicated by <protein-id="Q29458">PGE</protein-id> (2) levels) and inhibits IF formation in the testis, but has no appreciable effect on steroidogenesis or spermatogenesis, at least in the short term.	celecoxib__COX-2__interaction	celecoxib__PGE__no_interaction
18522674-792	These results indicate significant roles for products of the <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> pathway in testicular vascular control and steroidogenesis, which may have implications for men with marginal fertility taking <compound-id="2662">celecoxib</compound-id> for extended periods, but also highlight the potential of this drug to ameliorate testicular damage caused by systemic or local inflammation.	celecoxib__COX-2__interaction
18528683-286	At the end of the experiment (after 6 weeks), lung histological changes, collagen staining, the activity of <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR) and contents of <compound-id="124886">reduced glutathione</compound-id> (<compound-id="124886">GSH</compound-id>) and <compound-id="825,5810,69248,440015">hydroxyproline</compound-id> (Hpr) in the lung as well as serum level of <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>) were evaluated.	hydroxyproline__TNF-alpha__no_interaction	reduced glutathione__TNF-alpha__no_interaction	reduced glutathione__glutathione reductase__no_interaction	GSH__TNF-alpha__no_interaction	reduced glutathione__tumor necrosis factor__no_interaction	GSH__glutathione reductase__no_interaction	hydroxyproline__tumor necrosis factor__no_interaction	hydroxyproline__glutathione reductase__no_interaction	GSH__tumor necrosis factor__no_interaction
18528683-287	The obtained data revealed that <compound-id="2578">BCNU</compound-id> induced pathological changes and markedly increased lung collagen and level of <protein-id="P0AA04,P0AA07,P11065,P77335">Hpr</protein-id> but decreased <compound-id="124886">GSH</compound-id> content and GR activity and increased serum <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> compared to both control and MT-administered rats.	GSH__Hpr__no_interaction	BCNU__Hpr__interaction	BCNU__TNF-alpha__interaction	GSH__TNF-alpha__no_interaction
18528747-574	Collectively, <protein-id="P06116">HMB</protein-id> supplementation increased concentrations of <compound-id="176">short-chain fatty acids</compound-id> in intestinal lumen, expression of proglucagon, <protein-id="O95838,Q9Z0W0">GLP-2R</protein-id>, and <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id> genes, and net portal absorption of AA.	short-chain fatty acids__HMB__no_interaction	short-chain fatty acids__GLP-2R__no_interaction	short-chain fatty acids__eNOS__no_interaction
18528783-293	In search for the pharmacophore and to analyze structure-activity relationships we synthesized a series of truncated derivatives and analogs of <compound-id="656725">RB-2</compound-id>, including 1-amino-2-sulfo-4-ar(alk)ylaminoanthraquinones, 1-amino-2-methyl-4-arylaminoanthraquinones, <compound-id="22628">1-amino-4-bromoanthraquinone 2-sulfonic acid</compound-id> esters and sulfonamides, and bis-(1-amino-4-bromoanthraquinone) sulfonamides, and investigated them in preparations of rat <protein-id="O18956,O93295,P49961,P55772,P97687,Q9MYU4">NTPDase1</protein-id>, 2, and 3 using a capillary electrophoresis assay.	1-amino-4-bromoanthraquinone 2-sulfonic acid__NTPDase1__interaction	RB-2__NTPDase1__interaction
18533896-944	Plasma <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> 0.05) following ingestion of GluF than after Glu alone, without any differences between the effects of either intervention on plasma <compound-id="206,5793,64689,79025">glucose</compound-id> concentrations.	glucose__insulin__no_interaction
18534791-223	No significant differences were observed in plasma concentrations of <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="P80303">NEFA</protein-id>, and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-like growth factor or hepatic triglyceride content, but all supplements tended to decrease <compound-id="441">beta hydroxybutyrate</compound-id> postpartum compared to CTL cows.	glucose__NEFA__no_interaction	beta hydroxybutyrate__insulin__no_interaction	glucose__insulin__no_interaction	beta hydroxybutyrate__NEFA__no_interaction
18534811-234	The results showed that <compound-id="2833,6167,53278">colchicine</compound-id> augmented splenic-specific IgG1 and <protein-id="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58">IL-4</protein-id> as well as cell proliferation but suppressed specific IgG2a and <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> levels.	colchicine__IFN-gamma__interaction	colchicine__IL-4__interaction
18534874-957	<compound-id="5329102">Sunitinib malate</compound-id> (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, <protein-id="Q00342">Flt3</protein-id>, <protein-id="P07949">RET</protein-id>, and Kit.	Sunitinib malate__RET__interaction	Sunitinib malate__Flt3__interaction	Sunitinib malate__VEGF__interaction
18536700-664	<protein-id="P97738">Narp</protein-id> deletion blocks extinction of <compound-id="5288826,5479215">morphine</compound-id> place preference conditioning.	morphine__Narp__interaction
18536700-665	Accordingly, to assess its potential role in the long-lasting behavioral effects of drugs of abuse, we have investigated the impact of <protein-id="P97738">Narp</protein-id> deletion on sustained behavioral responses elicited by repeated <compound-id="5288826,5479215">morphine</compound-id> administration.	morphine__Narp__no_interaction
18536704-162	Decreased <protein-id="P21917,P30729,P51436,Q6TLJ0">dopamine D4 receptor</protein-id> expression increases extracellular <compound-id="611,23327,33032">glutamate</compound-id> and alters its regulation in mouse striatum.	glutamate__dopamine D4 receptor__interaction
18536705-163	injection of <protein-id="O70176,P13589,P16613,P18509,P41535,P41585,P48144,P81039,Q29W19">PACAP</protein-id> provoked a significant increase in plasma <compound-id="206,5793,64689,79025">glucose</compound-id> level.	glucose__PACAP__interaction
18536954-285	In 17 adults on a fixed metabolic diet, an 11-day course of <compound-id="156419">cinacalcet</compound-id> increased serum <protein-id="O02686,P01350,P01351,P01352,P01353,P01354,P04563,P04564,P06885,P10034,P33713,P33714,P48757,P55885">gastrin</protein-id> and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	cinacalcet__gastrin__interaction
18537150-81	Since <compound-id="5281884">PSC-833</compound-id> was found to be a weak inhibitor of CYP 3A4 and to have no inhibitory effects on <protein-id="P16397,P18773">esterases</protein-id>, <protein-id="P17988,P50227,P52840,P52846,P82609,Q29476,Q80VR3">phenol sulfotransferases</protein-id>, and glucuronyltransferases, it is suggested <compound-id="5281884">PSC-833</compound-id> enhances intestinal mucosal permeation of these cyclic prodrugs by inhibiting their polarized efflux and not by inhibiting their metabolism.	PSC-833__phenol sulfotransferases__no_interaction	PSC-833__esterases__no_interaction
18538372-777	We showed that after treatment of HCT116 cells with a low dose of <compound-id="31703">doxorubicin</compound-id> most of them stopped proliferation as documented by SA-<protein-id="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6">beta-galactosidase</protein-id> activity and the lack of Ki67 expression.	doxorubicin__beta-galactosidase__interaction
18538372-778	The vast majority of the <compound-id="31703">doxorubicin</compound-id>-treated cells did not enter mitoses, as evidenced by mitotic index analysis, as well as by the predominantly cytoplasmic localization of <protein-id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</protein-id> B1 and a lack of separation of multiplied centrosomes.	doxorubicin__cyclin__no_interaction
18538450-1221	Molecular modeling of the binding of the <compound-id="7583">diphenyl ether</compound-id> derivatives on enoyl-<protein-id="O14561,O19921,O34163,O51647,O67611,O69475,O83786,O84239,P07088,P08971,P0A001,P0A002,P0A003,P0A199,P0A1A0,P0A2W0,P0A2W1,P0A2W2,P0A2W3,P0A4W6,P0A4W7,P0A6A8,P0A6A9,P0A6B0,P0A6B1,P0A6B2,P0A6B3,P10352,P10977,P11829,P11830,P11943,P12784,P12884,P12885,P17650,P19372,P20803,P20804,P23153,P25701,P25702,P27060,P29189,P32463,P32887,P41174,P43677,P43709,P47529,P48078,P49517,P51280,P52411,P52412,P52413,P52414,P52505,P53665,P56464,P57433,P58553,P59449,P61156,P63437,P63438,P63439,P63440,P63441,P63442,P63443,P63444,P63445,P63446,P63447,P63448,P63449,P63452,P63453,P75378,P80643,P80916,P80917,P80918,P80919,P80920,P80921,P80922,P80923,P94123,Q00663,Q02054,Q02570,Q05363,Q0MQC1,Q0MQC2,Q0MQC3,Q10217,Q1BBA1,Q49X16,Q4L5T4,Q56035,Q5HGK0,Q5HPV9,Q5WFM5,Q5XAE1,Q606L6,Q62LT9,Q636H6,Q63S86,Q64ZV7,Q65RC8,Q660G8,Q669L4,Q6B8U3,Q6D687,Q6FDT7,Q6G056,Q6G442,Q6G9Y1,Q6GHK3,Q6HEW5,Q6MAF8,Q6MLJ8,Q6YPI8,Q71YL0,Q732M0,Q73ZP6,Q74CR8,Q75FW6,Q7M9W1,Q7MLZ9,Q7MU10,Q7U9V9,Q7UYY2,Q7V4J6,Q7V9R0,Q7VI80,Q7VKH6,Q7VR21,Q7VW32,Q7W5I7,Q7WD23,Q819V7,Q81WI7,Q823D5,Q83N02,Q83NH7,Q85FZ0,Q88LL5,Q89MV8,Q8A2E6,Q8CPI2,Q8D3A9,Q8D8G9,Q8DHS3,Q8EDH4,Q8ER06,Q8EXX4,Q8K9J4,Q8KAN9,Q8R9W1,Q8RGX5,Q8UGE2,Q8XJN7,Q8Z495,Q8ZFT4,Q92GD8,Q94519,Q97HJ4,Q97IA5,Q984T3,Q98QK3,Q9A7P3,Q9CHF9,Q9CJS5,Q9CR21,Q9EZI1,Q9KA04,Q9KQH8,Q9PI64,Q9PKF8,Q9PPY4,Q9R6Z3,Q9RA32,Q9RG22,Q9RK61,Q9RT27,Q9WZD0,Q9Z8P3,Q9ZCH9,Q9ZLS1">ACP</protein-id> reductase, the molecular target site of <compound-id="5564">triclosan</compound-id>, indicated that these compounds fit within the binding domain occupied by <compound-id="5564">triclosan</compound-id>.	triclosan__ACP__interaction	diphenyl ether__ACP__interaction
18539357-492	Tumor <protein-id="P08640,P15941,Q29435,Q60528">MUC1</protein-id> differs from normal <protein-id="P08640,P15941,Q29435,Q60528">MUC1</protein-id> by modified <compound-id="871">glycan</compound-id> side chains.	glycan__MUC1__interaction
18539387-509	Mineralization and dehalogenation of <compound-id="6914">2,4,6-TCP</compound-id> was evidenced by high <protein-id="P14678">COD</protein-id> removal efficiencies (approximately 95%), and by the stoichiometric release of <compound-id="312">chloride</compound-id> ions from the halogenated compound (approximately 80%).	2,4,6-TCP__COD__interaction	chloride__COD__no_interaction
18539426-489	Studies in postmenopausal women showed that an <protein-id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</protein-id> inhibitor (AI) as initial, upfront treatment reduces early recurrence, including distant metastases, compared with <compound-id="2733526">tamoxifen</compound-id>.	tamoxifen__aromatase__no_interaction
18541345-459	<compound-id="3475">Gliclazide</compound-id> can change the conformation of the active sites and decrease obviously the affinities between <compound-id="3475">gliclazide</compound-id> in the active site and enzymes when it is docked in the second active sites in <protein-id="P11712">CYP2C9</protein-id> and <protein-id="P33261">CYP2C19</protein-id>.	Gliclazide__CYP2C19__interaction	gliclazide__CYP2C9__interaction	Gliclazide__CYP2C9__interaction	gliclazide__CYP2C19__interaction
18543297-399	Metabolism of <compound-id="3918,5360697">dextrorphan</compound-id> by <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id> in different recombinantly expressed systems and its implications for the in vitro assessment of <compound-id="3008,5360696,5362449,12305042">dextromethorphan</compound-id> metabolism.	dextrorphan__CYP2D6__interaction	dextromethorphan__CYP2D6__no_interaction
18543297-400	<protein-id="P10635,Q2XNC8,Q2XNC9">Cytochrome P450 2D6</protein-id> (<protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id>) mediated formation of <compound-id="3918,5360697">dextrorphan</compound-id> (<compound-id="439216">DOR</compound-id>) from <compound-id="3008,5360696,5362449,12305042">dextromethorphan</compound-id> (DEX) is widely used as a marker to assess the activity of this enzyme both in vitro and in vivo.	dextromethorphan__Cytochrome P450 2D6__interaction	dextrorphan__Cytochrome P450 2D6__interaction	dextrorphan__CYP2D6__interaction	dextromethorphan__CYP2D6__interaction	DOR__Cytochrome P450 2D6__interaction	DOR__CYP2D6__interaction
18543297-401	The sequential metabolism of <compound-id="439216">DOR</compound-id> during in vitro studies, particularly using recombinant systems (rCYPs) expressing human <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id>, is assumed to be negligible.	DOR__CYP2D6__no_interaction
18543297-402	The extent of metabolism was investigated for a range of DEX and <compound-id="439216">DOR</compound-id> concentrations in microsomal preparations from three different rCYPs expressing human <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id> (yeast, Supersomes and Bactosomes) containing 10 pmol of the enzyme.	DOR__CYP2D6__interaction
18543297-403	Two novel <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id> related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of <compound-id="439216">DOR</compound-id> and <compound-id="11840954">HYM</compound-id> using ion-trap mass spectrometry.	DOR__CYP2D6__interaction	HYM__CYP2D6__interaction
18543330-427	The metal-coordinating residues in the active site of <protein-id="P54970">ILL2</protein-id> include a conserved <compound-id="594,5862,5360637">cysteine</compound-id> that clearly distinguishes this protein from previously structurally characterized members of the M20 peptidase family.	cysteine__ILL2__interaction
18543330-428	Finally, the active site of <protein-id="P54970">ILL2</protein-id> harbors an absolutely conserved <compound-id="611,23327,33032">glutamate</compound-id> (Glu172), which is well positioned to act as a general acid-base residue.	glutamate__ILL2__interaction
18544044-880	In this study, we tested the hypothesis that the Angiopoietin 1 (<protein-id="P21570">Ang1</protein-id>)/<protein-id="O73791,Q02858">Tie2</protein-id> pathway mediates <compound-id="54454,4677798">simvastatin</compound-id>-induced vascular integrity and migration of neuroblasts after stroke.	simvastatin__Tie2__interaction	simvastatin__Ang1__interaction
18544044-881	<compound-id="54454,4677798">Simvastatin</compound-id> treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased <protein-id="P21570">Ang1</protein-id>, <protein-id="O73791,Q02858">Tie2</protein-id> and <protein-id="Q16625,Q28269,Q28793,Q5RFS5,Q61146,Q6P6T5,Q91049,Q9PUN1">Occludin</protein-id> expression in the ischaemic border (IBZ) compared to the MCAo control group.	Simvastatin__Tie2__interaction	Simvastatin__Occludin__interaction	Simvastatin__Ang1__interaction
18544044-882	<compound-id="54454,4677798">Simvastatin</compound-id> also significantly increased doublecortin (<protein-id="O43602">DCX</protein-id>, a marker of migrating neuroblasts) expression in the IBZ compared to control MCAo rats.	Simvastatin__DCX__interaction
18544044-883	The data show that <compound-id="54454,4677798">simvastatin</compound-id> treatment of RBMEC increased <protein-id="P21570">Ang1</protein-id> and <protein-id="O73791,Q02858">Tie2</protein-id> gene and protein expression and promoted phosphorylated-<protein-id="O73791,Q02858">Tie2</protein-id> activity.	simvastatin__Tie2__interaction	simvastatin__Ang1__interaction
18544044-884	<compound-id="54454,4677798">Simvastatin</compound-id> treatment of stroke increases <protein-id="P21570">Ang1</protein-id>/<protein-id="O73791,Q02858">Tie2</protein-id> expression and thereby reduces BBB leakage and promotes vascular stabilization.	Simvastatin__Tie2__interaction	Simvastatin__Ang1__interaction
18544044-885	<protein-id="P21570">Ang1</protein-id>/<protein-id="O73791,Q02858">Tie2</protein-id> expression induced by <compound-id="54454,4677798">simvastatin</compound-id> treatment promotes neuroblast micro-vascular coupling after stroke.	simvastatin__Tie2__interaction	simvastatin__Ang1__interaction
18544047-888	Suppressing the activity of <protein-id="O08580,P11474">ERRalpha</protein-id> in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal <compound-id="206,5793,64689,79025">glucose</compound-id> uptake.	glucose__ERRalpha__interaction
18544047-889	Through suppressing the expression of another <protein-id="O08580,P11474">ERRalpha</protein-id> target gene <protein-id="O02623,P40530,P91622,Q02332,Q9P6P9">pyruvate dehydrogenase kinase</protein-id> 2 (<protein-id="Q15119">PDK2</protein-id>), we found that XCT-790 not only enhanced the conversion of <compound-id="1060">pyruvate</compound-id> to acetyl-CoA and hyper-activated the tricarboxylic acid (TCA) cycle, but also led to higher levels of mitochondrial membrane potential and reactive oxidant species (ROS) production.	pyruvate__PDK2__no_interaction	pyruvate__pyruvate dehydrogenase kinase__no_interaction	pyruvate__ERRalpha__no_interaction
18544047-891	Therefore, <protein-id="O08580,P11474">ERRalpha</protein-id> stands at the crossroad of <compound-id="206,5793,64689,79025">glucose</compound-id> and fatty acid utilization and acts as a homeostatic switch to regulate the flux of TCA cycle, mitochondrial membrane potential and glycolysis to maintain a steady level of <compound-id="5957">ATP</compound-id> production, particularly, when mitochondrial biogenesis is reduced.	ATP__ERRalpha__interaction	glucose__ERRalpha__interaction
18544592-1218	A significant decrease in mean total <compound-id="145068">nitric oxide</compound-id> (NOx), nitrite, and <compound-id="943">nitrate</compound-id> levels was also found after <protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id> plus <compound-id="5743">dexamethasone</compound-id> administration.	nitrate__G-CSF__interaction	dexamethasone__G-CSF__no_interaction	nitric oxide__G-CSF__interaction
18544592-1219	Even if partially compensated with u-PA and <protein-id="O55527,O55779,P02810,P03314,P03424,P04861,P04862,P06022,P06164,P06165,P06941,P07602,P08097,P10030,P14253,P14254,P14340,P26035,P26779,P27384,P28055,P29165,P32533,P32534,P32535,P35940,P35948,P35977,P69738,Q00794,Q03339,Q074N0,Q1X880,Q1X881,Q6DV88,Q6J3P1,Q89277,Q98803,Q997F1,Q9DUE0,Q9WS38,Q9YRV3">protein C</protein-id>, increased FVIII and <protein-id="P04275,P80012,Q28295,Q28833,Q8CIZ8">vWF</protein-id> activity, and decreased <compound-id="145068">nitric oxide</compound-id> levels may still partially contribute to progress of thrombosis risk in rhG-CSF plus <compound-id="5743">dexamethasone</compound-id> administered healthy granulocyte donors.	dexamethasone__protein C__interaction	nitric oxide__vWF__no_interaction	dexamethasone__vWF__interaction	nitric oxide__protein C__no_interaction
18546023-135	<protein-id="Q7M4U7">Lipase</protein-id> immobilized on <compound-id="3485">glutaraldehyde</compound-id>-crosslinked chitosan yielded the highest efficiency in terms of total coupled protein and protein loading efficiency.	glutaraldehyde__Lipase__interaction
18547170-484	Amyloglucosidase from Rhizopus mould and <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</protein-id> from sweet almond were employed for the preparation of phenolic and vitamin glycosides of <compound-id="1183">vanillin</compound-id>, <compound-id="2998">N-vanillylnonanamide</compound-id>, <compound-id="836">DL-dopa</compound-id>, <compound-id="681">dopamine</compound-id>, <compound-id="969516">curcumin</compound-id>, <compound-id="2116,14985">alpha-tocopherol</compound-id> (<compound-id="2116,14985,1548900,1742129">vitamin E</compound-id>), <compound-id="1054">pyridoxine</compound-id> (vitamin B(6)), <compound-id="3249">ergocalciferol (vitamin D</compound-id> (2)), <compound-id="1130">thiamin</compound-id> (vitamin B(1)) and <compound-id="1072,6759,493570">riboflavin</compound-id> (vitamin B(2)).	thiamin__beta-glucosidase__interaction	dopamine__beta-glucosidase__interaction	alpha-tocopherol__beta-glucosidase__interaction	curcumin__beta-glucosidase__interaction	DL-dopa__beta-glucosidase__interaction	pyridoxine__beta-glucosidase__interaction	vitamin E__beta-glucosidase__interaction	N-vanillylnonanamide__beta-glucosidase__interaction	vanillin__beta-glucosidase__interaction	ergocalciferol (vitamin D__beta-glucosidase__interaction	riboflavin__beta-glucosidase__interaction
18547363-1222	<compound-id="442530">Ochratoxin A</compound-id> impairs <protein-id="O54968,Q60795">Nrf2</protein-id>-dependent gene expression in porcine kidney tubulus cells.	Ochratoxin A__Nrf2__interaction
18547363-1223	Therefore, in the present study, the effects of <compound-id="444766">OTA</compound-id> on the nuclear translocation and transactivation of the transcription factor <protein-id="O54968,Q60795">Nrf2</protein-id> as well as mRNA levels of <protein-id="O54968,Q60795">Nrf2</protein-id> target genes including <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferase</protein-id> and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	OTA__Nrf2__interaction	OTA__glutathione-S-transferase__interaction
18547363-1224	<protein-id="O54968,Q60795">Nrf2</protein-id> was induced by <compound-id="5350">sulforaphane</compound-id>, a well-known activator of this transcription factor.	sulforaphane__Nrf2__interaction
18547363-1225	<compound-id="442530">Ochratoxin A</compound-id> significantly decreased gamma-glutamylcysteinyl synthetase and <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferase</protein-id> mRNA levels in LLC-PK1 cells.	Ochratoxin A__glutathione-S-transferase__interaction
18547363-1226	Furthermore, <compound-id="444766">OTA</compound-id> also lowered <protein-id="O54968,Q60795">Nrf2</protein-id> mRNA levels.	OTA__Nrf2__interaction
18547363-1227	Current data indicate that <compound-id="444766">OTA</compound-id> nephrotoxicity may be, at least partly, mediated by an <protein-id="O54968,Q60795">Nrf2</protein-id>-dependent signal transduction pathway.	OTA__Nrf2__interaction
18547754-637	Parthenogenetic porcine blastocysts were generated by the following methods: (1) electroporation followed by blocking the activity of specific <protein-id="P00513,P25848">protein kinases</protein-id> with <compound-id="123740,5235506,51340302">butyrolactone I</compound-id> ; (2) electroporation followed by inhibition of protein synthesis using <compound-id="6197">cycloheximide</compound-id> ; and (3) electroporation only (control).	butyrolactone I__protein kinases__interaction	cycloheximide__protein kinases__no_interaction
18547755-125	The aim of the present study was to investigate differences in the expression of mRNAs for <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id>, <protein-id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ERbeta</protein-id> and PR in the sow uterus at different stages of the estrous cycle as well as in inseminated sows at estrus and during early pregnancy by use of solution hybridization and in relation to plasma levels of <compound-id="5757">estradiol</compound-id> and <compound-id="5994">progesterone</compound-id>.	progesterone__ERalpha__interaction	estradiol__ERalpha__interaction	progesterone__ERbeta__interaction	estradiol__ERbeta__interaction
18547796-661	Increased incorporation of dietary plant sterols and <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> correlates with decreased expression of hepatic and intestinal <protein-id="Q99PE7,Q99PE8">Abcg5</protein-id> and <protein-id="P58428,Q9DBM0">Abcg8</protein-id> in diabetic BB rats.	cholesterol__Abcg8__interaction	cholesterol__Abcg5__interaction
18547796-662	This increase in <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal <protein-id="Q99PE7,Q99PE8">Abcg5</protein-id> (ATP-binding cassette transporter G5) and <protein-id="P58428,Q9DBM0">Abcg8</protein-id> (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	cholesterol__Abcg8__interaction	cholesterol__Abcg5__interaction
18547796-663	Therefore, lower expression levels of <protein-id="Q99PE7,Q99PE8">Abcg5</protein-id>/<protein-id="P58428,Q9DBM0">Abcg8</protein-id> in diabetic rats may account for the increased accumulation of plant sterols and <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> in these rats.	cholesterol__Abcg8__interaction	cholesterol__Abcg5__interaction
18547798-666	<compound-id="370">Gallic acid</compound-id>, <compound-id="445858">ferulic acid</compound-id> and <compound-id="637542">p-coumaric acid</compound-id> at a dosage of 100 mg kg(-1) body weight significantly increased the activities of cardiac <protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx) and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>.05).	ferulic acid__glutathione peroxidase__interaction	Gallic acid__glutathione peroxidase__interaction	p-coumaric acid__superoxide dismutase__interaction	p-coumaric acid__glutathione peroxidase__interaction	ferulic acid__CAT__interaction	Gallic acid__CAT__interaction	Gallic acid__catalase__interaction	Gallic acid__superoxide dismutase__interaction	p-coumaric acid__CAT__interaction	p-coumaric acid__catalase__interaction	ferulic acid__catalase__interaction	ferulic acid__superoxide dismutase__interaction
18547799-292	These effects of <compound-id="5280961">genistein</compound-id> during the differentiation period were associated with down-regulation of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> and <protein-id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ERbeta</protein-id> expression.	genistein__ERalpha__interaction	genistein__ERbeta__interaction
18548182-922	Activities of microbial extracellular enzymes involved in carbon, <compound-id="947,123329">nitrogen</compound-id>, and <compound-id="24404,139579">phosphorus</compound-id> cycling declined appreciably with depth, the only exception being <protein-id="P15984,P16147,P84714">peroxidase</protein-id>.	nitrogen__peroxidase__no_interaction	phosphorus__peroxidase__no_interaction
18548275-801	<compound-id="104818">Sulfonylurea</compound-id> (SU) treatment restores <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion in patients with <protein-id="O02822,Q14654,Q9JHJ9">KCNJ11</protein-id> mutations.	Sulfonylurea__KCNJ11__no_interaction	Sulfonylurea__insulin__interaction
18548615-1193	The purpose of this study was to investigate the effect of three zinc salts (i.e., <compound-id="14806">zinc oxide</compound-id>, <compound-id="767">zinc carbonate</compound-id>, and <compound-id="176">zinc acetate</compound-id>) on <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> encapsulation efficiency (EE), stability, and in vitro release kinetics from poly(lactic-co-<compound-id="757">glycolic acid</compound-id>) (<compound-id="36797">PLGA</compound-id>) microspheres.	zinc carbonate__insulin__interaction	zinc acetate__insulin__interaction	PLGA__insulin__interaction	glycolic acid__insulin__interaction	zinc oxide__insulin__interaction
18550063-794	<protein-id="Q8JFG3">Tumor necrosis factor</protein-id>-alpha inhibition protects against <compound-id="44268108">endotoxin</compound-id>-induced endothelial glycocalyx perturbation.	endotoxin__Tumor necrosis factor__interaction
18550063-795	In the present study, we investigated whether <compound-id="44268108">endotoxin</compound-id>-induced inflammatory reactions lead to a decrease of endothelial glycocalyx thickness in humans and whether <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id>) plays a role in this process.	endotoxin__tumor necrosis factor__no_interaction	endotoxin__TNFalpha__no_interaction
18550164-868	The amino acid sequence deduced from the coding sequence encodes for <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id> of 73 amino acids containing 21 <compound-id="594,5862,5360637">cysteine</compound-id> residues.	cysteine__a protein__interaction
18550594-1147	Ultrastructural analysis in the macaque mediodorsal nucleus revealed that thalamic interneurons are a main postsynaptic target of <protein-id="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DAT</protein-id>-ir axons ; this suggests that the marked expansion of the <compound-id="681">dopamine</compound-id> innervation in the primate in comparison to the rodent thalamus may be related to the presence of a sizable interneuron population in primates.	dopamine__DAT__no_interaction
18550596-1150	<protein-id="Q24546">Synapsin</protein-id>-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-<protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> polymerization with <compound-id="2919,5311281,5368686,5836499,6364615,6433621">cytochalasin B</compound-id> in hippocampal slices.	cytochalasin B__Synapsin__interaction	cytochalasin B__actin__interaction
18551377-641	Transformation was achieved using a vector that targets genes to the rrn16/<protein-id="O14062,P02368,P06368,P11524,P13576,P14149,P17293,P17294,P19461,P29161,P39573,P41196,P42344,P46296,P46308,P47333,P47840,P48856,P49168,P49500,P51289,P52762,P56354,P59168,P61941,P62127,P63196,P63199,P63200,P63323,P63324,P74230,Q2JMY0,Q2JUX7,Q318N2,Q3AMT3,Q3AW56,Q3MDM2,Q46IW1,Q5F1R7,Q68S28,Q6B8X8,Q6ENC0,Q6L3C7,Q6YXM6,Q70XU7,Q7NAV1,Q7NEF4,Q7U4D4,Q7UZY4,Q7V503,Q7VA02,Q85BW6,Q85FG4,Q85X49,Q8KTP6,Q8MA18,Q8RUK6,Q8VMU2,Q8YP60,Q9AIG9,Q9CL86,Q9MUP2,Q9PPW5,Q9TJR0,Q9TKZ7,Q9TLV6,Q9XQE1">rps12</protein-id> intergenic region of the sugar beet plastome, employing the <protein-id="P08881,P0AG05,P0AG06">aadA</protein-id> gene as a selectable marker against <compound-id="15541">spectinomycin</compound-id> and the gfp gene for visual screening of plastid transformants.	spectinomycin__aadA__interaction	spectinomycin__rps12__no_interaction
18552508-1057	<compound-id="2662">Celecoxib</compound-id> inhibits serum amyloid a-induced <protein-id="O55123,P07152,P09238">matrix metalloproteinase-10</protein-id> expression in human endothelial cells.	Celecoxib__matrix metalloproteinase-10__interaction
18553142-185	This article investigated the effect of sulfite on total antioxidant capacity (TAC), total oxidant status, lipid <compound-id="784">hydroperoxide</compound-id> (LOOH), and total free sulfydryl groups (-SH) levels in normal and <protein-id="P79371,Q8JGM4,Q9S850">SOX</protein-id>-deficient male albino rat plasma.	hydroperoxide__SOX__no_interaction
18553142-186	<protein-id="P79371,Q8JGM4,Q9S850">SOX</protein-id> deficiency was established by feeding rats a low <compound-id="6422,23932">molybdenum</compound-id> diet and adding to their drinking water 200 ppm <compound-id="23964">tungsten</compound-id>.	tungsten__SOX__interaction	molybdenum__SOX__interaction
18553215-218	an " <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> binding domain", as a singlet and which, in addition, contain the conserved <compound-id="594,5862,5360637">cysteine</compound-id> rich double Zn finger possessing Lim domain, also as a singlet.	cysteine__actin__interaction
18554595-1071	To test the hypothesis that <compound-id="12594">DHEAS</compound-id> production from <compound-id="5881">DHEA</compound-id> occurs in hepatic cells and that this production is augmented by the presence of sex steroids or <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>.	DHEA__insulin__interaction	DHEAS__insulin__interaction
18554598-1073	Changes in <protein-id="Q8JFG3">tumor necrosis factor</protein-id> (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>) production by <compound-id="11970143">lipopolysaccharide</compound-id>-stimulated peripheral blood mononuclear cells significantly correlated with serum P levels in postmenopausal women subjected to estrogen/<compound-id="10631">medroxyprogesterone</compound-id> therapy.	medroxyprogesterone__tumor necrosis factor__no_interaction	lipopolysaccharide__TNF__interaction	lipopolysaccharide__tumor necrosis factor__interaction	medroxyprogesterone__TNF__no_interaction
18554690-393	The differences in tissue distribution and protein levels of <protein-id="O18473,O18531,P34021,P49880,P49881,P49882,P49883">EcR</protein-id>-B1 during the programmed cell death indicate that the receptor plays a major role in the modulation and function of <compound-id="19212,4233007,5316996">ecdysone</compound-id> activity in Bombyx anterior silk glands.	ecdysone__EcR__interaction
18555241-208	<compound-id="969516">Curcumin</compound-id>, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases <protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id> expression.	Curcumin__fibronectin__interaction
18555557-379	Methylthioadenosine phosphorylase (<protein-id="Q13126">MTAP</protein-id>) is involved in the metabolism of purines and converts methylthioadenosine (MTA) to <compound-id="190">adenine</compound-id>.	adenine__MTAP__interaction
18555557-380	Methylation-specific primers were used to analyze methylation of the <protein-id="Q13126">MTAP</protein-id> promoter, using DNA treated with <compound-id="23665763">sodium bisulfite</compound-id>.	sodium bisulfite__MTAP__no_interaction
18555679-458	Long-chain <compound-id="62238">fatty alcohols</compound-id> also reduced <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha and prostaglandin E(2) production, although the potency of inhibition for the latter was lower.	fatty alcohols__tumor necrosis factor__interaction
18556000-671	<compound-id="4455">Neopterin</compound-id> is released from human monocyte-derived macrophages upon stimulation with <protein-id="Q9TTB0">interferon-gamma</protein-id> and is a sensitive indicator for cellular immune activation.	Neopterin__interferon-gamma__interaction
18556087-712	Both activity and expression of <protein-id="O70531,P50443,Q62273">sulfate transporters</protein-id> and <protein-id="O14492,P04802,P07288,P22325,P33619,P55228,Q12650,Q6DT45">APS</protein-id> reductase in plants are modulated by the <compound-id="402">sulfur</compound-id> status of the plant.	sulfur__sulfate transporters__interaction	sulfur__APS__interaction
18560889-729	<protein-id="Q07842">Complex I</protein-id> deficiency is a novel cause of secretory diarrhea and may act via disrupting the supply of <compound-id="5957">adenosine triphosphate</compound-id> (<compound-id="5957">ATP</compound-id>) needed for the maintenance of ion gradients across membranes.	adenosine triphosphate__Complex I__interaction	ATP__Complex I__interaction
18561093-53	This prospective cross-sectional study was performed to investigate the influence of GH excess on <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> levels at baseline and after <compound-id="206,5793,64689,79025">glucose</compound-id> load in a large group of acromegalic patients.	glucose__leptin__no_interaction	glucose__ghrelin__no_interaction
18561170-499	<protein-id="P23916,P24664,P35050,P83348,Q59149">Trypsin</protein-id> digestion, fluorescence anisotropy, and NMR experiments presented here were designed to resolve the issue and show that in arm-dimerization domain, the arms are structured, although differently, in the presence and absence of <compound-id="66308">arabinose</compound-id>.	arabinose__Trypsin__no_interaction
18561187-110	DNA array studies have revealed that <protein-id="P42624,P58115">YhaK</protein-id> is strongly up-regulated by nitroso-<compound-id="124886">glutathione</compound-id> (<compound-id="3514,104858,10404739">GSNO</compound-id>) and also displays a 12-fold increase in expression during biofilm growth of E. coli 83972 and VR50 in human urine.	glutathione__YhaK__interaction	GSNO__YhaK__interaction
18561187-111	We found that the third <compound-id="594,5862,5360637">cysteine</compound-id> in <protein-id="P42624,P58115">YhaK</protein-id>, Cys122, is oxidized to a <compound-id="447587">sulfenic acid</compound-id>.	cysteine__YhaK__interaction	sulfenic acid__YhaK__interaction
18561187-112	E. coli <protein-id="O14313,O22711,O30973,O32823,O43099,O66790,O69777,O83790,O84101,P0A9P4,P0A9P5,P0AE52,P0AE53,P0AE54,P0AE55,P14292,P14293,P21762,P26830,P30044,P34227,P39916,P40553,P43496,P43788,P44411,P44758,P46843,P47348,P49537,P50971,P51272,P51978,P52213,P52214,P52215,P55979,P56431,P56577,P56578,P56876,P57279,P57399,P61076,P65688,P65689,P66010,P66011,P73728,P75531,P80880,P80892,P81433,P94284,P99029,P99101,Q01116,Q05741,Q25861,Q53212,Q55624,Q5HHQ4,Q5HQW4,Q6BIS1,Q6C7L4,Q6FR39,Q6GB66,Q6GIM7,Q75CM8,Q7Z7S3,Q89AJ2,Q89AS1,Q8CPY8,Q8J0U0,Q8K9W0,Q8T6Z1,Q92375,Q928B5,Q92I02,Q98PK9,Q9BGI1,Q9GLW7,Q9GLW9,Q9KSS4,Q9M7T0,Q9PKT7,Q9PR71,Q9R063,Q9Z8M4,Q9ZD97,Q9ZHF0,Q9ZL18,Q9ZMU4">thioredoxin reductase</protein-id> and <compound-id="5884">NADPH</compound-id> produced ROS and caused oxidation and oligomerization of reduced <protein-id="P42624,P58115">YhaK</protein-id>.	NADPH__YhaK__interaction	NADPH__thioredoxin reductase__interaction
18562331-1081	In this report, we investigated the possible role of LA and vmPFC <protein-id="Q00960,Q01097,Q13224">NR2Bs</protein-id> in the consolidation of fear extinction using the <protein-id="Q00960,Q01097,Q13224">NR2B</protein-id>-selective antagonist <compound-id="3689,6604117,11198145,11771731">ifenprodil</compound-id>.	ifenprodil__NR2B__no_interaction	ifenprodil__NR2Bs__no_interaction
18562423-1156	Patients under <compound-id="2818">clozapine</compound-id>-<compound-id="5073">risperidone</compound-id> therapy developed a rise of serum <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> levels.	risperidone__prolactin__interaction	clozapine__prolactin__interaction
18562442-1178	In experiment 3, administration of E(2) or <compound-id="926,5893,447862">DPN</compound-id> to ovariectomised wildtype, but not betaERKO, mice decreased immobility compared with vehicle administration, these data suggest that <protein-id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ERbeta</protein-id> may be required for some of the anti-depressant-like effects of E(2).	DPN__ERbeta__no_interaction
18563306-164	<compound-id="54454,4677798">Simvastatin</compound-id> treatment significantly increased the number of peripheral blood CD34+ CD133+ cells, and serum concentration of vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>) and AKT was markedly increased in vivo.	Simvastatin__VEGF__interaction
18563306-165	In cultured EPC, <compound-id="54454,4677798">simvastatin</compound-id> increased the concentrations of <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, AKT and <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>.	simvastatin__VEGF__interaction	simvastatin__eNOS__interaction
18563306-166	Western blots analysis showed that <compound-id="54454,4677798">simvastatin</compound-id> increased the phosphorylation of <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id> and <protein-id="O43524">FKHRL1</protein-id>, which can be blocked by the PI3K/AKT pathway blocker <compound-id="3973">LY294002</compound-id>.	LY294002__eNOS__interaction	LY294002__FKHRL1__interaction	simvastatin__eNOS__interaction	simvastatin__FKHRL1__interaction
18563306-167	In in vitro study, <compound-id="54454,4677798">simvastatin</compound-id> increases the phosphorylation of <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id> and of <protein-id="O43524">FKHRL1</protein-id> through the <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>/AKT signaling pathway.	simvastatin__PI3K__interaction	simvastatin__eNOS__interaction	simvastatin__FKHRL1__interaction
18563517-342	Only the intracellular <protein-id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</protein-id> response in the lower tertile of <protein-id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</protein-id> production was improved with <compound-id="738,5961">glutamine</compound-id> indicating a small influence.	glutamine__IL-2__interaction
18563517-343	The elevation of <compound-id="738,5961">glutamine</compound-id> plasma levels by a perioperative intravenous infusion of L-alanyl-<compound-id="5961,145815">L-glutamine</compound-id> influenced the intracellular expression of <protein-id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</protein-id> in the lower tertile only slightly.	L-glutamine__IL-2__no_interaction	glutamine__IL-2__no_interaction
18563542-358	Determination of bioactive matter by affinity adsorption solid substrate-room temperature phosphorimetry based on <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> labeled with self-ordered ring of <compound-id="11049,27020">eosin Y</compound-id>.	eosin Y__lectin__interaction
18563542-359	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin <protein-id="P02872,P05046,P11218,P11219,P30617,P42088,P49329,P82859,P82953">agglutinin</protein-id> (<protein-id="P02866,P14894,P81460,P81461">Con A</protein-id>), triticum vulgaris <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> (WGA) labeled with ESOR and alpha-fetoprotein variant (<protein-id="O80994,O80995,P02771,P05140,P07835,P09031,P23699,P28050,P49066,P83128,P84407,Q01758,Q08617,Q12899,Q28789,Q3SZ57,Q8MJU5">AFP</protein-id>-V), <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> (<protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id>), <compound-id="206,5793,64689,79025">glucose</compound-id> (G), respectively.	glucose__agglutinin__no_interaction	glucose__ALP__no_interaction	glucose__lectin__no_interaction	glucose__AFP__no_interaction	glucose__alkaline phosphatase__no_interaction	glucose__Con A__no_interaction
18563554-369	In this paper we demonstrate that hedgehog signaling antagonists, including <compound-id="442972">cyclopamine</compound-id>, and a second compound, CUR0199691, can inhibit growth of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> (ER)-positive and ER-negative tumorigenic breast cancer cells at elevated doses.	cyclopamine__estrogen receptor__no_interaction
18563559-375	The equality of K (D) of <compound-id="43815">paroxetine</compound-id> binding to blood platelet membranes and to membranes from nerve endings appears to encourage the use of such membranes as a model for brain <protein-id="P31645,Q9XT49">SERT</protein-id>.	paroxetine__SERT__no_interaction
18563560-376	With supplementation of <compound-id="1123">taurine</compound-id> in diet, lower expression of <protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id> and <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> while higher expression of <protein-id="P24942,P56564">GLAST</protein-id>, GS and <protein-id="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20">GAD</protein-id> in retina of diabetic rats were determinated by RT-PCR 0.05).	taurine__VEGF__interaction	taurine__GFAP__interaction	taurine__GAD__interaction	taurine__GLAST__interaction
18563560-377	<protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id>, <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, <protein-id="P24942,P56564">GLAST</protein-id>, GS and <protein-id="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20">GAD</protein-id> expressions in normal controls were not altered by <compound-id="1123">taurine</compound-id> treatment.	taurine__GFAP__no_interaction	taurine__GLAST__no_interaction	taurine__GAD__no_interaction	taurine__VEGF__no_interaction
18563561-378	<compound-id="10964">Malondialdehyde</compound-id> (MDA), <compound-id="124886">glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), <compound-id="145068">nitric oxide</compound-id> (NO) levels and myeloperoxidase activity (<protein-id="P05164,P11247">MPO</protein-id>) were examined in plasma, liver and brain tissues.	GSH__MPO__no_interaction	Malondialdehyde__MPO__no_interaction	nitric oxide__MPO__no_interaction	glutathione__MPO__no_interaction
18563616-418	<protein-id="O23970,P00435,P04041,P07203,P11352,P11909,P36014,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">Glutathione peroxidase 1</protein-id> (<protein-id="O48646,P00435,P07203,P11909,P36014,P52032,Q00277,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">GPX1</protein-id>) is a ubiquitously expressed selenium-dependent enzyme that protects cells against oxidative damage by reducing <compound-id="784">hydrogen peroxide</compound-id> and a wide range of organic peroxides.	hydrogen peroxide__Glutathione peroxidase 1__interaction	hydrogen peroxide__GPX1__interaction
18563708-512	<compound-id="145068">Nitric oxide</compound-id> (NO), which is produced by <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id>), may play a role in the development of ASD.	Nitric oxide__NOS__interaction	Nitric oxide__nitric oxide synthase__interaction
18563803-210	In conclusion, <compound-id="124886,128225">TAD</compound-id>-A has sufficient bonding strength and comparatively low toxicity in clinical use of 0.3 mmol or less of <compound-id="124886,128225">TAD</compound-id> and 0.8 mL of 44 w/w % <protein-id="P24807,Q07490">HSA</protein-id> solution.	TAD__HSA__interaction
18563826-616	Long intercalated defects in canine ribs can be repaired successfully using porous <compound-id="24456">beta-tricalcium phosphate</compound-id> (beta-TCP) cylinders, infused with a biodegradable polymer (poly D,L-lactic acid-polyethylene block copolymer) containing recombinant human bone <protein-id="P07580">morphogenetic protein</protein-id>-2 (rhBMP-2).	beta-tricalcium phosphate__morphogenetic protein__no_interaction
18564056-810	In the present study we explored the possibility of using genetic engineering to increase the <compound-id="2240,68827,452191,641602,5458876,9838675,11836791,23757058,44266427,49796325">artemisinin</compound-id> content of A. annua by suppressing the expression of <protein-id="O74165,P29704,P36596,P37268,P53798,P53799,P53800,P78589,Q02769,Q752X9,Q7S4Z6,Q92459,Q9HGZ6,Q9Y753">SQS</protein-id> (squalene synthase), a key enzyme of sterol pathway (a pathway competitive with that of <compound-id="2240,68827,452191,641602,5458876,9838675,11836791,23757058,44266427,49796325">artemisinin</compound-id> biosynthesis) by means of a hairpin-RNA-mediated RNAi (RNA interference) technique.	artemisinin__SQS__interaction
18564176-915	<compound-id="3476">Glimepiride</compound-id> upregulates <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id> activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-<protein-id="P31750,Q8INB9">Akt</protein-id>-dependent pathway.	Glimepiride__Akt__interaction	Glimepiride__eNOS__interaction
18564211-943	It has been reported that <compound-id="2733526">tamoxifen</compound-id> may affect hepatoma cell growth in vitro by suppressing transforming growth factor beta-1 (<protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</protein-id>) expression, suggesting that <compound-id="2733526">tamoxifen</compound-id> might also retard fibrogenesis.	tamoxifen__TGF-beta1__interaction
18564211-944	Thus, we examined whether <compound-id="2733526">tamoxifen</compound-id> might suppress <protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</protein-id> expression and consequently inhibit the process of hepatic fibrosis in vivo.	tamoxifen__TGF-beta1__interaction
18564281-1010	We also explored the effect of <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</protein-id> released by <compound-id="1548943">capsaicin</compound-id> because this <protein-id="P21259">neuropeptide</protein-id> is known to affect the microvasculature environment.	capsaicin__substance P__interaction	capsaicin__neuropeptide__no_interaction
18565553-422	<compound-id="3907,5280493,5283121,5353716">Leukotriene C4</compound-id> release and gene expressions of <protein-id="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5">IL-8</protein-id> and <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id> in porcine alveolar epithelial type II cells.	Leukotriene C4__IL-8__no_interaction	Leukotriene C4__MCP-1__no_interaction
18565553-424	These findings suggest that AEC IIs play an important role in initial inflammatory reactions of the lung by releasing <compound-id="5280493">LTC4</compound-id>, and that they also modulate later inflammatory reactions, evidenced by consistent elevation of <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id> gene expression after and during exogenous challenge in pigs.	LTC4__MCP-1__no_interaction
18565581-347	Whereas their toxicity is due to <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> inhibition, their secondary toxic effects have been related to free <compound-id="977">oxygen</compound-id> radicals.	oxygen__acetylcholinesterase__no_interaction
18565581-348	<compound-id="3017">Diazinon</compound-id> diminished the plasma <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> activity on day 1 post-treatment, although <compound-id="6013">testosterone</compound-id> levels remained unaffected.	Diazinon__acetylcholinesterase__interaction	testosterone__acetylcholinesterase__no_interaction
18565581-349	<compound-id="896">Melatonin</compound-id> pretreatment prevented every alteration induced by <compound-id="3017">diazinon</compound-id>, except the diminution of <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> plasmatic activity.	diazinon__acetylcholinesterase__interaction	Melatonin__acetylcholinesterase__no_interaction
18566887-1426	Sialic acid-specific O-<protein-id="P16966">acetyltransferases</protein-id> and O-<protein-id="P23553,P23872,Q325C0,Q3Z4S3,Q57S73,Q5PFJ2,Q83M39,Q8FK82,Q8XD38,Q8Z8T1,Q8ZRA1">acetylesterases</protein-id> are responsible for the metabolism of esterified <compound-id="349960">sialic acids</compound-id>.	sialic acids__acetyltransferases__interaction	sialic acids__acetylesterases__interaction
18567517-267	<compound-id="5311081">Endomorphin-2</compound-id> vector injection also reduced spontaneous pain-related behaviors in the delayed phase of the formalin test and in both <protein-id="O04350,O75347,P48427,P48428,P48606,P80584,P80585,Q9Y703">CFA</protein-id> and formalin models suppressed spinal c-<protein-id="P01101,P12841,Q56415">fos</protein-id> expression.	Endomorphin-2__fos__interaction	Endomorphin-2__CFA__interaction
18568363-1000	Furthermore, <compound-id="104767">8-bromo-cGMP</compound-id> and <compound-id="104806">peroxynitrite</compound-id> failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on <protein-id="O94916">TonEBP</protein-id> rather than through classical NO signaling pathways.	peroxynitrite__TonEBP__no_interaction	8-bromo-cGMP__TonEBP__no_interaction
18568363-998	<compound-id="145068">Nitric oxide</compound-id> decreases expression of osmoprotective genes via direct inhibition of <protein-id="O94916">TonEBP</protein-id> transcriptional activity.	Nitric oxide__TonEBP__interaction
18568363-999	Because <compound-id="145068">nitric oxide</compound-id> (NO) is abundantly produced in the renal medulla, the present studies addressed the effect of NO on expression of osmoprotective genes and <protein-id="O94916">TonEBP</protein-id> activation in MDCK cells.	nitric oxide__TonEBP__interaction
18568422-1042	Ran GTPase guanine nucleotide exchange factor <protein-id="P18754,P23800,P52499">RCC1</protein-id> is phosphorylated on <compound-id="5951">serine</compound-id> 11 by <protein-id="P04551,P11440,P23572,P39951">cdc2</protein-id> kinase in vitro.	serine__RCC1__interaction	serine__cdc2__interaction
18568422-1043	An RCC1 mutant in which all N-terminal <compound-id="5951">serine</compound-id> and <compound-id="6288">threonine</compound-id> residues were substituted with <compound-id="611,23327,33032">glutamate</compound-id> residues to mimic phosphorylation at these residues showed decreased binding to the karyopherin, <protein-id="O00629">KPNA4</protein-id>, compared with wild type RCC1.	threonine__KPNA4__interaction	serine__KPNA4__interaction	glutamate__KPNA4__interaction
18568426-1046	<compound-id="5957">ATP</compound-id>, acting on <protein-id="P13900,P16604">P2X</protein-id> (7) receptors, stimulates changes in intracellular calcium concentrations, maturation, and release of interleukin-1beta (<protein-id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</protein-id>), and following prolonged agonist exposure, cell death.	ATP__IL-1beta__interaction	ATP__P2X__interaction
18570309-903	The enantioselective interaction between penicillium expansum alkaline <protein-id="Q7M4U7">lipase</protein-id> and chiral <compound-id="13658">phenoxypropionic acid</compound-id> herbicide <compound-id="8427,119435">dichlorprop</compound-id> was studied by using UV differential spectrophotometry and fluorescence spectrophotometry in the presence of a pH 8, <compound-id="1061,167704,644102">phosphate</compound-id> buffer solution.	dichlorprop__lipase__interaction	phenoxypropionic acid__lipase__no_interaction	phosphate__lipase__no_interaction
18570315-909	While the total <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> released during a 1 h <compound-id="206,5793,64689,79025">glucose</compound-id> stimulation period was the same from islets in each sample, increasing hydrogel crosslinking density contributed to delays in <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> release from hydrogel samples within the 1 h stimulation period.	glucose__insulin__no_interaction
18570630-1172	Ischaemia and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, but not ischaemia and contraction, act synergistically in stimulating muscle <compound-id="206,5793,64689,79025">glucose</compound-id> uptake in vivo in humans.	glucose__insulin__interaction
18570630-1173	In summary, ischaemia and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> independently stimulate skeletal muscle <compound-id="206,5793,64689,79025">glucose</compound-id> uptake in vivo in humans, whereas ischaemia and contraction do not.	glucose__insulin__interaction
18570631-224	A comparison of the inhibitory effect of <compound-id="9395">paraoxon</compound-id> on soluble and immobilized <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> showed that immobilization increased the linearity of the inhibition plot particularly in the range 0.1 nM-0.1 microM.	paraoxon__AChE__interaction
18570695-1236	7,12-Dimethyl-benz[a] <compound-id="8418">anthracene</compound-id> (<compound-id="6001">DMBA</compound-id>) can induce expressions of <protein-id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</protein-id> and <protein-id="Q16678">CYP1B1</protein-id> which are known to be responsive to PAH.	DMBA__CYP1B1__interaction	anthracene__CYP1B1__interaction	DMBA__CYP1A1__interaction	anthracene__CYP1A1__interaction
18571801-413	Extracellular <protein-id="Q7M4U7">lipase</protein-id> <protein-id="O59952,P21764,P49081,Q06383,Q96Q15">LIP</protein-id> prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic <compound-id="3672,39912">ibuprofen</compound-id>.	ibuprofen__LIP__interaction	ibuprofen__lipase__interaction
18571801-414	The high purity (<compound-id="39912">S)-ibuprofen</compound-id> (ee = 0.98) was obtained using <protein-id="Q7M4U7">lipase</protein-id> <protein-id="O59952,P21764,P49081,Q06383,Q96Q15">LIP</protein-id> to catalyze hydrolysis of (S)-ester in 0.1 M <compound-id="1061,167704,644102">phosphate</compound-id> buffer (pH = 8).	S)-ibuprofen__LIP__interaction	phosphate__LIP__no_interaction	S)-ibuprofen__lipase__interaction	phosphate__lipase__no_interaction
18571950-552	The potential action of <compound-id="6036,439353,439357">galactose</compound-id> as a "chemical chaperone": increase of <protein-id="O33815,O52629,O52847,P00722,P00723,P06219,P0C1Y0,P14288,P22498,P23989,P24131,P26257,P30812,P50388,P70753,P77989,P81650,Q1G9Z4,Q47077,Q48727,Q56307,Q59140,Q59750,Q9K9C6">beta galactosidase</protein-id> activity in fibroblasts from an adult GM1-gangliosidosis patient.	galactose__beta galactosidase__no_interaction
18571954-554	<compound-id="311">Citric acid</compound-id> perfusion marginally increased <protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id> levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.	Citric acid__NGF__interaction
18571954-555	In contrast, perfusion of the inflamed axilla with <compound-id="311">citric acid</compound-id> significantly enhanced the release of both <protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id> and <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>.	citric acid__NGF__interaction	citric acid__BDNF__interaction
18572174-747	<compound-id="5282452">Pitavastatin</compound-id> induces <protein-id="P27169,P27170">PON1</protein-id> expression through <protein-id="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3">p44</protein-id>/42 mitogen-activated <protein-id="P00513,P25848">protein kinase</protein-id> signaling cascade in Huh7 cells.	Pitavastatin__protein kinase__interaction	Pitavastatin__p44__interaction	Pitavastatin__PON1__interaction
18572174-748	Both <protein-id="P27169,P27170">PON1</protein-id> gene promoter activity and <protein-id="P27169,P27170">PON1</protein-id> protein expression were elevated by <compound-id="5282452">pitavastatin</compound-id> stimulation.	pitavastatin__PON1__interaction
18572174-749	<compound-id="5282452">Pitavastatin</compound-id> phosphorylated <protein-id="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3">p44</protein-id>/42 MAP kinase.	Pitavastatin__p44__interaction
18572174-751	<compound-id="5282452">Pitavastatin</compound-id> increased the <protein-id="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451">Sp1</protein-id>-<protein-id="P27169,P27170">PON1</protein-id> DNA complex and this effect was attenuated by <compound-id="4713">PD98059</compound-id>.	Pitavastatin__Sp1__interaction	PD98059__PON1__interaction	PD98059__Sp1__interaction	Pitavastatin__PON1__interaction
18572174-752	These observations suggest that <compound-id="5282452">pitavastatin</compound-id> phosphorylates <protein-id="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3">p44</protein-id>/42 MAP kinase and then activates the transcription of <protein-id="P27169,P27170">PON1</protein-id> gene and increases the <protein-id="P27169,P27170">PON1</protein-id> protein expression in Huh7 cells.	pitavastatin__p44__interaction	pitavastatin__PON1__interaction
18572174-753	Furthermore, we speculate that <compound-id="5282452">pitavastatin</compound-id> affects both the phosphorylation of <protein-id="Q12772,Q60429">SREBP-2</protein-id> and the <protein-id="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451">Sp1</protein-id> binding to <protein-id="P27169,P27170">PON1</protein-id> DNA through the activation of <protein-id="P16342,P19751,Q66198,Q8TCB0,Q8V439,Q8V6W7,Q91A29,Q93V93,Q9PYA3">p44</protein-id>/42 MAP kinase signaling cascade.	pitavastatin__p44__interaction	pitavastatin__SREBP-2__interaction	pitavastatin__Sp1__interaction	pitavastatin__PON1__interaction
18573668-277	Inhibition of <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase 2</protein-id> expression by <compound-id="11617">diallyl sulfide</compound-id> on joint inflammation induced by urate crystal and <protein-id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</protein-id>.	diallyl sulfide__IL-1beta__no_interaction	diallyl sulfide__cyclooxygenase 2__interaction
18573668-278	Investigation of the effects of <compound-id="11617">diallyl sulfide</compound-id> (DAS), a garlic <compound-id="402">sulfur</compound-id> compound, on joint tissue inflammatory responses induced by <compound-id="1175">monosodium urate</compound-id> (MSU) crystals and interleukin-1beta (<protein-id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</protein-id>).	sulfur__IL-1beta__no_interaction	diallyl sulfide__IL-1beta__no_interaction	monosodium urate__IL-1beta__no_interaction
18574025-577	Genetic variants of <protein-id="P11712">cytochrome P450 2C9</protein-id> (<protein-id="P11712">CYP2C9</protein-id>) and vitamin K epoxide reductase (<protein-id="Q6B4J2,Q9BQB6">VKORC1</protein-id>) are known to influence <compound-id="54678486">warfarin</compound-id> dose, but the effect of other genes has not been fully elucidated.	warfarin__cytochrome P450 2C9__interaction	warfarin__VKORC1__interaction	warfarin__CYP2C9__interaction
18574025-578	In conclusion, <protein-id="P11712">CYP2C9</protein-id> and <protein-id="Q6B4J2,Q9BQB6">VKORC1</protein-id> significantly influenced <compound-id="54678486">warfarin</compound-id> dose and predicted individuals predisposed to unstable anticoagulation.	warfarin__VKORC1__interaction	warfarin__CYP2C9__interaction
18574490-986	BMI and <compound-id="6013">testosterone</compound-id> levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (<protein-id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</protein-id>) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of <compound-id="148124">docetaxel</compound-id> and <compound-id="5865">prednisone</compound-id> compared with <compound-id="4212">mitoxantrone</compound-id> and <compound-id="5865">prednisone</compound-id>.	docetaxel__PSA__no_interaction	testosterone__PSA__interaction	mitoxantrone__PSA__no_interaction	prednisone__PSA__no_interaction
18574490-987	In multivariate analysis, neither BMI, presence of obesity, nor baseline <compound-id="6013">testosterone</compound-id> was significantly associated with OS or <protein-id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</protein-id> declines.	testosterone__PSA__no_interaction
18574670-1109	The interaction between PAF and the platelet agonists ADP, <protein-id="P84122">thrombin</protein-id> and convulxin was analyzed in vitro in whole blood with the use of flow cytometry and was further characterized with the use of receptor antagonists to PAF (ABT-491), P2Y1 (<compound-id="5311303">MRS-2179</compound-id>), and P2Y12 (<compound-id="9854012">cangrelor</compound-id>) as well as a monoclonal anti-PSGL-1 antibody (anti-CD162).	cangrelor__thrombin__no_interaction	MRS-2179__thrombin__no_interaction
18575957-472	Aim The present study sought insight into the effects of <compound-id="60815">remifentanyl</compound-id> and <compound-id="3345">fentanyl</compound-id> on LPS-induced release of <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>), <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>) and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> in human whole blood.	remifentanyl__TNF-alpha__interaction	fentanyl__IL-6__interaction	fentanyl__tumor necrosis factor__interaction	remifentanyl__IL-6__interaction	remifentanyl__tumor necrosis factor__interaction	fentanyl__IL-10__interaction	remifentanyl__interleukin-6__interaction	fentanyl__interleukin-6__interaction	fentanyl__TNF-alpha__interaction	remifentanyl__IL-10__interaction
18575957-473	Effects of <compound-id="60815">remifentanyl</compound-id> and <compound-id="3345">fentanyl</compound-id> on spontaneous and <compound-id="53481793">endotoxin (lipopolysaccharide</compound-id> ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> 0.01).	fentanyl__IL-10__no_interaction	remifentanyl__IL-10__no_interaction	fentanyl__TNF-alpha__no_interaction	remifentanyl__TNF-alpha__no_interaction	endotoxin (lipopolysaccharide__TNF-alpha__no_interaction	endotoxin (lipopolysaccharide__IL-6__no_interaction	endotoxin (lipopolysaccharide__IL-10__no_interaction	fentanyl__IL-6__no_interaction	remifentanyl__IL-6__no_interaction
18575957-475	<compound-id="60815">Remifentanyl</compound-id> and <compound-id="3345">fentanyl</compound-id> could inhibit the expressions of <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> induced by LPS.	Remifentanyl__TNF-alpha__interaction	fentanyl__IL-6__interaction	Remifentanyl__IL-6__interaction	fentanyl__IL-10__interaction	fentanyl__TNF-alpha__interaction	Remifentanyl__IL-10__interaction
18577298-1601	This reduction was associated with the storage of decreased TAG and increased <compound-id="439177">glycogen</compound-id>, which was a result of enhanced <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of <protein-id="P31749,P31750,P47196,Q01314,Q8INB9">protein kinase B</protein-id> (<protein-id="P31749,P31750,P47196,Q01314,Q8INB9">PKB</protein-id>, <protein-id="P31750,Q8INB9">Akt</protein-id>).	tyrosine__PKB__no_interaction	glycogen__Akt__interaction	glycogen__protein kinase B__interaction	glycogen__PKB__interaction	tyrosine__Akt__no_interaction	tyrosine__protein kinase B__no_interaction
18577298-1602	Improved hepatic <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> signalling led to decreased phosphoenolpyruvate carboxykinase expression and reduced hepatic <compound-id="206,5793,64689,79025">glucose</compound-id> output accordingly.	glucose__insulin__interaction
18577871-351	These data provide evidence that CMEC express <protein-id="O62714,P35384,P41180,P48442,Q9QY96">CaSR</protein-id>, which is able to respond to physiological agonists by mobilizing <compound-id="271">Ca(2</compound-id>+) from intracellular InsP(3)-sensitive stores.	Ca(2__CaSR__interaction
18579232-1493	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>/<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> mRNA level is under the control of endogenous <compound-id="804">iNO</compound-id>/<compound-id="24316">cGMP</compound-id> signaling system.	iNO__iNOS__interaction	cGMP__COX-2__interaction	cGMP__iNOS__interaction	iNO__COX-2__interaction
18580872-1175	Pre-synaptic <protein-id="P52451">CB1Rs</protein-id> inhibit neurotransmitter release, suggesting that <protein-id="P52451">CB1R</protein-id> activation during extinction may decrease <protein-id="O57312,O93464,P01355,P01356,P06307,P09240,P0C229,P23362,P41520,P50144,P50145,P68125,P68126,P80344,P80345,Q9PU29,Q9PU41">CCK</protein-id> peptide release as well as <compound-id="119">GABA</compound-id> release.	GABA__CB1R__interaction	GABA__CCK__no_interaction	GABA__CB1Rs__interaction
18580876-1179	Acute <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id>, through <protein-id="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1">D(2) dopamine receptors</protein-id>, induced a dose-response increase in <protein-id="Q13158,Q61160">FADD protein</protein-id> in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	cocaine__FADD protein__interaction	cocaine__D(2) dopamine receptors__interaction
18580876-1180	<protein-id="P46310,Q13158">FADD</protein-id> was increased by <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id> in cytosol (approximately 142%), membranes (approximately 23%) and nucleus (approximately 54%).	cocaine__FADD__interaction
18580876-1181	In a second experiment, possible <protein-id="P46310,Q13158">FADD</protein-id> differences were investigated in rats selectively bred for differential responsiveness to novelty, propensity for drug-seeking and <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id> sensitization.	cocaine__FADD__no_interaction
18581264-1465	<protein-id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">Lignin peroxidases</protein-id> have the unique ability to catalyze oxidative cleavage of C-C bonds and <compound-id="3283,5382654">ether</compound-id> (C-O-C) bonds in non-phenolic aromatic substrates of high redox potential.	ether__Lignin peroxidases__interaction
18581264-1466	Manganese <protein-id="P15984,P16147,P84714">peroxidases</protein-id> oxidize <compound-id="27854">Mn(II</compound-id>) to <compound-id="105130">Mn(III</compound-id>), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	Mn(III__peroxidases__interaction	Mn(II__peroxidases__interaction
18581264-1467	<protein-id="Q12570">Laccases</protein-id> are multi-<compound-id="23978">copper</compound-id>-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular <compound-id="977">oxygen</compound-id> to water.	copper__Laccases__interaction	oxygen__Laccases__interaction
18581270-1477	The co-expression of <protein-id="P31645,Q9XT49">SERT</protein-id> with <protein-id="Q13491,Q5R603">M6B</protein-id> results in a significant decrease in <protein-id="P31645,Q9XT49">SERT</protein-id>-mediated <compound-id="5202">serotonin</compound-id> uptake caused by a down-regulation of <protein-id="P31645,Q9XT49">SERT</protein-id> surface expression.	serotonin__SERT__interaction	serotonin__M6B__interaction
18582556-870	Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce <compound-id="206,5793,64689,79025">glucose</compound-id> utilization besides elevated adiponectin, reduced <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> and a lack of GH, <protein-id="O62781,O62819,O93337,P01236,P01237,P01238,P01239,P01240,P06879,P09585,P10765,P12420,P14676,P17572,P21993,P22393,P29234,P29235,P33089,P33090,P33091,P33096,P34181,P35395,P37884,P40424,P43001,P43299,P46403,P48096,P48249,P51904,P55151,P87495,Q28318,Q28632,Q3Y4G6,Q6UC74,Q7ZZV3,Q8HXS1,Q9QZL1,Q9YGV6">PRL</protein-id> and TSH, seen in both Snell and Ames dwarf mice.	glucose__PRL__no_interaction	glucose__IGF-I__no_interaction
18582992-1242	Therefore, <compound-id="156419">cinacalcet</compound-id>, which inhibit the production of <protein-id="P01270">parathormone</protein-id> by negative feedback, was considered a treatment option to control the evolution of calciphylaxis in a dialysed patient suffering from cholangiocarcinoma.	cinacalcet__parathormone__interaction
18583434-1596	<compound-id="206,5793,64689,79025">Glucose</compound-id> levels and hormones [<protein-id="P10082,P68004,Q9TR93">Peptide YY(3-36)</protein-id>, <protein-id="O12956,P01272,P01273,P01274,P01275,P01278,P05110,P06883,P15438,P22890,P29794,P55095,P68259,Q8MJ25">glucagon-like peptide-1</protein-id> (<protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id>), <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id>, <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id>, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>] that regulate EI were measured.	Glucose__glucagon-like peptide-1__no_interaction	Glucose__insulin__no_interaction	Glucose__ghrelin__no_interaction	Glucose__leptin__no_interaction	Glucose__GLP-1__no_interaction	Glucose__Peptide YY(3-36)__no_interaction
18584284-591	<protein-id="P08587,P21980,P21981,P51176,P52181,Q01841">Transglutaminase 2</protein-id> (TG2) is an inducible transamidating <protein-id="P05521,P19197,P21309,P23148,P41302,Q06878,Q7N576,Q9AJA7,Q9S3Z2">acyltransferase</protein-id> that catalyzes <compound-id="271">Ca(2</compound-id>+)-dependent protein modifications.	Ca(2__acyltransferase__interaction	Ca(2__Transglutaminase 2__interaction
18584285-592	<protein-id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">Transglutaminases</protein-id> catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate <compound-id="738,5961">glutamine</compound-id> residues and modifies the extracellular matrix.	glutamine__Transglutaminases__interaction
18584286-593	We fed rats <compound-id="866,5962">lysine</compound-id> or <compound-id="6287">valine</compound-id> deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, <protein-id="O43175,Q5EAD2,Q5R7M2,Q60HD7">PHGDH</protein-id>) and serine/threonine degrading enzymes (serine dehydratase, <protein-id="P20132">SDS</protein-id>) in the liver.	lysine__PHGDH__no_interaction	valine__PHGDH__no_interaction	valine__SDS__no_interaction	lysine__SDS__no_interaction
18584286-594	Dietary deficiency induced marked elevation of hepatic <compound-id="5951">serine</compound-id> and <compound-id="6288">threonine</compound-id> levels associated with enhancement of <protein-id="O43175,Q5EAD2,Q5R7M2,Q60HD7">PHGDH</protein-id> mRNA expression and repression of <protein-id="P20132">SDS</protein-id> mRNA expression.	threonine__PHGDH__no_interaction	serine__PHGDH__no_interaction	threonine__SDS__no_interaction	serine__SDS__no_interaction
18584306-333	Site-directed mutation test and <compound-id="29051,163659,230076,6326719">mithramycin A</compound-id> treatment demonstrated that the <protein-id="Q8WVD5,Q9UIE0">ZNF230</protein-id> promoter contained a functional <protein-id="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451">Sp1</protein-id> site.	mithramycin A__Sp1__interaction	mithramycin A__ZNF230__interaction
18584320-630	<compound-id="5994">Progesterone</compound-id> effects on neuronal ultrastructure and expression of <protein-id="P11137,P15146,P20357">microtubule-associated protein 2</protein-id> (<protein-id="P11137,P38174,Q5Z859,Q6XMH6,Q6XMH7,Q8SR45">MAP2</protein-id>) in rats with acute spinal cord injury.	Progesterone__microtubule-associated protein 2__interaction	Progesterone__MAP2__interaction
18584320-631	(4) Our data indicated that <compound-id="5994">progesterone</compound-id> maintained in part neuronal ultrastructure, attenuated chromatolysis, and preclude the loss of <protein-id="P11137,P38174,Q5Z859,Q6XMH6,Q6XMH7,Q8SR45">MAP2</protein-id>, suggesting a protective effect during the early phases of spinal cord injury.	progesterone__MAP2__interaction
18584336-637	In conclusion, our results indicate that chronic <compound-id="16078,134740">THC</compound-id> modulates the expression and subcellular localization of proteins implicated in <protein-id="P03967,P22126,Q07152">Ras</protein-id> signaling, calcium-buffering potential, and trafficking.	THC__Ras__no_interaction
18584896-1102	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor <compound-id="2703,411938">chelerythrine</compound-id> (CHE), <compound-id="1548943">capsaicin</compound-id> (CAP) to deplete <protein-id="P10286,P30880,P30881,P31888,P80511">CGRP</protein-id> from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (<compound-id="25058136">5HD</compound-id>).	chelerythrine__CGRP__no_interaction	5HD__CGRP__no_interaction	capsaicin__CGRP__interaction
18585399-1508	The anti-convulsant <compound-id="5311454">stiripentol</compound-id> acts directly on the <protein-id="P26714,Q08832,Q9BLY8">GABA(A) receptor</protein-id> as a positive allosteric modulator.	stiripentol__GABA(A) receptor__interaction
18585720-96	Di-<compound-id="5885531">oleoyl</compound-id> phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (<protein-id="P27169,P27170">PON1</protein-id>) enzymatic and biological activities: in vitro and in vivo studies.	oleoyl__PON1__interaction
18585721-97	With the exception of specific genetic defects in <compound-id="1044">purine</compound-id> metabolism, increased <compound-id="1175">uric acid</compound-id> is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, the metabolic syndrome and renal failure.	uric acid__insulin__interaction	purine__insulin__interaction
18585744-108	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different <compound-id="18730">fluorescein isothiocyanate</compound-id> (<compound-id="18730">FITC</compound-id>) conjugated <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id>.	fluorescein isothiocyanate__lectins__interaction	FITC__lectins__interaction
18586252-521	High <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="Q9TTB0">interferon gamma</protein-id> synergistically stimulate <protein-id="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5">MMP-1</protein-id> expression in U937 macrophages by increasing transcription factor <protein-id="P42224,Q764M5">STAT1</protein-id> activity.	glucose__interferon gamma__no_interaction	glucose__STAT1__interaction	glucose__MMP-1__interaction
18586252-522	To test our hypothesis that hyperglycemia interplays with <protein-id="Q9TTB0">interferon gamma</protein-id> (<protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN gamma</protein-id>), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high <compound-id="206,5793,64689,79025">glucose</compound-id> were challenged with <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN gamma</protein-id> and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).	glucose__interferon gamma__no_interaction	glucose__IFN gamma__no_interaction
18586252-523	Results showed that high <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN gamma</protein-id> had a synergistic effect on the expression of <protein-id="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5">MMP-1</protein-id>, <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id> and <protein-id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1 beta</protein-id>.	glucose__IL-1 beta__interaction	glucose__MMP-1__interaction	glucose__IFN gamma__no_interaction	glucose__MMP-9__interaction
18586252-525	Furthermore, high <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN gamma</protein-id> exert the synergistic effect on <protein-id="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5">MMP-1</protein-id> expression by enhancing <protein-id="P42224,Q764M5">STAT1</protein-id> phosphorylation and <protein-id="P42224,Q764M5">STAT1</protein-id> transcriptional activity.	glucose__STAT1__interaction	glucose__IFN gamma__no_interaction	glucose__MMP-1__interaction
18586420-663	In Experiment 2, <protein-id="O77698,O77811,P02788,P08071,P14632,P24627,Q29477,Q9TUM0">lactoferrin</protein-id> (10 mg/mL) combined with <compound-id="60613">cidofovir</compound-id> (62.5 microg/mL) inhibited up to 100,200 PFU/mL of virus in cell culture.	cidofovir__lactoferrin__no_interaction
18586549-790	We systematically investigated whether PD-related stresses including <compound-id="462382">MG132</compound-id> and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and <compound-id="6758">rotenone</compound-id> (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 <protein-id="O46543,P08565,P08618,P0C014,P0C072,P13117,P14624,P14792,P15174,P19848,P20685,P22589,P23324,P23398,P42739,P42740,P46574,P49634,P49635,P59263,P59669,P61862,P61863,P61864,P62972,P62973,P62974,P62975,P62976,P62977,P62988,P62989,P62990,P62991,P63049,P63051,P68195,P68196,P68197,P68198,P68199,P68201,P68204,P69308,P69309,P69310,P69311,P69312,P69313,P69314,P69315,P69316,P69317,P69318,P69319,P69320,P69321,P69322,P69323,P69324,P69325,P69326,P84589,Q05550,Q865C5,Q867C2,Q867C3,Q867C4,Q8MKD1,Q9Y848">ubiquitin</protein-id> ligases (<protein-id="Q9NV58">dorfin</protein-id>, SIAH-1).	rotenone__ubiquitin__interaction	rotenone__dorfin__interaction	MG132__dorfin__interaction	MG132__ubiquitin__interaction
18587580-1638	<compound-id="400769">CDDO-Me</compound-id>, a synthetic triterpenoid, inhibits expression of <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> and <protein-id="P42227,P52631">Stat3</protein-id> phosphorylation in multi-drug resistant ovarian cancer cells.	CDDO-Me__Stat3__interaction	CDDO-Me__IL-6__interaction
18587580-1639	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of <compound-id="400769">CDDO-Me</compound-id>, a synthetic triterpenoid, to inhibit <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> secretion, <protein-id="P42227,P52631">Stat3</protein-id> phosphorylation, <protein-id="P42227,P52631">Stat3</protein-id> nuclear translocation and <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> sensitivity in several cell line model systems.	paclitaxel__Stat3__no_interaction	CDDO-Me__IL-6__interaction	paclitaxel__IL-6__no_interaction	CDDO-Me__Stat3__interaction
18587580-1640	These studies demonstrated that <compound-id="400769">CDDO-Me</compound-id> significantly inhibits <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> secretion in paclitaxel-resistant ovarian cancer cells and specifically suppresses <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>-or oncostatin M-induced <protein-id="P42227,P52631">Stat3</protein-id> nuclear translocation.	CDDO-Me__Stat3__interaction	CDDO-Me__IL-6__interaction
18587580-1641	Treatment with <compound-id="400769">CDDO-Me</compound-id> significantly decreases the levels of Stat3, <protein-id="Q62120,Q62689">Jak2</protein-id>, and <protein-id="P05480,Q9WUD9">Src</protein-id> phosphorylation in ovarian and breast cancer cell lines with constitutively activated Stat3.	CDDO-Me__Jak2__interaction	CDDO-Me__Src__interaction
18587580-1642	Our data confirm that <compound-id="400769">CDDO-Me</compound-id> interrupts the signaling of multiple kinases involved in the <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>-<protein-id="P42227,P52631">Stat3</protein-id> and <protein-id="P05480,Q9WUD9">Src</protein-id> signaling pathways.	CDDO-Me__Stat3__interaction	CDDO-Me__Src__interaction	CDDO-Me__IL-6__interaction
18587601-1586	The anti-hyperlipemia effect of EPS and intracellular polysaccharide (IPS) extracted from mycelia were observed that both EPS and IPS can obviously reduce the serum triglyceride (TG), the blood <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (TC) and serum low density lipoprotein (LDL) level, and increase the <protein-id="P81182">high density lipoprotein</protein-id> (HDL) level of the hyperlipemia mice.	cholesterol__high density lipoprotein__no_interaction
18587610-1674	On a molar basis, <compound-id="5999,19649,6426892,6602485">streptomycin</compound-id> yields a signal that is approximately 0.67 times that of <protein-id="O32849,O32857,O32858,O33159,O33160,O51428,O54312,O67315,O84461,P0A5L2,P0A5L3,P0A749,P0A750,P0A751,P19670,P33038,P33986,P45025,P45821,P56189,P57466,P57821,P65452,P65453,P65454,P65455,P65458,P65459,P70965,P84058,P84059,Q2RQ67,Q2YAN2,Q2YPB6,Q30T46,Q315P9,Q319I9,Q31GZ1,Q31W66,Q32BE4,Q39K93,Q39YP9,Q3A131,Q3A949,Q3AR32,Q3B5D7,Q3BQX2,Q3IG20,Q3J077,Q3J7G9,Q3JMZ4,Q3KHZ4,Q3KLP3,Q3MD78,Q3SHP2,Q3SW27,Q3YX52,Q46JH1,Q46WL0,Q47AK9,Q47KH3,Q47VJ4,Q48EC7,Q48UD0,Q493Y9,Q4FNE4,Q4FQF6,Q4JXA4,Q4KI75,Q4L7Y1,Q4QLK7,Q4UKX7,Q4UX36,Q4ZNV7,Q55673,Q57F97,Q57JG1,Q59561,Q5E7V0,Q5F5K6,Q5FME5,Q5FSM2,Q5GRP6,Q5H3C7,Q5HEA0,Q5HMC2,Q5HUT8,Q5L6U5,Q5L9P3,Q5LL90,Q5LZI4,Q5M439,Q5NLR2,Q5P787,Q5PBP4,Q5PLD1,Q5R0J5,Q5SM03,Q5WB82,Q5WY61,Q5X6Q6,Q5XCX7,Q5Z0X7,Q5ZX85,Q606Q0,Q62GD7,Q630W1,Q63Q84,Q64PY6,Q65RU6,Q661E8,Q665K4,Q68WF7,Q6AJM7,Q6DAF2,Q6FED0,Q6FYT1,Q6G226,Q6G7L0,Q6GEX5,Q6HAZ8,Q6LMC9,Q6MEP6,Q6MRK7,Q6N176,Q6NFK1,Q71WQ2,Q726D3,Q72GJ4,Q73FX6,Q73Q03,Q73X63,Q748B3,Q74LG1,Q7MAC1,Q7MPA3,Q7MUW1,Q7N068,Q7NGP3,Q7P0X5,Q7U5R6,Q7V0G1,Q7V8L0,Q7VAC5,Q7VAT0,Q7VIM8,Q7VP51,Q7VQS0,Q7VSZ3,Q7W2Y6,Q7WDY6,Q82TN2,Q83DI0,Q87DN8,Q87LF4,Q87WV2,Q88P88,Q89AE9,Q89W71,Q8A681,Q8CRN6,Q8D2M5,Q8DEB6,Q8DKS7,Q8DNE8,Q8E5U6,Q8EAF7,Q8EM86,Q8FMR0,Q8K825,Q8K9G4,Q8KEX7,Q8NML5,Q8P719,Q8PID3,Q8RIQ1,Q8UHW9,Q8X9J9,Q8XID7,Q8XV78,Q8Y4C4,Q8Z0C4,Q8ZB56,Q927W7,Q92H88,Q92S27,Q931H5,Q97F79,Q97NQ4,Q9A5U7,Q9CI17,Q9HVW7,Q9JWS7,Q9K1Q9,Q9K6I0,Q9KP62,Q9PDG4,Q9PJT7,Q9PP65,Q9RVA6,Q9WXW3,Q9Z3Z6,Q9Z7Y2,Q9ZCX3,Q9ZH21,Q9ZLI6">MurA</protein-id>.	streptomycin__MurA__no_interaction
18587665-16	<compound-id="5281807,5385074,5486172,44257207,53384442">Puerarin</compound-id> regulates expressions of <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> and <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id> stimulated by STZ.	Puerarin__HIF-1alpha__interaction	Puerarin__VEGF__interaction
18588512-710	In patients with hypertension and diabetes, <compound-id="439764">ARB</compound-id>, ACEi and diuretic treatment increased <protein-id="P03967,P22126,Q07152">Ras</protein-id> activation only during the first week.	ARB__Ras__interaction
18590515-661	Although the co-expression of <protein-id="P54751,P61130,P61131,P72074,P72097,Q02745,Q11200,Q11201,Q11204,Q11205,Q11206,Q16842,Q48211,Q6KB58,Q6KB59,Q91Y74,Q9CNC4,Q9JUV5">alpha2,3-ST</protein-id> and CMP-SAS did not further increase sialylation, an increase in the intracellular pool of CMP-<compound-id="906,444885,445063">sialic acid</compound-id> was noted.	sialic acid__alpha2,3-ST__no_interaction
18590587-733	NOPE-<compound-id="65064">EGCG</compound-id> treatment improved <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> 0.0001).	EGCG__insulin__interaction
18590597-739	A 23.5-fold increase in <compound-id="130779">7-ethoxy-4-trifluoromethylcoumarin</compound-id> O-deethylation activity suggested that metabolic resistance through elevated levels of <protein-id="O08469">cytochrome P450</protein-id> dependent monooxygenase-activity is a possible resistance mechanism.However, synergism studies with different metabolic inhibitors revealed some contrasting resistance mechanisms between the METI-acaricides.	7-ethoxy-4-trifluoromethylcoumarin__cytochrome P450__interaction
18592271-409	The activities of <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> GTPases are predominantly controlled by guanine nucleotide exchange factors (<protein-id="Q9NR83">GEFs</protein-id>), which activate GTPases by catalyzing the exchange of bound <compound-id="8977">GDP</compound-id> for <compound-id="6830">GTP</compound-id>.	GTP__Rho__no_interaction	GDP__Rho__no_interaction	GTP__GEFs__interaction	GDP__GEFs__interaction
18592327-379	11beta-Hydroxysteroid dehydrogenase type 1 (<protein-id="P16232,P28845,P50172,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4">11beta-HSD1</protein-id>) enzyme catalyzes interconversion of inactive <compound-id="222786">cortisone</compound-id> to active <compound-id="5754">cortisol</compound-id>.	cortisol__11beta-HSD1__interaction	cortisone__11beta-HSD1__interaction
18592344-477	Rebinding experiments with Lys-<compound-id="750,5460845">Gly</compound-id>-Asp, an analogue of Arg-<compound-id="750,5460845">Gly</compound-id>-Asp, and other different peptides, such as <protein-id="P0C229,P50144,P50145,P68125,P68126">cholecystokinin</protein-id> C-terminal tri- and <compound-id="25201604">pentapeptide</compound-id> and <compound-id="16130140">gramicidin</compound-id>, further indicated the selectivity of <compound-id="4093">methacrylic acid</compound-id>-trimethylpropane trimethacrylate copolymer for Arg-<compound-id="750,5460845">Gly</compound-id>-Asp giving specific selectivity factor values 1.27, 1.98, 1.31 and 1.67, respectively.	gramicidin__cholecystokinin__no_interaction	pentapeptide__cholecystokinin__no_interaction	Gly__cholecystokinin__no_interaction	methacrylic acid__cholecystokinin__no_interaction
18592367-499	Parents (N = 19) of children with autism spectrum disorders (ASD) and adult controls (N = 17) underwent positron emission tomography (PET) using [(18)F] <compound-id="68604">setoperone</compound-id> to image cortical serotonin type-2 (<protein-id="O46635,P14842,P18599,P28223,P35363,P35382,P50128,P50129,Q5R4Q6,Q75Z89">5-HT2</protein-id>) receptors.	setoperone__5-HT2__interaction
18592408-535	Natural <compound-id="167551">anacardic acid</compound-id> was enzymatically polymerized using soybean <protein-id="P15984,P16147,P84714">peroxidase</protein-id>.	anacardic acid__peroxidase__interaction
18592416-542	Vesicle mobilization requires <compound-id="271">Ca(2</compound-id>+)-induced Ca2+ release by presynaptic endoplasmic reticulum (ER) ryanodine receptors (<protein-id="Q24498">RyRs</protein-id>) that in turn stimulates Ca2+/<protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">calmodulin</protein-id>-dependent kinase II (CamKII).	Ca(2__calmodulin__interaction	Ca(2__RyRs__interaction
18593507-1421	These results highlight both the interactions between <protein-id="P31424,P41594">mGluR5</protein-id> and NMDA receptors in the determination of schizophreniform behaviours and the potential for the effects of <compound-id="2818">clozapine</compound-id> to be mediated by NMDA receptor regulation.	clozapine__mGluR5__no_interaction
18594129-259	Expression of <protein-id="P0AG38,P0AG39,Q8Z3B3,Q9L6N7">rhtC</protein-id> reduced the intracellular <compound-id="6288">L-threonine</compound-id> concentration from 140 to 11 mM and resulted in maximal excretion rates of 11.2 nmol min(-1) mg(-1) as compared to 2.3 nmol min(-1) mg(-1) obtained without <protein-id="P0AG38,P0AG39,Q8Z3B3,Q9L6N7">rhtC</protein-id> expression.	L-threonine__rhtC__interaction
18594129-260	In combination with an <protein-id="P04968,P20506,P37946,P46493,P53607,P66897,P66898,Q02145,Q04513,Q2FF63,Q2YUE8,Q3V7T4,Q3V7T5,Q49Z16,Q4L7U4,Q5HEE0,Q5HMF5,Q7A4H2,Q8CNK9,Q8NVI8,Q99SJ1,Q9CKJ2,Q9KC63,Q9X7F1">ilvA</protein-id> mutation generated and introduced into the chromosome, an accumulation of up to 54 mM <compound-id="6288">L-threonine</compound-id> was achieved as compared to 21 mM obtained with the ancestor strain.	L-threonine__ilvA__interaction
18594817-847	This additive effect was not observed when glioma cells were pre-treated with <compound-id="5394">temozolomide</compound-id>, which was unable to increase <protein-id="P25446,Q63199">Fas</protein-id> expression in tumor.	temozolomide__Fas__no_interaction
18594817-848	Furthermore, the CD3(+) T cells co-cultured with <compound-id="60700">topotecan</compound-id> treated U-87 and autologous GBM tumor cells showed a significant increase in expression in <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id>, a key cytokine produced by activated T cells, and accordingly enhanced tumor cytotoxicity.	topotecan__IFN-gamma__interaction
18594856-883	Hypergravity also induced a transient reorganization of <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> fibers in 3 min, which was inhibited by Rho-kinase inhibitor (<compound-id="448042">Y27632</compound-id>) and tyrosine kinase inhibitors (<compound-id="3591,5311102,6436247">herbimycin A</compound-id> and <compound-id="5328768">tyrphostin 46</compound-id>).	Y27632__actin__interaction	herbimycin A__actin__interaction	tyrphostin 46__actin__interaction
18594856-886	Collectively, these results indicate that hypergravity induces <compound-id="5957">ATP</compound-id> release and <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> reorganization via <protein-id="Q9C3Y4">RhoA</protein-id> activation and <protein-id="Q00944,Q05397">FAK</protein-id> phosphorylation, thereby activating cell proliferation and migration in BAECs.	ATP__FAK__interaction	ATP__RhoA__interaction	ATP__actin__interaction
18594946-953	Cell exposure to 250 microM <compound-id="778">homocysteine</compound-id> was able to induce <protein-id="P08587,P21980,P21981,P51176,P52181,Q01841">transglutaminase 2</protein-id> up-regulation and increased in situ <protein-id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</protein-id> activity.	homocysteine__transglutaminase__interaction	homocysteine__transglutaminase 2__interaction
18594946-954	<compound-id="778">Homocysteine</compound-id> also induced NF-kappaB activation that seemed associated with <protein-id="P08587,P21980,P21981,P51176,P52181,Q01841">transglutaminase 2</protein-id> up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce <protein-id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</protein-id> expression and activity levels.	Homocysteine__transglutaminase__no_interaction	Homocysteine__transglutaminase 2__interaction
18594965-980	<compound-id="3988,5311263,5497152">Lysophosphatidic acid</compound-id> can support the formation of membranous structures and an increase in <protein-id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</protein-id> mRNA levels in differentiating oligodendrocytes.	Lysophosphatidic acid__MBP__interaction
18594989-1002	There was no correlation between the presence of significant heart-valve regurgitation and <compound-id="54746">cabergoline</compound-id> cumulative dose, duration of <compound-id="54746">cabergoline</compound-id> treatment, prior use of <compound-id="31101">bromocriptine</compound-id>, age, adenoma size, or <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> levels.	cabergoline__prolactin__no_interaction	bromocriptine__prolactin__no_interaction
18595002-930	<protein-id="O77220,P14944,P30814,P55845,P56687,P59685,P81032,P83800,Q25588,Q25589,Q25683,Q26181">CHH</protein-id> elevates <compound-id="206,5793,64689,79025">glucose</compound-id> levels in the hemolymph by stimulating glycogenolysis in target tissues.	glucose__CHH__interaction
18596195-276	Here, we assessed the regulation of pancreatic <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> release by <compound-id="271">Ca(2</compound-id>+), mitochondrial membrane potential (Delta Psi m), and reactive <compound-id="977">oxygen</compound-id> species (ROS), the signals involved in acute pancreatitis.	oxygen__cytochrome c__interaction	Ca(2__cytochrome c__interaction
18596687-690	Here, we report the efficacy of <compound-id="2369,60657">betaxolol</compound-id> in reducing increases in gene expression of amygdalar <protein-id="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">corticotropin-releasing factor</protein-id> (<protein-id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</protein-id>), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id> abstinence.	cocaine__CRF__interaction	betaxolol__corticotropin-releasing factor__interaction	betaxolol__CRF__interaction	cocaine__corticotropin-releasing factor__interaction
18596687-691	Results showed that <compound-id="2369,60657">betaxolol</compound-id> treatment during early <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id> withdrawal attenuated increases in amygdalar <protein-id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</protein-id> gene expression and cyclic adenosine monophosphate-dependent <protein-id="P00513,P25848">protein kinase</protein-id> regulatory and catalytic subunit (nuclear fraction) protein expression.	betaxolol__protein kinase__interaction	cocaine__CRF__no_interaction	betaxolol__CRF__interaction	cocaine__protein kinase__no_interaction
18596687-692	The present findings suggest that the efficacy of <compound-id="2369,60657">betaxolol</compound-id> treatment on <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id> withdrawal-induced anxiety may be related, in part, to its effect on amygdalar beta(1)-adrenergic receptor, modulation of its downstream cell-signaling elements and <protein-id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</protein-id> gene expression.	cocaine__CRF__no_interaction	betaxolol__CRF__interaction
18597051-1012	Furthermore, it is demonstrated that this strain has <protein-id="O43097,O59859,O60206,P07529,P09850,P17137,P23360,P23557,P29417,P40943,P45703,P48793,P56588,P81536,Q53317">xylanase</protein-id> activity, and the activity can be optimized under suitable growing conditions where wheat bran and <compound-id="1176,265993">urea</compound-id> are the primary sources of carbon and <compound-id="947,123329">nitrogen</compound-id>.	urea__xylanase__no_interaction	nitrogen__xylanase__no_interaction
18597073-1033	<protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">Glutathione S-transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>) isozymes catalyze nucleophilic attack by <compound-id="124886">reduced Glutathione</compound-id> (<compound-id="124886">GSH</compound-id>) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	GSH__GST__interaction	reduced Glutathione__Glutathione S-transferase__interaction	reduced Glutathione__GST__interaction	GSH__Glutathione S-transferase__interaction
18597869-1683	<compound-id="4091">Metformin</compound-id> inhibits <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>-induced <protein-id="O15111,Q60680">IkappaB kinase</protein-id> phosphorylation, <protein-id="P25963,Q08353,Q63746,Q91974,Q9Z1E3">IkappaB-alpha</protein-id> degradation and <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> production in endothelial cells through <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>-dependent <protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id> phosphorylation.	Metformin__AMPK__interaction	Metformin__TNF-alpha__interaction	Metformin__PI3K__interaction	Metformin__IkappaB-alpha__interaction	Metformin__IL-6__interaction	Metformin__IkappaB kinase__interaction
18599066-769	<compound-id="985">Palmitate</compound-id> phosphorylated <protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</protein-id> and <protein-id="P92208,Q966Y3">JNK</protein-id> kinases, and blocking of these kinases with specific inhibitors diminished the <compound-id="985">palmitate</compound-id>-induced cytokine secretion.	Palmitate__JNK__interaction	palmitate__p38__interaction	Palmitate__p38__interaction	palmitate__JNK__interaction
18599066-770	<compound-id="985">Palmitate</compound-id> also activated the <protein-id="P21525">AP-1</protein-id> (c-<protein-id="P05627,P17325,P18289">Jun</protein-id>) transcription factor.	Palmitate__AP-1__interaction	Palmitate__Jun__interaction
18599093-1004	Characterisation of <compound-id="5957">ATP</compound-id> analogues to cross-link and label <protein-id="P13900,P16604">P2X</protein-id> receptors.	ATP__P2X__interaction
18599093-1005	In this study we determined whether the UV light-reactive <compound-id="5957">ATP</compound-id> analogues <compound-id="123645,189791">2-azido ATP</compound-id>, <compound-id="5957">ATP</compound-id> azidoanilide (<compound-id="5957">ATP</compound-id>-AA) and 2', <compound-id="115205">3'-O-(4-benzoylbenzoyl)-ATP</compound-id> (<compound-id="115205">BzATP</compound-id>) can be used to label the ATP binding site of <protein-id="P47824,P51575,P51576">P2X1</protein-id> receptors.	ATP__P2X1__interaction	2-azido ATP__P2X1__interaction	BzATP__P2X1__interaction	3'-O-(4-benzoylbenzoyl)-ATP__P2X1__interaction
18599093-1006	cross-linked to <protein-id="P47824,P51575,P51576">P2X1</protein-id> receptors and this binding was reduced by co-incubation with <compound-id="5957">ATP</compound-id>.	ATP__P2X1__interaction
18599093-1007	These studies demonstrate that photo-reactive <compound-id="5957">ATP</compound-id> analogues can be used to label <protein-id="P13900,P16604">P2X</protein-id> receptor and may prove useful in elucidating the ATP binding site at this novel class of ATP binding proteins.	ATP__P2X__interaction
18599154-1053	<protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</protein-id> treatment for 72 h also induced EMT in the A549 cells and this transition led to resistance to <compound-id="123631">gefitinib</compound-id>.	gefitinib__TGF-beta1__interaction
18599191-1078	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id>-antagonistic effects of hormones, cytokines and excess metabolic substrates such as <compound-id="206,5793,64689,79025">glucose</compound-id> and fatty acids may be exerted via common mechanisms involving for example reactive <compound-id="977">oxygen</compound-id> species (ROS) accumulation and associated inflammatory responses.	oxygen__Insulin__interaction	glucose__Insulin__interaction
18599210-1087	Optimization of decolorization of <compound-id="4139">methylene blue</compound-id> (MB) dye by <protein-id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">lignin peroxidase</protein-id> (LiP) enzyme produced by white-rot fungus Phanerochaete chrysosporium using sewage treatment plant (STP) sludge as a major substrate was carried out in the laboratory.	methylene blue__lignin peroxidase__interaction
18600448-401	<compound-id="750">Glycine</compound-id> release was potentiated by the activation of <protein-id="P13678,Q25378">protein kinase C</protein-id> and diminished by increasing <compound-id="24316">cyclic guanosine monophosphate</compound-id> levels with a phosphodiesterase inhibitor, <compound-id="5722">zaprinast</compound-id>.	zaprinast__protein kinase C__no_interaction	cyclic guanosine monophosphate__protein kinase C__no_interaction	Glycine__protein kinase C__interaction
18600455-406	Our study demonstrates that <compound-id="6675">taurocholate</compound-id> causes evident damage to acinar cells, impairing both calcium homeostasis and secretory response to <protein-id="O57312,O93464,P01355,P01356,P06307,P09240,P0C229,P23362,P41520,P50144,P50145,P68125,P68126,P80344,P80345,Q9PU29,Q9PU41">CCK</protein-id>.	taurocholate__CCK__interaction
18600456-407	Enteric neuronal dopamine (DA) inhibits <compound-id="187">acetylcholine</compound-id> release and gastric motility; this has been thought to be mediated via neuronal dopamine-2 receptor (<protein-id="Q8IS44">D2R</protein-id>).	acetylcholine__D2R__interaction
18600473-984	As compared with parental B16 cells, the inhibitory effects of <protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</protein-id> and activin A on <compound-id="6325610">melanin</compound-id> content were relative smaller in B16 F10 cells, a subline of B16 cells that contain more pigment.	melanin__TGF-beta1__interaction
18601937-1660	ATP-gated <protein-id="P13900,P16604">P2X</protein-id> receptors on excitatory nerve terminals onto interneurons initiate a form of asynchronous <compound-id="611,23327,33032">glutamate</compound-id> release.	glutamate__P2X__interaction
18601937-1662	However asynchronous EPSCs were increased following synaptic depression and a component of these appeared to be initiated by endogenously released <compound-id="5957">ATP</compound-id> acting on presynaptic <protein-id="P13900,P16604">P2X</protein-id> receptors.	ATP__P2X__interaction
18601937-1663	Unexpectedly, the data suggest <protein-id="P13900,P16604">P2X</protein-id> receptor activation initiates a form of asynchronous <compound-id="611,23327,33032">glutamate</compound-id> release, rather than detectably affecting the vesicles underlying action potential evoked release.	glutamate__P2X__interaction
18601945-1673	The second enzyme of <compound-id="124886">GSH</compound-id> synthesis, <compound-id="124886">GSH</compound-id> synthase (GS) is also regulated in a coordinated manner as <protein-id="P28676,Q8NEA9,Q96IK5">GCL</protein-id> subunits and its up-regulation can further enhance the capacity of the cell to synthesize <compound-id="124886">GSH</compound-id>.	GSH__GCL__no_interaction
18602447-1075	The rise in [<compound-id="271">Ca(2</compound-id>+)](i) elicited by hGH is associated with an enhanced <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion, effects that are mediated mainly through the <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> receptor.	Ca(2__prolactin__interaction	Ca(2__insulin__interaction
18602447-1076	These mechanisms indicate that a rise in [<compound-id="271">Ca(2</compound-id>+)](i) elicited by activation of <protein-id="O46561,P14787,P16471,Q04594,Q28172,Q28235,Q6JTA8,Q90374,Q91094,Q91513">PRLR</protein-id> is <protein-id="O60674">JAK2</protein-id>-dependent and is associated with enhanced <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion.	Ca(2__JAK2__no_interaction	Ca(2__insulin__no_interaction	Ca(2__PRLR__interaction
18602447-1077	In contrast, <protein-id="O46600,P10912,P16310,P16882,P19756,P19941,P79108,P79194,Q02092,Q28575,Q90375,Q95JF2,Q95ML5,Q9JI97,Q9TU69,Q9XSZ1">GH receptor</protein-id>-mediated increase in [<compound-id="271">Ca(2</compound-id>+)](i) is <protein-id="O60674">JAK2</protein-id>-independent and is dissociated from <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion.	Ca(2__JAK2__interaction	Ca(2__insulin__interaction	Ca(2__GH receptor__interaction
18602691-569	<protein-id="P04279">SEMG</protein-id> I expression is upregulated by <protein-id="O77762,P05112,P07750,P20096,P30367,P30368,P42202,P46652,P47966,P51492,P51744,P55030,P79155,P79339,Q04745,Q2PE74,Q3S4V6,Q58M18,Q60440,Q7YS71,Q865X5,Q865Y0,Q8HYB1,Q9MZR8,Q9XS58">IL-4</protein-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> and <compound-id="9444">5-azacytidine</compound-id>.	5-azacytidine__IL-4__no_interaction	5-azacytidine__SEMG__interaction	5-azacytidine__IL-6__no_interaction
18602794-652	<compound-id="444732">Trichostatin A</compound-id> down-regulates <protein-id="O46512,P11511,P19098,P46194,P70091,P79690,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">CYP19</protein-id> transcript and protein levels in MCF-7 breast cancer cells.	Trichostatin A__CYP19__interaction
18602807-667	Consumption of the <compound-id="104763">trichothecene</compound-id> mycotoxin <compound-id="40024,430147,442408,6321385,6432495,49868109">deoxynivalenol</compound-id> (DON) induces <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>)-dependent IgA nephropathy (IgAN) in mice.	deoxynivalenol__interleukin-6__interaction	trichothecene__IL-6__interaction	deoxynivalenol__IL-6__interaction	trichothecene__interleukin-6__interaction
18602807-668	The purpose of this study was to identify the signal transduction pathways by which DON up-regulates <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> in the peritoneal macrophage and how consumption of fish oil enriched with the n-3 PUFA <compound-id="445580">docosahexaenoic acid</compound-id> (DHA) suppresses these processes.	docosahexaenoic acid__IL-6__interaction
18602811-670	<compound-id="5282349,53394606">gamma-Tocotrienol</compound-id> induced activation of caspase-3 and increased the cleavage of the downstream substrate poly(<protein-id="P02783">ADP</protein-id>-ribose) polymerase.	gamma-Tocotrienol__ADP__interaction
18602814-672	The aim of the present study was to determine the effects of <compound-id="938">niacin</compound-id> and <compound-id="23976">chromium</compound-id> on HDL formation by investigating the changes in <protein-id="O95477">ABCA1</protein-id> and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	chromium__ABCA1__interaction	niacin__ABCA1__interaction
18602814-674	<compound-id="938">Niacin</compound-id> and <compound-id="23976">chromium</compound-id> cotreatment significantly induced the expression of <protein-id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">peroxisome proliferator-activated receptor-alpha</protein-id> (<protein-id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">PPARalpha</protein-id>) mRNA by approximately 1.3-1.8-fold.	chromium__peroxisome proliferator-activated receptor-alpha__interaction	chromium__PPARalpha__interaction	Niacin__peroxisome proliferator-activated receptor-alpha__interaction	Niacin__PPARalpha__interaction
18602814-675	A combination of <compound-id="938">niacin</compound-id> and <compound-id="24808,24871">chromium chloride</compound-id> did not significantly increase (3+1 mM) but instead reduced (1+3 mM) <protein-id="O95477">ABCA1</protein-id> gene expression.	niacin__ABCA1__interaction	chromium chloride__ABCA1__interaction
18602814-676	We hypothesize that the stimulation of <protein-id="O95477">ABCA1</protein-id> gene expression causes an enhanced <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> efflux, perhaps mediated by <protein-id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">PPARalpha</protein-id> pathway(s).	cholesterol__ABCA1__interaction	cholesterol__PPARalpha__interaction
18602822-681	<compound-id="104815">Cu</compound-id> deficiency disrupts the architecture of mitochondria, impairs respiration, and inhibits the activity of <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> oxidase-the terminal, <compound-id="104815">Cu</compound-id>-dependent respiratory complex (Complex IV) of the electron transport chain.	Cu__cytochrome c__interaction
18602823-684	<compound-id="5350">Sulforaphane</compound-id> inhibited cell proliferation with IC(50) values at 24 and 48 h of 12.5 and 7.5 muM doses, respectively, and decreased <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> protein expression at concentrations between 2.5 and 30 muM.	Sulforaphane__ERalpha__interaction
18602823-685	30 muM, the SUL-induced suppression of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> protein was reversed by preincubation with the proteasome inhibitor <compound-id="462382">MG132</compound-id> and was accompanied by an increase in protein levels of the 20S catalytic core subunit <protein-id="P28074,P34065">PSMB5</protein-id>.	MG132__ERalpha__interaction	MG132__PSMB5__no_interaction
18602931-788	A-804598 was tritiated ([<compound-id="45481830">3H]A-804598</compound-id> ; 8.1Ci/mmol) and utilized to study recombinant rat <protein-id="Q64663,Q99572,Q9Z1M0">P2X7</protein-id> receptors expressed in 1321N1 cells.	3H]A-804598__P2X7__interaction
18602931-789	The pharmacological profile for P2X antagonists to inhibit [<compound-id="45481830">3H]A-804598</compound-id> binding correlated with their ability to block functional activation of <protein-id="Q64663,Q99572,Q9Z1M0">P2X7</protein-id> 0.05).	3H]A-804598__P2X7__no_interaction
18603252-1055	Of importance, treatment with <compound-id="150311">ezetimibe</compound-id> significantly improved endothelial dysfunction as assessed by the vasodilator response to <compound-id="187">acetylcholine</compound-id>, accompanied by inhibition of <protein-id="P41693">interleukin-6</protein-id> mRNA and an increase in endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>) mRNA in the aorta.	ezetimibe__eNOS__interaction	acetylcholine__interleukin-6__no_interaction	acetylcholine__nitric oxide synthase__no_interaction	ezetimibe__interleukin-6__interaction	acetylcholine__eNOS__no_interaction	ezetimibe__nitric oxide synthase__interaction
18603252-1056	Furthermore, <compound-id="150311">ezetimibe</compound-id> increased the mRNA expression of 3-hydroxy-3-methylglutaryl co-enzyme A (<protein-id="O74164,P40625,Q05153,Q39601">HMG</protein-id>-CoA) synthase as a counteraction in the liver, but not in the aorta.	ezetimibe__HMG__interaction
18603333-1106	A series of <compound-id="9238">adamantane</compound-id> derivatives of thiazolyl-N-substituted amides were synthesized in a three-step reaction and tested for anti-inflammatory activity as well as <protein-id="P27481,P38414">lipoxygenase</protein-id> and cycloxygenase inhibitory actions.	adamantane__lipoxygenase__interaction
18604600-443	<protein-id="P21917,P30729,P51436,Q6TLJ0">Dopamine D4 receptor</protein-id> involvement in the discriminative stimulus effects in rats of <compound-id="5761">LSD</compound-id>, but not the <compound-id="1001,31016">phenethylamine</compound-id> <compound-id="31374">hallucinogen</compound-id> <compound-id="1229,6603801,9840090">DOI</compound-id>.	phenethylamine__Dopamine D4 receptor__no_interaction	LSD__Dopamine D4 receptor__interaction	DOI__Dopamine D4 receptor__no_interaction	hallucinogen__Dopamine D4 receptor__no_interaction
18606045-1675	Plasma levels of <compound-id="5462224">magnesium</compound-id>, zinc and carotenoids did not vary across quintiles, but weak negative correlations were observed with serum <protein-id="Q26061">ferritin</protein-id> and <protein-id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</protein-id> saturation.	magnesium__transferrin__interaction	magnesium__ferritin__interaction
18606396-239	Two major groups of ligand-activated nuclear receptors/xenosensors evolved: the <protein-id="O02747,P30561,P35869,P41738,Q8R4S2,Q8R4S4,Q8R4S5,Q8R4S6,Q8R4S7,Q95LD9">Ah receptor</protein-id> (activated by aryl hydrocarbons and drugs such as <compound-id="4594,9579578">omeprazole</compound-id>) and type 2 steroid receptors such as <protein-id="O75469,Q8SQ01">PXR</protein-id> and CAR, activated by drugs such as <compound-id="5381226,5388984,5458213,6243627,6842115,6913622,16043998,17753751,25141428,45356263,56947149">rifampicin</compound-id>, carbamazepin and <compound-id="1775">phenytoin</compound-id>.	phenytoin__PXR__interaction	rifampicin__Ah receptor__interaction	rifampicin__PXR__interaction	omeprazole__PXR__interaction	phenytoin__Ah receptor__interaction	omeprazole__Ah receptor__interaction
18607531-1203	The structure-activity relationship between <compound-id="5281426">oxycoumarin</compound-id> derivatives showing inhibitory effects on <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> in mouse macrophage RAW264.7 cells.	oxycoumarin__iNOS__interaction
18607531-1204	We have investigated the structure-activity relationship between 63 natural <compound-id="5281426">oxycoumarin</compound-id> derivatives and their effects on the expression of inducible-<protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) induced by <compound-id="11970143">lipopolysaccharide</compound-id>.	oxycoumarin__iNOS__interaction	lipopolysaccharide__iNOS__interaction	lipopolysaccharide__nitric oxide synthase__interaction	oxycoumarin__nitric oxide synthase__interaction
18607542-1212	Inhibition of protein synthesis by <compound-id="68791">imexon</compound-id> reduces <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id> expression in normoxic and hypoxic pancreatic cancer cells.	imexon__HIF-1alpha__interaction
18607542-1213	Western blot analyses of <compound-id="68791">imexon</compound-id>-treated cells demonstrated that <compound-id="68791">imexon</compound-id> reduces <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id> protein levels in both normoxic and hypoxic conditions in a time- and concentration-dependant fashion.	imexon__HIF-1alpha__interaction
18607542-1214	<compound-id="60750">Gemcitabine</compound-id> did not similarly affect <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id> levels.	Gemcitabine__HIF-1alpha__no_interaction
18607542-1216	Concurrently, the half-life of existing <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id> protein was increased by <compound-id="68791">imexon</compound-id>, in association with a marked inhibition of chymotryptic activity in the 20S proteasome.	imexon__HIF-1alpha__interaction
18607542-1217	The inhibition of <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id> translation was not specific, rather it was part of a general decrease in protein translation caused by <compound-id="68791">imexon</compound-id>.	imexon__HIF-1alpha__interaction
18607689-1312	To determine whether a regimen of <compound-id="2244">aspirin</compound-id> pretreatment, <compound-id="16129704">bivalirudin</compound-id> during the procedure and <compound-id="2806,60606">clopidogrel</compound-id> (600 mg) immediately after percutaneous coronary intervention (PCI) was associated with platelet activation during and shortly after (1 and 2 h) PCI, we characterized platelet function in 10 patients with the use of flow cytometry in the absence of agonist and in response to <protein-id="P84122">thrombin</protein-id> (10 nM), ADP (1 microM), the collagen-mimetic convulxin (5 ng/ml), and <compound-id="108157">platelet activating factor</compound-id> (10 nM).	aspirin__thrombin__no_interaction	platelet activating factor__thrombin__no_interaction	clopidogrel__thrombin__no_interaction	bivalirudin__thrombin__no_interaction
18607722-1326	Brainstem concentrations of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> are not influenced by genetic ablation of the <protein-id="P01131,P20063,Q28832">low-density lipoprotein receptor</protein-id>.	cholesterol__low-density lipoprotein receptor__no_interaction
18607722-1327	The <protein-id="P01131,P20063,Q28832">low-density lipoprotein receptor</protein-id> (LDLr) mediates the uptake of LDL particles enriched with <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, into several tissues.	cholesterol__low-density lipoprotein receptor__interaction
18607918-1505	Under the condition of delayed intervention (30 days after deafening) following <compound-id="3467">gentamicin</compound-id>+ <compound-id="3440">furosemide</compound-id> deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id> (<protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	gentamicin__brain-derived neurotrophic factor__no_interaction	gentamicin__BDNF__no_interaction	furosemide__brain-derived neurotrophic factor__no_interaction	furosemide__BDNF__no_interaction
18608743-488	Design and synthesis of substituted <compound-id="795">imidazole</compound-id> and <compound-id="67516">triazole</compound-id> N-phenylbenzo[d]oxazolamine inhibitors of retinoic acid metabolizing enzyme <protein-id="O43174,Q9PUB4">CYP26</protein-id>.	triazole__CYP26__interaction	imidazole__CYP26__interaction
18608753-1365	For this purpose, human erythrocyte <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> was initially purified 2139-fold in a yield of 29% by using 2', 5'-ADP <compound-id="11966311">Sepharose</compound-id> 4B affinity gel and Sephadex G-200 gel filtration chromatography.	Sepharose__glutathione reductase__no_interaction
18608754-503	The enzyme <protein-id="O25536,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8RA46,Q8RER7,Q8SRS0,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">deoxyuridine 5'-triphosphate nucleotidohydrolase</protein-id> (<protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</protein-id>) catalyses the hydrolysis of <compound-id="65070">dUTP</compound-id> to dUMP and PPi thus controlling the incorporation of <compound-id="1174">uracil</compound-id> into DNA genomes.	uracil__dUTPase__interaction	uracil__deoxyuridine 5'-triphosphate nucleotidohydrolase__interaction	dUTP__deoxyuridine 5'-triphosphate nucleotidohydrolase__interaction	dUTP__dUTPase__interaction
18608754-504	In the present study we perform a kinetic analysis of Campylobacter <protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</protein-id> using the continuous spectrophotometric method and show that the enzyme is highly specific for <compound-id="13712">deoxyuridine</compound-id> nucleotides.	deoxyuridine__dUTPase__interaction
18608755-505	<protein-id="O07674,O30971,P0A853,P0A854,P21643,P28796,P48775,P48776,Q09474,Q2KIQ5,Q59342,Q5EBG2,Q5U4U6,Q7MCR1,Q7N8C9,Q7NYV9,Q7SY53,Q87JQ6,Q894M8,Q8D5Q4,Q8FBV2,Q8R9K5,Q8XB34,Q9CL27,Q9KN05,Q9ZNA8">Tryptophanase</protein-id> (tryptophan indole-lyase, Tnase, EC 4.1.99.1), a bacterial enzyme with no counterpart in eukaryotic cells, produces from <compound-id="4802,6305,5460850">L-tryptophan</compound-id> <compound-id="1060">pyruvate</compound-id>, <compound-id="222">ammonia</compound-id> and indole.	ammonia__Tryptophanase__interaction	L-tryptophan__Tryptophanase__interaction	pyruvate__Tryptophanase__interaction
18608764-1428	The structure-activity models of the <protein-id="O08775,P35918,P35968,P52583,Q8AXB3">VEGFR2</protein-id> kinase inhibitory activity of the derivatives of 2-<compound-id="137550">anilino</compound-id>-5-aryloxazole have been investigated using Combinatorial Protocol in Multiple Linear Regression (CP-MLR) with nearly 500 topological descriptors which were calculated from DRAGON software.	anilino__VEGFR2__interaction
18608765-513	Activity assays with <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</protein-id> indicated that <compound-id="5858639">compound 3</compound-id> was much more stable than the corresponding pentasaccharide.	compound 3__beta-glucosidase__interaction
18608766-514	<protein-id="O00084,O13465,P07374,P08298,Q5KCQ6,Q6A3P9">Urease</protein-id> allows soil microorganisms to use <compound-id="1176,265993">urea</compound-id> as a source of <compound-id="947,123329">nitrogen</compound-id> and aid in the rapid break down of <compound-id="1176,265993">urea</compound-id>-based fertilizers resulting in phytopathicity.	urea__Urease__interaction	nitrogen__Urease__no_interaction
18608782-527	<protein-id="O83085,P00813,P03958,P22333,P53909,P53984,P56658,P63907,P63908,P63909,P63910,Q2TZN9,Q4IMJ1,Q4X1Q4,Q59ZB1,Q5ZKP6,Q63ZU0,Q6CM42,Q6DG22,Q6FP78,Q6GP70,Q7M9R5,Q7MDL6,Q7N4H5,Q7VNV1,Q7WBG5,Q7WMY6,Q839J4,Q83RC0,Q889J2,Q88QA3,Q8D6Q8,Q8DTN8,Q8E8D4,Q8FH99,Q8UJ05,Q8X1T6,Q8X661,Q8XHH8,Q8XXL5,Q8Z6R2,Q8ZPL9,Q920P6,Q92T48,Q97EV1,Q98GV2,Q9A3M3,Q9CCL9,Q9CIR9,Q9I6Y4,Q9KNI7,Q9P6I7">Adenosine deaminase</protein-id> (<protein-id="P00813,P56658,Q5ZKP6">ADA</protein-id>), an enzyme involved in purine metabolism, catalyzes the hydrolytic breakdown of <compound-id="60961">adenosine</compound-id> into <compound-id="6021">inosine</compound-id> and free <compound-id="222">ammonia</compound-id>.	adenosine__ADA__interaction	inosine__ADA__interaction	ammonia__ADA__interaction	adenosine__Adenosine deaminase__interaction	ammonia__Adenosine deaminase__interaction	inosine__Adenosine deaminase__interaction
18609042-761	Diastolic function and <protein-id="P40753,P83965,Q805D7,Q805E8,Q9GLK4">BNP</protein-id> changes during exercise predict <compound-id="977">oxygen</compound-id> consumption in chronic heart failure patients.	oxygen__BNP__interaction
18609294-966	Although incubation with <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> (<protein-id="O62781,O62819,O93337,P01236,P01237,P01238,P01239,P01240,P06879,P09585,P10765,P12420,P14676,P17572,P21993,P22393,P29234,P29235,P33089,P33090,P33091,P33096,P34181,P35395,P37884,P40424,P43001,P43299,P46403,P48096,P48249,P51904,P55151,P87495,Q28318,Q28632,Q3Y4G6,Q6UC74,Q7ZZV3,Q8HXS1,Q9QZL1,Q9YGV6">PRL</protein-id>) and/or adrenocorticotrophic hormone (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>) resulted in a dose-dependent increase of <compound-id="5753">corticosterone</compound-id> and <compound-id="5994">progesterone</compound-id> release by adrenal cells from both HAA and LAA male rats, the responses were markedly increased for adrenal cells from LAA rats as compared with HAA rats.	corticosterone__ACTH__interaction	corticosterone__prolactin__interaction	progesterone__ACTH__interaction	corticosterone__PRL__interaction	progesterone__PRL__interaction	progesterone__prolactin__interaction
18609433-1079	<compound-id="5324346">Fluvoxamine</compound-id>, a SSRI, is mainly metabolized by <protein-id="O08469">cytochrome P450</protein-id> (<protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id>) 2D6 and 1A2.	Fluvoxamine__CYP__interaction	Fluvoxamine__cytochrome P450__interaction
18611940-1422	Ki-67 <compound-id="28486">LI</compound-id> in clear cell adenoma components was lower than in common adenoma components of the same dysplasia grades (while <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> and <protein-id="P26233,P35222,P35223,P35224,Q02248,Q9WU82">beta-catenin</protein-id> were similarly expressed).	LI__beta-catenin__no_interaction	LI__p53__no_interaction
18612599-292	<protein-id="P35557,Q12851,Q61161">GCK</protein-id> is expressed in the rat DVC, where mRNA is localized to neurons that exhibit electrophysiological sensitivity to <compound-id="206,5793,64689,79025">glucose</compound-id> imbalance.	glucose__GCK__no_interaction
18612687-586	However, <compound-id="23976">CR</compound-id>-ME had a little effect on the levels of reactive <compound-id="977">oxygen</compound-id> species, interleukin-1 and <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> in <compound-id="23976">CR</compound-id>-ME-treated macrophages.	oxygen__IFN-gamma__no_interaction	CR__IFN-gamma__interaction
18612687-587	Thus, the tumoricidal effect of <compound-id="23976">CR</compound-id>-ME appeared to be mainly mediated by NO and <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> production from macrophages.	CR__TNF-alpha__interaction
18612687-589	These results suggest that <compound-id="23976">CR</compound-id>-ME induces the tumoricidal activity via the <protein-id="O62618">p38 MAPK</protein-id>-dependent pathway.	CR__p38 MAPK__interaction
18612775-1047	<protein-id="P14902,P28776">Indoleamine 2,3-dioxygenase</protein-id> (<protein-id="P14902,P28776">IDO</protein-id>) catalyzes the first and rate-limiting step of <compound-id="846">Kynurenine</compound-id> pathway along the major route of Tryptophan catabolism.	Kynurenine__IDO__interaction	Kynurenine__Indoleamine 2,3-dioxygenase__interaction
18612777-425	Type I <protein-id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</protein-id> (TG1), an enzyme that catalyzes the formation of epsilon-(gamma-glutamyl) <compound-id="866,5962">lysine</compound-id> bonds, is the key protein responsible for generation of the crosslinks.	lysine__transglutaminase__interaction
18612811-461	<protein-id="P01108,P09416,P52160">Myc</protein-id>-oncogene inactivating effect by <compound-id="614,8988,145742">proline</compound-id> rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.	proline__Myc__interaction
18612819-471	Like PSC, DSL6A cells secrete less <protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id> when cultured with <compound-id="104865">bosentan</compound-id>.	bosentan__ET-1__interaction
18612824-1284	Caspase inhibition with z-<compound-id="5289545">VAD</compound-id> was unable to prevent <protein-id="O95831">AIF</protein-id> localization to the nucleus and subsequently unable to prevent cell death.	VAD__AIF__no_interaction
18614168-1607	Purinergic receptor agonists <compound-id="5957">ATP</compound-id> and <compound-id="6133">UTP</compound-id> selectively activate certain <protein-id="P05480,Q9WUD9">Src</protein-id> family tyrosine kinases and stimulate Na,K-ATPase activity.	ATP__Src__interaction	UTP__Src__interaction
18615010-596	Early deprivation led to decreases in hippocampal <protein-id="P06836,P06837,P07936,P17677,P17691,P35001,P55860,Q5IS67,Q5NVP7,Q6S9D9,Q95K78,Q98987">growth-associated protein-43</protein-id> (<protein-id="P09851,P20936,P50904,P74851,P74873,Q5PEA9,Q92211,Q92263">GAP</protein-id>-43) mRNA, serotonin 1A receptor (5-HT(1A)R) mRNA and binding ([<compound-id="5684">3H]WAY100635</compound-id>), and to increased <protein-id="O35458,O35633,P34579,Q95KE2,Q9H598">vesicular GABA transporter</protein-id> mRNA.	3H]WAY100635__GAP__no_interaction	3H]WAY100635__growth-associated protein-43__no_interaction	3H]WAY100635__vesicular GABA transporter__no_interaction
18615011-597	We measured the ability to increase GABA in eight healthy subjects by comparing the binding of [(11)C] <compound-id="3373">flumazenil</compound-id>, a positron emission tomography (PET) radiotracer specific for the benzodiazepine (BDZ) site, at baseline and in the presence of an acute elevation in GABA levels through the blockade of the GABA membrane transporter (<protein-id="P30531,P36148,P43574">GAT1</protein-id>).	flumazenil__GAT1__no_interaction
18615011-598	<protein-id="P30531,P36148,P43574">GAT1</protein-id> blockade resulted in significant increases in mean (+/-SD) [(11)C] <compound-id="3373">flumazenil</compound-id>-binding potential (BP(ND)) over baseline in brain regions representing the major functional domains of the cerebral cortex: association cortex+15.2+/-20.2% (p=0.05), sensory cortex+13.5+/-15.5% (p=0.03) and limbic (medial temporal lobe, MTL)+16.4+/-20.2% (p=0.03).	flumazenil__GAT1__interaction
18615280-830	<protein-id="O33830,O43451,O59645,P21517,P43473,Q02751">alpha-Glucosidase</protein-id> inhibitory activity of <compound-id="44256700">cyanidin-3-galactoside</compound-id> and synergistic effect with <compound-id="41774,441184,444254,445421,4432690">acarbose</compound-id>.	cyanidin-3-galactoside__alpha-Glucosidase__interaction	acarbose__alpha-Glucosidase__interaction
18615280-831	<compound-id="44256700">Cyanidin-3-galactoside</compound-id>, a natural <compound-id="145858">anthocyanin</compound-id>, was investigated for its <protein-id="O33830,O43451,O59645,P21517,P43473,Q02751">alpha-glucosidase</protein-id> inhibitory activity.	anthocyanin__alpha-glucosidase__no_interaction	Cyanidin-3-galactoside__alpha-glucosidase__interaction
18615288-840	A series of systematically modified vanadyl-beta-<compound-id="167775">diketone</compound-id> complexes, VO(beta-<compound-id="167775">diketone</compound-id>)(2), bearing substituent groups with different electron inductive properties were synthesized and evaluated as inhibitors against calf-intestine <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> (<protein-id="P00634,P19147,P21948">APase</protein-id>).	diketone__APase__interaction	diketone__alkaline phosphatase__interaction
18615705-81	The susceptibilities to three organophosphate (OP) insecticides (<compound-id="4004">malathion</compound-id>, <compound-id="2730">chlorpyrifos</compound-id>, and <compound-id="9570290">phoxim</compound-id>), responses to three metabolic synergists [<compound-id="8289">triphenyl phosphate</compound-id> (TPP), <compound-id="5794">piperonyl butoxide</compound-id> (PBO), and <compound-id="5271566">diethyl maleate</compound-id> (DEM)], activities of major detoxification enzymes [general <protein-id="P16397,P18773">esterases</protein-id> (ESTs), <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferases</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GSTs</protein-id>), and <protein-id="O08469">cytochrome P450</protein-id> monooxygenases (P450s)], and sensitivity of the target enzyme <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (<protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>) were compared between a laboratory-susceptible strain (LS) and a field-resistant population (FR) of the oriental migratory locust, Locusta migratoria manilensis (Meyen).	triphenyl phosphate__acetylcholinesterase__no_interaction	phoxim__acetylcholinesterase__no_interaction	phoxim__AChE__no_interaction	triphenyl phosphate__GSTs__no_interaction	phoxim__esterases__no_interaction	piperonyl butoxide__GSTs__no_interaction	triphenyl phosphate__glutathione S-transferases__no_interaction	phoxim__GSTs__no_interaction	chlorpyrifos__GSTs__no_interaction	piperonyl butoxide__glutathione S-transferases__no_interaction	piperonyl butoxide__esterases__no_interaction	diethyl maleate__cytochrome P450__no_interaction	diethyl maleate__acetylcholinesterase__no_interaction	malathion__acetylcholinesterase__no_interaction	malathion__GSTs__no_interaction	chlorpyrifos__cytochrome P450__no_interaction	chlorpyrifos__esterases__no_interaction	malathion__cytochrome P450__no_interaction	piperonyl butoxide__acetylcholinesterase__no_interaction	triphenyl phosphate__esterases__no_interaction	piperonyl butoxide__cytochrome P450__no_interaction	diethyl maleate__AChE__no_interaction	diethyl maleate__GSTs__no_interaction	piperonyl butoxide__AChE__no_interaction	chlorpyrifos__AChE__no_interaction	malathion__esterases__no_interaction	triphenyl phosphate__AChE__no_interaction	malathion__AChE__no_interaction	phoxim__cytochrome P450__no_interaction	chlorpyrifos__acetylcholinesterase__no_interaction	diethyl maleate__glutathione S-transferases__no_interaction	diethyl maleate__esterases__no_interaction	phoxim__glutathione S-transferases__no_interaction	malathion__glutathione S-transferases__no_interaction	chlorpyrifos__glutathione S-transferases__no_interaction	triphenyl phosphate__cytochrome P450__no_interaction
18615705-83	All these results clearly indicated that the observed <compound-id="4004">malathion</compound-id> resistance in the FR was conferred by multiple mechanisms, including increased detoxification by ESTs and <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GSTs</protein-id>, and increased activity and reduced sensitivity of <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> to OP inhibition.	malathion__GSTs__interaction	malathion__AChE__interaction
18615707-1194	<protein-id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7">Lysozymes</protein-id> act as crucial bacteriolytic enzymes in insect immune system by hydrolyzing the beta (1--&gt;4) bonds between <compound-id="24139">N-acetylglucosamine</compound-id> and <compound-id="440822,542212,5462244,6323218">N-acetylmuramic acid</compound-id> in the <compound-id="9816401">peptidoglycan</compound-id> of prokaryotic cell walls.	N-acetylglucosamine__Lysozymes__interaction	N-acetylmuramic acid__Lysozymes__interaction	peptidoglycan__Lysozymes__no_interaction
18615734-449	These mRNAs no longer encode the <protein-id="P08567,Q4KM33,Q6Q308,Q9JHK5">pleckstrin</protein-id> homology (PH) domain of <protein-id="O43307,Q3UTH8,Q58DL7,Q5RDK0,Q9QX73">collybistin</protein-id>, which we now show binds <compound-id="6857403,9776841">phosphatidylinositol-3-phosphate</compound-id> (PI3P/<compound-id="643964,24755494">PtdIns-3-P</compound-id>), a <compound-id="16738692">phosphoinositide</compound-id> with an emerging role in membrane trafficking and signal transduction, rather than <compound-id="643963">phosphatidylinositol 3,4,5-trisphosphate</compound-id> (PIP3/<compound-id="643963">PtdIns-3,4,5-P</compound-id>) as previously suggested in the " membrane activation model" of <protein-id="Q03555,Q9NQX3">gephyrin</protein-id> clustering.	phosphatidylinositol-3-phosphate__pleckstrin__no_interaction	phosphoinositide__collybistin__no_interaction	PtdIns-3-P__collybistin__interaction	phosphatidylinositol 3,4,5-trisphosphate__collybistin__no_interaction	phosphatidylinositol 3,4,5-trisphosphate__pleckstrin__no_interaction	PtdIns-3,4,5-P__collybistin__interaction	PtdIns-3-P__pleckstrin__no_interaction	PtdIns-3,4,5-P__pleckstrin__no_interaction	PtdIns-3,4,5-P__gephyrin__no_interaction	phosphatidylinositol-3-phosphate__collybistin__interaction	phosphoinositide__pleckstrin__no_interaction	PtdIns-3-P__gephyrin__no_interaction	phosphatidylinositol-3-phosphate__gephyrin__no_interaction	phosphoinositide__gephyrin__no_interaction	phosphatidylinositol 3,4,5-trisphosphate__gephyrin__no_interaction
18616717-310	We investigated whether several different inflammatory markers including C-reactive protein (<protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>) and <protein-id="P22775,P81070">fibrinogen</protein-id> and white blood cells (WBCs) count, are associated with maximal <compound-id="977">oxygen</compound-id> consumption (VO(2 max)) in women with polycystic ovary syndrome (PCOS).	oxygen__CRP__interaction	oxygen__fibrinogen__interaction
18616988-540	Microelectrode array recordings revealed that <compound-id="977">oxygen</compound-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> deprivation enhances hippocampal network firing rates, which induces c-<protein-id="P01101,P12841,Q56415">fos</protein-id> transcription through a signaling pathway that, in contrast to Clca1, is activated by synaptic but not extrasynaptic NMDA receptors.	oxygen__fos__interaction	glucose__fos__interaction
18617682-1119	CSE activated the <protein-id="P03956,P13943,P21692,P28053,P81563,Q11133,Q9XSZ5">MMP-1</protein-id> promoter, and this induction was prevented by <compound-id="4713">PD98059</compound-id> blockade of <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 phosphorylation.	PD98059__ERK1__interaction	PD98059__MMP-1__interaction
18617682-1120	Cotransfection, <compound-id="29051,163659,230076,457831,6326719">mithramycin</compound-id>, and electrophoretic mobility shift assay studies identified activating and repressive roles for <protein-id="O14300,O89090,P17379,Q01714,Q85439,Q85449,Q85451">Sp1</protein-id> and PEA3 transcription factors, respectively.	mithramycin__Sp1__no_interaction
18617751-1188	We have previously demonstrated that <compound-id="5311181,6435378,6443959,53394043,53486260">iloprost</compound-id>, a stable <compound-id="5280427,5282411,6434194">prostacyclin</compound-id> (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>)-dependent mechanism.	iloprost__VEGF__interaction	prostacyclin__VEGF__no_interaction
18617751-1189	In this study, we demonstrate that <compound-id="5311181,6435378,6443959,53394043,53486260">iloprost</compound-id>-induced angiogenesis and <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> upregulation are modulated by <protein-id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">peroxisome proliferator-activated receptor-alpha</protein-id> (<protein-id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">PPARalpha</protein-id>), a ligand-inducible transcription factor that belongs to the nuclear hormone receptor superfamily and plays multiple biological activities in the vascular system.	iloprost__VEGF__interaction	iloprost__PPARalpha__interaction	iloprost__peroxisome proliferator-activated receptor-alpha__interaction
18617751-1191	In contrast, <compound-id="5311181,6435378,6443959,53394043,53486260">iloprost</compound-id> induces a robust angiogenic response in wild-type mice, along with local upregulation of <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>.	iloprost__VEGF__interaction
18617751-1192	Importantly, mice lacking the PPARalpha gene exhibit a normal angiogenic response to <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, indicating that the absence of PPARalpha does not result in a general impairment of angiogenesis, but specifically affects the ability of <compound-id="5311181,6435378,6443959,53394043,53486260">iloprost</compound-id> to induce angiogenesis.	iloprost__VEGF__no_interaction
18618086-1424	Inhibition of acyl-<compound-id="317,6816,87642,444624,445126,447444,448506,44216777,44246472">coenzyme A</compound-id> : cholesterol <protein-id="P05521,P19197,P21309,P23148,P41302,Q06878,Q7N576,Q9AJA7,Q9S3Z2">acyltransferase</protein-id> (<protein-id="O77761,P23141,P24752,P35610,Q60457">ACAT</protein-id>), which generates intracellular cholesteryl esters from free cholesterol and fatty acids, reduces the biogenesis of the Abeta from the amyloid precursor protein (<protein-id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</protein-id>).	coenzyme A__ACAT__interaction	coenzyme A__acyltransferase__interaction	coenzyme A__APP__interaction
18618086-1425	The proportion of <protein-id="O73683,O93279,P05067,P08592,P0A3Z1,P0A3Z2,P0A3Z3,P0A3Z4,P12023,P29216,P47566,P53601,P75313,P79307,Q11207,Q28053,Q28280,Q28748,Q28757,Q29149,Q5IS80,Q60495,Q95241">APP</protein-id> molecules that are directed to the novel cleavage pathway is regulated by the ratio of free <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and cholesteryl esters in cells.	cholesterol__APP__interaction
18618240-1582	In the hormone receptor-positive breast cancer cell line T47-D expression of <protein-id="P78310">hCAR</protein-id> and its soluble isoforms was increased by treatment with <compound-id="5757">estradiol</compound-id> and <compound-id="2733526">tamoxifen</compound-id>.	tamoxifen__hCAR__interaction	estradiol__hCAR__interaction
18618241-1584	In contrast to the behavior in aqueous solution, lactose binding in <compound-id="679">DMSO</compound-id> resulted in an increase of the <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id>'s radius of gyration from 49+/-1 to 55.5+/-1 A.	DMSO__lectin__interaction
18618243-1587	<protein-id="Q8JFG3">Tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>) levels were also investigated in rat serum, but there was no statistically significant difference between the <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> levels of the <compound-id="2519">caffeine</compound-id>-treated rats groups and the control rats.	caffeine__Tumor necrosis factor__no_interaction	caffeine__TNF-alpha__no_interaction
18618243-1588	Our study indicates that brain <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id> activity decreases after <compound-id="2519">caffeine</compound-id> administration at doses of 30 mg/kg and 100 mg/kg.	caffeine__arginase__interaction
18618245-1590	Comparison of the PTM's of <protein-id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</protein-id>'s isolated from several vertebrate species reveals marked differences in their <compound-id="1061,167704,644102">phosphate</compound-id> content.	phosphate__MBP__interaction
18618245-1591	Chicken <protein-id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</protein-id> does not share any phosphorylated sites with dogfish <protein-id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</protein-id> ; However, it does contain phosphorylated <compound-id="5951">serine</compound-id> and <compound-id="6288">threonine</compound-id> residues in common with mammalian <protein-id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</protein-id>.	threonine__MBP__interaction	serine__MBP__interaction
18618304-1646	<compound-id="5070">Riluzole</compound-id>/<compound-id="4775">NaPB</compound-id> administration increased acetylation at H4 and increased NF-kappaB <protein-id="P23061,P38644,P83939,Q05894,Q28618,Q43731">p50</protein-id> translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	Riluzole__p50__interaction	NaPB__p50__interaction
18618472-1060	Due to the absence of hydrophobic solute-material interactions, which limit the scope of microstructures fabricated from poly(dimethylsiloxane) for biocatalytic applications, the new microreactor was fully compatible with the alternate enzyme substrate 2-nitro-<compound-id="16218547">phenyl-beta-D-galactoside</compound-id> and the <compound-id="6947">2-nitro-phenol</compound-id> product resulting from its hydrolysis catalyzed by <protein-id="P04956,P06565,P06963,P10474,P17334,P18126,P22698,P23550,P23661,P26222,P37701,P38569,P46317,Q45400">CelB</protein-id>.	2-nitro-phenol__CelB__interaction	phenyl-beta-D-galactoside__CelB__interaction
18618621-1255	These findings suggest that multiple variations in the <protein-id="O35899,P31645,Q9MYX0,Q9XT49">SLC6A4</protein-id> gene are associated with remission in white non-Hispanic depressed adults treated with <compound-id="2771,146570">citalopram</compound-id>.	citalopram__SLC6A4__interaction
18618694-248	The planar angle between the <compound-id="278">carbamoyl phosphate</compound-id> and <compound-id="5960">aspartate</compound-id> domains of the catalytic chain is more open at pH 8.5 than in <protein-id="O25716,O27464,O30130,O58451,O66726,P05654,P0A1Z4,P0A1Z5,P0A786,P0A787,P0A788,P0A789,P19910,P41008,P49077,P56585,P57450,P65611,P65612,P65613,P65614,P65615,P65616,P65617,P65618,P65619,P65620,P65621,P74163,P77883,P77918,P96079,P96111,P96174,Q04595,Q2W156,Q55338,Q58976,Q59653,Q59711,Q5E7U5,Q5FGW9,Q5FJB7,Q5FRG8,Q5H2Z0,Q5HBA3,Q5HGN2,Q5HPZ1,Q5HU06,Q5JHM9,Q5L0U6,Q5LX75,Q5M0X1,Q5M5F8,Q5N3S1,Q5NPE5,Q5P6I4,Q5PAN5,Q5PJB2,Q5SK66,Q5V2T3,Q5WFI9,Q5WYW3,Q5X7G7,Q5XCR9,Q5YTM0,Q5ZXZ2,Q60252,Q605F1,Q62I89,Q636D7,Q63RI2,Q64U74,Q65JV0,Q665I6,Q67Q01,Q6A917,Q6AF88,Q6AS40,Q6DA73,Q6FCR5,Q6FZS5,Q6G3F3,Q6GA13,Q6GHN5,Q6HES5,Q6L0F2,Q6LUX0,Q6LWQ0,Q6N565,Q6NH13,Q71YH8,Q727F4,Q72KU0,Q72NJ5,Q732I0,Q73GP1,Q741H5,Q74DP5,Q74J31,Q7M9Y9,Q7MHF1,Q7MX58,Q7MZ16,Q7NCV1,Q7P145,Q7U9G2,Q7UNR3,Q7V355,Q7V4X7,Q7VDV6,Q7VIT3,Q7W044,Q7W3U7,Q7WF77,Q819S0,Q81WE9,Q827R1,Q82U44,Q83A16,Q87C22,Q87LF8,Q87V99,Q88D30,Q89K19,Q8A9S3,Q8CPJ7,Q8D293,Q8DCF6,Q8DIM4,Q8DPH9,Q8DUP5,Q8DZQ5,Q8E5F3,Q8ER38,Q8EUX9,Q8F812,Q8FT39,Q8G655,Q8K9H9,Q8KBI7,Q8NQ38,Q8P1G1,Q8P767,Q8PII1,Q8PXK5,Q8R9R5,Q8RG89,Q8THL2,Q8TVB2,Q8U373,Q8UFT9,Q8XL59,Q8Y1L2,Q8Y662,Q8YWD2,Q8ZB39,Q8ZYH7,Q92AH0,Q92QL5,Q934T0,Q970X2,Q97B29,Q97FS3,Q97QE2,Q98M86,Q9A5K4,Q9CCR5,Q9CF79,Q9HHN4,Q9HKM2,Q9K9V6,Q9KP66,Q9KXR2,Q9L4N6,Q9L4T8,Q9PBB8,Q9PNJ6,Q9RVC0,Q9UX08,Q9YBD4,Q9ZM81">ATCase</protein-id> structures determined at lower pH values.	aspartate__ATCase__interaction	carbamoyl phosphate__ATCase__interaction
18618700-254	At 0.15 microM <compound-id="271">Ca(2</compound-id>+), [(35)S] <protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">CaM</protein-id> bound to <protein-id="P30957,Q92736">RyR2</protein-id> with decreased affinity and binding enthalpy compared with <protein-id="P11716,P16960,P21817">RyR1</protein-id>.	Ca(2__RyR2__interaction	Ca(2__CaM__interaction	Ca(2__RyR1__interaction
18618700-255	The rates of [(35)S] <protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">CaM</protein-id> dissociation from <protein-id="P11716,P16960,P21817">RyR1</protein-id> increased as the temperature was raised, whereas at 0.15 microM <compound-id="271">Ca(2</compound-id>+) the rate from <protein-id="P30957,Q92736">RyR2</protein-id> was little affected.	Ca(2__RyR2__interaction	Ca(2__RyR1__no_interaction	Ca(2__CaM__no_interaction
18619522-636	In rats, infusion of angiotensin II increases <protein-id="Q26061">ferritin</protein-id> levels and arterial thickness which are reversed by treatment with the iron chelator <compound-id="2973">deferoxamine</compound-id>.	deferoxamine__ferritin__interaction
18619705-1094	Furthermore, <compound-id="3213">ellipticine</compound-id> regulated endogenous survival signaling by up-regulating phosphorylated <protein-id="P31750,Q8INB9">Akt</protein-id> that returned to its basal level later.	ellipticine__Akt__interaction
18619705-1095	Furthermore, <compound-id="3213">ellipticine</compound-id> induced nucleus translocalization of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> and <protein-id="P31750,Q8INB9">Akt</protein-id> and recruitment of autophagosomes.	ellipticine__Akt__interaction	ellipticine__p53__interaction
18619713-1104	The ubiquitous enzyme dUTP nucleotidohydrolase (<protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</protein-id>) catalyses the hydrolysis of dUTP to dUMP and can be considered as the first line of defence against incorporation of <compound-id="1174">uracil</compound-id> into DNA.	uracil__dUTPase__interaction
18621093-545	Recent findings indicate that the polypyrimidine tract-binding protein (<protein-id="P17225,P26599,Q00438,Q29099,Q8WN55,Q9MAC5,Q9UKA9">PTB</protein-id>), also named <protein-id="P17225,P26599,Q00438,Q29099">hnRNP I</protein-id>, by binding to the 3'-UTR (untranslated region) of the preproinsulin mRNA molecule, stabilizes the messenger, thereby participating in the <compound-id="206,5793,64689,79025">glucose</compound-id>-induced increase in preproinsulin mRNA.	glucose__PTB__interaction	glucose__hnRNP I__interaction
18621373-794	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (<protein-id="O62618">p38MAPK</protein-id>) significantly decreased <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>-induced <compound-id="5359597">superoxide</compound-id> anion release from macrophages in vivo.	superoxide__CRP__interaction	superoxide__p38MAPK__no_interaction
18621413-823	The free radicals produced are thought to be generated during the production of <compound-id="1175">uric acid</compound-id>, a reaction catalyzed by <protein-id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</protein-id>.	uric acid__xanthine oxidase__interaction
18621448-855	In the diabetic group, a decrease in the pancreatic <compound-id="124886">glutathione</compound-id> levels, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> and <protein-id="O50258">superoxide dismutase</protein-id> activities and an increase in the pancreatic lipid peroxidation level and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> activities were observed.	glutathione__catalase__no_interaction	glutathione__superoxide dismutase__no_interaction	glutathione__glutathione peroxidase__no_interaction
18621563-947	The immunomodulatory effects of <compound-id="5426,75792,92142">thalidomide</compound-id> are at least partially mediated through its ability to down-regulate the pathogenic over-production of <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>).	thalidomide__TNF-alpha__interaction	thalidomide__tumor necrosis factor__interaction
18621563-948	In the central nervous system, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> is involved in induction of a fever response and triggers the release of other cytokines, and may also influence transport of compounds into the brain, leading to cerebrospinal fluid leukocytosis, increased protein influx, and <compound-id="612">lactate</compound-id> accumulation.	lactate__TNF-alpha__interaction
18621563-949	<compound-id="5426,75792,92142">Thalidomide</compound-id> has been shown to down-regulate the production of <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>.	Thalidomide__TNF-alpha__interaction
18622696-162	Both cell types expressed estrogen and <protein-id="P06186,P06401,P07812,P79373,Q00175,Q28590,Q63449,Q8AYI2,Q9GLW0">progesterone receptors</protein-id>, although only the epithelial LM05-E cells were stimulated by <compound-id="5757">estradiol</compound-id> and inhibited by <compound-id="2733526">tamoxifen</compound-id>.	estradiol__progesterone receptors__no_interaction	tamoxifen__progesterone receptors__no_interaction
18622720-185	This study was performed to investigate the effect of combined treatment with <compound-id="938">niacin</compound-id> and <compound-id="23976">chromium</compound-id> on vascular endothelial dysfunction, with the aim of gaining insight to the mechanisms by detecting the expression levels of ox-LDL and <protein-id="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8">LOX-1</protein-id>.	niacin__LOX-1__no_interaction	chromium__LOX-1__no_interaction
18622720-186	In HF group, the serum levels of total <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (TC), low-density lipoprotein (LDL), oxidized low-density lipoprotein (ox-LDL) and endothelin (ET) were higher, whereas the levels of <protein-id="P81182">high-density lipoprotein</protein-id> (HDL), serum NO were lower than those in CG group.	cholesterol__high-density lipoprotein__no_interaction
18622720-187	These findings indicated that combined treatment with <compound-id="938">niacin</compound-id> and <compound-id="23976">chromium</compound-id> has potential therapeutic protection of endothelial function by down-regulating ox-LDL/<protein-id="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8">LOX-1</protein-id> signaling pathway.	chromium__LOX-1__interaction	niacin__LOX-1__interaction
18622759-218	The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded <compound-id="594,5862,5360637">cysteine</compound-id> residues that define the CRD and two additional <compound-id="594,5862,5360637">cysteine</compound-id> residues at the amino terminus.	cysteine__lectins__interaction
18623061-1275	<protein-id="P05480,Q9WUD9">Src</protein-id> kinases can be activated by trans-phosphorylation of a <compound-id="1153,6057,5460803">tyrosine</compound-id> located in the central activation loop of the catalytic domain.	tyrosine__Src__interaction
18623061-1276	However, because the required exposure of this <compound-id="1153,6057,5460803">tyrosine</compound-id> is not observed in the down-regulated X-ray structures of <protein-id="P05480,Q9WUD9">Src</protein-id> kinases, transient partial opening of the activation loop appears to be necessary for such processes.	tyrosine__Src__no_interaction
18623078-486	The growth of L. minor (as fresh weight) and <compound-id="5351507,5459387,6326752,6433193,6914133,9600410">chlorophyll a</compound-id> content were significantly reduced and <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	chlorophyll a__superoxide dismutase__no_interaction	chlorophyll a__SOD__no_interaction
18623078-487	The experiment also indicated that <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>) activity was not significantly influenced by <compound-id="56841897">microcystin</compound-id> for both the two tested aquatic plants.	microcystin__CAT__no_interaction	microcystin__catalase__no_interaction
18623211-610	The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (<protein-id="P27043">ribonuclease A</protein-id>) containing <compound-id="5988">sucrose</compound-id> or <compound-id="7427">trehalose</compound-id> across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).	sucrose__ribonuclease A__interaction	trehalose__ribonuclease A__interaction
18624726-1067	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of <compound-id="5281">stearic acid</compound-id> on <protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id> secretion are mediated via <protein-id="P23799">TLR</protein-id>-4.	stearic acid__MCP-1__interaction	stearic acid__TLR__interaction
18624760-178	<compound-id="5284513">Acitretin</compound-id> increased the levels of CD95 (<protein-id="P25446,Q63199">Fas</protein-id>), CD95-ligand and <protein-id="P25446,Q63199">Fas</protein-id>-associated death domain.	Acitretin__Fas__interaction
18624766-181	Since <compound-id="28486,3028194">lithium</compound-id> and <compound-id="4210951">SB-415286</compound-id>-induced G(2)/M arrest we studied changes in the expression of proteins involved in this phase, specifically <protein-id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</protein-id> B, <protein-id="P04551,P11440,P23572,P39951">cdc2</protein-id> and the phosphorylated form of this protein (tyr15-<protein-id="P04551,P11440,P23572,P39951">cdc2</protein-id>).	SB-415286__cyclin__interaction	lithium__cdc2__interaction	SB-415286__cdc2__interaction	lithium__cyclin__interaction
18624766-182	On the other hand, <compound-id="4210951">SB-415286</compound-id> increased the expression of <protein-id="Q4R834,Q5RBF1,Q8IXJ6">SIRT2</protein-id>, involved in the regulation of proliferation.	SB-415286__SIRT2__interaction
18624766-184	We conclude that inhibitors of GSK-3 induced cell-cycle arrest, mediated by the phosphorylation of <protein-id="P04551,P11440,P23572,P39951">cdc2</protein-id> and, in the case of <compound-id="4210951">SB-415286</compound-id>, <protein-id="Q4R834,Q5RBF1,Q8IXJ6">SIRT2</protein-id> expression, which induced apoptosis in a caspase-independent manner.	SB-415286__SIRT2__interaction	SB-415286__cdc2__no_interaction
18624772-191	Reduced <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id> protein levels were accompanied by an increase in intracellular Ca(2+), augmented production of reactive <compound-id="977">oxygen</compound-id> species (ROS) and induction of Ca(2+)-dependent <protein-id="P27730">calpain</protein-id> activity.	oxygen__eNOS__interaction	oxygen__calpain__no_interaction
18624772-192	Reduction of intracellular <compound-id="271">Ca(2</compound-id>+) levels abolished <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id> reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator <compound-id="104751">BAPTA</compound-id> or inhibition of NAD(P)H oxidase (with <compound-id="2214">apocynin</compound-id>) or inhibition of calpain (calpain 1-specific siRNA).	Ca(2__eNOS__interaction	BAPTA__eNOS__interaction	apocynin__eNOS__interaction
18624794-206	In addition to transporting <compound-id="611,23327,33032">glutamate</compound-id>, <protein-id="P31597,P43005,Q95135">EAAC1</protein-id> plays other roles in regulating <compound-id="119">GABA</compound-id> synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	glutamate__EAAC1__interaction	GABA__EAAC1__interaction
18625283-633	Whereas both peptides <compound-id="44567785">lactoferricin</compound-id> (17-30) and lactoferrampin (265-284) did not have bactericidal activity, 40 microM of <protein-id="O77698,O77811,P02788,P08071,P14632,P24627,Q29477,Q9TUM0">lactoferrin</protein-id> chimera (a fusion of the two peptides) inhibited the growth of all Vibrio tested to the same extent as the antibiotic <compound-id="3467">gentamicin</compound-id>.	lactoferricin__lactoferrin__no_interaction	gentamicin__lactoferrin__no_interaction
18625298-638	We have recently shown that the antidepressant <compound-id="3386">fluoxetine</compound-id> enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on <protein-id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</protein-id>/CD8 subsets.	fluoxetine__CD4__no_interaction
18625298-639	We found that <compound-id="3386">fluoxetine</compound-id> restored T cell proliferation and interleukin-2, <protein-id="Q9TTB0">interferon-gamma</protein-id> and <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha production by compensatory mechanisms.	fluoxetine__interferon-gamma__interaction	fluoxetine__tumor necrosis factor__interaction
18625569-874	Here we report a case of intragenic <protein-id="P00533,P13387,P55245">EGFR</protein-id> microdeletion in renal cell carcinoma (RCC) associated with the effect of treatment by <compound-id="123631">gefitinib</compound-id>.	gefitinib__EGFR__no_interaction
18626508-1659	Taking advantage of this prostate cancer-specific property of PSMA (E/P), we successfully introduced bacterial <protein-id="Q26998">UPRT</protein-id> into LNCaP cells where the tumoricidal effect of <compound-id="3385">5-fluorouracil</compound-id> (<compound-id="3385">5-FU</compound-id>) was significantly increased when compared with the cells without the exogenous <protein-id="Q26998">UPRT</protein-id>.	5-FU__UPRT__interaction	5-fluorouracil__UPRT__interaction
18626658-281	<protein-id="O97562,P55851,Q9N2J1,Q9W725">UCP2</protein-id> is expressed in pancreatic beta cells where its postulated uncoupling activity will modulate <compound-id="206,5793,64689,79025">glucose</compound-id>-induced changes in <compound-id="5957">ATP</compound-id>/ADP ratio and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion.	glucose__UCP2__interaction	glucose__insulin__interaction	ATP__UCP2__interaction	ATP__insulin__interaction
18626658-282	The consequences of <protein-id="O97562,P55851,Q9N2J1,Q9W725">UCP2</protein-id> over/underexpression on beta-cell function has mainly been studied in the basal state; however, a <protein-id="P04575,P10861,P14271,P25874">UCP</protein-id> has no uncoupling activity unless stimulated by fatty acids and/or reactive <compound-id="977">oxygen</compound-id> species.	oxygen__UCP__interaction	oxygen__UCP2__interaction
18626658-283	Neither <protein-id="P04575,P10861,P14271,P25874,Q18P97,Q8K404,Q9ER18,Q9GMZ1">UCP1</protein-id> expression nor <protein-id="O97562,P55851,Q9N2J1,Q9W725">UCP2</protein-id> overexpression modified basal or <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated metabolic changes.	glucose__UCP1__no_interaction	glucose__UCP2__no_interaction
18626709-112	The <protein-id="P13656,P14529,P23472,P23473,P81241,P84754">chitinase</protein-id> activity was increased by <compound-id="27854">Mn(2</compound-id>+), <compound-id="27099">Cu(2</compound-id>+), and Mg(2+), while strongly inhibited by <compound-id="27284">Fe(2</compound-id>+) and <compound-id="104810">Ba(2</compound-id>+).	Cu(2__chitinase__interaction	Mn(2__chitinase__interaction	Ba(2__chitinase__interaction	Fe(2__chitinase__interaction
18626709-113	Meanwhile, SDS, ethyleneglycoltetraacetic acid, <compound-id="1176,265993">urea</compound-id>, and <compound-id="6049">ethylenediaminetetraacetic acid</compound-id> were found to have significantly inhibitory effect on <protein-id="P13656,P14529,P23472,P23473,P81241,P84754">chitinase</protein-id> activity.	ethylenediaminetetraacetic acid__chitinase__interaction	urea__chitinase__interaction
18626726-122	In the present study, we screened the inhibitory effect of the extract from 50 Thai medicinal plants on an inducible-<protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) expression induced by <compound-id="11970143">lipopolysaccharide</compound-id> (LPS) in mouse macrophages RAW 264.7.	lipopolysaccharide__iNOS__interaction	lipopolysaccharide__nitric oxide synthase__interaction
18626791-1140	Following thermal denaturation, rabbit reticulocyte lysate and <compound-id="5957">ATP</compound-id> were added and <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> activity measured.	ATP__luciferase__interaction
18626794-227	These results are in contrast to postmortem findings in schizophrenia and suggest that reduced <protein-id="P07825,P08247,P20488,Q5YJC1,Q62277">synaptophysin</protein-id> protein levels in schizophrenia patients' postmortem brain do not result from perinatal <compound-id="977">oxygen</compound-id> deprivation.	oxygen__synaptophysin__no_interaction
18627006-344	We found that the acetylated <protein-id="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1">histone H3</protein-id> at <compound-id="866,5962">lysine</compound-id> 9 and <compound-id="866,5962">lysine</compound-id> 14 (H3K9/K14ac) is reduced in both the <protein-id="P02686,P02687,P04370,P06906,P15720,P20939,P25188,P25274,P81558,P83487,P87346,P98190,Q91325,Q91439">myelin basic protein</protein-id> (<protein-id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</protein-id>) and proteolipid protein (<protein-id="P04116,P13085,P22858,P23289,P23294,P30044,P47789,P47790,P60201,P60202,P60203,P79826,P80145,P99029,Q8HXW7,Q96GD0,Q9R063">PLP</protein-id>) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in <protein-id="P02686,P02687,P04370,P06906,P13727,P15720,P20939,P25188,P25274,P25336,P81558,P83487,P87346,P98190,Q61878,Q63189,Q91325,Q91439,Q9SAV1">MBP</protein-id>, <protein-id="P04116,P13085,P22858,P23289,P23294,P30044,P47789,P47790,P60201,P60202,P60203,P79826,P80145,P99029,Q8HXW7,Q96GD0,Q9R063">PLP</protein-id>, and <protein-id="O22446">histone deacetylase</protein-id> (HDAC) 11 expression.	lysine__histone H3__interaction	lysine__MBP__interaction	lysine__histone deacetylase__interaction	lysine__myelin basic protein__interaction	lysine__PLP__interaction
18627414-696	Although the current studies associating particular genes and their variants with seizure control or adverse events have inherent weaknesses and have not provided unifying conclusions, several results, for example that Asian patients with a particular HLA allele, <protein-id="P01889,P03989,P10319,P18463,P18464,P18465,P30460,P30461,P30462,P30464,P30466,P30475,P30479,P30480,P30481,P30483,P30484,P30485,P30486,P30487,P30488,P30490,P30491,P30492,P30493,P30495,P30498,P30685,Q04826,Q29718,Q29836,Q29940,Q31610,Q31612,Q95365">HLA-B</protein-id> *1502, are at a higher risk for Stevens-Johnson syndrome when using <compound-id="2554">carbamazepine</compound-id>, are helpful to increase our knowledge how genetic variation affects the treatment of epilepsy.	carbamazepine__HLA-B__no_interaction
18627421-707	However, <protein-id="P10451,P14287,P31096,Q9XSY9">OPN</protein-id>-(/-) mice showed increased serum levels of tumour necrosis factor (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>)-alpha, which could be due to systemically present <compound-id="11970143">lipopolysaccharide</compound-id> translocated to the gut.	lipopolysaccharide__TNF__interaction	lipopolysaccharide__OPN__interaction
18627475-762	The expression of the <protein-id="O08703,O08962,O13306,O35219,P32476,Q12809,Q14534,Q75F69,Q7GC09,Q86QT3,Q86QU1,Q86QU6,Q86QV0,Q86QV3,Q86QV6,Q8WNY2,Q92206,Q9PT84,Q9TSZ3,Q9TUI4">ERG1</protein-id>, <protein-id="O13597,O93875,P32353,P50860,P78575,Q754B9,Q7F9X0,Q86QT9,Q86QU4,Q86QU8,Q86QV1,Q86QV4,Q86QV9,Q8J207,Q8NJ57,Q9NS40">ERG3</protein-id>, <protein-id="P38604,Q04782,Q96WJ0">ERG7</protein-id>, <protein-id="O74165,P29704,P78589,Q752X9,Q92459,Q9HGZ6">ERG9</protein-id>, <protein-id="P10613,P10614,P14263,P49602,P50859,Q759W0">ERG11</protein-id> and <protein-id="O59933,P53045,Q15800">ERG25</protein-id> genes in response to incubation with <compound-id="3365">fluconazole</compound-id> and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	fluconazole__ERG9__interaction	fluconazole__ERG11__interaction	fluconazole__ERG25__interaction	fluconazole__ERG3__interaction	fluconazole__ERG1__interaction	fluconazole__ERG7__interaction
18627475-763	Expression of the <protein-id="P10613,P10614,P14263,P49602,P50859,Q759W0">ERG11</protein-id> gene was found to be low or moderate and it was regulated by <compound-id="3365">fluconazole</compound-id> addition more so than by biofilm formation.	fluconazole__ERG11__interaction
18627475-764	The expression of the <protein-id="O74165,P29704,P78589,Q752X9,Q92459,Q9HGZ6">ERG9</protein-id> increased in the presence of <compound-id="3365">fluconazole</compound-id> in some isolates.	fluconazole__ERG9__interaction
18629545-780	Concentrations of <compound-id="174">polyethylene glycol</compound-id> 1000 and <compound-id="24436">Na2SO4</compound-id> were selected as independent variables to evaluate their impact on parameters of partitioning in aqueous two-phase system--the partition coefficient of <protein-id="O42824,O59925,O93883,P05117,P20041,P24548,P26215,P26216,P27644,P35335,P35336,P35337,P35338,P35339,P41749,P41750,P43212,P47180,P48978,P48979,P49062,P49063,P49575,P58598,Q00446,Q02096,Q05967,Q07181,Q12708,Q39766,Q39786,Q40312,Q7M1E7,Q9FY19,Q9LW07,Q9Y718">pectinase</protein-id>, purification factor and <protein-id="O42824,O59925,O93883,P05117,P20041,P24548,P26215,P26216,P27644,P35335,P35336,P35337,P35338,P35339,P41749,P41750,P43212,P47180,P48978,P48979,P49062,P49063,P49575,P58598,Q00446,Q02096,Q05967,Q07181,Q12708,Q39766,Q39786,Q40312,Q7M1E7,Q9FY19,Q9LW07,Q9Y718">pectinase</protein-id> yield.	polyethylene glycol__pectinase__no_interaction	Na2SO4__pectinase__no_interaction
18629605-1551	In aged animals, administration of <compound-id="10918">L-carnitine</compound-id> for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like <protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> and <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id>.	L-carnitine__catalase__interaction	L-carnitine__glutathione reductase__interaction	L-carnitine__glutathione peroxidase__interaction	L-carnitine__superoxide dismutase__interaction
18629605-1552	<compound-id="10918">L-Carnitine</compound-id> enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using [3H] <compound-id="5789">thymidine</compound-id> incorporation and also significantly reduced DNA damage, apoptosis and <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> level in lymphocytes of aged animals.	thymidine__TNF-alpha__no_interaction	L-Carnitine__TNF-alpha__interaction
18629630-845	In our microarray analysis we observed that <protein-id="O43255,Q06986,Q8R4T2,Q9I8X5,Q9M2P4">Seven-in-Absentia Homolog 2</protein-id> (<protein-id="O43255">SIAH2</protein-id>) levels were low in <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> (ER) positive breast tumors of patients resistant to first-line <compound-id="2733526">tamoxifen</compound-id> therapy.	tamoxifen__estrogen receptor__no_interaction	tamoxifen__Seven-in-Absentia Homolog 2__no_interaction	tamoxifen__SIAH2__no_interaction
18629637-851	<compound-id="107647">Fluorocitrate</compound-id>, an inhibitor of glial metabolism, inhibits the up-regulation of <protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id> expression, activity and NO production in the spinal cord induced by formalin test in rats.	Fluorocitrate__NOS__interaction
18629637-852	In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of <compound-id="107647">fluorocitrate</compound-id> (FC), an inhibitor of glial metabolism, on <protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id> expression and activity and NO production in the spinal cord during the process of peripheral inflammatory pain and hyperalgesia induced by formalin test in rats.	fluorocitrate__NOS__interaction
18629640-41	Oral administration of <compound-id="5281670">morin</compound-id> remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (<protein-id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">AST</protein-id>), and total <compound-id="5280352">bilirubin</compound-id> levels.	morin__AST__interaction	bilirubin__AST__no_interaction
18631247-468	<compound-id="65064">Green tea extract</compound-id> reduces induction of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> and apoptosis in UVB-irradiated human skin independent of transcriptional controls.	Green tea extract__p53__interaction
18631247-469	We found that while OM24 treatment did not significantly affect UV-induced erythema and <compound-id="5789">thymidine</compound-id> dimer formation, OM24 treatment significantly reduced UV-induced <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> expression in keratinocytes.	thymidine__p53__no_interaction
18632226-1291	Genetic characterization of the <protein-id="P46084">HA1</protein-id> portion of the haemagglutinin (HA) gene of virus isolated from the outbreak indicated that the isolate (A/equine/<compound-id="4033">Zagreb</compound-id>/04) was an H3N8 strain closely related to recent representative viruses of the American lineage Florida sub-lineage.	Zagreb__HA1__no_interaction
18632226-1292	In comparison with both H3N8 vaccine strains used in horses at the <compound-id="4033">Zagreb</compound-id> hippodrome, A/equine/<compound-id="4033">Zagreb</compound-id>/04 displayed amino acids changes localised to 4 of the 5 described antigenic sites (A-D) of subunit protein <protein-id="P46084">HA1</protein-id>.	Zagreb__HA1__no_interaction
18632742-27	Here we show that <protein-id="Q99988,Q9JKM5">NRG-1</protein-id> selectively increases the power of <compound-id="10255">kainate</compound-id>-induced, but not <compound-id="2551">carbachol</compound-id>-induced, gamma oscillations in acute hippocampal slices.	kainate__NRG-1__interaction	carbachol__NRG-1__no_interaction
18632742-28	These effects of NRG-1beta are blocked by <compound-id="4707">PD158780</compound-id>, a pan-specific antagonist of ErbB receptors, and are mediated specifically via ErbB4 receptors, because mice harboring a targeted mutation of ErbB4 do not respond to <protein-id="Q99988,Q9JKM5">NRG-1</protein-id>.	PD158780__NRG-1__no_interaction
18633436-86	Of various agents tested in HaCaT cell cultures, only <compound-id="444795">retinoic acid</compound-id> (10(-6) M) and <compound-id="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148">staurosporine</compound-id> (2.5 x 10(-8) M) upregulated <protein-id="O75900,O93470,Q8K3F2,Q8N119,Q90YC2,Q9R0S2">MMP-21</protein-id> mRNA and protein expression, whereas tumor promoters, hormones, or <compound-id="5743">dexamethasone</compound-id> were without effect.	retinoic acid__MMP-21__interaction	staurosporine__MMP-21__interaction	dexamethasone__MMP-21__no_interaction
18633446-279	We have generated two novel chimeric <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of <protein-id="P17948,P53767">Flt-1</protein-id> fused either to a human IgG1 Fc or solely to the <compound-id="297">CH3</compound-id> domain of IgG1 Fc through a <compound-id="750">polyglycine</compound-id> linker 9Gly.	CH3__VEGF__no_interaction	polyglycine__VEGF__no_interaction	CH3__Flt-1__no_interaction	polyglycine__Flt-1__no_interaction
18633600-1063	By contrast, treatment of N2a cells with 1-10 microM <compound-id="6419789">DZO</compound-id> resulted in marked reductions in the expression of the axon growth-associated protein <protein-id="P09851,P20936,P50904,P74851,P74873,Q5PEA9,Q92211,Q92263">GAP</protein-id>-43.	DZO__GAP__interaction
18633600-1064	<compound-id="6419789">DZO</compound-id>-treated cells also showed an increased expression of the heat shock protein <protein-id="P27894">HSP-70</protein-id> compared to controls.	DZO__HSP-70__interaction
18633619-1153	Resistance of neoplastic cells to the alkylating drug <compound-id="2578">BCNU</compound-id> [1,3-bis (2-chloroethyl)-1-nitrosourea] has been correlated with expression of O (6)-methylguanine-DNA <protein-id="O40976,P03588,P03589,P06011,P17769,P20122,P27752,P28726,P28931,Q00020,Q66121,Q83264,Q83270">methyltransferase</protein-id>, which repairs the O (6)-<compound-id="161383">chloroethylguanine</compound-id> produced by the drug.	chloroethylguanine__methyltransferase__interaction	BCNU__methyltransferase__interaction
18633701-1577	We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of <protein-id="O18158">O-GlcNAc</protein-id> correlating changes in <protein-id="O15294,O18158,P81436">OGT</protein-id> expression, but not in <compound-id="445675,643981,9547196">UDP-GlcNAc</compound-id> pools.	UDP-GlcNAc__OGT__no_interaction	UDP-GlcNAc__O-GlcNAc__no_interaction
18633701-1578	Upon <compound-id="5994">progesterone</compound-id> stimulation, an <protein-id="O18158">O-GlcNAc</protein-id> level burst occurred during meiotic resumption long before <protein-id="Q13421,Q61468,Q9ERA7">MPF</protein-id> and <protein-id="P00536,P00539,P12965">Mos</protein-id>-<protein-id="P63085,P63086">Erk2</protein-id> pathways activations.	progesterone__MPF__interaction	progesterone__Mos__interaction	progesterone__Erk2__interaction	progesterone__O-GlcNAc__interaction
18633707-828	Mean plasma levels of <compound-id="6037">folic acid</compound-id>, <compound-id="778">homocysteine</compound-id>, and vitamin B12 did not change, but there was a significant decrease of <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id> at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	homocysteine__CRP__no_interaction	folic acid__CRP__no_interaction
18634065-1113	Chondrocytes grown in monolayer were treated with interleukin-1alpha (<protein-id="O46612,O46613,P01582,P01583,P04822,P08831,P16598,P18430,P46647,P48089,P79161,P79340,Q28385,Q28579,Q3HWU1,Q60480,Q865X7">IL-1alpha</protein-id>), <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-like growth factor-I (<protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id>), C3 Transferase, <compound-id="448042">Y27632</compound-id>, or transfected with Rho wild type or two constitutively active mutants of Rho (Q63L and G14V).	Y27632__IL-1alpha__no_interaction	Y27632__insulin__no_interaction	Y27632__IGF-I__no_interaction
18634065-1115	Affinity assays were performed to measure endogenous <compound-id="6830">GTP</compound-id>-bound <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id>, and confocal microscopy was used to assess changes in organization of the <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> cytoskeleton.	GTP__Rho__interaction	GTP__actin__no_interaction
18634065-1116	<protein-id="O46612,O46613,P01582,P01583,P04822,P08831,P16598,P18430,P46647,P48089,P79161,P79340,Q28385,Q28579,Q3HWU1,Q60480,Q865X7">IL-1alpha</protein-id> and RhoG14V increased cytoplasmic <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> stress fiber formation, which was blocked by C3 Transferase, and <compound-id="448042">Y27632</compound-id>.	Y27632__actin__interaction	Y27632__IL-1alpha__interaction
18634065-1118	Expression of RhoQ63L or RhoG14V resulted in increased <protein-id="O18927,O62806,O77656,P23097,P33435,P45452,Q10835">MMP-13</protein-id> expression; however, inhibition of <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> with <compound-id="448042">Y27632</compound-id> was unable to inhibit <protein-id="O46612,O46613,P01582,P01583,P04822,P08831,P16598,P18430,P46647,P48089,P79161,P79340,Q28385,Q28579,Q3HWU1,Q60480,Q865X7">IL-1alpha</protein-id>-induced <protein-id="O18927,O62806,O77656,P23097,P33435,P45452,Q10835">MMP-13</protein-id> expression.	Y27632__IL-1alpha__no_interaction	Y27632__Rho__interaction	Y27632__MMP-13__no_interaction
18634706-392	Plasma total <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, <protein-id="P44321">TAG</protein-id>, HDL, HDL2, HDL3, LDL, C-reactive protein, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, <protein-id="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0">IL-18</protein-id>, intercellular adhesion molecule-1, oxidised LDL, <compound-id="977">oxygen</compound-id> radical absorbance capacity using <compound-id="24247">perchloric acid</compound-id> (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	cholesterol__IL-6__no_interaction	cholesterol__IL-18__no_interaction	perchloric acid__TAG__no_interaction	oxygen__IL-18__no_interaction	perchloric acid__IL-18__no_interaction	cholesterol__TAG__no_interaction	perchloric acid__IL-6__no_interaction	oxygen__IL-6__no_interaction	oxygen__TAG__no_interaction
18634843-1147	The increase of mature <protein-id="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0">IL-18</protein-id> by macrophages was inhibited by <compound-id="44134608">caspase-1 inhibitor</compound-id> : caspase-1 is known to cleave the proform of <protein-id="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0">IL-18</protein-id> to produce active mature <protein-id="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0">IL-18</protein-id>.	caspase-1 inhibitor__IL-18__interaction
18635261-398	In absence of stretch, we could activate <protein-id="P64267,P64268">Gns</protein-id> and deactivate <protein-id="Q9GTW9">GK1</protein-id> by <compound-id="1394,5353264,6437055">1-oleoyl-2-acetyl-sn-glycerol</compound-id> (<compound-id="5353264">OAG</compound-id>) and other amphipaths.	OAG__Gns__interaction	1-oleoyl-2-acetyl-sn-glycerol__Gns__interaction	1-oleoyl-2-acetyl-sn-glycerol__GK1__interaction	OAG__GK1__interaction
18635336-453	Using enzyme-linked immunosorbent assays, we showed <compound-id="9881652">DHMEQ</compound-id> to inhibit LPS-induced secretion of <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> and <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>.	DHMEQ__IL-6__interaction	DHMEQ__TNF-alpha__interaction
18635390-1443	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and <compound-id="124886">GSH</compound-id>, elevated buccal mucosa <compound-id="124886">GSH</compound-id> as well as induction of <protein-id="P27297,Q07813,Q63690">bax</protein-id> and <protein-id="O50017,P08469,P14043,P31669,P35875,P55057,Q08824,Q11208">PARP</protein-id>, and inhibition of <protein-id="P10417,P49950">bcl-2</protein-id>.	GSH__bax__interaction	GSH__bcl-2__interaction	GSH__PARP__interaction
18635693-781	Dopamine release and direct stimulation of dopamine D2 and serotonin <protein-id="P50129">5-HT2A</protein-id> receptors also contributes to the overall action of <compound-id="1615">MDMA</compound-id>.	MDMA__5-HT2A__interaction
18635693-783	Our findings suggest that <compound-id="1615">MDMA</compound-id> differentially affects higher cognitive functions, but does not support the hypothesis from animal studies, that some of the <compound-id="1615">MDMA</compound-id> effects are causally mediated through action at the <protein-id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</protein-id> receptor system.	MDMA__5-HT1A__no_interaction
18635704-791	These results suggest that <protein-id="P31749,Q01314,Q38998,Q8VYX2">AKT1</protein-id> does not play a significant role in clinical and functional manifestations in patients with schizophrenia who receive <compound-id="5073">risperidone</compound-id> treatment.	risperidone__AKT1__no_interaction
18635814-879	<compound-id="5641">Urethane</compound-id> is a chemical carcinogen found in tobacco smoke that causes activating mutations in <protein-id="P08644,P32883,Q05147">Kras</protein-id> and induces lung tumors in mice.	Urethane__Kras__interaction
18636040-1068	In the present study, we measured plasma <protein-id="P08263,Q08863">GSTA1-1</protein-id> levels by enzyme-linked immunosorbent assay in seven healthy volunteers after repeated experimental endotoxemia induced by 2 ng kg Escherichia coli <compound-id="44268108">endotoxin</compound-id> per day (to investigate inflammation-induced hepatic injury) and in 21 patients within 12 h after the occurrence of severe sepsis/septic shock (to investigate its ability to predict an increase of transaminases on day 7).	endotoxin__GSTA1-1__no_interaction
18636040-1069	Furthermore, <protein-id="P08263,Q08863">GSTA1-1</protein-id> levels did not correlate with <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> levels but did with <compound-id="36811">dobutamine</compound-id> infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	dobutamine__GSTA1-1__interaction	dobutamine__IL-6__no_interaction
18636042-1310	Heparin (H), <compound-id="2232,92722,152951,440542,445156">argatroban</compound-id> (A), <protein-id="P81050">antithrombin III</protein-id> (<protein-id="P01008,P32261,P32262,P41361,P81050,Q03352,Q5R5A3">ATIII</protein-id>), and recombinant human activated <protein-id="O55527,O55779,P02810,P03314,P03424,P04861,P04862,P06022,P06164,P06165,P06941,P07602,P08097,P10030,P14253,P14254,P14340,P26035,P26779,P27384,P28055,P29165,P32533,P32534,P32535,P35940,P35948,P35977,P69738,Q00794,Q03339,Q074N0,Q1X880,Q1X881,Q6DV88,Q6J3P1,Q89277,Q98803,Q997F1,Q9DUE0,Q9WS38,Q9YRV3">protein C</protein-id> (rhAPC) with and without <protein-id="P84122">thrombin</protein-id> were added to cells suspended in septic plasma and normal plasma.	argatroban__thrombin__no_interaction	argatroban__protein C__no_interaction	argatroban__ATIII__no_interaction	argatroban__antithrombin III__no_interaction
18636044-1070	<compound-id="402,108196">Hydrogen sulfide</compound-id> (<compound-id="6857678">H2S</compound-id>) is a novel gaseous mediator produced by <protein-id="P32232,P32582,P35520,P46794,Q58H57,Q91WT9,Q9N0V7,Q9YBL2">cystathionine-beta-synthase</protein-id> and <protein-id="P18757,P31373,P32929,Q58DW2,Q60HG7,Q8VCN5">cystathionine-gamma-lyase</protein-id> in the cardiovascular system, including the heart.	Hydrogen sulfide__cystathionine-beta-synthase__interaction	H2S__cystathionine-beta-synthase__interaction	Hydrogen sulfide__cystathionine-gamma-lyase__interaction	H2S__cystathionine-gamma-lyase__interaction
18636221-1488	Chemotaxis, <protein-id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7">lysozyme</protein-id> release and <compound-id="5359597">superoxide</compound-id> anion production have been measured.	superoxide__lysozyme__no_interaction
18636241-1243	According to <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</protein-id>-binding, arsenic trioxide (7 microM) within 48 h significantly increased <compound-id="445141,6323481,44147587">phosphatidylserine</compound-id> exposure of human erythrocytes without inducing hemolysis.	phosphatidylserine__annexin V__no_interaction
18636241-1244	Removal of extracellular Ca2+ or inhibition of the Ca2+-permeable cation channels with <compound-id="16231">amiloride</compound-id> blunted the effects of arsenic on <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</protein-id>-binding and cell shrinkage.	amiloride__annexin V__interaction
18636311-1287	In the present study, we investigated the inhibitory effect of the known oxycoumarins poncitrin (3), <compound-id="10228">osthol</compound-id> (4), and <compound-id="66548">xanthoxyletin</compound-id> (5), newly isolated from Clausena guillauminii (Rutaceae), together with the known carbazoles <compound-id="5318015">heptaphylline</compound-id> (1) and 7-methoxyheptaphylline (2) on inducible-<protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) expression induced by <compound-id="11970143">lipopolysaccharide</compound-id> (LPS) and the NO generation in RAW 264.7 mouse macrophages.	osthol__iNOS__interaction	xanthoxyletin__iNOS__interaction	heptaphylline__iNOS__interaction	osthol__nitric oxide synthase__interaction	lipopolysaccharide__nitric oxide synthase__interaction	lipopolysaccharide__iNOS__interaction	heptaphylline__nitric oxide synthase__interaction	xanthoxyletin__nitric oxide synthase__interaction
18636399-1328	Cell viability and reactive <compound-id="977">oxygen</compound-id> species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id> and GPx activity as well as the concentration of <compound-id="124886">reduced glutathione</compound-id>.	reduced glutathione__GST__no_interaction	oxygen__GST__no_interaction
18636508-1410	Fibril growth was a second-order process with an enthalpy of activation (27+/-5 kcal mol(-1)), which is indistinguishable from that of tetramer formation by <protein-id="P08935,P25973,P81061,P81714,Q06445">cystatins</protein-id>, which involves limited conformational changes including <compound-id="614,8988,145742">proline</compound-id> trans to cis isomerization.	proline__cystatins__interaction
18636565-515	Mutations in <protein-id="P36021">MCT8</protein-id> are associated with severe psychomotor retardation, high serum T3 and low <compound-id="5920,644280">3,3',5'-triiodothyronine</compound-id> (<compound-id="644280">rT3</compound-id>) levels.	3,3',5'-triiodothyronine__MCT8__interaction	rT3__MCT8__interaction
18637152-268	Results showed that <compound-id="19582,9838899">MENT</compound-id> treatments increased <protein-id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</protein-id> secretion and proliferation rate with a potency ranged between T and <compound-id="10635">DHT</compound-id>.	DHT__PSA__interaction	MENT__PSA__interaction
18637152-269	The studies with <compound-id="57363">finasteride</compound-id> showed that in BPH and CaP cells, the conversion of T into <compound-id="10635">DHT</compound-id> significantly contributes to its effect on the proliferation and <protein-id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</protein-id> secretion, and corroborated the resistance of <compound-id="19582,9838899">MENT</compound-id> to the 5-AR.	finasteride__PSA__interaction	MENT__PSA__no_interaction	DHT__PSA__interaction
18637154-273	Pregnant Sprague-Dawley female rats were treated once with <compound-id="15625">TCDD</compound-id> (0, 0.3 or 1 microg/kg) by gavage on embryonic day (ED) 11 and the expression levels of androgen (AR) and <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptors</protein-id> (ER), steroidogenic enzymes (P450scc and <protein-id="O46516,O57245,P14893,P21097,P26670,P27365,Q5IFP1,Q67477,Q9N119">3beta-HSD</protein-id>) and four regulatory factors (<protein-id="O46689,P49675,P51557,P58864,P70114,P79245,P97826,Q28918,Q28996,Q9DE06,Q9DEB4,Q9DG08,Q9DG09,Q9DG10">StAR</protein-id>, <protein-id="P33242,P50569,P79387,Q04752,Q13285,Q95L87,Q9GKL2">SF-1</protein-id>, <protein-id="P49604">GATA</protein-id>-4 and Insl-3) involved in foetal Leydig cell and adrenal function were analysed on ED 19.5.	TCDD__estrogen receptors__interaction	TCDD__SF-1__interaction	TCDD__3beta-HSD__interaction	TCDD__GATA__interaction	TCDD__StAR__interaction
18637154-274	In utero exposure to <compound-id="15625">TCDD</compound-id> reduced intratesticular T of foetal males (significant at 0.3 microg/kg <compound-id="15625">TCDD</compound-id>) and tended to reduce the protein expression of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> and AR of foetal male rat testis.	TCDD__ERalpha__interaction
18637154-275	mRNA expression of developmental regulatory factors was not influenced by foetal <compound-id="15625">TCDD</compound-id> exposure, except for significantly reduced adrenal <protein-id="P33242,P50569,P79387,Q04752,Q13285,Q95L87,Q9GKL2">SF-1</protein-id>.	TCDD__SF-1__interaction
18637708-746	<compound-id="947,123329">Nitrogen</compound-id>-containing bisphosphonates were found to inhibit <protein-id="O66126,O66952,P22939,P45204,P54383,P55539,P57537,Q08291,Q45220,Q8K9A0">farnesyl diphosphate synthase</protein-id>-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> synthesis per se in the central nervous system (CNS) remains unknown.	Nitrogen__farnesyl diphosphate synthase__interaction	cholesterol__farnesyl diphosphate synthase__no_interaction
18637712-756	hsBAFF-upregulated intracellular free <compound-id="271">Ca(2</compound-id>+) homeostasis regulates <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 activity and cell proliferation in B cells in vitro.	Ca(2__ERK1__interaction
18637712-757	Using immunocytochemistry and Western blot analysis, we found that the activation of <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 due to hsBAFF was triggered by a [<compound-id="271">Ca(2</compound-id>+)](i)-dependent pathway, leading to elevation of B cell proliferation.	Ca(2__ERK1__interaction
18637712-758	This is supported by the findings that intracellular Ca(2+) chelator <compound-id="2293">BAPTA/AM</compound-id> attenuated phosphorylated <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 expression and cell proliferation in hsBAFF-stimulated B cells.	BAPTA/AM__ERK1__interaction
18637712-759	Taken together, the main finding of this study is that hsBAFF elicits higher but homeostatic [<compound-id="271">Ca(2</compound-id>+)](i) levels, which regulates <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 activity and cell proliferation in in vitro B cells.	Ca(2__ERK1__interaction
18637714-1311	Surgical removal of pheochromocytoma significantly increased body weight, decreased both systolic and diastolic blood pressure, fasting blood <compound-id="206,5793,64689,79025">glucose</compound-id> and glycated <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> levels.	glucose__hemoglobin__no_interaction
18637715-1322	In this study we have investigated a long-term pattern of expression and production of spinal <protein-id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</protein-id> and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> in the model of osteoarthritis induced in rats by injection of <compound-id="5240">monoiodoacetate</compound-id> (MIA) into the knee joint.	monoiodoacetate__COX-2__no_interaction	monoiodoacetate__COX-1__no_interaction
18639339-380	The enzyme <protein-id="P14902,P28776">indoleamine 2,3-dioxygenase</protein-id> (<protein-id="P14902,P28776">IDO</protein-id>) converts <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> to <compound-id="846">kynurenine</compound-id>, blocking T-cell activation and inducing immunosuppression.	tryptophan__indoleamine 2,3-dioxygenase__interaction	kynurenine__IDO__interaction	tryptophan__IDO__interaction	kynurenine__indoleamine 2,3-dioxygenase__interaction
18639341-381	Serum l-<compound-id="846">kynurenine</compound-id> (l-<compound-id="161166">KYN</compound-id>) concentrations, l-<compound-id="161166">KYN</compound-id>/l-<protein-id="P07147,P17643">TRP</protein-id> ratio, and the level of <protein-id="P14902,P28776">IDO</protein-id> mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	kynurenine__TRP__no_interaction	KYN__TRP__no_interaction	KYN__IDO__no_interaction	kynurenine__IDO__no_interaction
18639629-311	Peripheral administration of the acetylcholinesterase inhibitor <compound-id="9651">galantamine</compound-id> significantly reduced serum <protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id> levels through vagus nerve signaling, and protected against lethality during murine endotoxemia.	galantamine__TNF__interaction
18639629-312	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of <protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id> by <compound-id="9651">galantamine</compound-id>, indicating that suppressing <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	galantamine__acetylcholinesterase__interaction	galantamine__TNF__interaction
18639629-313	Administration of <compound-id="9651">galantamine</compound-id> to alpha7nAChR knockout mice failed to suppress <protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id> levels, indicating that the alpha7nAChR-mediated cholinergic anti-inflammatory pathway is required for the anti-inflammatory effect of <compound-id="9651">galantamine</compound-id>.	galantamine__TNF__no_interaction
18639930-897	The involvement of <compound-id="5359597">superoxide</compound-id> and <compound-id="145068">nitric oxide</compound-id> was verified by the block of <protein-id="O60682">MSC</protein-id> using specific scavengers (<compound-id="9002">tiron</compound-id> and PTIO, respectively).	superoxide__MSC__interaction	tiron__MSC__no_interaction	nitric oxide__MSC__interaction
18639930-898	Accordingly, <protein-id="O60682">MSC</protein-id> were blocked by the <compound-id="104806">peroxynitrite</compound-id> scavenger <compound-id="1175">uric acid</compound-id> and could be mimicked by application of exogenous <compound-id="104806">peroxynitrite</compound-id>.	peroxynitrite__MSC__no_interaction	uric acid__MSC__interaction
18639930-899	This conclusion is supported by our findings that <protein-id="O60682">MSC</protein-id> were suppressed by inhibitors of phospholipases but could be mimicked by exogenous phospholipases or by amphipaths (<compound-id="445639">oleic acid</compound-id>, <compound-id="5590">Triton X-100</compound-id>).	Triton X-100__MSC__interaction	oleic acid__MSC__interaction
18640003-956	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by <compound-id="64966">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide</compound-id> (MTT), <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</protein-id>-<compound-id="18730">FITC</compound-id>/<compound-id="4939">propidium iodide</compound-id> (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide__annexin V__no_interaction	propidium iodide__annexin V__no_interaction	FITC__annexin V__no_interaction
18640059-934	To investigate the role of <compound-id="60961">adenosine</compound-id> analogs and electromagnetic field (EMF) stimulation on prostaglandin E(2) (<protein-id="Q29458">PGE</protein-id> (2)) release and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</protein-id> (<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>) expression in bovine synovial fibroblasts (SFs).	adenosine__PGE__interaction	adenosine__COX-2__interaction	adenosine__cyclooxygenase-2__interaction
18640663-1479	In this study, we compared the effects of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-like growth factor-I (<protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id>), <protein-id="P03969,P09038,P12226,P13109,P15655,P20003,P48798,P48799,P48800,Q60487">basic fibroblast growth factor</protein-id> (bFGF), transforming growth factor beta1 (<protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</protein-id>), and <compound-id="3034366">glucosamine sulphate</compound-id> on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	glucosamine sulphate__insulin__no_interaction	glucosamine sulphate__TGF-beta1__no_interaction	glucosamine sulphate__IGF-I__no_interaction	glucosamine sulphate__basic fibroblast growth factor__no_interaction
18640679-288	Meanwhile, both the enhanced expression of <protein-id="P19320,P29533,P29534,Q28260">VCAM-1</protein-id> and increased activation of NF-kappaB induced by <protein-id="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1">CRH</protein-id> in aortas of LDLr-/-mice were also largely suppressed by <compound-id="176157">NBI27914</compound-id>, whereas these inhibitory effects were not observed in anti-Svg-30 group.	NBI27914__VCAM-1__interaction	NBI27914__CRH__interaction
18640717-1523	<protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>/Akt activity, analyzed by <compound-id="53477912">phosphatidylinositol</compound-id> trisphosphate production and phosphorylated Akt (p-Akt) expression, was higher in the resistant cell lines than in the sensitive one and inhibition with <compound-id="312145">wortmannin</compound-id> or <compound-id="3973">LY294002</compound-id> improved apoptosis in the resistant cell lines.	wortmannin__PI3K__no_interaction	LY294002__PI3K__no_interaction	phosphatidylinositol__PI3K__interaction
18640717-1524	<compound-id="5978">Vincristine</compound-id> but not <compound-id="31703">doxorubicin</compound-id> increased p-<protein-id="P31750,Q8INB9">Akt</protein-id> expression whereas co-treatment with PI3K inhibitors and <compound-id="5978">vincristine</compound-id> increased apoptosis in the three cell lines.	doxorubicin__Akt__no_interaction	Vincristine__Akt__no_interaction	vincristine__Akt__no_interaction
18640717-1525	<compound-id="312145">Wortmannin</compound-id> and <compound-id="3973">LY294002</compound-id> inhibited P-<protein-id="P08163">glycoprotein</protein-id> (Pgp) function and also increased NF-kappaB activity.	LY294002__glycoprotein__interaction	Wortmannin__glycoprotein__interaction
18640746-1557	Namely, the results obtained for the most active compounds, 5-(chloroacetylamino) <compound-id="23648490">uracil (2</compound-id>) and its acyclic sugar analogue 18, suggest that formation of a covalent bond between reactive substituent and several possible targets within the <protein-id="O02604,O26868,O33380,O66108,O76511,O81395,O96650,P00469,P00471,P04818,P06785,P06854,P07382,P07606,P07607,P09249,P0A0M5,P0A884,P0A885,P0A886,P0C0M4,P0C0M5,P12461,P12462,P13100,P13922,P16126,P19368,P20712,P44420,P45350,P45351,P45352,P46103,P47469,P48464,P51820,P57515,P57808,P59427,P67042,P67043,P67044,P67045,P67046,P67047,P67048,P67049,P67050,P67051,P67052,P78029,P80305,P90463,Q05762,Q05763,Q07422,Q23695,Q27713,Q27783,Q27793,Q27828,Q2QRX6,Q4QM04,Q57931,Q5D189,Q5E7P1,Q5FKL6,Q5GWB5,Q5HFZ6,Q5HMP6,Q5KZ25,Q5M0S7,Q5M5B3,Q5NFK5,Q5P233,Q5PEN6,Q5R064,Q5UQG3,Q5WDS1,Q5WSU5,Q5X119,Q5XCM3,Q5YPL7,Q5ZRL3,Q603S2,Q63BV5,Q64PV5,Q65J44,Q65VJ8,Q667F9,Q67JQ1,Q6A761,Q6AFI0,Q6D8I6,Q6F145,Q6FER7,Q6FZ91,Q6G2S8,Q6G9D4,Q6GGY0,Q6HJC7,Q6KIQ6,Q6LUM1,Q6MID2,Q6N447,Q6NIF2,Q6REU8,Q6YQT0,Q71YE1,Q738X7,Q73VZ2,Q74IU3,Q7MNN6,Q7MTB5,Q7N8U4,Q7NZ95,Q7UID0,Q7VMH2,Q7VUE3,Q7W1A9,Q7WP13,Q81E05,Q81R23,Q82WU3,Q834R3,Q83BG2,Q87BT4,Q87SA0,Q87UL4,Q88CN9,Q88W05,Q89940,Q89G35,Q8A639,Q8D2N4,Q8DER9,Q8DUI4,Q8DZ07,Q8E4L6,Q8EH94,Q8EQG0,Q8EV81,Q8FR47,Q8G3T9,Q8K9C3,Q8NS38,Q8P1D1,Q8PCE7,Q8PP46,Q8PXI1,Q8RGP6,Q8THH4,Q8TVL9,Q8UDS3,Q8Y0U6,Q8Y626,Q8Z412,Q8ZHV1,Q8ZMA9,Q92AD4,Q92NQ5,Q97EV3,Q98KH9,Q98Q31,Q9A6H0,Q9CBW0,Q9I6F1,Q9JT57,Q9JY72,Q9K7B5,Q9P4T7,Q9PB13,Q9RAM7,Q9XC19,Q9Z671">thymidylate synthase</protein-id> mechanism (sulphur of the <compound-id="594,5862,5360637">cysteine</compound-id> residue, basic part of the enzyme, N,N-methylene tetrahydrofolate or its reactive iminium forms) is the most probable mode of action.	cysteine__thymidylate synthase__interaction	uracil (2__thymidylate synthase__interaction
18641920-846	<compound-id="151194">PTK787/ZK222584</compound-id>, a potent orally active angiogenesis inhibitor capable of inhibiting all known isoforms of Vascular Endothelial Growth Factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>) receptor, belongs to the class of aminophthalazines.	PTK787/ZK222584__VEGF__interaction
18642040-946	Recent evidence for toxic <compound-id="5359597">superoxide</compound-id> (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of <protein-id="P82953">mannose-specific lectins</protein-id> to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.	superoxide__mannose-specific lectins__no_interaction
18642088-995	Activation of these receptors can inhibit <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (<compound-id="56603683">pasireotide</compound-id>, or <compound-id="56841596">SOM230</compound-id>) or D(2) (<compound-id="54746">cabergoline</compound-id>) have shown significant efficacy in subsets of patients in recent clinical studies.	pasireotide__ACTH__no_interaction	cabergoline__ACTH__no_interaction	SOM230__ACTH__no_interaction
18642106-1330	The <compound-id="611,23327,33032">glutamate</compound-id> induced chemotaxis was accompanied by polarization of the <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> cytoskeleton, and by polymerization of F-<protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id>.	glutamate__actin__interaction
18642386-611	<compound-id="97663">SD4</compound-id> in anionic DSPG liposomes stimulated murine <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> production in RAW 264 cells at concentrations 25-to 30-fold lower than free drug.	SD4__IL-6__interaction
18643838-993	To elucidate the mechanism by which <compound-id="77999">rosiglitazone</compound-id> regulates adipose triglyceride <protein-id="Q7M4U7">lipase</protein-id> (ATGL).	rosiglitazone__lipase__interaction
18643908-800	<protein-id="O16005,O16017,O16018,O16019,O16020,O18312,O18315,O18481,O18485,O18486,O18766,O42268,O42294,O42300,O42301,O42307,O42327,O42328,O42330,O42427,O42431,O42451,O42452,O42466,O42604,O62791,O62792,O62793,O62794,O62795,O62796,O62798,O93441,O93459,P02699,P02700,P08100,P09241,P15409,P22328,P22671,P24603,P28681,P29403,P31355,P31356,P32308,P32309,P35356,P35359,P35362,P35403,P41590,P41591,P49912,P51470,P51488,P51489,P52202,P56514,P56515,P56516,P79756,P79798,P79807,P79808,P79809,P79812,P79848,P79863,P79898,P79901,P79902,P79903,P79911,P79914,P87369,Q17094,Q17292,Q17296,Q28886,Q68J47,Q6W3E1,Q769E8,Q8HY69,Q90245,Q90305,Q90373,Q95KU1,Q98980,Q9DGG4,Q9YGY9,Q9YGZ0,Q9YGZ1,Q9YGZ2,Q9YGZ3,Q9YGZ4,Q9YGZ5,Q9YGZ6,Q9YGZ7,Q9YGZ8,Q9YGZ9,Q9YH00,Q9YH01,Q9YH02,Q9YH03,Q9YH04,Q9YH05">Rhodopsin</protein-id> is one of the members of the G protein-coupled receptor family that can catalyze a <compound-id="8977">GDP</compound-id>-<compound-id="6830">GTP</compound-id> exchange reaction on the retinal G protein <protein-id="P49177">transducin</protein-id> (Gt) upon photon absorption.	GTP__Rhodopsin__interaction	GDP__transducin__interaction	GTP__transducin__interaction	GDP__Rhodopsin__interaction
18644606-1339	<compound-id="4585">Olanzapine</compound-id> was associated with a lower frequency of extrapyramidal symptoms than other antipsychotics, fewer <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id>-related adverse events than risperidone and other atypical antipsychotics, but greater weight gain than typicals and risperidone.	Olanzapine__prolactin__interaction
18646192-1003	In our earlier method, <compound-id="65359">glutathione disulfide</compound-id> (<compound-id="65359">GSSG</compound-id>) was measured by first reducing it to <compound-id="124886">GSH</compound-id> with <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR) in the presence of <compound-id="5884">NADPH</compound-id>.	GSSG__glutathione reductase__interaction	glutathione disulfide__glutathione reductase__interaction	NADPH__glutathione reductase__interaction	GSH__glutathione reductase__interaction
18647134-77	<protein-id="P01180,P01181,P01183,P01185,P01186,P10769,P35455">Copeptin</protein-id>, derived from the C-terminal portion of the precursor to AVP (<compound-id="8230,644077,44285245">arginine vasopressin</compound-id>), is secreted stoichiometrically with vasopressin, hence it can be used as a surrogate marker of the AVP system.	arginine vasopressin__Copeptin__interaction
18647135-78	The <protein-id="Q10751">angiotensin-converting enzyme</protein-id> insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent <compound-id="5359597">superoxide</compound-id> generation: potential implication in hypertension.	superoxide__angiotensin-converting enzyme__interaction
18648748-1370	Administration of <compound-id="72281">hesperetin</compound-id> to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>, GPx, <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, and <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id> activities.	hesperetin__SOD__interaction	hesperetin__GST__interaction	hesperetin__CAT__interaction
18648826-1446	Culture of mid-segments of hair follicles in low calcium culture medium kept on <compound-id="11966311">agarose</compound-id> increased expression of <protein-id="P11088,P20930">filaggrin</protein-id> and <protein-id="O09043">Kdap</protein-id>, but downregulated expression of <protein-id="P07476,P14590,P14591,P14708,P17941,P18174,P18175,P24708,P24709,P24710,P24711,P24712,P48997,P48998,Q95337">involucrin</protein-id>.	agarose__involucrin__interaction	agarose__filaggrin__interaction	agarose__Kdap__interaction
18648877-1504	The <compound-id="979">p-hydroxyphenylpyruvate</compound-id> produced by the Escherichia coli host was converted to <compound-id="449178">HGA</compound-id> through the oxidation reaction of introduced <protein-id="O42764">HPPD</protein-id>.	HGA__HPPD__interaction	p-hydroxyphenylpyruvate__HPPD__interaction
18649000-1622	The results showed that the intakes of dry matter (DM), organic matter (OM), <compound-id="947,123329">nitrogen</compound-id> (N), the N-balance, urinary <compound-id="1044">purine</compound-id> derivatives (PD) excretion, the ratios of <compound-id="204">allantoin</compound-id> to <compound-id="588">creatinine</compound-id> (<compound-id="23976">CR</compound-id>), PD to <compound-id="23976">CR</compound-id>, the plasma <compound-id="1176,265993">urea</compound-id>-N (PUN) and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> increased in the animals, but the intake of neutral detergent fiber (NDF), the coefficient of whole tract, apparent digestibility of NDF, the transit time (TT) and the mean retention time (TMRT) decreased, when the proportion of concentrate in the diet increased.	urea__insulin__no_interaction	nitrogen__insulin__no_interaction	purine__insulin__no_interaction	CR__insulin__no_interaction	creatinine__insulin__no_interaction	allantoin__insulin__no_interaction
18649135-39	Activation of <protein-id="P41693">interleukin-6</protein-id>/<protein-id="P40763,P61635">STAT3</protein-id> in rat cholangiocyte proliferation induced by <compound-id="11970143">lipopolysaccharide</compound-id>.	lipopolysaccharide__STAT3__interaction	lipopolysaccharide__interleukin-6__interaction
18650080-815	Determination of reactive <compound-id="977">oxygen</compound-id> species generated in <protein-id="Q12570">laccase</protein-id> catalyzed oxidation of wood fibers from Chinese fir (Cunninghamia lanceolata) by electron spin resonance spectrometry.	oxygen__laccase__interaction
18650080-816	To investigate the activation pathways triggered by <protein-id="Q12570">laccase</protein-id>, ESR spin-trapping techniques using N-tert-butyl-alpha-phenylnitrone (PBN) as spin trap followed by <compound-id="8857">ethyl acetate</compound-id> extraction were employed to identify and quantify the free radical intermediates.	ethyl acetate__laccase__no_interaction
18650805-1377	Methylation of these <compound-id="6804">CpG</compound-id> sites may lead to reduced <protein-id="P35372,P79350,P97266,Q5IS39,Q5IS84,Q95247,Q95M54,Q9MYW9">OPRM1</protein-id> expression in the lymphocytes of these former heroin addicts.	CpG__OPRM1__interaction
18651093-1447	Two infants with elevated serum <protein-id="Q05902">gamma-GT</protein-id> had a decreased serum <compound-id="738,5961">glutamine</compound-id>.	glutamine__gamma-GT__interaction
18651113-1681	Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on <compound-id="23963">titanium</compound-id> with surface-grafted chitosan and immobilized bone <protein-id="P07580">morphogenetic protein</protein-id>-2.	titanium__morphogenetic protein__no_interaction
18651133-1703	None of the compounds altered <protein-id="P15393">Cyp11b1</protein-id> gene expression, indicating that 3-<compound-id="119115">MeSO2-DDE</compound-id> inhibits <protein-id="P15150,P15538,P51663,P97720,Q29527,Q29552,Q64408">CYP11B1</protein-id> activity on the protein level.	MeSO2-DDE__Cyp11b1__interaction	MeSO2-DDE__CYP11B1__interaction
18651191-669	Functional analysis demonstrated that elkj encoded a <protein-id="Q9SDN0">C20</protein-id>-elongase that mediated the elongation of EPA into <compound-id="3145,5497182,6441454">docosapentaenoic acid</compound-id> (22:5n-3), confirming the two-step conversion from EPA to DHA in marine microalga.	docosapentaenoic acid__C20__interaction
18651838-564	<protein-id="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0">ANP</protein-id> (<protein-id="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0">atrial natriuretic peptide</protein-id>) exerts its biological effects by binding to GC (guanylate <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</protein-id>)-A/<protein-id="P20910,Q41249">NPR</protein-id> (<protein-id="P28374">natriuretic peptide</protein-id> receptor)-A, which generates the second messenger <compound-id="24316">cGMP</compound-id>.	cGMP__cyclase__interaction	cGMP__ANP__no_interaction	cGMP__NPR__interaction	cGMP__natriuretic peptide__no_interaction	cGMP__atrial natriuretic peptide__no_interaction
18651838-565	Overexpression of <protein-id="P27577,P41156">Ets-1</protein-id> enhanced significantly <protein-id="P18293,P18910">Npr1</protein-id> mRNA levels, protein expression, GC activity and <protein-id="O46540,P01160,P01161,P05125,P07499,P07500,P07501,P09196,P18144,P18908,P18909,P24259,P27104,P27596,P83964,Q805D8,Q805E9,Q9GLD0">ANP</protein-id>-stimulated intracellular accumulation of <compound-id="24316">cGMP</compound-id> in transfected cells.	cGMP__Npr1__no_interaction	cGMP__ANP__interaction	cGMP__Ets-1__interaction
18652538-1158	In the current study, these cells were cultured with three different media: " <protein-id="P35855">BMP</protein-id>-plus" medium containing <compound-id="5743">dexamethasone</compound-id> and 100 ng/mL of rhBMP-2, "odontogenic" medium containing <compound-id="5743">dexamethasone</compound-id>, and "control" medium without supplements.	dexamethasone__BMP__no_interaction
18652864-1389	The <protein-id="P42559">allatostatins</protein-id> (<protein-id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">ASTs</protein-id>), with a Tyr/Phe-Xaa-Phe-Gly-Leu/Ile-amide C-terminus, are <protein-id="P21259">neuropeptides</protein-id> that occur in many orders of insects, but are known to inhibit <compound-id="6439662">juvenile hormone</compound-id> (JH) synthesis by corpora allata (CA) only in cockroaches, crickets, and termites.	juvenile hormone__ASTs__interaction	juvenile hormone__allatostatins__interaction	juvenile hormone__neuropeptides__no_interaction
18652909-1018	Lecithin:retinol <protein-id="P05521,P19197,P21309,P23148,P41302,Q06878,Q7N576,Q9AJA7,Q9S3Z2">acyltransferase</protein-id> (<protein-id="O95237,Q9BGL2">LRAT</protein-id>) catalyzes the esterification of retinol (<compound-id="445354">vitamin A</compound-id>).	vitamin A__LRAT__interaction	vitamin A__acyltransferase__interaction
18652909-1019	<compound-id="444795">Retinoic acid</compound-id> (RA) treatment increased this <protein-id="O95237,Q9BGL2">LRAT</protein-id> promoter-<protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> activity in PrEC cells, but not in PC-3 cells.	Retinoic acid__LRAT__interaction	Retinoic acid__luciferase__interaction
18654608-1184	As multidrug resistance (MDR) is a major problem in the chemotherapy of progressive breast cancer, the in vitro effects of Ad-<protein-id="Q9UBP4">REIC</protein-id> treatment were investigated in terms of the sensitivity of multidrug-resistant MCF7/ADR cells to <compound-id="31703">doxorubicin</compound-id> and of the P-<protein-id="P08163">glycoprotein</protein-id> expression.	doxorubicin__glycoprotein__no_interaction	doxorubicin__REIC__interaction
18654608-1185	Ad-<protein-id="Q9UBP4">REIC</protein-id> treatment in MCF7/ADR cells also downregulated P-<protein-id="P08163">glycoprotein</protein-id> expresssion through <protein-id="P92208,Q966Y3">JNK</protein-id> activation, and sensitized its drug resistance against <compound-id="31703">doxorubicin</compound-id>.	doxorubicin__JNK__no_interaction	doxorubicin__glycoprotein__no_interaction	doxorubicin__REIC__interaction
18654747-1289	<compound-id="219023">Diflomotecan</compound-id>, a homocamptothecin, targets <protein-id="O27661,O28469,O34204,O51768,O58356,O66893,O69548,O73954,O83409,P04786,P06612,P07799,P0A2I1,P0A2I2,P0A620,P0A621,P11387,P16472,P30181,P30189,P32989,P34184,P34185,P39814,P40114,P41511,P41512,P43012,P46155,P46799,P47368,P55991,P57371,P68697,P68698,P73810,P78032,P93119,Q00313,Q04750,Q07050,Q59046,Q76ZS7,Q7YR26,Q87AQ6,Q8K9P7,Q92IH1,Q9CG80,Q9CN30,Q9HM08,Q9HZJ5,Q9JN65,Q9KA23,Q9KRB2,Q9PEV8,Q9PLZ2,Q9UYS8,Q9WUL0,Q9X3X7,Q9X909,Q9YB01,Q9ZDK2,Q9ZMV7">DNA topoisomerase I</protein-id>.	Diflomotecan__DNA topoisomerase I__interaction
18654835-1331	Both MudPIT and cDNA microarray analyses indicate that <compound-id="784">H2O2</compound-id> treatment caused elevated levels of <protein-id="P29509,Q17745,Q39243">thioredoxin reductase 1</protein-id>.	H2O2__thioredoxin reductase 1__interaction
18655070-1550	Altogether these changes offer a straightforward explanation for how following the addition of <compound-id="271">Ca(2</compound-id>+), the <compound-id="2830">coelenterazine</compound-id> could escape and become available for bioluminescence on Renilla <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id>.	coelenterazine__luciferase__interaction	Ca(2__luciferase__no_interaction
18655138-1615	The <compound-id="4346576">APTS</compound-id> functionalization was then used to immobilize bone <protein-id="P07580">morphogenetic protein</protein-id> on the bioactive glasses.	APTS__morphogenetic protein__interaction
18655158-1630	L-<compound-id="846">Kynurenine</compound-id> (<compound-id="161166">KYN</compound-id>), a <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> metabolite, is metabolized to <compound-id="3845">kynurenic acid</compound-id> (<compound-id="3845">KYNA</compound-id>), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by <compound-id="846">kynurenine</compound-id> aminotransferase (<protein-id="Q8NFU3">KAT</protein-id>) I and <protein-id="Q8NFU3">KAT</protein-id> II.	KYNA__KAT__interaction	KYN__KAT__interaction	Kynurenine__KAT__interaction	kynurenic acid__KAT__interaction	tryptophan__KAT__no_interaction	kynurenine__KAT__interaction
18655176-1654	Exposure to <compound-id="2336">benzo(a)pyrene</compound-id> (BaP) by intraperitoneal injection increased biliary BaP metabolites and liver <protein-id="Q6JZS3,Q92039,Q9YH64">CYP1A</protein-id> gene expression.	benzo(a)pyrene__CYP1A__interaction
18655177-1378	We examined the effect of several different doses of <compound-id="4004">malathion</compound-id> (25, 75, 200 microM), or <compound-id="4004">malathion</compound-id> in combination with <compound-id="54670067">vitamin C</compound-id> (VC; 10 microM) or <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> (VE; 30 microM), on the levels of <compound-id="10964">malondialdehyde</compound-id> (MDA), and <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx) activities in human erythrocytes in vitro.	vitamin E__CAT__interaction	malondialdehyde__catalase__no_interaction	vitamin C__CAT__interaction	malathion__glutathione peroxidase__interaction	vitamin E__superoxide dismutase__interaction	vitamin E__catalase__interaction	vitamin C__SOD__interaction	vitamin E__SOD__interaction	malathion__superoxide dismutase__interaction	malondialdehyde__SOD__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction	vitamin C__catalase__interaction	malathion__CAT__interaction	malathion__SOD__interaction	malondialdehyde__CAT__no_interaction	malathion__catalase__interaction	malondialdehyde__superoxide dismutase__no_interaction	vitamin C__glutathione peroxidase__interaction	vitamin E__glutathione peroxidase__interaction	vitamin C__superoxide dismutase__interaction
18655177-1379	Erythrocytes were incubated under various treatment conditions (<compound-id="4004">malathion</compound-id> alone, vitamins alone, or <compound-id="4004">malathion</compound-id> plus vitamin) at 37 degrees C for 60 min, and the levels of MDA, and <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id> and GPx activities, were determined.	malathion__CAT__interaction	malathion__SOD__interaction
18655177-1380	Treatment with <compound-id="4004">malathion</compound-id> alone increased the levels of MDA and decreased <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id> 0.05).	malathion__CAT__interaction	malathion__SOD__interaction
18655190-1668	<protein-id="O62827,O77559,P35318,P43145,P53366,P97297">Adrenomedullin</protein-id> reduces antioxidant defense system and enhances kidney tissue damage in <compound-id="23973">cadmium</compound-id> and lead exposed rats.	cadmium__Adrenomedullin__interaction
18655190-1669	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (<compound-id="124886">GSH</compound-id>-Px) activities as well as the level of <compound-id="10964">malondialdehyde</compound-id> (MDA) in the kidney.	GSH__SOD__no_interaction	GSH__glutathione peroxidase__no_interaction	GSH__superoxide dismutase__no_interaction	malondialdehyde__SOD__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction	GSH__CAT__no_interaction	malondialdehyde__CAT__no_interaction	GSH__catalase__no_interaction	malondialdehyde__superoxide dismutase__no_interaction	malondialdehyde__catalase__no_interaction
18655797-440	We found that <protein-id="P01101,P12841,Q56415">Fos</protein-id> expression in LH orexin neurons varied in proportion to preference for <compound-id="5288826,5479215">morphine</compound-id>, <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id> or food.	cocaine__Fos__interaction	morphine__Fos__interaction
18655797-441	Recent studies showed that LH orexin neurons that project to ventral tegmental area (VTA) have greater <protein-id="P01101,P12841,Q56415">Fos</protein-id> induction in association with elevated <compound-id="5288826,5479215">morphine</compound-id> preference during protracted withdrawal than non-VTA-projecting orexin neurons, indicating that the VTA is an important site of action for orexin's role in reward processing.	morphine__Fos__interaction
18655808-447	<protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">Cytochromes c</protein-id> are metalloproteins that function in electron transfer reactions and contain a <compound-id="4971">heme</compound-id> moiety covalently attached via thioether linkages between the co-factor and a CXXCH motif in the protein.	heme__Cytochromes c__interaction
18655848-489	The antioxidant roles of <compound-id="6326970">selenium</compound-id> (Se) were evaluated in Brycon cephalus exposed to 2 mg L(-1) of Folisuper 600 BR (MP commercial formulation-MPc, 600 g L(-1)) for 96 h. <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">Catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx), <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>), <compound-id="124886">reduced glutathione</compound-id> (<compound-id="124886">GSH</compound-id>) and lipid peroxidation (LPO) levels in the gills, white muscle and liver were evaluated in fish fed on diets containing 0 or 1.5 mg Se kg(-1) for 8 weeks.	selenium__glutathione S-transferase__no_interaction	GSH__glutathione S-transferase__no_interaction	reduced glutathione__Catalase__no_interaction	GSH__SOD__no_interaction	GSH__glutathione peroxidase__no_interaction	selenium__Catalase__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction	reduced glutathione__GST__no_interaction	selenium__CAT__no_interaction	GSH__superoxide dismutase__no_interaction	selenium__GST__no_interaction	reduced glutathione__SOD__no_interaction	GSH__CAT__no_interaction	selenium__glutathione peroxidase__no_interaction	reduced glutathione__CAT__no_interaction	GSH__Catalase__no_interaction	GSH__GST__no_interaction	selenium__superoxide dismutase__no_interaction	selenium__SOD__no_interaction	reduced glutathione__glutathione S-transferase__no_interaction	reduced glutathione__superoxide dismutase__no_interaction
18655848-490	MPc also increased <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id> activity in all tissues with a concurrent decrease in <compound-id="124886">GSH</compound-id> levels.	GSH__GST__no_interaction
18656273-863	<compound-id="445154">Resveratrol</compound-id> reverses <protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id>-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit <protein-id="P29323">ERK</protein-id>-enzymes.	Resveratrol__ERK__interaction	Resveratrol__ET-1__interaction
18656273-864	Pretreatment with the MEK-ERK inhibitor (<compound-id="4713">PD98059</compound-id>) appreciably reversed the mitogenic effects of <protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id>.	PD98059__ET-1__interaction
18656273-865	On the other hand, pretreatment with the polyphenolic <compound-id="638088">stilbene</compound-id> <compound-id="445154">resveratrol</compound-id> (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 activation.	stilbene__ERK1__no_interaction	resveratrol__ERK1__interaction
18656273-866	Further, pretreatment with the specific cGMP-phosphodiesterase inhibitor, <compound-id="5722">zaprinast</compound-id> (10 microM) appreciably augmented RSVL-evoked cGMP formation, <protein-id="P29323">ERK</protein-id> inhibition, and cytostatic response.	zaprinast__ERK__interaction
18656273-867	Moreover, the RSVL-induced <protein-id="P29323">ERK</protein-id>-inhibitory effects were significantly reversed by the kinase-G inhibitor, <compound-id="108152">KT-5823</compound-id> (10 microM; 69%), but not by the kinase-A inhibitor (<compound-id="3844,454202,16219545">KT-5720</compound-id>).	KT-5720__ERK__no_interaction	KT-5823__ERK__interaction
18656335-913	Adding <compound-id="5280489">beta-carotene</compound-id> to the diet of the mice during the period of irradiation suppressed the activity and expression of <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id> as well as the wrinkling and sagging formation.	beta-carotene__MMP-9__interaction
18656335-914	Dietary <compound-id="5280489">beta-carotene</compound-id> prevents the expression of <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id>, at least partly, by inhibiting photodynamic action involved in the formation of Chol-OOHs.	beta-carotene__MMP-9__interaction
18656337-916	Exposure to <compound-id="5280450">linoleic acid</compound-id> for 6 h induced expression of both <protein-id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</protein-id> and cyclooxygenase (<protein-id="P11353,P36551,P36552,Q9UTE2,Q9V3D2">COX</protein-id>)-2.	linoleic acid__COX__interaction	linoleic acid__caveolin-1__interaction
18656337-917	Pretreatment with <compound-id="65064">EGCG</compound-id> blocked fatty-acid-induced <protein-id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</protein-id> and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> expression in a time- and concentration-dependent manner.	EGCG__caveolin-1__interaction	EGCG__COX-2__interaction
18656337-918	Exposure to <compound-id="5280450">linoleic acid</compound-id> rapidly increased phosphorylation of several kinases, including <protein-id="O62618">p38 MAPK</protein-id>, <protein-id="P21708,P27361,P28869,P42525,Q63844">extracellular signal regulated kinase 1</protein-id>/2 (<protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2) and amino kinase terminal (<protein-id="P31750,Q8INB9">Akt</protein-id>), with maximal induction at about 10 min.	linoleic acid__p38 MAPK__interaction	linoleic acid__Akt__interaction	linoleic acid__extracellular signal regulated kinase 1__interaction	linoleic acid__ERK1__interaction
18656337-919	Inhibitors of ERK1/2 and Akt down-regulated the <compound-id="5280450">linoleic-acid</compound-id>-induced increase in <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> protein, which also occurred after pretreatment with <compound-id="65064">EGCG</compound-id>.	linoleic-acid__COX-2__interaction	EGCG__COX-2__interaction
18656337-920	<protein-id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">Caveolin-1</protein-id> silencing blocked <compound-id="5280450">linoleic-acid</compound-id>-induced phosphorylation of <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 and protein expression of <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>, suggesting that specific <protein-id="O42781,P27638,Q00859">MAPK</protein-id> signaling is caveolae dependent.	linoleic-acid__ERK1__interaction	linoleic-acid__Caveolin-1__interaction	linoleic-acid__MAPK__no_interaction	linoleic-acid__COX-2__no_interaction
18656338-921	<compound-id="5280443">Apigenin</compound-id> causes G(2)/M arrest associated with the modulation of <protein-id="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">p21</protein-id> (<protein-id="O42923,P39689">Cip1</protein-id>) and <protein-id="P04551,P11440,P23572,P39951">Cdc2</protein-id> and activates <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id>-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.	Apigenin__Cdc2__interaction	Apigenin__p53__interaction	Apigenin__p21__interaction	Apigenin__Cip1__interaction
18656338-922	To investigate the regulatory proteins of cell cycle arrest affected by <compound-id="5280443">apigenin</compound-id>, we treated cells with 50 and 100 microM <compound-id="5280443">apigenin</compound-id> for 72 h. <compound-id="5280443">Apigenin</compound-id> caused a slight decrease in <protein-id="Q5SCB5">cyclin D</protein-id> and <protein-id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</protein-id> E expression, with no change in <protein-id="O55076,P24941,P43450,P48963,Q5E9Y0">CDK2</protein-id> and <protein-id="P11802,P79432">CDK4</protein-id>.	apigenin__cyclin D__interaction	Apigenin__cyclin__interaction	Apigenin__CDK2__no_interaction	apigenin__cyclin__interaction	apigenin__CDK4__no_interaction	Apigenin__cyclin D__interaction	apigenin__CDK2__no_interaction	Apigenin__CDK4__no_interaction
18656338-923	In addition, the <compound-id="5280443">apigenin</compound-id>-induced accumulation of the cell population in the G(2)/M phase resulted in a decrease in <protein-id="P00546,P06493,P11440,P13863,P39951,P43063,P48734,P51958,Q5RCH1,Q9DG98,Q9DGA2,Q9DGA5,Q9DGD3">CDK1</protein-id> together with <protein-id="P20248,P30274,P37881,P43449,P51943,Q92161">cyclin A</protein-id> and <protein-id="O01377,O16852,P04961,P12004,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P61074,Q00265,Q00268">cyclin</protein-id> B.	apigenin__cyclin__interaction	apigenin__cyclin A__interaction	apigenin__CDK1__interaction
18656338-924	In an additional study, <compound-id="5280443">apigenin</compound-id> also increased the accumulation of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> and further enhanced the level of <protein-id="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">p21</protein-id> (<protein-id="O42923,P39689">Cip1</protein-id>), with no change in <protein-id="O11451,O11452,O11453,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P06934,P16342,P19751,P25880,P25881,P25882,P25884,P25989,P26660,P26661,P26662,P26663,P26664,P27958,P29833,P29846,P29996,P29997,P40305,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184,P69618,P69619,Q00269,Q43735,Q5I2N3,Q66198,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q81835,Q81842,Q8V439,Q8V6W7,Q913D4,Q91A29,Q91DH7,Q91DH8,Q91DH9,Q99IB8,Q9DHD6,Q9E925,Q9PYA3,Q9QAX1,Q9WMX2">p27</protein-id> (Kip1).	apigenin__p21__interaction	apigenin__Cip1__interaction	apigenin__p27__no_interaction	apigenin__p53__interaction
18656338-925	The expression of <protein-id="P27297,Q07813,Q63690">Bax</protein-id> and <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> downstream target was increased markedly at high concentration treatment over 50 microM <compound-id="5280443">apigenin</compound-id>.	apigenin__cytochrome c__interaction	apigenin__p53__interaction	apigenin__Bax__interaction
18656400-711	Therefore, we next examined whether <protein-id="P50129">5-HT2A</protein-id> and <protein-id="P08909,P28335,P34968,Q5IS66,Q60F97">5-HT2C</protein-id> receptors are involved, and from where <compound-id="5202">5-HT</compound-id> is released in the <compound-id="712">formalin</compound-id> test.	formalin__5-HT2A__no_interaction	5-HT__5-HT2C__no_interaction	5-HT__5-HT2A__no_interaction	formalin__5-HT2C__no_interaction
18656400-713	These results indicate that <compound-id="5202">5-HT</compound-id> released into peripheral tissue and its receptors, <protein-id="P50129">5-HT2A</protein-id> as well as <protein-id="P08909,P28335,P34968,Q5IS66,Q60F97">5-HT2C</protein-id>, at the periphery have an important role in pain-related behaviors during acute peripheral inflammation.	5-HT__5-HT2A__interaction	5-HT__5-HT2C__interaction
18656896-1449	<compound-id="3559">Haloperidol</compound-id> strongly decreased the expression of <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> 0.01).	Haloperidol__BDNF__interaction
18656896-1450	In contrast, the administration of <compound-id="60854">ziprasidone</compound-id> significantly attenuated the immobilization stress-induced decrease in <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> 0.01).	ziprasidone__BDNF__interaction
18656896-1451	<compound-id="60854">Ziprasidone</compound-id> exhibited differential effects on <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> mRNA expression in the rat hippocampus and neocortex.	Ziprasidone__BDNF__interaction
18656896-1452	These results suggest that <compound-id="60854">ziprasidone</compound-id> might have a neuroprotective effect by recovering stress-induced decreases in <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> mRNA expression.	ziprasidone__BDNF__interaction
18657000-1427	In conclusion, <compound-id="5984">fructose</compound-id> overload in rats induced hypertriglyceridemia and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance associated with an enhanced oxidative stress.	fructose__insulin__interaction
18657005-297	Clinical and biochemical parameters including <compound-id="20484">fructosamine</compound-id> (FAM), glycated <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> (HbA1c) and serum <protein-id="O18921,P17560,P51606,P51607,P82343">AGEs</protein-id> were investigated in children and adolescents with 1 type diabetes with (+DC) and without (-DC) complications.	fructosamine__AGEs__no_interaction	fructosamine__hemoglobin__no_interaction
18657007-1437	<protein-id="O02750,O93416,Q28603,Q95189,Q95234">Leptin</protein-id> and soluble <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> receptor changes after pulmonary endarterectomy: relations to <compound-id="5754">cortisol</compound-id> and cytokine network.	cortisol__leptin__interaction	cortisol__Leptin__interaction
18657007-1438	<protein-id="O02750,O93416,Q28603,Q95189,Q95234">Leptin</protein-id> and soluble <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> receptor (SLR) were compared with evolution of <compound-id="5754">cortisol</compound-id> and inflammatory cytokines in twenty-two patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy using cardiopulmonary bypass (CBP) and deep hypothermic circulatory arrest (DHCA).	cortisol__leptin__interaction	cortisol__Leptin__interaction
18657009-1440	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of <protein-id="Q9YGM8">CAV-1</protein-id>, and evaluated the effects of tight metabolic control (<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, 12 IU/day) and angiotensin receptor blocker, <compound-id="3961">losartan</compound-id> (4 weeks, 20 mg/kg/day).	losartan__CAV-1__no_interaction	losartan__insulin__no_interaction
18657194-724	Androgenic action correlates inversely with a polymorphic CAG repeat region in the AR gene encoding for <compound-id="738,5961">glutamine</compound-id> residues the length of which appears to influence <protein-id="P81182">high density lipoprotein</protein-id> (HDL) <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels.	cholesterol__high density lipoprotein__interaction	glutamine__high density lipoprotein__interaction
18657228-1396	These vessels are formed by proliferating cells that incorporate <compound-id="6035">bromodeoxyuridine</compound-id> and express the endothelial cell markers vegfr2/<protein-id="O08775,P35918,Q8AXB3">kdr</protein-id> and <protein-id="P26323,P41157,Q9JJ28">fli1</protein-id>.	bromodeoxyuridine__kdr__no_interaction	bromodeoxyuridine__fli1__no_interaction
18657228-1398	Moreover, similar to rFGF2, injection of the zebrafish form of <protein-id="P26617">vascular endothelial growth factor-A</protein-id> (<protein-id="P15691,P15692,P16612,P26617,P49151,P50412,P67860,P67964,P67965,P83906,Q00731,Q99PS1,Q9GKR0,Q9MYV3">VEGF-A</protein-id>) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor <compound-id="5329098">SU5416</compound-id>.	SU5416__vascular endothelial growth factor-A__interaction	SU5416__VEGF-A__interaction
18657961-1695	In this study, we examined <compound-id="445858">ferulate</compound-id> for its ability to suppress redox-sensitive, proinflammatory NF-kappaB activation via NF-kappaB-inducing kinase (<protein-id="O95819,Q99558">NIK</protein-id>)/<protein-id="O15111,Q60680">IkappaB kinase</protein-id> (IKK) and <protein-id="Q00859">mitogen-activated protein kinases</protein-id> (<protein-id="O42781,P27638,Q00859">MAPKs</protein-id>) by reducing oxidative stress in aged rats.	ferulate__IkappaB kinase__interaction	ferulate__mitogen-activated protein kinases__interaction	ferulate__MAPKs__interaction	ferulate__NIK__interaction
18657961-1696	Data show that in aged kidney tissue, <compound-id="445858">ferulate</compound-id> exhibited its antioxidative action by maintaining redox regulation, suppressing NF-kappaB activation and modulating the expression of NF-kappaB-induced, proinflammatory <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>, <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>, <protein-id="P19320,P29533,P29534,Q28260">VCAM-1</protein-id> and <protein-id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</protein-id>.	ferulate__COX-2__interaction	ferulate__VCAM-1__interaction	ferulate__iNOS__interaction	ferulate__ICAM-1__interaction
18657961-1698	The molecular modulation of NF-kappaB by <compound-id="445858">ferulate</compound-id> was further revealed in endothelial YPEN-1 cells through <compound-id="445858">ferulate</compound-id>'s ability to suppress the activation of <protein-id="O95819,Q99558">NIK</protein-id>/IKK and <protein-id="O42781,P27638,Q00859">MAPKs</protein-id>.	ferulate__NIK__interaction	ferulate__MAPKs__interaction
18657961-1699	Based on these results, we conclude that <compound-id="445858">ferulate</compound-id>'s antioxidative capacity suppressed the age-related increase in NF-kappaB activity through inhibition of <protein-id="O95819,Q99558">NIK</protein-id>/IKK and <protein-id="O42781,P27638,Q00859">MAPKs</protein-id> in vivo.	ferulate__NIK__interaction	ferulate__MAPKs__interaction
18658095-656	Previous studies have shown that wounding of human corneal epithelial cells (HCECs) results in the release of G-protein-coupled receptor ligands such as <compound-id="5957">ATP</compound-id> and <compound-id="3988,5311263,5497152">lysophosphatidic acid</compound-id> (LPA), which in turn transactivate <protein-id="P01132,P01133,P07522,Q00968,Q95ND4,Q9BEA0">epidermal growth factor</protein-id> (<protein-id="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0">EGF</protein-id>) receptor (<protein-id="P00533,P13387,P55245">EGFR</protein-id>) through ectodomain shedding of heparin-binding <protein-id="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0">EGF</protein-id>-like growth factor (<protein-id="Q01580,Q06175,Q06186,Q09118,Q99075">HB-EGF</protein-id>).	ATP__EGFR__interaction	lysophosphatidic acid__HB-EGF__interaction	ATP__epidermal growth factor__interaction	lysophosphatidic acid__EGFR__interaction	lysophosphatidic acid__EGF__interaction	lysophosphatidic acid__epidermal growth factor__interaction	ATP__EGF__interaction	ATP__HB-EGF__interaction
18660796-396	<compound-id="145068">Nitric oxide</compound-id> is a free radical molecule synthesized from <compound-id="6322">L-arginine</compound-id> by <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthases</protein-id> that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	Nitric oxide__nitric oxide synthases__interaction	L-arginine__nitric oxide synthases__interaction
18661133-1463	Furthermore, restoration of <protein-id="Q8IVT5">KSR1</protein-id> expression in KSR (-/-) MEFs following stable transduction of cells with a <protein-id="Q8IVT5">KSR1</protein-id> expression vector, enhanced sensitivity of cells to tunicamycin and <compound-id="5351303,6434468,13892272,17751001">cytochalasin H</compound-id> and decreased <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 activation following exposure to these drugs.	cytochalasin H__ERK1__no_interaction	cytochalasin H__KSR1__interaction
18661183-1518	NH(4) <compound-id="312">Cl</compound-id> treatment causes an increase in intracellular [pH]i of sperm, suggesting that <protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">CaM</protein-id> and CaMK are involved in sperm motility initiation caused by an increase in [pH]i.	Cl__CaM__interaction
18661233-1568	We demonstrated the increase in the levels of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id>, <protein-id="P27297,Q07813,Q63690">Bax</protein-id>, and <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> and decrease in the level of <protein-id="P10417,P49950">Bcl-2</protein-id>, which are associated with the induction of apoptotic cell death after 24 h treatment with <compound-id="5281605">baicalein</compound-id> in N18 cells.	baicalein__cytochrome c__interaction	baicalein__Bcl-2__interaction	baicalein__Bax__interaction	baicalein__p53__interaction
18661547-124	GFP-fluorescent cells were slowly cycling, as shown by their long-term retention of <compound-id="6035">BrdU</compound-id>, and less than 10% expressed the proliferative markers Ki67 and <protein-id="P07759,P40377,P49735,P55861,P97310,Q6DIH3">Mcm2</protein-id>.	BrdU__Mcm2__no_interaction
18662278-741	<protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id> gene polymorphisms and high levels of <compound-id="778">homocysteine</compound-id> are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	homocysteine__MTHFR__no_interaction
18662930-1285	<compound-id="24759">Hyaluronan</compound-id> inhibits expression of <protein-id="O75173,Q5RFQ8,Q9TT93">ADAMTS4</protein-id> (<protein-id="O75173,Q5RFQ8,Q8BNJ2,Q9ESP7,Q9TT93">aggrecanase-1</protein-id>) in human osteoarthritic chondrocytes.	Hyaluronan__aggrecanase-1__interaction	Hyaluronan__ADAMTS4__interaction
18663366-1650	The discovery that a common polymorphism (5-HTTLPR, short variant) in the human serotonin transporter gene (<protein-id="O35899,P31645,Q9MYX0,Q9XT49">SLC6A4</protein-id>) can influence personality traits and increase the risk for depression in adulthood has led to the hypothesis that a relative increase in the extracellular levels of serotonin (<compound-id="5202">5-HT</compound-id>) during development could be critical for the establishment of brain circuits.	5-HT__SLC6A4__no_interaction
18663367-1653	Besides the biogenesis of lysosome-related organelles complex 1 and <protein-id="O97592,P11530,P11531,P11532,P11533,Q5GN48">dystrophin</protein-id>-associated protein complex, several molecules in the <protein-id="Q96EV8">DTNBP1</protein-id> network likely provide insight into the role of <protein-id="Q96EV8">DTNBP1</protein-id> in biological systems: <compound-id="444795">retinoic acid</compound-id>, <compound-id="5757">beta-estradiol</compound-id>, <protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">calmodulin</protein-id> and tumour necrosis factor.	beta-estradiol__dystrophin__no_interaction	retinoic acid__calmodulin__no_interaction	retinoic acid__dystrophin__no_interaction	retinoic acid__DTNBP1__interaction	beta-estradiol__calmodulin__no_interaction	beta-estradiol__DTNBP1__interaction
18663553-101	Prior to the first dose of <compound-id="3899">leflunomide</compound-id>, serum concentrations of studied chemokines correlated with marker of RA activity such as the erythrocyte sedimentation rate and <protein-id="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5">IL-8</protein-id> level with DAS.	leflunomide__IL-8__no_interaction
18663559-103	Hypothetically, <protein-id="P10635,Q2XNC8,Q2XNC9">cytochrome P450 2D6</protein-id> influences the transport of <compound-id="1123">taurine</compound-id> across the blood-brain barrier.	taurine__cytochrome P450 2D6__interaction
18663659-168	Most genes involved in lipid metabolism and especially in ergosterol biosynthesis were up-regulated in response to <compound-id="3793,55283,6917738,14179013">itraconazole</compound-id>, including <protein-id="O74198,P25087,Q5EN22,Q6BRB7,Q6C2D9,Q6CYB3,Q6FRZ7,Q759S7,Q875K1">ERG6</protein-id>, <protein-id="P38604,Q04782,Q96WJ0">ERG7</protein-id>, <protein-id="P10613,P10614,P14263,P49602,P50859,Q759W0">ERG11</protein-id>, <protein-id="P32462">ERG24</protein-id>, <protein-id="O59933,P53045,Q15800">ERG25</protein-id> and <protein-id="P53199">ERG26</protein-id>.	itraconazole__ERG7__interaction	itraconazole__ERG11__interaction	itraconazole__ERG6__interaction	itraconazole__ERG25__interaction	itraconazole__ERG26__interaction	itraconazole__ERG24__interaction
18665046-1318	In prolonged OJ with LPS administration, hepatocyte apoptosis depending on <protein-id="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8">Fas ligand</protein-id> expression significantly increased in association with a decrease in <compound-id="5957">ATP</compound-id> contents, thus resulting in liver necrapoptosis.	ATP__Fas ligand__no_interaction
18665051-1321	Administration of <compound-id="12041">ethyl pyruvate</compound-id> to inhibit HMGB1 or anti-RAGE antibody could significantly decrease expression levels of <protein-id="P09793,P16410,P42072,Q9MYX7,Q9XSI1">CTLA-4</protein-id>, <protein-id="Q99JB6">Foxp3</protein-id> on Tregs, and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> production after burns.	ethyl pyruvate__Foxp3__interaction	ethyl pyruvate__IL-10__interaction	ethyl pyruvate__CTLA-4__interaction
18665052-290	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(<compound-id="6022">adenosine diphosphate</compound-id> [ADP] ribose) formation, (3) <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (<protein-id="O02789,O57486,P04053,P06526,P09838,P36195,P42118,Q92089">terminal deoxynucleotidyltransferase</protein-id>-mediated dUTP-biotin end labeling, <protein-id="P27297,Q07813,Q63690">Bax</protein-id>, and <protein-id="P10417,P49950">Bcl-2</protein-id>) was markedly reduced in spinal cord tissue obtained from mice treated with <compound-id="3495,14982,128229,44260118,45358130,46878350">glycyrrhizin</compound-id> extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	adenosine diphosphate__iNOS__no_interaction	glycyrrhizin__Bax__interaction	adenosine diphosphate__Bcl-2__no_interaction	glycyrrhizin__iNOS__interaction	adenosine diphosphate__Bax__no_interaction	adenosine diphosphate__terminal deoxynucleotidyltransferase__no_interaction	glycyrrhizin__terminal deoxynucleotidyltransferase__interaction	glycyrrhizin__Bcl-2__interaction
18665326-1562	<compound-id="5213,31553,1548994,3086637,24832061,44147684">Silymarin</compound-id> attenuated mast cell recruitment thereby decreased the expressions of <protein-id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">matrix metalloproteinases-2</protein-id> and 9 in rat liver carcinogenesis.	Silymarin__matrix metalloproteinases-2__interaction
18665326-1563	<compound-id="5921">NDEA</compound-id> administered rats showed increased MCD as revealed by toluidine blue staining along with upregulated expressions of <protein-id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">MMP-2</protein-id> and <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id>.	NDEA__MMP-9__interaction	NDEA__MMP-2__interaction
18665326-1564	<compound-id="5213,31553,1548994,3086637,24832061,44147684">Silymarin</compound-id> treatment inhibited this increase in MCD and downregulated the expressions of <protein-id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">MMP-2</protein-id> and <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id> as revealed by Western blotting and immunohistochemistry.	Silymarin__MMP-2__interaction	Silymarin__MMP-9__interaction
18665326-1565	In conclusion, <compound-id="5213,31553,1548994,3086637,24832061,44147684">silymarin</compound-id> exerted beneficial effects on liver carcinogenesis by attenuating the recruitment of mast cells and thereby decreased the expressions of <protein-id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">MMP-2</protein-id> and <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id>.	silymarin__MMP-2__interaction	silymarin__MMP-9__interaction
18665390-1624	As a result, combined <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> infusion significantly decreased plasma K+ concentration despite a significant decrease of urinary K+ excretion in sgk1+/+ but not in sgk1-/-mice.	glucose__insulin__no_interaction
18665391-1625	While it is clearly demonstrated that members of the <protein-id="Q13507">TRPC3</protein-id>/6/7 subfamily are activated by <compound-id="6026790">diacylglycerol</compound-id>, the mechanism by which phospholipase C activates members of the <protein-id="O18784,P48995,Q9TUN9">TRPC1</protein-id>/4/5 subfamily remains a mystery.	diacylglycerol__TRPC3__interaction	diacylglycerol__TRPC1__no_interaction
18665391-1626	Depletion of polyphosphatidylinositol 4-<compound-id="1061,167704,644102">phosphate</compound-id> and <compound-id="5311358">phosphatidylinositol 4,5-bisphosphate</compound-id> (PIP2) through inhibition of <protein-id="P54677">phosphatidylinositol 4-kinase</protein-id> activates calcium entry and membrane currents in <protein-id="O62852,Q9MYV9,Q9UL62">TRPC5</protein-id>-expressing but not in <protein-id="Q13507">TRPC3</protein-id>-or <protein-id="O94759,Q9HCX4">TRPC7</protein-id>-expressing cells.	phosphatidylinositol 4,5-bisphosphate__phosphatidylinositol 4-kinase__interaction	phosphatidylinositol 4,5-bisphosphate__TRPC3__no_interaction	phosphatidylinositol 4,5-bisphosphate__TRPC7__no_interaction	phosphatidylinositol 4,5-bisphosphate__TRPC5__interaction	phosphate__TRPC3__no_interaction	phosphate__TRPC7__no_interaction	phosphate__phosphatidylinositol 4-kinase__interaction	phosphate__TRPC5__interaction
18665391-1627	Inclusion of polyphosphatidylinositol 4-<compound-id="1061,167704,644102">phosphate</compound-id> or PIP2, but not <compound-id="643963">phosphatidylinositol 3,4,5-trisphosphate</compound-id>, in the patch pipette inhibited <protein-id="O62852,Q9MYV9,Q9UL62">TRPC5</protein-id> currents.	phosphate__TRPC5__no_interaction	phosphatidylinositol 3,4,5-trisphosphate__TRPC5__no_interaction
18665432-1672	Osteogenic differentiation was enhanced after treatment with <compound-id="2088">alendronate</compound-id> as confirmed by Alizarin Red S staining, elevated <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> activity and <protein-id="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9">osteocalcin</protein-id> mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against <protein-id="P14745,P16070,P20944,Q05078,Q28284,Q29423,Q60522">CD44</protein-id> by flow cytometric analysis.	alendronate__osteocalcin__interaction	alendronate__alkaline phosphatase__interaction	alendronate__CD44__interaction
18667202-1391	<protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">Ghrelin</protein-id> inhibits contraction and proliferation of human aortic smooth muscle cells by <compound-id="6076">cAMP</compound-id>/PKA pathway activation.	cAMP__Ghrelin__interaction
18667202-1393	<protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">Ghrelin</protein-id> was able to inhibit angiotensin II-induced proliferation and contraction in a dose-response fashion via the <compound-id="6076">cAMP</compound-id>/PKA pathway.	cAMP__Ghrelin__interaction
18667302-1496	The results indicated that the backbone of <protein-id="Q9XF19">POP</protein-id> was composed of (1--&gt;6)-linked-alpha-<compound-id="439271">D-galactopyranosyl</compound-id> and (1--&gt;2,6)-linked-alpha-<compound-id="439271">D-galactopyranosyl</compound-id> residues, which were terminated with a single terminal (1--&gt;)-<compound-id="206,64689">beta-D-glucose</compound-id> residue at the O-2 position of galactosyl along the main chain in the ratio of 1:1:1.	beta-D-glucose__POP__interaction	D-galactopyranosyl__POP__interaction
18667302-1497	Preliminary tests in vitro showed <protein-id="Q9XF19">POP</protein-id> is capable of enhancing <protein-id="P81460,P81461">concanavalin A</protein-id> (<protein-id="P02866,P14894,P81460,P81461">ConA</protein-id>)-or <compound-id="11970143">lipopolysaccharide</compound-id> (LPS)-induced lymphocyte proliferation, which suggested that <protein-id="Q9XF19">POP</protein-id> could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	lipopolysaccharide__ConA__no_interaction	lipopolysaccharide__POP__interaction	lipopolysaccharide__concanavalin A__no_interaction
18668138-492	Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by <compound-id="312145">wortmannin</compound-id> and specific abrogation of <protein-id="P31750,P47196,Q8INB9,Q98TY9">Akt1</protein-id> protein using small-interfering RNA revealed a regulatory function of <protein-id="P31750,P47196,Q8INB9,Q98TY9">Akt1</protein-id> in <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-mediated <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> biosynthesis in keratinocytes.	wortmannin__insulin__no_interaction	wortmannin__VEGF__no_interaction	wortmannin__Akt1__no_interaction
18668211-556	Cross-linked hydrogels showed increased resistance to digestion by testicular <protein-id="P15316,P26831,P49370,P49371,Q08169,Q53591,Q54699,Q54873,Q59634,Q59801,Q9U6V9">hyaluronidase</protein-id> and <protein-id="P15316,P26831,P49370,P49371,Q08169,Q53591,Q54699,Q54873,Q59634,Q59801,Q9U6V9">hyaluronidase</protein-id> SD with increasing <compound-id="24759">hyaluronan</compound-id> concentration.	hyaluronan__hyaluronidase__no_interaction
18668222-95	<compound-id="2730">Chlorpyrifos</compound-id> (CPF), a commonly used organophosphorus insecticide, induces <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> inhibition and cholinergic toxicity.	Chlorpyrifos__acetylcholinesterase__interaction
18668243-580	Role of <protein-id="Q05823,Q05921">RNase L</protein-id> in apoptosis induced by <compound-id="56841052">1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine</compound-id>.	1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine__RNase L__interaction
18668351-55	It was observed that administration of the PKC inhibitor <compound-id="2703">chelerythrine chloride</compound-id> (5 mg/kg) suppressed the activation of three exercise-induced PKC isoforms (<protein-id="P04409,P05696,P10102,P17252,P20444">PKCalpha</protein-id>, <protein-id="P10829">PKCdelta</protein-id>, and PKCepsilon) and attenuated the exercise-mediated reduction of myocardial infarct size during ischemia-reperfusion injury.	chelerythrine chloride__PKCdelta__interaction	chelerythrine chloride__PKCalpha__interaction
18668366-689	<compound-id="1548943">Capsaicin</compound-id> is known to have regulatory effects on gastrointestinal functions via the vanilloid receptor (<protein-id="Q8NER1">VR1</protein-id>).	Capsaicin__VR1__interaction
18670196-1382	<protein-id="P25914">Cholesteryl ester transfer protein</protein-id> (<protein-id="P11597,P22687,P25914,P47896">CETP</protein-id>) is a plasma <protein-id="P08163">glycoprotein</protein-id> that facilitates the transfer of neutral lipids and phospholipids between lipoproteins and contributes to the regulation of the plasma concentration of <protein-id="P81182">high density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (HDL-C).	cholesterol__CETP__interaction	cholesterol__high density lipoprotein__interaction	cholesterol__glycoprotein__no_interaction	cholesterol__Cholesteryl ester transfer protein__interaction
18670732-960	These studies frequently showed that erythropoietic stimulating agents (ESA) with oral or IV iron often resulted in improvement in left ventricular systolic and diastolic function, dilation, and hypertrophy, stabilization or improvement in renal function, reduced hospitalizations, diuretic dose, mitral regurgitation, pulmonary artery pressure, plasma volume, heart rate, serum <protein-id="P40753">brain natriuretic peptide</protein-id> levels, and the inflammatory markers C reactive protein and <protein-id="P41693">Interleukin 6</protein-id>, and an improvement in New York Heart Association class, exercise capacity, <compound-id="977">oxygen</compound-id> utilization during exercise, sleep apnea, caloric intake, depression, and quality of life.	oxygen__Interleukin 6__no_interaction	oxygen__brain natriuretic peptide__no_interaction
18670809-1037	DNA sequences of a <protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">calmodulin</protein-id> (<protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">CaM</protein-id>)-encoding gene region containing three exons, two introns and a 411-bp mt intergenic spacer (IGS) spanning the <protein-id="O03176,O03207,O03363,O03473,O03474,O03478,O03503,O03520,O03522,O03523,O03538,O03543,O03545,O03548,O03553,O03713,O03810,O03811,O03812,O20433,O20434,O20435,O20539,O20540,O20544,O20546,O20547,O20549,O20603,O20604,O20611,O20612,O20613,O20644,O20645,O20672,O20964,O20965,O20968,O20998,O21159,O21163,O21166,O21167,O21175,O21205,O21217,O21220,O21223,O21224,O21298,O21337,O21366,O21411,O21414,O21416,O21424,O21425,O21764,O21789,O21795,O21804,O21807,O21816,O31215,O47414,O47415,O47419,O47420,O47421,O47431,O47477,O47488,O47499,O47554,O47555,O47556,O47557,O47558,O47560,O47561,O47583,O47584,O47714,O47716,O47718,O47721,O47723,O47885,O47890,O47892,O47893,O47922,O47923,O47924,O47926,O47930,O47976,O47993,O48001,O48009,O48010,O48012,O48014,O48017,O48023,O48025,O48027,O48039,O48041,O48043,O48047,O48049,O48052,O48053,O48055,O48057,O48060,O48062,O48063,O48065,O48066,O48067,O48073,O48076,O48079,O48080,O48085,O48087,O48089,O48090,O48092,O48093,O48094,O48096,O48098,O48100,O48101,O48102,O48106,O48109,O48111,O48114,O48277,O48285,O48309,O48321,O48334,O48336,O48350,O48372,O54070,O63534,O63535,O63536,O63537,O63696,O63699,O63848,O78690,O78742,O78761,O78773,O78774,O78775,O78776,O78777,O78778,O78779,O78780,O78781,O78782,O78783,O78784,O78785,O78786,O78787,O78788,O78789,O78790,O78858,O78927,O78928,O78929,O78930,O78931,O78932,O78933,O78934,O78935,O78936,O78937,O79122,O79195,O79196,O79197,O79198,O79199,O79200,O79201,O79202,O79203,O79204,O79205,O79206,O79207,O79208,O79209,O79210,O79211,O79212,O79213,O79215,O79216,O79217,O79218,O79219,O79220,O79221,O79222,O79223,O79224,O79225,O79226,O79227,O79228,O79229,O79230,O79274,O79311,O79327,O79360,O79386,O79413,O79426,O79440,O79445,O79446,O79447,O79448,O79450,O79451,O79452,O79453,O79454,O79455,O79460,O79461,O79462,O79463,O79464,O79465,O79468,O79512,O79520,O79524,O79558,O79648,O79652,O79657,O79659,O79660,O79680,O79785,O79925,O79927,O79936,O79967,O79969,O79980,O79993,O79996,O79997,O80005,O80019,O99240,O99253,O99256,O99257,O99258,O99338,O99342,O99343,O99345,O99468,O99655,O99795,O99797,O99798,O99799,O99800,O99828,P00156,P00157,P00158,P00159,P00160,P00161,P00162,P00163,P00164,P04165,P05418,P05501,P05718,P07704,P07747,P08502,P09843,P11669,P12778,P14548,P14833,P15547,P15585,P16357,P16358,P16359,P16360,P16362,P16363,P16364,P16366,P16367,P16674,P18935,P18946,P21713,P21714,P21715,P21716,P21717,P21718,P21719,P21720,P21721,P21722,P21723,P23134,P23662,P23663,P24878,P24890,P24950,P24951,P24952,P24953,P24954,P24955,P24956,P24957,P24958,P24959,P24960,P24962,P24964,P24965,P24966,P24992,P26852,P29630,P29631,P29632,P29633,P29634,P29635,P29636,P29637,P29638,P29639,P29640,P29641,P29642,P29663,P29664,P29665,P29666,P29667,P29668,P29669,P29670,P29671,P29672,P29757,P33501,P34197,P34844,P34845,P34860,P34861,P34862,P34863,P34864,P34865,P34866,P34867,P34868,P34869,P34870,P34871,P34872,P34873,P34874,P34875,P34876,P35075,P38593,P38594,P39480,P41280,P41281,P41282,P41283,P41284,P41285,P41286,P41287,P41288,P41289,P41290,P41303,P42792,P48173,P48517,P48518,P48519,P48520,P48521,P48665,P48875,P48876,P48877,P48884,P48885,P48886,P49341,P49390,P50663,P51131,P51941,P56629,P56630,P56631,P56697,P56731,P62513,P68090,P68091,P68092,P68093,P68094,P68095,P68533,P68534,P69219,P69220,P69221,P81376,P81378,P81381,P82045,P82046,P82047,P82048,P82049,P87410,P87416,P87419,P87421,P92472,P92487,P92493,P92509,P92583,P92584,P92592,P92599,P92600,P92605,P92651,P92657,P92658,P92671,P92701,P92717,P92723,P92845,P92846,P92847,P92848,P92849,P92850,P92852,P92853,P92857,P92870,Q00228,Q00530,Q02655,Q02761,Q02768,Q04910,Q04911,Q104Y0,Q104Y1,Q104Y3,Q1EG05,Q1H8Y8,Q1HUU1,Q1HUV6,Q1KTB0,Q1MWH4,Q1MWK0,Q1PG50,Q1PG51,Q1PG54,Q1PG55,Q1PG56,Q1PG57,Q1PG58,Q1X6J6,Q1X6K1,Q1XA12,Q1XA32,Q1XII1,Q1XII7,Q1XII9,Q1XIJ0,Q1XIJ4,Q1XIK7,Q1XIK9,Q1XIL4,Q1XIM0,Q1XIM1,Q1XIM5,Q1XIM8,Q1XIN0,Q1XIN1,Q1XIN6,Q1XIP1,Q1XIP3,Q1XIP4,Q1XIP7,Q1XIP8,Q1XIQ2,Q1XIQ3,Q1XIQ4,Q1ZYR2,Q20FQ1,Q20FQ2,Q20FQ7,Q20FR3,Q20FR8,Q20FS0,Q20K40,Q20K43,Q25CF7,Q288H1,Q288H2,Q288H4,Q288H5,Q2N2B5,Q2N2B8,Q2N2J6,Q2N2J7,Q2Q1V7,Q2TVN0,Q2TVN1,Q2Y060,Q2Y067,Q31652,Q31684,Q33377,Q33401,Q33452,Q33487,Q33500,Q33537,Q33568,Q33607,Q33629,Q33645,Q33688,Q33695,Q33697,Q33706,Q33723,Q33754,Q33772,Q33782,Q33784,Q33798,Q33800,Q33818,Q33842,Q33865,Q33887,Q33941,Q33950,Q33954,Q33976,Q33987,Q33989,Q34028,Q34045,Q34070,Q34101,Q34106,Q34107,Q34108,Q34161,Q34169,Q34172,Q34179,Q34235,Q34253,Q34254,Q34260,Q34261,Q34279,Q34289,Q34300,Q34301,Q34302,Q34306,Q34321,Q34340,Q34341,Q34376,Q34382,Q34399,Q34409,Q34459,Q34462,Q34471,Q34473,Q34501,Q34534,Q34607,Q34653,Q34677,Q34683,Q34717,Q34724,Q34732,Q34760,Q34814,Q34876,Q34889,Q34890,Q34891,Q34893,Q34900,Q34902,Q34916,Q34945,Q34952,Q34957,Q34972,Q34973,Q35000,Q35019,Q35020,Q35038,Q35054,Q35065,Q35066,Q35075,Q35076,Q35078,Q35083,Q35111,Q35113,Q35117,Q35118,Q35130,Q35131,Q35157,Q35160,Q35172,Q35196,Q35273,Q35350,Q35377,Q35380,Q35409,Q35425,Q35438,Q35457,Q35459,Q35467,Q35468,Q35485,Q35505,Q35506,Q35516,Q35518,Q35522,Q35532,Q35533,Q35534,Q35553,Q35558,Q35614,Q35618,Q35621,Q35630,Q35653,Q35673,Q35675,Q35677,Q35695,Q35727,Q35805,Q35810,Q35819,Q35861,Q35873,Q35877,Q35886,Q35895,Q35925,Q35930,Q35942,Q35966,Q35968,Q35994,Q36012,Q36035,Q36055,Q36058,Q36082,Q36089,Q36096,Q36099,Q36118,Q36128,Q36192,Q36194,Q36201,Q36209,Q36222,Q36227,Q36229,Q36262,Q36266,Q36291,Q36294,Q36311,Q36319,Q36324,Q36368,Q36427,Q36445,Q36461,Q36507,Q36548,Q36549,Q36551,Q36572,Q36590,Q36644,Q36654,Q36659,Q36922,Q36976,Q37006,Q37064,Q37078,Q37080,Q37311,Q37378,Q37395,Q37713,Q3L2T5,Q3L6X7,Q3L701,Q3LTW2,Q3LZS3,Q3T4C8,Q3T4F1,Q3YLA8,Q3YLC2,Q3ZEC1,Q3ZEC3,Q3ZEC9,Q3ZED1,Q3ZEG3,Q4FBI3,Q4JQH5,Q4QXK3,Q4UJ67,Q4VGP8,Q4VKI6,Q4VKI7,Q4VUT8,Q4VUU0,Q4VUU2,Q4VUU4,Q4VUV4,Q4VUV8,Q4VUV9,Q4VUY0,Q4VUY6,Q4VUY8,Q4VUY9,Q4VWH4,Q4VWH9,Q508J0,Q508J1,Q508J2,Q508J3,Q508J4,Q508J5,Q508J7,Q508J9,Q508K1,Q508K2,Q508K4,Q508K5,Q508K6,Q508K7,Q508K8,Q508K9,Q508L0,Q508L1,Q508L2,Q508L3,Q508L4,Q508L6,Q508L8,Q508M1,Q508M2,Q508M3,Q508M4,Q508M6,Q508M8,Q508M9,Q508N0,Q508N1,Q508N2,Q508N3,Q508N6,Q508P2,Q50DL8,Q539B4,Q539Z1,Q53AJ7,Q53AK6,Q53AK8,Q53AL7,Q53AM3,Q564N6,Q564N8,Q564P1,Q564P2,Q58F56,Q58F69,Q58F82,Q597C5,Q597C7,Q597E2,Q597E3,Q597E4,Q597E6,Q597E7,Q597E8,Q597E9,Q597F0,Q597F1,Q597F2,Q598T9,Q598V2,Q599A4,Q5BQG8,Q5BQG9,Q5BU73,Q5C9H5,Q5DWG5,Q5DX17,Q5F4E4,Q5F4E8,Q5F4F1,Q5F4F4,Q5F4F5,Q5F4G0,Q5F4G2,Q5F4G3,Q5F4G7,Q5F4G9,Q5I191,Q5J1T0,Q5J1T3,Q5J1T4,Q5J1T5,Q5NUR5,Q5NUR7,Q5QD74,Q5QD76,Q5QFW4,Q5QFW5,Q5QFW6,Q5QS02,Q5QS15,Q5QS28,Q5QS41,Q5QS67,Q5S1V3,Q5UVI3,Q5UVI4,Q5UVI5,Q5UVI6,Q5UVI8,Q5UVJ0,Q5VJ36,Q5VJ37,Q5VJ39,Q5VJ41,Q5VJ42,Q5VJ44,Q5VJ45,Q5VJ46,Q5VJ49,Q5VJ50,Q5VJ52,Q5VJ55,Q5VJ57,Q5VJ58,Q5VJ59,Q5VJ60,Q5VJ61,Q5VJ65,Q5VJ67,Q5Y4Q0,Q5YBK0,Q5YJ58,Q5YJ78,Q5YJ93,Q5YKK4,Q5ZN98,Q64GI8,Q64GJ1,Q64J97,Q64JA0,Q678S1,Q678S2,Q678S3,Q678S5,Q678S8,Q678S9,Q692W3,Q698P7,Q6DUL2,Q6ED58,Q6ELU6,Q6ELU7,Q6ELU8,Q6ELU9,Q6ELV2,Q6ELV4,Q6ELV5,Q6ELV7,Q6ELV8,Q6ELV9,Q6ELW1,Q6ELW2,Q6ELW3,Q6ELW6,Q6IYG6,Q6JDN5,Q6JDP8,Q6JDQ6,Q6JDS2,Q6JDS4,Q6JDS5,Q6JDS6,Q6JDS8,Q6JDT0,Q6JDT3,Q6JDT4,Q6JDT8,Q6JDU0,Q6JDU8,Q6JWX5,Q6KF39,Q6KF53,Q6RSH5,Q6RSH6,Q6SQI7,Q6U1P6,Q6V8Y0,Q6V8Y1,Q6V9D6,Q6W6K7,Q6W6L7,Q6WRG2,Q6WRG3,Q6WRG4,Q6WRG7,Q6WRH2,Q6WRH4,Q6WRH5,Q6X2M0,Q6X9S4,Q6XBV1,Q6XBV6,Q6XBW1,Q6XBW4,Q6XBW5,Q6XBW7,Q6XBW8,Q6XZH2,Q6XZH3,Q6XZN8,Q6XZN9,Q6XZP4,Q6Y8J2,Q6Y8J6,Q6Y8J7,Q6YDK5,Q6YDK7,Q6YDL2,Q6YDL6,Q6YDL7,Q6YLN1,Q70RT7,Q70RV0,Q70RW3,Q70XG0,Q70XI6,Q710S3,Q711L6,Q71E87,Q71E89,Q71E95,Q71E97,Q71E99,Q71EA6,Q71EB0,Q71FH1,Q71FH2,Q71FI6,Q71FI8,Q71FI9,Q71FJ0,Q71FJ2,Q71MR3,Q71MR6,Q71RU1,Q75R30,Q76LN6,Q76MX5,Q7GEV4,Q7GGQ9,Q7GI23,Q7HEI2,Q7HFF9,Q7HFG0,Q7HKW1,Q7IY93,Q7IY99,Q7IYN8,Q7IYZ1,Q7J370,Q7J6I1,Q7JE02,Q7Y5X9,Q7Y778,Q7Y779,Q7Y7B2,Q7Y8F6,Q7Y8I2,Q7Y8J5,Q7Y8K8,Q7Y8L0,Q7Y8L4,Q7Y8L5,Q7Y8L6,Q7Y8L9,Q7Y8M0,Q7YA49,Q7YBY4,Q7YBY6,Q7YC63,Q7YC71,Q7YC73,Q7YC74,Q7YC75,Q7YC76,Q7YD12,Q7YD13,Q7YD16,Q7YD72,Q7YD73,Q7YD75,Q7YEV2,Q7YGD4,Q85AG5,Q85AV3,Q85C06,Q85C43,Q85DD9,Q85DE4,Q85DF2,Q85DF5,Q85DF8,Q85IN3,Q85IN4,Q85IN5,Q85IN6,Q85IN7,Q85IN8,Q85IN9,Q85PK7,Q85PM6,Q85PN0,Q85PN4,Q85PN6,Q85PN7,Q85PN8,Q85PP0,Q85PP1,Q85Q58,Q85QA4,Q85RV3,Q8HCJ4,Q8HD57,Q8HD60,Q8HEC2,Q8HEM1,Q8HF67,Q8HG55,Q8HL81,Q8HL93,Q8HLB9,Q8HLD2,Q8HLR2,Q8HMZ7,Q8HQ92,Q8HQE6,Q8HQE7,Q8HQE8,Q8HQE9,Q8HQF0,Q8HQF1,Q8HQF2,Q8LW83,Q8LWM2,Q8LWM4,Q8LWN0,Q8LWP6,Q8LWU4,Q8LX87,Q8LZ88,Q8LZ94,Q8LZ97,Q8M0A6,Q8M0E7,Q8M0K7,Q8M0K9,Q8M354,Q8M3J6,Q8M4C6,Q8M4C7,Q8M4D6,Q8M4E2,Q8M4E6,Q8M5M3,Q8M6Z3,Q8M700,Q8M703,Q8M706,Q8M708,Q8SE00,Q8SE72,Q8SE77,Q8SE89,Q8SEH7,Q8SEJ1,Q8SEL4,Q8SEP4,Q8SET9,Q8SFK5,Q8SFK7,Q8SG72,Q8SGA0,Q8SGQ9,Q8SJB6,Q8SJK5,Q8SJK6,Q8SJK7,Q8SJK8,Q8SJK9,Q8SJL1,Q8SJL2,Q8SJL3,Q8SJX4,Q8SJX5,Q8SJZ1,Q8SJZ2,Q8SJZ3,Q8SJZ4,Q8W7G4,Q8W822,Q8W8Q1,Q8W8W1,Q8W8Y1,Q8W926,Q8W9E4,Q8W9F5,Q8W9F9,Q8W9J6,Q8W9L2,Q8W9N7,Q8WA39,Q8WA47,Q8WB03,Q8WB05,Q8WBP9,Q8WBV2,Q8WCJ7,Q8WCK9,Q8WCL1,Q8WDK6,Q8WDU1,Q8WDV0,Q8WDV2,Q8WDV6,Q8WE97,Q8WEK2,Q8WEK7,Q8WEW8,Q8WFX3,Q8WGF6,Q8WGF7,Q8WGF8,Q8WGG5,Q8WGG8,Q8WGL0,Q94ND7,Q94NF7,Q94NM3,Q94P21,Q94PA3,Q94PB4,Q94Q38,Q94Q45,Q94Q84,Q94QD3,Q94QP2,Q94QQ7,Q94S37,Q94S78,Q94SA4,Q94SD0,Q94SJ5,Q94SK8,Q94SZ7,Q94T21,Q94T42,Q94T68,Q94TE4,Q94TI3,Q94UZ9,Q94V00,Q94V01,Q94V02,Q94VK4,Q94WP7,Q94WQ8,Q94WW5,Q94WW7,Q94WW9,Q94WX2,Q94WX4,Q94WX5,Q94WY6,Q94WY7,Q94Y46,Q94Y47,Q94Y50,Q94Y51,Q94Y56,Q94Y62,Q94Y64,Q94Y66,Q94Y71,Q94Y72,Q94YE5,Q94YL4,Q94YL5,Q94YL9,Q94ZD1,Q94ZJ2,Q94ZK8,Q950B9,Q950C2,Q950C6,Q950C7,Q950S3,Q951T4,Q951T6,Q953G9,Q953J5,Q953K8,Q955G5,Q955G6,Q956S6,Q956Y7,Q956Y9,Q956Z1,Q956Z2,Q956Z3,Q956Z5,Q956Z6,Q956Z7,Q956Z8,Q956Z9,Q95711,Q95718,Q95719,Q95723,Q95726,Q95727,Q95728,Q95729,Q95730,Q95731,Q95734,Q95735,Q95736,Q95737,Q95738,Q95739,Q95741,Q95744,Q95745,Q95750,Q95776,Q957A1,Q957A2,Q957A4,Q957A7,Q957A8,Q957A9,Q957B0,Q957B1,Q957B2,Q957B3,Q957B4,Q957B5,Q957B6,Q957B7,Q957B8,Q957B9,Q957C1,Q957C3,Q957C6,Q957C7,Q957C8,Q957D1,Q95920,Q959V6,Q96071,Q9B0S2,Q9B0Y1,Q9B106,Q9B161,Q9B167,Q9B1D2,Q9B1N0,Q9B1X4,Q9B1Z4,Q9B203,Q9B205,Q9B2C4,Q9B2F7,Q9B365,Q9B506,Q9B5Q1,Q9B5Q3,Q9B5Q4,Q9B5Q5,Q9B5Q6,Q9B5Q7,Q9B5Q8,Q9B5Q9,Q9B5R0,Q9B5R1,Q9B5R2,Q9B5R3,Q9B5R7,Q9B5R8,Q9B5S0,Q9B5S1,Q9B6D0,Q9B6F0,Q9B7V7,Q9B7W1,Q9B7W3,Q9B9E4,Q9B9E8,Q9B9F5,Q9B9F6,Q9B9F9,Q9B9G0,Q9B9Z1,Q9BA02,Q9G0M4,Q9G0S9,Q9G0W6,Q9G156,Q9G1B9,Q9G1C4,Q9G1F7,Q9G1R4,Q9G1Z0,Q9G210,Q9G215,Q9G250,Q9G273,Q9G2R8,Q9G2S5,Q9G2U4,Q9G2U7,Q9G2W6,Q9G396,Q9G3M2,Q9G3M7,Q9G3M9,Q9G3N1,Q9G3N2,Q9G3N4,Q9G3R1,Q9G3S4,Q9G3T7,Q9G4Q1,Q9G6G2,Q9G6G3,Q9G6M3,Q9G7T9,Q9G7U1,Q9G946,Q9G964,Q9G9J4,Q9G9J6,Q9G9J7,Q9GA18,Q9GAM6,Q9GAM7,Q9GAM9,Q9GAN2,Q9GAN4,Q9GAP0,Q9GAR5,Q9GAR6,Q9GAW0,Q9GAW3,Q9GAW6,Q9GBG9,Q9GBY1,Q9GBY4,Q9GBY5,Q9GBY6,Q9GBY8,Q9GBZ0,Q9GBZ1,Q9GBZ2,Q9GBZ4,Q9GBZ5,Q9GBZ6,Q9GBZ7,Q9MDF2,Q9MDZ9,Q9MED6,Q9MFN3,Q9MFN9,Q9MG84,Q9MGL5,Q9MGM4,Q9MI31,Q9MI32,Q9MI35,Q9MI36,Q9MI37,Q9MI38,Q9MI39,Q9MI64,Q9MI97,Q9MIX8,Q9MIZ2,Q9MJ99,Q9MJA1,Q9MJA2,Q9MJV1,Q9MLD6,Q9MLD7,Q9MLI3,Q9MLI6,Q9MLI7,Q9MLI8,Q9MLI9,Q9MLJ0,Q9MLJ1,Q9MLJ2,Q9MLJ3,Q9MLJ4,Q9MLJ5,Q9MLJ6,Q9MLJ7,Q9MLJ8,Q9MLJ9,Q9MLK0,Q9MLK1,Q9MLK2,Q9MLK3,Q9MLK4,Q9MLK5,Q9MLK6,Q9MLK7,Q9MLK8,Q9MLK9,Q9MLL0,Q9MLL3,Q9MLL4,Q9MLL5,Q9MLL6,Q9MMZ2,Q9MQX1,Q9MQX8,Q9MQY0,Q9MQY1,Q9MQY3,Q9MQY5,Q9MQY6,Q9MR49,Q9T3H9,Q9T3Q2,Q9T3R3,Q9T3S9,Q9T3Y0,Q9T3Y2,Q9T3Y3,Q9T443,Q9T469,Q9T475,Q9T4A7,Q9T4B2,Q9T4N0,Q9T4P2,Q9T4R0,Q9T4U3,Q9T5N4,Q9T6I4,Q9T6J0,Q9T6R2,Q9T6R3,Q9T6R5,Q9T6R8,Q9T6R9,Q9T7L5,Q9T7L6,Q9T7L7,Q9T7L8,Q9T7L9,Q9T7M0,Q9T7M3,Q9T7N2,Q9T7N5,Q9T7P0,Q9T7P1,Q9T7Q0,Q9T7Q5,Q9T7Q6,Q9T7Q8,Q9T7Q9,Q9T7S2,Q9T7T7,Q9T7T8,Q9T7T9,Q9T9A5,Q9T9A6,Q9T9A7,Q9T9A8,Q9T9B2,Q9T9B6,Q9T9B7,Q9T9B9,Q9T9C0,Q9T9C1,Q9T9C8,Q9T9I2,Q9T9I7,Q9T9J2,Q9T9J5,Q9T9V5,Q9T9W4,Q9T9Y3,Q9TA00,Q9TAB1,Q9TAD3,Q9TDJ6,Q9TDJ9,Q9TDK1,Q9TDK2,Q9TDK4,Q9TDK6,Q9TDK7,Q9TDK9,Q9TDL0,Q9TDL1,Q9TDL2,Q9TDL3,Q9TDL4,Q9TDL5,Q9TDL6,Q9TDL7,Q9TDL8,Q9TDL9,Q9TDM0,Q9TDM1,Q9TDM3,Q9TDM5,Q9TDM6,Q9TDM7,Q9TDN0,Q9TDN1,Q9TDN2,Q9TDQ5,Q9TDQ7,Q9TDT5,Q9TEB4,Q9TEB5,Q9TEC1,Q9TEU7,Q9TEX8,Q9TEY4,Q9TEY5,Q9TEY6,Q9TEY7,Q9TEY8,Q9TEZ5,Q9TF10,Q9TF12,Q9TF14,Q9TF17,Q9TF20,Q9TF27,Q9TF30,Q9TF31,Q9TF32,Q9TF34,Q9TF37,Q9TF45,Q9TF46,Q9TF47,Q9TF49,Q9TF50,Q9TF51,Q9TF52,Q9TF55,Q9TF57,Q9TF61,Q9TF73,Q9TF74,Q9TF80,Q9TF86,Q9TF89,Q9TF91,Q9TF93,Q9TF95,Q9TFA0,Q9TFX4,Q9TFX5,Q9TFX6,Q9TG16,Q9TGH6,Q9TGH8,Q9TGL9,Q9TH43,Q9TH45,Q9TH46,Q9TH47,Q9TH52,Q9TH56,Q9THD6,Q9XK52,Q9XK70,Q9XKC0,Q9XKK0,Q9XKK2,Q9XKK5,Q9XLE0,Q9XLE1,Q9XLE2,Q9XM10,Q9XMC1,Q9XMC2,Q9XNM0,Q9XNM1,Q9XNM5,Q9XNN0,Q9XNN1,Q9XNN3,Q9XNN4,Q9XNT9,Q9XNU0,Q9XNU2,Q9XNU4,Q9XNU5,Q9XNU6,Q9XNU9,Q9XNV3,Q9XNV4,Q9XNV7,Q9XNW3,Q9XNW4,Q9XNW5,Q9XNW7,Q9XNW8,Q9XNW9,Q9XNX0,Q9XNX1,Q9XNX3,Q9XNX4,Q9XNX6,Q9XNX7,Q9XNX8,Q9XP34,Q9XP68,Q9XP73,Q9XP76,Q9XP77,Q9XP78,Q9XP81,Q9XP82,Q9XP83,Q9XP84,Q9XP86,Q9XP87,Q9XP88,Q9XP89,Q9ZY14,Q9ZY15,Q9ZY46,Q9ZY49,Q9ZZ40,Q9ZZ42,Q9ZZD2,Q9ZZD4,Q9ZZD8,Q9ZZE3,Q9ZZE4,Q9ZZF6,Q9ZZR4,Q9ZZT5,Q9ZZT6,Q9ZZT7,Q9ZZT8,Q9ZZU1">cytochrome b</protein-id> (<protein-id="P00158,P00159,P00160,P00162,P05501,P07704,P18935,P24890,P51941,Q8HEC2,Q8HMZ7,Q8HQ92,Q8WA47,Q9MDZ9,Q9MGL5,Q9MGM4,Q9MIX8">cytb</protein-id>) and <compound-id="439153">NADH</compound-id> 2 genes, were obtained from 49 Acropora species.	NADH__CaM__no_interaction	NADH__cytochrome b__no_interaction	NADH__cytb__no_interaction	NADH__calmodulin__no_interaction
18670810-1039	Both expression of tac and <protein-id="P06767,P08435,P41539,P55099">tac2</protein-id> were induced by 2% <compound-id="5988">sucrose</compound-id>.	sucrose__tac2__interaction
18670880-1082	Contaminants of current high use in the LRGV, such as <compound-id="2256">atrazine</compound-id>, and some of the highly persistent organochlorines, such as <compound-id="5284469">toxaphene</compound-id> and <compound-id="3035">DDE</compound-id>, could be potentially associated with modulation of <protein-id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</protein-id> activity in avian tissues.	toxaphene__aromatase__interaction	atrazine__aromatase__interaction	DDE__aromatase__interaction
18670892-1460	In this view, this study aimed at the investigating the use of a crude <protein-id="P15984,P16147,P84714">peroxidase</protein-id> preparation from onion solid by-products for oxidising <compound-id="689043">caffeic acid</compound-id>, a widespread o-diphenol, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.	caffeic acid__peroxidase__interaction
18670896-1090	<compound-id="6599">Ziram</compound-id> exposures that caused a loss of binding function were examined for effects on expression of key NK cell-<protein-id="O12164,O41803,O42043,O56861,O70902,O71037,O89292,O91086,P03374,P03375,P03377,P03378,P03379,P03380,P03381,P03383,P03385,P03386,P03387,P03388,P03390,P03391,P03392,P03395,P03396,P03397,P03399,P04027,P04502,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P06445,P06751,P06752,P07575,P08359,P08360,P08810,P0C212,P10259,P10267,P10269,P11261,P11267,P11268,P11306,P12449,P12487,P12488,P12489,P12492,P14075,P14351,P15073,P15831,P16082,P16090,P16899,P17281,P17755,P18040,P18094,P18799,P19030,P19503,P19549,P19550,P19551,P19556,P19557,P20871,P20872,P20888,P21412,P21415,P21436,P21443,P21444,P21445,P22380,P22427,P22428,P22429,P22430,P23064,P23073,P23422,P23423,P24105,P25057,P25504,P25505,P25506,P25507,P26803,P26804,P27399,P27757,P27977,P31621,P31626,P31627,P31789,P31791,P31794,P31796,P31819,P31872,P32536,P32541,P33498,P35954,P35961,P51515,P51519,P51520,P60507,P60508,P60608,P61549,P61550,P61552,P61553,P61554,P61555,P61556,P61557,P61558,P61559,P61561,P61562,P61563,P61564,P61565,P61566,P61567,P61570,Q02076,Q02077,Q02282,Q02837,Q03804,Q03816,Q03817,Q04993,Q04995,Q05312,Q09SZ7,Q0R5Q9,Q14264,Q1A243,Q1A261,Q69384,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q85646,Q89607,Q8AIH5,Q8MIB6,Q902F8,Q902F9,Q96L62,Q9IDV2,Q9N2J8,Q9N2J9,Q9N2K0,Q9NX77,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9TTC0,Q9UKH3,Q9UQF0,Q9WC60,Q9WC69">surface proteins</protein-id> needed for binding to targets.	Ziram__surface proteins__interaction
18670905-814	Here, we have investigated how the post-synthetic acetylation of <protein-id="P07156,P09429,P10103,P12682,P36194,Q4R844,Q6YKA4">HMGB1</protein-id> affects its interaction with negatively supercoiled DNA by employing monoacetylated at Lys2 protein, isolated from <compound-id="264">butyrate</compound-id>-treated cells.	butyrate__HMGB1__no_interaction
18670906-1096	<protein-id="Q8IUC2">KAP8.1</protein-id> protein contains high <compound-id="750">glycine</compound-id> and <compound-id="1153,6057,5460803">tyrosine</compound-id>, which concerns regulation and function of the matrix structure fiber.	tyrosine__KAP8.1__interaction	glycine__KAP8.1__interaction
18671273-1368	<compound-id="6197">Cycloheximide</compound-id> inhibited <protein-id="O61389,O96605,P19806,P55321,P55846,P55847,P55848,P83220,P83636,Q10987,Q27225">MIH</protein-id> induced <protein-id="P00536,P00539,P12965">Mos</protein-id> expression and its phosphorylation, which in turn reduced <protein-id="P70047,Q8CFC2,Q91618,Q9ESG9,Q9NI63">Myt1</protein-id> phosphorylation and GVBD.	Cycloheximide__Myt1__interaction	Cycloheximide__Mos__interaction	Cycloheximide__MIH__interaction
18671672-48	<compound-id="11984615">CLNO2</compound-id> levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli <compound-id="11970143">lipopolysaccharide</compound-id> plus <protein-id="Q9TTB0">interferon-gamma</protein-id> ; this response was concurrent with an increase in the expression of <protein-id="O19114,O46660,O54705,O62699,P35228,P60321,P79290,Q27995,Q28314,Q90703,Q92037,Q92091">NOS2</protein-id> (inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id>) and was inhibited by the (*)NO (<compound-id="145068">nitric oxide</compound-id>) inhibitor L-NAME (<compound-id="39836">N(G)-nitro-L-arginine methyl ester</compound-id>).	CLNO2__interferon-gamma__interaction	N(G)-nitro-L-arginine methyl ester__interferon-gamma__no_interaction	CLNO2__nitric oxide synthase__interaction	nitric oxide__interferon-gamma__no_interaction	lipopolysaccharide__NOS2__no_interaction	N(G)-nitro-L-arginine methyl ester__NOS2__no_interaction	lipopolysaccharide__nitric oxide synthase__no_interaction	nitric oxide__nitric oxide synthase__no_interaction	CLNO2__NOS2__interaction	nitric oxide__NOS2__no_interaction	lipopolysaccharide__interferon-gamma__no_interaction	N(G)-nitro-L-arginine methyl ester__nitric oxide synthase__no_interaction
18671761-109	<compound-id="3290">Parkin</compound-id>-mediated ubiquitination regulates <protein-id="P08487,P10686,P19174,Q62077">phospholipase C-gamma1</protein-id>.	Parkin__phospholipase C-gamma1__interaction
18671795-129	Short-acting <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> analogues, in comparison with regular human <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> (<protein-id="P33279,Q9BQI3">HRI</protein-id>), provide a greater control of postprandial <compound-id="206,5793,64689,79025">glucose</compound-id>, while their superiority on haemoglobin A1c (HbA1c) is controversial.	glucose__insulin__interaction	glucose__HRI__interaction
18671897-205	Western blotting showed that <compound-id="21913,636403,5311038">carbenoxolone</compound-id> down-regulated <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> protein expression in the BA, which in the SAH-only group was significantly higher than that of the normal group.	carbenoxolone__Cx43__interaction
18672341-581	Hepatocytes exposed to resistin, but only in the presence of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, show a decrease in <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-stimulated <compound-id="439177">glycogen</compound-id> content.	glycogen__insulin__interaction
18672928-1390	To further test this hypothesis, we have measured the fluorescence quantum yield in solvents of different polarity for the following systems: <compound-id="2003,94230">N-acetyl-L-tryptophanamide</compound-id> (NATA), an analogue for Trp in <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id> ; <compound-id="304749,2724382">N-acetyl-L-tryptophan ethyl ester</compound-id> (NATE), wherein the Trp amide is replaced by an ester group, lowering the CT state energy; and <compound-id="6736">3-methylindole</compound-id> (<compound-id="11001318">3MI</compound-id>), a control wherein this quenching mechanism cannot take place.	3-methylindole__a protein__no_interaction	3MI__a protein__no_interaction	N-acetyl-L-tryptophanamide__a protein__interaction	N-acetyl-L-tryptophan ethyl ester__a protein__no_interaction
18673089-1229	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with <compound-id="6046885,6821284">oil red-O</compound-id>, and expressed adipocyte-specific genes (lipoprotein <protein-id="Q7M4U7">lipase</protein-id> [<protein-id="O46647,P06858,P11151,P11152,P11153,P11602,P49060,P49923,P55031,Q06000,Q29524">LPL</protein-id>], peroxisome proliferator activated receptor <protein-id="P02528">gamma2</protein-id>, and adipocyte-specific <protein-id="O42494,O45035,O76821,P80547,Q17284,Q8MUC1,Q9U5P1">fatty acid binding protein</protein-id> [alphaP2]).	oil red-O__lipase__no_interaction	oil red-O__fatty acid binding protein__no_interaction	oil red-O__LPL__no_interaction	oil red-O__gamma2__no_interaction
18673303-1358	In addition, AIT induced a more favourable regulation of blood <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> compared with MTG.	glucose__insulin__no_interaction
18673333-52	Beta1,4-<protein-id="P14769,P23336,P50127">galactosyltransferase</protein-id>-I (<protein-id="P08037,P15291">B4GALT1</protein-id>), one of seven beta1,4-<protein-id="P14769,P23336,P50127">galactosyltransferases</protein-id>, is an enzyme commonly found in the trans-Golgi complex that adds <compound-id="6036,439353,439357">galactose</compound-id> to oligosaccharides.	galactose__galactosyltransferase__interaction	galactose__B4GALT1__interaction	galactose__galactosyltransferases__interaction
18673333-53	When compared to the other mammalian <protein-id="P08037,P15291">B4GALT1</protein-id> genes, the porcine coding sequence contained a single <compound-id="6288">threonine</compound-id> codon inserted into the region encoding the cytoplasmic domain.	threonine__B4GALT1__interaction
18674953-1307	<compound-id="64947">Gyp</compound-id> inhibited the levels of the anti-apoptotic proteins <protein-id="P10417,P49950">Bcl-2</protein-id> and Bcl-xl, but promoted the levels of the pro-apoptotic <protein-id="P27297">protein Bax</protein-id>.	Gyp__Bcl-2__interaction	Gyp__protein Bax__interaction
18674953-1308	In conclusion, <compound-id="64947">Gyp</compound-id> induced ER stress and production of reactive <compound-id="977">oxygen</compound-id> species and <compound-id="271">Ca(2</compound-id>+), change the ratio of <protein-id="P10417,P49950">Bcl-2</protein-id> and <protein-id="P27297,Q07813,Q63690">Bax</protein-id>, followed by the dysfunction of mitochondria, caused <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> release, activation of caspase-3 before leading to apoptosis.	oxygen__Bcl-2__no_interaction	Ca(2__Bax__no_interaction	Ca(2__Bcl-2__no_interaction	oxygen__cytochrome c__no_interaction	Gyp__Bcl-2__interaction	Ca(2__cytochrome c__no_interaction	Gyp__cytochrome c__interaction	oxygen__Bax__no_interaction	Gyp__Bax__interaction
18675966-641	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (<protein-id="O62728,P09056,P15018,P17777,Q27956">LIF</protein-id>), <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>), and pinopodes in Indian women using <compound-id="35805,154413">ormeloxifene</compound-id> as a contraceptive with fertile and infertile subjects during the window of implantation.	ormeloxifene__IL-6__interaction	ormeloxifene__interleukin-6__interaction	ormeloxifene__LIF__interaction
18676014-229	We have also observed that the reduction of transition at 95+/-3 degrees C in thermal scans of nuclear preparations isolated from blood of B-CLL randomized patients who showed response to <compound-id="20279">cladribine</compound-id> or <compound-id="657237">fludarabine</compound-id> combined with <compound-id="2907,9554282">cyclophosphamide</compound-id>, i.e., CC and FC, respectively, corresponded with the decrease or disappearance of anti-apoptotic proteins <protein-id="P10417,P49950">Bcl-2</protein-id> and/or <protein-id="Q69FH1,Q9Z2H6">Mcl</protein-id> 1.	cladribine__Bcl-2__no_interaction	cyclophosphamide__Bcl-2__no_interaction	fludarabine__Mcl__no_interaction	cyclophosphamide__Mcl__no_interaction	fludarabine__Bcl-2__no_interaction	cladribine__Mcl__no_interaction
18676199-799	Exposure of erythrocytes to <protein-id="Q9UQ90">PGNs</protein-id> increased cytosolic <compound-id="271">Ca(2</compound-id>+) concentration, increased ceramide formation, enhanced the percentage of <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</protein-id>-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular <compound-id="5957">ATP</compound-id> concentration.	ATP__annexin V__no_interaction	ATP__PGNs__interaction	Ca(2__annexin V__no_interaction	Ca(2__PGNs__interaction
18676776-233	Inhibition of <protein-id="Q00859">mitogen-activated protein kinase</protein-id> (<protein-id="O42781,P27638,Q00859">MAPK</protein-id>) and <protein-id="P31750,Q8INB9">Akt</protein-id> prevented the antiapoptotic effects of <compound-id="942,89594,157672">nicotine</compound-id> and decreased chemotherapy-induced apoptosis.	nicotine__Akt__interaction	nicotine__MAPK__interaction	nicotine__mitogen-activated protein kinase__interaction
18676776-235	<compound-id="942,89594,157672">Nicotine</compound-id> up-regulated <protein-id="P31750,Q8INB9">Akt</protein-id>-mediated antiapoptotic X-linked <protein-id="Q90660">inhibitor of apoptosis protein</protein-id> and phosphorylated proapoptotic <protein-id="O35147,Q61337,Q92934">Bcl2-antagonist of cell death</protein-id>.	Nicotine__Akt__interaction	Nicotine__Bcl2-antagonist of cell death__interaction	Nicotine__inhibitor of apoptosis protein__interaction
18677478-391	Induction of NY-ESO-1 expression on tumor targets using the demethylating agent <compound-id="451668">5-aza-2'-deoxycytidine</compound-id> (alone or in combination with the histone deacetylase inhibitor <compound-id="5352062">depsipeptide</compound-id>) resulted in enhanced <protein-id="Q9TTB0">interferon-gamma</protein-id> secretion by the TCR-transduced PBL on culture with treated targets.	depsipeptide__interferon-gamma__interaction	5-aza-2'-deoxycytidine__interferon-gamma__interaction
18677521-1468	In the absence of <protein-id="P18151,P21354,P23603,P23700,P23701,P26758,P94664,Q253E5,Q3KLQ7,Q548P6,Q933I7,Q9AIS7,Q9PJV0">OmcB</protein-id>, cells lost the ability to reduce soluble or insoluble <compound-id="29936">Fe(III</compound-id>).	Fe(III__OmcB__interaction
18677521-1470	DNA sequences of upstream regions of coregulated operons in the adapted mutant are divergent, suggesting the presence of recognition sites for different <protein-id="Q9CJ45">transcriptional regulators</protein-id> and indicating that adaptation of the omcB mutant to growth on soluble <compound-id="29936">Fe(III</compound-id>) has shifted the relevant expression networks involved to a more diverse molecular basis.	Fe(III__transcriptional regulators__no_interaction
18677561-697	Elevated beta1,4-<protein-id="P14769,P23336,P50127">galactosyltransferase</protein-id>-I induced by the intraspinal injection of <compound-id="11970143">lipopolysaccharide</compound-id>.	lipopolysaccharide__galactosyltransferase__interaction
18677561-698	E-selectin, which ligand was modified by beta1,4-<protein-id="O33836,O84904,P09148,P13212,P22714,P31764,P39575,P45981,P96994,Q00054,Q5LYY8,Q5M3K1,Q836N8,Q88SF0,Q8R8R6,Q8RHC9,Q8VS92,Q8XKP8,Q93MM1,Q97EZ4,Q9CE63,Q9KDV2,Q9RGR9,Q9S6S3,Q9ZB09">GalT</protein-id>-I, was correlated with <compound-id="6036,439353,439357">galactose</compound-id>-containing glycans following injecting LPS into spinal cord.	galactose__GalT__no_interaction
18677571-1520	Effects of <protein-id="O43439,P46655,P49846,Q14155">P85</protein-id> on amino acid transporters were examined using their substrates: (3)H-<compound-id="994,6140,71567">phenylalanine</compound-id>, (3)H-<compound-id="866,5962">lysine</compound-id>, and (3)H-methylaminoisobutyric acid, respectively.	phenylalanine__P85__no_interaction	lysine__P85__no_interaction
18677583-1526	<compound-id="3121">Valproate</compound-id>, an anticonvulsant and mood stabilizer, up-regulates <protein-id="P10417,P49950">Bcl-2</protein-id>, a neurotrophic/neuroprotective protein.	Valproate__Bcl-2__interaction
18677583-1527	In this study, we investigated the molecular mechanism through which <protein-id="P10417,P49950">Bcl-2</protein-id> is up-regulated by <compound-id="3121">valproate</compound-id> using cultured human neuron-like cells.	valproate__Bcl-2__interaction
18677583-1528	<compound-id="3121">Valproate</compound-id>, within therapeutically relevant ranges, induced time- and concentration-dependent up-regulations of both <protein-id="P10417,P49950">Bcl-2</protein-id> messenger RNA and protein implicating an underlying gene transcriptional-mediated mechanism.	Valproate__Bcl-2__interaction
18677583-1529	<compound-id="3121">Valproate</compound-id> increased transcriptional activity of a human <protein-id="P10417,P49950">bcl-2</protein-id> promoter-reporter gene construct.	Valproate__bcl-2__interaction
18677583-1530	ERK and/or PI3K pathway inhibitors and RSK1 small hairpin RNA knockdown reduced, but did not abolish, baseline and <compound-id="3121">valproate</compound-id>-induced promoter activities and lowered <protein-id="P10417,P49950">Bcl-2</protein-id> protein levels.	valproate__Bcl-2__no_interaction
18677583-1531	These data collectively suggest that <compound-id="3121">valproate</compound-id> induces <protein-id="P10417,P49950">Bcl-2</protein-id> regulation partially through activations of the <protein-id="P29323">ERK</protein-id> and <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id> cascades and their convergent kinase, <protein-id="P18652">RSK</protein-id>, although other unknown mechanism(s) are likely involved.	valproate__PI3K__interaction	valproate__RSK__interaction	valproate__Bcl-2__interaction	valproate__ERK__interaction
18677583-1532	Given the known roles of <protein-id="P10417,P49950">Bcl-2</protein-id> in the central nervous system, the current findings offer a partial yet complex molecular mechanistic explanation for the known neurobiological effects of <compound-id="3121">valproate</compound-id> including neurite growth, neuronal survival, and neurogenesis.	valproate__Bcl-2__no_interaction
18679593-620	With covalent method, <compound-id="3485">glutaraldehyde</compound-id> was introduced to immobilize <protein-id="O33843,P06835,P07337,P10482,P12614,P14002,P15885,P16084,P22073,P22505,P22506,P22507,P26208,P27034,P29090,P29091,P33363,P38645,P40740,P42403,P48825,P49235,Q03506,Q08638,Q46684,Q56078">cellobiase</protein-id>.	glutaraldehyde__cellobiase__interaction
18679731-726	As metabolic flux for the operation of the <compound-id="10251">flavonoid</compound-id> pathway is maintained through the activities of <protein-id="O03979,O04058,O93967,P10248,P10731,P11544,P14166,P14717,P14925,P19021,P26600,P35511,P35512,P45726,P45727,P45730,P45731,P45735,P52777,P83388,P91268,P97467,Q42609,Q43210,Q9P2V4,Q9PSN0">PAL</protein-id> and <protein-id="O24312,O81928,P37114,P37115,P48522,P92994,Q04468,Q42797,Q43033,Q43054,Q43067,Q43240,Q96423,Q9AR74">C4H</protein-id>, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	flavonoid__PAL__interaction	flavonoid__C4H__interaction
18679812-4	Activities of antioxidant enzymes (<protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id>, <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id>, glutatione-S-transferase, and <compound-id="124886">reduced glutathione</compound-id>) in liver also decreased in carcinogen-administered rats, which were significantly elevated in bacoside A-pretreated rats.	reduced glutathione__superoxide dismutase__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione reductase__no_interaction
18679831-20	In this study, we report that AR-<compound-id="77681">M1896</compound-id>, a non-GalR1 agonist, inhibited plasma extravasation induced by <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</protein-id> and <protein-id="P30880,P30881,P31888">calcitonin gene-related peptide</protein-id> in a manner similar to <protein-id="P07480,P10683,P11242,P22466,P30802,P31234,P33710,P47212,P47213,P47214,P47215,P47216,Q9W6M9">galanin</protein-id>, confirming a non-GalR1-mediated effect.	M1896__calcitonin gene-related peptide__interaction	M1896__galanin__no_interaction	M1896__substance P__interaction
18680102-211	Inhibition of non-small cell lung cancer cell migration by grape seed <compound-id="108065">proanthocyanidins</compound-id> is mediated through the inhibition of nitric oxide, guanylate <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</protein-id>, and <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2.	proanthocyanidins__ERK1__interaction	proanthocyanidins__cyclase__interaction
18680102-215	Additionally, UO126 and <compound-id="1456">ODQ</compound-id> inhibited the migration restoring effects of <compound-id="6322">L-arginine</compound-id> in L-NAME-treated cells, suggesting the involvement of <compound-id="24316">cGMP</compound-id> and <protein-id="O42781,P27638,Q00859">MAPK</protein-id> pathways in NO-mediated migration.	ODQ__MAPK__no_interaction	L-arginine__MAPK__no_interaction	cGMP__MAPK__no_interaction
18680102-216	GSPs inhibited <compound-id="6322">L-arginine</compound-id> and <compound-id="104767">8-Br-cGMP</compound-id>-induced activation of <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 in A549 cells.	L-arginine__ERK1__interaction	8-Br-cGMP__ERK1__interaction
18680106-970	Enhancement of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> expression in keratinocytes by the <compound-id="5280805">bioflavonoid</compound-id> <compound-id="5280443">apigenin</compound-id> is associated with <protein-id="P03526,P04487,P07940,P12002,P56958,P82866">RNA-binding protein</protein-id> <protein-id="P70372,Q15717">HuR</protein-id>.	bioflavonoid__HuR__interaction	bioflavonoid__p53__interaction	apigenin__RNA-binding protein__no_interaction	apigenin__HuR__interaction	apigenin__p53__interaction	bioflavonoid__RNA-binding protein__no_interaction
18680106-971	We have reported previously that <compound-id="5280443">apigenin</compound-id>, a naturally occurring nonmutagenic <compound-id="10251">flavonoid</compound-id>, increased wild-type <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> protein expression in the mouse keratinocyte 308 cell line by a mechanism involving <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> protein stabilization.	apigenin__p53__interaction	flavonoid__p53__no_interaction
18680106-973	Instead, biosynthetic labeling showed that <compound-id="5280443">apigenin</compound-id> increased nascent <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> protein synthesis by enhancing <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> translation.	apigenin__p53__interaction
18680106-975	Furthermore, <compound-id="5280443">apigenin</compound-id> treatment increased the level of association of the <protein-id="P03526,P04487,P07940,P12002,P56958,P82866">RNA binding protein</protein-id> <protein-id="P70372,Q15717">HuR</protein-id> with endogenous <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> mRNA.	apigenin__p53__interaction	apigenin__HuR__interaction	apigenin__RNA binding protein__no_interaction
18680106-976	<compound-id="5280443">Apigenin</compound-id> treatment also augmented <protein-id="P70372,Q15717">HuR</protein-id> translocation into the cytoplasm.	Apigenin__HuR__interaction
18680106-979	Overall, these findings indicate that, in addition to modulating <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> protein stability, one of the mechanisms by which <compound-id="5280443">apigenin</compound-id> induces <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> protein expression is enhancement of translation through the <protein-id="P03526,P04487,P07940,P12002,P56958,P82866">RNA binding protein</protein-id> <protein-id="P70372,Q15717">HuR</protein-id>.	apigenin__p53__interaction	apigenin__HuR__interaction	apigenin__RNA binding protein__no_interaction
18680156-264	Immunoblot analysis of signaling molecules, including cyclic-<protein-id="O24006">AMP</protein-id> response element binding protein (<protein-id="P15337,P16220,P27925,P51984,P51985,Q01147">CREB</protein-id>), <protein-id="Q00859">mitogen-activated protein kinases</protein-id> (MAPKp44/42; <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2), in area CA1 revealed that <compound-id="5819">thyroxin</compound-id> treatment reversed hypothyroidism-induced reduction of signaling molecules essential for learning and memory, and L-LTP.	thyroxin__CREB__interaction	thyroxin__ERK1__interaction	thyroxin__mitogen-activated protein kinases__interaction	thyroxin__AMP__interaction
18680550-1533	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus <compound-id="37542">ribavirin</compound-id>.	ribavirin__Insulin__interaction
18680550-1535	Aim To investigate retrospectively the impact of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance on treatment response in Chinese genotype 1 CHC patients receiving a 24-week course therapy with peginterferon alpha-2b/<compound-id="37542">ribavirin</compound-id>.	ribavirin__insulin__interaction
18680626-658	We hypothesised that <protein-id="P04181,Q07805,Q4XWV5,Q6LFH8,Q7RT90">OAT</protein-id> could be a limiting step in <compound-id="738,5961">glutamine</compound-id>-<compound-id="232,4367,6322">arginine</compound-id> interconversion.	glutamine__OAT__interaction	arginine__OAT__interaction
18680626-659	<protein-id="P04181,Q07805,Q4XWV5,Q6LFH8,Q7RT90">OAT</protein-id> overexpression decreased plasma and liver <compound-id="389,6262,71082">ornithine</compound-id> concentrations but did not affect <compound-id="738,5961">glutamine</compound-id> or <compound-id="232,4367,6322">arginine</compound-id> homeostasis.	ornithine__OAT__interaction	glutamine__OAT__no_interaction	arginine__OAT__no_interaction
18680626-660	There was an inverse relationship between <compound-id="389,6262,71082">ornithine</compound-id> levels and <protein-id="P04181,Q07805,Q4XWV5,Q6LFH8,Q7RT90">OAT</protein-id> activity.	ornithine__OAT__interaction
18681858-1	In men there is a large interindividual variation of <protein-id="P04278,P08689,P15196,P97497,Q62588">SHBG</protein-id> levels and consequently of <compound-id="6013">testosterone</compound-id> (T) and E(2) levels.	testosterone__SHBG__interaction
18682334-364	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble <protein-id="O14788,O35235,Q9ESE2">RANKL</protein-id> (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL <protein-id="O00300">OPG</protein-id>, (D) 10ng/mL <protein-id="O00300">OPG</protein-id>, (E) 50ng/mL <protein-id="O00300">OPG</protein-id>, (F) 100ng/mL <protein-id="O00300">OPG</protein-id> and (G) 30ng/mL sRANKL, 6mmol/<compound-id="5281764">L Ca</compound-id> and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of <protein-id="O00300">OPG</protein-id> in a dose-dependent manner.	L Ca__RANKL__no_interaction	L Ca__OPG__no_interaction
18682988-518	Over-expression of <protein-id="O52310,O59650,O74024,O95479,P00366,P00367,P00368,P0AES2,P0AES3,P10860,P13443,P26443,P28270,P36234,P42174,P42206,P42238,P49448,P52596,P54385,P56201,P80319,P82264,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q53199,Q56304,Q59516,Q64HZ8,Q64HZ9,Q64I00,Q64I01,Q9HFR6,Q9HGU3,Q9HGU4,Q9RDE9,Q9URS1,Q9YC65">GDH</protein-id> decreased the yield of <compound-id="702">ethanol</compound-id> and <compound-id="262,225936">2,3-butanediol</compound-id>, meanwhile it increased the concentration of <compound-id="176,286,291512">acetic acid</compound-id>.	acetic acid__GDH__interaction	ethanol__GDH__interaction	2,3-butanediol__GDH__interaction
18683011-1547	<compound-id="5282199">Geranylgeranylacetone</compound-id> prevents acute liver damage after massive hepatectomy in rats through suppression of a CXC chemokine <protein-id="P09341">GRO1</protein-id> and induction of heat shock proteins.	Geranylgeranylacetone__GRO1__interaction
18683188-1093	Furthermore, HA induced dose-dependent elevation of reactive <compound-id="977">oxygen</compound-id> species (ROS) level in SMCs, and antioxidant <compound-id="54670067">vitamin C</compound-id> and <compound-id="40634">Trolox</compound-id> effectively suppressed HA-induced DNA damage and dysregulation of <protein-id="P10417,P49950">Bcl-2</protein-id>/<protein-id="P27297,Q07813,Q63690">Bax</protein-id>.	oxygen__Bcl-2__no_interaction	Trolox__Bax__interaction	Trolox__Bcl-2__interaction	vitamin C__Bcl-2__interaction	vitamin C__Bax__interaction	oxygen__Bax__no_interaction
18683221-1122	The adsorption of ovine <protein-id="P22775,P81070">fibrinogen</protein-id> onto <compound-id="27924,122634,22833501">PMA</compound-id>-modified surfaces was reduced relative to unmodified surfaces, and in vitro ovine blood contact through a rocking test revealed marked reductions in platelet deposition and bulk phase platelet activation relative to unmodified TiAl6V4 and polystyrene controls.	PMA__fibrinogen__interaction
18683225-1127	When the <protein-id="P84122">thrombin</protein-id> concentration was higher than 15 U/mL, the gelation could be finished within 1 min and yielded a composite with evenly suspended and distributed <compound-id="36797">PLGA</compound-id> microspheres.	PLGA__thrombin__interaction
18683233-58	The culture tests using MSCs show that the level of <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> (<protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id>) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and <compound-id="2526">beta-GP</compound-id>.	beta-GP__ALP__interaction	beta-GP__alkaline phosphatase__interaction
18683233-59	The level was unchanged in MSCs cultured on PV-H. In the case of supplementing Dex and <compound-id="2526">beta-GP</compound-id> to the medium, the level of <protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id> activity in MSCs cultured on SPV-H was higher than that on PV-H at all time points during the 21-day culture.	beta-GP__ALP__interaction
18683244-106	The combined treatment strategy not only decreased <protein-id="O46543,P08565,P08618,P0C014,P0C072,P13117,P14624,P14792,P15174,P19848,P20685,P22589,P23324,P23398,P42739,P42740,P46574,P49634,P49635,P59263,P59669,P61862,P61863,P61864,P62972,P62973,P62974,P62975,P62976,P62977,P62988,P62989,P62990,P62991,P63049,P63051,P68195,P68196,P68197,P68198,P68199,P68201,P68204,P69308,P69309,P69310,P69311,P69312,P69313,P69314,P69315,P69316,P69317,P69318,P69319,P69320,P69321,P69322,P69323,P69324,P69325,P69326,P84589,Q05550,Q865C5,Q867C2,Q867C3,Q867C4,Q8MKD1,Q9Y848">ubiquitin</protein-id>-positive aggregation in striatum, alleviated <compound-id="5961">polyglutamine</compound-id> aggregation formation, and reduced striatal volume, but also extended life span in the R6/2 animal model.	polyglutamine__ubiquitin__no_interaction
18683246-1143	<protein-id="P01282,P01283,P01284,P04566,P09684,P09685,P32648,P32649,P39089,P45644,P48142,P48143,P63289,P63290,P63291,P81016,P81401,P84488,P84771,P84772">Vasoactive intestinal peptide</protein-id> inhibits toll-like receptor 3-induced <compound-id="145068">nitric oxide</compound-id> production in Schwann cells and subsequent sensory neuronal cell death in vitro.	nitric oxide__Vasoactive intestinal peptide__interaction
18683252-1154	The <protein-id="P05804">GUS</protein-id> and LUC genes were chosen because they can be used as markers for the easy detection of transgenic plants, while <compound-id="773,6274">histidine</compound-id> tail better enables the isolation of protein expressed in plant tissue.	histidine__GUS__no_interaction
18683262-1162	Expression was performed in fusion to <compound-id="294,6255,439186,439341,10991489,45109807">maltose</compound-id> binding protein using chemically defined minimal medium, followed by a single-step affinity capture and enzymatic cleavage using tobacco etch virus <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">protease</protein-id>.	maltose__protease__no_interaction
18683263-1164	The amplification of <protein-id="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20902,P20903,P21553,P26491,P39812,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P94325,Q10530,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59977,Q9RWB2,Q9ZN37">gltA</protein-id> gene encoding <protein-id="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20901,P20902,P20903,P21553,P26491,P27660,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P84543,P94325,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59939,Q59977,Q9RWB2,Q9ZN37">citrate synthase</protein-id> of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during <compound-id="1183">vanillin</compound-id> production from <compound-id="445858">ferulic acid</compound-id>, to CoA, which is essential for <compound-id="1183">vanillin</compound-id> production.	ferulic acid__citrate synthase__interaction	ferulic acid__gltA__interaction	vanillin__citrate synthase__interaction	vanillin__gltA__interaction
18683263-1167	The <protein-id="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20902,P20903,P21553,P26491,P39812,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P94325,Q10530,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59977,Q9RWB2,Q9ZN37">gltA</protein-id> amplification of the glyoxylate bypass in the icdA null mutant remarkably increased the production rate of <compound-id="1183">vanillin</compound-id> with a little increase in the amount of <compound-id="1183">vanillin</compound-id> production.	vanillin__gltA__interaction
18683263-1168	The real synergistic effect of <protein-id="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20902,P20903,P21553,P26491,P39812,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P94325,Q10530,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59977,Q9RWB2,Q9ZN37">gltA</protein-id> amplification and <protein-id="P08200,P79089">icdA</protein-id> deletion was observed with use of XAD-2 resin reducing the toxicity of <compound-id="1183">vanillin</compound-id> produced during culture.	vanillin__gltA__no_interaction	vanillin__icdA__no_interaction
18683889-1688	Treatment of dermal fibroblasts with <compound-id="5280795,5283711">vitamin D(3</compound-id>) induced expression of <protein-id="O46576,P12644,P21275,P30885,Q06826,Q29607,Q2KJH1,Q8MJV5,Q90752">BMP-4</protein-id> (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and <protein-id="P20722,P22004,Q04906">BMP-6</protein-id> (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	vitamin D(3__BMP-4__interaction	vitamin D(3__BMP-6__interaction
18683889-1689	<compound-id="5280795,5283711">Vitamin D(3</compound-id>) was also shown to induce the expression of the osteoblast-specific markers, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> and <protein-id="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9">osteocalcin</protein-id>, in a dose-dependent manner in human dermal fibroblasts.	Vitamin D(3__alkaline phosphatase__interaction	Vitamin D(3__osteocalcin__interaction
18684212-1656	The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>) and <compound-id="5754">cortisol</compound-id> in IBS vs healthy controls; (ii) to compare stimulated <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, <compound-id="5754">cortisol</compound-id> and <compound-id="951,439260">noradrenaline</compound-id> responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	noradrenaline__ACTH__no_interaction	cortisol__ACTH__no_interaction
18684212-1657	In Study 1, basal <compound-id="5754">cortisol</compound-id> levels were analysed in 41 IBS and 25 controls using 24-h collections of plasma <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> and <compound-id="5754">cortisol</compound-id> (q10 min sampling).	cortisol__ACTH__no_interaction
18684212-1658	Basal <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> 0.05), while basal and stimulated plasma <compound-id="5754">cortisol</compound-id> levels were higher in patients.	cortisol__ACTH__no_interaction
18684339-438	A 3-fold increase in the expression of the <protein-id="P00448,P66828,P66829,Q8Z2V9,Q9RUV2">MnSOD</protein-id> gene was associated with decreased <compound-id="6804">CpG</compound-id> methylation of the analysed promoter region in the vegetarian group compared with the age-matched omnivores group.	CpG__MnSOD__interaction
18684712-650	<protein-id="Q9Y758">ALK2</protein-id> (R206H) with <protein-id="P70340,P97588,Q9I8V2">Smad1</protein-id> or <protein-id="P97454,Q99717,Q9R1V3,Q9W7E7">Smad5</protein-id> induced osteoblastic differentiation that could be inhibited by <protein-id="O15105,O35253,O88406">Smad7</protein-id> or <compound-id="11524144">dorsomorphin</compound-id>.	dorsomorphin__Smad1__interaction	dorsomorphin__Smad7__no_interaction	dorsomorphin__Smad5__interaction	dorsomorphin__ALK2__interaction
18685817-1575	Combustion products of <compound-id="7845">1,3-butadiene</compound-id> inhibit <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> activity and induce expression of oxidative DNA damage repair enzymes in human bronchial epithelial cells.	1,3-butadiene__catalase__interaction
18686014-49	The aim of the present study was to examine whether increased serum <protein-id="P30722,P47547,P49463,P75344,Q7YQC6,Q8TQR2,Q9UXR0,Q9WYK6">Hsp70</protein-id> levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (<protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id>), trophoblast debris (cell-free fetal DNA) and oxidative stress (<compound-id="10964">malondialdehyde</compound-id>).	malondialdehyde__fibronectin__no_interaction	malondialdehyde__Hsp70__no_interaction
18686014-50	Furthermore, serum levels of blood <compound-id="1176,265993">urea</compound-id> <compound-id="947,123329">nitrogen</compound-id>, <compound-id="588">creatinine</compound-id>, <compound-id="5280352">bilirubin</compound-id> and <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>, serum alanine aminotransferase and lactate dehydrogenase (<protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id>) activities, as well as plasma levels of <protein-id="P04275,P80012,Q28295,Q28833,Q8CIZ8">VWF</protein-id> :Ag, <protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id>, cell-free fetal DNA and <compound-id="10964">malondialdehyde</compound-id> were also significantly higher in preeclamptic patients than in normotensive, healthy pregnant women.	creatinine__fibronectin__no_interaction	malondialdehyde__VWF__no_interaction	bilirubin__VWF__no_interaction	nitrogen__CRP__no_interaction	creatinine__CRP__no_interaction	nitrogen__LDH__no_interaction	urea__fibronectin__no_interaction	urea__CRP__no_interaction	bilirubin__LDH__no_interaction	malondialdehyde__CRP__no_interaction	urea__VWF__no_interaction	creatinine__VWF__no_interaction	bilirubin__fibronectin__no_interaction	nitrogen__VWF__no_interaction	nitrogen__fibronectin__no_interaction	bilirubin__CRP__no_interaction	urea__LDH__no_interaction	malondialdehyde__LDH__no_interaction	malondialdehyde__fibronectin__no_interaction	creatinine__LDH__no_interaction
18686014-51	In preeclamptic patients, serum <protein-id="P30722,P47547,P49463,P75344,Q7YQC6,Q8TQR2,Q9UXR0,Q9WYK6">Hsp70</protein-id> levels showed significant correlations with serum <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id> levels (Spearman R = 0.32, p = 0.010), serum <protein-id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</protein-id> (R = 0.32, p = 0.008) and <protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id> (0.001), as well as with plasma <compound-id="10964">malondialdehyde</compound-id> levels (R = 0.25, p = 0.043).	malondialdehyde__CRP__interaction	malondialdehyde__Hsp70__interaction	malondialdehyde__aspartate aminotransferase__interaction	malondialdehyde__LDH__interaction
18686047-887	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, <compound-id="5040,478951,5284616,5358081,5374464,5460439,5497196,6436030,16760631,17753749,44295234,53627520,54600319">Rapamycin</compound-id>, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the <protein-id="P42345,P42346,Q9JLN9">mTOR</protein-id> receptor, is compared to <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> in combination therapy employing monospecific or bispecific oligos.	Rapamycin__mTOR__interaction	paclitaxel__mTOR__no_interaction
18686136-131	In this study we investigated the <compound-id="5359597">superoxide</compound-id> radicals scavenging effect and <protein-id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</protein-id> inhibitory activity by <compound-id="6451084">magnesium lithospermate B</compound-id>, which was originally isolated from the roots of Salvia miltiorrhiza (also named Danshen or Dansham), an important herb in Oriental medicine.	magnesium lithospermate B__xanthine oxidase__interaction	superoxide__xanthine oxidase__no_interaction
18686136-132	<compound-id="5359597">Superoxide</compound-id> radicals were generated both in <compound-id="928,439153,11250888">beta-NADH</compound-id>/<compound-id="9286">PMS</compound-id> system and <compound-id="1188">xanthine</compound-id>/<protein-id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</protein-id> system.	PMS__xanthine oxidase__no_interaction	beta-NADH__xanthine oxidase__no_interaction	xanthine__xanthine oxidase__interaction	Superoxide__xanthine oxidase__interaction
18686136-133	Further study suggested that <compound-id="6451084">magnesium lithospermate B</compound-id> can directly inhibit <protein-id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</protein-id> and exhibits competitive inhibition.	magnesium lithospermate B__xanthine oxidase__interaction
18686136-134	In addition, <compound-id="6451084">magnesium lithospermate B</compound-id> significantly protected HL-60 cells from superoxide radicals-induced apoptosis in the <compound-id="1188">xanthine</compound-id>/<protein-id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</protein-id> reactions.	magnesium lithospermate B__xanthine oxidase__interaction	xanthine__xanthine oxidase__interaction
18686165-403	Four different molecules contain galactofuranose in A. fumigatus: (i) the <compound-id="439336">galactomannan</compound-id> present in the alkali soluble and insoluble fraction of the cell wall (ii) N- and O <compound-id="871">glycan</compound-id> moieties of secreted <protein-id="P08163">glycoproteins</protein-id> (iii) a <protein-id="O25781,O51672,O59618,O66954,O82059,O83488,O84382,P06744,P06745,P08059,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P12341,P12709,P13377,P18240,P28718,P29333,P34795,P34796,P34797,P42861,P44312,P46479,P47357,P49105,P50309,P52029,P52030,P52031,P52983,P54234,P54235,P54236,P54237,P54238,P54239,P54240,P54241,P54242,P54243,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P78917,P80860,P81181,P83194,P83780,P84140,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q3ZBD7,Q44407,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JCA7,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4R591,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5JE38,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5R4E3,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6FRW1,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q711G1,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q758L0,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7S986,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8SRY1,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q8ZWV0,Q928R6,Q92SC4,Q96YC2,Q978F3,Q97FP8,Q97NG0,Q97WE5,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9FXM4,Q9FXM5,Q9HGZ2,Q9HIC2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9N1E2,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9UXW3,Q9X1A5,Q9X670,Q9YE01,Q9Z6N4,Q9ZK49">GPI</protein-id>-anchored lipophosphogalactomannan and (iv) several sphingolipids also anchored to the membrane by an <compound-id="57339182">inositol phosphoceramide</compound-id>.	galactomannan__glycoproteins__no_interaction	inositol phosphoceramide__glycoproteins__no_interaction	galactomannan__GPI__no_interaction	glycan__glycoproteins__interaction	inositol phosphoceramide__GPI__no_interaction	glycan__GPI__interaction
18687549-1315	The estimated <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id> level and the IMCL content in these patients were correlated with body mass index, percentage of body fat, other measures of abdominal obesity, serum lipoproteins, fasting and post-oral <compound-id="206,5793,64689,79025">glucose</compound-id> load serum <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> levels and other surrogate markers of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance.	glucose__CRP__no_interaction	glucose__insulin__no_interaction
18687985-1621	Studies suggest that <protein-id="O94907">DKK1</protein-id> activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic effects of <compound-id="5426,75792,92142">thalidomide</compound-id> on limb development.	thalidomide__DKK1__interaction
18688040-30	The <protein-id="P20109,P35225,P42203,P61126,Q5I6E4,Q864V6,Q865W5,Q865X3,Q95J68,Q9N0W9,Q9XSV9">IL-13</protein-id>-induced up-regulation of <protein-id="Q9C3Y4">RhoA</protein-id> was inhibited by <compound-id="3899">leflunomide</compound-id>, an inhibitor of signal transducer and activator of transcription 6 (<protein-id="P42226">STAT6</protein-id>).	leflunomide__IL-13__interaction	leflunomide__RhoA__interaction	leflunomide__STAT6__interaction
18688042-1313	The goal of this study was to determine the mechanisms by which <compound-id="5757">17beta-estradiol</compound-id> induces <protein-id="Q9HC84">MUC5B</protein-id> gene expression in airway epithelial cells.	17beta-estradiol__MUC5B__interaction
18688042-1314	Pretreatment with ER antagonist <compound-id="104741">ICI 182,780</compound-id> blocked both E2-induced <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2-<protein-id="O42781,P27638,Q00859">MAPK</protein-id> activation and <protein-id="Q9HC84">MUC5B</protein-id> gene expression.	ICI 182,780__ERK1__interaction	ICI 182,780__MAPK__interaction	ICI 182,780__MUC5B__interaction
18688696-558	We here show that calumenin in the presence of <compound-id="271">Ca(2</compound-id>+) binds to <protein-id="P07996,P54000,Q28178">TSP1</protein-id> with a dissociation constant K (d) around 0.4 muM.	Ca(2__TSP1__interaction
18688816-657	It represents transition in <compound-id="402">sulfur</compound-id>-deprived conditions, known to lead to H2 production in Chlamydomonas reinhardtii, and the two main processes then induced which are an over-accumulation of intracellular starch and a progressive reduction of <protein-id="O47040,O78462,O96813,P12185,P12186,P12187,P13165,P17227,P17228,P28251,P30980,P48116,P49159,P49484,P51387,P52768,P56768,P58214,P69396,P69397,P69398,Q31909,Q5QA78,Q5SCW1,Q68RZ6,Q6B8K8,Q6ENG4,Q6ENV4,Q6EW69,Q6L390,Q6L603,Q6QBN9,Q70XZ3,Q7FNS8,Q7YJW3,Q85CI4,Q85FL2,Q85X26,Q8M9X5,Q8WI10,Q9BBS0,Q9GDV2,Q9MTL2,Q9MUQ4,Q9TL12,Q9TM24">PSII</protein-id> activity for anoxia achievement.	sulfur__PSII__interaction
18689429-1187	We examined whether <compound-id="5839">aldosterone</compound-id> produced locally in the brain may contribute to the activation of <protein-id="P08235,P22199,P79404,Q29131,Q3YC04,Q4JM28,Q8QHI2,Q8VII8,Q91573,Q9BDJ7,Q9IAC6,Q9N0W8">mineralocorticoid receptors</protein-id> in the CNS.	aldosterone__mineralocorticoid receptors__interaction
18690415-286	Macrophages isolated from iron deficient rats, or pregnant rats at day 21 of gestation, either supplemented with a single dose of <compound-id="105075">iron dextran</compound-id>, 10 mg, at the commencement of pregnancy, or not, showed significant increases of macrophage ferroportin mRNA expression, which was paralleled by significant decreases in hepatic <protein-id="Q7T273,Q99MH3,Q9EQ21">Hamp</protein-id> mRNA expression.	iron dextran__Hamp__no_interaction
18690549-796	Rat dicarboxylate transporter (<protein-id="Q13183,Q28615">SDCT1</protein-id>), expressed in renal tubular epithelial cells, plays a key role in regulating blood and urinary <compound-id="311,2733526">citrate</compound-id> level by reabsorbing <compound-id="311,2733526">citrate</compound-id> from the lumen.	citrate__SDCT1__interaction
18690792-145	However, as opposed to exogenous <compound-id="5047209,46173182">HS</compound-id>, the continuous use of <protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id> during in vitro differentiation completely blocked rMSC mineralization.	HS__FGF-2__no_interaction
18690792-146	We show that the effects of both <protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id> and <compound-id="5047209,46173182">HS</compound-id> are mediated through <protein-id="O10284,P41444">FGF</protein-id> receptor 1 (<protein-id="P11362,P21804,Q8MY86,Q91285">FGFR1</protein-id>) and that inhibition of signaling through this receptor arrests cell growth, resulting in the cells being unable to reach the critical density necessary to induce differentiation.	HS__FGF__no_interaction	HS__FGF-2__no_interaction	HS__FGFR1__interaction
18690792-147	It also confirms the importance of <compound-id="5047209,46173182">HS</compound-id> as a coreceptor for the signaling of endogenous <protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id> and suggests that purified glycosaminoglycans may be attractive alternatives to growth factors for improved ex vivo growth and differentiation of MSCs.	HS__FGF-2__interaction
18691156-926	Two related polytopic <protein-id="P16629,P24266,P28991,Q04565,Q07252">membrane proteins</protein-id> of the major facilitator family, <protein-id="P10903,P46907">NarK</protein-id> and <protein-id="P37593,P37758">NarU</protein-id>, catalyse <compound-id="943">nitrate</compound-id> uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	nitrate__membrane proteins__no_interaction	nitrate__NarU__interaction	nitrate__NarK__interaction
18691343-1073	Intracellular interleukin-4 (Th2 cytokine) and <protein-id="Q9TTB0">interferon-gamma</protein-id> (<protein-id="Q64279,Q922L6">Th1</protein-id> cytokine) production was assessed in CD4+ T lymphocytes activated by <compound-id="4792,27924,122634,22833501">phorbol 12-myristate 13-acetate</compound-id> and <compound-id="3733,6434517,6912226,25134244">ionomycin</compound-id> using flow cytometry.	ionomycin__interferon-gamma__interaction	phorbol 12-myristate 13-acetate__Th1__interaction	phorbol 12-myristate 13-acetate__interferon-gamma__interaction	ionomycin__Th1__interaction
18691603-1685	This signaling system is engaged by the active component of cannabis, <compound-id="16078">Delta9-tetrahydrocannabinol</compound-id> (<compound-id="16078">Delta9-THC</compound-id>), which exerts its pharmacological effects by activation of G protein-coupled type-1 (<protein-id="O02777,P20272,P21554,P47746,P56971,Q333S9,Q5IS73,Q71SP5,Q801M1,Q9PUI7">CB1</protein-id>) and type-2 (<protein-id="P34972,P47936,Q9QZN9">CB2</protein-id>) cannabinoid receptors.	Delta9-THC__CB2__interaction	Delta9-tetrahydrocannabinol__CB2__interaction	Delta9-tetrahydrocannabinol__CB1__interaction	Delta9-THC__CB1__interaction
18691715-1342	<compound-id="778">Homocysteine</compound-id> stimulates antioxidant response element-mediated expression of <protein-id="O68838,P0A6W9,P0A6X0,P32477,P57485,P58994,P61379,Q09768,Q20117,Q57KV3,Q5E7F8,Q5LYY5,Q5M3J8,Q5PF10,Q65RX0,Q66E64,Q6ANW2,Q6D1T4,Q6LMV1,Q71VZ1,Q72RD4,Q7MHS5,Q7N7A4,Q7W3F2,Q7WES2,Q82ZG8,Q87LS2,Q88AR1,Q88R90,Q88UW5,Q89AD8,Q8D2V5,Q8DC38,Q8DW15,Q8DXM9,Q8E399,Q8EBF9,Q8F4D5,Q8X0X0,Q8X900,Q8XK30,Q8Y3R3,Q8Z4D6,Q8ZBU2,Q926X7,Q97IV1,Q9CM00,Q9HF78,Q9HTY6,Q9KUG5,Q9NFN6,Q9W3K5">glutamate-cysteine ligase</protein-id> in mouse macrophages.	Homocysteine__glutamate-cysteine ligase__interaction
18691715-1343	The current study investigated whether <compound-id="778">homocysteine</compound-id> induces transcription of <protein-id="O68838,P0A6W9,P0A6X0,P32477,P57485,P58994,P61379,Q09768,Q20117,Q57KV3,Q5E7F8,Q5LYY5,Q5M3J8,Q5PF10,Q65RX0,Q66E64,Q6ANW2,Q6D1T4,Q6LMV1,Q71VZ1,Q72RD4,Q7MHS5,Q7N7A4,Q7W3F2,Q7WES2,Q82ZG8,Q87LS2,Q88AR1,Q88R90,Q88UW5,Q89AD8,Q8D2V5,Q8DC38,Q8DW15,Q8DXM9,Q8E399,Q8EBF9,Q8F4D5,Q8X0X0,Q8X900,Q8XK30,Q8Y3R3,Q8Z4D6,Q8ZBU2,Q926X7,Q97IV1,Q9CM00,Q9HF78,Q9HTY6,Q9KUG5,Q9NFN6,Q9W3K5">glutamate-cysteine ligase</protein-id> (<protein-id="P0AEP7,P0AEP8,Q01820,Q920G9">Gcl</protein-id>), via ARE driven gene expression in mouse macrophages.	homocysteine__glutamate-cysteine ligase__interaction	homocysteine__Gcl__interaction
18691715-1344	Treatment of mouse macrophages with d-/l-<compound-id="778">homocysteine</compound-id> (50microM) induced depletion of intracellular <compound-id="124886">glutathione</compound-id> and a compensatory increase in <protein-id="P0AEP7,P0AEP8,Q01820,Q920G9">Gcl</protein-id> activity.	homocysteine__Gcl__interaction	glutathione__Gcl__no_interaction
18691715-1345	Real-time RT-PCR revealed increased mRNA-expression of the catalytic subunit of Gcl (Gclc) after treatment with <compound-id="778">homocysteine</compound-id>, and this occurred via increased transcription as demonstrated with <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> promoter reporter constructs for Gclc.	homocysteine__luciferase__no_interaction
18691757-12	Ligand-induced <protein-id="Q00342">Flt3</protein-id>-downregulation modulates cell death associated proteins and enhances chemosensitivity to <compound-id="42890">idarubicin</compound-id> in THP-1 acute myeloid leukemia cells.	idarubicin__Flt3__interaction
18692155-570	Only <protein-id="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0">EGF</protein-id> activated <protein-id="P29323">ERK</protein-id> signaling and up-regulated early gene expression, while <compound-id="10635">DHT</compound-id> triggered the expression of classical AR-responsive genes with the exception of the <protein-id="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0">EGF</protein-id>-induced <protein-id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</protein-id> transcript in A549 cells.	DHT__ERK__no_interaction	DHT__PSA__no_interaction	DHT__EGF__no_interaction
18692155-571	<compound-id="10635">DHT</compound-id> and <protein-id="P01132,P01133,P07522,P26224,Q00968,Q95ND4,Q9BEA0">EGF</protein-id> up-regulated cyclinD1 (<protein-id="P23043">CD1</protein-id>) at both mRNA and protein levels in A549 cells, while in LNCaP cells each mitogen increased only <protein-id="P23043">CD1</protein-id> protein expression.	DHT__EGF__no_interaction	DHT__CD1__interaction
18692592-835	High <compound-id="206,5793,64689,79025">glucose</compound-id> induced endothelial cell growth inhibition is associated with an increase in <protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGFbeta1</protein-id> secretion and inhibition of <protein-id="P03967,P22126,Q07152">Ras</protein-id> prenylation via suppression of the mevalonate pathway.	glucose__TGFbeta1__interaction	glucose__Ras__interaction
18692592-836	The influence of the prenylation status of <protein-id="P03967,P22126,Q07152">Ras</protein-id> on the observed changes in endothelial cell growth under high <compound-id="206,5793,64689,79025">glucose</compound-id> conditions has not previously been examined.	glucose__Ras__interaction
18692599-393	<protein-id="O88480,Q9Y6J0">Calcineurin inhibitors</protein-id> (CsA, <compound-id="6436007">FK-506</compound-id> and <compound-id="6447131,6509979,17753757,24847863,53394893,53486290">pimecrolimus</compound-id>) inhibited NO production and <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> expression in a concentration-dependent manner, CsA being more potent than <compound-id="6436007">FK-506</compound-id> and <compound-id="6447131,6509979,17753757,24847863,53394893,53486290">pimecrolimus</compound-id>.	FK-506__Calcineurin inhibitors__interaction	FK-506__iNOS__interaction	pimecrolimus__Calcineurin inhibitors__interaction	pimecrolimus__iNOS__interaction
18692599-395	In conclusion, the results suggest that <protein-id="O88480,Q9Y6J0">calcineurin inhibitors</protein-id> <compound-id="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938">cyclosporin A</compound-id>, <compound-id="5372,445643,445647,6426916,6436007,6473866,6536850,9940643,23581796,54611630">tacrolimus</compound-id> (<compound-id="6436007">FK-506</compound-id>) and <compound-id="6447131,6509979,17753757,24847863,53394893,53486290">pimecrolimus</compound-id> inhibit <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> expression and NO production in response to inflammatory stimuli by enhancing the decay of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> mRNA by a 3'UTR-dependent manner.	FK-506__calcineurin inhibitors__interaction	pimecrolimus__iNOS__interaction	pimecrolimus__calcineurin inhibitors__interaction	cyclosporin A__iNOS__interaction	tacrolimus__calcineurin inhibitors__interaction	tacrolimus__iNOS__interaction	cyclosporin A__calcineurin inhibitors__interaction	FK-506__iNOS__interaction
18692849-615	An increased activity of ATP-binding cassette transporter A1 (<protein-id="O95477">ABCA1</protein-id>) and <protein-id="Q9H222">ABCG5</protein-id>/G8 heterodimer has been proposed as a mechanism underlying the hypocholesterolaemic effect of <compound-id="12303662">phytosterols</compound-id>.	phytosterols__ABCA1__interaction	phytosterols__ABCG5__interaction
18692896-648	In sum, <compound-id="23978">copper</compound-id> exposure lowered TOSC, a result that at least in part can be related to lowering of antioxidant enzymes like <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>.	copper__CAT__interaction
18693051-793	Accumulation of <compound-id="206,5793,64689,79025">glucose</compound-id> in PA was increased by <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> at 10nM and by <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> at 1 nM and 10nM.	glucose__insulin__interaction	glucose__IGF-I__interaction
18693094-1555	<protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">Glucagon</protein-id> is important to this response because it increases <compound-id="738,5961">glutamine</compound-id> uptake.	glutamine__Glucagon__interaction
18693095-825	It was shown that PAR significantly increased serum ALT, <protein-id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">AST</protein-id>, <protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id>, liver MDA levels and significantly decreased liver <compound-id="124886">GSH</compound-id>-Px activity, when compared to the control group (Group 1).	GSH__AST__no_interaction	GSH__ALP__no_interaction
18693100-829	Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood <compound-id="206,5793,64689,79025">glucose</compound-id> levels and restoring the <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> levels in <compound-id="5300,29327,6420074,6713972,7067772,45357367">streptozotocin</compound-id>-induced diabetic rats.	streptozotocin__insulin__no_interaction	glucose__insulin__no_interaction
18693294-868	The activity of guanylyl <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</protein-id> was determined by the amount of <compound-id="24316">cGMP</compound-id> generated in responses to sodium nitroprusside (SNP) or ANP.	cGMP__cyclase__interaction
18694296-116	Both <compound-id="5311">SAHA</compound-id> and <compound-id="4261">MS-275</compound-id> induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of <protein-id="P27297,Q07813,Q63690">Bax</protein-id>/<protein-id="P10417,P49950">Bcl-2</protein-id> expression.	MS-275__Bax__interaction	SAHA__Bax__interaction	MS-275__Bcl-2__interaction	SAHA__Bcl-2__interaction
18694429-208	Immunolocalization of <protein-id="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90">androgen receptor</protein-id> in the boar epididymis: the effect of GnRH agonist <compound-id="25074999,25077495,25078016">deslorelin</compound-id>.	deslorelin__androgen receptor__no_interaction
18694845-560	E(2) increased the expression of <protein-id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</protein-id> and <protein-id="O46550,P51636,Q07DW0,Q07DX2,Q07DZ3,Q07E26,Q07E39,Q07E50,Q09YH9,Q09YJ1,Q09YK2,Q09YL4,Q09YN7,Q108U8,Q18879,Q2IBA4,Q2IBC2,Q2IBD6,Q2IBF3,Q2IBG9,Q2QL80,Q2QL91,Q2QLB1,Q2QLC2,Q2QLD3,Q2QLE2,Q2QLF3,Q2QLG7,Q2QLH8,Q66WT7,Q9WVC3,Q9YGM9">caveolin-2</protein-id> mRNA and proteins, but pre-treatment with <compound-id="104741">ICI 182,780</compound-id> [an estrogen receptor (ER) antagonist] inhibited E(2)-induced increase in <protein-id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</protein-id> and <protein-id="O46550,P51636,Q07DW0,Q07DX2,Q07DZ3,Q07E26,Q07E39,Q07E50,Q09YH9,Q09YJ1,Q09YK2,Q09YL4,Q09YN7,Q108U8,Q18879,Q2IBA4,Q2IBC2,Q2IBD6,Q2IBF3,Q2IBG9,Q2QL80,Q2QL91,Q2QLB1,Q2QLC2,Q2QLD3,Q2QLE2,Q2QLF3,Q2QLG7,Q2QLH8,Q66WT7,Q9WVC3,Q9YGM9">caveolin-2</protein-id> proteins expression.	ICI 182,780__caveolin-1__interaction	ICI 182,780__caveolin-2__interaction
18694845-561	Phospho-<protein-id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</protein-id> was significantly blocked by <compound-id="104741">ICI 182,780</compound-id> or <compound-id="15077741,21083976">pyrazolopyrimidine</compound-id> 2 (PP2 ; a Src-kinase inhibitor).	ICI 182,780__caveolin-1__interaction	pyrazolopyrimidine__caveolin-1__interaction
18694845-562	<compound-id="3973">LY 294002</compound-id> (a PI3K inhibitor) or <compound-id="4713">PD 98059</compound-id> (an ERK1/2 inhibitor) prevented E(2)-induced increase in <protein-id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</protein-id> expression and the accompanying [(3)H]-<compound-id="5789">thymidine</compound-id> incorporation.	thymidine__caveolin-1__interaction	PD 98059__caveolin-1__interaction	LY 294002__caveolin-1__interaction
18694845-563	Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, <protein-id="P18754,Q18211">cell cycle regulatory proteins</protein-id>, [(3)H]-<compound-id="5789">thymidine</compound-id> incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.	thymidine__cell cycle regulatory proteins__no_interaction
18694847-1230	Almost all <protein-id="P31750,Q8INB9">Akt</protein-id> kinase that translocates to the nucleus shows a marked phosphorylation on <compound-id="5951">serine</compound-id> 473.	serine__Akt__interaction
18695846-1364	During the early response in AR, <compound-id="774">histamine</compound-id> has been found to be the most abundant mediator and it is associated with many symptoms of this disease mediated through the <protein-id="P30546,P31389,P31390,P35367,P70174,Q9N2B0,Q9N2B1,Q9N2B2">histamine H1 receptor</protein-id>.	histamine__histamine H1 receptor__interaction
18695937-929	During the incubation of <compound-id="6140">L-phenylalanine</compound-id> with para-hydroquinones using <protein-id="Q12570">laccase</protein-id> as biocatalyst, one or two main products were formed.	L-phenylalanine__laccase__interaction
18696104-1256	The effect on activation voltage but not that on amplitude was absent when expressing a cAMP-insensitive mutant (HCN2R/E), while a C-terminal truncated form of <protein-id="Q9UL51">HCN2</protein-id> (HCN2DeltaCx) exhibited only the voltage dependent but not the amplitude effect of <compound-id="5328552">erbstatin</compound-id>.	erbstatin__HCN2__interaction
18696104-1257	Thus, the action of <compound-id="5328552">erbstatin</compound-id> on the activation relation and current amplitude are distinct and separable in newborn myocytes, and the effect on activation voltage depends on the <compound-id="6076">cAMP</compound-id> status of <protein-id="Q9UL51">HCN2</protein-id> channels.	cAMP__HCN2__interaction	erbstatin__HCN2__interaction
18696104-1258	In contrast to newborn myocytes, <compound-id="5328552">erbstatin</compound-id> had no effect on <protein-id="Q9UL51">HCN2</protein-id> under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated <compound-id="6076">cAMP</compound-id> was added to the pipette solution.	erbstatin__HCN2__no_interaction	cAMP__HCN2__no_interaction
18696216-140	<compound-id="232,4367,6322">Arginine</compound-id>-specific <protein-id="P14299">ADP-ribosyltransferase</protein-id> (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of <compound-id="5893">NAD</compound-id> to the <compound-id="232,4367,6322">arginine</compound-id> residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	arginine__ADP-ribosyltransferase__interaction	Arginine__ADP-ribosyltransferase__interaction	NAD__ADP-ribosyltransferase__interaction
18696256-54	Solute carrier family 27 (fatty acid transporter), member 4 (<protein-id="Q4R3Y4,Q5RDY4,Q6P1M0">SLC27A4</protein-id>) is a fatty <protein-id="P0A4X8,P0A4X9,P38135,P54200,P63523,P63524,P69451,P69452,Q02278,Q10776,Q10976,Q4L3Q0,Q50586,Q5HIA1,Q5HRH4,Q6GBR2,Q6GJ94,Q7A1Q0,Q7A769,Q8CQ67,Q8XDR6,Q99W34,Q9KWK5">acyl-CoA synthetase</protein-id> producing very <compound-id="284">long chain fatty acid</compound-id>-CoA for lipid metabolic pathways, suggesting that the <protein-id="Q4R3Y4,Q5RDY4,Q6P1M0">SLC27A4</protein-id> gene is a potential candidate gene for traits related to fat deposition in animals.	long chain fatty acid__SLC27A4__interaction	long chain fatty acid__acyl-CoA synthetase__interaction
18696261-327	A D-amino acid oxidase gene (<protein-id="O35078,P18894">dao</protein-id>) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of <protein-id="O01739,O35078,P00371,P14920,P18894,P22942,P24552,P80324,Q19564,Q99042,Q9Z1M5,Q9Z302">DAAO</protein-id> without the use of any inducer such as <compound-id="656894">isopropyl beta-D-1-thiogalactopyranoside</compound-id> which is poisonous to the cells and environment.	isopropyl beta-D-1-thiogalactopyranoside__DAAO__interaction	isopropyl beta-D-1-thiogalactopyranoside__dao__interaction
18698091-1558	In response to a <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>-containing atherogenic diet, C57BL/6J mice significantly increased expression of <protein-id="O97562,P55851,Q9N2J1,Q9W725">UCP2</protein-id> in the aorta, while mice lacking <protein-id="O97562,P55851,Q9N2J1,Q9W725">UCP2</protein-id>, in the absence of any other genetic modification, displayed significant endothelial dysfunction following the atherogenic diet.	cholesterol__UCP2__interaction
18698091-1559	These data establish that in the vasculature <protein-id="O97562,P55851,Q9N2J1,Q9W725">UCP2</protein-id> functions as an adaptive antioxidant defense to protect against the development of atherosclerosis in response to a fat and <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> diet.	cholesterol__UCP2__interaction
18698130-1197	To confirm that mouse <protein-id="Q13316,Q95120">DMP1</protein-id>-PG possesses a single GAG chain attached to Ser (89), we substituted Ser (89) by <compound-id="750,5460845">Gly</compound-id> (89).	Gly__DMP1__interaction
18698132-1603	PC-1 is the primary generator of <compound-id="644102">pyrophosphate</compound-id> in osteoblastic cells; therefore, regulated expression of PC-1 by <protein-id="O10284,P41444">FGFs</protein-id> may be a principal mechanism by which <protein-id="O10284,P41444">FGF</protein-id> signaling affects bone mineralization.	pyrophosphate__FGF__no_interaction	pyrophosphate__FGFs__no_interaction
18698333-75	In analogy to the reduction of <compound-id="271">Ca(2</compound-id>+) oscillation frequency, the blockers impaired HCEC contraction, NF-kappaB activation, and <protein-id="P19320,P29533,P29534,Q28260">VCAM-1</protein-id> expression.	Ca(2__VCAM-1__no_interaction
18698333-76	Cisternal SAH-CSF induces cytosolic <compound-id="271">Ca(2</compound-id>+) oscillations in HCEC that results in cellular constriction, NF-kappaB activation, and <protein-id="P19320,P29533,P29534,Q28260">VCAM-1</protein-id> expression.	Ca(2__VCAM-1__interaction
18698636-309	For proof of principle, we use <compound-id="107689">L-lactate</compound-id> and <compound-id="61503">D-lactate</compound-id> as representative pair of enantiomers, L-<protein-id="P21795">lactate oxidase</protein-id> as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced <compound-id="1060">pyruvate</compound-id>.	D-lactate__lactate oxidase__no_interaction	L-lactate__lactate oxidase__no_interaction	pyruvate__lactate oxidase__no_interaction
18698648-318	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent <protein-id="P38715">xylose reductase</protein-id> from Candida boidinii (CbXR) was previously reported to produce <compound-id="6912">xylitol</compound-id> from xylose while metabolizing <compound-id="206,5793,64689,79025">glucose</compound-id> [Cirino et al.	xylitol__xylose reductase__interaction	glucose__xylose reductase__interaction
18698648-319	Studies in which the expression of CbXR or a <protein-id="P96792">xylose transporter</protein-id> was increased suggest that enzyme activity and xylose transport are not limiting <compound-id="6912">xylitol</compound-id> production in PC09.	xylitol__xylose transporter__interaction
18698648-321	For the case of xylose-proton symport, omitting the <protein-id="O51581,O54537,O68282,O83491,O84188,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11411,P21907,P29686,P37986,P44311,P48848,P48992,P54547,P56110,P57405,P73411,P77809,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">Zwf</protein-id> (glucose-6-phosphate dehydrogenase) or <protein-id="P0C187,P51995,Q2RSB3">PntAB</protein-id> (membrane-bound transhydrogenase) reactions or TCA cycle activity from the model reduces the theoretical maximum yield from 9.2 to 8.8, 3.6, and 8.0 mol <compound-id="6912">xylitol</compound-id> (mol glucose)(-1), respectively.	xylitol__Zwf__interaction	xylitol__PntAB__interaction
18698648-322	Experimentally, deleting <protein-id="O25781,O51672,O83488,O84382,O88015,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P28718,P44312,P47357,P52029,P52030,P52031,P52983,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P80860,P81181,P96803,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q928R6,Q92SC4,Q97FP8,Q97NG0,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9X1A5,Q9X670,Q9Z6N4,Q9ZK49">pgi</protein-id> (encoding <protein-id="O25781,O51672,O59618,O66954,O82059,O83488,O84382,P06744,P06745,P08059,P0A0T0,P0A0T1,P0A6T1,P0A6T2,P12341,P12709,P13377,P18240,P28718,P29333,P34795,P34796,P34797,P42861,P44312,P46479,P47357,P49105,P50309,P52029,P52030,P52031,P52983,P54234,P54235,P54236,P54237,P54238,P54239,P54240,P54241,P54242,P54243,P57636,P64192,P64193,P64194,P64195,P64196,P77877,P78033,P78917,P80860,P81181,P83194,P83780,P84140,P96803,P99078,Q0TA36,Q0VR14,Q11MA0,Q13Z07,Q165T7,Q18FQ4,Q1ASN4,Q1BH79,Q1CSA0,Q1CX51,Q1GAY0,Q1GJQ5,Q1GTU1,Q1H1P4,Q1IYT4,Q1J8N2,Q1JDQ8,Q1JIS1,Q1JNM4,Q1LM68,Q1LU73,Q1MM06,Q1QEK1,Q1R3R3,Q1WUR2,Q21M11,Q21ZD5,Q24VW9,Q255I6,Q28QX4,Q2A2C5,Q2FIB3,Q2FZU0,Q2G7C4,Q2IE39,Q2JH03,Q2JHU0,Q2JX86,Q2KCY8,Q2KYE9,Q2LRD0,Q2NJ38,Q2NR04,Q2P380,Q2RQ51,Q2S8W1,Q2SS24,Q2SWP6,Q2VYV7,Q2YBU4,Q2YPF3,Q2YWS3,Q31AX5,Q31I19,Q31LL0,Q31TX1,Q328X7,Q38WF1,Q39FF4,Q39SU1,Q3A201,Q3AFH3,Q3AJU7,Q3ASZ0,Q3AXV8,Q3B3Q8,Q3BUL3,Q3IKH4,Q3IMS0,Q3J2U4,Q3JCN1,Q3JRE2,Q3K2Y2,Q3K6Q4,Q3KLX6,Q3M6S3,Q3YUW0,Q3ZBD7,Q44407,Q46L16,Q47IJ3,Q48N88,Q48VF9,Q491V0,Q49WA1,Q4A5S9,Q4A7J2,Q4A9F3,Q4FVH5,Q4JCA7,Q4JX51,Q4K5Y1,Q4L4X8,Q4QL07,Q4R591,Q4UTV8,Q4ZY88,Q57F73,Q57H06,Q59000,Q59088,Q5E847,Q5FL04,Q5H0A7,Q5HHC2,Q5HQJ9,Q5JE38,Q5KVS7,Q5L5E1,Q5L9E3,Q5LRS9,Q5M1N9,Q5N0B4,Q5NFC4,Q5P0T4,Q5PL07,Q5QWW0,Q5R4E3,Q5SLL6,Q5UXU0,Q5WDX0,Q5WYE0,Q5X6Y8,Q5XE09,Q5YPP1,Q5ZXH2,Q600A8,Q609I7,Q62JL8,Q632G4,Q63V31,Q64PM7,Q65FL6,Q65TC2,Q660E3,Q664W9,Q67QQ0,Q6A5X5,Q6AQ48,Q6D022,Q6F1L2,Q6FRW1,Q6G0T9,Q6GAW4,Q6GIC6,Q6HC08,Q6KH90,Q6LM51,Q6LXQ4,Q6MD44,Q6MTA3,Q6NIE5,Q6YQU0,Q711G1,Q71X61,Q72GY6,Q72MT7,Q72YI4,Q73K18,Q742E4,Q74DK5,Q74K31,Q758L0,Q7MH97,Q7MUV9,Q7MZB4,Q7NJY9,Q7S986,Q7U6T0,Q7V1I1,Q7V7M6,Q7VBZ6,Q7VNR9,Q7VRI4,Q7VUF4,Q7W197,Q7WP01,Q816G0,Q81K75,Q822E7,Q82SP4,Q835G1,Q83D91,Q83XM3,Q848I4,Q87EV7,Q87L81,Q888Q7,Q88UI4,Q891H2,Q89A35,Q8A5W2,Q8CT80,Q8D1V8,Q8DCK7,Q8DKY2,Q8DN74,Q8EBH1,Q8ENY8,Q8EVU1,Q8EZG6,Q8FB44,Q8FR39,Q8G2N3,Q8G7I6,Q8K8Q6,Q8K910,Q8KDQ7,Q8L1Z9,Q8NS31,Q8NXF1,Q8P2R3,Q8P9S7,Q8R924,Q8RHH5,Q8SRY1,Q8UI94,Q8VVB7,Q8XI54,Q8XYN9,Q8Y4R7,Q8YF86,Q8YY05,Q8Z1U7,Q8ZAS2,Q8ZKI4,Q8ZWV0,Q928R6,Q92SC4,Q96YC2,Q978F3,Q97FP8,Q97NG0,Q97WE5,Q98BV5,Q98R79,Q9A1L1,Q9ABK5,Q9CD75,Q9CNL2,Q9FXM4,Q9FXM5,Q9HGZ2,Q9HIC2,Q9HNQ6,Q9HV67,Q9K7L8,Q9KUY4,Q9KX58,Q9N1E2,Q9PGR6,Q9PK16,Q9PMD4,Q9RDY2,Q9RMC1,Q9RTL8,Q9UXW3,Q9X1A5,Q9X670,Q9YE01,Q9Z6N4,Q9ZK49">phosphoglucose isomerase</protein-id>) from strain PC09 improves the yield from 3.4 to 4.0 mol <compound-id="6912">xylitol</compound-id> (mol <compound-id="206,5793,64689,79025">glucose</compound-id>)(-1), while deleting either or both E. coli transhydrogenases (<protein-id="O05139,P27306,P50529,P57112,P66006,P66007,P66008,P66009,P71317,Q0TA96,Q1CBU5,Q1CNP4,Q1QX78,Q1R3U7,Q2NQZ3,Q2SIP2,Q3K9F5,Q48A14,Q48KI8,Q4KFA6,Q4ZV77,Q57H91,Q5E212,Q5PK71,Q66G61,Q6CZB1,Q6LLT9,Q7MBG9,Q7MQ83,Q83MI1,Q87KN5,Q884I6,Q88KY8,Q8DD46,Q8FB93,Q8X727,Q8ZA97,Q9XBQ9">sthA</protein-id> and <protein-id="P07001,P43842">pntA</protein-id>) has no significant effect on the measured yield.	glucose__pgi__interaction	xylitol__phosphoglucose isomerase__interaction	xylitol__pgi__interaction	xylitol__sthA__no_interaction	glucose__phosphoglucose isomerase__interaction	glucose__sthA__no_interaction	glucose__pntA__no_interaction	xylitol__pntA__no_interaction
18698648-323	Deleting either <protein-id="O51581,O54537,O68282,O83491,O84188,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11411,P21907,P29686,P37986,P44311,P48848,P48992,P54547,P56110,P57405,P73411,P77809,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">zwf</protein-id> or <protein-id="O05966,O27115,O67546,O84828,O87840,P0A836,P0A837,P0A838,P0A839,P25126,P45101,P53592,P53593,P66867,P66868,P66869,P66870,P66871,P66872,P71559,P80886,P99071,Q49X32,Q4L5U8,Q4ULQ7,Q57663,Q57RL3,Q5HGI7,Q5HPU5,Q5PBI8,Q5PCM7,Q66DA0,Q68WU5,Q6F8L4,Q6G9W8,Q6GHJ0,Q72PA2,Q7MMN3,Q7U0Z1,Q7UKI3,Q822A1,Q87A98,Q87RE8,Q8CPH5,Q8DFQ1,Q8EFN8,Q8F746,Q8KFE7,Q8NMK7,Q8P676,Q8PHL5,Q8UC60,Q8Y1Y3,Q8ZH00,Q8ZVF3,Q92I21,Q98EC5,Q9AB94,Q9CNZ0,Q9EYG9,Q9HPP1,Q9JUT0,Q9JZP4,Q9KA20,Q9KQB5,Q9PAH1,Q9PHY1,Q9PL99,Q9RUY3,Q9Z5H8,Q9Z6T6">sucC</protein-id> (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol <compound-id="6912">xylitol</compound-id> (mol <compound-id="206,5793,64689,79025">glucose</compound-id>)(-1), respectively.	glucose__zwf__interaction	xylitol__sucC__interaction	glucose__sucC__interaction	xylitol__zwf__interaction
18698649-324	In the process studied, the enzyme cellobiose dehydrogenase (<protein-id="P17444,P54223,P60336,P60337,Q01738,Q0TKW1,Q13NG7,Q1BQE2,Q1C932,Q1CFR7,Q1MJU4,Q1QXE1,Q1RFM3,Q2FDP9,Q2FV11,Q2KB43,Q2T6D0,Q2YWJ5,Q39A44,Q3BXK8,Q3JLL7,Q3K5H3,Q48CM7,Q4A0Q1,Q4K4K7,Q4L9D7,Q4UYN5,Q4ZM63,Q5HCU1,Q5HL11,Q62CH8,Q63KK7,Q66D54,Q6D6D9,Q6FDF9,Q6G664,Q6GDJ1,Q6LGH5,Q7MF12,Q88AE7,Q88CW6,Q8BJ64,Q8CMY2,Q8D3K2,Q8FKI9,Q8G1Z8,Q8NE62,Q8NUM0,Q8P5D7,Q8PPG8,Q8UH55,Q8X6C6,Q8YFY2,Q8ZGW0,Q985M5,Q9HTJ2,Q9L4K0,Q9RA05,Q9X2M2">CDH</protein-id>) oxidizes <compound-id="294,6134,84571,440995">lactose</compound-id> at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to <compound-id="7314">lactobionic acid</compound-id>.	lactobionic acid__CDH__no_interaction	lactose__CDH__interaction
18698649-325	2,2'-Azino-bis (3-ethylbenzothiazoline-6-<compound-id="104748">sulfonic acid</compound-id>) diammonium salt was used as electron acceptor for <protein-id="P17444,P54223,P60336,P60337,Q01738,Q0TKW1,Q13NG7,Q1BQE2,Q1C932,Q1CFR7,Q1MJU4,Q1QXE1,Q1RFM3,Q2FDP9,Q2FV11,Q2KB43,Q2T6D0,Q2YWJ5,Q39A44,Q3BXK8,Q3JLL7,Q3K5H3,Q48CM7,Q4A0Q1,Q4K4K7,Q4L9D7,Q4UYN5,Q4ZM63,Q5HCU1,Q5HL11,Q62CH8,Q63KK7,Q66D54,Q6D6D9,Q6FDF9,Q6G664,Q6GDJ1,Q6LGH5,Q7MF12,Q88AE7,Q88CW6,Q8BJ64,Q8CMY2,Q8D3K2,Q8FKI9,Q8G1Z8,Q8NE62,Q8NUM0,Q8P5D7,Q8PPG8,Q8UH55,Q8X6C6,Q8YFY2,Q8ZGW0,Q985M5,Q9HTJ2,Q9L4K0,Q9RA05,Q9X2M2">CDH</protein-id> and was continuously regenerated (reoxidized) by <protein-id="Q12570">laccase</protein-id>, a blue multi-copper oxidase.	sulfonic acid__CDH__interaction	sulfonic acid__laccase__interaction
18698649-326	<compound-id="977">Oxygen</compound-id> served as the terminal electron acceptor of the reaction and was fully reduced to water by <protein-id="Q12570">laccase</protein-id>.	Oxygen__laccase__interaction
18699724-117	Immunocytochemical localization of cell surface markers like <compound-id="53262342">SSEA-3</compound-id>, SSEA-4, <compound-id="444212">TRA</compound-id>-1-60, and <compound-id="444212">TRA</compound-id>-1-81, staining for <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> and <protein-id="P03358,P03554,P03555,P03556,P04323,P05400,P09523,P0A3U0,P0A3U1,P10394,P10399,P10400,P10401,P10978,P11283,P11369,P15629,P16423,P19199,P20825,P21325,P21328,P21329,P23070,P23071,P23072,P27502,Q00962,Q02964,Q03269,Q03270,Q03271,Q03272,Q03273,Q03274,Q03275,Q03276,Q03277,Q03278,Q03279,Q05118,Q8I7P9,Q95SX7,Q9NBX4,Q9QC07">reverse transcriptase</protein-id> polymerase chain reaction (RT-<protein-id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</protein-id>) analysis of pluripotency state markers viz.	TRA__reverse transcriptase__no_interaction	SSEA-3__reverse transcriptase__no_interaction	TRA__alkaline phosphatase__no_interaction	TRA__PCR__no_interaction	SSEA-3__PCR__no_interaction	SSEA-3__alkaline phosphatase__no_interaction
18699774-1334	<compound-id="73611">Solamargine</compound-id> induces apoptosis and enhances susceptibility to trastuzumab and <compound-id="41867">epirubicin</compound-id> in breast cancer cells with low or high expression levels of <protein-id="P04626">HER2</protein-id>/<protein-id="O35657,P06494,P29503,P70424,Q24746">neu</protein-id>.	epirubicin__neu__no_interaction	Solamargine__HER2__no_interaction	epirubicin__HER2__no_interaction	Solamargine__neu__no_interaction
18699774-1335	SM (<compound-id="73611">solamargine</compound-id>), a major <compound-id="452975">steroidal alkaloid</compound-id> glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of <protein-id="P04626">HER2</protein-id>/<protein-id="O35657,P06494,P29503,P70424,Q24746">neu</protein-id> expression by SM was investigated.	solamargine__HER2__no_interaction	steroidal alkaloid__neu__no_interaction	solamargine__neu__no_interaction	steroidal alkaloid__HER2__no_interaction
18700056-1486	Since <compound-id="4595">ondansetron</compound-id> completely reversed the effects of <compound-id="4380">clorgyline</compound-id> on DA neuronal activity, the effects of <protein-id="O18851,P21397,P21398,P58027,Q5NU32,Q5RE60,Q6Q2J0">MAOA</protein-id> inhibition appeared to be mediated by <protein-id="O70212,P23979,P35563,P46098">5-HT3</protein-id> receptors.	clorgyline__5-HT3__no_interaction	clorgyline__MAOA__no_interaction	ondansetron__5-HT3__no_interaction	ondansetron__MAOA__no_interaction
18700057-534	The effects of <protein-id="P0A3L5,P0A3L6,P15653,P25018,P46376,Q04590,Q47851,Q80UN9">Ipt</protein-id> were reversed by the mitochondrial KATP blocker, <compound-id="1825">5-hydroxydecanoate</compound-id>, indicating that mitochondrial KATP channels participate in the regulation of astrocyte activation.	5-hydroxydecanoate__Ipt__interaction
18700809-895	The cell proliferation, the up-regulation of pS2, and the down-regulation of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> and <protein-id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ERbeta</protein-id> gene expressions induced by the racemate and enantiomers of o,p'-DDT were all reversed by cotreatment with 10(-6) mol/L <compound-id="104741">ICI 182,780</compound-id>.	ICI 182,780__ERalpha__interaction	ICI 182,780__ERbeta__interaction
18700818-411	While bass in all <compound-id="3017">diazinon</compound-id> treatment groups had significantly inhibited brain <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> activity, only the medium and high treatment groups showed a dose- and time-dependent increase in time to capture prey.	diazinon__AChE__interaction
18701427-85	The aim of this phase 0 study was to investigate whether <compound-id="60750">gemcitabine</compound-id> passes the blood-tumor barrier, and is phosphorylated in the tumor by <protein-id="P27707,P43346,P48769">deoxycytidine kinase</protein-id> (<protein-id="P21974,P27707,P43346,P48769,Q9J579">dCK</protein-id>) to <compound-id="60750">gemcitabine</compound-id> nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	gemcitabine__deoxycytidine kinase__interaction	gemcitabine__dCK__interaction
18701806-1254	The <compound-id="614,8988,145742">proline</compound-id> mutation at amino acid location 164 significantly reduced the initial hydrolysis of either the <protein-id="O97646,O97647,Q28462">amelogenins</protein-id> in solution or the proteins bound on HAP, which was confirmed by amelogenin oligopeptide assays.	proline__amelogenins__interaction
18701809-777	In conclusion, dentin mineralization in a corrected <compound-id="1061,167704,644102">phosphate</compound-id> and <compound-id="5280795">vitamin D</compound-id> environment compensates the adverse effect of <protein-id="P78562">PHEX</protein-id> mutation.	phosphate__PHEX__no_interaction	vitamin D__PHEX__no_interaction
18702173-1549	The considered biological model system consisted of a coating antibody (goat IgG), bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) as blocking agent, and a complementary antibody labelled with <compound-id="18730">FITC</compound-id> (anti-goat IgG).	FITC__BSA__no_interaction	FITC__serum albumin__no_interaction
18702613-201	Prolonged L-<compound-id="602,4580,5950,71080">alanine</compound-id> exposure induces changes in metabolism, <compound-id="271">Ca(2</compound-id>+) handling and desensitization of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion in clonal pancreatic beta-cells.	Ca(2__insulin__no_interaction	alanine__insulin__interaction
18702613-203	Collectively, these results illustrate the phenomenon of beta-cell desensitization by amino acids, indicating that prolonged exposure to <compound-id="602,4580,5950,71080">alanine</compound-id> can induce reversible alterations to metabolic flux, <compound-id="271">Ca(2</compound-id>+) handling and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion.	Ca(2__insulin__no_interaction	alanine__insulin__interaction
18702682-263	Acylation-stimulating protein (<protein-id="P32765,P42127,P45381,P79407,Q03288,Q16937,Q1XGU5,Q1XGU6,Q1XGU7,Q1XGU8,Q1XGU9,Q1XGV0,Q1XGV1,Q1XGV2,Q1XGV3,Q1XGV4,Q1XGV5,Q1XGV6,Q1XGV7,Q29414,Q5UK76,Q6ZYM3,Q865F0,Q95MP2,Q99JA2,Q9H1Y0,Q9NQ94">ASP</protein-id>) has been shown to positively stimulate fatty acid esterification and <compound-id="206,5793,64689,79025">glucose</compound-id> uptake in adipocytes.	glucose__ASP__interaction
18703100-623	Using a set of experiments aimed at manipulate a putative <compound-id="33032">l-glutamate</compound-id>/<compound-id="22880">NMDA</compound-id>/NO signal transduction pathway, we have demonstrated, by quantitative real-time PCR, that <compound-id="22880">NMDA</compound-id> enhances the expression of <protein-id="P27429">GnRH</protein-id> mRNA in a dose-response manner.	l-glutamate__GnRH__interaction	NMDA__GnRH__interaction
18703333-1701	Reaction parameters for the production of XOS from corncob using <protein-id="Q60042">endoxylanase</protein-id> from Aspergillus oryzae MTCC 5154 were optimized and an XOS yield of 10.2+/-0.14 mg ml(-1) corresponding to 81+/-3.9% with 73.5% <compound-id="439538">xylobiose</compound-id> was obtained.	xylobiose__endoxylanase__no_interaction
18703532-1538	<compound-id="2754">Cilostazol</compound-id> inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated <protein-id="P00513,P25848">protein kinase</protein-id> activation in vascular endothelial cells.	Cilostazol__protein kinase__interaction
18703532-1539	<compound-id="2754">Cilostazol</compound-id> is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (<compound-id="6076">cAMP</compound-id>) levels and activates <protein-id="Q05608,Q9RI12">protein kinase A</protein-id>, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.	cAMP__protein kinase A__no_interaction	Cilostazol__protein kinase A__interaction
18703532-1540	We hypothesized that <compound-id="2754">cilostazol</compound-id> may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated <protein-id="P00513,P25848">protein kinase</protein-id> (<protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id>) in vascular endothelial cells.	cilostazol__AMPK__interaction	cilostazol__protein kinase__interaction
18703622-1294	Serum <compound-id="5757">estradiol</compound-id> (E2) levels were not altered at any time point after <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id>, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.	estradiol__IGF-I__no_interaction
18703794-1209	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, keratinocyte chemoattractant (KC), macrophage inflammatory protein (<protein-id="P06624,P28238,P30301,P35999,P37932,Q01992,Q09734,Q10415,Q6J8I9,Q6RZ07,Q92973,Q99797">MIP</protein-id>)-2, and <protein-id="P10147,P10855,P50229,Q5I1Z0,Q8HYQ3,Q8SQA6">MIP-1alpha</protein-id> while simultaneously synergizing with <compound-id="24759">hyaluronan</compound-id> fragments to up-regulate the TH1 cytokine IL-12.	hyaluronan__TNF-alpha__no_interaction	hyaluronan__MIP__no_interaction	hyaluronan__MIP-1alpha__no_interaction
18703795-1210	In addition, treatment of primary mouse lung fibroblasts with <compound-id="123831">ADMA</compound-id> stimulated <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id> activity and collagen formation in vitro.	ADMA__arginase__interaction
18703795-1211	These data support the idea that <compound-id="123831">ADMA</compound-id> may play a role in airway diseases, including asthma and pulmonary fibrosis, through <protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id> inhibition and enhancement of <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id> activity.	ADMA__arginase__interaction	ADMA__NOS__interaction
18703867-1272	Osteopontin (<protein-id="P10451,P14287,P31096,Q9XSY9">OPN</protein-id>) inhibits the growth of <compound-id="971">calcium oxalate monohydrate</compound-id> (COM) and other crystal phases in a phosphorylation-dependent manner.	calcium oxalate monohydrate__OPN__interaction
18703992-1333	Prostaglandins D2, E2, and F2alpha were increased in the tissues from mouse pups exposed to &gt;95% <compound-id="977,5359597">O2</compound-id> at 7 d indicating a differential expression of <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</protein-id> products.	O2__cyclooxygenase-2__no_interaction
18704001-1340	<compound-id="206,5793,64689,79025">Glucose</compound-id> replacement to euglycemia causes hypoxia, acidosis, and decreased <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion in fetal sheep with intrauterine growth restriction.	Glucose__insulin__interaction
18704001-1341	<compound-id="206,5793,64689,79025">Glucose</compound-id> stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion (GSIS) was lower in the Glu group.	Glucose__insulin__interaction
18704095-238	These data confirm that endogenous miR-<compound-id="7248">34a</compound-id> regulates <protein-id="Q14831,Q5RDQ8">GRM7</protein-id> levels and supports the notion that miR-<compound-id="7248">34a</compound-id> contributes to the effects of <compound-id="28486,3028194">lithium</compound-id> and VPA on <protein-id="Q14831,Q5RDQ8">GRM7</protein-id>.	34a__GRM7__interaction	lithium__GRM7__interaction
18704096-1413	These results confirm the therapeutic potential of <protein-id="P31424,P41594">mGluR5</protein-id> blockade on motor symptoms induced by reduced striatal <compound-id="681">dopamine</compound-id> function.	dopamine__mGluR5__interaction
18704096-1414	Further, they demonstrate that <protein-id="P31424,P41594">mGluR5</protein-id> blockade may also have beneficial effects on cognitive deficits induced by <compound-id="681">dopamine</compound-id> depletion.	dopamine__mGluR5__interaction
18704103-600	Here, we found that the addition of glucocorticoids, such as <compound-id="5743">dexamethasone</compound-id> and <compound-id="5754">cortisol</compound-id>, to cultured human keratinocytes increased their <protein-id="O60603,Q2V897,Q689D1,Q95LA9,Q95M53,Q9R1F8">TLR2</protein-id> gene expression.	cortisol__TLR2__interaction	dexamethasone__TLR2__interaction
18704103-601	Gene expression of mitogen-activated protein kinase (<protein-id="O42781,P27638,Q00859">MAPK</protein-id>) phosphatase-1 was also increased by the addition of <compound-id="5743">dexamethasone</compound-id>.	dexamethasone__MAPK__interaction
18704264-1595	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker <protein-id="P06731">carcinoembryonic antigen</protein-id> (<protein-id="P06731">CEA</protein-id>) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (<protein-id="P15557,P19440,P20735,Q05053">GGT</protein-id>), <protein-id="P07024,P52307,Q56878,Q9I767,Q9RN37,Q9XZ43">5'nucleotidase</protein-id> (5'ND) and lactate dehydrogenase (<protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id>) with concomitant decrease in the levels of tissue antioxidants like <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx), <compound-id="124886">reduced glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> and <compound-id="54670067">vitamin C</compound-id>.	GSH__SOD__no_interaction	reduced glutathione__SOD__no_interaction	vitamin C__CEA__no_interaction	vitamin C__CAT__no_interaction	GSH__GGT__no_interaction	reduced glutathione__LDH__no_interaction	vitamin C__catalase__no_interaction	reduced glutathione__GGT__no_interaction	vitamin E__CEA__no_interaction	vitamin E__CAT__no_interaction	GSH__CEA__no_interaction	vitamin E__SOD__no_interaction	vitamin E__catalase__no_interaction	GSH__carcinoembryonic antigen__no_interaction	vitamin E__GGT__no_interaction	GSH__CAT__no_interaction	reduced glutathione__CAT__no_interaction	vitamin E__carcinoembryonic antigen__no_interaction	vitamin C__carcinoembryonic antigen__no_interaction	vitamin E__5'nucleotidase__no_interaction	vitamin C__GGT__no_interaction	GSH__glutathione peroxidase__no_interaction	reduced glutathione__5'nucleotidase__no_interaction	reduced glutathione__superoxide dismutase__no_interaction	GSH__superoxide dismutase__no_interaction	vitamin E__glutathione peroxidase__no_interaction	vitamin E__superoxide dismutase__no_interaction	GSH__LDH__no_interaction	reduced glutathione__CEA__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction	reduced glutathione__catalase__no_interaction	GSH__catalase__no_interaction	GSH__5'nucleotidase__no_interaction	vitamin C__superoxide dismutase__no_interaction	vitamin C__glutathione peroxidase__no_interaction	vitamin C__LDH__no_interaction	vitamin C__5'nucleotidase__no_interaction	vitamin C__SOD__no_interaction	reduced glutathione__carcinoembryonic antigen__no_interaction	vitamin E__LDH__no_interaction
18704417-141	Achieving CCgR within 12 months and maintaining it without an increase in <protein-id="P11274">BCR</protein-id>-<protein-id="P00519,P00521,P10447,P11681,Q00022">ABL</protein-id> transcripts might indicate that low-dose <compound-id="5291">imatinib</compound-id> therapy can produce acceptable outcomes without excess toxicity.	imatinib__BCR__interaction	imatinib__ABL__interaction
18704487-89	<protein-id="P40792,P63001,Q6RUV5">Rac1</protein-id> (-/-) platelets displayed defective thrombus formation on collagen under flow conditions which could be fully restored by co-infusion of ADP and the <compound-id="5280497">TxA(2</compound-id>) analog U46619, indicating that impaired <protein-id="P0C191,Q9HCN6">GPVI</protein-id>-, but not G-protein signaling, was responsible for the observed defect.	TxA(2__GPVI__no_interaction	TxA(2__Rac1__no_interaction
18704543-120	<protein-id="P09848,P09849">LCT</protein-id> 13910 CC genotype is associated with <compound-id="294,6134,84571,440995">lactose</compound-id> intolerance, a condition often resulting in reduced milk intake.	lactose__LCT__interaction
18704651-196	Osteointegration of <compound-id="23963">titanium</compound-id> or its alloy with bone can be greatly improved by <compound-id="24441,24456,24632">calcium phosphate</compound-id> coatings, and further enhanced by an extracellular <protein-id="O12705,O18559,O57299,O89341,P03314,P03344,P03419,P03426,P03519,P04876,P04888,P05769,P06157,P06166,P06446,P06502,P06503,P06935,P06942,P06943,P07564,P07720,P07873,P08325,P08671,P09732,P09866,P11206,P12446,P12823,P13616,P13844,P14335,P14336,P14340,P14403,P15200,P16287,P16628,P16629,P17748,P17763,P18356,P18611,P19110,P19692,P19718,P22046,P22338,P24266,P24615,P25058,P25182,P25223,P25224,P26034,P27019,P27020,P27287,P27395,P27663,P27910,P27912,P27913,P27915,P29165,P29837,P29838,P29983,P29984,P29990,P29991,P30026,P31035,P31620,P32886,P33478,P33482,P33515,P35947,P35976,P36355,P36356,P41358,P52637,P62683,P62684,P62685,P62689,P62690,P63117,P63126,P63128,P63130,P63145,P87577,P87889,Q01299,Q01427,Q04538,Q074N0,Q1X880,Q1X881,Q66112,Q6DV88,Q6J3P1,Q7LDI9,Q84131,Q88266,Q88428,Q89277,Q91B74,Q96PI4,Q98803,Q9HDB9,Q9IK90,Q9JAF2,Q9NRZ4,Q9UKH8,Q9YNA8,Q9YRV3">matrix protein</protein-id> layer such as collagen.	titanium__matrix protein__interaction	calcium phosphate__matrix protein__no_interaction
18704653-197	Use of <protein-id="P08587,P21980,P21981,P51176,P52181,Q01841">tissue transglutaminase</protein-id> and <protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id> to influence osteoblast responses to <compound-id="24456">tricalcium phosphate</compound-id> scaffolds.	tricalcium phosphate__tissue transglutaminase__interaction	tricalcium phosphate__fibronectin__interaction
18704653-198	To explore the possibility of controlling cell interaction with biomaterials, <compound-id="24456">tricalcium phosphate</compound-id> scaffolds were modified using the enzyme <protein-id="P08587,P21980,P21981,P51176,P52181,Q01841">tissue transglutaminase</protein-id> (tTgase) in conjunction with <protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id>.	tricalcium phosphate__tissue transglutaminase__interaction	tricalcium phosphate__fibronectin__interaction
18704755-900	A special rigid planar structural octupolar molecule titled 2,4,6-tris(p-methylstyryl)-<compound-id="9262,20437">s-triazine</compound-id> (TMT) was synthesized and its interaction with bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) were studied by molecular spectroscopy.	s-triazine__BSA__interaction	s-triazine__serum albumin__interaction
18704762-296	<protein-id="Q865F8,Q9NZD4">AHSP</protein-id> inhibits cellular production of the reactive <compound-id="977">oxygen</compound-id> species.	oxygen__AHSP__interaction
18704766-300	Four MPTP monkeys received <compound-id="6047">L-DOPA</compound-id>/<compound-id="2327">Benserazide</compound-id> plus CI-1041 an NMDA antagonist selective for <protein-id="P11605,P11832,P16081,P39865,Q9SML8">NR1</protein-id>/<protein-id="Q00960,Q01097,Q13224">NR2B</protein-id> and four were treated with <compound-id="6047">L-DOPA</compound-id>/<compound-id="2327">Benserazide</compound-id> plus a small dose of <compound-id="54746">cabergoline</compound-id> ; one monkey of each group developed mild dyskinesias at the end of treatment.	Benserazide__NR1__no_interaction	cabergoline__NR1__no_interaction	Benserazide__NR2B__no_interaction	L-DOPA__NR1__no_interaction	cabergoline__NR2B__no_interaction	L-DOPA__NR2B__no_interaction
18704766-304	Hence, MPTP lesion, <compound-id="6047">L-DOPA</compound-id> treatment and prevention of LID with CI-1041 and <compound-id="54746">cabergoline</compound-id>, or reduction with <compound-id="5282337">Ro 61-8048</compound-id> were associated with modulation of <protein-id="Q00960,Q01097,Q13224">NR2B</protein-id>/NMDA glutamate receptors.	Ro 61-8048__NR2B__interaction	L-DOPA__NR2B__interaction	cabergoline__NR2B__interaction
18704940-430	<protein-id="O06222,O07108,O07669,O25236,O51532,O67852,O83873,O84763,P0A089,P0A090,P0A091,P0C0D7,P0C0D8,P14900,P45063,P57313,P57995,P73668,Q03522,Q0SHR9,Q0SQ91,Q0TLQ1,Q0TMJ3,Q0VS04,Q11GS3,Q11RH3,Q12EL7,Q13TZ0,Q14J05,Q163I6,Q182Y7,Q1AVX1,Q1BZG5,Q1C212,Q1CMM9,Q1CU35,Q1D0S8,Q1GAT6,Q1GIV4,Q1GRX7,Q1GYZ9,Q1IKG8,Q1J147,Q1J5S5,Q1JAT4,Q1JG10,Q1JKY4,Q1LIM4,Q1LSW4,Q1ME31,Q1MPC1,Q1Q883,Q1QNU5,Q1QVG5,Q1RGA7,Q1RI52,Q1WT99,Q216E0,Q21MH1,Q21SW7,Q24TE4,Q255W7,Q28NN2,Q2A1Z9,Q2FHQ4,Q2FZ92,Q2G997,Q2IG29,Q2IYL0,Q2JD52,Q2JHP5,Q2JVR9,Q2K6B9,Q2KVF5,Q2LR50,Q2NVV3,Q2P5V2,Q2RK81,Q2RVU2,Q2S530,Q2S9Z0,Q2SZI5,Q2W0H5,Q2Y636,Q2YM69,Q2YXD9,Q313Q5,Q319C4,Q31I61,Q31MM2,Q326E7,Q32K04,Q38XM9,Q39JX2,Q39YM1,Q3A2G4,Q3AAE4,Q3AHP0,Q3ANV5,Q3AZI5,Q3B127,Q3BR29,Q3IG02,Q3J4M6,Q3J787,Q3JND6,Q3K2P4,Q3K742,Q3KKT4,Q3MF19,Q3SMH5,Q3STT0,Q3Z5S1,Q46JA8,Q46WZ2,Q47AA2,Q47QX1,Q47VQ7,Q48EF6,Q48SK8,Q493Q3,Q49WW5,Q4FQ21,Q4JW97,Q4K6J1,Q4L5N4,Q4QLG0,Q4ULT8,Q4UWX9,Q4ZNY8,Q52953,Q57C76,Q57TD2,Q5E2P8,Q5F6L6,Q5FKV3,Q5FUJ7,Q5GSC8,Q5H2Y1,Q5HGP8,Q5HQ09,Q5HW34,Q5L0X7,Q5L521,Q5LIJ5,Q5LU71,Q5M0D5,Q5M4Y2,Q5MZA8,Q5NHK3,Q5NPA7,Q5P6Z4,Q5PBH9,Q5PDC2,Q5R0M3,Q5SJD2,Q5WFG8,Q5WTI5,Q5X1S4,Q5XB04,Q5YYY1,Q5ZSA3,Q604V5,Q62GS5,Q636B4,Q63QJ5,Q64ZL9,Q65JY2,Q65RY4,Q66EK7,Q67QM7,Q68WW9,Q6A9Q4,Q6AE62,Q6AJ52,Q6D0I1,Q6FFC2,Q6G122,Q6G2Q3,Q6GA29,Q6GHQ2,Q6HEQ2,Q6LMF4,Q6MBS4,Q6MIF8,Q6N409,Q6NGC6,Q71XX7,Q728U6,Q72JQ1,Q72NP4,Q732F6,Q73GT3,Q73YQ6,Q748D4,Q74JY5,Q7MNV3,Q7MWM5,Q7N145,Q7NEZ5,Q7NPZ7,Q7U8T1,Q7V0A5,Q7V5V5,Q7VAM1,Q7VEP7,Q7VP56,Q7VQI9,Q7VUQ1,Q7W4B2,Q7WFS0,Q819Q2,Q81WC9,Q821S1,Q82AD8,Q82VS5,Q83F20,Q83GN2,Q83HK0,Q83MF9,Q879A1,Q87EA7,Q87SG6,Q87WY3,Q88N78,Q88V80,Q899G5,Q89AQ2,Q89FU5,Q8A256,Q8CSX6,Q8D2Z4,Q8DEK8,Q8DMN8,Q8DQM2,Q8DVE3,Q8E186,Q8E6P1,Q8E9P6,Q8ER50,Q8F7V4,Q8FL65,Q8FNT8,Q8FZP2,Q8G4Q6,Q8K9T2,Q8KGD2,Q8NX35,Q8P063,Q8P775,Q8PII9,Q8R9G4,Q8RDQ1,Q8UDM6,Q8X9Y9,Q8XHM4,Q8XVI5,Q8Y5M1,Q8YI68,Q8YPS9,Q8Z9H0,Q8ZIF1,Q8ZRU4,Q929Y1,Q92I60,Q97EB9,Q97RU8,Q98KB1,Q9A597,Q9CF91,Q9CPB0,Q9F1N2,Q9HVZ9,Q9JSZ5,Q9K0Y4,Q9K9S8,Q9KPG5,Q9PEB0,Q9PI73,Q9PLG5,Q9RRJ4,Q9S2W9,Q9WY76,Q9Z705,Q9ZDC2,Q9ZLY0">MurD</protein-id> (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (<compound-id="5496796">UMA</compound-id>) utilizing ATP hydrolysis to ADP and P(i).	UMA__MurD__interaction
18704940-431	On the basis of structural studies of <protein-id="O06222,O07108,O07669,O25236,O51532,O67852,O83873,O84763,P0A089,P0A090,P0A091,P0C0D7,P0C0D8,P14900,P45063,P57313,P57995,P73668,Q03522,Q0SHR9,Q0SQ91,Q0TLQ1,Q0TMJ3,Q0VS04,Q11GS3,Q11RH3,Q12EL7,Q13TZ0,Q14J05,Q163I6,Q182Y7,Q1AVX1,Q1BZG5,Q1C212,Q1CMM9,Q1CU35,Q1D0S8,Q1GAT6,Q1GIV4,Q1GRX7,Q1GYZ9,Q1IKG8,Q1J147,Q1J5S5,Q1JAT4,Q1JG10,Q1JKY4,Q1LIM4,Q1LSW4,Q1ME31,Q1MPC1,Q1Q883,Q1QNU5,Q1QVG5,Q1RGA7,Q1RI52,Q1WT99,Q216E0,Q21MH1,Q21SW7,Q24TE4,Q255W7,Q28NN2,Q2A1Z9,Q2FHQ4,Q2FZ92,Q2G997,Q2IG29,Q2IYL0,Q2JD52,Q2JHP5,Q2JVR9,Q2K6B9,Q2KVF5,Q2LR50,Q2NVV3,Q2P5V2,Q2RK81,Q2RVU2,Q2S530,Q2S9Z0,Q2SZI5,Q2W0H5,Q2Y636,Q2YM69,Q2YXD9,Q313Q5,Q319C4,Q31I61,Q31MM2,Q326E7,Q32K04,Q38XM9,Q39JX2,Q39YM1,Q3A2G4,Q3AAE4,Q3AHP0,Q3ANV5,Q3AZI5,Q3B127,Q3BR29,Q3IG02,Q3J4M6,Q3J787,Q3JND6,Q3K2P4,Q3K742,Q3KKT4,Q3MF19,Q3SMH5,Q3STT0,Q3Z5S1,Q46JA8,Q46WZ2,Q47AA2,Q47QX1,Q47VQ7,Q48EF6,Q48SK8,Q493Q3,Q49WW5,Q4FQ21,Q4JW97,Q4K6J1,Q4L5N4,Q4QLG0,Q4ULT8,Q4UWX9,Q4ZNY8,Q52953,Q57C76,Q57TD2,Q5E2P8,Q5F6L6,Q5FKV3,Q5FUJ7,Q5GSC8,Q5H2Y1,Q5HGP8,Q5HQ09,Q5HW34,Q5L0X7,Q5L521,Q5LIJ5,Q5LU71,Q5M0D5,Q5M4Y2,Q5MZA8,Q5NHK3,Q5NPA7,Q5P6Z4,Q5PBH9,Q5PDC2,Q5R0M3,Q5SJD2,Q5WFG8,Q5WTI5,Q5X1S4,Q5XB04,Q5YYY1,Q5ZSA3,Q604V5,Q62GS5,Q636B4,Q63QJ5,Q64ZL9,Q65JY2,Q65RY4,Q66EK7,Q67QM7,Q68WW9,Q6A9Q4,Q6AE62,Q6AJ52,Q6D0I1,Q6FFC2,Q6G122,Q6G2Q3,Q6GA29,Q6GHQ2,Q6HEQ2,Q6LMF4,Q6MBS4,Q6MIF8,Q6N409,Q6NGC6,Q71XX7,Q728U6,Q72JQ1,Q72NP4,Q732F6,Q73GT3,Q73YQ6,Q748D4,Q74JY5,Q7MNV3,Q7MWM5,Q7N145,Q7NEZ5,Q7NPZ7,Q7U8T1,Q7V0A5,Q7V5V5,Q7VAM1,Q7VEP7,Q7VP56,Q7VQI9,Q7VUQ1,Q7W4B2,Q7WFS0,Q819Q2,Q81WC9,Q821S1,Q82AD8,Q82VS5,Q83F20,Q83GN2,Q83HK0,Q83MF9,Q879A1,Q87EA7,Q87SG6,Q87WY3,Q88N78,Q88V80,Q899G5,Q89AQ2,Q89FU5,Q8A256,Q8CSX6,Q8D2Z4,Q8DEK8,Q8DMN8,Q8DQM2,Q8DVE3,Q8E186,Q8E6P1,Q8E9P6,Q8ER50,Q8F7V4,Q8FL65,Q8FNT8,Q8FZP2,Q8G4Q6,Q8K9T2,Q8KGD2,Q8NX35,Q8P063,Q8P775,Q8PII9,Q8R9G4,Q8RDQ1,Q8UDM6,Q8X9Y9,Q8XHM4,Q8XVI5,Q8Y5M1,Q8YI68,Q8YPS9,Q8Z9H0,Q8ZIF1,Q8ZRU4,Q929Y1,Q92I60,Q97EB9,Q97RU8,Q98KB1,Q9A597,Q9CF91,Q9CPB0,Q9F1N2,Q9HVZ9,Q9JSZ5,Q9K0Y4,Q9K9S8,Q9KPG5,Q9PEB0,Q9PI73,Q9PLG5,Q9RRJ4,Q9S2W9,Q9WY76,Q9Z705,Q9ZDC2,Q9ZLY0">MurD</protein-id> complexes, a stepwise catalytic mechanism was proposed that commences with a formation of the acyl-<compound-id="1061,167704,644102">phosphate</compound-id> intermediate, followed by a nucleophilic attack of <compound-id="23327">D-glutamate</compound-id> that, through the formation of a tetrahedral reaction intermediate and subsequent <compound-id="1061,167704,644102">phosphate</compound-id> dissociation, affords the final product, UDP-N-acetyl-muramoyl-<compound-id="14534790">L-alanine-D-glutamate</compound-id> (UMAG).	phosphate__MurD__interaction	D-glutamate__MurD__interaction	L-alanine-D-glutamate__MurD__interaction
18704946-1065	Although the overall amino acid identity between <protein-id="P31645,Q9XT49">SERTs</protein-id> and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of <compound-id="1150">tryptamine</compound-id> derivatives in atomic detail.	tryptamine__SERTs__interaction
18704953-1278	Mal-<protein-id="P56862">sCT</protein-id>, prepared by conjugating <protein-id="P56862">sCT</protein-id> via thio-<compound-id="3283,5382654">ether</compound-id> bonds with aqueous-soluble <compound-id="985">palmitic acid</compound-id> derivative at Cys 1 and Cys 7, was reacted with <compound-id="8019">mPEG</compound-id>-<compound-id="11439">succinimide</compound-id> (<compound-id="8019">mPEG</compound-id>-Suc, 5 kDa).	succinimide__sCT__interaction	palmitic acid__sCT__interaction	ether__sCT__interaction	mPEG__sCT__interaction
18704955-1137	Our findings suggest that <protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id> substituted with a PEG of an appropriate Mw at Lys (34) could be used as a promising type 2 anti-diabetic agent to timely control postprandial <compound-id="206,5793,64689,79025">glucose</compound-id> levels.	glucose__GLP-1__interaction
18706130-1404	The antidepressant <compound-id="82148">agomelatine</compound-id> blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (<protein-id="P13591,P13592,P31836">NCAM</protein-id>) expression in the hippocampus of rats.	agomelatine__NCAM__interaction
18706695-1298	<protein-id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">Phosphatase</protein-id> activity was also inhibited for all the soils treated with <compound-id="5564">triclosan</compound-id> (from 0.1 to 50mg/kg dry soil), but a declining inhibition was observed after 2 days of incubation.	triclosan__Phosphatase__interaction
18706848-328	The interaction between bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id> (5-)) as well as the damage of <protein-id="P02769">BSA</protein-id> in the presence of <compound-id="29936">Fe(III</compound-id>)-<compound-id="875,439655,444305">tartrate</compound-id> complexes under ultrasonic irradiation was studied by UV-vis and fluorescence spectra.	Fe(III__serum albumin__interaction	tartrate__BSA__interaction	tartrate__serum albumin__interaction	Fe(III__BSA__interaction
18706848-329	In addition, the influences of ultrasonic irradiation time, <compound-id="29936">Fe(III</compound-id>)-<compound-id="875,439655,444305">tartrate</compound-id> complex concentration, ionic strength and solution acidity (pH value) were also examined on the damage of <protein-id="P02769">BSA</protein-id>.	tartrate__BSA__interaction	Fe(III__BSA__interaction
18706848-330	Otherwise, under ultrasonic irradiation the <protein-id="P02769">BSA</protein-id> molecules were obviously damaged by the <compound-id="29936">Fe(III</compound-id>)-<compound-id="875,439655,444305">tartrate</compound-id> complexes.	tartrate__BSA__interaction	Fe(III__BSA__interaction
18706940-826	The magnitude of autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations and <compound-id="5957">ATP</compound-id> levels via signaling pathways that include the nutrient sensing kinase <protein-id="P51450">TOR</protein-id>.	ATP__TOR__no_interaction
18707755-1088	Normoglycemic (4.72 mmol/L), moderate (11.1 mmol/L) or high grade (16.7 mmol/<compound-id="2724488,10954115">L) glucose</compound-id> clamps were maintained for 6 hours by infusion of <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="16129681,16129706">somatostatin</compound-id>.	L) glucose__insulin__no_interaction	glucose__insulin__no_interaction	somatostatin__insulin__no_interaction
18708066-1324	or=6 ng/ml) was associated with increased expression of <protein-id="O24999,O35379,O66946,P0AF08,P0AF09,P28667,P32653,P45135,P50863,P53381,P53382,P53383,P65441,P65442,Q92JA4,Q9RVM9,Q9ZE27,Q9ZMM5">mrp</protein-id>-1 and <protein-id="P34712">pgp-1</protein-id> and decreased <compound-id="124886">glutathione</compound-id>, while higher level resistance (10 ng/ml) was primarily associated with the increased expression of P-<protein-id="P08163">glycoproteins</protein-id>.	glutathione__pgp-1__no_interaction	glutathione__glycoproteins__no_interaction	glutathione__mrp__no_interaction
18708157-1383	<compound-id="104729">Co(2</compound-id>+) also induces the release of the pro-apoptotic factors, <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> and <protein-id="O95831">AIF</protein-id>.	Co(2__cytochrome c__interaction	Co(2__AIF__interaction
18708157-1384	Incubation of rat hepatocyte primary cultures with <compound-id="104729">Co(2</compound-id>+) results in apoptosis induction with caspase activation and increased level of expression of <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id>.	Co(2__HIF-1alpha__interaction
18708158-1385	<compound-id="160355">Roscovitine</compound-id> reduced amounts of the caspase inhibitor XIAP, and API-2 increased amounts of the BH3-only protein <protein-id="O54918,O88498">Bim</protein-id>.	Roscovitine__Bim__no_interaction
18708158-1386	<protein-id="P27297,Q07813,Q63690">Bax</protein-id> accumulated in mitochondria in response to API-2, whereas release of <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> from mitochondria required both API-2 and <compound-id="160355">roscovitine</compound-id>.	roscovitine__Bax__no_interaction	roscovitine__cytochrome c__interaction
18708158-1387	We suggest that <compound-id="160355">roscovitine</compound-id> elicits events that activate <protein-id="P27297,Q07813,Q63690">Bax</protein-id> once it translocates to mitochondria and that inactivation of <protein-id="Q641Z4,Q6GLD8,Q96WV9,Q99J95">cdk9</protein-id> signals these events and the down-regulation of XIAP.	roscovitine__cdk9__interaction	roscovitine__Bax__interaction
18708191-1226	Intravenous <compound-id="738,5961">glutamine</compound-id> enhances <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> activity giving cardioprotection.	glutamine__COX-2__interaction
18708191-1227	We investigated whether acute intravenous <compound-id="738,5961">glutamine</compound-id>, through an effect on cyclooxygenase (<protein-id="P11353,P36551,P36552,Q9UTE2,Q9V3D2">COX</protein-id>)-2 and heat shock protein (<protein-id="P32590">HSP</protein-id>) 72, might induce preconditioning.	glutamine__HSP__interaction	glutamine__COX__interaction
18708284-1027	Islets from <compound-id="1123">taurine</compound-id>-supplemented mice had: (i) significantly higher <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> content, (ii) increased <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion at stimulatory glucose concentrations, (iii) significantly displaced the dose-response curve for glucose-induced <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> release to the left, (iv) increased glucose metabolism at 5.6 and 11.1-mmol/L concentrations; (v) slowed cytosolic Ca2+ concentration ([Ca2+]i) oscillations in response to stimulatory glucose concentrations; (vi) increased <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, <protein-id="Q09427,Q09428,Q09429">sulfonylurea receptor-1</protein-id>, <protein-id="O25731,P0A4E1,P0A4E2,P0A6V8,P0A6V9,P17712,P21908,P35557,P52792,P54495,P58616,P58617,P58618,P58619,P64253,P64254,P82680,Q55855,Q56198,Q59171,Q668N7,Q6D7C4,Q7N6Y0,Q83K86,Q87EG6,Q8FFD4,Q8FV09,Q8P8U7,Q8PKU2,Q8UIV7,Q8YDC6,Q92407,Q92T27,Q93IM5,Q98DM2,Q9A6N3,Q9HZ46,Q9KCZ4,Q9PEG4,Q9ZKB0">glucokinase</protein-id>, <protein-id="P12336,P14246">Glut-2</protein-id>, proconvertase and <protein-id="P52945,P52946">pancreas duodenum homeobox-1</protein-id> (<protein-id="P52945">PDX-1</protein-id>) gene expression and (vii) increased <protein-id="P52945">PDX-1</protein-id> expression in the nucleus.	taurine__insulin__interaction	taurine__Glut-2__interaction	taurine__pancreas duodenum homeobox-1__interaction	taurine__glucokinase__interaction	taurine__PDX-1__interaction	taurine__sulfonylurea receptor-1__interaction
18708284-1028	Moreover, <compound-id="1123">taurine</compound-id> supplementation significantly increased both basal and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> stimulated <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of the <protein-id="Q28516">insulin receptor</protein-id> in skeletal muscle and liver tissues.	taurine__insulin__interaction	taurine__insulin receptor__interaction	tyrosine__insulin receptor__interaction	tyrosine__insulin__interaction
18708284-1029	These results indicate that <compound-id="1123">taurine</compound-id> controls glucose homeostasis by regulating the expression of genes required for <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion.	taurine__insulin__interaction	glucose__insulin__interaction
18708284-1030	In addition, <compound-id="1123">taurine</compound-id> enhances peripheral <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity.	taurine__insulin__interaction
18708285-1040	Furthermore, treatment of <compound-id="446925">lycopene</compound-id> and EPA also synergistically blocked the activation of downstream <protein-id="P42345,P42346,Q9JLN9">mTOR</protein-id> molecule.	lycopene__mTOR__interaction
18708285-1041	Immunocytochemical staining results revealed that <compound-id="446925">lycopene</compound-id> and EPA could also up-regulate the expression of apoptotic proteins such as <protein-id="P27297,Q07813,Q63690">Bax</protein-id> and <protein-id="P36940,P41047,P48023,P63306,P63307,P63308,Q861W5,Q9BDN1,Q9BEA8">Fas ligand</protein-id> to suppress cell survival.	lycopene__Bax__interaction	lycopene__Fas ligand__interaction
18709446-802	Amino acids (<compound-id="602,4580,5950,71080">alanine</compound-id>, <compound-id="424,5960,83887">aspartic acid</compound-id>, glutamic acid) and <protein-id="P81156">glucose oxidase</protein-id> (GOx) were adsorbed on CNF and the results were compared with those obtained when <compound-id="297">activated carbon</compound-id> (AC) was used as support.	alanine__glucose oxidase__no_interaction	activated carbon__glucose oxidase__no_interaction	aspartic acid__glucose oxidase__no_interaction
18709455-1296	Seven analogues of p-nitrophenyl T-antigen [Galbeta(1--&gt;3)GalNAcalpha(1--&gt;O) <compound-id="980">PNP</compound-id>] have been synthesized as potential substrates for elucidation of the substrate specificity of endo-<protein-id="P83127,Q90744">alpha-N-acetylgalactosaminidase</protein-id>.	PNP__alpha-N-acetylgalactosaminidase__no_interaction
18709646-694	The NSCs and neuroblasts had <protein-id="P55245">epidermal growth factor receptor</protein-id> (<protein-id="P00533,P13387,P55245">EGFR</protein-id>) and platelet-derived growth factor receptor alpha (<protein-id="P16234,P20786,P26618,P26619,Q8AXC7,Q9DE49,Q9PUF6">PDGFRalpha</protein-id>) expressed on the ciliary apparatus and were the only cell types incorporating the proliferation marker <compound-id="6035">BrdU</compound-id>.	BrdU__PDGFRalpha__no_interaction	BrdU__epidermal growth factor receptor__no_interaction	BrdU__EGFR__no_interaction
18709646-695	Ependymal and displaced ependymal cells also expressed <protein-id="P00533,P13387,P55245">EGFR</protein-id> and <protein-id="P16234,P20786,P26618,P26619,Q8AXC7,Q9DE49,Q9PUF6">PDGFRalpha</protein-id> on their cilia but did not incorporate <compound-id="6035">BrdU</compound-id>.	BrdU__PDGFRalpha__no_interaction	BrdU__EGFR__no_interaction
18709647-968	Both 17alpha- and <compound-id="5757">17beta-estradiol</compound-id> elicited rapid phosphorylation of <protein-id="P46672,Q27272,Q8NFH3,Q9SB81">p42</protein-id>/44MAPK, <protein-id="P31750,Q8INB9">Akt</protein-id>, and <protein-id="P18266,P49841,Q5YJC2,Q9WV60">GSK-3beta</protein-id> within 8 min.	17beta-estradiol__Akt__interaction	17beta-estradiol__GSK-3beta__interaction	17beta-estradiol__p42__interaction
18709649-718	Whereas <compound-id="32051">Zn2</compound-id>+-dependent upregulation of <protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</protein-id> may help to counteract excessive astrocyte swelling and production of reactive <compound-id="977">oxygen</compound-id> and <compound-id="945,948,25352,61526,160954,3609161">nitrogen oxide</compound-id> species, stimulation of <protein-id="P16257,P30535,P30536,P50637">PBR</protein-id> expression may augment HE development.	nitrogen oxide__metallothionein__interaction	nitrogen oxide__PBR__no_interaction	Zn2__PBR__no_interaction	oxygen__metallothionein__interaction	oxygen__PBR__no_interaction	Zn2__metallothionein__interaction
18709661-989	Accordingly, the TLR3 agonist <compound-id="32744,213546,274740">poly(I:C</compound-id>) (<compound-id="1854">PIC</compound-id>) induced higher release of <protein-id="O77812,P01574,P01575,P05012,P70499,Q6XZW6,Q9N2J0">IFN-beta</protein-id> in primary and purified astroglia than in microglia.	poly(I:C__IFN-beta__interaction	PIC__IFN-beta__interaction
18709661-990	As siRNA, <compound-id="1854">PIC</compound-id> induced <protein-id="P02778,P17515,P48973">IP-10</protein-id>, <protein-id="P42225">Stat1</protein-id>, <protein-id="P19320,P29533,P29534,Q28260">VCAM-1</protein-id>, and <protein-id="P00411,P24894,P35355,Q05769,Q8HEC3,Q8SEM9">Cox-2</protein-id> and increased <protein-id="O15455,Q0PV50,Q5TJ59">TLR3</protein-id> mRNA expression.	PIC__IP-10__interaction	PIC__VCAM-1__interaction	PIC__Stat1__interaction	PIC__TLR3__interaction	PIC__Cox-2__interaction
18710402-1097	Intracellular concentrations of <compound-id="271">Ca(2</compound-id>+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte <protein-id="P31522,Q26721,Q56982">antigen-4</protein-id> (<protein-id="P16410">CD152</protein-id>)-<protein-id="P33681,P42070">CD80</protein-id>/<protein-id="P42071,P42081">CD86</protein-id> interactions in CD4 (+) T lymphocytes.	Ca(2__CD80__interaction	Ca(2__CD86__interaction	Ca(2__antigen-4__interaction	Ca(2__CD152__interaction
18710402-1099	During activation with <compound-id="27924,122634,22833501">PMA</compound-id> and low amounts of I, intracellular concentrations of calcium ([<compound-id="271">Ca(2</compound-id>+)](i)) were greatly reduced upon <protein-id="P09793,P16410,P42072,Q9MYX7,Q9XSI1">CTLA-4</protein-id>-<protein-id="P33681,P42070">CD80</protein-id>/<protein-id="P42071,P42081">CD86</protein-id> blockade.	PMA__CD80__interaction	Ca(2__CD86__interaction	PMA__CD86__interaction	PMA__CTLA-4__interaction	Ca(2__CD80__interaction	Ca(2__CTLA-4__interaction
18710402-1100	Further experiments demonstrated that <protein-id="P09793,P16410,P42072,Q9MYX7,Q9XSI1">CTLA-4</protein-id>-<protein-id="P33681,P42070">CD80</protein-id>/<protein-id="P42071,P42081">CD86</protein-id> interactions reduced cell cycling upon activation with <compound-id="27924,122634,22833501">PMA</compound-id> and high amounts of I or TG (high <compound-id="8885">SOS</compound-id>) but the opposite occurred with <compound-id="27924,122634,22833501">PMA</compound-id> and low amounts of I or TG (low <compound-id="8885">SOS</compound-id>).	PMA__CD80__interaction	SOS__CD80__interaction	SOS__CTLA-4__interaction	PMA__CD86__interaction	PMA__CTLA-4__interaction	SOS__CD86__interaction
18710402-1101	Also, <protein-id="P09793,P16410,P42072,Q9MYX7,Q9XSI1">CTLA-4</protein-id>-<protein-id="P33681,P42070">CD80</protein-id>/<protein-id="P42071,P42081">CD86</protein-id> interactions enhanced the generation of reactive <compound-id="977">oxygen</compound-id> species (ROS).	oxygen__CD86__interaction	oxygen__CTLA-4__interaction	oxygen__CD80__interaction
18710604-62	<compound-id="5288258">FSO</compound-id> decreased fasting <compound-id="206,5793,64689,79025">glucose</compound-id> by 20 % and liver weights by 37 % compared with those in the CLA group; it maintained circulating <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, HOMA1-IR and HOMA1 for beta cell function at levels found in the control group.	FSO__insulin__no_interaction	glucose__insulin__no_interaction
18710606-240	Animal evidence indicates that <compound-id="4630">green tea</compound-id> may modulate <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity, with <compound-id="65064">epigallocatechin-3-gallate</compound-id> (<compound-id="65064">EGCG</compound-id>) proposed as a likely health-promoting component.	EGCG__insulin__no_interaction	epigallocatechin-3-gallate__insulin__no_interaction	green tea__insulin__no_interaction
18710606-241	The purpose of this study was to investigate the effect of dietary supplementation with <compound-id="65064">EGCG</compound-id> on <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and associated metabolic risk factors in man.	EGCG__insulin__interaction
18710606-242	<compound-id="65064">EGCG</compound-id> treatment had no effect on <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion or <compound-id="206,5793,64689,79025">glucose</compound-id> tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; <compound-id="65064">EGCG</compound-id>-2.68 (se 0.72) mmHg; P = 0.014).	EGCG__insulin__no_interaction	glucose__insulin__no_interaction
18710606-243	In conclusion, regular intake of <compound-id="65064">EGCG</compound-id> had no effect on <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance but did result in a modest reduction in diastolic blood pressure.	EGCG__insulin__no_interaction
18710702-125	We found that postovulatory administration of 1.5 mg of <compound-id="13109">levonorgestrel</compound-id> to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptors</protein-id> (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), <protein-id="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90">androgen receptor</protein-id> (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	levonorgestrel__estrogen receptors__no_interaction	levonorgestrel__androgen receptor__no_interaction
18710819-1300	<compound-id="3385">5-FU</compound-id> effect on HS cell viability was markedly reduced in hypoxic condition without an induction of chemoresistant related protein, P-<protein-id="P08163">glycoprotein</protein-id>.	5-FU__glycoprotein__no_interaction
18710908-298	High-level toxin production occurred after detectable spore germination in all experiments except those with C. difficile PCR ribotype 027 and <compound-id="152946">moxifloxacin</compound-id>, in which marked <protein-id="P07845,P81662">cytotoxin</protein-id> production preceded detectable germination, which coincided with isolate recovery on fluoroquinolone-containing medium.	moxifloxacin__cytotoxin__no_interaction
18711728-143	Furthermore, <protein-id="Q90YJ2,Q99JA8,Q9ER97">Ngb</protein-id> overexpression reduced <compound-id="5359597">superoxide</compound-id> anion generation after H/R, whereas <compound-id="124886">glutathione</compound-id> levels were significantly improved compared with WT controls.	superoxide__Ngb__interaction	glutathione__Ngb__interaction
18711746-961	Our previous studies have shown that <compound-id="5202">serotonin</compound-id> (<compound-id="5202">5-HT</compound-id>) altered under diabetic condition was accompanied by alterations of <protein-id="P13678,Q25378">protein kinase C</protein-id>-alpha (<protein-id="P04409,P05696,P10102,P17252,P20444">PKC-alpha</protein-id>) and <protein-id="Q00168">CaMKII</protein-id>, and those alterations were reversed after <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> administration.	serotonin__PKC-alpha__interaction	serotonin__insulin__interaction	5-HT__PKC-alpha__interaction	5-HT__CaMKII__interaction	5-HT__protein kinase C__interaction	5-HT__insulin__interaction	serotonin__protein kinase C__interaction	serotonin__CaMKII__interaction
18711746-962	The current study showed that <compound-id="5781">alloxan</compound-id>-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of <compound-id="5202">5-HT</compound-id>, <protein-id="P04409,P05696,P10102,P17252,P20444">PKC-alpha</protein-id> expression and <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> 0.05) simultaneously in striatum (ST), midbrain (MB), <protein-id="P52430,P55159">pons</protein-id> medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	5-HT__PKC-alpha__no_interaction	alloxan__pons__no_interaction	5-HT__PKC__no_interaction	5-HT__pons__no_interaction	alloxan__PKC-alpha__no_interaction	alloxan__PKC__no_interaction
18711746-963	Although the <compound-id="5202">5-HT</compound-id> levels in hippocampus (HC) and hypothalamus (HT) were not altered, the <protein-id="P04409,P05696,P10102,P17252,P20444">PKC-alpha</protein-id> expression and <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> 0.05) in level in HC.	5-HT__PKC-alpha__no_interaction	5-HT__PKC__no_interaction
18711749-1020	We tested the hypothesis that a <compound-id="145068">nitric oxide</compound-id> donor, <compound-id="1606">DETA-NONOate</compound-id>, up-regulates stromal cell-derived factor-1 (<protein-id="O62657,P48061">SDF1</protein-id>) and angiopoietin 1 (<protein-id="P21570">Ang1</protein-id>) in the ischemic brain and their respective receptors chemokine CXC motif receptor 4 (<protein-id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</protein-id>) and <protein-id="O73791,Q02858">Tie2</protein-id> in the subventricular zone (SVZ) and thereby promote SVZ neuroblast cell migration after stroke.	DETA-NONOate__CXCR4__interaction	DETA-NONOate__SDF1__interaction	nitric oxide__Tie2__no_interaction	nitric oxide__SDF1__no_interaction	nitric oxide__Ang1__no_interaction	DETA-NONOate__Tie2__interaction	DETA-NONOate__Ang1__interaction	nitric oxide__CXCR4__no_interaction
18711749-1021	To elucidate whether <protein-id="O62657,P48061">SDF1</protein-id>/CXCR4 and Ang1/Tie2 pathways mediate <compound-id="1606">DETA-NONOate</compound-id>-induced SVZ migration after stroke, SDF1alpha, Ang1 <compound-id="52944803">peptide, a</compound-id> specific antagonist of CXCR4 (<compound-id="65015">AMD3100</compound-id>), and a neutralizing antibody of Tie2 (anti-Tie2) were used in vitro.	AMD3100__SDF1__interaction	DETA-NONOate__SDF1__interaction	peptide, a__SDF1__interaction
18711749-1023	<compound-id="1606">DETA-NONOate</compound-id> significantly increased the expression of <protein-id="O62657,P48061">SDF1</protein-id> and <protein-id="P21570">Ang1</protein-id> in the ischemic border and up-regulated <protein-id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</protein-id> and <protein-id="O73791,Q02858">Tie2</protein-id> in the SVZ compared with MCAo control.	DETA-NONOate__CXCR4__interaction	DETA-NONOate__Tie2__interaction	DETA-NONOate__SDF1__interaction	DETA-NONOate__Ang1__interaction
18711749-1025	Our data indicate that treatment of stroke with a <compound-id="145068">nitric oxide</compound-id> donor up-regulates <protein-id="O62657,P48061">SDF1</protein-id>/<protein-id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</protein-id> and <protein-id="P21570">Ang1</protein-id>/<protein-id="O73791,Q02858">Tie2</protein-id> pathways and thereby likely increases SVZ neuroblast cell migration.	nitric oxide__Tie2__interaction	nitric oxide__Ang1__interaction	nitric oxide__SDF1__interaction	nitric oxide__CXCR4__interaction
18711750-1026	The MEK inhibitor <compound-id="4713">PD98059</compound-id> did not inhibit neurite outgrowth, and Y-27632 and <compound-id="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148">staurosporine</compound-id> did not induce <protein-id="P29323">ERK</protein-id> phosphorylation, suggesting that the inhibitory effect of <compound-id="1456">ODQ</compound-id> on neurite outgrowth is independent of the <protein-id="P29323">ERK</protein-id> signaling pathway.	PD98059__ERK__no_interaction	ODQ__ERK__no_interaction	staurosporine__ERK__no_interaction
18712272-1403	We used this model to identify a potent competitive inhibitor, N1,N7-dihexyl-1,7-diamino-4-azaheptane, and to develop an affinity column, 1,16-diamino4,13-diazahexadecane-linked <compound-id="11966311">Sepharose</compound-id>, which was useful for the purification of <protein-id="O64411,Q6QHF9,Q865R1,Q9FYC2">PAO</protein-id>.	Sepharose__PAO__no_interaction
18712288-246	Rapid determination of <compound-id="5961,145815">L-glutamine</compound-id> using engineered Escherichia coli overexpressing <protein-id="O00088,O04867,O08467,O27612,O29313,O58097,O59648,O66514,P00964,P04773,P07804,P09606,P0A039,P0A040,P0A1P6,P0A1P7,P0A9C5,P0A9C6,P0A9C7,P0A9C8,P10583,P10656,P11600,P12424,P12425,P13499,P15103,P15104,P15105,P15106,P15124,P15623,P16580,P19064,P19904,P20479,P21154,P22248,P23712,P23794,P25821,P28605,P28786,P32288,P33035,P36205,P43386,P43518,P43794,P45627,P46410,P51120,P51121,P60890,P77961,P94126,P94845,P99095,Q04831,Q05650,Q05907,Q06378,Q09179,Q12613,Q4R7U3,Q5HGC3,Q5HPN2,Q60182,Q6B4U7,Q6C3E0,Q6FMT6,Q6G9Q4,Q6GHC6,Q75BT9,Q86ZF9,Q86ZU6,Q874T6,Q8CSR8,Q8HZM5,Q8J1R3,Q8X169,Q96UG9,Q96UV5,Q96V52,Q9C2U9,Q9CDL9,Q9CLP2,Q9HH09,Q9HNI2,Q9HU65,Q9KNJ2,Q9QY94,Q9UUN6,Q9UY99,Q9ZLW5">glutamine synthetase</protein-id>.	L-glutamine__glutamine synthetase__interaction
18712290-619	Purification, characterization, and preliminary X-ray diffraction analysis of a <compound-id="294,6134,84571,440995">lactose</compound-id>-specific <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> from Cymbosema roseum seeds.	lactose__lectin__interaction
18712290-620	Here, we report the purification, partial primary structure, carbohydrate affinity characterization, crystallization, and preliminary X-ray diffraction analysis of a <compound-id="294,6134,84571,440995">lactose</compound-id>-specific <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> from Cymbosema roseum seeds (CRLII).	lactose__lectin__interaction
18712361-637	Effects on haemolytic activity of single <compound-id="614,8988,145742">proline</compound-id> substitutions in the Bordetella pertussis <protein-id="P00936,P0A1A7,P0A1A8,P15318,P19485,P40127,P40134,P40137,P59739,P98009,Q57506,Q8FBP0,Q8XAP1,Q9WXC3">CyaA</protein-id> pore-forming fragment.	proline__CyaA__interaction
18712381-639	Associations between the uptake of 111In-<compound-id="3053">DTPA</compound-id>-trastuzumab, <protein-id="P04626">HER2</protein-id> density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.	DTPA__HER2__interaction
18712381-640	The purpose of the study was to investigate the associations between uptake of (111)In-<compound-id="3053">DTPA</compound-id>-trastuzumab, tumour <protein-id="P04626">HER2</protein-id> density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.	DTPA__HER2__interaction
18712598-674	The <compound-id="60961">adenosine</compound-id> (the final product of ATP hydrolysis by <protein-id="P29240">ectonucleotidases</protein-id>), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	adenosine__ectonucleotidases__interaction
18712838-744	To this end, the cultured fibroblasts were analyzed for very <compound-id="284">long chain fatty acid</compound-id> (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, <protein-id="O15228,P98192,Q9ES71">dihydroxyacetone-phosphate acyltransferase</protein-id> (<protein-id="O15228">DHAPAT</protein-id>) activity, peroxisomal <protein-id="Q6L8K7">thiolase</protein-id>, and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> immunofluorescence.	long chain fatty acid__dihydroxyacetone-phosphate acyltransferase__no_interaction	long chain fatty acid__catalase__no_interaction	long chain fatty acid__DHAPAT__no_interaction	long chain fatty acid__thiolase__no_interaction
18713274-881	Also, <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> induction and concomitant <compound-id="145068">nitric oxide</compound-id> generation appear to participate in the cytotoxicity of excessive portal pressure after extended hepatectomy.	nitric oxide__iNOS__interaction
18713277-882	<protein-id="O50258">Superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GSH-Px), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>) enzyme activities, antioxidant potential (AOP) value, <compound-id="10964">malondialdehyde</compound-id> (MDA), <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and triglyceride levels in the liver tissues and total <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and triglyceride levels in serum samples were measured.	cholesterol__glutathione peroxidase__no_interaction	cholesterol__catalase__no_interaction	cholesterol__CAT__no_interaction	malondialdehyde__SOD__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction	cholesterol__Superoxide dismutase__no_interaction	malondialdehyde__CAT__no_interaction	malondialdehyde__Superoxide dismutase__no_interaction	cholesterol__SOD__no_interaction	malondialdehyde__catalase__no_interaction
18714161-1109	Inhibition of apoptotic signaling and neointimal hyperplasia by <compound-id="137994">tempol</compound-id> and <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> following vascular injury.	tempol__nitric oxide synthase__no_interaction
18715145-1378	Forced cytoplasmic overexpression of <protein-id="P14904">APE1</protein-id> profoundly attenuated the upregulation of <protein-id="P07156,P09429,P10103,P12682,P36194,Q4R844,Q6YKA4">HMGB1</protein-id>-mediated reactive <compound-id="977">oxygen</compound-id> species generation, cytokine secretion, and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</protein-id> expression by primary monocytes and macrophage-like THP-1 cell lines.	oxygen__cyclooxygenase-2__no_interaction	oxygen__APE1__interaction	oxygen__HMGB1__interaction
18715148-1380	NO, a gas, is produced from L-<compound-id="232,4367,6322">arginine</compound-id> by different isoforms of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id>) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	arginine__nitric oxide synthase__interaction	arginine__NOS__interaction
18715149-1381	As one of the very few repair systems for oxidized proteins, <protein-id="O25011,O26635,O69761,O83641,P0A081,P0A082,P0A083,P0A084,P0A085,P0A086,P0A3Q9,P0A3R0,P0A5L0,P0A5L1,P0A744,P0A745,P23212,P47648,P54154,P65443,P65444,P75188,Q4J9L3,Q53W34,Q576P8,Q5HG58,Q5HVD4,Q5PJ81,Q5XDH1,Q66F89,Q6D151,Q6L2S4,Q6LV65,Q6LYY1,Q6NEL2,Q71YF6,Q746G0,Q7MYW1,Q87D27,Q87SW6,Q88AI5,Q88QZ8,Q899M3,Q8DE84,Q8DSY4,Q8DYH1,Q8E434,Q8FAG4,Q8FLU6,Q8FUZ0,Q8NLL5,Q8P272,Q8PCA6,Q8PNY8,Q8PUD6,Q8TQV6,Q8VS50,Q8XCG3,Q8XH97,Q8Y1C6,Q8Y640,Q8YDE7,Q8Z150,Q8ZB94,Q8ZK71,Q92AE8,Q93KF3,Q93S39,Q97MV3,Q97Y45,Q98PE5,Q99YT1,Q9A149,Q9AJF7,Q9APY4,Q9CCZ3,Q9CN40,Q9EWF7,Q9HQG0,Q9HUF1,Q9KAN8,Q9KP30,Q9LAM9,Q9PC45,Q9PQK2,Q9RTB6,Q9ZEQ8,Q9ZMK8">MsrA</protein-id> and <protein-id="O26807,P0A087,P0A088,P0A746,P0A747,P0A748,P47686,P54155,P65447,P65448,P65449,P65450,P65451,P75129,P99065,Q49XN4,Q4L6D3,Q5HPB4,Q5WH73,Q5XCD0,Q66AP6,Q6D4P7,Q6G9D8,Q6GGY4,Q71YF7,Q72NN2,Q7MMC4,Q83L66,Q87AJ9,Q87MS5,Q885Q1,Q88LQ6,Q88W33,Q89EM9,Q8CSK6,Q8D849,Q8DJK9,Q8E026,Q8E5Q9,Q8F7W8,Q8K7M6,Q8P172,Q8UGX7,Q8XJZ6,Q8XYL1,Q8Y641,Q8ZEK7,Q92AE9,Q97IU0,Q99ZV6,Q9A6B1,Q9CJ17,Q9CMB1,Q9I016,Q9KCX2,Q9KQK0,Q9PF29,Q9RUK6,Q9XB39,Q9ZNJ9">MsrB</protein-id> enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive <compound-id="977">oxygen</compound-id> species.	oxygen__MsrA__interaction	oxygen__MsrB__interaction
18715284-1402	<protein-id="P81182">High density lipoprotein</protein-id>-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels increase with age in American women but not in Hong Kong Chinese women.	cholesterol__High density lipoprotein__interaction
18715284-1403	<protein-id="P81182">High-density lipoprotein</protein-id> (HDL) <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> is a powerful cardiovascular risk factor.	cholesterol__High-density lipoprotein__interaction
18715643-1517	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and <protein-id="O60109,P81800,P83456">alkaline phosphatases</protein-id>, lipid peroxidation along with reduction of <protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <compound-id="124886">reduced glutathione</compound-id> content, <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> and succinate dehydrogenase activities.	reduced glutathione__superoxide dismutase__no_interaction	reduced glutathione__alkaline phosphatases__no_interaction	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione reductase__no_interaction
18715643-1518	Hepatoprotective potential of vitamin C was indicated by its ability to restore <compound-id="124886">GSH</compound-id>, <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>, <protein-id="P56544">AcP</protein-id>, AlkP and <protein-id="Q24352">GRD</protein-id> levels towards near normal.	GSH__CAT__no_interaction	GSH__SOD__no_interaction	GSH__AcP__no_interaction	GSH__GRD__no_interaction
18715823-1582	The interaction of <compound-id="5280343">quercetin</compound-id>, which is a <compound-id="5280805">bioflavonoid</compound-id>, with bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	bioflavonoid__serum albumin__no_interaction	quercetin__serum albumin__interaction	bioflavonoid__BSA__no_interaction	quercetin__BSA__interaction
18715823-1585	1x10(-5) mol L(-1)), most of the site marker reacted with the quercetin-<protein-id="P02769">BSA</protein-id>, but free <compound-id="54678486">warfarin</compound-id> was present at higher concentrations.	warfarin__BSA__no_interaction
18715824-1587	Under optimum conditions, the fluorescence intensity of <protein-id="P02769">BSA</protein-id>-GNPs is linearly proportional to <compound-id="935">nickel</compound-id> concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.	nickel__BSA__interaction
18716315-1771	C18 and C20Gb(3) were, in mixtures without <compound-id="446804">C24</compound-id> :1Gb(3), dominant negative for <protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</protein-id> vesicle binding.	C24__gp120__no_interaction
18716315-1772	<protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">Gp120</protein-id>/VT1bound C18 and <compound-id="446804">C24</compound-id> :1Gb(3) mixtures, although neither isoform bound alone.	C24__Gp120__interaction
18716315-1773	Monolayer surface pressure measurement showed VT1, but not VT2, bound <compound-id="5353448">Gb(3</compound-id>) at cellular DRM surface pressures, and confirmed loss of VT1 and <protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</protein-id> (but not VT2) specific C18Gb(3) binding.	Gb(3__gp120__no_interaction
18716607-1835	<protein-id="P32749,P32750,P32751,P32752,P32753,P81908">Cholinesterase</protein-id> inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary <compound-id="62764">TCPy</compound-id>.	TCPy__Cholinesterase__no_interaction
18716607-1836	The objective of this study was to evaluate the quantitative relation between measured red blood cell <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to <compound-id="2730">chlorpyrifos</compound-id> (CPF) as assessed by measurement of urinary <compound-id="23017">3,5,6-trichloro-2-pyridinol</compound-id> (<compound-id="62764">TCPy</compound-id>) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	chlorpyrifos__acetylcholinesterase__interaction	TCPy__acetylcholinesterase__interaction	3,5,6-trichloro-2-pyridinol__acetylcholinesterase__interaction
18716756-1877	Immunofluorescence analysis revealed that two known virulence-associated <protein-id="O12164,O41803,O42043,O56861,O70902,O71037,O89292,O91086,P03374,P03375,P03377,P03378,P03379,P03380,P03381,P03383,P03385,P03386,P03387,P03388,P03390,P03391,P03392,P03395,P03396,P03397,P03399,P04027,P04502,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P06445,P06751,P06752,P07575,P08359,P08360,P08810,P0C212,P10259,P10267,P10269,P11261,P11267,P11268,P11306,P12449,P12487,P12488,P12489,P12492,P14075,P14351,P15073,P15831,P16082,P16090,P16899,P17281,P17755,P18040,P18094,P18799,P19030,P19503,P19549,P19550,P19551,P19556,P19557,P20871,P20872,P20888,P21412,P21415,P21436,P21443,P21444,P21445,P22380,P22427,P22428,P22429,P22430,P23064,P23073,P23422,P23423,P24105,P25057,P25504,P25505,P25506,P25507,P26803,P26804,P27399,P27757,P27977,P31621,P31626,P31627,P31789,P31791,P31794,P31796,P31819,P31872,P32536,P32541,P33498,P35954,P35961,P51515,P51519,P51520,P60507,P60508,P60608,P61549,P61550,P61552,P61553,P61554,P61555,P61556,P61557,P61558,P61559,P61561,P61562,P61563,P61564,P61565,P61566,P61567,P61570,Q02076,Q02077,Q02282,Q02837,Q03804,Q03816,Q03817,Q04993,Q04995,Q05312,Q09SZ7,Q0R5Q9,Q14264,Q1A243,Q1A261,Q69384,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q85646,Q89607,Q8AIH5,Q8MIB6,Q902F8,Q902F9,Q96L62,Q9IDV2,Q9N2J8,Q9N2J9,Q9N2K0,Q9NX77,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9TTC0,Q9UKH3,Q9UQF0,Q9WC60,Q9WC69">surface proteins</protein-id> featuring <compound-id="3977067">Leu-Pro</compound-id>-X-Thr-<compound-id="750,5460845">Gly</compound-id> motif, <protein-id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P15057,P19385,P19386,P27359,P33486,P51728,P51771,P62692,P62693,P68920,P68921,P76159,P78285,Q37875,Q37896,Q9T1T5,Q9T1X2,Q9ZXB7">muramidase</protein-id>-released protein and surface antigen one, were absent in the DeltasrtA.	Leu-Pro__muramidase__no_interaction	Leu-Pro__surface proteins__interaction	Gly__surface proteins__interaction	Gly__muramidase__no_interaction
18716761-1880	In addition, neuronal <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id>, another component of the <compound-id="22880">NMDA</compound-id>/<compound-id="145068">nitric oxide</compound-id>/<compound-id="24316">cGMP</compound-id> intracellular pathway, has been reported to be dysregulated in schizophrenia patients.	nitric oxide__nitric oxide synthase__interaction	NMDA__nitric oxide synthase__interaction	cGMP__nitric oxide synthase__interaction
18716776-1883	Vitamin K deficiency amplifies anticoagulation response to <compound-id="9574101">ximelagatran</compound-id> : possible implications for direct <protein-id="P82354">thrombin inhibitors</protein-id> and their clinical safety.	ximelagatran__thrombin inhibitors__no_interaction
18716776-1884	This study examined whether vitamin K insufficiency affected anticoagulation response to the direct <protein-id="P82354">thrombin inhibitor</protein-id>, <compound-id="9574101">ximelagatran</compound-id>.	ximelagatran__thrombin inhibitor__interaction
18716782-1887	A role for <protein-id="P28374">natriuretic peptide</protein-id> in <compound-id="11970143">lipopolysaccharide</compound-id>-induced fever in Pekin ducks (Anas platyrhynchos): is <protein-id="P28374">natriuretic peptide</protein-id> an endogenous antipyretic in birds.	lipopolysaccharide__natriuretic peptide__no_interaction
18716782-1888	We induced fever in Pekin ducks with <compound-id="11970143">lipopolysaccharide</compound-id> and, at the same time, treated the animals with <protein-id="P28374">natriuretic peptide</protein-id> antiserum at a dose that effectively inhibited the known renal actions of endogenously secreted <protein-id="P28374">natriuretic peptide</protein-id>.	lipopolysaccharide__natriuretic peptide__no_interaction
18716808-1894	Among the Gram-negative bacteria, 100% of the Escherichia coli isolates (including extended spectrum <protein-id="P80298,P80545,P81173">beta-lactamase</protein-id> [ESBL]-producers) were <compound-id="54686904">tigecycline</compound-id>-susceptible, while about 10% of the Enterobacter cloacae and Klebsiella pneumoniae isolates were resistant.	tigecycline__beta-lactamase__no_interaction
18716858-1921	Sequencing of the 5'-upstream region of the <protein-id="O01739,O35078,P00371,P14920,P18894,P19801,P22942,P24552,P36633,P80324,Q19564,Q8JZQ5,Q99042,Q9TRC7,Q9Z1M5,Q9Z302">DAO</protein-id> gene revealed the deletion of one triplet in the 15 <compound-id="2723949">TAA</compound-id> repeats approximately 700-bp upstream of the transcription start point.	TAA__DAO__interaction
18716864-1923	The data presented here show that NH4Cl (5 mM) mediates astroglial cell swelling, and that treatment with NH4Cl or <compound-id="612">lactate</compound-id> (25 mM) causes rearrangements of <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> filaments and reduces astroglial glutamate uptake capacity.	lactate__actin__interaction
18716881-1939	<protein-id="Q80U72">Lap4</protein-id>, a <protein-id="P14904">vacuolar aminopeptidase I</protein-id>, is involved in <compound-id="23973">cadmium</compound-id>-glutathione metabolism.	cadmium__Lap4__interaction	cadmium__vacuolar aminopeptidase I__no_interaction
18716881-1940	Here, we proposed that <protein-id="Q80U72">Lap4</protein-id>, a vacuolar amino peptidase, is involved in glutathione catabolism under <compound-id="23973">cadmium</compound-id> stress.	cadmium__Lap4__interaction
18716881-1941	Saccharomyces cerevisiae cells deficient in <protein-id="Q80U72">Lap4</protein-id> absorbed almost 3-fold as much cadmium as the wild-type strain (wt), probably due to the lower rate of cadmium-<compound-id="124886">glutathione</compound-id> complex synthesis in the cytoplasm.	glutathione__Lap4__no_interaction
18716881-1942	Thus, under <compound-id="23973">cadmium</compound-id> stress, <protein-id="Q80U72">Lap4</protein-id> and gamma-glutamyl transferase seem to work together to assure an efficient <compound-id="124886">glutathione</compound-id> turnover stored in the vacuole.	glutathione__Lap4__interaction	cadmium__Lap4__no_interaction
18716920-1959	In this research, the effects of pH, temperature, and <compound-id="977">oxygen</compound-id> on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with <protein-id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</protein-id> (<protein-id="P40746,P81453,Q05187,Q819L3,Q81MS1,Q8GR90,Q9K5W7">TGase</protein-id>) production and cell sporulation were investigated.	oxygen__transglutaminase__interaction	oxygen__TGase__interaction
18717617-2177	No relationships were observed among <compound-id="23931">mercury</compound-id>, <compound-id="6326970">selenium</compound-id>, and several other neurochemical biomarkers (<compound-id="681">dopamine</compound-id>-2, <compound-id="119">gamma-aminobutyric acid</compound-id> type A, muscarinic cholinergic, and nicotinic cholinergic receptors; <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</protein-id> and <protein-id="P49253">monoamine oxidase</protein-id> enzymes).	gamma-aminobutyric acid__cholinesterase__no_interaction	selenium__cholinesterase__no_interaction	dopamine__cholinesterase__no_interaction	selenium__monoamine oxidase__no_interaction	dopamine__monoamine oxidase__no_interaction	gamma-aminobutyric acid__monoamine oxidase__no_interaction	mercury__monoamine oxidase__no_interaction	mercury__cholinesterase__no_interaction
18717625-2181	Despite responsive antioxidative defense (increased activities of <protein-id="O50258">superoxide dismutase</protein-id>, ascorbate <protein-id="P15984,P16147,P84714">peroxidase</protein-id>, and pyrogallol <protein-id="P15984,P16147,P84714">peroxidase</protein-id>), <compound-id="105005">Tl</compound-id>+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	Tl__peroxidase__no_interaction	Tl__superoxide dismutase__no_interaction
18717627-2182	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive <compound-id="977">oxygen</compound-id> species (ROS) through activation of the components of NADPH oxidase, like <protein-id="O75935,P03304,P11691,P15961,P16342,P17593,P17594,P19751,P23169,P24102,P50629,P50630,P50631,P50632,P50633,P50634,P82796,Q05903,Q66198,Q8V439,Q8V6W7,Q91A29,Q9PYA3">p22</protein-id> (phox), <protein-id="O10300,P08567,P26642,P34051,Q12802,Q91375,Q9SZB9,Q9Y240">p47</protein-id> (phox), and <protein-id="Q924V1,Q9JHI8">Nox4</protein-id>.	oxygen__p47__interaction	oxygen__p22__interaction	oxygen__Nox4__interaction
18717628-2183	We conclude that mitochondrial dysfunction can induce <protein-id="O55042,P37377,P37840,P61138,P61139,P61140,P61141,P61142,P61143,P61144,P61145,P61146,P61147,Q3I5G7,Q3T0G8,Q91448">alpha-synuclein</protein-id> oligomerization via <compound-id="5957">ATP</compound-id> depletion-driven microtubule depolymerization and via ROS increase-driven protein oxidation.	ATP__alpha-synuclein__interaction
18717715-2195	Decreased expression of <protein-id="Q02563,Q9JIS5">synaptic vesicle protein 2A</protein-id>, the binding site for <compound-id="5284583">levetiracetam</compound-id>, during epileptogenesis and chronic epilepsy.	levetiracetam__synaptic vesicle protein 2A__interaction
18717715-2196	We previously showed that gene expression of <protein-id="Q02563,Q9JIS5">synaptic vesicle protein 2A</protein-id> (<protein-id="Q29397,Q4R4X3,Q5R4L9,Q7L0J3">SV2A</protein-id>), the binding site for the antiepileptic drug <compound-id="5284583">levetiracetam</compound-id>, is reduced during epileptogenesis in the rat.	levetiracetam__synaptic vesicle protein 2A__interaction	levetiracetam__SV2A__interaction
18718483-1342	The pharmacological profile of AL-38022A suggests that it could be a useful tool in defining <protein-id="O46635,P14842,P18599,P28223,P35363,P35382,P50128,P50129,Q5R4Q6,Q75Z89">5-HT2</protein-id> receptor signaling and receptor characterization where <compound-id="5202">5-HT</compound-id> may function as a neurotransmitter.	5-HT__5-HT2__interaction
18718549-2503	We also demonstrated that the deletion of the <protein-id="P20166,P37439,P42015,P47315,P57437,P69786,P69787,P69788,P75569,Q45298,Q46072,Q89AG6,Q8K9J0">ptsG</protein-id> gene doubled ATP-driven <compound-id="124886">glutathione</compound-id> synthesis and increased cellular ATP synthetic activity.	glutathione__ptsG__interaction
18718551-2505	Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> phosphorylation and reactive <compound-id="977">oxygen</compound-id> species generation.	oxygen__p53__no_interaction
18718551-2506	In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(<protein-id="P02783">ADP</protein-id>-ribose) polymerase (<protein-id="O50017,P08469,P14043,P31669,P35875,P55057,Q08824,Q11208">PARP</protein-id>) cleavage, caspase activation, DNA fragmentation, <compound-id="445141,6323481,44147587">phosphatidylserine</compound-id> exposure and nuclear condensation.	phosphatidylserine__PARP__no_interaction	phosphatidylserine__ADP__no_interaction
18718551-2507	Silencing and attenuating of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> activation with RNA interference and <compound-id="4817">pifithrin-alpha</compound-id> treatment, respectively, partially suppressed SeC-induced cell apoptosis.	pifithrin-alpha__p53__interaction
18718660-2524	Activation of c-<protein-id="P05627,P17325,P18289">Jun</protein-id> N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by <compound-id="25423">monochloramine</compound-id>.	monochloramine__Jun__interaction
18718660-2525	Within 10min of NH(2) <compound-id="312">Cl</compound-id> treatment, c-<protein-id="P05627,P17325,P18289">Jun</protein-id> N-terminal kinase (<protein-id="P92208,Q966Y3">JNK</protein-id>) activation and elevation of cytosolic <compound-id="271">Ca(2</compound-id>+) were observed.	Ca(2__JNK__no_interaction	Cl__JNK__interaction	Ca(2__Jun__no_interaction	Cl__Jun__interaction
18718713-2535	Induction in the activity of <protein-id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">lignin peroxidase</protein-id> and <protein-id="P05982,P15559,Q5RD31,Q64669,Q8CHK7">azoreductase</protein-id> was observed during decolorization of <compound-id="6093247">Reactive Red 2</compound-id> in the batch culture, which represented their role in degradation.	Reactive Red 2__lignin peroxidase__interaction	Reactive Red 2__azoreductase__interaction
18718986-79	Inhibition of radiographic progression with combination <protein-id="P20333">etanercept</protein-id> and <compound-id="126941">methotrexate</compound-id> in patients with moderately active rheumatoid arthritis previously treated with monotherapy.	methotrexate__etanercept__no_interaction
18718986-80	To determine the effect of changing from <protein-id="P20333">etanercept</protein-id> or <compound-id="126941">methotrexate</compound-id> monotherapy to <protein-id="P20333">etanercept</protein-id> plus <compound-id="126941">methotrexate</compound-id> combination therapy on radiographic progression in rheumatoid arthritis (RA) patients.	methotrexate__etanercept__no_interaction
18719855-2110	Treatment with <compound-id="100017">nimbolide</compound-id> resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of <protein-id="O01377,O02115,O16852,O82134,O82797,P04961,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00268,Q03392,Q43124,Q43266,Q6B6N4,Q9DDF1,Q9DEA3,Q9MAY3,Q9PTP1,Q9W644">proliferating cell nuclear antigen</protein-id>.	nimbolide__proliferating cell nuclear antigen__interaction
18719891-434	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of <compound-id="876,6137">methionine</compound-id> or <compound-id="3034082,6713940,25243974">cobalamin</compound-id> to the plant growth media or by the presence of a copy of the <protein-id="P29930">cobO</protein-id> gene in cosmid pMUS756.	methionine__cobO__no_interaction	cobalamin__cobO__no_interaction
18719894-435	Ameliorating prefrontal cortical dysfunction in mental illness: inhibition of phosphotidyl <compound-id="892">inositol</compound-id>-<protein-id="P13678,Q25378">protein kinase C</protein-id> signaling.	inositol__protein kinase C__interaction
18719894-436	DISCUSSION: Recent genetic and biochemical studies have also linked these illnesses to disinhibition of phosphotidyl <compound-id="892">inositol</compound-id>-<protein-id="P13678,Q25378">protein kinase C</protein-id> signaling.	inositol__protein kinase C__interaction
18719894-437	Animal studies have shown that high levels of phosphotidyl <compound-id="892">inositol</compound-id>-<protein-id="P13678,Q25378">protein kinase C</protein-id> signaling in the PFC markedly impair PFC function at the behavioral and cellular levels.	inositol__protein kinase C__interaction
18719969-461	Obesity increases <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes.	glucose__insulin__no_interaction
18720192-531	Inhibition of <protein-id="O08328,O66935,O84804,P05416,P0A6U8,P0A6U9,P0A6V0,P39125,P45179,P58395,Q21BQ1,Q221N9,Q255S3,Q28MN0,Q2A4U4,Q2G7S7,Q2IM81,Q2J308,Q2K485,Q2P9F6,Q2RH55,Q2RS50,Q2T6R2,Q2W5G0,Q2YB48,Q30Z13,Q31BS5,Q31IB5,Q31VJ4,Q32AV6,Q3A0B8,Q3AKK1,Q3APL6,Q3AVF9,Q3B6C3,Q3BYI1,Q3K1K2,Q3KD65,Q3KKP3,Q3SH79,Q3YW96,Q46LU1,Q47IJ4,Q48JG9,Q4KCP0,Q4QK70,Q4UZL8,Q4ZS46,Q57IU1,Q5DZC1,Q5FL65,Q5H6Q4,Q5L562,Q5N1P1,Q5NHN2,Q5NXZ7,Q5PM09,Q5SMC5,Q632H4,Q65FS7,Q65TI3,Q664I5,Q6CZK3,Q6HC18,Q6KHP2,Q6LKA1,Q6MAS9,Q6NCT7,Q729V4,Q72G68,Q72YJ6,Q73MC7,Q7MJ50,Q7NM37,Q7U7I2,Q7UPY2,Q7V275,Q7V8F0,Q7VBP0,Q7W6L5,Q7WIJ0,Q816G8,Q81K85,Q821W4,Q82SP3,Q83PV4,Q87QX5,Q880M9,Q88FN9,Q890I8,Q8CWX0,Q8DAR0,Q8DKU2,Q8DPS3,Q8E079,Q8E5V5,Q8ET54,Q8KAY6,Q8PDD2,Q8PQA3,Q8RF65,Q8XPA1,Q8XT73,Q8Z232,Q8ZA78,Q935Y7,Q97GX6,Q97QS5,Q985P2,Q9CHM9,Q9CN91,Q9EUT5,Q9I1V0,Q9KDX6,Q9KRB6,Q9PLC3,Q9RNH6,Q9RWS1,Q9WZZ7,Q9Z6V8">glycogen synthase</protein-id> kinase by <compound-id="969516">curcumin</compound-id> : Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.	curcumin__glycogen synthase__interaction
18720192-532	The investigation included simulated docking experiments to fit <compound-id="969516">curcumin</compound-id> within the binding pocket of <protein-id="P18266,P49841,Q5YJC2,Q9WV60">GSK-3beta</protein-id> followed by experimental in vitro and in vivo validations.	curcumin__GSK-3beta__interaction
18720192-533	<compound-id="969516">Curcumin</compound-id> was found to optimally fit within the binding pocket of <protein-id="P18266,P49841,Q5YJC2,Q9WV60">GSK-3beta</protein-id> via several attractive interactions with key amino acids.	Curcumin__GSK-3beta__interaction
18720446-603	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (<compound-id="5328791">CHCA</compound-id>) and 2,5-dihydroxy <compound-id="243,167551">benzoic acid</compound-id> (<compound-id="9882105">DHB</compound-id>) on <compound-id="6422">trifluoro acetic acid</compound-id> (<protein-id="Q27203">TFA</protein-id>) etched latex glove surfaces allowed the direct determination (exact molecular weight) of <protein-id="P02877">Hevein</protein-id>, <protein-id="P15252,P45951">REF</protein-id> and a truncated form of <protein-id="P15252,P45951">REF</protein-id> (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	benzoic acid__REF__no_interaction	trifluoro acetic acid__REF__no_interaction	trifluoro acetic acid__Hevein__no_interaction	DHB__TFA__no_interaction	CHCA__REF__no_interaction	CHCA__Hevein__no_interaction	benzoic acid__Hevein__no_interaction	trifluoro acetic acid__TFA__no_interaction	CHCA__TFA__no_interaction	benzoic acid__TFA__no_interaction	DHB__REF__no_interaction	DHB__Hevein__no_interaction
18721130-774	Increased <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of <protein-id="P31016,P78352,Q62108,Q6R005">PSD-95</protein-id> by <protein-id="P05480,Q9WUD9">Src</protein-id> family kinases after brain ischaemia.	tyrosine__Src__interaction	tyrosine__PSD-95__interaction
18721130-776	The present study demonstrates that brain ischaemia and reperfusion increase the <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of <protein-id="P31016,P78352,Q62108,Q6R005">PSD-95</protein-id> in the rat hippocampus.	tyrosine__PSD-95__interaction
18721130-777	Thus the present study reveals an additional mechanism for the regulation of <protein-id="P31016,P78352,Q62108,Q6R005">PSD-95</protein-id> by <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation.	tyrosine__PSD-95__interaction
18721153-786	Pathological role of <protein-id="P14745,P16070,P20944,Q05078,Q28284,Q29423,Q60522">CD44</protein-id> on NKT cells in <compound-id="5943">carbon tetrachloride</compound-id>-mediated liver injury.	carbon tetrachloride__CD44__no_interaction
18721153-787	Methods: We injected <protein-id="P14745,P16070,P20944,Q05078,Q28284,Q29423,Q60522">CD44</protein-id> knock out (KO) or wild type mice with <compound-id="5943">carbon tetrachloride</compound-id> (CCl(4)) and examined the difference of liver injury by immunological or histological analysis.	carbon tetrachloride__CD44__no_interaction
18721245-809	Studies using 1-<compound-id="98112">methyl-tryptophan</compound-id> (<compound-id="98112">1-MT</compound-id>), the specific inhibitor of IDO, showed that this enzyme is important in <protein-id="Q9TTB0">interferon-gamma</protein-id> (<protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id>)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	methyl-tryptophan__interferon-gamma__no_interaction	1-MT__IFN-gamma__no_interaction	methyl-tryptophan__IFN-gamma__no_interaction	1-MT__interferon-gamma__no_interaction
18721829-966	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for <compound-id="5202">serotonin</compound-id>, <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">Substance P</protein-id>, <protein-id="O02777,P20272,P21554,P47746,P56971,Q333S9,Q5IS73,Q71SP5,Q801M1,Q9PUI7">cannabinoid receptors 1</protein-id> and 2 (CB(1), CB(2)), and the neuronal activation marker <protein-id="P01101,P12841,Q56415">Fos</protein-id> in the least shrew (Cryptotis parva).	serotonin__Fos__no_interaction	serotonin__Substance P__no_interaction	serotonin__cannabinoid receptors 1__no_interaction
18722097-1040	To observe the inhibitory effects of <protein-id="P11032,Q28178">TSP-1</protein-id> functional fragments, critical for <protein-id="P16671,P26201,P70110">CD36</protein-id> binding, on the activation of L-<protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</protein-id>, we isolated alveolar macrophages from Wistar rat lungs 7 days after <compound-id="456190,5360373,5460769">bleomycin</compound-id> administration (5mg/kg body weight) and cultured the cells with or without <protein-id="P11032,Q28178">TSP-1</protein-id> functional or control fragments.	bleomycin__CD36__no_interaction	bleomycin__TSP-1__no_interaction	bleomycin__TGF-beta1__no_interaction
18722104-1045	The pEREGFP9 vector was delivered to a single MCF-7 using a nanoneedle and the effect of <compound-id="104741">ICI 182,780</compound-id>, which is an antagonist of estrogen, was observed using the <protein-id="P42212">GFP</protein-id> expression level.	ICI 182,780__GFP__interaction
18722104-1046	By <compound-id="104741">ICI 182,780</compound-id> treatment, the fluorescence intensity of the <protein-id="P42212">GFP</protein-id> was decreased by 30-50% within 24h.	ICI 182,780__GFP__interaction
18722114-1051	Effect of different <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> dosages on cell viability and <compound-id="702">ethanol</compound-id> production by Kluyveromyces marxianus in SSF processes.	ethanol__cellulase__interaction
18722114-1052	This study was aimed to study the effect of commercial <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulases</protein-id> (Celluclast 1.5 LFG) on Kluyveromyces marxianus CECT 10875 growth and <compound-id="702">ethanol</compound-id> production in SSF processes.	ethanol__cellulases__interaction
18722394-1736	We examined both basal and stress-induced <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> and <compound-id="5753">corticosterone</compound-id> (CORT) release in two stress contexts thought to differ in intensity: novel environment ('mild') and restraint ('intense').	corticosterone__ACTH__no_interaction
18722490-1167	<protein-id="O77220,P14944,P30814,P55845,P56687,P59685,P81032,P83800,Q25588,Q25589,Q25683,Q26181">Crustacean hyperglycemic hormone</protein-id> (<protein-id="O77220,P14944,P30814,P55845,P56687,P59685,P81032,P83800,Q25588,Q25589,Q25683,Q26181">CHH</protein-id>) not only plays an important role in the modulation of hemolymph <compound-id="206,5793,64689,79025">glucose</compound-id> level but also functions in other biological events including molting, reproduction and stress response.	glucose__CHH__interaction	glucose__Crustacean hyperglycemic hormone__interaction
18722763-1249	As a proof-of-concept, <protein-id="P81460,P81461">Concanavalin A</protein-id>-coated QDs (<protein-id="P02866,P14894,P81460,P81461">ConA</protein-id>-QDs) and <compound-id="4125253,5460037">dextran</compound-id>-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	dextran__Concanavalin A__no_interaction	dextran__ConA__no_interaction
18722763-1250	As a result, the PL intensity of QDs was found to be linearly correlated with the concentration and the number of <compound-id="871">glycan</compound-id> moiety of the <protein-id="P08163">glycoprotein</protein-id>.	glycan__glycoprotein__interaction
18723022-1306	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id>, which is responsible for the hydrolysis of l-<compound-id="232,4367,6322">arginine</compound-id> to <compound-id="6262">l-ornithine</compound-id> and <compound-id="1176,265993">urea</compound-id>.	arginine__arginase__interaction	urea__arginase__interaction	l-ornithine__arginase__interaction
18723107-1332	To overcome this limitation we turned to the yeast Pichia stipitis, which naturally produces <compound-id="6912">xylitol</compound-id>, as a source of <protein-id="O75191,P09099,P12867,P21939,P26909,P27155,P27156,P29444,P35850,P39211,P42826,P44401,P54271,Q3MIF4,Q3SYZ6,Q3TNA1,Q5R830,Q9CFG8,Q9RK00">xylulokinase</protein-id> (Xyl3).	xylitol__xylulokinase__interaction
18723107-1333	We examined the effects of plasmid-based expression of Xyl3 versus <protein-id="O30360,P09099,P12867,P21939,P26909,P27155,P27156,P29444,P35850,P39211,P39849,P44401,P45982,P54271,Q5HL88,Q8CR47,Q9CFG8,Q9RK00">XylB</protein-id> on growth and <compound-id="6912">xylitol</compound-id> production by engineered E. coli strains.	xylitol__XylB__interaction
18723121-1340	Behavioral and biochemical responses including filtering rates, key phase I, II and antioxidant enzymes and levels of <protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothioneins</protein-id>, <compound-id="124886">glutathione</compound-id>, lipid peroxidation and DNA strand breaks were determined in digestive glands of mussels after being exposed to sublethal levels of mercury chloride, methyl mercury, cadmium and Aroclor 1260 during 5 days.	glutathione__metallothioneins__no_interaction
18723336-870	In this study, a representative FRET system (<protein-id="P27918,Q5RBP8,Q64181">CFP</protein-id> donor and <protein-id="P21578">YFP</protein-id> acceptor) is compared with the BRET(2) system (Renilla <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> donor, <protein-id="P42212">green fluorescent protein</protein-id> (2) (<protein-id="P42212">GFP</protein-id> (2)) acceptor and <compound-id="22832089">coelenterazine 400a</compound-id> substrate).	coelenterazine 400a__CFP__no_interaction	coelenterazine 400a__GFP__interaction	coelenterazine 400a__luciferase__interaction	coelenterazine 400a__YFP__no_interaction	coelenterazine 400a__green fluorescent protein__interaction
18723342-981	If no pretreatment applied, hydrolyses of the textiles by <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> and <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</protein-id> for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g <compound-id="702">ethanol</compound-id>/g textiles, which was 25-26% of the corresponding theoretical yield.	ethanol__beta-glucosidase__interaction	ethanol__cellulase__interaction
18723440-1394	In cystic fibrosis, this equilibrium is disrupted by mutations in the <protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">cystic fibrosis transmembrane conductance regulator</protein-id> (<protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">CFTR</protein-id>) gene resulting in the absence of functional <protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">CFTR</protein-id> protein, which in turn results in deficient <compound-id="6076">cAMP</compound-id>-dependent <compound-id="312">Cl</compound-id> (-) secretion and predominant <compound-id="923,373840">Na</compound-id> (+) absorption.	Na__CFTR__interaction	cAMP__CFTR__interaction	Na__cystic fibrosis transmembrane conductance regulator__interaction	cAMP__cystic fibrosis transmembrane conductance regulator__interaction	Cl__CFTR__interaction	Cl__cystic fibrosis transmembrane conductance regulator__interaction
18723471-1399	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the <protein-id="Q8NFJ6,Q8SPN1">PROKR2</protein-id>, which results in a <compound-id="857,6106,439524">leucine</compound-id>-to-<compound-id="232,4367,6322">arginine</compound-id> substitution at codon 173.	arginine__PROKR2__interaction	leucine__PROKR2__interaction
18723570-1420	<compound-id="446541">Mycophenolic acid</compound-id> inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of <protein-id="P08046">Egr-1</protein-id> in rat mesangial cells.	Mycophenolic acid__Egr-1__interaction
18723579-1422	<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Angiotensin II</protein-id> (<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>) stimulation of water and <compound-id="5234">NaCl</compound-id> intake is a classic model of the behavioural effects of hormones.	NaCl__AngII__interaction	NaCl__Angiotensin II__interaction
18723579-1423	Previous studies support the hypotheses that <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> is involved in AngII-induced water, but not <compound-id="5234">NaCl</compound-id> intake and that MAP kinase plays a role in <compound-id="5234">NaCl</compound-id> consumption, but not water intake, after injection of AngII.	NaCl__PKC__no_interaction
18723579-1424	Pretreatment with the PKC inhibitor <compound-id="2703,411938">chelerythrine</compound-id> attenuated <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>-induced water intake, but <compound-id="5234">NaCl</compound-id> intake was unaffected.	NaCl__AngII__interaction	chelerythrine__AngII__interaction
18723579-1425	In contrast, pretreatment with U0126, a MAP kinase inhibitor, had no effect on <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>-induced water intake, but attenuated <compound-id="5234">NaCl</compound-id> intake.	NaCl__AngII__interaction
18723580-1427	<compound-id="5957">Adenosine triphosphate</compound-id>, <protein-id="P30880,P30881,P31888">calcitonin gene-related peptide</protein-id> and <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</protein-id> coexist in some sensory-motor nerves.	Adenosine triphosphate__calcitonin gene-related peptide__no_interaction	Adenosine triphosphate__substance P__no_interaction
18723580-1428	Three cotransmitters are involved, namely ATP, <compound-id="145068">nitric oxide</compound-id> and <protein-id="P01282,P01283,P01284,P04566,P09684,P09685,P32648,P32649,P39089,P45644,P48142,P48143,P63289,P63290,P63291,P81016,P81401,P84488,P84771,P84772">vasoactive intestinal polypeptide</protein-id>.	nitric oxide__vasoactive intestinal polypeptide__no_interaction
18724397-1741	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood <compound-id="206,5793,64689,79025">glucose</compound-id> and low <protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> were not.	glucose__high-density lipoprotein__no_interaction	cholesterol__high-density lipoprotein__interaction
18725236-2014	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in <compound-id="681">dopamine</compound-id> and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as <protein-id="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">corticotropin-releasing factor</protein-id> (<protein-id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</protein-id>), in the extended amygdala.	dopamine__CRF__interaction	dopamine__corticotropin-releasing factor__interaction
18726068-972	Neither enzymatic activity of transaminases (<protein-id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">AST</protein-id> and ALT) nor <compound-id="1176,265993">urea</compound-id> levels were significantly altered.	urea__AST__no_interaction
18726117-2302	On other hand, <protein-id="P00533,P13387,P55245">EGFR</protein-id> gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to <compound-id="123631">gefitinib</compound-id> or <compound-id="176870">erlotinib</compound-id>.	gefitinib__EGFR__interaction	erlotinib__EGFR__interaction
18726675-2476	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, <protein-id="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">monocyte chemotactic protein-1</protein-id>, <compound-id="10964">malondialdehyde</compound-id>, osteopontin, and <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	malondialdehyde__alkaline phosphatase__no_interaction	malondialdehyde__monocyte chemotactic protein-1__no_interaction
18726677-2477	Transitions in the <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> microenvironment and secondary structure of two monocot <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> from Sauromatum guttatum and Arisaema tortuosum under different denaturing conditions were studied by steady state and time resolved fluorescence and CD spectroscopy.	tryptophan__lectins__interaction
18726677-2478	The <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> exist as tetramers with a single <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> residue estimated per monomer, present in a polar environment.	tryptophan__lectins__interaction
18726677-2479	Similarly, both the <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> showed a drastic loss of secondary structure in 5 M <compound-id="97535">Gdn</compound-id>-<compound-id="313">HCl</compound-id> or 6 M <compound-id="1176,265993">Urea</compound-id> or at pH 2.0 and below.	HCl__lectins__interaction	Urea__lectins__interaction	Gdn__lectins__interaction
18726687-2490	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (<protein-id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</protein-id>) and <protein-id="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">monocyte chemoattractant protein-1</protein-id> (<protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id>), generation of reactive <compound-id="977">oxygen</compound-id> species (ROS), and NF-kappaB activation in rat BMECs.	oxygen__monocyte chemoattractant protein-1__no_interaction	oxygen__ICAM-1__no_interaction	oxygen__MCP-1__no_interaction
18726998-19	We examined <compound-id="5280453">1,25 dihydroxyvitamin D</compound-id> (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (<protein-id="Q07973">CYP24</protein-id>) and apical calcium channel (<protein-id="Q9H1D0">TRPV6</protein-id>) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1,25 dihydroxyvitamin D__TRPV6__interaction	1,25 dihydroxyvitamin D__CYP24__interaction
18727009-26	Here, we tested the hypothesis that interactions with <protein-id="P38086">DNA-topoisomerases</protein-id> play a role in the DNA-damaging properties of <compound-id="5359485">AOH</compound-id>.	AOH__DNA-topoisomerases__interaction
18727009-27	Next, we selected <compound-id="5359485">AOH</compound-id> as the most DNA-damaging Alternaria metabolite for further studies of interactions with <protein-id="P38086">DNA topoisomerases</protein-id>.	AOH__DNA topoisomerases__interaction
18727009-28	Stabilisation of covalent <protein-id="O29238,O51934,O58530,O67037,O67226,P74759,P95479,Q08582,Q58907,Q6F598,Q8R979,Q8ZXT5,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9UZ86,Q9YC75,Q9YCB6">topoisomerase</protein-id> II-DNA intermediates by <compound-id="5359485">AOH</compound-id> was also detectable in cell culture, and here, the IIalpha isoform was preferentially targeted.	AOH__topoisomerase__interaction
18727113-70	Bone formation and maturation processes were evaluated by double staining for <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> and tartrate-resistant acid <protein-id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">phosphatase</protein-id>, immunohistochemistry for bone <protein-id="O12705,O18559,O57299,O89341,P03314,P03344,P03419,P03426,P03519,P04876,P04888,P05769,P06157,P06166,P06446,P06502,P06503,P06935,P06942,P06943,P07564,P07720,P07873,P08325,P08671,P09732,P09866,P11206,P12446,P12823,P13616,P13844,P14335,P14336,P14340,P14403,P15200,P16287,P16628,P16629,P17748,P17763,P18356,P18611,P19110,P19692,P19718,P22046,P22338,P24266,P24615,P25058,P25182,P25223,P25224,P26034,P27019,P27020,P27287,P27395,P27663,P27910,P27912,P27913,P27915,P29165,P29837,P29838,P29983,P29984,P29990,P29991,P30026,P31035,P31620,P32886,P33478,P33482,P33515,P35947,P35976,P36355,P36356,P41358,P52637,P62683,P62684,P62685,P62689,P62690,P63117,P63126,P63128,P63130,P63145,P87577,P87889,Q01299,Q01427,Q04538,Q074N0,Q1X880,Q1X881,Q66112,Q6DV88,Q6J3P1,Q7LDI9,Q84131,Q88266,Q88428,Q89277,Q91B74,Q96PI4,Q98803,Q9HDB9,Q9IK90,Q9JAF2,Q9NRZ4,Q9UKH8,Q9YNA8,Q9YRV3">matrix proteins</protein-id>, vital staining with <compound-id="65079">calcein</compound-id>, and elemental mapping with an electron probe microanalyzer.	calcein__phosphatase__no_interaction	calcein__matrix proteins__no_interaction	calcein__alkaline phosphatase__no_interaction
18728222-493	Phosphorylation of <protein-id="Q28516">insulin receptor</protein-id> substrate (<protein-id="P41252,Q8BU30,Q9XTN2">IRS</protein-id>) proteins on <compound-id="5951">serine</compound-id> residues has emerged as a key step in these control processes under both physiological and pathological conditions.	serine__IRS__interaction	serine__insulin receptor__interaction
18728345-519	In contrast, <protein-id="Q14703,Q9WTZ2,Q9WTZ3,Q9Z2A8">SKI-1</protein-id> (<protein-id="Q14703,Q9Z2A8">S1P</protein-id> or site-1) is a membrane-bound <protein-id="P83290">serine protease</protein-id> inhibitable by <compound-id="1701">AEBSF</compound-id>.	AEBSF__S1P__interaction	AEBSF__SKI-1__interaction	AEBSF__serine protease__no_interaction
18728347-520	The progressive ankylosis gene (<protein-id="P58366,Q9JHZ2">ank</protein-id>) is a <protein-id="O12164,O41803,O42043,O56861,O70902,O71037,O89292,O91086,P03374,P03375,P03377,P03378,P03379,P03380,P03381,P03383,P03384,P03385,P03386,P03387,P03388,P03390,P03391,P03392,P03396,P03397,P03398,P03399,P04027,P04502,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P06445,P06751,P06752,P07575,P08359,P08360,P08810,P0C212,P10259,P10267,P10269,P11261,P11267,P11268,P11306,P12449,P12487,P12488,P12489,P12492,P14075,P14351,P15073,P15831,P16082,P16090,P16899,P17281,P17755,P18040,P18094,P18799,P19030,P19503,P19549,P19550,P19551,P19556,P19557,P20871,P20872,P20888,P21412,P21415,P21436,P21443,P21445,P22380,P22427,P22428,P22429,P22430,P23064,P23073,P23422,P23423,P24105,P25057,P25504,P25505,P25506,P25507,P26803,P26804,P27399,P27757,P27977,P31621,P31626,P31627,P31789,P31791,P31794,P31796,P31819,P31872,P32536,P32541,P33498,P35954,P35961,P51515,P51519,P51520,P60507,P60508,P61550,P61552,P61553,P61554,P61555,P61556,P61557,P61558,P61559,P61561,P61562,P61563,P61564,P61565,P61566,P61567,P61570,Q02076,Q02077,Q02282,Q02837,Q03804,Q03816,Q03817,Q04993,Q04995,Q05312,Q09SZ7,Q0R5Q9,Q14264,Q1A243,Q1A261,Q69384,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q85646,Q89607,Q8AIH5,Q8MIB6,Q902F8,Q902F9,Q96L62,Q9IDV2,Q9N2J8,Q9N2J9,Q9N2K0,Q9NX77,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9TTC0,Q9UKH3,Q9UQF0,Q9WC60,Q9WC69">transmembrane protein</protein-id> that transports intracellular <compound-id="644102">pyrophosphate</compound-id> to the extracellular milieu.	pyrophosphate__ank__interaction	pyrophosphate__transmembrane protein__no_interaction
18728678-624	<protein-id="Q8JFG3">Tumor necrosis factor</protein-id> receptor-1 is essential for LPS-induced sensitization and tolerance to <compound-id="977">oxygen</compound-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> deprivation in murine neonatal organotypic hippocampal slices.	oxygen__Tumor necrosis factor__interaction	glucose__Tumor necrosis factor__interaction
18728678-625	The role of <protein-id="Q8JFG3">tumor necrosis factor</protein-id> (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>) receptors 1 and 2 in <compound-id="11970143">lipopolysaccharide</compound-id> (LPS)-induced sensitization and tolerance to <compound-id="977">oxygen</compound-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	glucose__tumor necrosis factor__interaction	oxygen__tumor necrosis factor__interaction	lipopolysaccharide__TNF__interaction	oxygen__TNF__interaction	glucose__TNF__interaction	lipopolysaccharide__tumor necrosis factor__interaction
18729103-711	The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with <compound-id="128853">delphinidin</compound-id> resulted in the inhibition of (i) <protein-id="O15111,Q60680">IKKalpha</protein-id>, (ii) phosphorylation and degradation of <protein-id="P25963,Q08353,Q63746,Q91974,Q9Z1E3">IkappaBalpha</protein-id>, (iii) phosphorylation of NF-kappaB/<protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> at Ser (536), (iv) nuclear translocation of NF-kappaB/<protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id>, (v) NF-kappaB/<protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> DNA binding activity, and (vi) transcriptional activation of NF-kappaB.	delphinidin__p65__interaction	delphinidin__IKKalpha__interaction	delphinidin__IkappaBalpha__interaction
18729824-936	Accommodation of <compound-id="5983,14107712">physostigmine</compound-id> and its analogues by <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> is dominated by hydrophobic interactions.	physostigmine__acetylcholinesterase__interaction
18729824-937	The role of the functional architecture of the HuAChE (human <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id>) in reactivity toward the carbamates <compound-id="4991">pyridostigmine</compound-id>, <compound-id="77991">rivastigmine</compound-id> and several analogues of <compound-id="5983,14107712">physostigmine</compound-id>, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	rivastigmine__acetylcholinesterase__interaction	physostigmine__acetylcholinesterase__interaction	pyridostigmine__acetylcholinesterase__interaction
18751681-68	Cells were grown for 24 h with <compound-id="1983">APAP</compound-id> in the presence or absence of 4-methylpyrazole (4MP), <compound-id="550788">L-arginine methyl ester</compound-id> (L-NAME), <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), or <compound-id="23950">ruthenium</compound-id> red (<compound-id="4971">RuR</compound-id>).	ruthenium__superoxide dismutase__no_interaction	ruthenium__SOD__no_interaction	RuR__superoxide dismutase__no_interaction	L-arginine methyl ester__SOD__no_interaction	RuR__SOD__no_interaction	APAP__superoxide dismutase__no_interaction	L-arginine methyl ester__superoxide dismutase__no_interaction	APAP__SOD__no_interaction
18751889-128	Synaptic vesicle-bound <protein-id="O05118,O06134,O08309,O44006,O51323,O62619,O94122,P19680,P22360,P30614,P31865,P32044,P34038,P43924,P46614,P47458,P51181,P51182,P57404,P70789,P78031,P80885,P81344,P94685,P94939,Q02499,Q04668,Q07637,Q10208,Q12669,Q27686,Q27788,Q44473,Q46078,Q46289,Q56301,Q57572,Q6BS75,Q759A9,Q7RVA8,Q875M9,Q875S4,Q875Z9,Q89AI8,Q8FP04,Q8K9M3,Q9PK61,Q9Z984">pyruvate kinase</protein-id> can support vesicular <compound-id="611,23327,33032">glutamate</compound-id> uptake.	glutamate__pyruvate kinase__interaction
18751889-129	We present evidence that ATP generated by synaptic vesicle-associated <protein-id="O05118,O06134,O08309,O44006,O51323,O62619,O94122,P19680,P22360,P30614,P31865,P32044,P34038,P43924,P46614,P47458,P51181,P51182,P57404,P70789,P78031,P80885,P81344,P94685,P94939,Q02499,Q04668,Q07637,Q10208,Q12669,Q27686,Q27788,Q44473,Q46078,Q46289,Q56301,Q57572,Q6BS75,Q759A9,Q7RVA8,Q875M9,Q875S4,Q875Z9,Q89AI8,Q8FP04,Q8K9M3,Q9PK61,Q9Z984">pyruvate kinase</protein-id> is harnessed to transport <compound-id="611,23327,33032">glutamate</compound-id> into synaptic vesicles.	glutamate__pyruvate kinase__no_interaction
18751891-135	We examined the expression of <protein-id="O08651,Q61753">Phgdh</protein-id> and <protein-id="O35874,P43007">ASCT1</protein-id> in <compound-id="10255">kainic acid</compound-id> (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	kainic acid__Phgdh__interaction	kainic acid__ASCT1__interaction
18751892-136	In the present study the effect of the convulsant drug <compound-id="6514">3-mercaptopropionic acid</compound-id> (MP) repetitive administration (4-7 days) on the hippocampal <protein-id="Q00960,Q01097,Q13224">NR2B</protein-id> subunit was studied.	3-mercaptopropionic acid__NR2B__no_interaction
18751892-137	A significant decrease in <protein-id="Q00960,Q01097,Q13224">NR2B</protein-id> in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in <compound-id="49766501">MP7</compound-id> by western blot assay.	MP7__NR2B__interaction
18751894-139	Heart glycogen represents a store of glucosyl residues which are mobilized by the catalysis of <protein-id="O66932,O84250,P06738,P0AC86,P0AC87,P39123,P45180,P73511,Q10639,Q7U078,Q9CN90,Q9PKE6,Q9XTL9,Q9Z8N1">glycogen phosphorylase</protein-id> (GP) and are mainly destined to serve as substrates for the generation of <compound-id="5957">ATP</compound-id>.	ATP__glycogen phosphorylase__no_interaction
18752001-187	However, <compound-id="8249">phenformin</compound-id> was equally effective in AMPKalpha1(-/-) and wild-type animals, suggesting additional <protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id>-independent action of <compound-id="8249">phenformin</compound-id>.	phenformin__AMPK__no_interaction
18752070-205	The relationship between <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> (<protein-id="O62781,O62819,O93337,P01236,P01237,P01238,P01239,P01240,P06879,P09585,P10765,P12420,P14676,P17572,P21993,P22393,P29234,P29235,P33089,P33090,P33091,P33096,P34181,P35395,P37884,P40424,P43001,P43299,P46403,P48096,P48249,P51904,P55151,P87495,Q28318,Q28632,Q3Y4G6,Q6UC74,Q7ZZV3,Q8HXS1,Q9QZL1,Q9YGV6">PRL</protein-id>), <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id>, <compound-id="145068">nitric oxide</compound-id> (NO), and cytokines in patients with hyperprolactinemia.	nitric oxide__PRL__interaction	nitric oxide__prolactin__interaction	nitric oxide__leptin__interaction
18752070-206	The aim of this study was to determine the changes in serum <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id>, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>), <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>), <compound-id="145068">nitric oxide</compound-id> (NO) levels in patients with hyperprolactinemia.	nitric oxide__leptin__no_interaction	nitric oxide__IL-6__no_interaction	nitric oxide__tumor necrosis factor__no_interaction	nitric oxide__TNF-alpha__no_interaction	nitric oxide__interleukin-6__no_interaction
18752089-210	Joint analysis of individual participants' data from 17 studies on the association of the <protein-id="O35736,P05231,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL6</protein-id> variant-174G&gt;C with circulating <compound-id="206,5793,64689,79025">glucose</compound-id> levels, <protein-id="P41693">interleukin-6</protein-id> levels, and body mass index.	glucose__interleukin-6__no_interaction	glucose__IL6__no_interaction
18752284-283	Effect of <protein-id="P20815,P80056">cytochrome P450 3A5</protein-id> *3 genotype on the stereoselective pharmacokinetics of <compound-id="2162">amlodipine</compound-id> in healthy subjects.	amlodipine__cytochrome P450 3A5__interaction
18752284-286	In conclusion, the present study showed that despite the evidence that <compound-id="2162">amlodipine</compound-id> is stereoselectively metabolized, <protein-id="P20815">CYP3A5</protein-id> *3 genotype did not affect stereoselective disposition of <compound-id="2162">amlodipine</compound-id>.	amlodipine__CYP3A5__no_interaction
18752284-287	It provides the evidence that <protein-id="P20815">CYP3A5</protein-id> *3genotype plays a minor role in the interindividual variability of stereoselective disposition of <compound-id="2162">amlodipine</compound-id> in humans.	amlodipine__CYP3A5__interaction
18752291-293	Tissues were stained for <compound-id="6035">BrdU</compound-id>, <protein-id="P47239">Pax-7</protein-id>, <protein-id="P02543,P02544,P08670,P09654,P20152,P31000,P48616,P48670,P48674,P84198,Q4R4X4,Q5R1W8,Q92155,Q9MZA9">vimentin</protein-id>, and <compound-id="442514">haematoxylin</compound-id> and eosin staining.	haematoxylin__Pax-7__no_interaction	BrdU__Pax-7__no_interaction	BrdU__vimentin__no_interaction	haematoxylin__vimentin__no_interaction
18752295-295	Differences in the expression of inwardly rectifying potassium channels (<protein-id="P49655">Kir4.1</protein-id>), glial fibrillary <protein-id="P01538,P01543,P01544,P01545,P08772,P08943,P09617,P09618,P21742,P32032,Q05806,Q42596,Q42597,Q42838,Q8H0Q5,Q8VZK8,Q9C8D6,Q9SBK8">acidic protein</protein-id> (<protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id>), and <compound-id="1123">taurine</compound-id> levels in cortical astrocytes were detected using immunohistochemical methods.	taurine__acidic protein__no_interaction	taurine__Kir4.1__no_interaction	taurine__GFAP__no_interaction
18752295-296	Immunohistochemical analysis suggests that the diverse expression of <protein-id="P49655">Kir4.1</protein-id> channels and <protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id> as well as differences in the accumulation of <compound-id="1123">taurine</compound-id> might contribute to the distinct ability of astrocytes to regulate their volume.	taurine__Kir4.1__no_interaction	taurine__GFAP__no_interaction
18752301-300	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by <compound-id="16219535">5'-iodoresiniferatoxin</compound-id> (5 microg) or <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> was inhibited by <compound-id="2703,411938">chelerythrine</compound-id> <compound-id="312">chloride</compound-id> (5 microg).	chelerythrine__PKC__interaction	5'-iodoresiniferatoxin__PKC__no_interaction	chloride__PKC__interaction
18752305-1438	Regulation of the phosphoinositide-3 kinase and <protein-id="Q00859">mitogen-activated protein kinase</protein-id> signaling pathways by <compound-id="5994">progesterone</compound-id> and its reduced metabolites in the rat brain.	progesterone__mitogen-activated protein kinase__interaction
18752305-1439	Several growth factors, such as vascular endothelial growth factor, <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id>, and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-like growth factor-I are involved in the actions of <compound-id="5994">progesterone</compound-id> in the central nervous system.	progesterone__brain-derived neurotrophic factor__interaction	progesterone__insulin__interaction
18752305-1440	Significant increases in the phosphorylation of <protein-id="P29323">ERK</protein-id>, in the expression of the catalytic (<protein-id="P07566,P08563,P08564,P14907,P19725,P47825,Q6X2U1,Q6X2U3,Q8VA10,Q99IE6,Q9J6K8">p110</protein-id>) and the regulatory (<protein-id="O43439,P46655,P49846,Q14155">p85</protein-id>) subunits of <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id> and in the phosphorylation of <protein-id="P31750,Q8INB9">Akt</protein-id> were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after <compound-id="5994">progesterone</compound-id> administration.	progesterone__ERK__interaction	progesterone__p85__interaction	progesterone__p110__interaction	progesterone__Akt__interaction	progesterone__PI3K__interaction
18752414-337	In addition, we used PET to evaluate the striatal dopamine transporter availability (<protein-id="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DAT</protein-id>) with [(11)C]d-threo-<compound-id="4158">methylphenidate</compound-id> in the patient group.	methylphenidate__DAT__interaction
18752468-361	Associated with the mitochondrial permeabilization, PdC also induced the release of <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id>, which is sensitive to inhibition by <compound-id="439352">DTT</compound-id>.	DTT__cytochrome c__interaction
18752565-399	Toll-like receptor 4 (<protein-id="P23799">TLR</protein-id>-4)/myeloid differentiation <protein-id="P03548,P03549,P03550,P05397,P09521,P19818,Q00965,Q01087,Q02966">protein-2</protein-id> complex ligation by <compound-id="11970143">lipopolysaccharide</compound-id> induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	lipopolysaccharide__TLR__interaction	lipopolysaccharide__protein-2__interaction
18752633-420	Immunohistochemistry was performed on paraffin-embedded sections, using anti-<compound-id="65040">5-methylcytosine</compound-id> (5mc) and anti-Acetyl-<protein-id="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1">Histone H3</protein-id> (Lys 9).	5-methylcytosine__Histone H3__no_interaction
18752635-423	Here, the <protein-id="O43763">NCX</protein-id>-mediated (45)Ca(2+) uptake was compared in <compound-id="923,373840">Na</compound-id> (+)-loaded pig coronary artery smooth muscle and endothelial cells.	Na__NCX__no_interaction
18752635-425	The concept of a linkage between <protein-id="O43763">NCX</protein-id> and SERCA in smooth muscle was also confirmed by similar distribution of <protein-id="O43763">NCX</protein-id> and <protein-id="O46674,O55143,P11507,P11607,P16615,P20647,Q00779,Q03669">SERCA2</protein-id> proteins when detergent-treated microsomes were fractionated by flotation on <compound-id="5988">sucrose</compound-id> density gradients.	sucrose__SERCA2__no_interaction	sucrose__NCX__no_interaction
18752971-536	The recent approval of <compound-id="5329102">sunitinib</compound-id>, <compound-id="216239">sorafenib</compound-id>, <compound-id="148191,6918289,18293306,23724530,24847874,53486199,54608508">temsirolimus</compound-id> and bevacizumab in combination with <protein-id="P35849">IFN-alpha</protein-id> has revolutionized the management of renal cell carcinoma.	temsirolimus__IFN-alpha__no_interaction	sorafenib__IFN-alpha__no_interaction	sunitinib__IFN-alpha__no_interaction
18753126-578	Here we report identification of the first three in vivo non-histone protein substrates of <compound-id="866,5962">lysine</compound-id> propionylation in eukaryotic cells: <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id>, <protein-id="Q01705,Q09472">p300</protein-id>, and <protein-id="P45481,Q92793">CREB-binding protein</protein-id>.	lysine__CREB-binding protein__interaction	lysine__p53__interaction	lysine__p300__interaction
18753126-580	<protein-id="Q01705,Q09472">p300</protein-id> was able to perform autopropionylation on <compound-id="866,5962">lysine</compound-id> residues in cells.	lysine__p300__interaction
18753604-688	This study determined the effects of the estrous cycle, pregnancy, <compound-id="5994">progesterone</compound-id> (P4), and interferon <protein-id="P10637,P16525,P19332,P58384">tau</protein-id> (<protein-id="O46633,P28171,P28172,Q95187">IFNT</protein-id>) on expression of both facilitative (<protein-id="P11166,P13355,P20303,P27674,P46896,P79365">SLC2A1</protein-id>, <protein-id="O62787,P11169,P28568,P47842,P47843,P58352,Q5R608,Q9XSC2">SLC2A3</protein-id>, and <protein-id="P14672,Q27994,Q9XST2,Q9XT10">SLC2A4</protein-id>) and sodium-dependent (<protein-id="P11170,P13866,P26429,P53791">SLC5A1</protein-id> and SLC5A11) <protein-id="P23586">glucose transporters</protein-id> in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	progesterone__SLC2A1__interaction	progesterone__SLC2A3__interaction	progesterone__SLC5A1__interaction	progesterone__glucose transporters__interaction	progesterone__SLC2A4__interaction	progesterone__IFNT__no_interaction	progesterone__tau__no_interaction
18753675-708	In <protein-id="P16671,P26201,P70110">CD36</protein-id>-D patients, plasma triglycerides, <protein-id="P04114">apolipoprotein B-48</protein-id> (<protein-id="P04114">apoB-48</protein-id>), free fatty acids (FFAs), and free <compound-id="753">glycerol</compound-id> levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	glycerol__CD36__no_interaction	glycerol__apoB-48__no_interaction	glycerol__apolipoprotein B-48__no_interaction
18753676-709	Identification of <protein-id="Q5MIZ7">SMEK2</protein-id> as a candidate gene for regulation of responsiveness to dietary <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> in rats.	cholesterol__SMEK2__interaction
18753676-710	Here we narrowed Dihc2 to a region including 33 genes and predicted transcripts and identified RGD1309450_predicted, a homologous gene of <protein-id="Q5MIZ7">SMEK2</protein-id>, as a strong candidate for responsiveness to dietary <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>.	cholesterol__SMEK2__interaction
18753737-733	<compound-id="6013">Testosterone</compound-id> is a strong correlate of <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> levels in men and postmenopausal women.	Testosterone__ghrelin__interaction
18754081-829	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% <compound-id="1118">sulfuric acid</compound-id> at 140 degrees C for 30 min and enzymatic hydrolysis with <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> (15 filter per unit (FPU)/g cellulose) and <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</protein-id> (50 cellobiose units (CBU)/g cellulose).	sulfuric acid__beta-glucosidase__no_interaction	sulfuric acid__cellulase__no_interaction
18754092-832	<compound-id="124886">Glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), and <compound-id="10964">malondialdehyde</compound-id> (MDA) activities in blood were measured.	Glutathione__CAT__no_interaction	GSH__CAT__no_interaction	malondialdehyde__CAT__no_interaction	GSH__catalase__no_interaction	malondialdehyde__catalase__no_interaction	Glutathione__catalase__no_interaction
18754092-833	<protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">Catalase</protein-id>, myeloperoxidase (<protein-id="P05164,P11247">MPO</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GSH-Px), <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), <compound-id="10964">malondialdehyde</compound-id>, and <compound-id="145068">nitric oxide</compound-id> (NO) activities were measured from tissue samples.	malondialdehyde__MPO__no_interaction	nitric oxide__glutathione reductase__no_interaction	nitric oxide__Catalase__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction	nitric oxide__glutathione peroxidase__no_interaction	malondialdehyde__Catalase__no_interaction	malondialdehyde__glutathione reductase__no_interaction	nitric oxide__MPO__no_interaction
18754101-836	In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of <compound-id="7906">methylmercury</compound-id> (<compound-id="6860">MeHg</compound-id>) and the association between <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	methylmercury__glutathione peroxidase__no_interaction	MeHg__glutathione peroxidase__no_interaction
18754103-838	To investigate any similarities in the inhibition of <protein-id="O18963,P05181,P08682,P33266,P51581,P79383,Q6GUQ4">CYP2E1</protein-id> by quinacrine and <compound-id="3117">disulfiram</compound-id>, molecular modeling techniques were adopted and revealed that quinacrine molecule anchors inside the same binding pocket of the protein where <compound-id="3117">disulfiram</compound-id> is also attached.	disulfiram__CYP2E1__interaction
18754105-839	administered during 7 days at 20 mg/kg per day (subacute treatment), <compound-id="445154">resveratrol</compound-id> abrogated LPS-induced erythrocytes lipoperoxidation and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>) activity depression to control levels.	resveratrol__CAT__interaction	resveratrol__catalase__interaction
18754702-986	H2S can be produced from <compound-id="594,5862,5360637">cysteine</compound-id> by enzymes such as <protein-id="P32232,P32582,P35520,P46794,Q58H57,Q91WT9,Q9N0V7,Q9YBL2">cystathionine beta-synthase</protein-id>.	cysteine__cystathionine beta-synthase__interaction
18754757-1000	The influence of carbon sources on rhGH (recombinant human <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id>) production by two Pichia pastoris strains having different <compound-id="19314">methanol</compound-id> utilization phenotypes (P. pastoris-hGH-Mut (+) and P. pastoris-hGH-Mut (s)) was investigated using batch bioreactors.	methanol__growth hormone__no_interaction
18754816-1023	The present study was undertaken to test the hypothesis that PPARalpha activator <compound-id="3339">fenofibrate</compound-id> plays a key role in left ventricular hypertrophic remodelling via the formation of c-<protein-id="P01101,P12841,Q56415">fos</protein-id>/c-<protein-id="P05627,P17325,P18289">jun</protein-id> heterodimers in spontaneous hypertensive rats (SHRs).	fenofibrate__fos__interaction	fenofibrate__jun__interaction
18755047-1448	Effects of <compound-id="446284">eicosapentaenoic acid</compound-id> <compound-id="8857">ethyl ester</compound-id> on <protein-id="P43490,Q52I78,Q80Z29,Q99KQ4">visfatin</protein-id> and <compound-id="56841713">apelin</compound-id> in lean and overweight (cafeteria diet-fed) rats.	eicosapentaenoic acid__visfatin__no_interaction	ethyl ester__visfatin__no_interaction	apelin__visfatin__no_interaction
18755051-1093	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), <protein-id="P10961,P12850,P19875,P22121,P22813,P41154,Q02953">HSF</protein-id> (about 454 %) and P-<protein-id="P10961,P12850,P19875,P22121,P22813,P41154,Q02953">HSF</protein-id> (about 371 %) when compared with ferrous <compound-id="1117">sulfate</compound-id> or <protein-id="Q26061">ferritin</protein-id> without AA.	sulfate__HSF__no_interaction	sulfate__ferritin__no_interaction
18755266-1173	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id>-like growth factor-I (<protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id>) is neuroprotective against <compound-id="702">ethanol</compound-id>-related toxicity and promotes white matter production following a number of insults.	ethanol__IGF-I__interaction	ethanol__Insulin__interaction
18755266-1174	These data indicate that <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> may be a potential treatment for some of <compound-id="702">ethanol</compound-id>'s damaging effects, a finding that has important implications for children of women who drink alcohol during pregnancy.	ethanol__IGF-I__interaction
18755506-1246	This study is aimed to investigate the effects of <compound-id="7979">triethyleneglycol dimethacrylate</compound-id> (TEGDMA) and <compound-id="13360">2-hydroxyethyl methacrylate</compound-id> (HEMA) on expression of <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</protein-id> (<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>) and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) in cultured murine macrophage cell line RAW 264.7.	triethyleneglycol dimethacrylate__cyclooxygenase-2__interaction	triethyleneglycol dimethacrylate__COX-2__interaction	triethyleneglycol dimethacrylate__iNOS__interaction	2-hydroxyethyl methacrylate__nitric oxide synthase__interaction	2-hydroxyethyl methacrylate__COX-2__interaction	2-hydroxyethyl methacrylate__iNOS__interaction	triethyleneglycol dimethacrylate__nitric oxide synthase__interaction	2-hydroxyethyl methacrylate__cyclooxygenase-2__interaction
18755582-1265	SWCNT coatings were thus functionalized with poly(<compound-id="9238">adamantane</compound-id>-pyrrole) and applied to the anchoring of <protein-id="P81156">glucose oxidase</protein-id> (<protein-id="P05414,Q92452,Q9UJM8,Q9WU19">GOX</protein-id>), modified with beta-cyclodextrin.	adamantane__GOX__interaction	adamantane__glucose oxidase__interaction
18755582-1266	This allows the immobilization of <compound-id="9238">adamantane</compound-id>-tagged <protein-id="P05414,Q92452,Q9UJM8,Q9WU19">GOX</protein-id>.	adamantane__GOX__interaction
18755616-1270	<compound-id="4677798">Statin</compound-id>-induced bone <protein-id="P07580">morphogenetic protein</protein-id> (<protein-id="P35855">BMP</protein-id>) 2 expression during bone regeneration: an immunohistochemical study.	Statin__morphogenetic protein__interaction	Statin__BMP__interaction
18755616-1271	The purpose of this study was to investigate bone <protein-id="P07580">morphogenetic protein</protein-id> (<protein-id="P35855">BMP</protein-id>) 2 expression after implantation of a <compound-id="4677798">statin</compound-id> and recombinant human <protein-id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</protein-id> (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	statin__BMP-2__no_interaction	statin__morphogenetic protein__interaction	statin__BMP__no_interaction
18755796-1307	<compound-id="6076">cAMP</compound-id>, a second messenger in LH signaling, was identified as a factor in hCG-dependent regulation of <protein-id="P48609,P49615,P51166,Q03114">Cdk5</protein-id>/<protein-id="P04083,P07150,P08160,P10107,P12723,P14087,P16342,P19619,P19751,P27920,P30047,P31354,P38626,P46193,P51662,P51948,P51949,P61809,P61810,P70552,P99025,Q03148,Q15078,Q28199,Q66198,Q80YF6,Q864V4,Q8V439,Q8V6W7,Q91A29,Q91QT2,Q92108,Q96510,Q96FF9,Q9BT76,Q9PYA3">p35</protein-id>.	cAMP__p35__interaction	cAMP__Cdk5__interaction
18755820-1310	Intracellular production of <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id> and <protein-id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</protein-id> after stimulation with <compound-id="290670,442070,24832117">phorbol</compound-id> <compound-id="11005">myristate</compound-id>/<compound-id="3733,6434517,6912226,25134244">ionomycin</compound-id> was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	ionomycin__TNFalpha__interaction	phorbol__IL-2__interaction	phorbol__TNFalpha__interaction	ionomycin__IL-2__interaction	myristate__TNFalpha__interaction	myristate__IL-2__interaction
18756496-1463	Although we reported that 8-Cl-cAMP induces growth inhibition via p38 mitogen-activated protein kinase (<protein-id="O42781,P27638,Q00859">MAPK</protein-id>) and a metabolite of 8-Cl-cAMP, 8-Cl-<compound-id="60961">adenosine</compound-id> mediates this process, the action mechanism of 8-Cl-cAMP is still uncertain.	adenosine__MAPK__interaction
18756527-1486	Certain non-steroidal anti-inflammatory drugs, e.g., the <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase 2</protein-id>-specific nonsteroidal anti-inflammatory drugs, <compound-id="2662">celecoxib</compound-id>, raise Abeta(42) levels.	celecoxib__cyclooxygenase 2__interaction
18756589-1515	This was significantly in accordance with intracellular oxidative stress levels measured by <compound-id="124886">glutathione</compound-id> depletion, <compound-id="10964">malondialdehyde</compound-id> production, <protein-id="O50258">superoxide dismutase</protein-id> inhibition as well as reactive <compound-id="977">oxygen</compound-id> species generation.	malondialdehyde__superoxide dismutase__no_interaction	oxygen__superoxide dismutase__no_interaction	glutathione__superoxide dismutase__no_interaction
18757054-1690	<compound-id="7847">Acrolein</compound-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> and <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id> as markers of silent brain infarction.	Acrolein__IL-6__no_interaction	Acrolein__CRP__no_interaction
18757054-1691	We found previously that increased levels of <protein-id="Q6QHF9,Q865R1,Q8C0L6">polyamine oxidase</protein-id> (<protein-id="O64411,Q6QHF9,Q865R1,Q9FYC2">PAO</protein-id>) [acetylpolyamine oxidase (AcPAO) plus <protein-id="Q99K82,Q9NWM0">spermine oxidase</protein-id> (<protein-id="O42224,P56726,P97698,Q99835,Q9NWM0">SMO</protein-id>)], and <compound-id="7847">acrolein</compound-id> (CH(2)CHCHO) are good markers of stroke.	acrolein__SMO__no_interaction	acrolein__PAO__no_interaction	acrolein__polyamine oxidase__no_interaction	acrolein__spermine oxidase__no_interaction
18757054-1692	We then investigated whether silent brain infarction (SBI) can be detected by measuring <compound-id="7847">acrolein</compound-id>, <protein-id="O64411,Q6QHF9,Q865R1,Q9FYC2">PAO</protein-id>, or other biomarkers.	acrolein__PAO__no_interaction
18757054-1693	It was found that the levels of protein-conjugated <compound-id="7847">acrolein</compound-id> (PC-Acro), <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>) and C-reactive protein (<protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>) were significantly higher in SBI than in normal subjects.	acrolein__interleukin-6__no_interaction	acrolein__IL-6__no_interaction	acrolein__CRP__no_interaction
18757097-1716	Human skin keratinocytes HaCat attacked by Staphylococcus aureus <protein-id="P09616,P0C216,Q0TV31,Q9RF12">alpha-toxin</protein-id> showed a transient drop of cellular <compound-id="5957">ATP</compound-id> levels whereas in toxin-perforated bovine mammary epithelial cells (BMEC), the <compound-id="5957">ATP</compound-id> levels dropped more slowly.	ATP__alpha-toxin__interaction
18757185-1747	Catalepsy, serum <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id>, receptor binding profile and cortical (PFC), hippocampal (Hip) and <compound-id="681">dopamine</compound-id> (DA) levels were determined.	dopamine__prolactin__no_interaction
18757188-1748	Estrogenic effect was determined by the change of uterine weight, and oxidant effects were determined by the content of <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, <compound-id="124886">GSH</compound-id>-Px, <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id> and MDA.	GSH__CAT__no_interaction	GSH__SOD__no_interaction
18757188-1749	The intake of formononetin increased the uterine weight of the mice significantly as well as the content of <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, <compound-id="124886">GSH</compound-id>-Px, <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>, and reduced MDA in body.	GSH__CAT__no_interaction	GSH__SOD__no_interaction
18757189-1750	A novel <compound-id="906,444885,445063">sialic acid</compound-id>-specific <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities.	sialic acid__lectin__interaction
18757189-1751	A novel <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> (PCL) with specificity towards <compound-id="906,444885,445063">sialic acid</compound-id> was purified from Phaseolus coccineus L. (P. multiflorus willd) seeds using ion exchange chromatography on CM and DEAE-Sepharose, and gel filtration on Sephacryl S-200 column.	sialic acid__lectin__interaction
18757233-1762	The characterization for the binding of calcium and <compound-id="23958">terbium</compound-id> to Euplotes octocarinatus <protein-id="P05434,P41210,P43645,P43646,P53441,P54213,Q06827,Q24956,Q27177,Q27178,Q27179">centrin</protein-id>.	terbium__centrin__interaction
18757307-1779	We have previously shown that ROS-induced <protein-id="P98088">MUC5AC</protein-id> expression in NHBE cells is dependent on <compound-id="24759">hyaluronan</compound-id> depolymerization and <protein-id="P55245">epidermal growth factor receptor</protein-id> (<protein-id="P00533,P13387,P55245">EGFR</protein-id>)/<protein-id="Q00859">mitogen-activated protein kinase</protein-id> (<protein-id="O42781,P27638,Q00859">MAPK</protein-id>) activation.	hyaluronan__MAPK__no_interaction	hyaluronan__mitogen-activated protein kinase__no_interaction	hyaluronan__MUC5AC__interaction	hyaluronan__epidermal growth factor receptor__no_interaction	hyaluronan__EGFR__no_interaction
18757495-1808	<protein-id="O60109,P81800,P83456">Alkaline phosphatase</protein-id> activity and <protein-id="O93390,P07214,P09486,P13213,P16975,P20112,P34714,P36233,P36377,P36378,P36379">osteonectin</protein-id> expression of the osteoblasts cultured on the <compound-id="36797">PLGA</compound-id> scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	PLGA__osteonectin__no_interaction	PLGA__Alkaline phosphatase__no_interaction
18757495-1809	The <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> activity of osteoblasts cultured on <compound-id="36797">PLGA</compound-id> scaffolds is comparable with that from two commercially-available scaffolds-OPLA and collagen scaffolds (Becton-Dickinson (BD) Inc., Franklin Lakes, NJ, USA).	PLGA__alkaline phosphatase__no_interaction
18757514-1816	The vasodilating effect of <compound-id="1986">acetazolamide</compound-id> and <compound-id="5284549">dorzolamide</compound-id> involves mechanisms other than <protein-id="P27134,P46281,P46510,P46511,P54212,P84537,Q54735,Q92051,Q9ZN54">carbonic anhydrase</protein-id> inhibition.	acetazolamide__carbonic anhydrase__no_interaction	dorzolamide__carbonic anhydrase__no_interaction
18757837-1932	The objective of the present study was to investigate the effects of a high-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> diet on <protein-id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</protein-id> expression and IR localization and activity in the rat liver.	cholesterol__caveolin-1__interaction
18758183-2073	<protein-id="O11451,O11452,O11453,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P06934,P16342,P19751,P25880,P25881,P25882,P25884,P25989,P26660,P26661,P26662,P26663,P26664,P27958,P29833,P29846,P29996,P29997,P40305,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184,P69618,P69619,Q00269,Q43735,Q5I2N3,Q66198,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q81835,Q81842,Q8V439,Q8V6W7,Q913D4,Q91A29,Q91DH7,Q91DH8,Q91DH9,Q99IB8,Q9DHD6,Q9E925,Q9PYA3,Q9QAX1,Q9WMX2">P27</protein-id> and <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">P53</protein-id> play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to <compound-id="5040,478951,5284616,5358081,5374464,5460439,5497196,6436030,16760631,17753749,44295234,53627520,54600319">rapamycin</compound-id> and <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id>.	paclitaxel__P27__interaction	rapamycin__P53__interaction	rapamycin__P27__interaction	paclitaxel__P53__interaction
18758695-2200	Immobilization of <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> on the <compound-id="23985">gold colloid</compound-id> modified pretreated glassy carbon electrode for preparing a novel hydrogen peroxide biosensor.	gold colloid__hemoglobin__interaction
18758695-2201	A novel hydrogen peroxide (H2O2) biosensor was developed by immobilizing <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> on the <compound-id="23985">gold colloid</compound-id> modified electrochemical pretreated glassy carbon electrode (PGCE) via the bridging of an ethylenediamine monolayer.	gold colloid__hemoglobin__interaction
18758751-2238	Involvement of <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> in TPA-potentiated apoptosis induction during <compound-id="4971">hemin</compound-id>-mediated erythroid differentiation in K562 cells.	hemin__PKC__no_interaction
18758751-2239	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> pathway with an activator of the protein kinase C, <compound-id="27924">12-O-tetradecanoylphorbol-13-acetate</compound-id> (TPA), during <compound-id="4971">hemin</compound-id>-induced erythroid differentiation of K562 erythroleukemia cells.	hemin__PKC__no_interaction	12-O-tetradecanoylphorbol-13-acetate__PKC__interaction
18758751-2244	Taken together, our results suggested the involvement of <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> in TPA-potentiated apoptosis induction during <compound-id="4971">hemin</compound-id>-mediated erythroid differentiation in K562 cells.	hemin__PKC__no_interaction
18758757-2247	At glutamatergic synapses, increased binding to the <compound-id="750">glycine</compound-id>-B site located in the <protein-id="P35439,Q9R1M7">N-methyl-D-aspartate receptor</protein-id> (NMDAR) can enhance neurotransmission via NMDARs.	glycine__N-methyl-D-aspartate receptor__interaction
18758781-2256	The most common adverse events were mild and transient gastrointestinal disturbances, skin rash, nonprogressive transient increases in serum <compound-id="588">creatinine</compound-id> and urine <protein-id="P01885,P01886,P19341,P21612,P30442,P55077,P55078,Q03423,Q04714">beta2-microglobulin</protein-id>, and a temporary reduction of the <compound-id="588">creatinine</compound-id> clearance.	creatinine__beta2-microglobulin__no_interaction
18758819-2275	In vitro effect of radiation, antibody to <protein-id="P55245">epidermal growth factor receptor</protein-id> and <compound-id="148124">Docetaxel</compound-id> in human head and neck squamous carcinoma cells with mutant <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">P53</protein-id> and over-expressed <protein-id="P00533,P13387,P55245">EGFR</protein-id>.	Docetaxel__P53__interaction	Docetaxel__EGFR__interaction	Docetaxel__epidermal growth factor receptor__no_interaction
18758925-2312	The optimal condition for the labeling of cypate to <protein-id="O25424,O34482,P06608,P26900,P30363,P43843,P50286,P63627,P63628,Q9RRX9,Q9X7E6,Q9ZLB9">L-ASNase</protein-id> was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by <compound-id="75771">HOBt</compound-id>/<compound-id="130500">HBTU</compound-id>.	HBTU__L-ASNase__interaction	HOBt__L-ASNase__interaction
18758938-2315	Effects of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="54670067,54690394">ascorbic acid</compound-id> on expression of <protein-id="P10417,P49950">Bcl-2</protein-id> family proteins and caspase-3 activity in hippocampus of diabetic rats were evaluated in this study.	ascorbic acid__Bcl-2__interaction	ascorbic acid__insulin__no_interaction
18758940-2316	Chemo-enzymatic synthesis of <compound-id="119547">poly-N-acetyllactosamine</compound-id> (poly-<compound-id="16760443">LacNAc</compound-id>) structures and their characterization for <protein-id="P20718">CGL2</protein-id>-<protein-id="Q801X7">galectin</protein-id>-mediated binding of ECM <protein-id="P08163">glycoproteins</protein-id> to biomaterial surfaces.	LacNAc__CGL2__interaction	poly-N-acetyllactosamine__galectin__interaction	LacNAc__galectin__interaction	poly-N-acetyllactosamine__CGL2__interaction	LacNAc__glycoproteins__interaction	poly-N-acetyllactosamine__glycoproteins__interaction
18758940-2317	<compound-id="119547">Poly-N-acetyllactosamine</compound-id> (poly-<compound-id="16760443">LacNAc</compound-id>) structures have been identified as important ligands for <protein-id="Q801X7">galectin</protein-id>-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	Poly-N-acetyllactosamine__galectin__interaction	LacNAc__galectin__interaction
18758940-2318	We here present the biofunctionalization of surfaces with poly-<compound-id="16760443">LacNAc</compound-id> structures and subsequent binding of ECM <protein-id="P08163">glycoproteins</protein-id>.	LacNAc__glycoproteins__interaction
18758940-2319	A mixture of poly-<compound-id="16760443">LacNAc</compound-id>-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model <protein-id="Q801X7">galectin</protein-id> His(6) <protein-id="P20718">CGL2</protein-id>.	LacNAc__CGL2__interaction	LacNAc__galectin__interaction
18758940-2320	We further demonstrate for the first time that these poly-<compound-id="16760443">LacNAc</compound-id> surfaces are suitable for further <protein-id="Q801X7">galectin</protein-id>-mediated binding of the <protein-id="Q13201">ECM</protein-id> <protein-id="P08163">glycoproteins</protein-id> <compound-id="44342165">laminin</compound-id> and <protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id>.	laminin__glycoproteins__interaction	LacNAc__galectin__interaction	LacNAc__fibronectin__interaction	laminin__ECM__interaction	LacNAc__glycoproteins__interaction	laminin__fibronectin__interaction	LacNAc__ECM__interaction	laminin__galectin__interaction
18758978-2339	Seasonal variation of the metal (Zn, Fe, <compound-id="23930">Mn</compound-id>) and <protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</protein-id> concentrations in the liver cytosol of the European chub (Squalius cephalus L.).	Mn__metallothionein__no_interaction
18758978-2340	The specimens caught in the spring period had higher biometric (liver mass, condition and hepatosomatic indices) and some biochemical parameters (<protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</protein-id> (MT) and <compound-id="23930">Mn</compound-id>) that are characteristic for the reproductive period.	Mn__metallothionein__no_interaction
18758993-2343	<protein-id="O30418,P20228,P54767,Q04792,Q07346,Q9CG20">Glutamate decarboxylase</protein-id> (<protein-id="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20">GAD</protein-id>) is the rate-limiting enzyme in the synthesis of <compound-id="119">gamma-aminobutyric acid</compound-id> (<compound-id="119">GABA</compound-id>), the most important inhibitory neurotransmitter in central nervous system (CNS).	GABA__Glutamate decarboxylase__interaction	gamma-aminobutyric acid__GAD__interaction	GABA__GAD__interaction	gamma-aminobutyric acid__Glutamate decarboxylase__interaction
18758993-2344	These transcripts were predicted to synthesis of <protein-id="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20">GAD</protein-id> proteins truncated of the binding site for <compound-id="1051">pyridoxal phosphate</compound-id>, an essential cofactor, therefore cannot function as a decarboxylase.	pyridoxal phosphate__GAD__interaction
18759148-2382	Loss-of-expression of <protein-id="P30874,P34993,P34994">SSTR2</protein-id> in tumor tissues has been suggested to correlate with tumor progression and to the relatively poorer outcomes of <compound-id="16129681,16129706">somatostatin</compound-id> analog treatment in some clinical trials.	somatostatin__SSTR2__interaction
18760301-213	<compound-id="56842156">Cobra venom factor</compound-id> (CVF) is a structural and functional analog of <protein-id="P23667,P98094">complement C3</protein-id> isolated from cobra venom.	Cobra venom factor__complement C3__interaction
18760497-301	Activities of malate- and succinate-dehydrogenases (<protein-id="O24047,P20932,P33216,P46487,P52426,Q04820,Q43744">MDH</protein-id>, <protein-id="O34607,O34635,O86564,P09367,P20132,P21801,P21912,P21914,P33073,P33074,P38997,P38998,P42630,P43065,P56072,P66773,P66774,P71349,P80212,P80213,Q02912,Q09694,Q48838,Q6FU27,Q75BV4,Q7SFX6,Q870G1,Q8LGI2,Q99K67,Q9SMZ4,Q9SQT8,Q9UDR5,Q9ZMU7">SDH</protein-id>) and NADH- and succinate-<protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> reductases (NCCR, SCCR) were rapidly inhibited, while <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> oxidase (CCO) was unaltered by <compound-id="23973">cadmium</compound-id> treatment.	cadmium__SDH__interaction	cadmium__cytochrome c__no_interaction	cadmium__MDH__interaction
18760497-302	However, this stimulated the NADPH-generating enzyme activities of the <compound-id="854">pentose</compound-id> phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (<protein-id="P37830,P48826">G6PDH</protein-id>, 6PGDH), as well as enzyme activity of fermentation, <protein-id="O31186,P00332,P00334,P06525,P07159,P07162,P0A9Q7,P0A9Q8,P10807,P12311,P14940,P17648,P21518,P21898,P22245,P23277,P23278,P23361,P25139,P25721,P25988,P26719,P28483,P28484,P33744,P37473,P42327,P42328,P48584,P48585,P48977,P51549,P51550,P51551,P51552,P71017,P84328,Q00669,Q00670,Q00671,Q00672,Q03384,Q05114,Q07588,Q09009,Q09010,Q24641,Q24803,Q27404,Q6LCE4,Q9GN94,Q9NAR7,Q9NG40,Q9NG42,Q9U8S9">alcohol dehydrogenase</protein-id> (<protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id>), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	pentose__alcohol dehydrogenase__no_interaction	pentose__G6PDH__no_interaction	pentose__ADH__no_interaction
18760912-456	We also examined cellular impedance responsiveness of PC 12 cells in response to phenotypic alteration especially with regard to modulation of ion fluxes using nerve growth factor (<protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id>), <compound-id="5743">dexamethasone</compound-id> and <compound-id="47936">forskolin</compound-id>.	forskolin__NGF__no_interaction	dexamethasone__NGF__no_interaction
18760952-480	This paper investigates the effect of sterilisation by gamma irradiation (dose 2.5Mrad) on the following properties of <compound-id="10401">polycaprolactone</compound-id> (PCL): (1) degradation rate (catalysed by <protein-id="Q7M4U7">lipase</protein-id>), (2) mechanical properties, (3) the ability of cells to attach and subsequently grow on its surface.	polycaprolactone__lipase__interaction
18761029-495	Specifically, animals were exposed to one of five dipsetic stimuli: (1) 24-h water deprivation, (2) replacement of drinking water with 2.5% <compound-id="5234">NaCl</compound-id>, (3) peripheral administration of hypertonic saline, (4) ICV injection of <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">angiotensin II</protein-id> (<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>), or (5) the combination of peripheral hypertonic saline and central <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>.	NaCl__AngII__no_interaction	NaCl__angiotensin II__no_interaction
18761103-512	We therefore propose <compound-id="23978">copper</compound-id>-dependent homodimerization to be an essential step in the regulation of <protein-id="O00244,Q9TT99,Q9XT28">ATOX1</protein-id>-dependent transcription.	copper__ATOX1__interaction
18761380-599	In order to investigate the role of spinal <protein-id="P84814">opioid peptide</protein-id> in the phenomenon of <compound-id="5284596,16395294">naloxone</compound-id>-precipitated withdrawal we examined the effect of herpes simplex virus vector-mediated overexpression of proenkephalin in lumbar dorsal root ganglia in rats with neuropathic pain treated with morphine.	naloxone__opioid peptide__interaction
18761426-612	The <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> were isolated by <compound-id="6097028">ammonium sulphate</compound-id> treatment of crude extracts followed by chromatography on chitin.	ammonium sulphate__lectins__interaction
18761603-651	One hundred and forty-four HCV-2- and HCV-3-infected patients initiated Peg-<protein-id="P35849">IFN alpha</protein-id>-2a (180 microg/week) and <compound-id="37542">ribavirin</compound-id> (1000 or 1200 mg/day); those with viral clearance at week 4 were randomized to either Peg-<protein-id="P35849">IFN alpha</protein-id>-2a monotherapy (n = 59) or continuing combination therapy (n = 61) until week 12.	ribavirin__IFN alpha__no_interaction
18761603-652	Thus in HCV-2- and HCV-3-infected patients, withdrawal of <compound-id="37542">ribavirin</compound-id> and continuation of Peg-<protein-id="P35849">IFN alpha</protein-id>-2a monotherapy may be appropriate to attain an SVR, providing viraemia is cleared early during therapy and associated with low baseline viral load.	ribavirin__IFN alpha__no_interaction
18761779-682	The <protein-id="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8">apoE</protein-id>-deficient mouse, which develops atherosclerotic lesions rapidly when fed <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, was used to determine the ability of dried plums to reduce atherosclerosis.	cholesterol__apoE__no_interaction
18761779-683	Urinary <compound-id="2723628">thiobarbituric acid</compound-id>-reactive substances (TBARS) excretion and <protein-id="P15697,P19095,P20677">serum amyloid P-component</protein-id> (<protein-id="O19063,O60880,P02743,P07629,P12246,P19095,P20677,P23680,P24047,P35827,P49255,Q9FKH1">SAP</protein-id>) were measured as indicators of oxidative stress and inflammation, respectively.	thiobarbituric acid__SAP__no_interaction	thiobarbituric acid__serum amyloid P-component__no_interaction
18762200-801	Inhibition in the brain is dominated by the neurotransmitter <compound-id="119">gamma-aminobutyric acid</compound-id> (<compound-id="119">GABA</compound-id>); operating through <protein-id="P26714,Q08832,Q9BLY8">GABA(A) receptors</protein-id>.	gamma-aminobutyric acid__GABA(A) receptors__interaction	GABA__GABA(A) receptors__interaction
18762201-805	Thus, in keeping with the ability of neurosteroids to potentiate <compound-id="119">GABA</compound-id> currents via a broad variety of <protein-id="P26714,Q08832,Q9BLY8">GABA(A) receptor</protein-id> isoforms in neurons, the potentiation site is structurally highly conserved on this important neurotransmitter receptor family.	GABA__GABA(A) receptor__interaction
18762202-807	The 5-HT2AR response dominated the <protein-id="O42781,P27638,Q00859">MAPK</protein-id> signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist <compound-id="3822">Ketanserin</compound-id> could not be rescued by the 5-HT1AR agonist.	Ketanserin__MAPK__interaction
18762271-826	The inhibitors include mitogen-inducible gene-6 (<protein-id="P05432,Q99JZ7,Q9UJM3">Mig-6</protein-id>)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (<protein-id="Q91WJ0">FRS2beta</protein-id>)/<protein-id="O43559,Q52RG8">suc1-associated neurotrophic factor target-2</protein-id> (<protein-id="O43559,Q52RG8">SNT-2</protein-id>)/<protein-id="O43559">FRS3</protein-id>, <protein-id="O14543,O35718,O88583,Q68AM8,Q90X67,Q9BEG9">suppressor of cytokine signaling 3</protein-id> (<protein-id="O14543,Q68AM8,Q90X67,Q9BEG9">SOCS3</protein-id>)/<protein-id="O14544,Q8WXH5">SOCS4</protein-id>/<protein-id="O75159,Q29RN6">SOCS5</protein-id>, and <compound-id="857,6106,439524">leucine</compound-id>-rich repeats and immunoglobulin-like domains 1 (<protein-id="Q96JA1">LRIG1</protein-id>).	leucine__Mig-6__no_interaction	leucine__LRIG1__no_interaction	leucine__SOCS4__no_interaction	leucine__SOCS5__no_interaction	leucine__suppressor of cytokine signaling 3__no_interaction	leucine__SNT-2__no_interaction	leucine__FRS3__no_interaction	leucine__suc1-associated neurotrophic factor target-2__no_interaction	leucine__SOCS3__no_interaction	leucine__FRS2beta__no_interaction
18762369-869	Novel homo- and hetero-nuclear <compound-id="23978">copper</compound-id> (II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>-like activity studies.	copper__catalase__no_interaction
18762913-991	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the <protein-id="Q42665">hemoglobin A</protein-id> (1c), non-fasting plasma <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, fasting blood <compound-id="206,5793,64689,79025">glucose</compound-id> levels, <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>) with neutral effect on body weight.	glucose__insulin__no_interaction	glucose__hemoglobin A__no_interaction	cholesterol__hemoglobin A__no_interaction	cholesterol__insulin__no_interaction
18762977-1011	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, <compound-id="1061">PO4</compound-id> 4.4+/-1.3 mg/dL, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> (<protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id>) 1,341+/-823, <compound-id="5283731,6433735">25-hydroxyvitamin D</compound-id> (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	25-hydroxyvitamin D__ALP__no_interaction	25-hydroxyvitamin D__alkaline phosphatase__no_interaction	PO4__ALP__no_interaction	PO4__alkaline phosphatase__no_interaction
18763027-1031	There are no controlled trials comparing <protein-id="P20333">etanercept</protein-id> and <compound-id="5284513">acitretin</compound-id> efficacy and therapeutic mechanisms in psoriasis.	acitretin__etanercept__no_interaction
18763047-1035	Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (<compound-id="10196533">As16</compound-id>) of Ascaris suum fused with cholera <protein-id="P01380,P18177,P25669">toxin B</protein-id> subunit.	As16__toxin B__no_interaction
18763168-1076	Inhibition of human poly(A)-specific <protein-id="P00645,P00646,P04061,P13312,P17999,P35078,P37203,P84784,P84844,P84867">ribonuclease</protein-id> (<protein-id="O95453,P69341,Q5RC51,Q9LG26">PARN</protein-id>) by <compound-id="1044">purine</compound-id> nucleotides: kinetic analysis.	purine__ribonuclease__interaction	purine__PARN__interaction
18764779-1509	The aqueous extract was found to be more effective than <compound-id="31703">doxorubicin</compound-id>, a classical anticarcinogenic drug, with respect to its action on antioxidant enzymes and <protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id> in the liver of mice with developing lymphomas.	doxorubicin__LDH__interaction
18764780-1510	Cu,Zn-<protein-id="O50258">superoxide dismutase</protein-id>-driven free radical modifications: <compound-id="23978">copper</compound-id>- and carbonate radical anion-initiated protein radical chemistry.	copper__superoxide dismutase__no_interaction
18764780-1511	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type <protein-id="O42724,O46412,O59924,O94178,P00441,P00442,P00443,P00445,P04178,P09212,P09670,P33431,P60052,P80566,P93258,Q42684,Q52RN5,Q5FB29,Q6C662,Q6CPE2,Q6FWL5,Q6T3B0,Q711T9,Q751L8,Q7M1R5,Q8HXP8,Q8HXP9,Q8HXQ0,Q8HXQ1,Q8HXQ2,Q8HXQ3,Q8HXQ4,Q8J0N2,Q8J0N3,Q8WNN6,Q96VL0,Q9C0N4,Q9SQL5">SOD1</protein-id> (Cu,Zn-<protein-id="O50258">superoxide dismutase</protein-id>) with <compound-id="784">H2O2</compound-id> and their fate is incomplete, but a better understanding of the role of this reaction is needed.	H2O2__SOD1__interaction	H2O2__superoxide dismutase__interaction
18764780-1512	In the absence of (bi)carbonate, site-specific radical-mediated fragmentation is produced by <protein-id="O42724,O46412,O59924,O94178,P00441,P00442,P00443,P00445,P04178,P09212,P09670,P33431,P60052,P80566,P93258,Q42684,Q52RN5,Q5FB29,Q6C662,Q6CPE2,Q6FWL5,Q6T3B0,Q711T9,Q751L8,Q7M1R5,Q8HXP8,Q8HXP9,Q8HXQ0,Q8HXQ1,Q8HXQ2,Q8HXQ3,Q8HXQ4,Q8J0N2,Q8J0N3,Q8WNN6,Q96VL0,Q9C0N4,Q9SQL5">SOD1</protein-id> active-site <compound-id="23978">copper</compound-id>.	copper__SOD1__interaction
18764780-1513	Finally, we propose a biochemical mechanism to explain CO(*-) production from CO2, enhanced protein radical formation and protection by (bi)carbonate against <compound-id="784">H2O2</compound-id>-induced fragmentation of the <protein-id="O42724,O46412,O59924,O94178,P00441,P00442,P00443,P00445,P04178,P09212,P09670,P33431,P60052,P80566,P93258,Q42684,Q52RN5,Q5FB29,Q6C662,Q6CPE2,Q6FWL5,Q6T3B0,Q711T9,Q751L8,Q7M1R5,Q8HXP8,Q8HXP9,Q8HXQ0,Q8HXQ1,Q8HXQ2,Q8HXQ3,Q8HXQ4,Q8J0N2,Q8J0N3,Q8WNN6,Q96VL0,Q9C0N4,Q9SQL5">SOD1</protein-id> active site.	H2O2__SOD1__interaction
18764784-1516	Furthermore, lysosomal integrity was disrupted after addition of <compound-id="2788">clioquinol</compound-id> and zinc to the cells, as shown by redistribution of both <compound-id="62344">Acridine Orange</compound-id> and cathepsin D. <compound-id="2788">Clioquinol</compound-id> plus zinc resulted in a cleavage of Bid (<protein-id="P55957,P70444,Q4JHS0,Q8JGM8,Q9JLT6">BH3-interacting domain death agonist</protein-id>), a hallmark of lysosome-mediated apoptotic cell death.	Clioquinol__BH3-interacting domain death agonist__no_interaction	clioquinol__BH3-interacting domain death agonist__no_interaction	Acridine Orange__BH3-interacting domain death agonist__no_interaction
18764864-1538	<compound-id="68156">Imidazoline</compound-id>-induced amplification of <compound-id="206,5793,64689,79025">glucose</compound-id>- and <compound-id="2551">carbachol</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> release includes a marked suppression of islet nitric oxide generation in the mouse.	carbachol__insulin__interaction	glucose__insulin__interaction	Imidazoline__insulin__interaction
18764923-1564	The picture of signalling mechanisms underlying the wound-regulated <protein-id="P46310,P48618,P48620,P48621">FAD7</protein-id> expression, and potential roles of <protein-id="P26602,P81711,Q0TA23,Q0VTA8,Q142T1,Q1BUR8,Q1C0T7,Q1CE94,Q1GXB4,Q1LIU6,Q1QE02,Q1QSG3,Q1R3P7,Q21U27,Q2L1H6,Q2NR06,Q2SZY9,Q2Y5S2,Q31DN1,Q31TU7,Q327U6,Q39E37,Q3IHW4,Q3SLJ3,Q3YUU5,Q46XB3,Q47AZ9,Q48AM0,Q48BQ6,Q4FUZ9,Q4K3M0,Q4ZLB5,Q57GZ4,Q5E206,Q5P5L9,Q5PL18,Q5QUP2,Q609A0,Q62ID2,Q63W06,Q66FH1,Q6D9I9,Q6F9N7,Q6FZ67,Q6G5M1,Q6LVS4,Q70C33,Q7MQ88,Q7MZB5,Q7VZD6,Q7WAC9,Q7WJH0,Q82TP3,Q83F94,Q83IP6,Q87KM8,Q87U40,Q88C66,Q8DD50,Q8EKG2,Q8FB35,Q8XEC3,Q8XVQ0,Q8Z1T7,Q8ZJ20,Q8ZKI0,Q9CMB5,Q9FD32,Q9HTK1,Q9KVP6">CPL</protein-id> proteins as attenuators of wound-induced <compound-id="5281166">JA</compound-id> biosynthesis, are discussed.	JA__CPL__interaction	JA__FAD7__no_interaction
18765263-1705	KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by <compound-id="10255">kainate</compound-id> or <compound-id="31304,518601,5311359,5458938,6473767,24867522,57402144">picrotoxin</compound-id>, while mRNA for <protein-id="Q6BD04,Q969F8">GPR54</protein-id> remained essentially unchanged.	picrotoxin__GPR54__no_interaction	kainate__GPR54__no_interaction
18765295-1718	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> oxidase (<protein-id="P11353,P36551,P36552,Q9UTE2,Q9V3D2">COX</protein-id>) activity after 49 days of <compound-id="6860">MeHg</compound-id> exposure.	MeHg__COX__interaction	MeHg__cytochrome c__interaction
18765678-1803	The dominant positive regulator of mTORC1 is the <compound-id="6830">GTP</compound-id>-charged form of the <protein-id="P03967,P22126,Q07152">ras</protein-id>-like GTPase <protein-id="Q62639,Q921J2,Q9VND8">Rheb</protein-id>.	GTP__ras__interaction	GTP__Rheb__interaction
18765678-1804	In contrast, amino acids, especially leucine, regulate mTORC1 by controlling the ability of <protein-id="Q62639,Q921J2,Q9VND8">Rheb</protein-id>-<compound-id="6830">GTP</compound-id> to activate mTORC1.	GTP__Rheb__interaction
18765850-1867	<compound-id="5754">Cortisol</compound-id>, hematocrit, blood urea nitrogen, total protein, albumin, <protein-id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</protein-id> 0.05) after transport regardless of space allowance.	Cortisol__aspartate aminotransferase__no_interaction
18766172-2008	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were <compound-id="65180">7-aminoactinomycin D</compound-id> (7-<protein-id="P23670,P81336,Q01752,Q7NSA6,Q8XR10,Q9EYI7,Q9RPK1">AAD</protein-id>) positive and <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</protein-id> negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	7-aminoactinomycin D__AAD__no_interaction	7-aminoactinomycin D__annexin V__no_interaction
18766385-2075	Iron uptake by the ubiquitous iron-storage protein <protein-id="Q26061">ferritin</protein-id> involves the oxidation of two <compound-id="27284">Fe(II</compound-id>) ions located at the highly conserved dinuclear " <protein-id="P00450,P13635,Q61147,Q9XT27">ferroxidase</protein-id> centre" in individual subunits.	Fe(II__ferroxidase__interaction	Fe(II__ferritin__interaction
18766385-2076	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear <protein-id="P00450,P13635,Q61147,Q9XT27">ferroxidase</protein-id> site) of recombinant human H-chain <protein-id="Q26061">ferritin</protein-id> (rHuHF) in their complexes with reactive <compound-id="27284">Fe(II</compound-id>) and redox-inactive <compound-id="32051">Zn(II</compound-id>).	Zn(II__ferritin__interaction	Fe(II__ferroxidase__interaction	Zn(II__ferroxidase__interaction	Fe(II__ferritin__interaction
18766955-2250	The aim of this study was to determine the effect of <compound-id="5833">spironolactone</compound-id> on endothelial function in anti-tumour necrosis factor (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>)-naive RA patients.	spironolactone__TNF__interaction
18767058-2287	Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, <compound-id="206,5793,64689,79025">glucose</compound-id> consumption, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> activity, and osteopontin.	glucose__alkaline phosphatase__no_interaction
18767059-2288	Behavior of rat periodontal ligament cells on <protein-id="Q60487">fibroblast growth factor-2</protein-id>-immobilized <compound-id="23963">titanium</compound-id> surfaces treated by plasma modification.	titanium__fibroblast growth factor-2__interaction
18767059-2289	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on <protein-id="Q60487">fibroblast growth factor-2</protein-id> (<protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id>)-immobilized <compound-id="23963">titanium</compound-id> surfaces treated by <compound-id="977">oxygen</compound-id> (<compound-id="977,5359597">O2</compound-id>) plasma.	oxygen__FGF-2__no_interaction	O2__FGF-2__no_interaction	oxygen__fibroblast growth factor-2__no_interaction	titanium__FGF-2__interaction	O2__fibroblast growth factor-2__no_interaction	titanium__fibroblast growth factor-2__interaction
18767059-2290	These were treated with <compound-id="977">oxygen</compound-id> plasma and dipped in <protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id> solution.	oxygen__FGF-2__no_interaction
18767059-2291	Cells from fourth subculture were seeded onto the <protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id>-immobilized <compound-id="23963">titanium</compound-id> surface.	titanium__FGF-2__interaction
18767059-2292	These findings suggest that <compound-id="977">oxygen</compound-id> plasma modification can immobilize <protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id> onto a <compound-id="23963">titanium</compound-id> surface.	oxygen__FGF-2__interaction	titanium__FGF-2__interaction
18767063-2297	One of the best triads for bone engineering is bone marrow stromal cells, <compound-id="24441,24456,24632">calcium phosphate</compound-id> ceramics, and bone <protein-id="P07580">morphogenetic protein</protein-id> (<protein-id="P35855">BMP</protein-id>).	calcium phosphate__morphogenetic protein__no_interaction	calcium phosphate__BMP__no_interaction
18767063-2298	The cells were mixed with <compound-id="24456">beta-tricalcium phosphate</compound-id> (beta-TCP) granules followed by osteoblast induction with recombinant human <protein-id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</protein-id> (rhBMP-2) (first mixture), or were first induced with rhBMP-2 on plastic dishes and then mixed with the beta-TCP granules (last mixture) just prior to the operation.	beta-tricalcium phosphate__BMP-2__no_interaction
18767136-1171	Effect of short-time exposures to <compound-id="935">nickel</compound-id> and lead on brain <protein-id="P49253">monoamine oxidase</protein-id> from Danio rerio and Poecilia reticulata.	nickel__monoamine oxidase__no_interaction
18767136-1172	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of <compound-id="935">nickel</compound-id> and lead, on brain <protein-id="P49253">monoamine oxidase</protein-id> (<protein-id="P49253">MAO</protein-id>), an important neural enzyme.	nickel__MAO__no_interaction	nickel__monoamine oxidase__no_interaction
18767138-2325	<protein-id="O84081,O96553,P07245,P09440,P11586,P24186,P27653,P44313,P47259,P51696,P54382,P55818,P56467,P57557,P58688,P75096,P96050,Q05213,Q27772,Q60006,Q89A92,Q8K979,Q922D8,Q92HY4,Q9PKW1,Q9Z8K3,Q9ZD32,Q9ZLQ4">Methylenetetrahydrofolate dehydrogenase</protein-id>) <protein-id="O84081,O96553,P07245,P09440,P11586,P13995,P18155,P24186,P27653,P44313,P47259,P51696,P54382,P56467,P57557,P58688,P75096,P96050,Q04448,Q05213,Q27772,Q49135,Q5ZKA5,Q60006,Q89A92,Q8K979,Q922D8,Q92HY4,Q9PKW1,Q9Z8K3,Q9ZD32,Q9ZLQ4">methenyltetrahydrofolate cyclohydrolase</protein-id>) <protein-id="O66164,O96553,P07245,P09440,P11586,P13419,P21164,P27653,P28723,Q07064,Q27772,Q3Z8K3,Q3ZX40,Q4FL49,Q4JVW2,Q4L776,Q59925,Q5E3V8,Q5FAG1,Q5HF42,Q5HNH4,Q5LD60,Q5LNV0,Q5M083,Q5M4U2,Q5NQC7,Q5V5Y2,Q5XZD9,Q605Q9,Q63C61,Q64U80,Q65IA6,Q67JH9,Q6ABS5,Q6AL19,Q6G8J5,Q6GFX6,Q6HJK9,Q6KZM3,Q6LNJ0,Q6NH87,Q71YD9,Q72GY9,Q739F4,Q73RR6,Q74JC1,Q7A535,Q7MEE8,Q7MUZ8,Q7VLW6,Q81E87,Q81RE1,Q834D6,Q83WS0,Q87HX2,Q88W76,Q891R3,Q8A9S8,Q8CNV9,Q8D7D8,Q8DPL5,Q8DZP5,Q8E5E3,Q8EJA7,Q8EUQ1,Q8G700,Q8NW37,Q8R7L3,Q8RHF4,Q8XHL4,Q8Y624,Q922D8,Q92AD2,Q92N42,Q97CL3,Q97EB3,Q97QI2,Q98HQ4,Q99TD2,Q9CH07,Q9HI67,Q9JVY8,Q9JXY2,Q9KLX7,Q9PQS1,Q9SPK5,Q9X287">formyltetrahydrofolate synthetase</protein-id> (<protein-id="P11586">MTHFD1</protein-id>) is a trifunctional enzyme that interconverts <compound-id="91443">tetrahydrofolate</compound-id> (THF) derivatives for nucleotide synthesis.	tetrahydrofolate__methenyltetrahydrofolate cyclohydrolase__interaction	tetrahydrofolate__MTHFD1__interaction	tetrahydrofolate__Methylenetetrahydrofolate dehydrogenase__interaction	tetrahydrofolate__formyltetrahydrofolate synthetase__interaction
18767147-1187	An oncogenetic tree model was built using data on mutations of <protein-id="O09185,O12946,O36006,O57538,O93379,P04637,P10360,P13481,P25035,P41685,P51664,P56423,P56424,P61260,P67938,P67939,P79820,P79892,Q00366,Q29480,Q29537,Q64662,Q8SPZ3,Q92143,Q95330,Q9TTA1,Q9TUB2,Q9W678,Q9W679,Q9WUR6">TP53</protein-id>, <protein-id="P01116">KRAS2</protein-id>, <protein-id="P25054">APC</protein-id>, and <protein-id="P15056,P34908,Q04982">BRAF</protein-id> genes, methylation at <compound-id="6804">CpG</compound-id> sites of <protein-id="P38920,P40692">MLH1</protein-id> and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	CpG__BRAF__no_interaction	CpG__APC__no_interaction	CpG__MLH1__interaction	CpG__KRAS2__no_interaction	CpG__TP53__no_interaction
18767149-2331	We characterized this selenoprotein <protein-id="O25011,O26635,O69761,O83641,P0A081,P0A082,P0A083,P0A084,P0A085,P0A086,P0A3Q9,P0A3R0,P0A5L0,P0A5L1,P0A744,P0A745,P23212,P47648,P54154,P65443,P65444,P75188,Q4J9L3,Q53W34,Q576P8,Q5HG58,Q5HVD4,Q5PJ81,Q5XDH1,Q66F89,Q6D151,Q6L2S4,Q6LV65,Q6LYY1,Q6NEL2,Q71YF6,Q746G0,Q7MYW1,Q87D27,Q87SW6,Q88AI5,Q88QZ8,Q899M3,Q8DE84,Q8DSY4,Q8DYH1,Q8E434,Q8FAG4,Q8FLU6,Q8FUZ0,Q8NLL5,Q8P272,Q8PCA6,Q8PNY8,Q8PUD6,Q8TQV6,Q8VS50,Q8XCG3,Q8XH97,Q8Y1C6,Q8Y640,Q8YDE7,Q8Z150,Q8ZB94,Q8ZK71,Q92AE8,Q93KF3,Q93S39,Q97MV3,Q97Y45,Q98PE5,Q99YT1,Q9A149,Q9AJF7,Q9APY4,Q9CCZ3,Q9CN40,Q9EWF7,Q9HQG0,Q9HUF1,Q9KAN8,Q9KP30,Q9LAM9,Q9PC45,Q9PQK2,Q9RTB6,Q9ZEQ8,Q9ZMK8">MsrA</protein-id> which had a single Sec residue at the catalytic site but no <compound-id="594,5862,5360637">cysteine</compound-id> (Cys) residues in the protein sequence.	cysteine__MsrA__no_interaction
18767150-2332	Zn2+-linked dimerization of <protein-id="O54424,P0A4R7,P0A4R8,P0A664,P0A665,P18319,P42871,P42877,P44396,P69992,P69993,P72955,Q03287,Q06206,Q07403,Q09066,Q55057,Q56561,Q9ZMZ7">UreG</protein-id> from Helicobacter pylori, a chaperone involved in <compound-id="935">nickel</compound-id> trafficking and <protein-id="O00084,O13465,P07374,P08298,Q5KCQ6,Q6A3P9">urease</protein-id> activation.	nickel__UreG__interaction	nickel__urease__no_interaction
18767150-2333	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme <protein-id="O00084,O13465,P07374,P08298,Q5KCQ6,Q6A3P9">urease</protein-id> involves the formation of a <compound-id="866,5962">lysine</compound-id>-<compound-id="277">carbamate</compound-id> functional group concomitantly with the delivery of two <compound-id="934">Ni(2</compound-id>+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	lysine__urease__interaction	Ni(2__urease__interaction	carbamate__urease__interaction
18767155-2335	Residue-wise conformational stability of <protein-id="P63167,P63168,P63169,P63170,Q9D0M5">DLC8</protein-id> dimer from native-state <compound-id="783">hydrogen</compound-id> exchange.	hydrogen__DLC8__interaction
18767934-15	Whereas the role of locally produced 1, <compound-id="5283731,6433735">25-dihydroxyvitamin D</compound-id> is not yet clear, it is possible that it contributes importantly to <compound-id="5280795">vitamin D</compound-id>-mediated inhibition of parathyroid cell growth, so <protein-id="O15528">CYP27B1</protein-id> can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	25-dihydroxyvitamin D__CYP27B1__no_interaction	vitamin D__CYP27B1__no_interaction
18768213-91	Mechanistically, we showed EphA2 knockdown suppressed <protein-id="P84122">thrombin</protein-id>-induced <compound-id="5951">serine</compound-id> 536 phosphorylation of NFkappaB, an event critical of <protein-id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</protein-id> transcriptional upregulation.	serine__thrombin__interaction	serine__ICAM-1__interaction
18768362-173	Total antioxidant capacity, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <compound-id="2723628">thiobarbituric acid</compound-id>-reactive substances, <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id>, <protein-id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</protein-id> saturation and <protein-id="Q26061">ferritin</protein-id> did not change significantly.	thiobarbituric acid__ferritin__no_interaction	thiobarbituric acid__transferrin__no_interaction	thiobarbituric acid__catalase__no_interaction	thiobarbituric acid__hemoglobin__no_interaction
18768916-385	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> to <compound-id="8955">pregnenolone</compound-id> by <protein-id="O46515,P00189,P05108,P10612,P14137,P79153,P79202,Q07217,Q28827,Q2XV99,Q92045,Q9EPT4,Q9QZ82">cholesterol side-chain cleavage enzyme</protein-id> (<protein-id="P05108,Q2XV99,Q9EPT4">CYP11A</protein-id>).	pregnenolone__CYP11A__interaction	cholesterol__cholesterol side-chain cleavage enzyme__interaction	cholesterol__CYP11A__interaction	pregnenolone__cholesterol side-chain cleavage enzyme__interaction
18768916-386	Finally, HA increased <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (NOS) activity, and the NOS inhibitor NG-nitro-<compound-id="550788">L-arginine methyl ester</compound-id> (L-NAME) markedly attenuated the effect of the amine on steroid synthesis.	L-arginine methyl ester__nitric oxide synthase__no_interaction
18769443-565	LH, FSH, 17 <compound-id="5757">beta-estradiol</compound-id>, <compound-id="5994">progesterone</compound-id>, aldosterone and <protein-id="P06703,P10977">PRA</protein-id> were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	beta-estradiol__PRA__no_interaction	progesterone__PRA__no_interaction
18769443-566	Aldosterone was positively related to <protein-id="P06703,P10977">PRA</protein-id> and <compound-id="5994">progesterone</compound-id>.	progesterone__PRA__no_interaction
18769474-571	<protein-id="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2">COMT</protein-id> activity and <compound-id="614,8988,145742">proline</compound-id> levels may therefore be altered in 22q11DS individuals.	proline__COMT__no_interaction
18769474-572	<protein-id="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2">COMT</protein-id> (158) genotype and plasma <compound-id="614,8988,145742">proline</compound-id> levels were determined in the 22q11DS children.	proline__COMT__no_interaction
18769875-666	We have investigated its antibacterial activity and binding activity to pathogenic whole cell antigens, <compound-id="11970143">lipopolysaccharide</compound-id> (LPS) and staphylococcal <protein-id="P22542">enterotoxin B</protein-id>.	lipopolysaccharide__enterotoxin B__no_interaction
18770028-698	Quinone formation is closely linked to other representative hypotheses such as mitochondrial dysfunction, inflammation, oxidative stress, and dysfunction of the <protein-id="O46543,P08565,P08618,P0C014,P0C072,P13117,P14624,P14792,P15174,P19848,P20685,P22589,P23324,P23398,P42739,P42740,P46574,P49634,P49635,P59263,P59669,P61862,P61863,P61864,P62972,P62973,P62974,P62975,P62976,P62977,P62988,P62989,P62990,P62991,P63049,P63051,P68195,P68196,P68197,P68198,P68199,P68201,P68204,P69308,P69309,P69310,P69311,P69312,P69313,P69314,P69315,P69316,P69317,P69318,P69319,P69320,P69321,P69322,P69323,P69324,P69325,P69326,P84589,Q05550,Q865C5,Q867C2,Q867C3,Q867C4,Q8MKD1,Q9Y848">ubiquitin</protein-id>-proteasome system, in the pathogenesis of neurodegenerative diseases such as Parkinson's disease and <compound-id="1206,10836,36604">methamphetamine</compound-id>-induced neurotoxicity.	methamphetamine__ubiquitin__no_interaction
18771337-1073	The effect of <compound-id="31200">fenitrothion</compound-id> exposure on birds was examined by measuring aerobic metabolism, blood <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> content, plasma <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterases</protein-id>, and body weight for up to 21 d postdose.	fenitrothion__cholinesterases__interaction	fenitrothion__hemoglobin__interaction
18771515-1111	Of the 37 E. coli isolated from diarrhoeic calves, <compound-id="49837850">K99</compound-id> (18.9%), <compound-id="760826">F41</compound-id> (18.9%), heat-stable <protein-id="P54355,P80567,P80568">enterotoxin</protein-id> a (STa) (18.9%), Shiga <protein-id="P45629">toxin 1</protein-id> (Stx1; 13.5%) and Shiga toxin 2 (<protein-id="P50279,Q00262">Stx2</protein-id> ; 5.4%) and <protein-id="O31000,P19809,P43261,P52869,Q07591">intimin</protein-id> (8.1%) genes were identified by multiplex <protein-id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</protein-id>.	K99__toxin 1__no_interaction	K99__Stx2__no_interaction	F41__intimin__no_interaction	F41__toxin 1__no_interaction	K99__enterotoxin__no_interaction	F41__PCR__no_interaction	K99__PCR__no_interaction	F41__enterotoxin__no_interaction	F41__Stx2__no_interaction	K99__intimin__no_interaction
18771515-1112	Of the 18 E. coli isolated from healthy calves, <compound-id="49837850">K99</compound-id> (16.6%) and <protein-id="O31000,P19809,P43261,P52869,Q07591">intimin</protein-id> (55.5%) genes were identified by <protein-id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</protein-id>.	K99__PCR__no_interaction	K99__intimin__no_interaction
18771515-1113	<compound-id="49837850">K99</compound-id>, <compound-id="760826">F41</compound-id>, STa, Stx1 and <protein-id="P50279,Q00262">Stx2</protein-id> were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	K99__Stx2__no_interaction	F41__Stx2__no_interaction
18771570-1136	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of <compound-id="206,5793,64689,79025">glucose</compound-id>-dependent <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion, suppression of <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id> secretion, slowing of gastric emptying, and reduction of food intake.	glucose__insulin__interaction	glucose__glucagon__no_interaction
18771604-1158	Induction of the spliced form of <protein-id="P17861,P40489">XBP1</protein-id> as well as total <protein-id="P17861,P40489">XBP1</protein-id> by <compound-id="446378">thapsigargin</compound-id> was significantly attenuated in patients with BD.	thapsigargin__XBP1__interaction
18771604-1159	Induction of <protein-id="O18750,P08113,P08712,P14625,P41148,Q29092,Q95M18">GRP94</protein-id> by <compound-id="446378">thapsigargin</compound-id> was also decreased in the BD group.	thapsigargin__GRP94__interaction
18771683-1179	Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan <compound-id="1117">sulphate</compound-id> glycosaminoglycan structures, integrins, Siglecs, <protein-id="Q801X7">galectins</protein-id>, C-type <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> and toll-like receptors.	sulphate__lectins__no_interaction	sulphate__galectins__no_interaction
18771795-1211	Reversal of the inhibitory effect of <compound-id="5282448">fondaparinux</compound-id> on <protein-id="P84122">thrombin</protein-id> generation by rFVIIa, aPCC and <compound-id="62529">PCC</compound-id>.	fondaparinux__thrombin__interaction	PCC__thrombin__interaction
18771857-1234	It appears that <protein-id="P09488,P16413,Q9N0V4,Q9TSM5">GSTM1</protein-id> null and <protein-id="P20135,P30711,Q2NL00">GSTT1</protein-id> null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GSTs</protein-id> (mostly alkylating agents and <compound-id="23939">platinum compounds</compound-id>).	platinum compounds__GSTs__interaction	platinum compounds__GSTT1__interaction	platinum compounds__GSTM1__interaction
18771904-1247	<compound-id="5213,31553,3086637,16211710">Silibinin</compound-id> attenuates antigen-specific IgE production through the modulation of <protein-id="Q64279,Q922L6">Th1</protein-id>/Th2 balance in ovalbumin-sensitized BALB/c mice.	Silibinin__Th1__interaction
18771904-1248	BALB/c mice were either left untreated or administered daily with vehicle (VH; saline) and/or <compound-id="5213,31553,3086637,16211710">silibinin</compound-id> (200 or 400 mg/kg) by gavage for 3 consecutive days prior to sensitization with <protein-id="O73860,P01012,P19104,Q6V115">ovalbumin</protein-id> (OVA).	silibinin__ovalbumin__no_interaction
18772236-1315	Treatment with <compound-id="23931">HG</compound-id>, but not equimolar <compound-id="6251">mannitol</compound-id> or 3-O-methyl <compound-id="206,5793,64689,79025">glucose</compound-id>, resulted in phosphorylation and activation of <protein-id="O77636,P78536,Q9Z0F8,Q9Z1K9">TNF-alpha converting enzyme</protein-id> (<protein-id="O77636,P78536">TACE</protein-id>) (<protein-id="O77636,P78536">ADAM17</protein-id>), which were attenuated by <compound-id="337359">sorbinil</compound-id> or AR-specific small interference RNA.	HG__ADAM17__interaction	mannitol__TNF-alpha converting enzyme__no_interaction	glucose__TACE__no_interaction	sorbinil__TNF-alpha converting enzyme__interaction	HG__TNF-alpha converting enzyme__interaction	mannitol__ADAM17__no_interaction	sorbinil__ADAM17__interaction	glucose__TNF-alpha converting enzyme__no_interaction	HG__TACE__interaction	sorbinil__TACE__interaction	glucose__ADAM17__no_interaction	mannitol__TACE__no_interaction
18772236-1316	These results indicate that <compound-id="23931">HG</compound-id>-induced <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> shedding could be attributed to <protein-id="O77636,P78536">TACE</protein-id> activation, which is regulated, in part, by <protein-id="P10829">PKC-delta</protein-id> and AR.	HG__TACE__interaction	HG__TNF-alpha__interaction	HG__PKC-delta__no_interaction
18772240-1321	We conclude that gastrocnemius, heart, and liver mitochondria of streptozotocin diabetic rats are not irrevocably altered toward excess <compound-id="5359597">superoxide</compound-id> production either by <protein-id="Q07842">complex I</protein-id> or complex III.	superoxide__complex I__interaction
18772354-1356	Consequently, the primary mechanism of resistance to <compound-id="5394">temozolomide</compound-id> is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA <protein-id="O40976,P03588,P03589,P06011,P17769,P20122,P27752,P28726,P28931,Q00020,Q66121,Q83264,Q83270">methyltransferase</protein-id> (<protein-id="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8">MGMT</protein-id>).	temozolomide__methyltransferase__interaction	temozolomide__MGMT__interaction
18772483-962	Despite their inhibitory effects on inflammatory gene expression, loss of <protein-id="Q07869">PPARs</protein-id> or LXRs in macrophages did not exert major effects on obesity or <compound-id="206,5793,64689,79025">glucose</compound-id> tolerance induced by a high-fat diet.	glucose__PPARs__no_interaction
18772483-964	Our results do not exclude a contribution of macrophage <protein-id="Q07869">PPAR</protein-id> and LXR expression to systemic metabolism in certain contexts, but these factors do not appear to be dominant contributors to <compound-id="206,5793,64689,79025">glucose</compound-id> tolerance in a high-fat-fed Th1-biased bone marrow transplant model.	glucose__PPAR__no_interaction
18772488-1372	The dark side of <compound-id="6013">testosterone</compound-id> deficiency: II. Type 2 diabetes and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance.	testosterone__insulin__interaction
18772488-1373	A considerable body of evidence exists suggesting a link among reduced <compound-id="6013">testosterone</compound-id> plasma levels, type 2 diabetes (T2D), and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance (IR).	testosterone__insulin__interaction
18772488-1376	Androgen therapy of hypogonadal men improves <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity, fasting <compound-id="206,5793,64689,79025">glucose</compound-id>, and HbA1c levels.	glucose__insulin__no_interaction
18772894-1473	Effects of <compound-id="5280644,5282796">conjugated linoleic acid</compound-id> plus n-3 <compound-id="56842239">polyunsaturated fatty acids</compound-id> on <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion and estimated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity in men.	polyunsaturated fatty acids__insulin__interaction	conjugated linoleic acid__insulin__interaction
18773149-1572	A mechanism for the bioreduction of H2PtCl6 and PtCl2 into <compound-id="23939">platinum</compound-id> nanoparticles by a <protein-id="P80509,P80510">hydrogenase</protein-id> enzyme from Fusarium oxysporum is proposed.	platinum__hydrogenase__interaction
18773198-1602	Responses of limbic and extrapyramidal <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</protein-id> systems to <compound-id="942,89594,157672">nicotine</compound-id> treatment.	nicotine__substance P__interaction
18773247-1624	Radioisotopic localization of (90) <compound-id="23993">Yttrium</compound-id>-ibritumomab tiuxetan in patients with <protein-id="P11836,Q3C2E2">CD20</protein-id>+ non-Hodgkin's lymphoma.	Yttrium__CD20__no_interaction
18773910-1819	We solved the crystal structures of Aquifex aeolicus <protein-id="P31927,P49031,P49903,Q43845,Q43876">SPS</protein-id> and its complex with adenosine 5 '-(alpha,beta-<compound-id="123164">methylene</compound-id>) triphosphate (<compound-id="92199">AMPCPP</compound-id>).	AMPCPP__SPS__interaction	methylene__SPS__interaction
18773910-1820	To identify the amino-acid residues that contribute to <protein-id="P31927,P49031,P49903,Q43845,Q43876">SPS</protein-id> activity, we prepared six mutants of <protein-id="P31927,P49031,P49903,Q43845,Q43876">SPS</protein-id> and examined their <compound-id="107674">selenide</compound-id>-dependent ATP consumption.	selenide__SPS__interaction
18773910-1821	In <protein-id="P31927,P49031,P49903,Q43845,Q43876">SPS</protein-id>. <compound-id="92199">AMPCPP</compound-id>, the N-terminal loop, including the two residues, assumes different conformations ("open" and "closed") between the two subunits.	AMPCPP__SPS__interaction
18773925-1827	The results indicated that <protein-id="O02777,P20272,P21554,P47746,P56971,Q333S9,Q5IS73,Q71SP5,Q801M1,Q9PUI7">CB1</protein-id> receptors within the nucleus accumbens are involved in the acquisition and expression of <compound-id="5288826,5479215">morphine</compound-id>-induced CPP in sensitized rats.	morphine__CB1__interaction
18773927-1828	Effect of <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9UBU3">obestatin</protein-id> on <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id> and <compound-id="16129681,16129706">somatostatin</compound-id> secretion in the perfused rat pancreas.	somatostatin__glucagon__no_interaction	somatostatin__obestatin__interaction	somatostatin__insulin__no_interaction
18773927-1829	The potentiated effect of <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9UBU3">obestatin</protein-id> on <compound-id="206,5793,64689,79025">glucose</compound-id>-induced <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> output was not observed in the presence of <compound-id="3019">diazoxide</compound-id>, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	glucose__insulin__interaction	glucose__obestatin__interaction	diazoxide__insulin__interaction	diazoxide__obestatin__interaction
18773954-1841	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (<compound-id="923,373840">Na</compound-id> (+), K(+), <compound-id="312">Cl</compound-id> (-)) contents, immunostained for albumin and glial fibrillary <protein-id="P01538,P01543,P01544,P01545,P08772,P08943,P09617,P09618,P21742,P32032,Q05806,Q42596,Q42597,Q42838,Q8H0Q5,Q8VZK8,Q9C8D6,Q9SBK8">acidic protein</protein-id> (<protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id>), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	Na__acidic protein__no_interaction	Na__GFAP__no_interaction	Cl__GFAP__no_interaction	Cl__acidic protein__no_interaction
18773955-1842	We administered <compound-id="991">parathion</compound-id> to newborn rats on postnatal days (PN) 1-4 at doses spanning the threshold for detectable <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</protein-id> inhibition (0.1 mg/kg/day) and the first signs of loss of viability (0.2 mg/kg/day).	parathion__cholinesterase__interaction
18774132-1889	The Arg105 in <protein-id="O95528,Q9BYW1">GLUT10</protein-id> is highly conserved across species and its replacement with <compound-id="594,5862,5360637">cysteine</compound-id> is predicted to be pathogenic.	cysteine__GLUT10__interaction
18774203-1922	<compound-id="4583,149096,452723">[Ofloxacin</compound-id> is contraindicated in case of <protein-id="O00091,O24357,O51581,O54537,O55044,O68282,O83491,O84188,P05370,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11410,P11411,P11412,P11413,P12646,P15588,P21907,P29686,P37830,P37986,P41571,P41764,P44311,P48826,P48828,P48848,P48992,P54547,P54996,P56110,P57405,P73411,P77809,P80619,P97324,Q00612,Q23711,Q24625,Q25019,Q25537,Q27464,Q27638,Q29492,Q42919,Q43793,Q43839,Q7YS37,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">G6PD</protein-id> deficiency: is it evidenced based?].	[Ofloxacin__G6PD__no_interaction
18774319-1994	We also assess prostaglandin (<protein-id="Q29458">PGE</protein-id> (2)) and <compound-id="114873">thromboxane</compound-id> (<compound-id="9548654">TXB</compound-id> (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for <protein-id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</protein-id> and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>.	TXB__COX-2__no_interaction	TXB__COX-1__no_interaction	thromboxane__COX-2__no_interaction	thromboxane__COX-1__no_interaction	TXB__PGE__no_interaction	thromboxane__PGE__no_interaction
18774664-2104	High-dose steroid therapy for the former symptoms of AHS, and immunoglobulin, <protein-id="P35834,Q28746">granulocyte colony-stimulating factor</protein-id>, and <compound-id="5491295">cefepime</compound-id> for the latter agranulocytosis were successfully performed.	cefepime__granulocyte colony-stimulating factor__no_interaction
18774689-2116	0.05 vs. aortic IR) plasma levels of <compound-id="10964">malondialdehyde</compound-id>, P-selectin, intercellular adhesion molecule-1 (ICAM-I), and tissue levels of <compound-id="10964">malondialdehyde</compound-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>.	malondialdehyde__catalase__no_interaction
18774957-2175	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of <protein-id="O15118,P56941">NPC1</protein-id> or <protein-id="O93388,O97763,P61916,P61917,P61918,P79345,Q12408,Q28895,Q4P580,Q52FS9,Q5A8A2,Q5KIR9,Q6BV42,Q6CHU5,Q6CNE0,Q6FNB1,Q756Q3,Q9VQ62">NPC2</protein-id> proteins, leading to an accumulation of unesterified <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and glycosphingolipids (GSLs) in the lysosomes.	cholesterol__NPC1__interaction	cholesterol__NPC2__interaction
18775028-2185	<protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id>-diminished <compound-id="232,4367,6322">arginine</compound-id> and indolamine 2,3-dioxygenase-diminished <compound-id="1148,6305,9060,5460840">tryptophan</compound-id>) or <compound-id="145068">nitric oxide</compound-id> (NO) production.	nitric oxide__arginase__no_interaction	arginine__arginase__interaction	tryptophan__arginase__no_interaction
18775088-2206	Memory impairment in young women at increased risk of depression: influence of <compound-id="5754">cortisol</compound-id> and 5-<protein-id="P31645">HTT</protein-id> genotype.	cortisol__HTT__no_interaction
18775088-2207	The aim of the present study was to determine whether memory impairments were present in young women at increased familial risk of depression and whether memory performance was related either to <compound-id="5754">cortisol</compound-id> secretion or to allelic variation in the promoter region of the serotonin transporter gene (5-<protein-id="P31645">HTT</protein-id>).	cortisol__HTT__no_interaction
18775090-2208	The relative gene expression of <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> 0.05) in-<compound-id="104815">Cu</compound-id> calves compared with+ <compound-id="104815">Cu</compound-id> or-<compound-id="104815">Cu</compound-id>+Mn calves.	Cu__cytochrome c__interaction
18775100-2213	Effects of a flaxseed-derived <compound-id="261166">lignan</compound-id> supplement on C-reactive protein, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> and retinol-binding <protein-id="P09048,P69610,P69611">protein 4</protein-id> in type 2 diabetic patients.	lignan__IL-6__interaction	lignan__protein 4__interaction
18775100-2214	The present study explored the effects of flaxseed-derived <compound-id="261166">lignan</compound-id> on inflammatory factors and <protein-id="P02753,P06912,P18902,P27485,P41263,P61641,Q28369">RBP4</protein-id> concentrations in type 2 diabetics, who have higher levels of these biomarkers.	lignan__RBP4__interaction
18775100-2215	No between-treatment differences were found with regard to <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> or <protein-id="P02753,P06912,P18902,P27485,P41263,P61641,Q28369">RBP4</protein-id> ; though <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> 0.001 following <compound-id="261166">lignan</compound-id> and placebo treatments, respectively).	lignan__RBP4__no_interaction	lignan__IL-6__no_interaction
18775460-2359	These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular <compound-id="271">Ca(2</compound-id>+) mobilization, and activation of <protein-id="P13678,Q25378">protein kinase C</protein-id>.	Ca(2__protein kinase C__no_interaction
18775471-2362	Here we report the discovery of a series of novel adamantyl <compound-id="713">carboxamides</compound-id> as selective inhibitors of human 11beta-HSD1 in HEK-293 cells transfected with the <protein-id="P28845,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4">HSD11B1</protein-id> gene.	carboxamides__HSD11B1__no_interaction
18775538-2383	Polymorphism in the <protein-id="P14417">apolipoprotein(a)</protein-id> gene, plasma lipoprotein(a), cardiovascular disease, and low-dose <compound-id="2244">aspirin</compound-id> therapy.	aspirin__apolipoprotein(a)__no_interaction
18775538-2384	We investigated whether this allele was associated with elevated <protein-id="P08519,P14417">Lp(a)</protein-id> and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose <compound-id="2244">aspirin</compound-id>, and whether <compound-id="2244">aspirin</compound-id> reduced cardiovascular risk in minor allele carriers.	aspirin__Lp(a)__no_interaction
18775593-2403	The study was prompted to characterize the B-type <protein-id="P16397,P18773">esterase</protein-id> activities in the terrestrial snail Xeropicta derbentina and to evaluate its sensitivity to organophosphorus and <compound-id="277">carbamate</compound-id> pesticides.	carbamate__esterase__interaction
18775593-2404	Specific <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</protein-id> and carboxylesterase activities were mainly obtained with <compound-id="20544">acetylthiocholine</compound-id> (K(m)=77.2 mM; V(max)=38.2 mU/mg protein) and <compound-id="13247">1-naphthyl acetate</compound-id> (K(m)=222 mM, V(max)=1095 mU/mg protein) substrates, respectively.	acetylthiocholine__cholinesterase__interaction	1-naphthyl acetate__cholinesterase__interaction
18775733-2451	To distinguish between isoform-specific and context-dependent modulation as possible explanations for this selectivity, the effects of <compound-id="5904">penicillin</compound-id> were evaluated on recombinant <protein-id="P26714,Q08832,Q9BLY8">GABA(A) receptors</protein-id> expressed in HEK293T cells.	penicillin__GABA(A) receptors__interaction
18775745-2455	Drosophila responds to detection of diamonopimelic-type microbial <compound-id="9816401">peptidoglycan</compound-id> through activation of the immune deficiency (Imd) pathway, a signaling pathway with numerous similarities to the mammalian pro-inflammatory <protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id> pathway.	peptidoglycan__TNF__interaction
18775894-2504	We measured serum high-sensitivity C-reactive protein (hs-<protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>), <protein-id="O70159,P02765,P12763,P24090,P29699,P29700,P29701,P80191,P97515,Q9N2D0">fetuin-A</protein-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, <protein-id="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0">IL-18</protein-id>, <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> (ELISA) and others (haemoglobin level, white blood cell count, serum <compound-id="24441,24456,24632">calcium, phosphate</compound-id>, <compound-id="24441,24456,24632">calcium-phosphate</compound-id> product, albumin, <protein-id="P22775,P81070">fibrinogen</protein-id>, <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, <protein-id="P81182">high-density lipoprotein</protein-id> (HDL), triglycerides and <protein-id="P01270">parathormone</protein-id>).	cholesterol__CRP__no_interaction	calcium-phosphate__IL-6__no_interaction	cholesterol__fibrinogen__no_interaction	calcium, phosphate__IL-6__no_interaction	cholesterol__fetuin-A__no_interaction	calcium-phosphate__CRP__no_interaction	calcium, phosphate__fetuin-A__no_interaction	cholesterol__IL-18__no_interaction	cholesterol__IL-6__no_interaction	calcium, phosphate__high-density lipoprotein__no_interaction	cholesterol__high-density lipoprotein__no_interaction	calcium, phosphate__IL-18__no_interaction	calcium-phosphate__fibrinogen__no_interaction	calcium-phosphate__parathormone__no_interaction	calcium-phosphate__IL-10__no_interaction	cholesterol__IL-10__no_interaction	calcium-phosphate__IL-18__no_interaction	calcium-phosphate__high-density lipoprotein__no_interaction	cholesterol__parathormone__no_interaction	calcium, phosphate__IL-10__no_interaction	calcium, phosphate__fibrinogen__no_interaction	calcium, phosphate__parathormone__no_interaction	calcium, phosphate__CRP__no_interaction	calcium-phosphate__fetuin-A__no_interaction
18775944-2518	Serum <compound-id="5283731,6433735">25-hydroxyvitamin D</compound-id> (25-OHD), calcium, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> and <compound-id="24404,139579">phosphorus</compound-id> were measured.	25-hydroxyvitamin D__alkaline phosphatase__no_interaction	phosphorus__alkaline phosphatase__no_interaction
18776133-17	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated <compound-id="5743">dexamethasone</compound-id> (DEX)-induced <protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptor</protein-id> (GCR)-alpha nuclear translocation in both <protein-id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</protein-id> (+) and CD8(+) T cells.	dexamethasone__glucocorticoid receptor__interaction	dexamethasone__CD4__interaction
18776170-42	Linear regression analyses showed that <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and phospholipid efflux and cellular <protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id> binding correlated significantly with the ability of <protein-id="O95477">ABCA1</protein-id> to form cell surface lipid domains.	cholesterol__ABCA1__interaction	cholesterol__apoA-I__no_interaction
18776171-43	<compound-id="5280644,5282796">Conjugated linoleic acid</compound-id>-mediated inflammation and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance in human adipocytes are attenuated by <compound-id="445154">resveratrol</compound-id>.	Conjugated linoleic acid__insulin__no_interaction	resveratrol__insulin__interaction
18776171-44	Inflammation plays a role in trans-10, cis-12 (10,12)-<compound-id="5280644,5282796">conjugated linoleic acid</compound-id> (CLA)-mediated delipidation and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance in adipocytes.	conjugated linoleic acid__insulin__no_interaction
18776171-45	Given the anti-inflammatory role of <compound-id="445154">resveratrol</compound-id> (RSV), we hypothesized that RSV would attenuate inflammation and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance caused by 10,12 CLA in human adipocytes.	resveratrol__insulin__no_interaction
18777013-349	Near-infrared fluorescence detection of <compound-id="5957">ATP</compound-id>-<compound-id="253,171548">biotin</compound-id>-mediated <protein-id="O55778,O57285,P03421,P03422,P03520,P04859,P04860,P04877,P04878,P04879,P04880,P06162,P06163,P06747,P06940,P11208,P12579,P14156,P14251,P14252,P15198,P16072,P16073,P16286,P16380,P16595,P19717,P21299,P21738,P22044,P22363,P23055,P23056,P24567,P24698,P26033,P26668,P28054,P32530,P32531,P32532,P33454,P35939,P35945,P35974,P60166,P69479,P69480,Q00793,Q01769,Q03335,Q06427,Q83956,Q86606,Q9DUE2,Q9IK91,Q9WS39">phosphoprotein</protein-id> labeling.	ATP__phosphoprotein__interaction	biotin__phosphoprotein__interaction
18777014-352	Wheat germ <protein-id="Q7M4U7">lipase</protein-id> had a high activity and enantioselectivity only in n-hexane with a high initial water activity (alpha(w) = 0.97), especially with <compound-id="7409">1-phenylethanol</compound-id> (C 32%, E &gt; 200).	1-phenylethanol__lipase__interaction
18777087-373	We determined effects of the vasopeptidase inhibitor (VPI) <compound-id="656629">omapatrilat</compound-id> and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) <compound-id="2541">candesartan</compound-id> in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (<protein-id="P01033">TIMP</protein-id>)-3, inducible-<protein-id="O61309,O61608,Q27571,Q9I9M2">nitric-oxide-synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>), oxidant-generating myeloperoxidase (<protein-id="P05164,P11247">MPO</protein-id>), and cytokines <protein-id="Q8JFG3">tumor-necrosis-factor</protein-id> (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>)-alpha, interleukin (IL)-6 and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id>, and transforming-growth-factor (TGF)-beta(1), and collagens.	candesartan__tumor-necrosis-factor__no_interaction	omapatrilat__tumor-necrosis-factor__no_interaction	omapatrilat__nitric-oxide-synthase__no_interaction	omapatrilat__iNOS__no_interaction	candesartan__MPO__no_interaction	omapatrilat__TIMP__no_interaction	candesartan__TNF__no_interaction	candesartan__iNOS__no_interaction	omapatrilat__IL-10__no_interaction	omapatrilat__MPO__no_interaction	omapatrilat__TNF__no_interaction	candesartan__TIMP__no_interaction	candesartan__IL-10__no_interaction	candesartan__nitric-oxide-synthase__no_interaction
18777087-374	The results suggest that modulation of matrix <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</protein-id>, oxidants, cytokines, and NOSs with <compound-id="656629">omapatrilat</compound-id> and <compound-id="2541">candesartan</compound-id> contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	candesartan__proteases__interaction	omapatrilat__proteases__interaction
18777088-375	We recently reported <compound-id="778">homocysteine</compound-id> (Hcy)-induced <protein-id="P29323">ERK</protein-id>-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	homocysteine__ERK__interaction
18777110-388	Other factors prognostic for inferior survival were <protein-id="P21847,P83517">serum albumin</protein-id> 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-<compound-id="2907,9554282">cyclophosphamide</compound-id>, <compound-id="31703">doxorubicin</compound-id>, <compound-id="5978">vincristine</compound-id>, and <compound-id="5755">prednisolone</compound-id> chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	doxorubicin__serum albumin__no_interaction	cyclophosphamide__serum albumin__no_interaction	vincristine__serum albumin__no_interaction	prednisolone__serum albumin__no_interaction
18777117-392	Association between <compound-id="107487">Val/Leu</compound-id> (247) polymorphism of <protein-id="P02749,P17690,P26644,P33703,Q01339,Q95LB0">apolipoprotein H</protein-id> and cerebral infarction in a Chinese population.	Val/Leu__apolipoprotein H__interaction
18777117-393	The purpose of this study was to identify associations between the <compound-id="107487">Val/Leu</compound-id> (247) polymorphism of <protein-id="P02749,P17690,P26644,P33703,Q01339,Q95LB0">apoH</protein-id> gene and CI in a Chinese cohort.	Val/Leu__apoH__interaction
18777136-397	We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to <compound-id="349960">sialic acids</compound-id> and in Siglecs (Sia-recognizing Ig superfamily <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id>).	sialic acids__lectins__no_interaction
18777160-404	Possible binding site for the substrate, prostaglandin H(2) (<compound-id="445049">PGH(2</compound-id>)), was identified by systematically probing the refined molecular structure of <protein-id="Q9JM51">mPGES-1</protein-id>.	PGH(2__mPGES-1__interaction
18777180-406	We cloned the zGCAP4 gene, purified non-myristoylated and myristoylated forms of the protein after heterologous expression in Escherichia coli and studied its properties: zGCAP4 was a strong activator of membrane-bound guanylate <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclases</protein-id> from bovine and zebrafish retina, showing half-maximal activation at 520-570 nM free <compound-id="271">Ca(2</compound-id>+) concentration.	Ca(2__cyclases__no_interaction
18777180-408	Thus, expression and biochemical properties of zGCAP4 are in agreement with its function as an efficient <compound-id="271">Ca(2</compound-id>+)-sensitive regulator of guanylate <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</protein-id> activity in cone vision.	Ca(2__cyclase__no_interaction
18777181-411	The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by <protein-id="P07156,P09429,P10103,P12682,P36194,Q4R844,Q6YKA4">HMGB1</protein-id> protein, their repair, and reactivity of the <compound-id="2915">platinum complex</compound-id> with <compound-id="124886">GSH</compound-id>.	platinum complex__HMGB1__no_interaction	GSH__HMGB1__no_interaction
18778244-705	However, in addition to <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id> activity, we discovered that EGST also possesses <compound-id="45102689">thiol</compound-id> : <protein-id="O84179,P0A6M2,P0A6M3,P44707,P59343,P59346,P59347,P63993,P63994,P94287,Q44856,Q54155,Q56578,Q7MJN7,Q7VKY2,Q822U2,Q83D55,Q87AV3,Q87N03,Q887H2,Q8ERY3,Q8GHM3,Q8PC32,Q8PNQ6,Q8XZM2,Q8ZEM1,Q9JTA9,Q9JYC6,Q9KBI6,Q9KQU6,Q9L6B3,Q9PGG2,Q9PKL7,Q9RWB5,Q9Z8V7">disulfide oxidoreductase</protein-id> activity, for which the residue Cys (10) plays an essential role.	thiol__GST__no_interaction	thiol__disulfide oxidoreductase__no_interaction
18778281-720	Anti-P mAb promoted <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> overproduction in a dose- and time-dependent manner in both <compound-id="11970143">lipopolysaccharide</compound-id> (LPS)-activated RAW 264.7 cells and primary human macrophages.	lipopolysaccharide__IL-10__no_interaction
18778289-732	Increased secretion of hyperimmune antibodies following <compound-id="11970143">lipopolysaccharide</compound-id> stimulation of <protein-id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</protein-id>-activated human B cells in vitro.	lipopolysaccharide__CD40__interaction
18778316-735	The addition of a bisecting <compound-id="24139">N-acetylglucosamine</compound-id> residue by beta(1,4)-<protein-id="Q02527,Q09327,Q10470">N-acetylglucosaminyltransferase III</protein-id> (GnTIII) is known to control the processing of N-linked glycans in mammals, for example by preventing alpha(1,6)-fucosylation of the core glycan.	N-acetylglucosamine__N-acetylglucosaminyltransferase III__interaction
18778316-736	Both CTSs targeted enhanced <protein-id="P21578">yellow fluorescent protein</protein-id> (eYFP) to a <compound-id="5287620">brefeldin A</compound-id>-sensitive compartment, indicative of Golgi localization.	brefeldin A__yellow fluorescent protein__no_interaction
18778404-750	The Solanum lycopersicum <protein-id="P93022">auxin response factor 7</protein-id> (SlARF7) regulates <compound-id="802">auxin</compound-id> signaling during tomato fruit set and development.	auxin__auxin response factor 7__interaction
18778748-865	We have investigated the pre-receptor metabolism of <compound-id="5994">progesterone</compound-id> in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of <protein-id="P19871">3beta-hydroxysteroid dehydrogenase</protein-id> (<protein-id="O46516,O57245,P14893,P21097,P26670,P27365,Q5IFP1,Q67477,Q9N119">3beta-HSD</protein-id>) by inflammatory, anti-inflammatory and apoptotic factors.	progesterone__3beta-HSD__no_interaction	progesterone__3beta-hydroxysteroid dehydrogenase__no_interaction
18778749-866	Coexpression with H6PDH potentiated <protein-id="P16232,P28845,P50172,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4">11beta-HSD1</protein-id> reductase activity at high <compound-id="206,5793,64689,79025">glucose</compound-id>.	glucose__11beta-HSD1__interaction
18778749-867	<protein-id="P16232,P28845,P50172,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4">11beta-HSD1</protein-id> dehydrogenase activity was observed in H4IIE cells only at subphysiological <compound-id="206,5793,64689,79025">glucose</compound-id> levels, indicating a highly efficient supply of substrate for H6PDH and NADPH generation in the ER-lumen.	glucose__11beta-HSD1__interaction
18778768-874	There are data to suggest that psychological intervention can influence neuroendocrine (e.g., <compound-id="5754">cortisol</compound-id>) and immune function indicators, especially lymphocyte proliferation and <protein-id="Q24134,Q8IXH7,Q9UVI4">TH1</protein-id> cytokine production.	cortisol__TH1__no_interaction
18778874-903	The proteins identified belong to the photosynthesis, carbohydrate and <compound-id="947,123329">nitrogen</compound-id> metabolism, and <protein-id="Q41112,Q9SW70">stress-related protein</protein-id> functional categories.	nitrogen__stress-related protein__no_interaction
18778892-914	In the present study, we investigated whether CD147/<protein-id="Q99PA3">basigin</protein-id> is involved, via its association with <protein-id="O35439,P53985,Q03064,Q12283">MCT1</protein-id> and 4 to transport <compound-id="612">lactate</compound-id>, in glycolysis and then contributes to the progression of A375 melanoma cells.	lactate__MCT1__interaction	lactate__basigin__interaction
18779389-1017	TCblR belongs to the <protein-id="P01131,P20063,Q28832">low-density lipoprotein receptor</protein-id> family, with 2 low-density lipoprotein receptor <protein-id="P02855">type A</protein-id> domains separated by a complement-like <compound-id="594,5862,5360637">cysteine</compound-id>-rich region.	cysteine__low-density lipoprotein receptor__interaction	cysteine__type A__interaction
18780301-1284	Variability of <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>, BChE, and <protein-id="P07668,P13222,P28329,P32738,P32756,Q03059">ChAT</protein-id> genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with <compound-id="3152">Donepezil</compound-id> and <compound-id="77991">Rivastigmine</compound-id>.	Donepezil__ChAT__interaction	Rivastigmine__ChAT__interaction	Rivastigmine__AChE__interaction	Donepezil__AChE__interaction
18780328-1293	Extended-release PEG-<compound-id="5484207">luciferin</compound-id> allows for long-term imaging of firefly <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> activity in vivo.	luciferin__luciferase__interaction
18780332-1296	Spectrofluorimetric determination of vitamin B(1) using horseradish <protein-id="P15984,P16147,P84714">peroxidase</protein-id> as catalyst in the presence of <compound-id="784">hydrogen peroxide</compound-id>.	hydrogen peroxide__peroxidase__interaction
18780332-1297	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="Q08168">HRP</protein-id>) in the presence of <compound-id="784">hydrogen peroxide</compound-id> (<compound-id="784">H2O2</compound-id>), has been developed.	H2O2__HRP__interaction	H2O2__peroxidase__interaction	hydrogen peroxide__HRP__interaction	hydrogen peroxide__peroxidase__interaction
18780360-1305	Electrospun <compound-id="123833">polyglyconate</compound-id> (<compound-id="123833">Maxon</compound-id>) and its blends with proteins such as gelatin and <protein-id="P11547">elastin</protein-id>, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	Maxon__elastin__interaction	polyglyconate__elastin__interaction
18781168-1823	So far, in maize, three classes of mutants involved in <compound-id="890">phytic acid</compound-id> biosynthesis have been isolated: <protein-id="P61793,P61794">lpa1</protein-id>, <protein-id="Q9JL06">lpa2</protein-id> and <protein-id="Q8K5E0,Q9EQ31">lpa3</protein-id>.	phytic acid__lpa1__interaction	phytic acid__lpa2__interaction	phytic acid__lpa3__interaction
18781316-1566	Bevacizumab (Avastin), ranibizumab (Lucentis) and <compound-id="158786">pegaptanib sodium</compound-id> (<compound-id="158786">Macugen</compound-id>) are anti-<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> medications that have been used in the treatment of CNV.	Macugen__VEGF__interaction	pegaptanib sodium__VEGF__interaction
18781338-1571	Blood samples were collected to assay for biomarkers of oxidative stress (<compound-id="10964">malondialdehyde</compound-id> and carbonyl groups) and antioxidants (<protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id>, <compound-id="124886">reduced glutathione</compound-id>, alpha-tocopherol, and beta-carotene).	reduced glutathione__glutathione peroxidase__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction
18781385-1599	The low content of sphingomyelin, sulfatide and <compound-id="52949283">galactosylceramide</compound-id> is consistent with the immunohistochemical results showing that in the grey-lethal brain significant depletion and disorganization of the myelinated fibres is present, thus supporting the hypothesis that loss of function of the <protein-id="Q86WC4">OSTM1</protein-id> causes neuronal impairment and myelin deficit.	galactosylceramide__OSTM1__no_interaction
18781596-1677	Finally and most importantly, our data indicate that a decrease in AKT activity followed by a total decrease in <protein-id="O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P08133,P14824,P26660,P26661,P26662,P26663,P26664,P27694,P27958,P29846,P48037,P51901,P79134,Q00269,Q01588,Q24492,Q5FW17,Q5I2N3,Q5R7Q4,Q5ZJJ2,Q68749,Q68798,Q68801,Q6NY74,Q81258,Q81487,Q81495,Q81754,Q8VEE4,Q913D4,Q99IB8,Q9DHD6,Q9FMI7,Q9QAX1,Q9WMX2">p70</protein-id> (<protein-id="P23443,P67998,P67999,Q6TJY3,Q8BSK8">S6K</protein-id>) phosphorylation reflecting a decrease in <protein-id="P42345,P42346,Q9JLN9">mTOR</protein-id> activity occurs during high <compound-id="977">oxygen</compound-id> consumption, resulting from high cell density.	oxygen__S6K__interaction	oxygen__p70__interaction	oxygen__mTOR__interaction
18781650-1708	Some of the peptide derivatives inhibited <protein-id="P36836,P46059,Q8WMX5">PEPT1</protein-id>-mediated uptake of [(3)H] <compound-id="750,5460845">Gly</compound-id>-Sar.	Gly__PEPT1__interaction
18781688-1721	Effect of enzyme supplementation at moderate <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> loadings on initial <compound-id="5793">glucose</compound-id> and xylose release from corn stover solids pretreated by leading technologies.	glucose__cellulase__no_interaction
18781688-1722	For a combined mass loading of <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> and <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</protein-id> of 16.1 mg/g original <compound-id="5793">glucan</compound-id> (about 7.5 FPU/g), <compound-id="5793">glucose</compound-id> release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	glucan__beta-glucosidase__interaction	glucose__beta-glucosidase__interaction	glucan__cellulase__interaction	glucose__cellulase__interaction
18782461-1964	PCFT/<protein-id="Q13946,Q96NT5">HCP1</protein-id> could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of <compound-id="6037">folate</compound-id> and haem at the level of intestinal absorption.	folate__HCP1__interaction
18782463-1965	Following an oral <compound-id="206,5793,64689,79025">glucose</compound-id> challenge, there was a weak trend for <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> release to be increased in the offspring of dams fed the folate-deficient diet.	glucose__insulin__interaction
18782570-2009	Association between serum retinol-binding <protein-id="P09048,P69610,P69611">protein 4</protein-id> and small dense low-density lipoprotein <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels in young adult women.	cholesterol__protein 4__interaction
18782588-2018	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<compound-id="5289486">TNP</compound-id>-<protein-id="P02769">BSA</protein-id>).	TNP__serum albumin__interaction	TNP__BSA__interaction
18782661-2054	By using the system, we obtained four event timing data sets (stimulation by <protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id> with and without <compound-id="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148">staurosporine</compound-id> at the concentrations of 0.01, 0.1, and 1 microM).	staurosporine__NGF__no_interaction
18783254-2197	Because of their critical biological roles, <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> and <protein-id="O77003,P02144,P02145,P02147,P02148,P02150,P02151,P02152,P02153,P02154,P02155,P02156,P02157,P02159,P02160,P02161,P02163,P02164,P02165,P02166,P02167,P02168,P02169,P02170,P02171,P02173,P02174,P02177,P02178,P02179,P02180,P02181,P02182,P02183,P02184,P02185,P02186,P02187,P02189,P02190,P02191,P02192,P02193,P02194,P02195,P02196,P02197,P02199,P02200,P02201,P02202,P02203,P02204,P02205,P02206,P02210,P02211,P02214,P02215,P04247,P04248,P04249,P04250,P09965,P0C227,P11343,P14393,P14396,P14397,P14398,P14399,P15160,P17724,P20856,P29287,P30562,P31331,P32428,P49672,P51535,P51537,P56208,P56532,P62734,P62735,P63113,P63114,P68080,P68081,P68082,P68083,P68084,P68085,P68086,P68189,P68190,P68276,P68277,P68278,P68279,P80721,P80722,P83682,P84997,P87497,Q01966,Q03459,Q0KIY0,Q0KIY1,Q0KIY2,Q0KIY3,Q0KIY5,Q0KIY9,Q2MJN4,Q6I7B0,Q6PL31,Q6VN46,Q701N9,Q76G09,Q7LZM1,Q7LZM2,Q7LZM3,Q7LZM4,Q7LZM5,Q7M3C1,Q7M424,Q7T044,Q9DEN8,Q9DEN9,Q9DEP0,Q9DEP1,Q9DGI8,Q9DGI9,Q9DGJ0,Q9DGJ1,Q9DGJ2,Q9QZ76">myoglobin</protein-id> are among the most extensively studied proteins in human history, while nitrite <compound-id="169814">tops</compound-id> the list of most-studied small molecules.	tops__hemoglobin__no_interaction	tops__myoglobin__no_interaction
18783254-2198	First, R-state, or allosteric, autocatalysis of nitrite reduction increases the rate of NO generation by deoxyhemoglobin and results in maximal NO production at approximately 50% <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> <compound-id="977">oxygen</compound-id> saturation, which is physiologically associated with greatest NO-dependent vasodilation.	oxygen__hemoglobin__interaction
18783311-2231	Role of <protein-id="Q924V1,Q9JHI8">Nox4</protein-id> and Nox2 in hyperoxia-induced reactive <compound-id="977">oxygen</compound-id> species generation and migration of human lung endothelial cells.	oxygen__Nox4__interaction
18783311-2234	Downregulation of <protein-id="Q924V1,Q9JHI8">Nox4</protein-id>, or pretreatment with <compound-id="12035">N-acetylcysteine</compound-id>, attenuated hyperoxia-induced cell migration and capillary tube formation, suggesting that ROS generated by <protein-id="Q924V1,Q9JHI8">Nox4</protein-id> regulate endothelial cell motility.	N-acetylcysteine__Nox4__no_interaction
18783384-2267	Using newly designed degenerate primers targeting the <protein-id="P09785,P0AFJ1,P0AFJ2,P0AFJ3,P0AFJ4,P44479,Q02419">phnA</protein-id> gene we analysed the potential for <compound-id="546">phosphonoacetate</compound-id> utilization in DNA and cDNA libraries constructed from a phytoplankton bloom in the Western English Channel during July 2006.	phosphonoacetate__phnA__interaction
18783774-2396	Low-density lipoprotein <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and non-<protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.	cholesterol__high-density lipoprotein__no_interaction
18783774-2397	Only a small number of population-based cohort studies have directly compared the predictive value of low-density lipoprotein <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (LDL-C) and non-<protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (non-HDLC) for coronary artery disease in Asian populations, such as Japan.	cholesterol__high-density lipoprotein__no_interaction
18783827-2422	Finally, we show that Vcx1 helps return cytosolic <compound-id="271">Ca(2</compound-id>+) toward resting levels after shock with high extracellular <compound-id="271">Ca(2</compound-id>+) much more effectively than <protein-id="Q9P7Y4">Pmc1</protein-id> and that calcineurin, a protein phosphatase regulator of Vcx1 and <protein-id="Q9P7Y4">Pmc1</protein-id>, had no detectable effects on these factors within the first few minutes of its activation.	Ca(2__Pmc1__no_interaction
18783828-2424	It is a serious problem that effective treatment choices to T315I, in the <protein-id="P00519,P00521,P10447,P11681,Q00022">ABL</protein-id> kinase domain that shows a strong tolerance in <compound-id="5291">imatinib</compound-id> do not exist clinically.	imatinib__ABL__interaction
18783846-2433	Moreover, diacylgycerol-dependent <protein-id="P13678,Q25378">protein kinase C</protein-id> isoenzymes and activation of extracellular signal-regulated <protein-id="P00513,P25848">protein kinase</protein-id> (<protein-id="P29323">ERK</protein-id>) are required for <compound-id="206,5793,64689,79025">glucose</compound-id>-, <compound-id="5505">tolbutamide</compound-id>- and KCl-induced <protein-id="P08046">Egr-1</protein-id> expression.	tolbutamide__ERK__interaction	glucose__protein kinase C__interaction	tolbutamide__protein kinase C__interaction	tolbutamide__Egr-1__interaction	glucose__Egr-1__interaction	glucose__ERK__interaction	glucose__protein kinase__interaction	tolbutamide__protein kinase__interaction
18784063-2498	Long-term blinded placebo-controlled study of <compound-id="3686">SNT-MC17</compound-id>/<compound-id="3686">idebenone</compound-id> in the <protein-id="O97592,P11530,P11531,P11532,P11533,Q5GN48">dystrophin</protein-id> deficient mdx mouse: cardiac protection and improved exercise performance.	idebenone__dystrophin__interaction	SNT-MC17__dystrophin__interaction
18784648-124	<protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">Glucocorticoid receptor</protein-id> blockade normalizes hippocampal alterations and cognitive impairment in <compound-id="5300,29327,6420074,6713972,7067772,45357367">streptozotocin</compound-id>-induced type 1 diabetes mice.	streptozotocin__Glucocorticoid receptor__no_interaction
18784734-168	The study aim was to determine whether urine albumin/<compound-id="588">creatinine</compound-id> ratio (UACR), high-sensitivity C-reactive protein (hsCRP) or N-terminal pro-<protein-id="P40753">brain natriuretic peptide</protein-id> (Nt-proBNP) added to risk prediction based on HeartScore and history of diabetes or cardiovascular disease.	creatinine__brain natriuretic peptide__no_interaction
18784749-176	Transgene optimization significantly improves SIN vector titers, <protein-id="O46522,P04839,P52649,Q61093,Q95L74">gp91phox</protein-id> expression and reconstitution of <compound-id="5359597">superoxide</compound-id> production in X-CGD cells.	superoxide__gp91phox__no_interaction
18784906-222	Quantitative evaluation of <protein-id="P36836,P46059,Q8WMX5">PEPT1</protein-id> contribution to oral absorption of <compound-id="27447">cephalexin</compound-id> in rats.	cephalexin__PEPT1__interaction
18784908-224	<compound-id="104815">Cu</compound-id> concentration in the liver and in plasma alanine aminotransferase (ALT) and aspartate transaminase (<protein-id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">AST</protein-id>) activities were determined.	Cu__AST__interaction
18784908-225	In brain tissue, <compound-id="104815">Cu</compound-id> concentration, <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) activities, <compound-id="10964">malondialdehyde</compound-id> (MDA) levels and glutathione (GSH) concentrations were determined.	malondialdehyde__SOD__no_interaction	malondialdehyde__superoxide dismutase__no_interaction	Cu__superoxide dismutase__no_interaction	Cu__SOD__no_interaction
18785000-243	We previously reported that inhibition of <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id>-kinase (ROCK) by hydroxyl <compound-id="3547">fasudil</compound-id> improves cognitive deficit and neuronal damage in rats with chronic cerebral ischemia (Huang et al., Cell Mol Neurobiol 28:757-768, 2008).	fasudil__Rho__interaction
18785000-244	Finally, in the presence of OGD and <compound-id="3547">fasudil</compound-id> mesylate, <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	fasudil__SOD__interaction	fasudil__superoxide dismutase__interaction
18785066-298	Na+/H+ exchanger isoform 3 (<protein-id="P26432,P26433,P48764,Q28362,Q84WG1">NHE-3</protein-id>) is responsible for net uptake of <compound-id="5234">NaCl</compound-id> and water from the gastrointestinal (GI) tract.	NaCl__NHE-3__interaction
18785206-418	<protein-id="Q07343">PDE4B</protein-id> is also important in the regulation of <compound-id="6076">cAMP</compound-id> signaling, a second messenger implicated in learning, memory, and mood.	cAMP__PDE4B__interaction
18785212-354	Elevated amounts of <protein-id="P00558,P00559,P00560,P29405,P29407,P29408,P41757,P46273,P50310,Q3T0P6,Q5NVB5,Q60HD8,Q6BLA0,Q6FKY1,Q757Q0,Q7SIB7,Q7ZA46">PGK1</protein-id>, one of the <compound-id="5957">ATP</compound-id>-generating reactions of glycolysis, in wood frog brain during freezing would enhance the glycolytic capacity of the organ and support the maintenance of cellular energetics under the ischemic conditions of the frozen state.	ATP__PGK1__interaction
18785685-518	SNs and SMs were exposed to macrophages with and without addition of <compound-id="53481793">endotoxin lipopolysaccharide</compound-id> (LPS), a positive inducer of <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>), <protein-id="P41693">interleukin 6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>), and <compound-id="145068">nitric oxide</compound-id> (NO).	endotoxin lipopolysaccharide__IL-6__interaction	nitric oxide__interleukin 6__no_interaction	nitric oxide__tumor necrosis factor__no_interaction	nitric oxide__TNF-alpha__no_interaction	endotoxin lipopolysaccharide__TNF-alpha__interaction	endotoxin lipopolysaccharide__interleukin 6__interaction	nitric oxide__IL-6__no_interaction	endotoxin lipopolysaccharide__tumor necrosis factor__interaction
18785878-575	We therefore hypothesized that a diffusible product of the <protein-id="O15886,P09194">GPI-PLC</protein-id> enzyme reaction [possibly DAG (<compound-id="6026790">diacylglycerol</compound-id>)] mediated the biological effects of the protein.	diacylglycerol__GPI-PLC__interaction
18786000-610	Silencing of <protein-id="O04111,O04220,O22586,O22652,O65872,O82144,P06515,P13114,P16107,P17818,P23569,P30078,P30079,P48385,P48389,P48405,P51075,P51080,P51089,P51090,Q9FUB7,Q9LKP7,Q9MBB1,Q9SEP2,Q9SEP4,Q9ZRR8,Q9ZRS4,Q9ZU06">chalcone synthase</protein-id>, the key entry-point enzyme for flavonoid biosynthesis led to <compound-id="10251">flavonoid</compound-id>-deficient roots.	flavonoid__chalcone synthase__interaction
18786181-656	<protein-id="P13448,P13449,P27763,P27764,P33036,P82605,P97051,P97052,Q53117,Q53118">Nitrilase</protein-id> enzymes have been characterised in plants, bacteria and fungi and are thought to be important in detoxification of nitriles, utilisation of <compound-id="947,123329">nitrogen</compound-id> and synthesis of plant hormones.	nitrogen__Nitrilase__interaction
18786181-657	In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to <compound-id="424,5960,83887">aspartic acid</compound-id> and <compound-id="222">ammonia</compound-id> by <protein-id="P46011,Q42965">NIT4</protein-id>.	ammonia__NIT4__interaction	aspartic acid__NIT4__interaction
18786182-658	The mitochondrial membrane potential (Delta psi (mit)) was also tested with <compound-id="65218">rhodamine 123</compound-id> 30 min after SI challenge, and was shown to have collapsed in the incompatible pollen tubes after exposure to <protein-id="P00669">S-RNase</protein-id>.	rhodamine 123__S-RNase__interaction
18786279-668	In conclusion, female rats undernourished in utero had normophagic obesity as adults but had an absence of <compound-id="5202">serotonin</compound-id>-induced hypophagia and low hypothalamic levels of the <protein-id="P08909,P28335,P34968,Q5IS66,Q60F97">5-HT 2C</protein-id> receptor.	serotonin__5-HT 2C__no_interaction
18786279-669	Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of <compound-id="5202">serotonin</compound-id> in response to a meal allied to up-regulated hypothalamic <protein-id="O08892,P28222,P28286,P28334,P28564,P35404,P46636,P49144,P56496,P60020,P79250,P79399,Q588Y6,Q6XXX8,Q9N2B7">5-HT1B</protein-id> and transporter expression.	serotonin__5-HT1B__interaction
18786604-753	The proliferation of the parental cell line was most efficiently stimulated by <compound-id="10635">5alpha-dihydrotestosterone</compound-id> (<compound-id="10635">DHT</compound-id>), but the LNCaP[<protein-id="O54939,P37058,P70385">17beta-HSD3</protein-id>] cells were equally stimulated by Adione, indicating that <protein-id="O54939,P37058,P70385">17beta-HSD3</protein-id> efficiently converts Adione to T in this model.	5alpha-dihydrotestosterone__17beta-HSD3__no_interaction	DHT__17beta-HSD3__no_interaction
18786605-754	They potentiate <compound-id="206,5793,64689,79025">glucose</compound-id>-induced <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion and may be responsible for up to 70% of postprandial <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion.	glucose__insulin__interaction
18786605-755	However, in supraphysiological doses, <protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id> administration may completely normalize beta as well as alpha cell sensitivity to <compound-id="206,5793,64689,79025">glucose</compound-id>.	glucose__GLP-1__interaction
18786649-767	The induction of signal transduction by serum and growth factors significantly increases the level of <protein-id="P23443,P67998,P67999,Q6TJY3,Q8BSK8">S6K</protein-id> ubiquitination, while the treatment of cells with UV and <compound-id="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148">staurosporine</compound-id> has the opposite effect.	staurosporine__S6K__interaction
18786760-796	Interaction of <compound-id="11295">malachite green</compound-id> with bovine <protein-id="P21847,P83517">serum albumin</protein-id> : determination of the binding mechanism and binding site by spectroscopic methods.	malachite green__serum albumin__interaction
18786760-797	The interaction between <compound-id="11295">malachite green</compound-id> (MG) and bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	malachite green__serum albumin__interaction	malachite green__BSA__interaction
18786760-798	The binding distance (r) between MG and the <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> residue of <protein-id="P02769">BSA</protein-id> was obtained to be 4.79 nm according to Frster theory of non-radioactive energy transfer.	tryptophan__BSA__interaction
18786974-878	Unlike <compound-id="588">creatinine</compound-id>, <protein-id="P08935,P25973,P81061,P81714,Q06445">Cystatin</protein-id> C (<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id>) is believed to be independent of body composition in both adults and children.	creatinine__CysC__no_interaction	creatinine__Cystatin__no_interaction
18787021-886	Levels of endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> did not differ among the groups, nor did total nitrite plus <compound-id="943">nitrate</compound-id> levels.	nitrate__nitric oxide synthase__no_interaction
18787024-887	<compound-id="79025">Glucose</compound-id> controls cytosolic Ca2+ and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion in mouse islets lacking <compound-id="5957">adenosine triphosphate</compound-id>-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	Glucose__insulin__interaction	adenosine triphosphate__insulin__interaction
18787032-890	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of <protein-id="O42781,P27638,Q00859">MAPK</protein-id> pathway with 50 microM <compound-id="4713">PD98059</compound-id> but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm <compound-id="312145">wortmannin</compound-id>.	PD98059__MAPK__interaction	wortmannin__MAPK__no_interaction
18787174-941	Lung injury was assessed by measuring vascular permeability (via <compound-id="9566058">Evans blue dye</compound-id>), edema, neutrophil infiltration (via myeloperoxidase [<protein-id="P05164,P11247">MPO</protein-id>), and expression of proinflammatory cytokines.	Evans blue dye__MPO__no_interaction
18787236-950	<compound-id="304,5997,6432564,11025495">Cholesterol</compound-id> efflux from [(3)H] <compound-id="5283632">cholesterol-oleate</compound-id>-acetyl-LDL-loaded monocyte-derived macrophages to standard <protein-id="P18647">apolipoprotein A-I</protein-id> (<protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id>), HDL(2), and serum was measured.	cholesterol-oleate__apoA-I__interaction	Cholesterol__apoA-I__interaction	cholesterol-oleate__apolipoprotein A-I__interaction	Cholesterol__apolipoprotein A-I__interaction
18787236-952	<compound-id="304,5997,6432564,11025495">Cholesterol</compound-id> efflux to <protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id>, HDL(2), and serum from macrophage foam cells derived from low- and high-HDL subjects was similar.	Cholesterol__apoA-I__no_interaction
18787236-954	<compound-id="304,5997,6432564,11025495">Cholesterol</compound-id> efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), <protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id> (P = 0.004), <protein-id="P02652,P02653,P04638,P09813,P18656,P81644,P83704,Q8MIQ5">apoA-II</protein-id> 0.0001), and the percentage of <protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id> present in the form of prebeta-HDL (P = 0.0001).	Cholesterol__apoA-I__interaction	Cholesterol__apoA-II__interaction
18787748-1079	In this study, the degradation of <protein-id="P31750">Rac</protein-id>- and R-<compound-id="42586,11150163">metalaxyl</compound-id> under anaerobic conditions was studied.	metalaxyl__Rac__no_interaction
18787757-1084	Regulation of muscle protein degradation, not synthesis, by dietary <compound-id="857,6106,439524">leucine</compound-id> in rats fed <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id>-deficient diet.	leucine__a protein__no_interaction
18787837-1099	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified <compound-id="6288">threonine</compound-id> residues in the <protein-id="Q62433,Q92597">n-myc downstream-regulated gene 1 protein</protein-id> (<protein-id="Q92597">NDRG1</protein-id>-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	threonine__n-myc downstream-regulated gene 1 protein__interaction	threonine__NDRG1__interaction
18787837-1100	Although G (Na) is negligible in hormone-deprived cells, these cells displayed basal <protein-id="O00141,Q9XT18">SGK1</protein-id> activity that was sensitive to <compound-id="3973">LY294002</compound-id>, an inhibitor of 3-phosphatidylinositol phosphate kinase (PI3K).	LY294002__SGK1__interaction
18787840-1103	<protein-id="P55245">Epidermal growth factor receptor</protein-id> expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with <compound-id="23939">platinum</compound-id>-based chemotherapy.	platinum__Epidermal growth factor receptor__interaction
18787967-1145	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as <protein-id="O50258">superoxide dismutase</protein-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> and <compound-id="6326970">selenium</compound-id>, incorporated in conventional treatment regimen.	vitamin E__superoxide dismutase__no_interaction	vitamin E__catalase__no_interaction	selenium__superoxide dismutase__no_interaction	selenium__catalase__no_interaction
18787973-1149	This study was designed to determine the effect of <compound-id="4239">molsidomine</compound-id> (MO), a precursor of <compound-id="145068">nitric oxide</compound-id> (NO) donor, on hypoxia inducible factor alpha (<protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id>) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	nitric oxide__HIF-1alpha__no_interaction	molsidomine__HIF-1alpha__interaction
18787978-1152	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and <protein-id="P10265,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63129,P63131,Q9Y6I0">proteinase</protein-id>) and antifungal drug sensitivity (<compound-id="5280965">amphotericin B</compound-id>, <compound-id="3365">fluconazole</compound-id> and <compound-id="3793,55283,6917738,14179013">itraconazole</compound-id>) by the reference method of the Clinical and Laboratory Standards Institute.	amphotericin B__proteinase__no_interaction	fluconazole__proteinase__no_interaction	itraconazole__proteinase__no_interaction
18788036-1175	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S([<compound-id="1061">PO4</compound-id>])KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) as a control.	PO4__BSA__no_interaction	PO4__serum albumin__no_interaction
18789002-1201	Colon cancer cells maintain low levels of <compound-id="1060">pyruvate</compound-id> to avoid cell death caused by inhibition of <protein-id="P56517,P56518,Q13547,Q94517">HDAC1</protein-id>/<protein-id="O15379,P56520">HDAC3</protein-id>.	pyruvate__HDAC1__no_interaction	pyruvate__HDAC3__no_interaction
18789002-1204	This process is associated with an increase in intracellular levels of <compound-id="1060">pyruvate</compound-id>, increase in the acetylation status of <protein-id="P02309,P04914,P04915,P08436,P09322,P27996,P35057,P35059,P40287,P50566,P59259,P62776,P62777,P62778,P62779,P62780,P62781,P62782,P62783,P62784,P62787,P62788,P62789,P62790,P62791,P62792,P62793,P62794,P62795,P62796,P62797,P62798,P62799,P62800,P62801,P62802,P62803,P62804,P62805,P62806,P62887,P80738,P80739,P82888,P83865,P84040,P84041,P84042,P84043,P84044,P84045,P84046,P84047,P84048,P84049,P84050,P90516,P91849,P91882,P91890,Q27443,Q27765,Q43083,Q6LAF1,Q6LAF3,Q6PMI5,Q6V9I2,Q6WV72,Q6WV73,Q6WV74,Q6WV90,Q6WZ83,Q6ZXX3,Q71V09,Q76FD9,Q76FE7,Q76FF1,Q76FF5,Q76H85,Q76MU7,Q7K8C0,Q7KQD1,Q7LKT3,Q7M3Z5,Q8I0Y4,Q8J1L3,Q8MTV8,Q8NIG3,Q8SQP4,Q8T7J8,Q9HDF5,Q9U7D0">histone H4</protein-id>, and enhanced cell death.	pyruvate__histone H4__no_interaction
18789341-1500	The <compound-id="6076">cAMP</compound-id>/<protein-id="Q05608,Q9RI12">protein kinase A</protein-id> (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.	cAMP__protein kinase A__interaction
18789398-1523	Epigenetic reprogramming of breast cancer cells by <compound-id="3121">valproic acid</compound-id> occurs regardless of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> status.	valproic acid__estrogen receptor__no_interaction
18789440-1646	In the present study, we have investigated the effect of <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> on <protein-id="O95477">ABCA1</protein-id> expression and <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> efflux in THP-1 macrophage-derived foam cells.	cholesterol__IFN-gamma__interaction	cholesterol__ABCA1__no_interaction
18789466-1548	Every 12 weeks intestinal permeability (<compound-id="3872,11333,11024312,16217605,16760534">lactulose</compound-id>/<compound-id="6251">mannitol</compound-id> ratio), haemoglobin, plasma albumin, <protein-id="Q08398">alpha-1</protein-id>-acid <protein-id="P08163">glycoprotein</protein-id>, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	lactulose__glycoprotein__no_interaction	mannitol__alpha-1__no_interaction	lactulose__alpha-1__no_interaction	mannitol__glycoprotein__no_interaction
18789492-1558	As such, the aim of the present study was to investigate whether <protein-id="P11597,P22687,P25914,P47896">CETP</protein-id>-inhibition with <compound-id="6918540">JTT-705</compound-id>, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.	JTT-705__CETP__interaction
18789529-1570	In this review we discuss the <protein-id="P16629,P24266,P28991,Q04565,Q07252">membrane proteins</protein-id> that transport arsenic and <compound-id="6326970">selenium</compound-id> into cells, from bacteria to humans, as well as some of the efflux proteins involved in detoxification.	selenium__membrane proteins__interaction
18789530-2169	Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, <compound-id="7505">benzonitrile</compound-id> analogues) and the corresponding enzymes (<protein-id="P13448,P13449,P27763,P27764,P33036,P82605,P97051,P97052,Q53117,Q53118">nitrilase</protein-id>, nitrile hydratase) are described in detail.	benzonitrile__nitrilase__interaction
18789597-659	Since stellate cells have been found to express the beta but not the alpha isoform of the <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id>, it can be predicted that nutritional intakes of the soy <compound-id="72304">isoflavone</compound-id> <compound-id="5280961">genistein</compound-id>-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	genistein__estrogen receptor__no_interaction	isoflavone__estrogen receptor__no_interaction
18789664-1638	We report that the PP inhibition of proteolysis in young rats was mediated by the increased <protein-id="P01308,P01310,P01311,P01313,P01314,P01315,P01316,P01317,P01318,P01319,P01320,P01321,P01324,P01327,P01328,P01329,P01330,P01331,P01333,P01334,P01335,P01336,P01340,P01342,P04667,P06306,P07453,P09476,P09477,P0C236,P12703,P12704,P12705,P12708,P13190,P17715,P18109,P21563,P29335,P30406,P30407,P30410,P41522,P42633,P51463,P67968,P67969,P67970,P67971,P67972,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69045,P69046,P69047,P69048,P81025,P81423,P81881,Q62587,Q6YK33,Q8HXV2,Q91XI3,Q98TA8,Q9TQY7,Q9W7R2">INS</protein-id> secretion and resulted from a down-regulation of both lysosomal and <compound-id="271">Ca(2</compound-id>+)-dependent proteolysis.	Ca(2__INS__no_interaction
18789666-1639	Aqueous extract of cumin was tested for its antiglycating ability against <compound-id="5984">fructose</compound-id>-induced glycation of goat lens total soluble protein (<protein-id="P07996,P12528,Q9XJP3">TSP</protein-id>), alpha-crystallin from goat lens and a nonlenticular protein bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>).	fructose__serum albumin__interaction	fructose__TSP__interaction	fructose__BSA__interaction
18789669-1641	To investigate the effects of <compound-id="6326970">selenium</compound-id> on mRNA expressions of proinflammatory cytokines and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a <compound-id="1090">selenite</compound-id>-treated diabetes mellitus group.	selenite__iNOS__no_interaction	selenite__nitric oxide synthase__no_interaction	selenium__nitric oxide synthase__interaction	selenium__iNOS__interaction
18789669-1642	The results showed that pancreatic <compound-id="6326970">selenium</compound-id> content and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id>.05), respectively, in <compound-id="1090">selenite</compound-id>-treated diabetes mellitus group compared with untreated diabetes mellitus group.	selenium__glutathione peroxidase__no_interaction	selenite__glutathione peroxidase__no_interaction
18789669-1643	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha and <protein-id="Q9TTB0">interferon-gamma</protein-id> ; mRNA expression and activity of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>.05), respectively, in <compound-id="1090">selenite</compound-id>-treated diabetes mellitus group compared with untreated diabetes mellitus group.	selenite__tumor necrosis factor__no_interaction	selenite__iNOS__no_interaction	selenite__interferon-gamma__no_interaction
18789733-21	Decreases in PNNs, aggrecan and <compound-id="24759,453618,3084050,24728612">hyaluronic acid</compound-id> were observed only in the terminal stages and correlated with the distribution of <protein-id="O18754,O46501,P04156,P04273,P04925,P10279,P13852,P23907,P40242,P40243,P40244,P40245,P40246,P40247,P40248,P40249,P40251,P40252,P40255,P40256,P40257,P40258,P47852,P49927,P51446,P51780,P52113,P52114,P61761,P61762,P61766,P61767,P61768,P67986,P67987,P67988,P67989,P67990,P67991,P67992,P67993,P67994,P67995,P67996,P67997,P79141,Q5UAF1,Q5UJG1,Q5UJG3,Q5UJG7,Q5UJH0,Q5UJH8,Q5UJI7,Q5XVM4,Q60468,Q60506,Q68G95,Q6EH52,Q7JIH3,Q7JIY2,Q7JK02,Q95174,Q95176,Q95211,Q95270,Q95M08,Q9Z0T3">PrP</protein-id> (BSE) and activated glial cells.	hyaluronic acid__PrP__interaction
18789733-22	This study suggests that the loss of <protein-id="P79122,P79149,Q5R5X0,Q9H307">PNNs</protein-id>, aggrecan and <compound-id="24759,453618,3084050,24728612">hyaluronic acid</compound-id> is a consequence of <protein-id="O18754,O46501,P04156,P04273,P04925,P10279,P13852,P23907,P40242,P40243,P40244,P40245,P40246,P40247,P40248,P40249,P40251,P40252,P40255,P40256,P40257,P40258,P47852,P49927,P51446,P51780,P52113,P52114,P61761,P61762,P61766,P61767,P61768,P67986,P67987,P67988,P67989,P67990,P67991,P67992,P67993,P67994,P67995,P67996,P67997,P79141,Q5UAF1,Q5UJG1,Q5UJG3,Q5UJG7,Q5UJH0,Q5UJH8,Q5UJI7,Q5XVM4,Q60468,Q60506,Q68G95,Q6EH52,Q7JIH3,Q7JIY2,Q7JK02,Q95174,Q95176,Q95211,Q95270,Q95M08,Q9Z0T3">PrP</protein-id> (BSE) accumulation.	hyaluronic acid__PrP__interaction	hyaluronic acid__PNNs__interaction
18789802-1681	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with <compound-id="23978">copper</compound-id> or <compound-id="27284">ferrous ions</compound-id> or by exposure to auto-oxidation products of <compound-id="444899">arachidonic acid</compound-id> for 16h, and <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> was then assayed in medium.	copper__VEGF__no_interaction	arachidonic acid__VEGF__no_interaction	ferrous ions__VEGF__no_interaction
18789953-507	In hypersensitive alpha4L9'A mice, injections of a low dose of <compound-id="942,89594,157672">nicotine</compound-id> (0.1 mg/kg) led to strong c-<protein-id="P01101,P12841,Q56415">fos</protein-id> expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice.	nicotine__fos__interaction
18790021-1764	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of <compound-id="4624">6-hydroxydopamine</compound-id>-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal <protein-id="P21259">neuropeptide</protein-id> precursors, <protein-id="P14748,P48319,Q5IS68,Q99259">GAD67</protein-id>, <protein-id="P45021">cytochrome oxidase subunit I</protein-id>) by quantitative in situ hybridization histochemistry.	6-hydroxydopamine__neuropeptide__interaction	6-hydroxydopamine__cytochrome oxidase subunit I__interaction	6-hydroxydopamine__GAD67__interaction
18790083-1786	Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor <compound-id="6830">GTP</compound-id> and complex Gbeta/Ggamma were identified as "housekeeping" molecules, through which all pathways of <protein-id="P00533,P13387,P55245">EGFR</protein-id> network are cross-talking.	GTP__EGFR__interaction
18790533-1437	These effects were probably associated with the increase of intracellular <compound-id="5359597">superoxide</compound-id> in mitochondrial signaling pathway which attributed to the down-regulation of <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>).	superoxide__superoxide dismutase__interaction	superoxide__SOD__interaction
18790812-2041	This initiates a <compound-id="6076">cAMP</compound-id> signalling cascade resulting in the translocation of <protein-id="O62735,O77697,O77714,O77722,O77740,P41181,P79099,P79144,P79164,P79165,P79168,P79200,P79213,P79229,P79803">AQP2</protein-id>-bearing vesicles to the apical membrane.	cAMP__AQP2__interaction
18790996-2085	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (<protein-id="P0C075,P38182,P87068,Q4P2U6,Q51MW4,Q5KN30,Q5QFG1,Q6BT31,Q6C794,Q6CMF8,Q6FXR8,Q755X2,Q8H715,Q8J282,Q8NJJ4">ATG8</protein-id>) and <protein-id="O94817,P38316,Q3T0W7,Q51P78,Q55S70,Q5AKU4,Q5R7W1,Q69NP0,Q6BU30,Q6BZZ1,Q6CUD5,Q6FMM7,Q75EB4">ATG12</protein-id> proteins to their respective targets, <compound-id="114944">phosphatidylethanolamine</compound-id> and the <protein-id="Q12380,Q3MQ04,Q3MQ24,Q525E4,Q59VY1,Q5K6S9,Q5R792,Q6BVI8,Q6C4Q6,Q6CKE2,Q6FJZ6,Q6ZGL4,Q75BY9,Q9FFI2,Q9H1Y0">ATG5</protein-id> protein.	phosphatidylethanolamine__ATG8__interaction	phosphatidylethanolamine__ATG12__interaction	phosphatidylethanolamine__ATG5__no_interaction
18790996-2086	Levels of Atg transcripts and/or the <protein-id="P0C075,P38182,P87068,Q4P2U6,Q51MW4,Q5KN30,Q5QFG1,Q6BT31,Q6C794,Q6CMF8,Q6FXR8,Q755X2,Q8H715,Q8J282,Q8NJJ4">ATG8</protein-id>-<compound-id="114944">phosphatidylethanolamine</compound-id> adduct increase during leaf senescence and nitrogen and fixed-carbon limitations, indicating that autophagy plays a key role in nutrient remobilization.	phosphatidylethanolamine__ATG8__interaction
18791141-99	This study confirmed QTL previously identified for pH except those on <protein-id="O43315,P12398,Q9BW60">SSC1</protein-id>, 11, 12, and X, and found 11 new 5% genome-wise significant QTL for <compound-id="439177">glycogen</compound-id>-related traits.	glycogen__SSC1__no_interaction
18791145-109	The objective of this study was to examine the effect of level and duration of feeding of an n-3 PUFA-enriched fish oil (<compound-id="46209,69711">FO</compound-id>) supplement in combination with soybean oil (SO) on the transcriptional regulation of <protein-id="O00767,O02858,O62849,O94523,Q12618,Q64420,Q92038,Q95MI7,Q9TT94">Delta(9)-desaturase</protein-id> gene expression in bovine muscle.	FO__Delta(9)-desaturase__interaction
18791154-2132	Whole blood and plasma were analyzed for total Se, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> activity in whole blood (<protein-id="P47236">GPX-1</protein-id>) and plasma, and thyroid hormones (<compound-id="853,5819">thyroxine</compound-id> and <compound-id="861,5920,71212">triiodothyronine</compound-id>) in plasma.	triiodothyronine__glutathione peroxidase__no_interaction	thyroxine__glutathione peroxidase__no_interaction	triiodothyronine__GPX-1__no_interaction	thyroxine__GPX-1__no_interaction
18791496-2222	Studies have shown that administration of <compound-id="5757">17beta-estradiol</compound-id> (estrogen) after trauma-hemorrhage normalized cardiac <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> levels and restored cardiac functions under those conditions.	17beta-estradiol__IL-6__interaction
18791496-2223	Vehicle, the HIF-alpha inhibitor <compound-id="5712">YC-1</compound-id> [<compound-id="5712">3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole</compound-id>, a novel activator of platelet guanylate <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</protein-id>], or estrogen was administered to trauma-hemorrhage and sham groups during resuscitation.	3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole__cyclase__interaction	YC-1__cyclase__interaction
18791811-2349	Chemopreventive potential of <compound-id="445154">resveratrol</compound-id> in mouse skin tumors through regulation of mitochondrial and <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>/AKT signaling pathways.	resveratrol__PI3K__interaction
18791821-2351	<compound-id="41867">Epirubicin</compound-id> plus low-dose trastuzumab in <protein-id="P04626">HER2</protein-id> positive metastatic breast cancer.	Epirubicin__HER2__no_interaction
18791821-2352	This phase II study, evaluated the activity and cardiotoxicity of first-line <compound-id="41867">epirubicin</compound-id> plus low-dose trastuzumab (LD-T) in patients with <protein-id="P04626">HER2</protein-id> positive MBC.	epirubicin__HER2__no_interaction
18791856-2363	The roles of endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>), and its putative association with <protein-id="P31749,P31750,P47196,Q01314,Q8INB9">protein kinase B</protein-id> (<protein-id="P31749,P31750,P47196,Q01314,Q8INB9">PKB</protein-id>), and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) are not well characterized in hypoxic cardiac cells and there is a lack of studies that measure <compound-id="145068">nitric oxide</compound-id> (NO) directly.	nitric oxide__PKB__no_interaction	nitric oxide__protein kinase B__no_interaction	nitric oxide__eNOS__no_interaction	nitric oxide__nitric oxide synthase__no_interaction	nitric oxide__iNOS__no_interaction
18791914-2380	The DEP-induced increases in peribronchial eosinophils and mucous goblet cells in the lung tissues, and of <protein-id="O02699,O08987,O77515,P04401,P05113,P46685,P48093,P52173,Q08125,Q28586,Q62575,Q95J76,Q9ESI9,Q9XT91">IL-5</protein-id> and <protein-id="P20109,P35225,P42203,P61126,Q5I6E4,Q864V6,Q865W5,Q865X3,Q95J68,Q9N0W9,Q9XSV9">IL-13</protein-id> in the BAL fluid, were significantly attenuated by the antioxidant <compound-id="12035">N-acetylcysteine</compound-id>.	N-acetylcysteine__IL-5__interaction	N-acetylcysteine__IL-13__interaction
18792056-2438	Each of the developed consortium has a <compound-id="1061,167704,644102">phosphate</compound-id> solubilizer, <compound-id="947,123329">nitrogen</compound-id> fixer, <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id> producer, heterotrophic member and an antagonist.	nitrogen__growth hormone__no_interaction	phosphate__growth hormone__no_interaction
18792785-89	Using cannabinoid receptor antagonists and cannabinoid receptor gene deficient mice (CB(1) (-/-) and CB(2) (-/-)), we showed that both CB(1) and CB(2) receptors were involved in the <compound-id="134740">THC</compound-id>-induced attenuation of serum IL-12 and <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFNgamma</protein-id>.	THC__IFNgamma__no_interaction
18792801-694	Promoter analysis of the <protein-id="P11464">PSG1</protein-id>, 4, and 11 genes in HeLa cells did not reveal a cis-regulatory element responsive to <compound-id="6035">5-bromodeoxyuridine</compound-id> in their 5'-flanking sequences.	5-bromodeoxyuridine__PSG1__no_interaction
18792915-162	<protein-id="O62618">p38-MAPK</protein-id>- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by <compound-id="444795">retinoic acid</compound-id>.	retinoic acid__p38-MAPK__interaction
18793216-256	In vivo administration of a synthetic phospholipid, named hereafter phospho-ceramide analogue-1 (PCERA-1), was previously found to suppress <compound-id="11970143">lipopolysaccharide</compound-id> (LPS)-induced <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> blood levels.	lipopolysaccharide__TNF-alpha__interaction
18793216-258	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of <compound-id="6076">cAMP</compound-id> production, and eventually <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> suppression and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> induction.	cAMP__IL-10__no_interaction	cAMP__TNF-alpha__no_interaction
18793341-327	Acylated <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> and <protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id> , <protein-id="P28172,P51526">IFN</protein-id> , IL-1 and <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> were measured with <compound-id="636403">bioplex</compound-id>.	bioplex__IFN__interaction	bioplex__TNF__interaction	bioplex__ghrelin__interaction	bioplex__IL-6__interaction
18793347-2512	Pre-gravid physical activity and reduced risk of <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance in pregnancy : the role of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity.	glucose__insulin__interaction
18793347-2513	Thus, we sought to study the relationships between types of pre-gravid physical activity and metabolic parameters in pregnancy, including <compound-id="206,5793,64689,79025">glucose</compound-id> tolerance, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity and beta-cell function.	glucose__insulin__no_interaction
18793351-330	Inhibition of autophagy by treating rats with <compound-id="312145">Wortmannin</compound-id> (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of <protein-id="P82160">LC3</protein-id>-II, <protein-id="O88597,Q14457,Q4A1L4,Q4A1L5">Beclin-1</protein-id>, <protein-id="Q60739,Q99933">BAG-1</protein-id> and cardioprotection.	Wortmannin__LC3__interaction	Wortmannin__BAG-1__interaction	Wortmannin__Beclin-1__interaction
18793654-448	Mutations within the glycine-binding site of the GlyR <protein-id="Q08398">alpha1</protein-id> subunit reduced the inhibitory potency of Cu2+ and led to an up to 4-fold potentiation of <compound-id="750">glycine</compound-id>-elicited currents by Cu2+.	glycine__alpha1__interaction
18793694-459	When myosin molecules work as an aggregate, the sliding movement of a myosin filament driven by the power strokes of some myosin heads makes other myosin heads that have completed their power strokes detach from the <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> without consuming <compound-id="5957">ATP</compound-id>.	ATP__actin__no_interaction
18793694-460	A critical requirement for this mechanism is that <compound-id="5957">ATP</compound-id> must preferentially facilitate the detachment of myosins that have completed their power strokes, but are still strongly attached to the <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id>.	ATP__actin__no_interaction
18793801-496	Urinary <protein-id="P54802">NAG</protein-id> (N-acetyl-beta-glucosaminidase), a kidney function test, blood <compound-id="206,5793,64689,79025">glucose</compound-id>, triglyceride, <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, high density lipid and low density lipid were measured.	cholesterol__NAG__no_interaction	glucose__NAG__no_interaction
18794178-604	Efficacy, safety and patient-reported outcomes of combination <protein-id="P20333">etanercept</protein-id> and <compound-id="5353980,5359476,5384001">sulfasalazine</compound-id> versus <protein-id="P20333">etanercept</protein-id> alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.	sulfasalazine__etanercept__no_interaction
18794178-605	To determine the efficacy and safety of <protein-id="P20333">etanercept</protein-id> and <protein-id="P20333">etanercept</protein-id> plus <compound-id="5353980,5359476,5384001">sulfasalazine</compound-id> versus <compound-id="5353980,5359476,5384001">sulfasalazine</compound-id> in patients with rheumatoid arthritis (RA) despite <compound-id="5353980,5359476,5384001">sulfasalazine</compound-id> therapy.	sulfasalazine__etanercept__no_interaction
18794865-1914	A randomized trial of <compound-id="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217">etoposide</compound-id> and <protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id> with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.	etoposide__G-CSF__no_interaction
18794865-1915	Twenty seven patients were mobilized with <compound-id="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217">etoposide</compound-id> and <protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id> and 28 with <compound-id="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217">etoposide</compound-id>, <protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id> and rituximab.	etoposide__G-CSF__no_interaction
18795231-893	Aberrant methylation of the <protein-id="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8">MGMT</protein-id> (O6-methylguanine-DNA <protein-id="O40976,P03588,P03589,P06011,P17769,P20122,P27752,P28726,P28931,Q00020,Q66121,Q83264,Q83270">methyltransferase</protein-id>) DNA-repair gene is a predictive marker for the response to chemotherapy with alkylating agents (e.g., <compound-id="5394">temozolomide</compound-id>) in malignant gliomas.	temozolomide__methyltransferase__interaction	temozolomide__MGMT__interaction
18795240-896	This work describes the influence of two polar lipids, Sn-1/3 and Sn-<compound-id="123409">2 monopalmitin</compound-id>, on the activity of <protein-id="Q7M4U7">lipase</protein-id> in biphasic systems and in microemulsions.	2 monopalmitin__lipase__interaction
18795240-897	In previous communications, we have shown that Sn-<compound-id="17756737">2 monoglycerides</compound-id> can replace Sn-1,3 regiospecific <protein-id="Q7M4U7">lipases</protein-id> at the oil-water interface, causing a drastically reduced rate of lipolysis.	2 monoglycerides__lipases__interaction
18795263-905	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on <compound-id="1032">propionate</compound-id> plus <compound-id="444972">fumarate</compound-id> significantly, although the specific activities of <protein-id="P80509,P80510">hydrogenase</protein-id> and especially <protein-id="P33160,P33677,Q07103">formate dehydrogenase</protein-id> were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	propionate__hydrogenase__no_interaction	propionate__formate dehydrogenase__no_interaction	fumarate__hydrogenase__no_interaction	fumarate__formate dehydrogenase__no_interaction
18795263-906	Our results suggest a more prominent role for H2 as electron carrier in the syntrophic conversion of <compound-id="1032">propionate</compound-id>, when the essential trace metals W and Mo for the functioning of <protein-id="P33160,P33677,Q07103">formate dehydrogenase</protein-id> are depleted.	propionate__formate dehydrogenase__interaction
18795264-907	Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (<protein-id="P35372,P79350,P97266,Q5IS39,Q5IS84,Q95247,Q95M54,Q9MYW9">OPRM1</protein-id>) and response to <compound-id="5360515">naltrexone</compound-id> treatment.	naltrexone__OPRM1__interaction
18795290-925	Based on the preclinical evidence of <protein-id="O29238,O51934,O58530,O67037,O67226,P74759,P95479,Q08582,Q58907,Q6F598,Q8R979,Q8ZXT5,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9UZ86,Q9YC75,Q9YCB6">topoisomerase</protein-id> I (Topo-1) upregulation by <compound-id="5746">mitomycin C</compound-id> (MMC) and decreased NF-kappaB activation by celecoxib, we evaluated combinations of irinotecan/MMC and irinotecan/MMC/celecoxib in patients with advanced solid malignancies.	mitomycin C__topoisomerase__interaction
18795320-932	The cells expressed <protein-id="P29972,P29975,P47865,P53386,P56401,P61837,P61838,Q02013,Q5R819,Q6PQZ1,Q9N2J4">aquaporin-1</protein-id> sensitive to <compound-id="24182">HgCl</compound-id> (2) and decreased by siRNA, which both reduced fast volume changes.	HgCl__aquaporin-1__interaction
18795889-1063	Two conserved <compound-id="857,6106,439524">leucine</compound-id> repeats within the COMM domain were found to be critically required for <protein-id="P98170">XIAP</protein-id> binding.	leucine__XIAP__interaction
18795892-1064	Functional analysis of rat liver <protein-id="P0AE74,P0AE75">citrate carrier</protein-id> promoter: differential responsiveness to <compound-id="56842239">polyunsaturated fatty acids</compound-id>.	polyunsaturated fatty acids__citrate carrier__interaction
18795918-1074	Wet-wrap treatment using dilutions of <compound-id="5372,445643,445647,6426916,6436007,6473866,6536850,9940643,23581796,54611630">tacrolimus</compound-id> ointment and <compound-id="444036">fluticasone propionate</compound-id> cream in human <protein-id="P02654,P18657,P33047,P34929,P56595,Q9XSN5">APOC1</protein-id> (+/+) mice with atopic dermatitis.	tacrolimus__APOC1__no_interaction	fluticasone propionate__APOC1__no_interaction
18795969-1090	The use of low-dose COCs is preferable in PCOS, especially among patients with <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and uncomplicated diabetes mellitus.	glucose__insulin__no_interaction
18796314-1192	Due to its faculty to protect <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</protein-id> (ChE) activity against irreversible inactivation by OP, <compound-id="4991">pyridostigmine bromide</compound-id> (PB) was used as a prophylaxis treatment during the first Persian Gulf War.	pyridostigmine bromide__cholinesterase__no_interaction
18796403-1220	Mice lacking Niemann-Pick C1-Like 1 (<protein-id="Q9UHC9">NPC1L1</protein-id>) (<protein-id="Q9UHC9">NPC1L1</protein-id> (-/-)mice) exhibit a defect in intestinal absorption of cholesterol and <compound-id="12303662">phytosterols</compound-id>.	phytosterols__NPC1L1__interaction
18796403-1222	In this study, we examined the role of <protein-id="Q9UHC9">NPC1L1</protein-id> in <compound-id="222284,457801">phytosterol</compound-id> and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).	phytosterol__NPC1L1__interaction
18796403-1223	We found that mice lacking <protein-id="Q9H222">ABCG5</protein-id>/G8 and <protein-id="Q9UHC9">NPC1L1</protein-id> [triple knockout (TKO) mice] did not accumulate <compound-id="12303662">phytosterols</compound-id> in plasma and the liver.	phytosterols__NPC1L1__interaction	phytosterols__ABCG5__interaction
18796403-1224	In conclusion, <protein-id="Q9UHC9">NPC1L1</protein-id> is essential for <compound-id="12303662">phytosterols</compound-id> to enter the body in mice.	phytosterols__NPC1L1__interaction
18796561-1268	The slow BSO-induced <compound-id="124886">GSH</compound-id> depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a <protein-id="P23061,P38644,P83939,Q05894,Q28618,Q43731">p50</protein-id>-<protein-id="P23061,P38644,P83939,Q05894,Q28618,Q43731">p50</protein-id> homodimer.	GSH__p50__no_interaction
18796623-1276	In contrast, Notch-signaling inhibition by the <compound-id="16760646">gamma-secretase inhibitor I</compound-id> (GSI ; z-Leu-Leu-Nle-CHO) and the specific <protein-id="O35516,Q9QW30">Notch2</protein-id> down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis.	gamma-secretase inhibitor I__Notch2__no_interaction
18797825-1625	Effects of exhaustion and calcium supplementation on <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> and <compound-id="5754">cortisol</compound-id> levels in athletes.	cortisol__adrenocorticotropic hormone__no_interaction
18797825-1626	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on <compound-id="5754">cortisol</compound-id> and <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> levels in athletes at rest and exhaustion.	cortisol__adrenocorticotropic hormone__no_interaction
18797825-1627	One-month supplementation with calcium does not influence the <compound-id="5754">cortisol</compound-id> and <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> 0.05).	cortisol__adrenocorticotropic hormone__no_interaction
18797870-1649	Effects of nonspecific targeting of <protein-id="P36888">FLT3</protein-id> were evaluated with addition of imatinib (<compound-id="5291">Gleevec</compound-id>) to cell cultures.	Gleevec__FLT3__no_interaction
18797914-1664	In the pericentral necrotic zone after <compound-id="5943">CCl4</compound-id>-treatment, no induction of <protein-id="P01830,P01831">Thy-1</protein-id> was found.	CCl4__Thy-1__no_interaction
18797943-1672	Sixty-one percent of the isolates were <protein-id="P80298,P80545,P81173">beta-lactamase</protein-id> producers, which explains the poor activity of <compound-id="5904">penicillin</compound-id>.	penicillin__beta-lactamase__interaction
18798087-1724	Since the discovery of <compound-id="5280754,5284373,5497195,6435893,24883466,25246316">cyclosporine</compound-id> in 1971, <protein-id="O88480,Q9Y6J0">calcineurin inhibitors</protein-id> have played a critical role in the therapeutic suppression of the immune response.	cyclosporine__calcineurin inhibitors__interaction
18798087-1725	With the introduction of <compound-id="5372,445643,445647,6426916,6436007,6473866,6536850,9940643,23581796,54611630">tacrolimus</compound-id>, a more potent <protein-id="O88480,Q9Y6J0">calcineurin inhibitor</protein-id>, clinical outcomes of transplants have continued to improve; however, little improvement has been noted in lung transplantation.	tacrolimus__calcineurin inhibitor__interaction
18798281-1790	In contrast, chelating intracellular calcium ([<compound-id="271">Ca(2</compound-id>+)](i)) by <compound-id="2293">BAPTA-AM</compound-id> abolished <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>-mediated Arc up-regulation.	BAPTA-AM__BDNF__interaction	Ca(2__BDNF__interaction
18798281-1791	These data suggested novel functions of [<compound-id="271">Ca(2</compound-id>+)](i) and <protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">CaM</protein-id> in <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> signaling.	Ca(2__BDNF__interaction	Ca(2__CaM__interaction
18798281-1792	Comparison of the Arc transcription profiles between <compound-id="271">Ca(2</compound-id>+)-stimulated and <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>-stimulated neurons demonstrated that the regulatory mechanisms were distinctively tailored to the complex features of neuronal activity.	Ca(2__BDNF__no_interaction
18798567-1853	Bark of elderberry (Sambucus nigra) contains a <compound-id="6036,439353,439357">galactose</compound-id> (Gal)/<compound-id="899,35717,84265,439174">N-acetylgalactosamine</compound-id> (<compound-id="35717,84265">GalNAc</compound-id>)-specific <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II <protein-id="P10297,P21326,P23339,P24475,P24476,P24477,P80750,Q03464,Q40772">ribosome-inactivating protein</protein-id> (Type-II <protein-id="P24817,P52594,P56626,Q13546,Q2TA45,Q86UA6">RIPs</protein-id>, SNA-V), found in the same species.	galactose__RIPs__no_interaction	N-acetylgalactosamine__lectin__interaction	galactose__lectin__interaction	GalNAc__lectin__interaction	galactose__ribosome-inactivating protein__no_interaction	N-acetylgalactosamine__ribosome-inactivating protein__no_interaction	N-acetylgalactosamine__RIPs__no_interaction	GalNAc__RIPs__no_interaction	GalNAc__ribosome-inactivating protein__no_interaction
18798730-1896	Infusion of each receptor antagonist alone similarly reduced basal unstressed volume and blood flow in <protein-id="Q9P8W3">ACEI</protein-id>-treated CHF patients, but not in healthy volunteers or <compound-id="439764">ARB</compound-id>-treated CHF patients.	ARB__ACEI__no_interaction
18798730-1897	In <compound-id="439764">ARB</compound-id>-treated heart failure, venous responses to <protein-id="O08677,P01042,P01044,P01045,P08934,P83055,P83060,P83856,P83857,P84697,P84825,P84895,Q7T3L1,Q90W88,Q90WZ1">bradykinin</protein-id> are preserved but arterial responses are reduced compared with healthy controls.	ARB__bradykinin__no_interaction
18798833-1679	Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-<compound-id="5950">polyalanine</compound-id> repeat expansion mutation in the <protein-id="Q99453">PHOX2B</protein-id> gene.	polyalanine__PHOX2B__interaction
18798833-1680	to describe a family with later onset congenital central hypoventilation syndrome (LO-CCHS) and heterozygosity for a 24-<compound-id="5950">polyalanine</compound-id> repeat expansion mutation in the <protein-id="Q99453">PHOX2B</protein-id> gene, rendered phenotypically apparent with exposure to anesthetics.	polyalanine__PHOX2B__interaction
18798864-1974	Effects of <compound-id="5035">raloxifene</compound-id> on breast cancer cell migration and invasion through the <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> cytoskeleton.	raloxifene__actin__interaction
18798867-1982	High <compound-id="206,5793,64689,79025">glucose</compound-id> attenuates <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> expression in rat multipotent adult progenitor cells in association with inhibition of <protein-id="O60674">JAK2</protein-id>/<protein-id="P40763,P61635">STAT3</protein-id> signalling.	glucose__STAT3__interaction	glucose__JAK2__interaction	glucose__VEGF__interaction
18798867-1983	This study was to investigate the effect of high <compound-id="206,5793,64689,79025">glucose</compound-id> (<compound-id="23931">HG</compound-id>) on vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>) expression in bone marrow stem cells and <protein-id="O60674">JAK2</protein-id>/<protein-id="P08457,P35610,Q7QDU4">STAT</protein-id>-3 signalling.	glucose__STAT__interaction	glucose__JAK2__interaction	HG__VEGF__interaction	HG__JAK2__interaction	HG__STAT__interaction	glucose__VEGF__interaction
18798873-1986	In this study, a calcineurin B-like (<protein-id="P06721,P0A4K2,P0A4K3,P18949,P22681,P23256,P43623,P44527,P53101,P53780,Q07703,Q52811">CBL</protein-id>)-interacting <protein-id="P00513,P25848">protein kinase</protein-id> (CIPK) gene, CIPK8, was found to be involved in early <compound-id="943">nitrate</compound-id> signaling.	nitrate__CBL__no_interaction	nitrate__protein kinase__interaction
18798873-1988	Taken together, our results indicate that <protein-id="P06721,P0A4K2,P0A4K3,P18949,P22681,P23256,P43623,P44527,P53101,P53780,Q07703,Q52811">CBL</protein-id>-CIPK networks are responsible not only for stress responses and potassium shortage, but also for <compound-id="943">nitrate</compound-id> sensing.	nitrate__CBL__interaction
18799187-2083	Hepatic stellate cell activation in focal nodular hyperplasia with a central scar was accompanied by the expression of <compound-id="73318">8-hydroxy-2'-deoxyguanosine</compound-id> and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> in the liver.	8-hydroxy-2'-deoxyguanosine__nitric oxide synthase__no_interaction
18799187-2084	Expression of <compound-id="73318">8-hydroxy-2'-deoxyguanosine</compound-id> and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> was rarely seen in focal nodular hyperplasia without a central scar, focal nodular hyperplasia-like nodules, or nodular regenerative hyperplasia.	8-hydroxy-2'-deoxyguanosine__nitric oxide synthase__no_interaction
18799201-2087	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for <compound-id="5202">serotonin</compound-id> (<compound-id="5202">5-HT</compound-id>), <compound-id="16129681,16129706">somatostatin</compound-id> (D cells), <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id>, <protein-id="O18811,O18845,O46617,O62820,P01307,P12872,P19863,P27114,Q99MP5,Q9PRP6,Q9XSE2">motilin</protein-id>, polypeptide YY (<protein-id="P09641,P10082,P10631,P29203,P29204,P29205,P29206,P48098,P51694,P68004,P68005,P69092,P69093,P69094,P69095,P69096,P81028,Q76CL2,Q9EPS2,Q9PT99,Q9TR93">PYY</protein-id>) and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>.	somatostatin__PYY__no_interaction	serotonin__glucagon__no_interaction	5-HT__insulin__no_interaction	serotonin__motilin__no_interaction	5-HT__motilin__no_interaction	somatostatin__glucagon__no_interaction	serotonin__insulin__no_interaction	serotonin__PYY__no_interaction	5-HT__glucagon__no_interaction	somatostatin__insulin__no_interaction	5-HT__PYY__no_interaction	somatostatin__motilin__no_interaction
18799201-2088	In the gizzard, endocrine cells secreting <compound-id="16129681,16129706">somatostatin</compound-id>, <compound-id="5202">5-HT</compound-id> and <protein-id="P09641,P10082,P10631,P29203,P29204,P29205,P29206,P48098,P51694,P68004,P68005,P69092,P69093,P69094,P69095,P69096,P81028,Q76CL2,Q9EPS2,Q9PT99,Q9TR93">PYY</protein-id> were detected, while those secreting <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> were not.	somatostatin__PYY__no_interaction	5-HT__insulin__no_interaction	somatostatin__glucagon__no_interaction	5-HT__glucagon__no_interaction	5-HT__PYY__no_interaction	somatostatin__insulin__no_interaction
18799201-2089	In the final part of the gizzard, endocrine cells secreting <compound-id="5202">5-HT</compound-id> were more frequent, and cells secreting <compound-id="16129681,16129706">somatostatin</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> were not detected.	5-HT__insulin__no_interaction	somatostatin__insulin__no_interaction
18799634-2193	Cell fractionation by <compound-id="5988">sucrose</compound-id> gradient and differential centrifugation demonstrated that in bradykinin-stimulated cells, <protein-id="Q96QT4">TRPM7</protein-id> localized in fractions corresponding to caveolae.	sucrose__TRPM7__no_interaction
18799753-2260	However, there are conflicting data regarding the role of Gpr30 as an <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> (ER): several laboratories were unable to demonstrate <compound-id="5757">estradiol</compound-id> binding to GPR30 or <compound-id="5757">estradiol</compound-id>-activated signal transduction in Gpr30-expressing cells.	estradiol__estrogen receptor__no_interaction
18799753-2261	Our data demonstrate that in vivo <protein-id="O08878,Q8BMP4">Gpr30</protein-id> is dispensable for the mediation of <compound-id="5757">estradiol</compound-id> effects in reproductive organs.	estradiol__Gpr30__interaction
18799757-2262	<compound-id="5780">Sorbitol</compound-id> can fuel mouse sperm motility and protein <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation via <protein-id="P07846,P27867,Q00796,Q02912,Q06004,Q29318,Q4R639,Q58D31,Q59787,Q64442,Q9Z9U1">sorbitol dehydrogenase</protein-id>.	tyrosine__sorbitol dehydrogenase__interaction	Sorbitol__sorbitol dehydrogenase__interaction
18799757-2263	Here we characterize <protein-id="P27867,Q64442">Sord</protein-id> mRNA and <protein-id="P07846,Q00796,Q29318,Q4R639,Q58D31">SORD</protein-id> expression during mouse spermatogenesis and examine the ability of <compound-id="5780">sorbitol</compound-id> to support epididymal sperm motility and <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation.	sorbitol__Sord__no_interaction	sorbitol__SORD__no_interaction	tyrosine__SORD__no_interaction	tyrosine__Sord__no_interaction
18800037-1366	Increase in <compound-id="5212">sildenafil</compound-id> clearance in the early postnatal period likely reflects maturation of <protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id>-mediated N-demethylation.	sildenafil__CYP__interaction
18800064-2365	<compound-id="2995">Desipramine</compound-id> modulation of alpha-, <protein-id="O76070,Q2PFW6,Q63544,Q9NZ50,Q9Z0F7">gamma-synuclein</protein-id>, and the <protein-id="O55192,P23975,P51143">norepinephrine transporter</protein-id> in an animal model of depression.	Desipramine__gamma-synuclein__interaction	Desipramine__norepinephrine transporter__interaction
18800064-2366	The <protein-id="O55192,P23975,P41970,P51143,P54762">NET</protein-id>-selective antidepressant <compound-id="2995">desipramine</compound-id> (DMI) was chronically administered for 14 days to WKY rats and the strain from which it was outbred that does not show depressive-like behavior, the Wistar rat.	desipramine__NET__interaction
18800198-2413	The present study was designed to evaluate the impact of zinc status before burn on the recovery of injury with focus on plasma <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id> levels.	glucose__insulin__no_interaction
18800198-2414	Blood and tissue samples were collected 3, 6, and 24 h after injury in order to study biochemical parameters and the <compound-id="206,5793,64689,79025">glucose</compound-id>/<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> response in relation with the zinc status.	glucose__insulin__no_interaction
18800198-2415	In addition, the burn-induced <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, leading to protein catabolism, was emphasized, with higher plasma <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, <compound-id="206,5793,64689,79025">glucose</compound-id>, and <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> levels in zinc-deficient animals versus normal-fed rats.	glucose__leptin__no_interaction	glucose__insulin__no_interaction
18800204-2418	methoxyphenoxy)benzyl) <compound-id="8083">morpholine</compound-id>) is a positron emission tomography (PET) radioligand recently applied in clinical studies of <protein-id="O55192,P23975,P51143">norepinephrine transporters</protein-id> (<protein-id="O55192,P23975,P41970,P51143,P54762">NETs</protein-id>) in the human brain in vivo.	morpholine__NETs__interaction	morpholine__norepinephrine transporters__interaction
18800231-631	The most predictive model of <protein-id="P01588,P07865,P11678,P33707,P33708,P33709,P48617,P49157,P49290,P80550,Q28513,Q6H8S9,Q6H8T1,Q6H8T2,Q867B1,Q9GKA2">EPO</protein-id> response for the pediatric cohort had, as the major variables, <compound-id="1176,265993">urea</compound-id> clearance x dialysis duration/total body water (Kt/V), <compound-id="1176,265993">urea</compound-id> reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and <compound-id="6037">folate</compound-id> deficiencies as the dominant variables.	urea__EPO__interaction	folate__EPO__interaction
18800231-632	In summary <protein-id="P01588,P07865,P11678,P33707,P33708,P33709,P48617,P49157,P49290,P80550,Q28513,Q6H8S9,Q6H8T1,Q6H8T2,Q867B1,Q9GKA2">EPO</protein-id> resistance in the pediatric dialysis cohort was predicted by nutritional deficits, inflammation, poor dialysis, and hyperparathyroidism, while iron and <compound-id="6037">folate</compound-id> deficits were the major determinants in adults.	folate__EPO__interaction
18800270-2444	<protein-id="O14463,O17486,O22022,O30974,O51088,O51890,O83889,O84544,O96952,O97508,O97680,P00276,P08058,P08628,P08629,P09857,P0A0K4,P0A0K5,P0A0K6,P0A4L3,P0A4L4,P0A616,P0A617,P10472,P10473,P10599,P10639,P11232,P14930,P14949,P21609,P21610,P29429,P29451,P33791,P34723,P37395,P42115,P43785,P46843,P47370,P50254,P50338,P50413,P51225,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P82460,P96132,P99122,P99505,Q05739,Q57755,Q5HGT9,Q5HQ29,Q5R9M3,Q6GA69,Q6GHU0,Q7KQL8,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q98TX1,Q9BDJ3,Q9CM49,Q9DGI3,Q9JWM8,Q9K1N8,Q9PJK3,Q9R6P9,Q9UW02,Q9X2T1,Q9Z7P5,Q9ZEE0">Thioredoxin</protein-id> (<protein-id="O17486,O30974,O51088,O51890,O83889,O84544,P08058,P09857,P0A0K4,P0A0K5,P0A0K6,P0A616,P0A617,P0AA25,P0AA26,P0AA27,P0AA28,P0AA29,P0AA30,P10472,P10473,P10599,P14949,P21609,P21610,P33791,P43785,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P96132,P99122,Q05739,Q5HGT9,Q5HQ29,Q6GA69,Q6GHU0,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q9BDJ3,Q9CM49,Q9DGI3,Q9PJK3,Q9X2T1,Q9Z7P5,Q9ZEE0">TRX</protein-id>) is a redox protein that scavenges reactive <compound-id="977">oxygen</compound-id> species (ROS).	oxygen__TRX__interaction	oxygen__Thioredoxin__interaction
18800351-2001	<compound-id="16315">Diallyl trisulfide</compound-id> selectively causes <protein-id="P27297,Q07813,Q63690">Bax</protein-id>- and <protein-id="O08734">Bak</protein-id>-mediated apoptosis in human lung cancer cells.	Diallyl trisulfide__Bak__interaction	Diallyl trisulfide__Bax__interaction
18800351-2002	The <compound-id="75552">DATS</compound-id>-mediated G2-M phase cell cycle arrest was explained by down-regulation of <protein-id="P06493,P11440,P13863,P39951,P48734,P51958,Q5RCH1,Q9DG98,Q9DGA2,Q9DGA5,Q9DGD3">cyclin-dependent kinase 1</protein-id> (<protein-id="P34556">Cdk1</protein-id>) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) <protein-id="P34556">Cdk1</protein-id>.	DATS__Cdk1__interaction	DATS__cyclin-dependent kinase 1__interaction
18800351-2003	Knockdown of <protein-id="P27297,Q07813,Q63690">Bax</protein-id> and <protein-id="O08734">Bak</protein-id> proteins conferred significant protection against <compound-id="75552">DATS</compound-id>-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	DATS__Bak__interaction	DATS__Bax__interaction
18800985-2514	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated <compound-id="597">cytosine</compound-id> <compound-id="764">guanine</compound-id> motifs (<compound-id="6804">CpG</compound-id>) are able to stimulate, in the presence of <protein-id="Q9TTB0">interferon-gamma</protein-id> (<protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id>), both <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id> and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) in murine Mphi.	guanine__iNOS__interaction	guanine__IFN-gamma__interaction	cytosine__interferon-gamma__interaction	cytosine__nitric oxide synthase__interaction	CpG__IFN-gamma__interaction	CpG__arginase__interaction	guanine__interferon-gamma__interaction	CpG__interferon-gamma__interaction	cytosine__arginase__interaction	guanine__arginase__interaction	CpG__nitric oxide synthase__interaction	guanine__nitric oxide synthase__interaction	cytosine__iNOS__interaction	cytosine__IFN-gamma__interaction	CpG__iNOS__interaction
18800985-2515	A significant increase in <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id> activity was observed upon a short pre-incubation (1 hr) with <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> and subsequent <compound-id="6804">CpG</compound-id> stimulation.	CpG__arginase__interaction	CpG__IFN-gamma__no_interaction
18800985-2516	Therefore, a very interesting observation of this study was that the <compound-id="6804">CpG</compound-id>-mediated <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id> activity is dependent on <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> priming.	CpG__IFN-gamma__interaction	CpG__arginase__interaction
18800985-2517	This report reveals a singular effect of the combination of <compound-id="6804">CpG</compound-id> and <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id>, one of the mayor cytokines produced in response to <compound-id="6804">CpG</compound-id> administration in vivo.	CpG__IFN-gamma__interaction
18801207-197	<compound-id="5321439,5468522">Bakuchiol</compound-id> has a three-fold higher binding affinity for <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> than for <protein-id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ERbeta</protein-id>.	Bakuchiol__ERbeta__interaction	Bakuchiol__ERalpha__interaction
18801387-245	While rtTA mRNA levels were high in developmental and adult tissues, <protein-id="P06956,P16961">Cre</protein-id> <protein-id="P22877">recombinase</protein-id> mRNA levels remained low after <compound-id="54671203">doxycycline</compound-id> treatment.	doxycycline__recombinase__interaction	doxycycline__Cre__interaction
18801483-309	In the present study, we examined the effect of <compound-id="3475">gliclazide</compound-id>, a second generation <compound-id="104818">sulfonylurea</compound-id> with antioxidant properties, on <protein-id="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8">LOX-1</protein-id> expression and <protein-id="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8">LOX-1</protein-id>-mediated <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id> expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	sulfonylurea__MMP-9__no_interaction	gliclazide__MMP-9__interaction	gliclazide__LOX-1__interaction	sulfonylurea__LOX-1__no_interaction
18801573-338	The phenolics: <compound-id="145858">anthocyanin</compound-id> (ATH), sinapoyl esters and activity of antioxidant enzymes: <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), guaiacol <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="P07003,P37063,P92983,Q54970">POX</protein-id>), ascorbate <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="P27695,Q01613,Q42564">APX</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (<protein-id="O77834,P83564,Q00277">GPX</protein-id>) and <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	anthocyanin__POX__no_interaction	anthocyanin__catalase__no_interaction	anthocyanin__CAT__no_interaction	anthocyanin__GPX__no_interaction	anthocyanin__glutathione reductase__no_interaction	anthocyanin__glutathione peroxidase__no_interaction	anthocyanin__SOD__no_interaction	anthocyanin__APX__no_interaction	anthocyanin__superoxide dismutase__no_interaction	anthocyanin__peroxidase__no_interaction
18801573-339	It could results from the fact that phenolic compounds (<compound-id="444567">PhC</compound-id>), which could be also substrates for different <protein-id="P15984,P16147,P84714">peroxidases</protein-id>, were the first line of defence against metal stress.	PhC__peroxidases__interaction
18801652-367	The affinity characteristics of developed immunosensors were investigated in reaction with <compound-id="445434,6437057">microcystin-LR</compound-id>, and <protein-id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</protein-id>.	microcystin-LR__PSA__no_interaction
18801652-368	The detection limit for <compound-id="445434,6437057">microcystin-LR</compound-id> was 10 ngmL(-1) and for <protein-id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</protein-id> 0.01 ngmL(-1).	microcystin-LR__PSA__no_interaction
18801682-382	This was achieved by (1) direct comparison of the sensitivity of <protein-id="P55926,P78348,Q7T1N4">ASIC1</protein-id>, <protein-id="Q16515">ASIC2</protein-id>, <protein-id="O35240,Q6X1Y6,Q9UHC3">ASIC3</protein-id> and <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or <compound-id="712">formalin</compound-id>.	formalin__ASIC3__no_interaction	formalin__ASIC2__no_interaction	formalin__ASIC1__no_interaction	formalin__TRPV1__no_interaction
18801682-383	Following <compound-id="712">formalin</compound-id> injection, <protein-id="P55926,P78348,Q7T1N4">ASIC1</protein-id> (-/-) and <protein-id="Q16515">ASIC2</protein-id> (-/-), but not <protein-id="O35240,Q6X1Y6,Q9UHC3">ASIC3</protein-id> (-/-) or <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	formalin__ASIC3__no_interaction	formalin__ASIC2__interaction	formalin__TRPV1__no_interaction	formalin__ASIC1__interaction
18801894-463	The biochemical parameters studied are: albumin (<protein-id="O35090,P02768,P02769,P08835,P14639,P19121,P21847,P35747,P49064,P49065,P49822,Q28522,Q5XLE4">ALB</protein-id>), alanine aminotransferase (ALT), amylase (<protein-id="Q9BXS0">AMY</protein-id>), total <compound-id="5280352">bilirubin</compound-id> (TBI), blood urea nitrogen (BUN), <compound-id="588">creatinine</compound-id> (CRE), <compound-id="206,5793,64689,79025">glucose</compound-id>, globulin, total proteins (TP), and the ions calcium, <compound-id="24404,139579">phosphorus</compound-id>, sodium, and potassium.	bilirubin__AMY__no_interaction	phosphorus__AMY__no_interaction	bilirubin__ALB__no_interaction	phosphorus__ALB__no_interaction	creatinine__AMY__no_interaction	glucose__ALB__no_interaction	creatinine__ALB__no_interaction	glucose__AMY__no_interaction
18801899-465	In addition, serum levels of <compound-id="206,5793,64689,79025">glucose</compound-id>, adiponectin, and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> were measured.	glucose__insulin__no_interaction
18801899-466	In addition, <compound-id="6083">adenosine monophosphate</compound-id>-activated <protein-id="P00513,P25848">protein kinase</protein-id> levels were high during fasting and low during HF diet.	adenosine monophosphate__protein kinase__interaction
18801901-901	This action of <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> was abolished by SB 212090 but not by <compound-id="312145">wortmannin</compound-id>.	wortmannin__IGF-I__no_interaction
18801905-473	After 7 d central <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> treatment, the total content of <compound-id="5283565">ceramides</compound-id> was analyzed by quantitative shotgun lipidomics mass spectrometry.	ceramides__leptin__no_interaction
18801908-476	Previously we have shown that <compound-id="77999">rosiglitazone</compound-id> has antiinflammatory actions not explicable by activation of <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">PPARgamma</protein-id>,but possibly by the <protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptor</protein-id> (GR).	rosiglitazone__PPARgamma__no_interaction	rosiglitazone__glucocorticoid receptor__interaction
18801908-477	<compound-id="77999">Rosiglitazone</compound-id> drives <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> expression from a simple glucocorticoid-response element containing reporter gene in a GR-dependent manner (EC50 4 microm), with a similar amplitude response to the partial GR agonist RU486.	Rosiglitazone__luciferase__interaction
18801909-478	To begin to understand the mechanisms for the development of acute <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, <compound-id="5951">serine</compound-id> phosphorylation of <protein-id="Q28516">insulin receptor</protein-id> substrate (<protein-id="P41252,Q8BU30,Q9XTN2">IRS</protein-id>)-1 and c-<protein-id="P05627,P17325,P18289">Jun</protein-id> N-terminal kinase phosphorylation/activation was investigated.	serine__IRS__interaction	serine__insulin__no_interaction	serine__Jun__no_interaction	serine__insulin receptor__interaction
18802196-558	Circulating oxidized LDL (oxLDL) levels are strongly correlated to LDL-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (LDL-c) and apolipoprotein-B100 (<protein-id="P04114">apoB100</protein-id>), making it difficult to disentangle their independent contributions to cardiovascular risk.	cholesterol__apoB100__no_interaction
18802196-559	FMD of the brachial artery and plasma concentrations of oxLDL, LDL-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, and <protein-id="P04114">apoB100</protein-id> were measured in 624 men and women (age range 50 to 87 years), participating in a population-based cohort study.	cholesterol__apoB100__no_interaction
18802196-560	After adjustment for age, sex, <compound-id="206,5793,64689,79025">glucose</compound-id> tolerance status, and Framingham risk score, the oxLDL/<protein-id="P04114">apoB100</protein-id> ratio was negatively related to FMD (P = 0.017).	glucose__apoB100__no_interaction
18802325-593	The <protein-id="O81439">fibrillin-1</protein-id> isolated from the youngest group had the highest capacity to form <compound-id="20484">fructosamine</compound-id> and AGEs under glycation in vitro.	fructosamine__fibrillin-1__interaction
18802724-681	The patterns of nerves immunoreactive (IR) to antibodies towards <compound-id="5202">serotonin</compound-id> (<compound-id="5202">5-HT</compound-id>) and the invertebrate <protein-id="P21259">neuropeptide</protein-id> <protein-id="P08020,P08021,P08022,P69145,P69146,P69147,P69148">FMRFamide</protein-id> are described in relation to the musculature.	5-HT__neuropeptide__no_interaction	serotonin__FMRFamide__no_interaction	serotonin__neuropeptide__no_interaction	5-HT__FMRFamide__no_interaction
18802750-687	Based on these results we analyzed the expression of either M1 receptors or <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> following <compound-id="27924,122634,22833501">PMA</compound-id> treatment of retinal cell cultures.	PMA__BDNF__interaction
18802816-701	Immunotoxicity of perfluorooctanoic acid and perfluorooctane <compound-id="1099">sulfonate</compound-id> and the role of <protein-id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">peroxisome proliferator-activated receptor alpha</protein-id>.	sulfonate__peroxisome proliferator-activated receptor alpha__no_interaction
18803227-822	Inhibitory activities of Cassia tora and its <compound-id="6780">anthraquinone</compound-id> constituents on <protein-id="Q10751">angiotensin-converting enzyme</protein-id>.	anthraquinone__angiotensin-converting enzyme__interaction
18803284-847	The results obtained from the <compound-id="104978">Fluo-3</compound-id> image experiments showed that <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the <compound-id="271">Ca(2</compound-id>+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	Ca(2__VEGF__interaction	Fluo-3__VEGF__interaction
18803286-849	<compound-id="6035">5-Bromo-2'-deoxyuridine (BrdU</compound-id>) was injected into pregnant mice 3 hr after the <protein-id="P59275,P80958,Q99523">NT3</protein-id> administration to label the neural progenitor cells.	5-Bromo-2'-deoxyuridine (BrdU__NT3__no_interaction
18803297-852	A vitreous fraction showing <protein-id="Q02011">growth-promoting activity</protein-id> 1000 Da, consistent with <compound-id="54670067,54690394">ascorbic acid</compound-id>.	ascorbic acid__growth-promoting activity__no_interaction
18803462-1385	The secretion of endorphins, <compound-id="5994">progesterone</compound-id> (P(4)), human chorionic gonadotropin, <compound-id="5757">17beta-estradiol</compound-id>, and <protein-id="P27429">gonadotropin-releasing hormone</protein-id> by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	progesterone__gonadotropin-releasing hormone__no_interaction	17beta-estradiol__gonadotropin-releasing hormone__no_interaction
18803582-1273	A specific <compound-id="15478">digoxigenin</compound-id>-labelled probe, obtained by PCR amplification of a 270-bp fragment of the gene coding the LCDV <protein-id="O39163,O39164,P03226,P03530,P03531,P04509,P04535,P06491,P08035,P09245,P14162,P16487,P16488,P16592,P16593,P16729,P17499,P17500,P17887,P18162,P18610,P22166,P22176,P22535,P22776,P26596,P28920,P30328,P35840,P51720,P52347,P69481,P69482,P69483,Q00705,Q00734,Q00999,Q04754,Q04755,Q05815,Q06386,Q38055,Q67473,Q6S6S9,Q91QZ8,Q9ZXI0">major capsid protein</protein-id>, was used for ISH.	digoxigenin__major capsid protein__interaction
18803655-955	In particular, a Cimicifuga heracleifolia extract (CHE) was reported to inhibit the formation of <compound-id="611,23327,33032">glutamate</compound-id> and the <protein-id="O52310,O59650,O74024,P28270,P52596,P80319,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q56304,Q9YC65">glutamate dehydrogenase</protein-id> activity in cultured rat islet.	glutamate__glutamate dehydrogenase__no_interaction
18804292-1116	No differences in <compound-id="5757">estradiol</compound-id>, <compound-id="6013">testosterone</compound-id>, or <protein-id="P19615">vitellogenin</protein-id> plasma concentrations were observed in exposed males or females compared to controls.	testosterone__vitellogenin__no_interaction	estradiol__vitellogenin__no_interaction
18804314-557	Macrophages located in the media differentiate into giant cells and/or produce reactive <compound-id="977">oxygen</compound-id> species, <compound-id="145068">nitric oxide</compound-id> and matrix metallo-<protein-id="P10265,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63129,P63131,Q9Y6I0">proteinases</protein-id>.	nitric oxide__proteinases__no_interaction	oxygen__proteinases__no_interaction
18804365-1156	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with <protein-id="P02810,P03064,P07602,P18164,P26779,Q66929,Q96631,Q992J0,Q993M1,Q9DIC5,Q9IMM4,Q9J7Z2,Q9QAZ8">protein A</protein-id> on a mixed self-assembled monolayer (SAM) of <compound-id="543502">11-mercaptoundecanoic acid</compound-id> (11-<compound-id="108714">MUA</compound-id>) and <compound-id="560126">6-mercaptohexan-1-ol</compound-id> (6-<compound-id="10062737">MHO</compound-id>) as adhesive layer.	11-mercaptoundecanoic acid__protein A__no_interaction	MUA__protein A__no_interaction	MHO__protein A__no_interaction	6-mercaptohexan-1-ol__protein A__no_interaction
18804521-2419	<compound-id="2462,40000,63006,3033890,5281004,5702148,24867460">Budesonide</compound-id> is a potent glucocorticoid with high affinity for the <protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptor</protein-id>, which is now used for the treatment of inflammatory bowel diseases.	Budesonide__glucocorticoid receptor__interaction
18804525-2139	Studies on the antioxidant effect and interaction of <compound-id="15460">diphenyl diselenide</compound-id> and dicholesteroyl diselenide with hepatic <protein-id="O26839,O28305,O33357,O42768,O67876,O84638,P05373,P06214,P0ACB2,P0ACB3,P0C1R9,P10518,P13716,P30950,P42504,P43087,P45622,P46723,P54919,P56074,P64333,P64334,P64335,P77923,P77969,P78974,Q02250,Q2FXR3,Q59295,Q59334,Q59643,Q5HFA4,Q5HNN5,Q5R971,Q60178,Q60HH9,Q6G8Q7,Q6GG37,Q750E0,Q8CNZ0,Q8KCJ0,Q9K8G2,Q9PLU4,Q9Z7G1,Q9ZMR8">delta-aminolevulinic acid dehydratase</protein-id> and isoforms of lactate dehydrogenase.	diphenyl diselenide__delta-aminolevulinic acid dehydratase__interaction
18804525-2140	Studies on the interaction of dicholesteroyl diselenide (DCDS) and <compound-id="15460">diphenyl diselenide</compound-id> (DPDS) with hepatic <protein-id="O26839,O28305,O33357,O42768,O67876,O84638,P05373,P06214,P0ACB2,P0ACB3,P0C1R9,P10518,P13716,P30950,P42504,P43087,P45622,P46723,P54919,P56074,P64333,P64334,P64335,P77923,P77969,P78974,Q02250,Q2FXR3,Q59295,Q59334,Q59643,Q5HFA4,Q5HNN5,Q5R971,Q60178,Q60HH9,Q6G8Q7,Q6GG37,Q750E0,Q8CNZ0,Q8KCJ0,Q9K8G2,Q9PLU4,Q9Z7G1,Q9ZMR8">delta-aminolevulinic acid dehydratase</protein-id> (ALA-D) and different isoforms of lactate dehydrogenase (<protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id>) from different tissues were investigated.	diphenyl diselenide__delta-aminolevulinic acid dehydratase__interaction	diphenyl diselenide__LDH__interaction
18804848-1280	A single <compound-id="6802">guanosine</compound-id> insertion/deletion (4G/<compound-id="2763225">5G</compound-id>) polymorphism in the promoter region of the <protein-id="P05121,P13909,P20961,P22777,P50449,P79335">PAI-1</protein-id> gene, may play an important role in the regulation of <protein-id="P05121,P13909,P20961,P22777,P50449,P79335">PAI-1</protein-id> expression.	guanosine__PAI-1__interaction	5G__PAI-1__interaction
18804908-377	<compound-id="18897,439213,441477,445621,45933887">Glucosamine</compound-id> is an effective chemo-sensitizer via <protein-id="P08587,P21980,P21981,P51176,P52181,Q01841">transglutaminase 2</protein-id> inhibition.	Glucosamine__transglutaminase 2__interaction
18804908-379	<compound-id="18897,439213,441477,445621,45933887">Glucosamine</compound-id> also recovered the depletion of <protein-id="P25963,Q08353,Q63746,Q91974,Q9Z1E3">I-kappaBalpha</protein-id> via <protein-id="P40746,P81453,Q05187,Q819L3,Q81MS1,Q8GR90,Q9K5W7">TGase</protein-id> 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	Glucosamine__TGase__interaction	Glucosamine__I-kappaBalpha__interaction
18804927-1300	Influence of <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> on buffalo (Bubalus bubalis) spermatozoa motility, membrane integrity, lipid peroxidation and <compound-id="5984">fructose</compound-id> uptake in vitro.	fructose__IGF-I__interaction
18804927-1301	The objective of the present experiment was to examine the influence of mean physiological concentration of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-like growth factor-I (<protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id>) on frozen-thawed Surti buffalo (Bubalus bubalis) spermatozoa functional parameters, i.e., motility, plasmalemma integrity, acrosomal integrity, functional membrane integrity, lipid peroxidation and <compound-id="5984">fructose</compound-id> uptake in vitro.	fructose__insulin__interaction	fructose__IGF-I__interaction
18804927-1302	Frozen-thawed semen samples (n=6) were washed in <compound-id="6503">tris buffer</compound-id> and divided into two equal parts (control and <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> groups).	tris buffer__IGF-I__no_interaction
18804927-1303	<compound-id="5984">Fructose</compound-id> utilization was significantly higher in <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> 0.01) of incubation.	Fructose__IGF-I__interaction
18804950-1309	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the <protein-id="P02461,P04258,P12105">COL3A1</protein-id> gene, c.2545G--&gt;C, leading to a codon encoding for <compound-id="232,4367,6322">arginine</compound-id> instead of <compound-id="750">glycine</compound-id> (p.Gly849Arg).	arginine__COL3A1__interaction	glycine__COL3A1__interaction
18804984-1311	Animal studies show that ecosapentaenoic acid (EPA) and <compound-id="445580">docosahexaenoic acid</compound-id> (DHA) are effective for the prevention and treatment of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance (IR).	docosahexaenoic acid__insulin__interaction
18805402-1407	Signaling involving <compound-id="6076">cAMP</compound-id> is organized in subcellular compartments and a distinct <compound-id="6076">cAMP</compound-id> compartment might be required for proper <protein-id="O02747,P35869,Q95LD9">AHR</protein-id> mobility and function.	cAMP__AHR__interaction
18805433-1411	We also found an inhibitory effect of <compound-id="216326">lenalidomide</compound-id> on the associations between cadherin 5, <protein-id="P26233,P35222,P35223,P35224,Q02248,Q9WU82">beta-catenin</protein-id> and CD31, adherens junction proteins whose interaction is critical for endothelial cell cord formation.	lenalidomide__beta-catenin__interaction
18805433-1412	We also found a strong inhibitory effect of <compound-id="216326">lenalidomide</compound-id> on hypoxia-induced endothelial cell formation of cords and <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1 alpha</protein-id> expression, the main mediator of hypoxia-mediated effects and a key driver of angiogenesis and metastasis.	lenalidomide__HIF-1 alpha__interaction
18805442-1416	Differential effects of <protein-id="P08909,P28335,P34968,Q5IS66,Q60F97">5-HT2C</protein-id> receptor activation by WAY 161503 on <compound-id="942,89594,157672">nicotine</compound-id>-induced place conditioning and locomotor activity in rats.	nicotine__5-HT2C__no_interaction
18805484-1419	Control <compound-id="3955">loperamide</compound-id>-loaded <protein-id="P24807,Q07490">HSA</protein-id> nanoparticles with IgG2a antibodies yielded only marginal effects.	loperamide__HSA__interaction
18805505-1370	Engineered <compound-id="6326970">selenium</compound-id>-containing <protein-id="O81187,P00276,P45242,P55142,P55143,Q9HU55,Q9JVU9,Q9JY15,Q9KSW0,Q9ZDW1,Q9ZR41">glutaredoxin</protein-id> displays strong <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> activity rivaling natural enzyme.	selenium__glutathione peroxidase__no_interaction	selenium__glutaredoxin__interaction
18805505-1371	The use of a common thioredoxin fold with a high affinity for <compound-id="124886">glutathione</compound-id> in <protein-id="O81187,P00276,P45242,P55142,P55143,Q9HU55,Q9JVU9,Q9JY15,Q9KSW0,Q9ZDW1,Q9ZR41">glutaredoxin</protein-id> (Grx) and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	glutathione__glutathione peroxidase__interaction	glutathione__glutaredoxin__interaction
18805508-1434	The potassium channels blockade by either <compound-id="5413">tetraethylammonium</compound-id> or <protein-id="P13487">charybdotoxin</protein-id> also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas <compound-id="16129677">apamine</compound-id> only slightly reduced it.	tetraethylammonium__charybdotoxin__no_interaction	apamine__charybdotoxin__no_interaction
18805632-1457	ROS activated almost immediately in a time- and concentration-dependent manner the <protein-id="O42781,P27638,Q00859">MAPK</protein-id> pathways <protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</protein-id>, <protein-id="P29323">ERK</protein-id> and <protein-id="P92208,Q966Y3">JNK</protein-id> (their activation was abrogated by the antioxidant <compound-id="12035">N-acetylcysteine</compound-id>).	N-acetylcysteine__JNK__interaction	N-acetylcysteine__ERK__interaction	N-acetylcysteine__MAPK__no_interaction	N-acetylcysteine__p38__interaction
18805639-1461	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of <compound-id="223">ammonium</compound-id>, <compound-id="795">imidazolium</compound-id>, <compound-id="8083">morpholinium</compound-id>, <compound-id="5460504">phosphonium</compound-id>, <compound-id="8082">piperidinium</compound-id>, <compound-id="1049">pyridinium</compound-id>, <compound-id="31268">pyrrolidinium</compound-id> and <compound-id="7047">quinolinium</compound-id> ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">Acetylcholinesterase</protein-id> (<protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>) using only their empirical formulas (elemental composition) and molecular weights.	pyridinium__AChE__interaction	ammonium__AChE__interaction	pyrrolidinium__Acetylcholinesterase__interaction	phosphonium__Acetylcholinesterase__interaction	phosphonium__AChE__interaction	piperidinium__AChE__interaction	piperidinium__Acetylcholinesterase__interaction	imidazolium__Acetylcholinesterase__interaction	quinolinium__Acetylcholinesterase__interaction	ammonium__Acetylcholinesterase__interaction	morpholinium__AChE__interaction	pyrrolidinium__AChE__interaction	morpholinium__Acetylcholinesterase__interaction	pyridinium__Acetylcholinesterase__interaction	quinolinium__AChE__interaction	imidazolium__AChE__interaction
18805685-1489	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, <compound-id="10964">malondialdehyde</compound-id> (MDA) production, inflammatory cell infiltration, <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>) expression and caspase-3 activity.	malondialdehyde__IL-6__no_interaction	malondialdehyde__interleukin-6__no_interaction
18805685-1490	Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased <protein-id="O50258">superoxide dismutase</protein-id> activity and <compound-id="124886">glutathione</compound-id> level, was detected only in the chronic daily-administration group.	glutathione__superoxide dismutase__no_interaction
18806218-232	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> secretion is highly sensitive to desorption of plasma membrane <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>.	cholesterol__Insulin__interaction
18806218-233	<compound-id="304,5997,6432564,11025495">Cholesterol</compound-id>-rich clusters of SNARE (<protein-id="Q23983">soluble NSF attachment protein</protein-id> receptor) proteins have been implicated as being important for exocytosis.	Cholesterol__soluble NSF attachment protein__interaction
18806296-1733	Suppression of retinal <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">peroxisome proliferator-activated receptor gamma</protein-id> in experimental diabetes and <compound-id="977">oxygen</compound-id>-induced retinopathy: role of NADPH oxidase.	oxygen__peroxisome proliferator-activated receptor gamma__no_interaction
18806930-1949	TKTL 1 was highest expressed in cell lines derived from more invasive tumors but the expression level was not strongly correlated to proliferation rate, to <protein-id="P79365">GLUT-1</protein-id> expression or to the response to <compound-id="8682">oxythiamine</compound-id>.	oxythiamine__GLUT-1__no_interaction
18806932-1906	<compound-id="5462224">Magnesium</compound-id> (Mg), <protein-id="P10145">interleukin 8</protein-id> (<protein-id="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5">IL-8</protein-id>), and <compound-id="10964">malondialdehyde</compound-id> levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	malondialdehyde__interleukin 8__no_interaction	malondialdehyde__IL-8__no_interaction	Magnesium__interleukin 8__no_interaction	Magnesium__IL-8__no_interaction
18807018-1954	Study of multiple binding constants of <compound-id="5743">dexamethasone</compound-id> with human <protein-id="P21847,P83517">serum albumin</protein-id> by capillary electrophoresis-frontal analysis and multivariate regression.	dexamethasone__serum albumin__interaction
18807018-1955	In this paper, to evaluate the pharmacokinetic and pharmacodynamic properties of <compound-id="5743">dexamethasone</compound-id> (DXM), the interaction between DXM and <protein-id="P24807,Q07490">HSA</protein-id> was studied by capillary electrophoresis-frontal analysis (CE-FA).	dexamethasone__HSA__interaction
18807050-1745	Arthropod <protein-id="P80888">hemocyanins</protein-id> transport and store <compound-id="977">oxygen</compound-id> and are composed of six subunits, or multiples thereof depending on the species.	oxygen__hemocyanins__no_interaction
18807050-1746	The protein is insensitive to lactate, but affected by urate which markedly increased <protein-id="P80888">hemocyanin</protein-id>-<compound-id="977">oxygen</compound-id> affinity, acting as the physiological major positive effector.	oxygen__hemocyanin__interaction
18807177-2028	The estrogen-induced increase in <protein-id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</protein-id> protein in MCF-7-HER2 cells was abrogated by the antiestrogen <compound-id="104741">ICI 182780</compound-id> and by <compound-id="123631">gefitinib</compound-id> (<compound-id="123631">Iressa</compound-id> ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	Iressa__CXCR4__interaction	gefitinib__CXCR4__interaction	ICI 182780__CXCR4__interaction
18807200-2046	Enzymatic activities of an H(2)O(2) independent oxidase along with <protein-id="Q12570">laccase</protein-id> and an <protein-id="P05982,P15559,Q5RD31,Q64669,Q8CHK7">azoreductase</protein-id> suggest their prominent role during the decolorization of reactive yellow <compound-id="24180624">84A</compound-id>.	84A__laccase__interaction	84A__azoreductase__interaction
18807200-2047	<protein-id="P05982,P15559,Q5RD31,Q64669,Q8CHK7">Azoreductase</protein-id> activity was prominent in presence of cofactors <compound-id="439153">NADH</compound-id> and <compound-id="5886">NADP</compound-id> in mineral salt medium.	NADH__Azoreductase__interaction	NADP__Azoreductase__interaction
18807214-2051	The increase of <compound-id="977">oxygen</compound-id> availability caused the induction of the antioxidant enzyme <protein-id="O50258">superoxide dismutase</protein-id>, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	oxygen__superoxide dismutase__interaction
18808217-2356	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="Q08168">HRP</protein-id>), <compound-id="784">hydrogen peroxide</compound-id>, and a phenolic cosubstrate (<compound-id="9015">4-methoxyphenol</compound-id>).	4-methoxyphenol__HRP__interaction	4-methoxyphenol__peroxidase__interaction	hydrogen peroxide__peroxidase__interaction	hydrogen peroxide__HRP__interaction
18808217-2357	Approximately 68% depletion of the parent compound and 98% depletion of its related acute aquatic toxicity are achieved in 6 h. Because no PFOA removal is observed in the absence of cosubstrate and/or following consumption thereof, we conclude that radical intermediate species generated during reaction between <protein-id="Q08168">HRP</protein-id> and <compound-id="9015">4-methoxyphenol</compound-id> mediate nonspecific depletion of PFOA and that these intermediates may be sufficiently reactive to sever the extremely stable C-F bonds of PFOA.	4-methoxyphenol__HRP__interaction
18808365-2406	In the present study, the mRNA expression and promoter <compound-id="6804">CpG</compound-id> methylation of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> isoforms (i.e.	CpG__ERalpha__interaction
18808365-2407	The present study is the first report that demonstrates selective inactivation of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> isoforms through the promoter <compound-id="6804">CpG</compound-id> methylation pathway in leukaemias.	CpG__ERalpha__interaction
18808455-2441	<protein-id="P02854">Type-B</protein-id> monogalactosyldiacylglycerol synthases are involved in <compound-id="1061,167704,644102">phosphate</compound-id> starvation-induced lipid remodeling, and are crucial for low-<compound-id="1061,167704,644102">phosphate</compound-id> adaptation.	phosphate__Type-B__interaction
18809244-141	This study was performed to evaluate the effects of <compound-id="5291">imatinib</compound-id> on breast cancer cell lines with respect to the activity of <protein-id="P05622,P09619,P79749,Q05030,Q6QNF3">PDGFR beta</protein-id> and <protein-id="P31750,Q8INB9">Akt</protein-id> : a downstream modulator of cell growth and survival.	imatinib__PDGFR beta__interaction	imatinib__Akt__interaction
18809262-150	The mechanisms may include the recently revealed anti-inflammatory effects of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> as well as its conventional <compound-id="206,5793,64689,79025">glucose</compound-id> and free fatty acids lowering effects, and possibly may also include changes in body fat distribution and plasma adiponectin level.	glucose__insulin__interaction
18809347-188	Recently, we reported stimulatory effect of <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> alone and in combination with <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id> (GH) on <compound-id="5757">estradiol</compound-id> secretion, <protein-id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</protein-id> activity in parallel with inhibitory effect on cell apoptosis.	estradiol__aromatase__no_interaction	estradiol__growth hormone__interaction	estradiol__ghrelin__interaction
18809347-189	In cultures treated together <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> and (D-Lys-3)-GHRP-6, <compound-id="5757">estradiol</compound-id> secretion, <protein-id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</protein-id> activity and cell proliferation returned to control levels.	estradiol__aromatase__no_interaction	estradiol__ghrelin__interaction
18809364-192	Expression levels of the functional activities (albumin secretion and <compound-id="222">ammonia</compound-id> removal) and the cell-cell adhesion molecules (cadherin and <protein-id="O18968,P08033,P08034,P28230,Q60HF7,Q6WGK6">connexin-32</protein-id>) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.	ammonia__connexin-32__no_interaction
18809367-193	Nevertheless, certain clinical cases manifest themselves with the onset of acute renal failure bought upon by the administration of blockers of the rennin-<protein-id="Q10757">angiotensin</protein-id>-<compound-id="5839">aldosterone</compound-id> system, or by some other causes responsible for a sudden drop in renal plasma flow (e.g., thrombosis of the renal artery).	aldosterone__angiotensin__no_interaction
18809432-1105	The function of rhamnose-binding <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> in innate immunity by restricted binding to <compound-id="11963508">Gb3</compound-id>.	Gb3__lectin__interaction
18809432-1106	This is the first finding that <compound-id="11963508">Gb3</compound-id> plays a role in innate immunity by cooperating with natural ligands, <protein-id="Q9PVW8">RBLs</protein-id>.	Gb3__RBLs__interaction
18809481-220	Effect of polyols on the solubility of bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) in the presence of <compound-id="6325">polyethylene</compound-id> glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	polyethylene__BSA__no_interaction	polyethylene__serum albumin__no_interaction
18810331-544	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and <compound-id="906,444885,445063">sialic acid</compound-id> (free and total) concentration and amylase and <protein-id="P15984,P16147,P84714">peroxidase</protein-id> activities were determined.	sialic acid__peroxidase__no_interaction
18810331-545	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (160%) activities, free (150%) and total (170%) <compound-id="906,444885,445063">sialic acid</compound-id> concentration.	sialic acid__peroxidase__no_interaction
18810466-577	To investigate the change pattern of <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</protein-id> (SP) and <compound-id="145068">nitric oxide</compound-id> (NO) in the portal vein during the recto-anal inhibitory reflex (RAIR), and its physiological significance; the influence of external splanchnic nerve (ESN) of rectum and anus to the RAIR.	nitric oxide__substance P__no_interaction
18810510-591	Considering the common metabolic pathway and synergism between dopamine and <compound-id="5202">serotonin</compound-id>, the role of dopamine transporter (<protein-id="P27922,Q01959,Q9GJT6">SLC6A3</protein-id>, <protein-id="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DAT</protein-id>) and <protein-id="P49253">monoamine oxidase</protein-id> A (<protein-id="O18851,P21397,P21398,P58027,Q5NU32,Q5RE60,Q6Q2J0">MAOA</protein-id>) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	serotonin__monoamine oxidase__no_interaction	serotonin__MAOA__no_interaction	serotonin__SLC6A3__no_interaction	serotonin__DAT__no_interaction
18810517-648	A <protein-id="Q7M4U7">lipase</protein-id> (F2) and <protein-id="Q7M4U7">lipase</protein-id>-like materials (F1) were purified from the culture supernatant of P. monteilii TKU009 with soybean powder as the sole carbon/<compound-id="947,123329">nitrogen</compound-id> source.	nitrogen__lipase__no_interaction
18810712-643	DHEA, <compound-id="12594">DHEA-S</compound-id>, <compound-id="10635">dihydrotestosterone</compound-id>, total <compound-id="6013">testosterone</compound-id>, free <compound-id="6013">testosterone</compound-id>, sex hormone-binding globulin, <compound-id="5870">estrone</compound-id>, <compound-id="5757">estradiol</compound-id>, <compound-id="5754">cortisol</compound-id>, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, <protein-id="Q95222">IGF-1</protein-id>, <protein-id="P08833,P21743,P24591,P47876,Q6Q484,Q75ZP3">IGFBP-1</protein-id>, <protein-id="P15473,P16611,P17936,P20959,P47878">IGFBP-3</protein-id>, and adiponectin in plasma or serum were measured.	dihydrotestosterone__IGF-1__no_interaction	estrone__IGF-1__no_interaction	cortisol__IGFBP-3__no_interaction	testosterone__IGFBP-3__no_interaction	DHEA-S__IGF-1__no_interaction	DHEA-S__insulin__no_interaction	dihydrotestosterone__insulin__no_interaction	cortisol__insulin__no_interaction	estradiol__IGFBP-1__no_interaction	testosterone__IGF-1__no_interaction	DHEA-S__IGFBP-3__no_interaction	estradiol__insulin__no_interaction	estradiol__IGF-1__no_interaction	DHEA-S__IGFBP-1__no_interaction	cortisol__IGFBP-1__no_interaction	estrone__insulin__no_interaction	dihydrotestosterone__IGFBP-1__no_interaction	testosterone__insulin__no_interaction	dihydrotestosterone__IGFBP-3__no_interaction	testosterone__IGFBP-1__no_interaction	estrone__IGFBP-1__no_interaction	cortisol__IGF-1__no_interaction	estradiol__IGFBP-3__no_interaction	estrone__IGFBP-3__no_interaction
18812013-984	Our data indicate that genetic differences in <protein-id="P02638,P04271,Q6YNR6">S100B</protein-id> gene expression may predispose individual differences in the responsivity to repeated intake of <compound-id="1615">MDMA</compound-id>.	MDMA__S100B__interaction
18812209-396	<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Angiotensin II</protein-id> (<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Ang II</protein-id>) is the key <protein-id="P81626">peptide hormone</protein-id> in the renin-<protein-id="Q10757">angiotensin</protein-id>-<compound-id="5839">aldosterone</compound-id> system (RAAS).	aldosterone__Ang II__interaction	aldosterone__peptide hormone__interaction	aldosterone__angiotensin__interaction	aldosterone__Angiotensin II__interaction
18812225-1232	The enzyme responsible for D-<compound-id="5951">serine</compound-id> biosynthesis, <protein-id="Q9GZT4,Q9QZX7">serine racemase</protein-id> (SR), is therefore a promising target for treatment of neuropathologies related to glutamate receptor excitotoxicity, such as stroke or Alzheimer's disease.	serine__serine racemase__interaction
18812229-1054	Hepatocyte apoptosis was estimated morphologically using <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">Annexin-V</protein-id> combined with <compound-id="4939">propidium iodide</compound-id>, or <compound-id="7084">toluidine blue</compound-id> staining.	propidium iodide__Annexin-V__no_interaction	toluidine blue__Annexin-V__no_interaction
18812233-1056	To investigate the metabolism of <compound-id="5282105">NADA</compound-id> through the <protein-id="O08469">cytochrome P450</protein-id> (CYP450) metabolic pathway, we studied the in vitro rat liver microsomal production of hydroxylated metabolites and their activity at recombinant human TRPV(1) receptors.	NADA__cytochrome P450__interaction
18812596-1164	The FFA fractions elicited pro-inflammatory responses inducing <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id> and intracellular adhesion molecule expression and reactive <compound-id="977">oxygen</compound-id> species (ROS) production in human aortic endothelial cells (HAECs).	oxygen__TNFalpha__no_interaction
18812689-1190	<protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id> single nucleotide polymorphism G2677T/A and haplotype are correlated with response to <compound-id="148124">docetaxel</compound-id>-cisplatin chemotherapy in patients with non-small-cell lung cancer.	docetaxel__MDR1__interaction
18814142-2252	Functional expression of <protein-id="O70431,P04274,P07550,P10608,P18762,P54833,Q28044,Q28509,Q28997,Q4KWL2,Q8UUY8,Q9TST5">beta2 adrenergic receptors</protein-id> responsible for protection against oxidative stress through promotion of <compound-id="124886">glutathione</compound-id> synthesis after <protein-id="O54968,Q60795">Nrf2</protein-id> upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	glutathione__beta2 adrenergic receptors__interaction	glutathione__Nrf2__no_interaction
18814142-2253	Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (<protein-id="P15337,P16220,P27925,P51984,P51985,Q01147">CREB</protein-id>) on serine133 and CRE reporter activity in a manner sensitive to <compound-id="4946,21138,91536">propranolol</compound-id>, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of <compound-id="784">hydrogen peroxide</compound-id>, but not of either 2,4-dinitirophenol or tunicamycin.	propranolol__CREB__interaction	hydrogen peroxide__CREB__interaction
18814142-2254	These results suggest that adrenaline may selectively protect mesenchymal C3H10T1/2 cells from oxidative stress through a mechanism related to the promoted biosynthesis of <compound-id="124886">glutathione</compound-id> in association with transient <protein-id="O54968,Q60795">Nrf2</protein-id> expression after activation of beta(2)AdR.	glutathione__Nrf2__no_interaction
18814181-1610	Two principal signaling pathways that regulate proliferation are <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>/<compound-id="643963">PI(3,4,5)P3</compound-id>/<protein-id="P31750,Q8INB9">Akt</protein-id> and <protein-id="P33247,P33990,P54924,P55348,P98083">Shc</protein-id>/<protein-id="P03967,P22126,Q07152">Ras</protein-id>/<protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2.	PI(3,4,5)P3__Shc__no_interaction	PI(3,4,5)P3__Ras__no_interaction	PI(3,4,5)P3__PI3K__interaction	PI(3,4,5)P3__Akt__interaction	PI(3,4,5)P3__ERK1__no_interaction
18814266-2509	However, <compound-id="53232">lovastatin</compound-id> treatment resulted in intracellular accumulation of <protein-id="P04116,P13085,P22858,P23289,P23294,P30044,P47789,P47790,P60201,P60202,P60203,P79826,P80145,P99029,Q8HXW7,Q96GD0,Q9R063">PLP</protein-id> and prevented its translocation to the cell surface.	lovastatin__PLP__interaction
18814279-1660	<compound-id="5291">Imatinib mesylate</compound-id> (<compound-id="5291">imatinib</compound-id>) is a potent and selective inhibitor of the tyrosine kinases, <protein-id="P28246,P45123">Bcr</protein-id>-<protein-id="P00520,P00522">Abl</protein-id>, <protein-id="O97799,P05532,P10721,P43481,Q08156,Q28317,Q28889,Q2HWD6,Q76II0,Q8AXC6">c-Kit</protein-id> and platelet-derived growth factor receptors (PDGFRs).	Imatinib mesylate__c-Kit__interaction	imatinib__Abl__interaction	Imatinib mesylate__Bcr__interaction	imatinib__c-Kit__interaction	imatinib__Bcr__interaction	Imatinib mesylate__Abl__interaction
18814300-1665	The large and diverse family of <protein-id="O08469">cytochrome P450</protein-id> monooxygenases (<protein-id="P21568,P21569,P24525,P34887,Q26551">CYPs</protein-id>) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the <compound-id="4971">heme</compound-id> center.	heme__cytochrome P450__no_interaction	heme__CYPs__no_interaction
18814300-1666	In 98.4% of all <protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id> sequences a preferentially hydrophobic residue is located at position 5 after the ExxR motif that is predicted to point close to the <compound-id="4971">heme</compound-id> center.	heme__CYP__no_interaction
18814316-53	We report the interaction of a potent synthetic derivative of <compound-id="969516">curcumin</compound-id>, isoxazolcurcumin (<compound-id="446240">IOC</compound-id>) with human <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P24807,Q07490">HSA</protein-id>) using various biophysical methods.	curcumin__HSA__interaction	IOC__serum albumin__interaction	curcumin__serum albumin__interaction	IOC__HSA__interaction
18814316-54	The observed fluorescence quenching of <protein-id="P24807,Q07490">HSA</protein-id> by <compound-id="446240">IOC</compound-id> is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	IOC__HSA__interaction
18814316-55	From the observed Frster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in <protein-id="P24807,Q07490">HSA</protein-id>) to acceptor (<compound-id="446240">IOC</compound-id>) distance is calculated to be 3.2 nm.	IOC__HSA__interaction
18814316-56	The preferred binding site of <compound-id="446240">IOC</compound-id> was analyzed by ligand displacement experiments with <compound-id="1369">1-anilino-8-naphthalenesulfonate</compound-id> (ANS) and <compound-id="54678486">warfarin</compound-id>-bound <protein-id="P24807,Q07490">HSA</protein-id>.	warfarin__HSA__interaction	1-anilino-8-naphthalenesulfonate__HSA__interaction	IOC__HSA__interaction
18814864-1818	A number of site-specific modifications of the nucleosome core histones-including the trimethylated forms of <protein-id="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1">histone H3</protein-id> lysines K4, K9, and <compound-id="5492535">K27</compound-id>-are of particular interest for postmortem research, because these marks differentiate between active and inactive chromatin and seem to remain relatively stable during tissue autolysis.	K27__histone H3__interaction
18814910-1833	We here demonstrate that <protein-id="O75762">TRPA1</protein-id> confers a sensitivity towards near ultraviolet (UVA) light, which rapidly causes <compound-id="271">Ca(2</compound-id>+) entry.	Ca(2__TRPA1__interaction
18814910-1834	In the presence of the photosensitising agents <compound-id="62344">acridine orange</compound-id> (100 nM) or <compound-id="5281051">hypericin</compound-id> (10 nM), the sensitivity of light-induced <protein-id="O75762">TRPA1</protein-id> activation was increased and extended towards the visible spectrum.	acridine orange__TRPA1__interaction	hypericin__TRPA1__interaction
18814934-1845	To verify the possible involvement of lipids and several other compounds including <compound-id="784">hydrogen peroxide</compound-id> (H(2)O(2)) and <protein-id="O01360,O13507,O27090,O28542,O32755,O42259,O52631,O57479,O57672,O59494,O59841,O67161,O83816,P00355,P00356,P00357,P00361,P00362,P04406,P04797,P08439,P09316,P09317,P0A1P0,P0A1P1,P0C0G6,P0C0G7,P10096,P10618,P15115,P16858,P17244,P17721,P19089,P19314,P19315,P20287,P20445,P23722,P24163,P24164,P24166,P24746,P24748,P24749,P24750,P24751,P24753,P26988,P27726,P28844,P29497,P32637,P32638,P34783,P35143,P39460,P44304,P46406,P46713,P46795,P46796,P47543,P48812,P51009,P51469,P51640,P52694,P52987,P53430,P54117,P54118,P54226,P55070,P55071,P55971,P56649,P57384,P58839,P61879,P61880,P64178,P64179,P68777,P70685,P75358,P83601,P87197,P94915,Q00301,Q00584,Q00640,Q01597,Q01651,Q01982,Q05025,Q07234,Q12552,Q1DTF9,Q27652,Q28259,Q28554,Q2NEN0,Q3IUT3,Q46450,Q48335,Q4J940,Q4KYY3,Q58546,Q59199,Q59309,Q59800,Q59906,Q5JHB5,Q5R2J2,Q5RAB4,Q5V061,Q5XDW3,Q6BMK0,Q6CCU7,Q6L125,Q6M0E6,Q757I2,Q89AK1,Q8J1H3,Q8K8M9,Q8NK47,Q8PTD3,Q8TFJ2,Q8WZN0,Q8X1X3,Q8ZWK7,Q92211,Q92243,Q92263,Q94469,Q96US8,Q971K2,Q97BJ8,Q9HFX1,Q9HGY7,Q9HJ69,Q9HSS7,Q9N2D5,Q9N655,Q9P8C0,Q9PJN6,Q9UR38,Q9UVC0,Q9UW96,Q9V1P1,Q9Y796,Q9Y8E9,Q9YFS9,Q9Z518,Q9Z7T0,Q9ZKT0">glyceraldehyde-3-phosphate dehydrogenase</protein-id> (<protein-id="P51640,Q28554">G3PDH</protein-id>) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	hydrogen peroxide__G3PDH__no_interaction	hydrogen peroxide__glyceraldehyde-3-phosphate dehydrogenase__no_interaction
18815024-1868	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two <compound-id="206,79025">alpha,d-glucose</compound-id> molecules, and a <protein-id="P13006,P81156,Q92452">GOD</protein-id> (<protein-id="P81156">glucose oxidase</protein-id>) amperometric biosensor is employed for the <compound-id="206,64689,79025">glucose</compound-id> determination.	alpha,d-glucose__glucose oxidase__no_interaction	glucose__glucose oxidase__no_interaction	glucose__GOD__no_interaction	alpha,d-glucose__GOD__no_interaction
18815084-1886	The angiogenic potential of vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>) and its <compound-id="977">oxygen</compound-id> pressure-dependent regulation suggest a strong connection between this growth factor and the 'delay phenomenon'.	oxygen__VEGF__interaction
18815123-1901	Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated <protein-id="P29323">ERK</protein-id> activation in response to <compound-id="11970143">lipopolysaccharide</compound-id>.	lipopolysaccharide__ERK__interaction
18815141-1912	<compound-id="7906">Methylmercury</compound-id> toxicity and <protein-id="O54968,Q60795">Nrf2</protein-id>-dependent detoxification in astrocytes.	Methylmercury__Nrf2__interaction
18815243-1973	After serum <compound-id="588">creatinine</compound-id> reached a stable nadir in the transplant recipients, <protein-id="Q92565">GFR</protein-id> and its hemodynamic determinants were evaluated and the whole allograft K(f) was computed.	creatinine__GFR__no_interaction
18815356-1953	Lower expression of <protein-id="P08833,P24591,Q6Q484,Q75ZP3">IGFBP1</protein-id> and <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to <compound-id="32014">8-Br-cAMP</compound-id>, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	8-Br-cAMP__prolactin__interaction	8-Br-cAMP__IGFBP1__interaction
18815358-2022	Furthermore, constitutive expression of an <compound-id="977">oxygen</compound-id>-insensitive, active form of <protein-id="Q0PGG7,Q16665,Q309Z6,Q98SW2,Q9XTA5,Q9YIB9">HIF1A</protein-id> protein mimicked the effects of low <compound-id="977">oxygen</compound-id>, inhibiting the differentiation of trophoblast giant cells.	oxygen__HIF1A__no_interaction
18815782-2147	Finally, the results showed that the <protein-id="Q7M4U7">lipase</protein-id> covalently attached onto <compound-id="169944">epoxy resin</compound-id> exhibited the highest enantioselectivity and operational stability.	epoxy resin__lipase__interaction
18815831-2150	Effect of the inoculum size on carbapenem susceptibilities of <protein-id="P80298,P80545,P81173">beta-lactamase</protein-id>-negative, <compound-id="6249">ampicillin</compound-id>-resistant Haemophilus influenzae.	ampicillin__beta-lactamase__no_interaction
18815831-2151	However, the effect of inoculum size of <protein-id="P80298,P80545,P81173">beta-lactamase</protein-id>-negative, <compound-id="6249">ampicillin</compound-id>-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.	ampicillin__beta-lactamase__no_interaction
18815849-2155	It has been proposed that there is improvement in <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.	glucose__insulin__no_interaction
18815869-2158	<compound-id="6037">Folate</compound-id> deficiency due to the <protein-id="P42898,Q5I598,Q60HE5,Q9WU20">methylenetetrahydrofolate reductase</protein-id> (<protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id>) and <protein-id="O26869,O33259,O33465,O58816,P13009,P37586,P55299,P57704,Q49775,Q4JAI4,Q4JIJ3,Q55786,Q58868,Q5E814,Q5JH51,Q7MHB1,Q87L95,Q8DCJ7,Q8TH63,Q975N4,Q979L4,Q980A9,Q99707,Q9AJQ8,Q9KUW9,Q9V085,Q9YA91">methionine synthase</protein-id> (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	Folate__MTHFR__interaction	Folate__methionine synthase__interaction	Folate__methylenetetrahydrofolate reductase__interaction
18815881-2160	<compound-id="2733526">Tamoxifen</compound-id> has been the mainstay of endocrine therapy for <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id>-positive breast cancer.	Tamoxifen__estrogen receptor__interaction
18815882-2164	The bifunctional enzyme <protein-id="O35826,P27828,P39131,P52642,Q7TQ49,Q8XAR8,Q8Z388,Q8ZAE3,Q91WG8,Q9L6R5,Q9Y223">UDP-N-acetylglucosamine 2-epimerase</protein-id>/N-acetylmannosamine kinase (<protein-id="Q7TQ49,Q9Y223">GNE</protein-id>) is the key enzyme for the biosynthesis of <compound-id="349960">sialic acids</compound-id>, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	sialic acids__UDP-N-acetylglucosamine 2-epimerase__interaction	sialic acids__GNE__interaction
18816186-2283	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal <protein-id="O54851,O70610,Q866T7,Q9UKL4">Cx36</protein-id> and glial <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> hemichannel activity, favoring <compound-id="5957">ATP</compound-id> release and generation of preconditioning.	ATP__Cx36__interaction	ATP__Cx43__interaction
18816698-2452	A study of rituximab and <compound-id="3690,9588020">ifosfamide</compound-id>, <compound-id="2568">carboplatin</compound-id>, and <compound-id="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217">etoposide</compound-id> chemotherapy in children with recurrent/refractory B-cell (<protein-id="P11836,Q3C2E2">CD20</protein-id>+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	etoposide__CD20__interaction	carboplatin__CD20__interaction	ifosfamide__CD20__interaction
18816790-2482	4) PKA regulates neurotransmission without <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> involvement because, after <compound-id="27924,122634,22833501">PMA</compound-id> or CaC modulation of the <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> activity, coupling to the ACh release of PKA can normally be stimulated with Sp-8-BrcAMP or inhibited with H-89.	PMA__PKC__no_interaction
18816790-2483	5) After PKA inhibition with H-89, <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> stimulation with <compound-id="27924,122634,22833501">PMA</compound-id> (or inhibition with CaC) does not lead to any change in evoked ACh release.	PMA__PKC__interaction
18816790-2484	In contrast, PKA inhibition prevent <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> stimulation (with the <compound-id="27924,22833501">phorbol ester</compound-id>) and coupling to ACh output.	phorbol ester__PKC__interaction
18817778-252	The inhibition of female rabbit sexual behavior by <compound-id="5994">progesterone</compound-id> : <protein-id="P06186,P06401,P07812,P79373,Q00175,Q28590,Q63449,Q8AYI2,Q9GLW0">progesterone receptor</protein-id>-dependent and-independent effects.	progesterone__progesterone receptor__interaction
18817795-259	Reproductive experience alters <compound-id="5753">corticosterone</compound-id> and <protein-id="P08185,P23775,P31211,P49920,P50451,Q06770,Q5R9E3,Q5RF65,Q60543,Q9H227">CBG</protein-id> levels in the rat dam.	corticosterone__CBG__no_interaction
18817795-260	The present study investigated whether the levels of circulating <compound-id="5753">corticosterone</compound-id> and its binding protein, <protein-id="P23775">corticosteroid binding globulin</protein-id> (<protein-id="P08185,P23775,P31211,P49920,P50451,Q06770,Q5R9E3,Q5RF65,Q60543,Q9H227">CBG</protein-id>), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	corticosterone__corticosteroid binding globulin__interaction	corticosterone__CBG__interaction
18817795-261	Total serum <compound-id="5753">corticosterone</compound-id> and <protein-id="P08185,P23775,P31211,P49920,P50451,Q06770,Q5R9E3,Q5RF65,Q60543,Q9H227">CBG</protein-id> were assayed from five groups; multiparous, primiparous, nulliparous, primip-no-pups, and sensitized rats during gestation (days 14 and 19) and the postpartum period (days 1, 5, 14, 21, and 35).	corticosterone__CBG__no_interaction
18817797-263	The influence of <compound-id="54454,4677798">simvastatin</compound-id>, <compound-id="60823">atorvastatin</compound-id> and high-cholesterol diet on <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> activity, amyloid beta and cholesterol synthesis in rat brain.	simvastatin__acetylcholinesterase__interaction	atorvastatin__acetylcholinesterase__interaction
18817816-1059	The expressions of <protein-id="Q17239,Q25190,Q25414">serotonin receptors</protein-id> (<protein-id="O46635,Q17239,Q25190,Q25414">5-hydroxytryptamine receptor</protein-id>), <protein-id="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">corticotropin-releasing hormone</protein-id> (<protein-id="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1">CRH</protein-id>) and <compound-id="8230,644077,44285245">arginine vasopressin</compound-id> (AVP) mRNA in the hypothalamus were detected by real time PCR.	arginine vasopressin__CRH__no_interaction	arginine vasopressin__corticotropin-releasing hormone__no_interaction	arginine vasopressin__5-hydroxytryptamine receptor__no_interaction	arginine vasopressin__serotonin receptors__no_interaction
18817841-391	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, <compound-id="5870">estrone</compound-id> (E1) and <compound-id="5757">estradiol</compound-id> (E2), detected suggesting that the pathway of <protein-id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</protein-id> is not important in these cell lines.	estradiol__aromatase__no_interaction	estrone__aromatase__no_interaction
18817845-305	The aim of this study was to investigate the effects of acute and chronic exercise on <compound-id="2723628">thiobarbituric acid</compound-id> reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of <protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptors</protein-id>, and prefrontal cortex and striatum, which have high <compound-id="681">dopamine</compound-id> content.	thiobarbituric acid__glucocorticoid receptors__no_interaction	dopamine__glucocorticoid receptors__no_interaction
18817845-306	Additionally we examined antioxidant enzyme activities, <protein-id="O50258">superoxide dismutase</protein-id> and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> and nitrite-<compound-id="943">nitrate</compound-id> levels to assess the effects of reactive oxygen and nitrogen species.	nitrate__superoxide dismutase__no_interaction	nitrate__glutathione peroxidase__no_interaction
18818063-283	Oral administration of (PhSe)(2) in rats did not change plasma alanine and <protein-id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</protein-id> activities (<protein-id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">AST</protein-id> and ALT) as well as <compound-id="1176,265993">urea</compound-id> and <compound-id="588">creatinine</compound-id> levels.	urea__aspartate aminotransferase__no_interaction	urea__AST__no_interaction	creatinine__aspartate aminotransferase__no_interaction	creatinine__AST__no_interaction
18818229-311	Total plasma <compound-id="778">homocysteine</compound-id> level, <protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id> C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma <compound-id="6037">folate</compound-id> and <compound-id="3034082,6713940,25243974">cobalamin</compound-id> levels were determined.	homocysteine__MTHFR__no_interaction	cobalamin__MTHFR__no_interaction	folate__MTHFR__no_interaction
18818289-2648	Immunohistochemical colabeling for nesfatin-1 and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id>, <protein-id="P05034,P16453,P19113,P23738,P28577,P28578,P54772,P95477,Q05733,Q56581,Q5EA83,Q8L0Z4,Q98A07">histidine decarboxylase</protein-id>, or <compound-id="16129681,16129706">somatostatin</compound-id> revealed two subtypes of nesfatin-1-positive endocrine cells.	somatostatin__ghrelin__no_interaction	somatostatin__histidine decarboxylase__no_interaction
18818289-2649	Cells in the midportion of the glands coexpressed nesfatin-1 and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id>, whereas few cells in the glandular base coexpressed nesfatin-1 and <compound-id="16129681,16129706">somatostatin</compound-id> or <protein-id="P05034,P16453,P19113,P23738,P28577,P28578,P54772,P95477,Q05733,Q56581,Q5EA83,Q8L0Z4,Q98A07">histidine decarboxylase</protein-id>.	somatostatin__ghrelin__no_interaction	somatostatin__histidine decarboxylase__no_interaction
18818294-345	Importantly, <protein-id="P00750,P11214,P19637,Q28198">tPA</protein-id> and <protein-id="P05121,P13909,P20961,P22777,P50449,P79335">PAI-1</protein-id> proteins and <protein-id="P00750,P11214,P19637,Q28198">tPA</protein-id> activity were low/nondetectable in granulosa cells obtained after treatment with hCG and the PG synthesis inhibitor <compound-id="2662">celecoxib</compound-id>.	celecoxib__tPA__interaction	celecoxib__PAI-1__interaction
18818294-346	To determine whether hCG stimulation of <protein-id="P00750,P11214,P19637,Q28198">tPA</protein-id> and <protein-id="P05121,P13909,P20961,P22777,P50449,P79335">PAI-1</protein-id> requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus <compound-id="3715">indomethacin</compound-id> to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	indomethacin__PAI-1__no_interaction	indomethacin__tPA__no_interaction
18818299-354	The role of <compound-id="164676">tanshinone IIA</compound-id> in the treatment of obesity through <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">peroxisome proliferator-activated receptor gamma</protein-id> antagonism.	tanshinone IIA__peroxisome proliferator-activated receptor gamma__interaction
18818375-367	In conclusion, the enhanced H(2)O(2) contraction in resistance arteries from SHRs seems to be mediated by increased TXA(2) release from <protein-id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</protein-id> followed by elevations in vascular smooth muscle [<compound-id="271">Ca(2</compound-id>+)](i) levels and O(2)(.	Ca(2__COX-1__no_interaction
18818396-379	The <protein-id="P01103,P06876,P10242,P46200">c-myb</protein-id> proto-oncogene and microRNA-<compound-id="10036366">15a</compound-id> comprise an active autoregulatory feedback loop in human hematopoietic cells.	15a__c-myb__interaction
18818396-380	Herein we show that <protein-id="P01103,P06876,P10242,P46200">c-Myb</protein-id> expression is subject to posttranscriptional regulation by microRNA (miRNA)-<compound-id="10036366">15a</compound-id>.	15a__c-Myb__interaction
18818396-381	Exogenous expression of <protein-id="P01103,P06876,P10242,P46200">c-myb</protein-id> mRNA lacking the 3'-UTR partially rescued the miR-<compound-id="10036366">15a</compound-id> induced cell-cycle block.	15a__c-myb__interaction
18818396-382	Occupancy of one canonical <protein-id="P01103,P06876,P10242,P46200">c-Myb</protein-id> binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-<compound-id="10036366">15a</compound-id> expression in K562 cells.	15a__c-Myb__interaction
18818396-384	In aggregate, these findings suggest the presence of a <protein-id="P01103,P06876,P10242,P46200">c-Myb</protein-id>-miR-<compound-id="10036366">15a</compound-id> autoregulatory feedback loop of potential importance in human hematopoiesis.	15a__c-Myb__interaction
18818486-396	The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (<protein-id="P0C187,Q2RSB3">DII</protein-id>) activity, and <compound-id="6076">cAMP</compound-id> content.	cAMP__DII__no_interaction
18818687-454	This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for <compound-id="5839">aldosterone</compound-id> signaling and the control of epithelial <protein-id="P02719">Na(+) channel</protein-id>-alpha (ENaCalpha) subunit gene expression in the collecting duct.	aldosterone__Na(+) channel__no_interaction
18818710-2729	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus <protein-id="O50519,O52951,O57203,O81263,O96720,P03176,P03177,P04363,P04364,P04407,P04408,P06478,P06479,P07605,P08333,P09250,P0A3L9,P0A3M0,P0C0E5,P0C0E6,P0C0E7,P10052,P13157,P13159,P13300,P14342,P14343,P16600,P17402,P17653,P18555,P21293,P22649,P23331,P23335,P23983,P24096,P24424,P24425,P25987,P27363,P28851,P28852,P28855,P33802,P36226,P44309,P47280,P47848,P57926,P65230,P65231,P68563,P68564,P69185,P69186,P75070,Q03221,Q05879,Q05880,Q21Q74,Q28M21,Q2A3U3,Q2FF09,Q2G5F0,Q2K5N6,Q2NIM1,Q2P902,Q2RZH4,Q2SSX9,Q2YUN4,Q31ZS8,Q32GW8,Q38WJ3,Q3BM98,Q3IBU5,Q3K118,Q3Z0V3,Q483R5,Q48TL1,Q492N1,Q49Z66,Q4A7B8,Q4A977,Q4L800,Q4QN19,Q4UNV0,Q57NR0,Q5E4F2,Q5FKZ1,Q5H6C5,Q5HE81,Q5HMA3,Q5JGT7,Q5KUH1,Q5LHP5,Q5LUY8,Q5M0B8,Q5M4W5,Q5NH50,Q5NQ29,Q5PCT4,Q5QWC7,Q5UP25,Q5WB52,Q5WYR3,Q5X7B5,Q5XC70,Q5ZXU5,Q5ZZT0,Q630R8,Q64YL9,Q65DU6,Q65RN9,Q66AM8,Q6A8W6,Q6D4R3,Q6F0I2,Q6G7J1,Q6GEV6,Q6HAV3,Q6KH30,Q6LT81,Q6MHW4,Q6YRB1,Q71WN4,Q72XC1,Q74K26,Q7CQF3,Q7CXF9,Q7MLR4,Q7MVV7,Q7N457,Q7NVK0,Q7UFR1,Q7VLH2,Q7VQZ6,Q814U0,Q81JX0,Q82KI9,Q831F5,Q83A42,Q878R8,Q87QJ8,Q88UT1,Q898Y8,Q8A5G4,Q8CRM9,Q8D8R2,Q8DPZ6,Q8DU63,Q8DZM3,Q8E5C2,Q8ECK0,Q8EM59,Q8EU99,Q8FHX4,Q8NVG5,Q8P126,Q8P3C8,Q8PEQ8,Q8RDA1,Q8RLE0,Q8VVL0,Q8XFQ8,Q8Y4A7,Q8ZEJ1,Q8ZV53,Q90029,Q90033,Q927U9,Q92N38,Q97F65,Q97R22,Q98HR4,Q99ZP6,Q9CHX5,Q9HPQ9,Q9JFB7,Q9K6F0,Q9KST9,Q9PPP5,Q9Q8N6,Q9QNF7,Q9RSY5,Q9WYN2,Q9ZIG2">thymidine kinase</protein-id> (HSVtk)/<compound-id="3454">ganciclovir</compound-id> (<compound-id="445994">GCV</compound-id>) therapy directed by the <protein-id="P06731">carcinoembryonic antigen</protein-id> (<protein-id="P06731">CEA</protein-id>) promoter.	ganciclovir__carcinoembryonic antigen__interaction	GCV__CEA__interaction	ganciclovir__CEA__interaction	GCV__thymidine kinase__interaction	GCV__carcinoembryonic antigen__interaction	ganciclovir__thymidine kinase__interaction
18818710-2730	Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by <protein-id="P06731">CEA</protein-id> promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific <protein-id="Q00398">CAG</protein-id> promoter) with <compound-id="445994">GCV</compound-id> administration were examined in several GBC lines and normal cells.	GCV__CAG__no_interaction	GCV__CEA__no_interaction
18818914-538	Low-temperature (77 K) steady-state fluorescence emission spectroscopy and dynamic light scattering were applied to the main <compound-id="5351507,5459387,6326752,6433193,6914133,9600410">chlorophyll a</compound-id>/<protein-id="P03168">b protein</protein-id> light harvesting complex of photosystem II (LHC II) in different aggregation states to elucidate the mechanism of fluorescence quenching within LHC II oligomers.	chlorophyll a__b protein__interaction
18818946-557	This mutation in the <protein-id="O95528">SLC2A10</protein-id> gene replaces a <compound-id="594,5862,5360637">cysteine</compound-id> encoding codon with a stop signal.	cysteine__SLC2A10__interaction
18819019-595	<protein-id="O53021,P0AFL3,P0AFL4,P0AFL5,P10111,P14851,P17742,P62935,P62936,P62937,P62938,P62940,P62941,Q0ZQK3,Q0ZQK6,Q0ZQK7,Q0ZQK8,Q0ZQL0,Q0ZQL1,Q0ZQL2,Q59641,Q5R8S7,Q6DTV9,Q8HXS3,Q9TTC6">Cyclophilin A</protein-id> (<protein-id="O08469">CypA</protein-id>), a receptor for the immunosuppressive agent <compound-id="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938">cyclosporin A</compound-id> (CsA), is a cis-trans peptidyl-prolyl isomerase (<protein-id="O00060,O00845,O04287,O07046,O08437,O22870,O25748,O25982,O42123,O46638,O49886,O52980,O54998,O60046,O66105,O74191,O75344,O83369,O94746,O95302,P0A9K9,P0A9L0,P0A9L1,P0A9L2,P0A9L3,P0A9L4,P0ABZ6,P0ABZ7,P0ABZ8,P0ABZ9,P0AEM0,P0AEM1,P0AEM2,P0AEM3,P0C196,P0C1B0,P0C1I4,P0C1I5,P0C1I6,P0C1J1,P0C1J3,P0C1J4,P0C1J5,P0C1J6,P0C1J7,P10255,P14088,P14832,P15425,P18203,P18253,P21568,P21569,P21863,P22011,P23284,P23285,P24367,P24368,P24369,P24525,P25007,P25334,P25719,P26623,P26882,P26883,P26884,P26885,P27124,P28517,P28870,P29117,P29820,P30404,P30405,P30412,P30416,P30417,P31106,P32472,P34887,P35176,P35627,P38911,P42693,P44760,P44830,P45523,P45877,P45878,P47103,P48375,P51752,P52009,P52010,P52011,P52012,P52013,P52014,P52015,P52016,P52017,P52018,P53605,P53691,P53728,P54397,P54985,P57599,P59024,P59724,P62942,P62943,P65764,P65765,P69059,P72704,P73789,P80311,P81104,P81531,P82536,P84342,P84343,P91791,Q00688,Q01490,Q02790,Q06205,Q08752,Q09637,Q09734,Q10175,Q11004,Q13356,Q13451,Q26486,Q26551,Q26565,Q2KJC8,Q2U256,Q2U316,Q2U5W8,Q2U6U0,Q2UN37,Q2UPT7,Q38931,Q38935,Q38936,Q39613,Q41649,Q41651,Q43207,Q4HZB8,Q4I1Y1,Q4IBK5,Q4IE79,Q4IN00,Q4INZ9,Q4IPB8,Q4P555,Q4PCH8,Q4PIN7,Q4W9R2,Q4WAQ9,Q4WCR3,Q4WHX4,Q4WLV6,Q4WMB6,Q4WMV5,Q4WVU5,Q57726,Q58235,Q59VR3,Q5ARI5,Q5ASQ0,Q5ATN7,Q5AXD5,Q5AXT6,Q5BAH7,Q5E992,Q5KAW8,Q5KGT9,Q5KHA8,Q5KIJ5,Q5KKX7,Q5KMG3,Q5KNY5,Q5R941,Q5RET2,Q5RF88,Q5UP71,Q5ZLV2,Q5ZXE0,Q61576,Q62446,Q62658,Q64378,Q66H94,Q6BP84,Q6BSE7,Q6BX45,Q6C4C9,Q6CF41,Q6CGG3,Q6CUZ8,Q6CWE8,Q6CX30,Q6DGG0,Q6FK71,Q6FKH7,Q6FMA3,Q6FSC1,Q6KBA8,Q6M981,Q6MWS8,Q754K8,Q756V1,Q7DMA9,Q7RXA6,Q7SCN0,Q7SF72,Q812D3,Q86ZF2,Q871A4,Q89A61,Q8K943,Q8LGG0,Q8WUA2,Q8X191,Q91XW8,Q96AY3,Q99KR7,Q9CR16,Q9CXG3,Q9D0W5,Q9D1M7,Q9D6L8,Q9D787,Q9H2H8,Q9LDC0,Q9LM71,Q9NWM8,Q9NYL4,Q9P3X9,Q9PJK1,Q9QVC8,Q9SCY2,Q9SCY3,Q9TRY0,Q9VL78,Q9Y3C6,Q9Y680,Q9Z247,Q9Z7P3,Q9ZJH5,Q9ZK89">PPIase</protein-id>) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	cyclosporin A__PPIase__no_interaction	cyclosporin A__CypA__interaction	cyclosporin A__Cyclophilin A__interaction
18819053-613	While studies have shown that <compound-id="443872">eplerenone</compound-id> does not exhibit nonspecific actions on <protein-id="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90">androgen receptor</protein-id>, its effects on steroid hormone production have not been reported.	eplerenone__androgen receptor__no_interaction
18819705-825	New treatments for type 2 diabetes mellitus are needed to retain <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> coupling and lower the risk of weight gain and hypoglycaemia.	glucose__insulin__interaction
18819713-827	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total <compound-id="124886">glutathione</compound-id> (TG), as well as the enzymatic activities of <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx) and <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>).	glutathione__CAT__no_interaction	glutathione__GST__no_interaction	glutathione__SOD__no_interaction	glutathione__glutathione S-transferase__no_interaction	glutathione__superoxide dismutase__no_interaction	glutathione__glutathione reductase__no_interaction	glutathione__glutathione peroxidase__no_interaction	glutathione__catalase__no_interaction
18819820-872	Augmentation of antibody responses by <compound-id="444795">retinoic acid</compound-id> and <protein-id="Q5ZPR3,Q7TPB4,Q8VE98">costimulatory molecules</protein-id>.	retinoic acid__costimulatory molecules__no_interaction
18820127-944	In accord with published results, we could show that treatment with <compound-id="6440175">17AAG</compound-id> resulted in depletion of <protein-id="O35280,P34208,Q6DE87,Q91ZN7">Chk1</protein-id>, a known <protein-id="P40292,P41887,Q90474">Hsp90</protein-id> client protein.	17AAG__Chk1__interaction	17AAG__Hsp90__no_interaction
18820127-945	In addition, we observed a time- and dose-dependent decrease in <protein-id="P07527,P47810,Q63802">Wee1</protein-id> kinase level, a negative regulator of mitosis, after <compound-id="6440175">17AAG</compound-id> treatment in gastrointestinal cancer cells.	17AAG__Wee1__interaction
18820134-953	<protein-id="Q8JFG3">Tumor necrosis factor</protein-id> alpha is a proximal mediator of synergistic hepatotoxicity from <compound-id="62959">trovafloxacin</compound-id>/lipopolysaccharide coexposure.	trovafloxacin__Tumor necrosis factor__interaction
18820153-959	A small cytoplasmic protein, <protein-id="Q8N668,Q8WMD0">MURR1</protein-id>, has been identified in human hepatic tissue, but its role in <compound-id="104815">Cu</compound-id> metabolism is unknown.	Cu__MURR1__no_interaction
18820153-962	As with <protein-id="O14618,Q42435,Q6PWT7,Q9SEA0">CCS</protein-id>, they are involved in making <compound-id="104815">Cu</compound-id> available to apo-enzymes inside the cell.	Cu__CCS__interaction
18820175-973	BrdU proliferation assays showed that in vivo proliferation of CD8+ T cells was reduced in <compound-id="702">ethanol</compound-id>-fed mice, and <protein-id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</protein-id>-dependent in vitro proliferation of naive CD8+ T cells was also reduced.	ethanol__IL-2__no_interaction
18820241-987	Multiple studies suggest increased conversion of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> to bile acids by <protein-id="O46491,P18125,P22680,P46634,P51542,Q64505">cholesterol 7alpha-hydroxylase</protein-id> (<protein-id="O46491,P22680,P46634,P51542">CYP7A1</protein-id>) protects against dyslipidemia and atherosclerosis.	cholesterol__cholesterol 7alpha-hydroxylase__interaction	cholesterol__CYP7A1__interaction
18820279-997	Therefore, we queried whether <compound-id="446157">rosuvastatin</compound-id> is prosurvival in podocytes through a <protein-id="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">p21</protein-id>-dependent pathway.	rosuvastatin__p21__interaction
18820825-2189	Treatment with pioglitazone, associated with <compound-id="4091">metformin</compound-id>, showed a reduction of <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> monocyte production after their in vitro activation with LPS.	metformin__IL-6__interaction
18820838-1229	Regulation of T-type <protein-id="P51637,P51638">Cav3</protein-id>.1 channels expression by synthetic glucocorticoid <compound-id="5743">dexamethasone</compound-id> in neonatal cardiac myocytes.	dexamethasone__Cav3__interaction
18820905-1243	The supernatant of the majority of the strains did not release the aglycone from <compound-id="107971,1023571,4183640,11992452,44257214">daidzin</compound-id>, suggesting that cell-associated <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidases</protein-id> (beta-<protein-id="P00864">Glu</protein-id>) are mainly responsible for the metabolism of soybean glyco-conjugates.	daidzin__Glu__no_interaction	daidzin__beta-glucosidases__no_interaction
18820913-1250	Role of <protein-id="Q9UNQ0">BCRP</protein-id> as a biomarker for predicting resistance to <compound-id="3385">5-fluorouracil</compound-id> in breast cancer.	5-fluorouracil__BCRP__interaction
18821018-1286	Acute regulation is mediated by the <protein-id="P58864,Q9DG08">steroidogenic acute regulatory protein</protein-id> (<protein-id="O46689,P49675,P51557,P58864,P70114,P79245,P97826,Q28918,Q28996,Q9DE06,Q9DEB4,Q9DG08,Q9DG09,Q9DG10">StAR</protein-id>), which facilitates the rapid influx of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> into mitochondria, where P450scc resides.	cholesterol__steroidogenic acute regulatory protein__interaction	cholesterol__StAR__interaction
18821018-1287	In the absence of <protein-id="O57525,O73853,P05093,P05185,P11715,P12394,P19100,P27786,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q91Z85,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7">P450c17</protein-id> in the zona glomerulosa, C21 deoxy steroids are produced, leading to the mineralocorticoid, <compound-id="5839">aldosterone</compound-id>.	aldosterone__P450c17__interaction
18821018-1288	In the presence of the 17alpha-hydroxylase but not the 17,20 lyase activity of <protein-id="O57525,O73853,P05093,P05185,P11715,P12394,P19100,P27786,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q91Z85,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7">P450c17</protein-id> in the zona fasciculata, C21, 17-hydroxy steroids are produced, leading to the glucocorticoid, <compound-id="5754">cortisol</compound-id>.	cortisol__P450c17__interaction
18821018-1289	When both the 17alpha-hydroxylase and 17,20 lyase activities of <protein-id="O57525,O73853,P05093,P05185,P11715,P12394,P19100,P27786,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q91Z85,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7">P450c17</protein-id> are present in the zona reticularis, the androgen precursor <compound-id="5881">DHEA</compound-id> is produced.	DHEA__P450c17__interaction
18821018-1291	In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and <protein-id="O04354,P00167,P00168,P00169,P00170,P00171,P00172,P00173,P00174,P40312,P40934,P49096,P49097,P49098,P49100,P56395,Q874I5,Q9HFV1,Q9V4N3,Q9Y706">cytochrome b5</protein-id>, and the low expression of <protein-id="P19871">3beta-hydroxysteroid dehydrogenase</protein-id> (<protein-id="P26439,Q64421">HSD3B2</protein-id>) result in the production of the large amounts of <compound-id="5881">DHEA</compound-id> that characterize adrenarche.	DHEA__3beta-hydroxysteroid dehydrogenase__interaction	DHEA__cytochrome b5__interaction	DHEA__HSD3B2__interaction
18821058-2709	These were mutated in onion <protein-id="O24509,P29000,P29001,Q43857">vacuolar invertase</protein-id> (acINV) according to the residue in festuca <compound-id="5988">sucrose</compound-id> : <protein-id="P49175">sucrose 1</protein-id>-fructosyltransferase (saSST) and vice versa.	sucrose__vacuolar invertase__no_interaction	sucrose__sucrose 1__no_interaction
18821074-2737	<compound-id="24632">Calcium pyrophosphate</compound-id> dihydrate (CPPD) crystals are known to accumulate as substrates of <protein-id="P05186,P08289,P09242">TNSALP</protein-id> in tissues and joints of patients with HP.	Calcium pyrophosphate__TNSALP__interaction
18821127-1366	Optimization of chitosan succinate and chitosan <compound-id="1017">phthalate</compound-id> microspheres for oral delivery of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> using response surface methodology.	phthalate__insulin__interaction
18821127-1367	The relative pharmacological efficacy for chitosan <compound-id="1017">phthalate</compound-id> and chitosan succinate microspheres (18.66+/-3.84%, 16.24+/-4%) was almost three-fold higher than the efficacy of the oral <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> administration (4.68+/-1.52%).	phthalate__insulin__no_interaction
18821579-1511	Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor <compound-id="5352062">FK228</compound-id> through <protein-id="O95831">AIF</protein-id> translocation.	FK228__AIF__interaction
18821579-1513	<compound-id="5352062">FK228</compound-id> converted unconjugated microtubule-associated protein light <protein-id="Q00285">chain 3</protein-id> (<protein-id="P82160">LC3</protein-id>-I) to conjugated light <protein-id="Q00285">chain 3</protein-id> (<protein-id="P82160">LC3</protein-id>-II) and induced localization of <protein-id="P82160">LC3</protein-id> to autophagosomes.	FK228__chain 3__interaction	FK228__LC3__interaction
18821579-1514	<protein-id="O95831,Q9JM53,Q9Z0X1">Apoptosis inducing factor</protein-id> (<protein-id="O95831">AIF</protein-id>), which plays a role in caspase-independent cell death, translocated to the nucleus in response to <compound-id="5352062">FK228</compound-id> treatment.	FK228__Apoptosis inducing factor__interaction	FK228__AIF__interaction
18821853-1612	Furthermore, the effect of <compound-id="445228">HBO</compound-id> on <protein-id="P89113,Q16832">DDR2</protein-id> has not been reported previously.	HBO__DDR2__interaction
18821853-1613	In the present study, we investigated the cellular and molecular mechanisms of <protein-id="P89113,Q16832">DDR2</protein-id> regulation by <compound-id="445228">HBO</compound-id> in VSMCs (vascular SMCs).	HBO__DDR2__interaction
18822097-1667	This <protein-id="P13807,P13834,Q8MJ26">GYS1</protein-id> point mutation appears to cause a gain-of-function of the enzyme and to result in the accumulation of a <compound-id="439177">glycogen</compound-id>-like, less-branched polysaccharide in skeletal muscle.	glycogen__GYS1__interaction
18822097-1668	The aim of this work was to test for possible associations between genetic polymorphisms in four candidate genes of the <compound-id="439177">glycogen</compound-id> pathway or the <protein-id="P13807,P13834,Q8MJ26">GYS1</protein-id> mutation in Cob Normand draught horses diagnosed with PSSM by muscle biopsy.	glycogen__GYS1__no_interaction
18822099-1671	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol <protein-id="P05521,P19197,P21309,P23148,P41302,Q06878,Q7N576,Q9AJA7,Q9S3Z2">acyltransferase</protein-id> (<protein-id="O75907,Q8MK44,Q9GMF1">DGAT1</protein-id>), <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> and <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id> receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of <compound-id="441">beta-hydroxybutyrate</compound-id>, <compound-id="206,5793,64689,79025">glucose</compound-id> and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	beta-hydroxybutyrate__leptin__no_interaction	beta-hydroxybutyrate__DGAT1__no_interaction	glucose__growth hormone__no_interaction	glucose__leptin__no_interaction	beta-hydroxybutyrate__acyltransferase__no_interaction	glucose__DGAT1__no_interaction	glucose__acyltransferase__no_interaction	beta-hydroxybutyrate__growth hormone__no_interaction
18822105-1672	Pretransplant conditioning consisted of <compound-id="657237">fludarabine</compound-id>, l-<protein-id="O75592,P10731,P14925,P19021,P83388,P97467">PAM</protein-id> and TBI (2 Gy).	fludarabine__PAM__no_interaction
18822107-1673	Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, <protein-id="P00083,P00090,P00091,P00094,P00096,P00149,P00154,P04164,P0AAE0,P0AAE1,P0C0X8,P0C189,P38091,P42426,P43302,P56205,Q2RVM4,Q3J164,Q45233,Q57142,Q5SME3,Q9RQB9">CycA</protein-id>, daclizumab, and <protein-id="P15513">MMF</protein-id>, daily protein excretion and serum <compound-id="588">creatinine</compound-id> increased.	creatinine__MMF__no_interaction	creatinine__CycA__no_interaction
18822278-1745	Inhibition of <protein-id="O14313,O22711,O30973,O32823,O43099,O66790,O69777,O83790,O84101,P0A9P4,P0A9P5,P0AE52,P0AE53,P0AE54,P0AE55,P14292,P14293,P21762,P26830,P30044,P34227,P39916,P40553,P43496,P43788,P44411,P44758,P46843,P47348,P49537,P50971,P51272,P51978,P52213,P52214,P52215,P55979,P56431,P56577,P56578,P56876,P57279,P57399,P61076,P65688,P65689,P66010,P66011,P73728,P75531,P80880,P80892,P81433,P94284,P99029,P99101,Q01116,Q05741,Q25861,Q53212,Q55624,Q5HHQ4,Q5HQW4,Q6BIS1,Q6C7L4,Q6FR39,Q6GB66,Q6GIM7,Q75CM8,Q7Z7S3,Q89AJ2,Q89AS1,Q8CPY8,Q8J0U0,Q8K9W0,Q8T6Z1,Q92375,Q928B5,Q92I02,Q98PK9,Q9BGI1,Q9GLW7,Q9GLW9,Q9KSS4,Q9M7T0,Q9PKT7,Q9PR71,Q9R063,Q9Z8M4,Q9ZD97,Q9ZHF0,Q9ZL18,Q9ZMU4">thioredoxin reductase</protein-id> by <compound-id="94304">mansonone F</compound-id> analogues: Implications for anticancer activity.	mansonone F__thioredoxin reductase__interaction
18822413-1812	<protein-id="P81182">High-density-lipoproteins</protein-id>-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (HDL-C) is invertedly related to the incidence of cardiovascular events.	cholesterol__High-density-lipoproteins__interaction
18823071-2096	An isocratic fluorescence HPLC assay for the monitoring of <protein-id="O88202,P26900,P30363,P50286,Q9U518">l-asparaginase</protein-id> activity and l-<compound-id="236,6267,342043,439600">asparagine</compound-id> depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.	asparagine__l-asparaginase__no_interaction
18823430-2181	Effects of <protein-id="P33261">CYP2C19</protein-id> and <protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id> genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and <compound-id="54688,84029,4663848,5284534,5311050,6426662,11969952,13048687,44629879">clarithromycin</compound-id>.	clarithromycin__MDR1__interaction	clarithromycin__CYP2C19__interaction
18823436-2183	Anti-gastric cancer effects of <compound-id="2662">celecoxib</compound-id>, a selective COX-2 inhibitor, through inhibition of <protein-id="P31750,Q8INB9">Akt</protein-id> signaling.	celecoxib__Akt__interaction
18823687-2243	Effect of renin-angiotensin-<compound-id="5839">aldosterone</compound-id> system inhibition, dietary sodium restriction, and/or diuretics on urinary <protein-id="O54947">kidney injury molecule 1</protein-id> excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.	aldosterone__kidney injury molecule 1__interaction
18823722-2255	Among the R-Nx strains, a substitution of <compound-id="750,5460845">Gly</compound-id> to Cys at position 81 (Gly81 Cys) of the <protein-id="O33149,O33926,O50628,O51396,O67108,O83051,O84192,P05653,P0AES4,P0AES5,P0C0Q9,P0C0R0,P14829,P20831,P21557,P22446,P34030,P35810,P35885,P37411,P41080,P41513,P43700,P47235,P47250,P47719,P48354,P48369,P48370,P48371,P48372,P50071,P57277,P72065,P72524,P94605,Q03470,Q07702,Q2FKQ0,Q2G2Q0,Q49166,Q49467,Q49608,Q55738,Q57532,Q5HJZ0,Q5HK04,Q5XC58,Q6GD84,Q6GKT9,Q89AS3,Q8DPM2,Q8K7H2,Q8K9W2,Q8NKW8,Q8P116,Q92IZ6,Q932M0,Q99XG5,Q9L7Q5,Q9PKK4,Q9PR63,Q9Z8R4,Q9ZLD9">gyrA</protein-id> gene in 10 strains isolated from wild birds and ovine foetuses, and of Asp to Tyr at position 87 (Asp87 Tyr) in one strain isolated from ewe faeces, were revealed by sequencing the gene.	Gly__gyrA__interaction
18823727-2261	Expansion of the first <compound-id="5950">polyalanine</compound-id> tract of the <protein-id="O42115,Q96QS3">ARX</protein-id> gene in a boy presenting with generalized dystonia in the absence of infantile spasms.	polyalanine__ARX__interaction
18823727-2262	Gene sequencing detected an additional seven GCG repeats in the first <compound-id="5950">polyalanine</compound-id> tract of the <protein-id="O42115,Q96QS3">ARX</protein-id> gene, a mutation which leads to an expansion of the normal 16 <compound-id="602,4580,5950,71080">alanine</compound-id> residues to 23.	alanine__ARX__interaction	polyalanine__ARX__interaction
18823739-2263	Vascular endothelial dysfunction (VED) results in reduced activation of endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>), reduced generation and bioavailability of <compound-id="145068">nitric oxide</compound-id> (NO) and increased production of reactive oxygen species (ROS).	nitric oxide__eNOS__no_interaction	nitric oxide__nitric oxide synthase__no_interaction
18823877-2298	Emerging evidence that both <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id> (<protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>) and <compound-id="28486,3028194">lithium</compound-id> suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	lithium__brain-derived neurotrophic factor__no_interaction	lithium__BDNF__no_interaction
18823890-2301	We determined the plasma concentrations of <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> (TRP), <compound-id="161166">KYN</compound-id>, <compound-id="89">3-hydroxykynurenine</compound-id> (3-HKYN); two distinct SOX markers: Cu/Zn <protein-id="O50258">superoxide dismutase</protein-id> (Cu/Zn <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) and total <compound-id="784">peroxide</compound-id> ; and high sensitivity C-reactive protein (hs <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>) as a indicator of inflammation in 146 ESRD patients and healthy controls.	KYN__superoxide dismutase__no_interaction	tryptophan__SOD__no_interaction	tryptophan__superoxide dismutase__no_interaction	KYN__CRP__no_interaction	peroxide__CRP__no_interaction	3-hydroxykynurenine__SOD__no_interaction	KYN__SOD__no_interaction	3-hydroxykynurenine__superoxide dismutase__no_interaction	tryptophan__CRP__no_interaction	peroxide__superoxide dismutase__no_interaction	peroxide__SOD__no_interaction	3-hydroxykynurenine__CRP__no_interaction
18823890-2304	ESRD patients showed a significant increase in Cu/Zn <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, total <compound-id="784">peroxide</compound-id> and hs <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id> levels between controls and all patients group.	peroxide__SOD__no_interaction	peroxide__CRP__no_interaction
18823964-2330	Diabetes is characterized by elevated fasting blood <compound-id="206,5793,64689,79025">glucose</compound-id> (FBG) resulting from improper <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> regulation and/or <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance.	glucose__insulin__interaction
18823964-2332	THII significantly diminished these changes in <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>.	glucose__insulin__no_interaction
18824011-260	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of <compound-id="951,439260">noradrenaline</compound-id> (<compound-id="923,373840">NA</compound-id>), adenosine 5 '-triphosphate (ATP), and <compound-id="5893">beta-nicotinamide adenine dinucleotide</compound-id> (<compound-id="5893">beta-NAD</compound-id>) in the presence of low nanomolar concentrations of omega-<protein-id="P83301,P83390">conotoxin</protein-id> GVIA or <protein-id="P30288">omega-agatoxin IVA</protein-id> in the canine mesenteric arteries and veins.	beta-nicotinamide adenine dinucleotide__omega-agatoxin IVA__interaction	NA__conotoxin__interaction	beta-NAD__conotoxin__interaction	NA__omega-agatoxin IVA__interaction	beta-nicotinamide adenine dinucleotide__conotoxin__interaction	noradrenaline__conotoxin__interaction	noradrenaline__omega-agatoxin IVA__interaction	beta-NAD__omega-agatoxin IVA__interaction
18824106-2403	An extensive kinetic profile towards a plethora of purines and mutational analyses have established models on how <protein-id="Q07307">UapA</protein-id> recognizes the <compound-id="1044">purine ring</compound-id> and revealed specific amino acid residues involved in proper folding, topogenesis, function and specificity.	purine ring__UapA__interaction
18824106-2404	The present work describes for the first time the purification of the <protein-id="Q07307">UapA</protein-id> transporter of A. nidulans through overexpression via the strong, <compound-id="702">ethanol</compound-id>-inducible, <compound-id="206,5793,64689,79025">glucose</compound-id>-repressible, <protein-id="P08843,P65199,P65200,Q44740">alcA</protein-id> promoter.	ethanol__UapA__interaction	glucose__UapA__interaction	ethanol__alcA__interaction	glucose__alcA__interaction
18824121-2411	Three enzymes function in biosynthesis of <compound-id="8977">GDP</compound-id>-<compound-id="18950">mannose</compound-id> from the glycolytic intermediate <compound-id="69507">fructose 6-phosphate</compound-id> : <protein-id="O66954,P00946,P07874,P25081,P29951,P29952,P29954,P29956,P34650,P34948,P34949,P39841,P59785,Q3SZI0,Q44407,Q4JCA7,Q59935,Q66WM4,Q68FX1,Q75AB5,Q76IQ2,Q83KZ1,Q870Y1,Q887Q9,Q88ND5,Q8HXX2,Q8J093,Q8ZWV0,Q924M7,Q96YC2,Q978F3,Q97WE5,Q9GP38,Q9HFU4,Q9HIC2,Q9YE01">phosphomannose isomerase</protein-id> (<protein-id="O66954,P00946,P07874,P25081,P29951,P29952,P29954,P29956,P34650,P34948,P34949,P39841,P59785,Q3SZI0,Q44407,Q4JCA7,Q59935,Q66WM4,Q68FX1,Q75AB5,Q76IQ2,Q83KZ1,Q870Y1,Q887Q9,Q88ND5,Q8HXX2,Q8J093,Q8ZWV0,Q924M7,Q96YC2,Q978F3,Q97WE5,Q9GP38,Q9HFU4,Q9HIC2,Q9YE01">PMI</protein-id>), <protein-id="O43976,O85343,P07283,P24175,P26341,P26405,P29955,P31353,P37742,P37755,P45632,P47299,P47723,P55356,P75050,Q00330,Q01411,Q06951,Q48463,Q9UTJ2">phosphomannomutase</protein-id> (<protein-id="O43976,O80840,O85343,P07283,P18159,P24175,P26341,P26405,P29955,P31353,P37742,P37755,P45632,P47299,P47723,P55356,P75050,Q00330,Q01411,Q06951,Q48463,Q57290,Q57842,Q9UTJ2,Q9VTZ6,Q9XUE6">PMM</protein-id>) and <protein-id="O74484,O74624,O85342,O93827,P07874,P24174,P26340,P26404,P29956,P37741,P37753,P37820,P41940,P55357,P59785,Q00473,Q01410,Q07024,Q2UJU5,Q48462,Q4I1Y5,Q4U3E8,Q5B1J4,Q5KKH2,Q6BN12,Q6CCU3,Q70SJ2,Q752H4,Q7RVR8,Q887Q9,Q88ND5,Q9P8N0">GDP-mannose pyrophosphorylase</protein-id> (GMPP).	GDP__PMI__interaction	fructose 6-phosphate__GDP-mannose pyrophosphorylase__interaction	GDP__PMM__interaction	fructose 6-phosphate__phosphomannomutase__interaction	fructose 6-phosphate__phosphomannose isomerase__interaction	mannose__phosphomannose isomerase__interaction	mannose__PMM__interaction	mannose__GDP-mannose pyrophosphorylase__interaction	GDP__phosphomannomutase__interaction	GDP__phosphomannose isomerase__interaction	fructose 6-phosphate__PMI__interaction	fructose 6-phosphate__PMM__interaction	mannose__PMI__interaction	mannose__phosphomannomutase__interaction	GDP__GDP-mannose pyrophosphorylase__interaction
18824121-2412	Synthesis of <compound-id="8977">GDP</compound-id>-<compound-id="18950">mannose</compound-id> from exogenous <compound-id="18950">mannose</compound-id> requires <protein-id="P33284,P50506,P80581,Q02155,Q26609,Q969A8">hexokinase</protein-id> or phosphotransferase enzymes together with <protein-id="O43976,O80840,O85343,P07283,P18159,P24175,P26341,P26405,P29955,P31353,P37742,P37755,P45632,P47299,P47723,P55356,P75050,Q00330,Q01411,Q06951,Q48463,Q57290,Q57842,Q9UTJ2,Q9VTZ6,Q9XUE6">PMM</protein-id> and GMPP.	GDP__PMM__interaction	mannose__hexokinase__interaction	GDP__hexokinase__interaction	mannose__PMM__interaction
18824341-1648	Preincubation of airway epithelial cells with <compound-id="446925">lycopene</compound-id> (dissolved in <compound-id="8028">tetrahydrofuran</compound-id>) delivered <compound-id="446925">lycopene</compound-id> into the cells and resulted in a 24% reduction in <protein-id="P41693">interleukin-6</protein-id> after rhinovirus-1B infection, 31% reduction in <protein-id="P02778,P17515,P48973">IP-10</protein-id> after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	lycopene__IP-10__interaction	tetrahydrofuran__IP-10__interaction	lycopene__interleukin-6__interaction	tetrahydrofuran__interleukin-6__interaction
18824415-2564	<protein-id="P84122">Thrombin</protein-id>, vascular endothelial growth factor, and <compound-id="784">hydrogen peroxide</compound-id> increased EC permeability, disrupted cell junctions, and induced stress fiber formation.	hydrogen peroxide__Thrombin__interaction
18824476-2583	Clarified glycomic and protemic information combined with publicly available microarray data sets allowed us to identify <protein-id="P08699,P16110,P17931,P38486,P47845,P47953">galectin-3</protein-id> as a receptor of <compound-id="16219440">Galalpha1-3Gal</compound-id> epitope.	Galalpha1-3Gal__galectin-3__interaction
18824496-2592	Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by <compound-id="5961">polyglutamine</compound-id> expansion mutation in the <protein-id="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90">androgen receptor</protein-id> (AR).	polyglutamine__androgen receptor__interaction
18824518-2598	Also, our previous studies implicated the SphK1/<protein-id="Q14703,Q9Z2A8">S1P</protein-id> pathway in the induction of the <compound-id="444899">arachidonic acid</compound-id> cascade, a major inflammatory pathway involved in colon carcinogenesis.	arachidonic acid__S1P__interaction
18824518-2599	In the <compound-id="33184">azoxymethane</compound-id> (<compound-id="33184">AOM</compound-id>) murine model of colon cancer, SphK1 and <protein-id="Q14703,Q9Z2A8">S1P</protein-id> were significantly elevated in colon cancer tissues compared to normal mucosa.	AOM__S1P__interaction	azoxymethane__S1P__interaction
18824524-2604	Uptake of <compound-id="60846">valsartan</compound-id>, <compound-id="3961">losartan</compound-id>, and <compound-id="47965">cefadroxil</compound-id> was quantified in HeLa cells after heterologous expression of human <protein-id="P36836,P46059,Q8WMX5">PEPT1</protein-id> (hPEPT1).	valsartan__PEPT1__interaction	losartan__PEPT1__interaction	cefadroxil__PEPT1__interaction
18824524-2605	In contrast to <compound-id="47965">cefadroxil</compound-id>, no <protein-id="P36836,P46059,Q8WMX5">PEPT1</protein-id>-specific uptake of <compound-id="60846">valsartan</compound-id> and <compound-id="3961">losartan</compound-id> was found.	valsartan__PEPT1__no_interaction	losartan__PEPT1__no_interaction	cefadroxil__PEPT1__interaction
18824527-2607	The 2-(acylamino)-3-thiophenecarboxylates suppressed <protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">CFTR</protein-id>-mediated <compound-id="312">Cl</compound-id> (-) current in T84 colonic cells in response to cholera and Escherichia coli (STa) toxins, and prevented intestinal fluid accumulation in a closed-loop mouse model of secretory diarrhea.	Cl__CFTR__interaction
18824596-2638	We investigated the hypothesis that modulation of EPC biology and attenuation of allograft vasculopathy by increased <protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> after human apo A-I (AdA-I) transfer requires scavenger receptor (SR)-BI expression in bone marrow-derived EPCs.	cholesterol__high-density lipoprotein__interaction
18824635-2654	<protein-id="P15304,P16386,P54310,Q05469,Q68J42,Q9R101">Hormone-sensitive lipase</protein-id> (<protein-id="P15304,P16386,P54310,Q05469,Q68J42,Q9R101">HSL</protein-id>) is a key regulator of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> esters metabolism.	cholesterol__HSL__interaction	cholesterol__Hormone-sensitive lipase__interaction
18825162-2817	We found associations between the <compound-id="4192">midazolam</compound-id> phenotype and age, diagnosis of hypertension and one htSNP (141689) located upstream of <protein-id="P08684">CYP3A4</protein-id>.	midazolam__CYP3A4__no_interaction
18825163-2818	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> and free <compound-id="5757">oestradiol</compound-id> are independent risk factors for benign prostatic hyperplasia.	oestradiol__Insulin__no_interaction
18825163-2819	The objective of the present study was to test the <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, <compound-id="5757">oestradiol</compound-id> and metabolic syndrome hypotheses as promoters of BPH.	oestradiol__insulin__no_interaction
18825163-2820	Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> (beta=0.200, P=0.028), free <compound-id="5757">oestradiol</compound-id> (beta=0.233, P=0.008) and lean body mass (beta=0.257, P=0.034).	oestradiol__insulin__no_interaction
18825163-2821	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> and free <compound-id="5757">oestradiol</compound-id> appear to be independent risk factors for BPH, confirming both the <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and the <compound-id="5757">oestradiol</compound-id> hypotheses.	oestradiol__Insulin__no_interaction	oestradiol__insulin__no_interaction
18825302-18	<compound-id="65981">Repaglinide</compound-id> plus single-dose <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.	Repaglinide__insulin__no_interaction
18825335-25	Much interest has been directed to the study of the <protein-id="Q697L1,Q8NER1">TRPV1</protein-id>, because <compound-id="1548943">capsaicin</compound-id> has been instrumental in discovering the unique role of a subset of primary sensory neurons in causing nociceptive responses, in activating reflex pathways including cough, and in producing neurogenic inflammation.	capsaicin__TRPV1__no_interaction
18825368-41	To evaluate <compound-id="8230,644077,44285245">arginine vasopressin</compound-id> (AVP) and <protein-id="P01180,P01181,P01183,P01185,P01186,P10769,P35455">copeptin</protein-id> plasma concentrations in patients with vasodilatory shock after cardiac surgery.	arginine vasopressin__copeptin__no_interaction
18825380-47	In this study, we report a novel <protein-id="P13224,P56400,Q04785">GPIbbeta</protein-id> defect in a Tunisian family, in which <compound-id="5951">Serine</compound-id> 23 is substituted by a Stop codon causing a premature termination of translation.	Serine__GPIbbeta__interaction
18825527-114	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) <compound-id="1702">NHP</compound-id> (O) Cl2 with R = pCl-C6H4 1a, <compound-id="11852">pBr</compound-id>-C6H4 2a, C6H5 3a, and <compound-id="134601">pMe</compound-id>-C6H4 4a and RC(O) <compound-id="1702">NHP</compound-id> (O)(NC4H8O)2 R = pCl-C6H4 1b, <compound-id="11852">pBr</compound-id>-C6H4 2b, C6H5 3b, <compound-id="134601">pMe</compound-id>-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of <compound-id="398803">compound 2a</compound-id>, 2b and 3a, were studied.	compound 2a__acetylcholinesterase__no_interaction	NHP__acetylcholinesterase__no_interaction	pBr__acetylcholinesterase__no_interaction	pMe__acetylcholinesterase__no_interaction
18825528-117	The presented study is aimed at reactivation of <compound-id="5853">trichlorfon</compound-id>-inhibited butyrylcholinesterase since this enzyme play an important role in Alzheimer's disease as deputy for <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> and furthermore it could be applied as a scavenger in case of overdosing.	trichlorfon__acetylcholinesterase__no_interaction
18825531-118	Among them, <compound-id="5858639">compound 3</compound-id> and 5 had significant <protein-id="P27730">calpain</protein-id> inhibitory activities.	compound 3__calpain__interaction
18825537-122	Here we report the docking study of four <compound-id="4630">green tea</compound-id> catechins and four alkylating anticancer drugs into the <protein-id="P80031">GST P1-1</protein-id> model, as <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GSTs</protein-id> were found to be affected by tea catechins.	green tea__GST P1-1__interaction	green tea__GSTs__interaction
18825553-139	The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine <protein-id="P21847,P83517">serum albumin</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id>.	glucose__serum albumin__no_interaction
18825555-141	In vitro effects of <compound-id="104806">peroxynitrite</compound-id> treatment on fish liver <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> activity.	peroxynitrite__catalase__interaction
18825555-142	The effect of <compound-id="104806">peroxynitrite</compound-id> (PN), a highly toxic agent, on <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>) activity in fish liver microsomal homogenates was determined.	peroxynitrite__catalase__interaction	peroxynitrite__CAT__interaction
18825778-209	NMR-derived <compound-id="6037">folate</compound-id>-bound structure of <protein-id="Q5V3R2">dihydrofolate reductase 1</protein-id> from the halophile Haloferax volcanii.	folate__dihydrofolate reductase 1__interaction
18826375-301	<compound-id="773,6274">Histidine</compound-id>-regulated activity of <protein-id="O00602,O70165,Q9WTS8">M-ficolin</protein-id>.	Histidine__M-ficolin__interaction
18826375-305	The biological roles of the <compound-id="773,6274">histidine</compound-id>-regulated conformational equilibrium of <protein-id="O00602,O70165,Q9WTS8">M-ficolin</protein-id> are discussed in terms of the self and non-self discrimination mechanism.	histidine__M-ficolin__interaction
18826425-314	The Iowa Gambling Task (IGT) was used to examine (i) social decision-making in women with borderline personality disorder (BPD), and (ii) the relationship between impaired decision-making and the tryptophan hydroxylase-1 (<protein-id="P90697">TPH-1</protein-id>) gene, involved in <compound-id="5202">serotonin</compound-id> synthesis.	serotonin__TPH-1__interaction
18826485-2656	These results underscore the differential regulation of <protein-id="O77834,P83564,Q00277">GPX</protein-id> expression in response to cadmium, <compound-id="5359268">aluminium</compound-id> and <compound-id="145068">nitric oxide</compound-id>, and strongly support a role for <protein-id="O48646,P59796,Q96SL4">GPX6</protein-id> and possibly other <protein-id="O77834,P83564,Q00277">GPX</protein-id> genes in stress and/or metabolic signalling.	nitric oxide__GPX6__interaction	aluminium__GPX__interaction	aluminium__GPX6__interaction	nitric oxide__GPX__interaction
18827283-620	Effects of acceptor composition and mechanism of <protein-id="P45844">ABCG1</protein-id>-mediated cellular free <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> efflux.	cholesterol__ABCG1__interaction
18827283-621	Among the known mechanisms of reverse cholesterol transport (RCT), ATP binding cassette transporter G1 (<protein-id="P45844">ABCG1</protein-id>)-mediated free <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (FC) transport is the most recent and least studied.	cholesterol__ABCG1__interaction
18827283-622	Here, we have characterized the efficiencies of different acceptors using baby hamster kidney (BHK) cells transfected with human <protein-id="P45844">ABCG1</protein-id> cDNA, which is inducible upon treatment with <compound-id="55245">mifepristone</compound-id>.	mifepristone__ABCG1__interaction
18827741-766	<compound-id="3961">Losartan</compound-id> treatment significantly attenuated <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, and <protein-id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</protein-id> 6 h after CLP.	Losartan__IL-1beta__interaction	Losartan__IL-6__interaction	Losartan__TNF-alpha__interaction
18827742-767	<protein-id="P15160,P17724,P73925,Q03459">Hemoglobin</protein-id> vesicles and red blood cells as carriers of <compound-id="281">carbon monoxide</compound-id> prior to <compound-id="977">oxygen</compound-id> for resuscitation after hemorrhagic shock in a rat model.	carbon monoxide__Hemoglobin__interaction	oxygen__Hemoglobin__interaction
18827746-775	Reduced responses of <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P41589,P61280,P61281,P68000,P68001,P87352,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">alpha-MSH</protein-id> or <protein-id="O26279,O30024,O59193,P0C0K9,Q01631,Q08597,Q47005,Q4J6D8,Q57728,Q5JGB7,Q5V5C9,Q6L1N3,Q6M0I0,Q8PVF0,Q8TSA1,Q8TWS7,Q8U0P1,Q96YI2,Q97CI3,Q9HI94,Q9HS36,Q9V0Z2,Q9YFQ1">Nac</protein-id>-beta-END IRM to <protein-id="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1">CRH</protein-id> and the invalid suppression by <compound-id="5743">dexamethasone</compound-id> reflect a state of dysfunction of the melanotroph-type <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01201,P06297,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q91082,Q9YGK2">POMC</protein-id> system in nonsurvivors.	dexamethasone__Nac__no_interaction	dexamethasone__POMC__no_interaction	dexamethasone__CRH__no_interaction	dexamethasone__alpha-MSH__no_interaction
18827747-776	Systemic, hepatosplanchnic, and renal hemodynamics; <compound-id="977">oxygen</compound-id> exchange; energy metabolism (<compound-id="612">lactate</compound-id>/<compound-id="1060">pyruvate</compound-id> and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>); nitrosative/oxidative stress (<compound-id="2723628">thiobarbituric acid</compound-id> reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (<compound-id="123831">asymmetric dimethylarginine</compound-id>, <protein-id="Q62935">von Willebrand factor</protein-id>, <protein-id="P84122">thrombin</protein-id>-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	thiobarbituric acid__TNF-alpha__no_interaction	oxygen__von Willebrand factor__no_interaction	thiobarbituric acid__IL-6__no_interaction	pyruvate__IL-6__no_interaction	lactate__von Willebrand factor__no_interaction	pyruvate__thrombin__no_interaction	pyruvate__von Willebrand factor__no_interaction	oxygen__IL-6__no_interaction	thiobarbituric acid__thrombin__no_interaction	oxygen__TNF-alpha__no_interaction	asymmetric dimethylarginine__thrombin__no_interaction	lactate__thrombin__no_interaction	lactate__TNF-alpha__no_interaction	asymmetric dimethylarginine__von Willebrand factor__no_interaction	asymmetric dimethylarginine__TNF-alpha__no_interaction	thiobarbituric acid__von Willebrand factor__no_interaction	asymmetric dimethylarginine__IL-6__no_interaction	lactate__IL-6__no_interaction	pyruvate__TNF-alpha__no_interaction	oxygen__thrombin__no_interaction
18827975-862	The purpose of this retrospective study was to compare the effects of <protein-id="P01050">lepirudin</protein-id> and <compound-id="2232,92722,152951,440542,445156">argatroban</compound-id> in the management of HIT.	argatroban__lepirudin__no_interaction
18828007-864	The outer membrane <protein-id="P02930,Q54001,Q9K2Y1">TolC</protein-id> is involved in <compound-id="594,5862,5360637">cysteine</compound-id> tolerance and overproduction in Escherichia coli.	cysteine__TolC__interaction
18828007-866	Gene expression analysis revealed that the <protein-id="P02930,Q54001,Q9K2Y1">tolC</protein-id> gene encoding the outer membrane channel is essential for <compound-id="581,5862,5460838">L-cysteine</compound-id> tolerance in E. coli cells.	L-cysteine__tolC__interaction
18828019-168	The present study was performed to elucidate the relationship between the expression of <protein-id="P08183,P21448">ABCB1</protein-id>/<protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id> and <protein-id="P33527,Q5F364">ABCC1</protein-id>/<protein-id="P10662,P20585,P33527,Q5F364,Q6UR05,Q864R9,Q8HXQ5,Q9C8G9">MRP1</protein-id> with resistance to either <compound-id="108150,44584244">ET-743</compound-id> or PM00104.	ET-743__MRP1__interaction	ET-743__ABCC1__interaction	ET-743__ABCB1__interaction	ET-743__MDR1__interaction
18828793-1124	The previous <compound-id="5280965">amphotericin B</compound-id>, <protein-id="P35834,Q28746">granulocyte colony-stimulating factor</protein-id>, hyperbaric <compound-id="977">oxygen</compound-id> and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	oxygen__granulocyte colony-stimulating factor__no_interaction	amphotericin B__granulocyte colony-stimulating factor__no_interaction
18829006-1222	<protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">Glutathione S-transferase</protein-id> (<protein-id="P09488,P16413,Q9N0V4,Q9TSM5">GSTM1</protein-id>) plays an important role in the excretion of <compound-id="289,9064,73160">catechol</compound-id> estrogens and is therefore a candidate marker for fibroids.	catechol__GSTM1__interaction	catechol__Glutathione S-transferase__interaction
18829132-1261	Bacterial strains differed in their ability to synthesize <compound-id="802">auxin</compound-id> and <compound-id="768">hydrogen cyanide</compound-id> compounds, as well as in their <protein-id="O57809,P30297,Q00740,Q51813,Q5KMX3,Q5PWZ8,Q62CE3,Q63KN7,Q6J256,Q7M523,Q87YW7,Q89XR6,Q8U4R3,Q8XS35,Q93AG0,Q98AM7,Q9AHF0,Q9URX3,Q9V2L2,Q9WY68,Q9ZHW3">ACC deaminase</protein-id> activity.	auxin__ACC deaminase__no_interaction	hydrogen cyanide__ACC deaminase__no_interaction
18829266-1329	Toll-like receptor (<protein-id="P23799">TLR</protein-id>) 4 is a critical receptor and signal transducer for <compound-id="11970143">lipopolysaccharide</compound-id> (LPS), a major component of Gram-negative bacteria.	lipopolysaccharide__TLR__interaction
18829281-1345	Postprandial <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>.05) in HTAG.	glucose__CRP__no_interaction
18829286-1353	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the <compound-id="6326970">selenium</compound-id>-dependent <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidases</protein-id>, <protein-id="P18283,P83645,Q4AEH7,Q4AEH8,Q4AEH9,Q4AEI0,Q9JHC0">GPx2</protein-id>.	selenium__GPx2__interaction	selenium__glutathione peroxidases__interaction
18829287-2771	The purpose of this study was to investigate whether or not the role of <compound-id="445580">docosahexaenoic acid</compound-id> (DHA) supplementation on cognitive capability was related with <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id> (<protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>), <compound-id="145068">nitric oxide</compound-id> (NO) and <compound-id="681">dopamine</compound-id> (DA) in aged mice.	nitric oxide__BDNF__no_interaction	dopamine__brain-derived neurotrophic factor__no_interaction	docosahexaenoic acid__BDNF__interaction	nitric oxide__brain-derived neurotrophic factor__no_interaction	docosahexaenoic acid__brain-derived neurotrophic factor__interaction	dopamine__BDNF__no_interaction
18829372-151	Model analysis of local <compound-id="977">oxygen</compound-id> delivery with liposome-encapsulated <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id>.	oxygen__hemoglobin__interaction
18829372-152	Liposome-encapsulated <protein-id="P15160,P17724,P73925,Q03459">hemoglobins</protein-id> (LHs) are comparable to red blood cells (RBCs) in terms of <compound-id="977">oxygen</compound-id> (O(2))-carrying capacity.	oxygen__hemoglobins__interaction
18829677-1475	Moreover, both lung and plasma concentrations of the pro-inflammatory cytokines tumour necrosis factor-alpha and <protein-id="Q9TTB0">interferon-gamma</protein-id> were higher in <compound-id="942,89594,157672">nicotine</compound-id>-treated animals at this time-point.	nicotine__interferon-gamma__interaction
18829704-1495	The role of <compound-id="26623">Hg(2</compound-id>+)-insensitive <protein-id="O14520">AQP7</protein-id>, if any, in sperm volume regulation was studied in transgenic mice.	Hg(2__AQP7__no_interaction
18829704-1496	Therefore, the <compound-id="26623">Hg(2</compound-id>+)-sensitive <protein-id="O94778,Q5I4F8">AQP8</protein-id>, which was localized in elongated spermatids and spermatozoa, is a likely candidate for a water channel responsible for physiological sperm volume regulation crucial to in vivo fertilization.	Hg(2__AQP8__interaction
18829979-1580	Increased intrahepatic vascular tone in cirrhosis has been attributed to a decrease of hepatic <compound-id="145068">nitric oxide</compound-id> (NO) secondary to disturbances in the post-translational regulation of the enzyme <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>.	nitric oxide__eNOS__no_interaction
18830228-1650	<protein-id="O27580,O28041,O58582,O60105,O66856,P0AB89,P0AB90,P12047,P21265,P30566,P44797,P52201,P54822,P56468,P57351,P72478,P74384,Q05911,Q21774,Q2FFI7,Q2G2S0,Q2YU66,Q49YV3,Q4L7M3,Q58339,Q5HEL4,Q5HN26,Q60Q90,Q6G825,Q6GFE9,Q7A0G9,Q7A4Q3,Q89AM3,Q8CRT6,Q8HXY5,Q8K9Q7,Q99SX9,Q9RSE6,Q9UZ99,Q9X0I0,Q9ZKA2">Adenylosuccinate lyase</protein-id> deficiency is a rare autosomal disorder of de novo <compound-id="1044">purine</compound-id> synthesis, which results in the accumulation of succinylpurines in body fluids.	purine__Adenylosuccinate lyase__interaction
18830228-1651	Both patients had an increased <compound-id="165243,20849086">succinyladenosine</compound-id>/SAICAr ratio of 1.6, and exhibited a novel homozygous missense mutation (c.674T&gt;C; p.Met225Thr) in the exon 6 of the <protein-id="P21265,P30566,Q8HXY5">ADSL</protein-id> gene.	succinyladenosine__ADSL__interaction
18830381-1696	The profile of global DNA and <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> (ER)-alpha gene methylation during cancer development was determined by analysis of <compound-id="65040">5-methylcytosine</compound-id> (5-<compound-id="448166">MeC</compound-id>) using immunohistochemical (IHC) staining, dot blot analysis or a quantitative gene methylation assay (QGMA).	5-methylcytosine__estrogen receptor__interaction	MeC__estrogen receptor__interaction
18830594-1807	Zebularine suppresses the apoptotic potential of <compound-id="3385">5-fluorouracil</compound-id> via <compound-id="6076">cAMP</compound-id>/PKA/<protein-id="P15337,P16220,P27925,P51984,P51985,Q01147">CREB</protein-id> pathway against human oral squamous cell carcinoma cells.	5-fluorouracil__CREB__no_interaction	cAMP__CREB__no_interaction
18830620-1813	Complex modulation of L-type <compound-id="271">Ca(2</compound-id>+) current inactivation by <protein-id="P05044,P30626,Q5R4U9,Q6P069,Q94743">sorcin</protein-id> in isolated rabbit cardiomyocytes.	Ca(2__sorcin__interaction
18830680-1821	Donor testicular cells were prepared from heterozygous chicken <protein-id="O18840,O42161,O93400,P15475,P29751,P48975,P60706,P60707,P60708,P60709,P60710,P60711,P60712,P60713,P68143,P79818,P83750,P83751,P84336,P84856,Q0PGG4,Q4L0Y2,Q5R1X3,Q711N9,Q71FK5,Q76N69,Q91ZK5,Q9Y702">beta actin</protein-id> (<protein-id="Q00398">CAG</protein-id>)/enhanced <protein-id="P42212">green fluorescent protein</protein-id> (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with <compound-id="2478">busulfan</compound-id> to remove endogenous spermatogonia.	busulfan__green fluorescent protein__no_interaction	busulfan__CAG__no_interaction	busulfan__beta actin__no_interaction
18830721-1832	Models of noncoupled dinuclear <compound-id="23978">copper</compound-id> centers in <protein-id="P00279,P00281,P00283,P00284,P00285,P00286,P34097,P80546">azurin</protein-id>.	copper__azurin__interaction
18830721-1833	Toward this goal, models of the noncoupled <compound-id="23978">copper</compound-id> centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (<protein-id="P10731,P14925,P19021,P83388,P97467,Q95XM2">PHM</protein-id>), <protein-id="P09172,P15101,Q05754,Q64237">dopamine beta-monooxygenase</protein-id> (DBM), and nitrite reductase (<protein-id="Q39161,Q43090">NiR</protein-id>) were designed into the small soluble protein <protein-id="P00279,P00281,P00283,P00284,P00285,P00286,P34097,P80546">azurin</protein-id>.	copper__PHM__interaction	copper__azurin__interaction	copper__NiR__interaction	copper__dopamine beta-monooxygenase__interaction
18830721-1834	The models are significant because they maintain the existing type 1 (T1) <compound-id="23978">copper</compound-id>, electron transfer site of <protein-id="P00279,P00281,P00283,P00284,P00285,P00286,P34097,P80546">azurin</protein-id> while including the second designed type 2 (T2) <compound-id="23978">copper</compound-id> center that mimics the T2 catalytic sites in the target enzymes.	copper__azurin__interaction
18830722-1835	Intraprotein electron transfer (IET) from <compound-id="710,8965,643976">flavin mononucleotide</compound-id> (<compound-id="710,8965,643976">FMN</compound-id>) to <compound-id="4971">heme</compound-id> is essential in NO synthesis by NO synthase (<protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id>).	flavin mononucleotide__NOS__interaction	heme__NOS__interaction	FMN__NOS__interaction
18830729-1841	The <protein-id="P16397,P18773">esterase</protein-id> and <protein-id="Q7M4U7">lipase</protein-id> activities were determined by the hydrolysis of pNPB and <compound-id="378">pNPP</compound-id>, respectively.	pNPP__lipase__interaction	pNPP__esterase__interaction
18830730-1843	In the present work, the activity of the enzymes <protein-id="P38715">xylose reductase</protein-id> (XR); <protein-id="P22144,P83049,Q59545,Q8U7Y1,Q92MT4,Q98D10">xylitol dehydrogenase</protein-id> (XD); and glucose-6-phosphate dehydrogenase (<protein-id="O00091,O24357,O51581,O54537,O55044,O68282,O83491,O84188,P05370,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11410,P11411,P11412,P11413,P12646,P15588,P21907,P29686,P37830,P37986,P41571,P41764,P44311,P48826,P48828,P48848,P48992,P54547,P54996,P56110,P57405,P73411,P77809,P80619,P97324,Q00612,Q23711,Q24625,Q25019,Q25537,Q27464,Q27638,Q29492,Q42919,Q43793,Q43839,Q7YS37,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">G6PD</protein-id>) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with <compound-id="6912">xylitol</compound-id> production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	xylitol__G6PD__interaction	xylitol__xylose reductase__interaction	xylitol__xylitol dehydrogenase__interaction
18830873-1896	QSAR studies for the inhibition of the transmembrane <protein-id="P27134,P46281,P46510,P46511,P54212,P84537,Q54735,Q92051,Q9ZN54">carbonic anhydrase</protein-id> isozyme XIV with <compound-id="12145736">sulfonamides</compound-id> using PRECLAV software.	sulfonamides__carbonic anhydrase__interaction
18830873-1897	QSAR studies for the inhibition of isozyme XIV of human <protein-id="P27134,P46281,P46510,P46511,P54212,P84537,Q54735,Q92051,Q9ZN54">carbonic anhydrase</protein-id> (CA, EC 4.2.1.1) by a series of <compound-id="12145736">sulfonamides</compound-id> including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.	sulfonamides__carbonic anhydrase__interaction
18830874-1898	Inhibition of human <protein-id="P13929,P15429,P21550,P25704">muscle-specific enolase</protein-id> by <compound-id="880">methylglyoxal</compound-id> and irreversible formation of advanced glycation end products.	methylglyoxal__muscle-specific enolase__interaction
18830874-1900	The affinity of <protein-id="O02654,O26149,O29133,O30885,O32513,O51312,O52191,O59605,O66778,O69174,O74286,O84591,O85348,P0A6P9,P0A6Q0,P0A6Q1,P0A6Q2,P15007,P25696,P26300,P29201,P31683,P33675,P33676,P37869,P42040,P42448,P42848,P42894,P42896,P42897,P43806,P47647,P48285,P56252,P57492,P57975,P59566,P64074,P64075,P64076,P64077,P64078,P64079,P64080,P64081,P69949,P69950,P69951,P74934,P75189,P77972,P84208,P84541,P96377,P99088,Q12560,Q27527,Q27655,Q27727,Q27877,Q42971,Q43130,Q43321,Q4J920,Q5E326,Q5F8Z2,Q5FKM6,Q5FNN5,Q5GYK4,Q5HHP1,Q5HQV0,Q5HSC1,Q5JEV6,Q5KVE7,Q5LQL4,Q5M0M5,Q5M561,Q5N3P4,Q5NGW8,Q5NZ69,Q5PEH4,Q5R143,Q5SME1,Q5WDK9,Q5WV02,Q5X3L4,Q5XD01,Q5YQ30,Q5ZTX1,Q60173,Q601S2,Q62J10,Q631M2,Q63SQ0,Q65VZ7,Q661T0,Q66ED8,Q67SV9,Q6AAB8,Q6ADR6,Q6AM97,Q6C1F3,Q6D182,Q6F0Z7,Q6FAT9,Q6G173,Q6GB54,Q6GIL4,Q6HBF3,Q6KIB0,Q6LMT1,Q6M075,Q6MEY2,Q6MPQ2,Q6MTZ2,Q6N5U6,Q6NI61,Q6RG04,Q6W3C0,Q6YQT9,Q70CP7,Q71WX1,Q72F92,Q72H85,Q72QZ8,Q72XY5,Q73HQ2,Q73P50,Q741U7,Q74AR6,Q756H2,Q76KF9,Q7M8Q0,Q7MHQ1,Q7MTV8,Q7N835,Q7NAY0,Q7NIR1,Q7RA60,Q7RV85,Q7U0U6,Q7U3T1,Q7UIR2,Q7V377,Q7V483,Q7VDY0,Q7VIH4,Q7VNM6,Q7VQH3,Q7VW79,Q7W5N9,Q7WD75,Q815K8,Q81X78,Q821H7,Q82HH5,Q83B44,Q83FF7,Q83H73,Q870B9,Q87DY6,Q87LQ0,Q88MF9,Q898R0,Q89KV6,Q89Z05,Q8CPY3,Q8D2K1,Q8DC62,Q8DL40,Q8DPS0,Q8DTS9,Q8EBR0,Q8ENP5,Q8EW32,Q8F4T8,Q8FQS7,Q8G0G3,Q8G5I9,Q8GE63,Q8GR70,Q8IJN7,Q8K9E0,Q8KNX9,Q8L202,Q8NRS1,Q8P9Z3,Q8PLS0,Q8PT81,Q8R967,Q8RI55,Q8TQ79,Q8TUV6,Q8U477,Q8UFH1,Q8XKU4,Q8Y0B5,Q8YHF0,Q8YRB0,Q8ZBN2,Q8ZYE7,Q92Q98,Q967Y8,Q96VP4,Q96X30,Q96X46,Q972B6,Q979Z9,Q97L52,Q97QS2,Q97ZJ3,Q98MZ3,Q98Q50,Q9A7J9,Q9CD42,Q9HDT3,Q9HJT1,Q9HQI9,Q9HXZ5,Q9JU46,Q9JZ53,Q9K596,Q9K717,Q9KPC5,Q9PDT8,Q9PJF3,Q9PQV9,Q9RR60,Q9U615,Q9UAL5,Q9UXZ0,Q9XDS7,Q9Y927,Q9Z7A6,Q9ZMS6">enolase</protein-id> for gluconeogenic substrate <compound-id="1005">phosphoenolpyruvate</compound-id> altered after preincubation with MG in the same manner, but less intensively.	phosphoenolpyruvate__enolase__interaction
18830875-307	Inhibitory effects of <compound-id="33255">Cefazolin</compound-id> and <compound-id="5361871">Cefodizime</compound-id> on the activity of mushroom <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id>.	Cefodizime__tyrosinase__interaction	Cefazolin__tyrosinase__interaction
18830876-308	The order of the cytotoxicity of the compounds was; IV &gt; III &gt; II &gt; I &gt; V. <compound-id="55717">Compound IV</compound-id>, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest <protein-id="O27661,O28469,O34204,O51768,O58356,O66893,O69548,O73954,O83409,P04786,P06612,P07799,P0A2I1,P0A2I2,P0A620,P0A621,P11387,P16472,P30181,P30189,P32989,P34184,P34185,P39814,P40114,P41511,P41512,P43012,P46155,P46799,P47368,P55991,P57371,P68697,P68698,P73810,P78032,P93119,Q00313,Q04750,Q07050,Q59046,Q76ZS7,Q7YR26,Q87AQ6,Q8K9P7,Q92IH1,Q9CG80,Q9CN30,Q9HM08,Q9HZJ5,Q9JN65,Q9KA23,Q9KRB2,Q9PEV8,Q9PLZ2,Q9UYS8,Q9WUL0,Q9X3X7,Q9X909,Q9YB01,Q9ZDK2,Q9ZMV7">DNA topoisomerase I</protein-id> inhibition.	Compound IV__DNA topoisomerase I__interaction
18830877-1907	Tests were carried out on cell cultures of human keratinocytes and mouse 3T3 fibroblasts incubated with radiolabeled acetate, and on homogenates prepared from yeast cells expressing human <protein-id="P38604,P48449,P48450,P84466,Q04782,Q10231,Q8BLN5,Q96WJ0">lanosterol synthase</protein-id>, incubated with radiolabeled <compound-id="5280395">oxidosqualene</compound-id>.	oxidosqualene__lanosterol synthase__no_interaction
18830880-1910	Hepatic antioxidant status viz, <compound-id="124886">reduced glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx), quinone reductase (QR), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id> 0.001).	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione reductase__no_interaction	GSH__glutathione peroxidase__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction	GSH__CAT__no_interaction	GSH__catalase__no_interaction	GSH__glutathione reductase__no_interaction	reduced glutathione__CAT__no_interaction
18830882-1911	Inhibition of rat liver <protein-id="P81494,P83205">cathepsins B</protein-id> and L by the peptide aldehyde <compound-id="107707">benzyloxycarbonyl-leucyl-leucyl-leucinal</compound-id> and its analogues.	benzyloxycarbonyl-leucyl-leucyl-leucinal__cathepsins B__interaction
18830882-1913	The concentration required for 50% inhibition (IC(50)) by <compound-id="107707">ZLLLal</compound-id> was 88 nM for <protein-id="P81494,P83205">cathepsin B</protein-id> and 163 nM for <protein-id="P09648,P25773,Q10991">cathepsin L</protein-id>.	ZLLLal__cathepsin L__interaction	ZLLLal__cathepsin B__interaction
18830885-1914	Preliminary structure-activity relationships and a molecular modeling study for 9a have revealed that the <compound-id="72304">isoflavone</compound-id> moiety plays a key role in the interaction of this series of derivatives with <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> by acting as an anchor in its peripheral anionic site.	isoflavone__AChE__interaction
18830972-1951	<protein-id="P06762,P09601,P14791,P14901,P32394,P72849,Q5E9F2">Heme oxygenase-1</protein-id> (<protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id>) and <compound-id="145068">Nitric oxide</compound-id> (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	Nitric oxide__HO-1__no_interaction	Nitric oxide__Heme oxygenase-1__no_interaction
18831007-1971	One potential target for reducing T cell migration is inhibition of the <compound-id="271">Ca(2</compound-id>+)-activated <protein-id="P05806,P06832,P29148,P43133,P43263,P68734,P68735,P68736,Q00891">neutral protease</protein-id> <protein-id="P27730">calpain</protein-id>.	Ca(2__calpain__interaction	Ca(2__neutral protease__no_interaction
18831010-1974	A shift toward proinflammatory microglial activation is indicated by the release of <protein-id="P41693">interleukin-6</protein-id>, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha, and <compound-id="145068">nitric oxide</compound-id> and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	nitric oxide__tumor necrosis factor__no_interaction	nitric oxide__interleukin-6__no_interaction
18831033-1984	<compound-id="5284583">Levetiracetam</compound-id>, a newer anticonvulsant, does not undergo <protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id> metabolism and does not alter the pharmacokinetics of chemotherapy, antiemetics, and corticosteroids, which are metabolized by the liver.	Levetiracetam__CYP__interaction
18831035-1985	By combining a favorable turn sequence with a turn flanking <protein-id="P19334,P55965,Q920J4">Trp</protein-id>/<protein-id="P19334,P55965,Q920J4">Trp</protein-id> interaction and a C-terminal H-bonding interaction between a backbone amide and an i-2 <compound-id="1148,5460840">Trp</compound-id> ring, a particularly stable (DeltaG(U) &gt; 7 kJ/mol) truncated hairpin, Ac-WI-(<compound-id="8988">D-Pro</compound-id>-D-Asn)-KWTG-NH(2), results.	D-Pro__Trp__interaction	Trp__Trp__interaction
18831052-2002	The human AU <protein-id="P03526,P04487,P07940,P12002,P56958,P82866">RNA binding protein</protein-id>/enoyl-Coenzyme A hydratase (<protein-id="O42887,P60651,P60652,P60653,P60654,P60655,P60656,P60657,P70999,Q10088,Q13825,Q57K36,Q5F6R3,Q5PJH7,Q7N122,Q7P0S6,Q7VRG4,Q7X3P1,Q814Q2,Q81JT1,Q8FE36,Q90XD2,Q9BSE5,Q9K6B9">AUH</protein-id>) is a 3-hydroxy-3-methylglutaconyl-CoA dehydratase in the <compound-id="857,6106,439524">leucine</compound-id> degradation pathway.	leucine__RNA binding protein__interaction	leucine__AUH__interaction
18831980-2703	<protein-id="P19217,P49887,P49888">SULT1E1</protein-id> is responsible for the sulfation and inactivation of <compound-id="5757">beta-estradiol</compound-id> (E2) at physiological concentrations.	beta-estradiol__SULT1E1__interaction
18832050-2295	The main mechanism of resistance to <compound-id="126941">methotrexate</compound-id> was extra-chromosomal amplification of the <protein-id="O02604,O62583,O81395,P00374,P00375,P00376,P00377,P00378,P00380,P00381,P04174,P04382,P04753,P07382,P07807,P0A016,P0A017,P0A546,P0A547,P0ABQ4,P0ABQ5,P0ABQ6,P0C0P0,P0C0P1,P11045,P13922,P15093,P16126,P16184,P17719,P20712,P22906,P27498,P28019,P31073,P31074,P36591,P43791,P45350,P46103,P47470,P51820,P57243,P78028,P99079,Q05762,Q05763,Q07422,Q07801,Q23695,Q27713,Q27783,Q27793,Q27828,Q2QRX6,Q54277,Q54801,Q59487,Q5HFZ7,Q5HPB1,Q5UQG3,Q60034,Q6G9D5,Q6GGY1,Q89AV2,Q8K9Z8,Q8NWQ9,Q920D2,Q98Q32,Q9CBW1,Q9JSQ9,Q9K168,Q9PR30,Q9U8B8">dihydrofolate reductase</protein-id> gene.	methotrexate__dihydrofolate reductase__interaction
18832097-2311	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by <compound-id="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148">staurosporine</compound-id> (STS) abolished [(3)H] <compound-id="9547243">1,25-dihydroxy vitamin D</compound-id> (3) binding and <protein-id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</protein-id> protein, suggesting that the <protein-id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</protein-id> may be targeted for inactivation by caspases during apoptosis.	1,25-dihydroxy vitamin D__VDR__no_interaction	staurosporine__VDR__interaction
18832102-2313	The use of lipoproteins as a substrate for <compound-id="5994">progesterone</compound-id> synthesis remains unclear, and the expression of lipoprotein receptors [very-<protein-id="P01131,P20063,Q28832">low-density lipoprotein receptor</protein-id> (<protein-id="P35953,P98155,P98165">VLDLR</protein-id>), <protein-id="P01131,P20063,Q28832">low-density lipoprotein receptor</protein-id> (<protein-id="P01130,P01131,P20063,P35950,Q28832">LDLR</protein-id>), and scavenger receptor-BI (<protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> 12 h) has not been characterized.	progesterone__VLDLR__no_interaction	progesterone__low-density lipoprotein receptor__no_interaction	progesterone__SR-BI__no_interaction	progesterone__LDLR__no_interaction
18832102-2314	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a <compound-id="5994">progesterone</compound-id> substrate and that as these are depleted, new cholesterol esters are obtained through an <protein-id="P01130,P01131,P20063,P35950,Q28832">LDLR</protein-id>- and/or <protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id>-mediated mechanism.	progesterone__SR-BI__no_interaction	progesterone__LDLR__no_interaction
18832185-2341	The <compound-id="37034">2,2',4,4',5,5'-hexachlorobiphenyl</compound-id>-enhanced degradation of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">connexin 43</protein-id> involves both proteasomal and lysosomal activities.	2,2',4,4',5,5'-hexachlorobiphenyl__connexin 43__interaction
18832185-2343	As this effect might be related to deregulation of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">connexin 43</protein-id> (<protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id>) synthesis, trafficking, or degradation, we investigated the impact of <compound-id="37034">PCB 153</compound-id> on these events.	PCB 153__connexin 43__interaction	PCB 153__Cx43__interaction
18832185-2345	Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> protein levels, thus suggesting that both proteasomes and lysosomes may participate in the <compound-id="37034">PCB 153</compound-id>-enhanced <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> internalization and degradation.	PCB 153__Cx43__interaction
18832185-2346	Finally, <compound-id="37034">PCB 153</compound-id> also interfered with restoration of gap junction plaques following the inhibition of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> transport to plasma membrane.	PCB 153__Cx43__interaction
18832185-2347	Taken together, multiple modes of action seem to contribute to downregulation of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> in <compound-id="37034">PCB 153</compound-id>-treated rat liver epithelial cells.	PCB 153__Cx43__interaction
18832295-2399	<compound-id="6918537">Vildagliptin</compound-id> demonstrates potent inhibition of <protein-id="P97399,Q62598,Q9NZW4">DPP</protein-id>-4 activity with excellent tolerability at doses of up to and including 200 mg qd.	Vildagliptin__DPP__interaction
18832330-479	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with <compound-id="6442441">MK-801</compound-id> or <protein-id="P31424,P41594">mGluR5</protein-id> receptor with <compound-id="3025961">2-methyl-6-(phenylethynyl)-pyridine</compound-id> (<compound-id="3025961">MPEP</compound-id>).	MK-801__mGluR5__no_interaction	MPEP__mGluR5__interaction	2-methyl-6-(phenylethynyl)-pyridine__mGluR5__interaction
18832453-2471	Here, PCA is applied to three problems in <protein-id="P01105,P32503">GAG</protein-id> research: (i) distinguishing origins of heparin preparations, (ii) structural analysis of heparin derivatives, and (iii) classification of <compound-id="24766">chondroitin sulfates</compound-id> (CS).	chondroitin sulfates__GAG__interaction
18832454-2473	In addition, high levels of ketals of <compound-id="1060">pyruvic acid</compound-id> were found mainly at 3,4-of some terminal beta-D-<protein-id="Q9QXQ6">Galp</protein-id> units forming a five-membered ring.	pyruvic acid__Galp__interaction
18832476-2484	The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with <compound-id="16132042,16132684">alamethicin</compound-id> activation and in the presence and absence of 2% bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>).	alamethicin__BSA__no_interaction	alamethicin__serum albumin__no_interaction
18832480-801	By using purified bovine <protein-id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</protein-id>, the reduction was observed in the presence of <compound-id="5893">NAD</compound-id> (P)H. These results suggest that FLU-1 N-OH is involved in flutamide-induced hepatotoxicity and that cytosolic reduction of FLU-1 N-OH plays a major role in protection against flutamide-induced hepatotoxicity.	NAD__xanthine oxidase__interaction
18832589-2551	Recent studies have provided important insight into the homeoprotein <protein-id="Q25132">LIM</protein-id> homeobox transcription factor 1alpha (<protein-id="Q9JKU8">Lmx1a</protein-id>) and its role in the commitment of cells to a midbrain <compound-id="681">dopamine</compound-id> (mDA) fate in the developing mouse.	dopamine__Lmx1a__interaction	dopamine__LIM__interaction
18832593-1025	An acute increase in <compound-id="977">oxygen</compound-id> tension led to Smad activation within 30 minutes, even in the absence of exogenous <protein-id="P35855">BMP</protein-id> treatment.	oxygen__BMP__no_interaction
18832596-2558	Recognition of <compound-id="16218585,20758205">galactan</compound-id> components of pectin by <protein-id="P08699,P16110,P17931,P38486,P47845,P47953">galectin-3</protein-id>.	galactan__galectin-3__interaction
18832596-2559	By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin <compound-id="16218585,20758205">galactan</compound-id> to the recombinant form of human <protein-id="Q9DG58">Gal3</protein-id>.	galactan__Gal3__interaction
18832659-2578	<protein-id="Q13586,Q58CP9">STIM1</protein-id> has been identified as an endoplasmic reticulum (ER)-resident <compound-id="271">Ca(2</compound-id>+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.	Ca(2__STIM1__interaction
18832772-2632	A sensitive and specific ELISA detects <compound-id="847">methionine sulfoxide</compound-id>-containing <protein-id="P18647">apolipoprotein A-I</protein-id> in HDL.	methionine sulfoxide__apolipoprotein A-I__interaction
18832772-2633	A wide range of reactive intermediates oxidizes methionine residues to <compound-id="847">methionine sulfoxide</compound-id> (MetO) in <protein-id="P18647">apolipoprotein A-I</protein-id> (<protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id>), the major HDL protein.	methionine sulfoxide__apolipoprotein A-I__interaction	methionine sulfoxide__apoA-I__interaction
18832826-1553	The renin-angiotensin-<compound-id="5839">aldosterone</compound-id> system: approaches to guide <protein-id="Q10751">angiotensin-converting enzyme</protein-id> inhibition in patients with coronary artery disease.	aldosterone__angiotensin-converting enzyme__no_interaction
18834674-2651	It was identified as producer of extended-spectrum <protein-id="P80298,P80545,P81173">beta-lactamases</protein-id> (ESBL) by double-disk synergy test between <compound-id="33613">amoxicillin</compound-id>-<compound-id="5280980">clavulanate</compound-id> and <compound-id="5479527,5742673,6540461">cefotaxime</compound-id>, <compound-id="5479530">ceftriaxone</compound-id>, <compound-id="6321415">ceftazidime</compound-id> and <compound-id="5742832">aztreonam</compound-id>.	amoxicillin__beta-lactamases__interaction	ceftazidime__beta-lactamases__interaction	cefotaxime__beta-lactamases__interaction	ceftriaxone__beta-lactamases__interaction	aztreonam__beta-lactamases__interaction	clavulanate__beta-lactamases__interaction
18834690-355	The binding of <compound-id="3016">diazepam</compound-id> to human <protein-id="P21847,P83517">serum albumin</protein-id> was used as the model system in order to evaluate the performance of automated SPME.	diazepam__serum albumin__interaction
18834707-357	<compound-id="145068">Nitric oxide</compound-id> (NO) and interlukin-6 (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>) are highly reactive mediators that have been shown to play different roles in a variety of different biological process.	Nitric oxide__IL-6__no_interaction
18834868-391	Mitochondrial <protein-id="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11">aldehyde dehydrogenase</protein-id> (<protein-id="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2">ALDH</protein-id>-2)--maker of and marker for <compound-id="943">nitrate</compound-id> tolerance in response to <compound-id="4510">nitroglycerin</compound-id> treatment.	nitroglycerin__aldehyde dehydrogenase__interaction	nitroglycerin__ALDH__interaction	nitrate__ALDH__interaction	nitrate__aldehyde dehydrogenase__interaction
18834868-392	According to the oxidative stress concept, increased vascular <compound-id="5359597">superoxide</compound-id> and <compound-id="104806">peroxynitrite</compound-id> production as well as an increased sensitivity to vasoconstrictors secondary to activation of <protein-id="P13678,Q25378">protein kinase C</protein-id> as well as vascular NADPH oxidases contribute to the development of tolerance.	superoxide__protein kinase C__no_interaction	peroxynitrite__protein kinase C__no_interaction
18834868-393	mitochondrial <protein-id="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11">aldehyde dehydrogenase</protein-id> [<protein-id="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2">ALDH</protein-id>-2]) and mitochondria as potential sources of reactive <compound-id="977">oxygen</compound-id> species (ROS).	oxygen__ALDH__interaction	oxygen__aldehyde dehydrogenase__interaction
18834868-395	Finally, we will address the question whether <protein-id="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2">ALDH</protein-id>-2 inactivation by <compound-id="4510">nitroglycerin</compound-id> could be a useful marker for clinical <compound-id="943">nitrate</compound-id> tolerance and discuss the redox-regulation of this enzyme by oxidative stress and <compound-id="421">dihydrolipoic acid</compound-id>.	dihydrolipoic acid__ALDH__interaction	nitroglycerin__ALDH__interaction	nitrate__ALDH__interaction
18834871-397	Sex steroids enhance <protein-id="Q28516">insulin receptors</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id> oxidation in Chang liver cells.	glucose__insulin receptors__no_interaction
18834871-398	The present study was designed to assess the effect of sex steroids (<compound-id="6013">testosterone</compound-id> and <compound-id="5757">17beta-estradiol</compound-id>) on <protein-id="Q28516">insulin receptor</protein-id> expression, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> binding and <compound-id="206,5793,64689,79025">glucose</compound-id> oxidation in human liver cell line.	glucose__insulin__no_interaction	testosterone__insulin__interaction	17beta-estradiol__insulin__interaction	testosterone__insulin receptor__interaction	glucose__insulin receptor__no_interaction	17beta-estradiol__insulin receptor__interaction
18834900-402	It is predicted to possess all the expected features of proPO members, including two putative <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id> copper-binding motifs with six <compound-id="773,6274">histidine</compound-id> residues and a <compound-id="519335">thiol ester</compound-id>-like motif, sharing 67% amino acid sequence identity with PmproPO1.	histidine__tyrosinase__interaction	thiol ester__tyrosinase__interaction
18834946-408	Examination of <compound-id="23973">cadmium</compound-id>-induced expression of the small heat shock protein gene, <protein-id="P19752,P40920">hsp30</protein-id>, in Xenopus laevis A6 kidney epithelial cells.	cadmium__hsp30__interaction
18834946-409	In the present study, we have characterized the effect of <compound-id="23973">cadmium</compound-id> on the accumulation of the small heat shock protein (<protein-id="P32590">HSP</protein-id>), <protein-id="P25619,P42931">HSP30</protein-id>, in Xenopus laevis A6 kidney epithelial cells.	cadmium__HSP__no_interaction	cadmium__HSP30__interaction
18834946-410	Immunocytochemical analysis of <compound-id="24633,24947">cadmium chloride</compound-id>-treated A6 cells revealed <protein-id="P25619,P42931">HSP30</protein-id> accumulation primarily in the cytoplasm in a punctate pattern supplemented with larger <protein-id="P25619,P42931">HSP30</protein-id> staining structures.	cadmium chloride__HSP30__interaction
18834946-411	Also, <protein-id="P25619,P42931">HSP30</protein-id> co-localized with the F-<protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> cytoskeleton at higher <compound-id="24633,24947">cadmium chloride</compound-id> concentrations.	cadmium chloride__HSP30__interaction	cadmium chloride__actin__interaction
18834950-413	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, <compound-id="611,23327,33032">glutamic acid</compound-id> (E) and <compound-id="866,5962">lysine</compound-id> (K), at the solvent accessible site of <protein-id="P32910">C34</protein-id>.	glutamic acid__C34__interaction	lysine__C34__interaction
18834958-415	Cloning, expression, and characterization of <compound-id="23973">cadmium</compound-id>-induced <protein-id="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P67981,P68041,P68301,P68302,P68303,P68304,P80394,Q5NVS0,Q7ZSY6,Q9I9I0,Q9XST5">metallothionein-2</protein-id> from the earthworms Metaphire posthuma and Polypheretima elongata.	cadmium__metallothionein-2__interaction
18834958-416	In this study we report the sequences of <protein-id="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P43392,P55943,P67981,P68041,P68301,P68302,P68303,P68304,P80394,P94029,Q39459,Q5NVS0,Q7ZSY6,Q9I9I0,Q9VG55,Q9XST5">MT-2</protein-id> cDNA from two species of Megascoleidae earthworms, Metaphire posthuma and Polypheretima elongata, by mRNA differential display after exposure of the organisms to <compound-id="23973">cadmium</compound-id>.	cadmium__MT-2__interaction
18834958-417	Complementary (c)DNA was verified as the <protein-id="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P43392,P55943,P67981,P68041,P68301,P68302,P68303,P68304,P80394,P94029,Q39459,Q5NVS0,Q7ZSY6,Q9I9I0,Q9VG55,Q9XST5">MT-2</protein-id> gene by the characteristics of its predicted translation product, namely a high <compound-id="594,5862,5360637">cysteine</compound-id> content, conserved CXC motifs, and a molecular weight of around 8 kDa.	cysteine__MT-2__interaction
18834958-420	These earthworms could be used to evaluate heavy-metal pollution in soil due to the inducible <protein-id="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P43392,P55943,P67981,P68041,P68301,P68302,P68303,P68304,P80394,P94029,Q39459,Q5NVS0,Q7ZSY6,Q9I9I0,Q9VG55,Q9XST5">MT-2</protein-id> by <compound-id="23973">cadmium</compound-id> exposure.	cadmium__MT-2__interaction
18834983-429	Despite the reciprocal relationship that exists between inflammation and thrombosis, we asked whether thrombosis can develop without inflammation, and whether stress-related hormones (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> and <compound-id="5754">cortisol</compound-id>) influence platelet-mediated thrombosis.	cortisol__ACTH__no_interaction
18835067-453	The most active compound to emerge from the in vitro and in vivo murine studies was 2b, suggesting an antimalarial activity via inhibition of <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> hydrolysis, however, not as efficient as <compound-id="2719">chloroquine</compound-id>.	chloroquine__hemoglobin__no_interaction
18835228-501	The culture medium was analyzed for pH value, concentration of free calcium and <compound-id="1061">phosphate ions</compound-id> and <protein-id="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9">osteocalcin</protein-id>.	phosphate ions__osteocalcin__no_interaction
18835260-516	Surprisingly, no role of <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 or <protein-id="P08457,P35610,Q7QDU4">STAT</protein-id>-3 was found in the protein-mediated protection of hepatocytes during <compound-id="1983">acetaminophen</compound-id> exposure.	acetaminophen__ERK1__no_interaction	acetaminophen__STAT__no_interaction
18835277-527	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl <compound-id="977">oxygen</compound-id> in <compound-id="1174">uracil</compound-id> or <compound-id="1188">xanthine</compound-id>, cause substantial reductions in XDG and <protein-id="O51082,O74834,O84613,P04303,P09307,P0A4P3,P0A4P4,P0A4P5,P10186,P12295,P12887,P12888,P13051,P13158,P16769,P20536,P21968,P23379,P28275,P28866,P29950,P32941,P32988,P39615,P43731,P47343,P50639,P52345,P52447,P52506,P52507,P53764,P53765,P53766,P56397,P57280,P57807,P59465,P67071,P67072,P67073,P67074,P67075,P67076,P67077,P67078,P67079,P69859,P75536,P97931,Q01019,Q5FL46,Q5HI95,Q5HRG5,Q5HX80,Q5KUD0,Q5L4Q4,Q5NEP2,Q5R080,Q5UPT2,Q5WAZ9,Q5XCK3,Q65DN9,Q662W1,Q6D208,Q6F9Y2,Q6GBQ6,Q6GJ88,Q6HAN7,Q72X51,Q74K70,Q7MA00,Q7MNR0,Q7MXF6,Q7N1U8,Q7P1I1,Q7VGS1,Q7VMC0,Q7VRQ7,Q7VUM8,Q7W1Y7,Q7WQW5,Q814M9,Q81JQ4,Q821F7,Q836Z5,Q83CW4,Q879Z0,Q87SC4,Q87XE2,Q88N05,Q88YG1,Q8A5V6,Q8CQ65,Q8DEP7,Q8DPQ4,Q8DTV8,Q8EB78,Q8EPH6,Q8FF08,Q8FPQ4,Q8G3E9,Q8K7U9,Q8NQU9,Q8P1B6,Q8P4D7,Q8PFZ6,Q8R634,Q8UCM8,Q8X444,Q8XNR7,Q8XVE4,Q8ZD85,Q91UM2,Q92LU5,Q98PV4,Q9A072,Q9CBS3,Q9CIX2,Q9I5H9,Q9JUC4,Q9JZA1,Q9K682,Q9KPK8,Q9PA28,Q9PJ40,Q9PJD2,Q9PPU2,Q9RWH9,Q9Z7D3,Q9ZJN9">UDG</protein-id> activities.	xanthine__UDG__no_interaction	oxygen__UDG__no_interaction	uracil__UDG__no_interaction
18835277-528	Most interestingly, a <compound-id="614,8988,145742">proline</compound-id> substitution at the G63 position switches the <protein-id="Q51061">Gme</protein-id> <protein-id="Q53HV7,Q59I47">SMUG1</protein-id> enzyme to an exclusive <protein-id="O51082,O74834,O84613,P04303,P09307,P0A4P3,P0A4P4,P0A4P5,P10186,P12295,P12887,P12888,P13051,P13158,P16769,P20536,P21968,P23379,P28275,P28866,P29950,P32941,P32988,P39615,P43731,P47343,P50639,P52345,P52447,P52506,P52507,P53764,P53765,P53766,P56397,P57280,P57807,P59465,P67071,P67072,P67073,P67074,P67075,P67076,P67077,P67078,P67079,P69859,P75536,P97931,Q01019,Q5FL46,Q5HI95,Q5HRG5,Q5HX80,Q5KUD0,Q5L4Q4,Q5NEP2,Q5R080,Q5UPT2,Q5WAZ9,Q5XCK3,Q65DN9,Q662W1,Q6D208,Q6F9Y2,Q6GBQ6,Q6GJ88,Q6HAN7,Q72X51,Q74K70,Q7MA00,Q7MNR0,Q7MXF6,Q7N1U8,Q7P1I1,Q7VGS1,Q7VMC0,Q7VRQ7,Q7VUM8,Q7W1Y7,Q7WQW5,Q814M9,Q81JQ4,Q821F7,Q836Z5,Q83CW4,Q879Z0,Q87SC4,Q87XE2,Q88N05,Q88YG1,Q8A5V6,Q8CQ65,Q8DEP7,Q8DPQ4,Q8DTV8,Q8EB78,Q8EPH6,Q8FF08,Q8FPQ4,Q8G3E9,Q8K7U9,Q8NQU9,Q8P1B6,Q8P4D7,Q8PFZ6,Q8R634,Q8UCM8,Q8X444,Q8XNR7,Q8XVE4,Q8ZD85,Q91UM2,Q92LU5,Q98PV4,Q9A072,Q9CBS3,Q9CIX2,Q9I5H9,Q9JUC4,Q9JZA1,Q9K682,Q9KPK8,Q9PA28,Q9PJ40,Q9PJD2,Q9PPU2,Q9RWH9,Q9Z7D3,Q9ZJN9">UDG</protein-id> as demonstrated by the uniform excision of <compound-id="1174">uracil</compound-id> in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	uracil__UDG__interaction	uracil__SMUG1__interaction	proline__SMUG1__interaction	uracil__Gme__interaction	proline__UDG__interaction	proline__Gme__interaction
18835344-566	<protein-id="P21847,P83517">Serum albumin</protein-id>-<compound-id="6850754">alginate</compound-id> coated microspheres: role of the inner gel in binding and release of the KRFK peptide.	alginate__Serum albumin__interaction
18835350-570	Furthermore, increased production of high inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase 2</protein-id> (<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>) expressions were detected in the hippocampus and cerebral cortex of <compound-id="23978">copper</compound-id> and cholesterol co-treated mice by immunohistochemical analysis.	copper__cyclooxygenase 2__interaction	copper__nitric oxide synthase__interaction	copper__COX-2__interaction	copper__iNOS__interaction
18835362-575	We report herein some novel phenomena between <compound-id="4971">hemin</compound-id>-H(2)O(2)-NO(2)(-) and <compound-id="5219">3-morpholinosydnonimine hydrochloride</compound-id> (SIN-1)-mediated oxidation and nitration reactions of <protein-id="O52310,O59650,O74024,P28270,P52596,P80319,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q56304,Q9YC65">glutamate dehydrogenase</protein-id> (<protein-id="O52310,O59650,O74024,O95479,P00366,P00367,P00368,P0AES2,P0AES3,P10860,P13443,P26443,P28270,P36234,P42174,P42206,P42238,P49448,P52596,P54385,P56201,P80319,P82264,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q53199,Q56304,Q59516,Q64HZ8,Q64HZ9,Q64I00,Q64I01,Q9HFR6,Q9HGU3,Q9HGU4,Q9RDE9,Q9URS1,Q9YC65">GDH</protein-id>).	hemin__GDH__interaction	3-morpholinosydnonimine hydrochloride__GDH__interaction	hemin__glutamate dehydrogenase__interaction	3-morpholinosydnonimine hydrochloride__glutamate dehydrogenase__interaction
18835442-614	After intravenous administration of either <compound-id="6437371">DOTAP</compound-id>/<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> or <compound-id="6913074">DOTMA</compound-id>/<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> liposomes, serum <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id> and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	cholesterol__TNFalpha__no_interaction	DOTMA__TNFalpha__no_interaction	DOTAP__TNFalpha__no_interaction
18835585-659	<compound-id="6830">GTP</compound-id> was the most potent regulator of <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> affinity, with concentrations of 5 mmol L(-1) causing an increase in p(50) from 5 to 19 mm Hg at pH 7.5, while the order of potency of the other phosphates was IHP&gt;ATP&gt;BPG.	GTP__hemoglobin__interaction
18835652-693	Functional inactivation of <protein-id="P35240,P59750">NF2</protein-id>/<compound-id="84098">merlin</compound-id> in human mesothelioma.	merlin__NF2__no_interaction
18835652-694	The tumor suppressor <compound-id="84098">merlin</compound-id> is encoded by the neurofibromatosis type 2 gene (<protein-id="P35240,P59750">NF2</protein-id>) which is located on chromosome 22q12 and mutations in this gene have been found in 40% of mesothelioma.	merlin__NF2__interaction
18835662-698	No main effect of group assignment on TSST responses was found for <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, <compound-id="5754">cortisol</compound-id> or POMS scores.	cortisol__IL-6__no_interaction
18835763-723	The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum <protein-id="P80298,P80545,P81173">beta-lactamases</protein-id> (ESBLs) and <compound-id="6087">methicillin</compound-id> resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates.	methicillin__beta-lactamases__interaction
18835829-730	<compound-id="6076">cAMP</compound-id>-induced expression of the orphan nuclear receptor <protein-id="P12813">Nur77</protein-id> in MA-10 Leydig cells involves a <protein-id="Q9P7I2">CaMKI</protein-id> pathway.	cAMP__Nur77__interaction	cAMP__CaMKI__interaction
18835829-731	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the <protein-id="P00936,P08678,P0A1A7,P0A1A8,P0A4Y0,P0A4Y1,P14605,P23466,P27580,P30528,P40127,P40130,P40134,P40135,P43524,P49606,P59739,Q01513,Q01631,Q05766,Q59119,Q59685,Q8FBP0,Q8XAP1,Q9WXC3">adenylate cyclase</protein-id>/<compound-id="188955">cyclic adenosine monophosphate</compound-id> (<compound-id="6076">cAMP</compound-id>) signaling pathway.	cyclic adenosine monophosphate__adenylate cyclase__interaction	cAMP__adenylate cyclase__interaction
18835829-732	Here, we report that <compound-id="6076">cAMP</compound-id>-mediated induction of <protein-id="P12813">Nur77</protein-id> expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.	cAMP__Nur77__interaction
18835829-733	In addition, our detailed analysis of the <protein-id="P12813">Nur77</protein-id> promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and <compound-id="6076">cAMP</compound-id>-induced <protein-id="P12813">Nur77</protein-id> transcription.	cAMP__Nur77__interaction
18835830-734	Expression of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> during germ cell apoptosis in testis of cynomolgus monkey after <compound-id="6013">testosterone</compound-id> and heat treatment.	testosterone__nitric oxide synthase__interaction
18835831-735	Comparing expression of <compound-id="5994">progesterone</compound-id> and <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptors</protein-id> in testicular tissue from men with obstructive and nonobstructive azoospermia.	progesterone__estrogen receptors__no_interaction
18835926-762	Together, these results provide compelling evidence that <protein-id="Q8VI82,Q9EPC2">Fgf23</protein-id> does not have a klotho-independent role in the regulation of systemic phosphate and <compound-id="5280795">vitamin D</compound-id> homeostasis.	vitamin D__Fgf23__no_interaction
18835976-780	Based on fasting <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id>, several indices of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity have been developed in adults.	glucose__insulin__no_interaction
18835979-782	LDL from all subjects stimulated both the basal and <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>-induced <compound-id="5839">aldosterone</compound-id> and <compound-id="5754">cortisol</compound-id> release from adrenocortical cells.	aldosterone__AngII__interaction	cortisol__AngII__interaction
18835981-786	Here we present evidence of distinct <compound-id="5291">STI571</compound-id>-induced modulation of <protein-id="P00520,P00522">abl</protein-id> functions using high-resolution live-cell imaging approaches.	STI571__abl__interaction
18835981-787	Quantitative analysis yielded 0.81 and 1.8 microM for EC(50) values of <compound-id="5291">STI571</compound-id>-induced cell edge translocation of <protein-id="P00520,P00522">abl</protein-id>-KD-<protein-id="P42212">green fluorescent protein</protein-id> (<protein-id="P42212">GFP</protein-id>) and wild-type <protein-id="P00520,P00522">abl</protein-id>-<protein-id="P42212">GFP</protein-id>, respectively.	STI571__GFP__interaction	STI571__abl__interaction	STI571__green fluorescent protein__interaction
18836089-2732	Association of the <protein-id="P08183,P21448">ABCB1</protein-id> gene polymorphisms 2677G&gt;T/A and 3435C&gt;T with clinical outcomes of <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> monotherapy in metastatic breast cancer patients.	paclitaxel__ABCB1__interaction
18836089-2733	We evaluated the association between clinical outcome (safety and efficacy) of <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> monotherapy in metastatic breast cancer patients with <protein-id="P08183,P21448">ABCB1</protein-id> gene polymorphisms 2677G&gt;T/A or 3435C&gt;T.	paclitaxel__ABCB1__interaction
18836137-847	<protein-id="O46678,O55235,P09340,P09341,P12850,P14095">CXCL1</protein-id>/KC was detected as early as 6 hours after <compound-id="456190,5360373,5460769">bleomycin</compound-id> instillation and returned to basal levels after Day 8.	bleomycin__CXCL1__interaction
18836137-848	DF2162 treatment reduced <compound-id="456190,5360373,5460769">bleomycin</compound-id>-induced expression of <protein-id="Q62935">von Willebrand Factor</protein-id>, a marker of angiogenesis, in the lung.	bleomycin__von Willebrand Factor__interaction
18836482-927	This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (<protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>) inhibitor <compound-id="3973">LY294002</compound-id> or pharmacological inhibition of <protein-id="P31749,P31750,P47196,Q01314,Q8INB9">PKB</protein-id>.	LY294002__PI3K__no_interaction	LY294002__PKB__no_interaction
18836681-1004	<compound-id="3845">Kynurenic acid</compound-id> (<compound-id="3845">KYNA</compound-id>) is an agonist of the G-protein-coupled receptor <protein-id="Q9HC97">GPR35</protein-id>, which is predominantly expressed in gastrointestinal tissues.	Kynurenic acid__GPR35__interaction	KYNA__GPR35__interaction
18836710-1021	Molecular dynamics simulation techniques have been used to study the unbinding pathways of <compound-id="22811021">1alpha,25-dihydroxyvitamin D(3</compound-id>) from the ligand-binding pocket of the vitamin D receptor (<protein-id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</protein-id>).	1alpha,25-dihydroxyvitamin D(3__VDR__interaction
18836740-1043	Activation of the Na+/K+-ATPase by <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id> as a putative negative feedback mechanism in pancreatic beta-cells.	glucose__insulin__no_interaction
18836740-1046	Inhibiting <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> signalling in SUR1 (-/-) beta-cells blunted the <compound-id="206,5793,64689,79025">glucose</compound-id>-induced decrease of [Ca(2+)](c).	glucose__insulin__interaction
18836843-1091	Relaxation to <protein-id="P10286,P30880,P30881,P31888,P80511">CGRP</protein-id> (10(-8) M) was unaffected by L-NAME (3 x 10(-4) M) and <compound-id="3715">indomethacin</compound-id> (10(-6) M) suggesting no involvement of <compound-id="145068">nitric oxide</compound-id> or prostaglandins in the <protein-id="P10286,P30880,P30881,P31888,P80511">CGRP</protein-id>-induced relaxation.	nitric oxide__CGRP__no_interaction	indomethacin__CGRP__no_interaction
18836851-1099	In the mouse model of demyelination-remyelination induced by oral administration of <compound-id="9723">cuprizone</compound-id>, in situ hybridization showed an upregulation of the <protein-id="Q08345,Q7YR43">DDR1</protein-id> gene in three different white matter areas (corpus callosum, dorsal fornix, and external capsule) during the remyelination period.	cuprizone__DDR1__interaction
18836851-1100	Cells positive for <protein-id="Q08345,Q7YR43">DDR1</protein-id> mRNA were also positive for oligodendrocyte markers (<protein-id="Q13516,Q90XB3">OLIG2</protein-id>, <compound-id="9369,439224">carnosine</compound-id>, and <protein-id="P25054">APC</protein-id>) but not for markers of oligodendrocyte precursors (<protein-id="Q99942">NG2</protein-id>), myelin markers (<protein-id="P06623,P09543,P13233,P16330">CNPase</protein-id>), microglia (CD11b), or reactive glia (<protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id>).	carnosine__APC__no_interaction	carnosine__CNPase__no_interaction	carnosine__GFAP__no_interaction	carnosine__DDR1__interaction	carnosine__NG2__no_interaction	carnosine__OLIG2__no_interaction
18836996-1126	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to <compound-id="451668">5-azadC</compound-id>/TSA, we were able to identify two characterized breast cancer TSGs (<protein-id="O73746,P39876,P48032">Timp3</protein-id> and Rprm) and four putative TSGs (Atp1B2, <protein-id="Q05922">Dusp2</protein-id>, <protein-id="Q5M7N6">FoxJ1</protein-id> and <protein-id="O35049,Q9JJY3">Smpd3</protein-id>) silenced in this line.	5-azadC__Dusp2__interaction	5-azadC__Timp3__interaction	5-azadC__FoxJ1__interaction	5-azadC__Smpd3__interaction
18837008-1129	Therapeutic strategy to rescue mutation-induced exon skipping in <protein-id="O16005,O16017,O16018,O16019,O16020,O18312,O18315,O18481,O18485,O18486,O18766,O42268,O42294,O42300,O42301,O42307,O42327,O42328,O42330,O42427,O42431,O42451,O42452,O42466,O42604,O62791,O62792,O62793,O62794,O62795,O62796,O62798,O93441,O93459,P02699,P02700,P08100,P09241,P15409,P22328,P22671,P24603,P28681,P29403,P31355,P31356,P32308,P32309,P35356,P35359,P35362,P35403,P41590,P41591,P49912,P51470,P51488,P51489,P52202,P56514,P56515,P56516,P79756,P79798,P79807,P79808,P79809,P79812,P79848,P79863,P79898,P79901,P79902,P79903,P79911,P79914,P87369,Q17094,Q17292,Q17296,Q28886,Q68J47,Q6W3E1,Q769E8,Q8HY69,Q90245,Q90305,Q90373,Q95KU1,Q98980,Q9DGG4,Q9YGY9,Q9YGZ0,Q9YGZ1,Q9YGZ2,Q9YGZ3,Q9YGZ4,Q9YGZ5,Q9YGZ6,Q9YGZ7,Q9YGZ8,Q9YGZ9,Q9YH00,Q9YH01,Q9YH02,Q9YH03,Q9YH04,Q9YH05">rhodopsin</protein-id> by adaptation of <compound-id="23989">U1</compound-id> snRNA.	U1__rhodopsin__interaction
18837008-1130	As a therapeutic strategy, <compound-id="23989">U1</compound-id> snRNAs were adapted to the novel <protein-id="O16005,O16017,O16018,O16019,O16020,O18312,O18315,O18481,O18485,O18486,O18766,O42268,O42294,O42300,O42301,O42307,O42327,O42328,O42330,O42427,O42431,O42451,O42452,O42466,O42604,O62791,O62792,O62793,O62794,O62795,O62796,O62798,O93441,O93459,P01122,P02699,P02700,P08100,P09241,P22328,P22671,P24603,P28681,P30403,P31355,P31356,P32308,P32309,P35356,P35403,P41590,P41591,P49912,P51470,P51488,P52202,P56514,P56515,P56516,P79756,P79798,P79807,P79808,P79809,P79812,P79848,P79863,P79898,P79901,P79902,P79903,P79911,P79914,P87369,Q17094,Q28886,Q68J47,Q6W3E1,Q769E8,Q8HY69,Q90245,Q90305,Q90373,Q95KU1,Q98980,Q9DGG4,Q9YGY9,Q9YGZ0,Q9YGZ1,Q9YGZ2,Q9YGZ3,Q9YGZ4,Q9YGZ5,Q9YGZ6,Q9YGZ7,Q9YGZ8,Q9YGZ9,Q9YH00,Q9YH01,Q9YH02,Q9YH03,Q9YH04,Q9YH05">RHO</protein-id> mutation and tested for its potential to reverse missplicing.	U1__RHO__interaction
18837469-2746	Urinary concentrations of <compound-id="176907">dihydrodaidzein</compound-id>, <compound-id="9838356">dihydrogenistein</compound-id>, <compound-id="89472">O-desmethylangolensin</compound-id>, and <compound-id="91469,382975">equol</compound-id> exceeded <protein-id="P28172,P51526">IFN</protein-id> aglycone equivalents.	dihydrodaidzein__IFN__no_interaction	equol__IFN__no_interaction	O-desmethylangolensin__IFN__no_interaction	dihydrogenistein__IFN__no_interaction
18837470-2752	Concentrations of <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, C-peptide, nonesterified fatty acids, triacylglycerol, total and exogenous <compound-id="206,5793,64689,79025">glucose</compound-id> kinetics were assessed for 6 h postprandially.	glucose__insulin__no_interaction
18837470-2754	After 120 min, <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.	glucose__insulin__no_interaction
18837522-1374	Keeping <compound-id="1174">uracil</compound-id> out of DNA: physiological role, structure and catalytic mechanism of <protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPases</protein-id>.	uracil__dUTPases__interaction
18837522-1375	To prevent <compound-id="1174">uracil</compound-id> incorporation into DNA, representatives of the dUTP nucleotidohydrolase (<protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</protein-id>) enzyme family eliminate excess dUTP.	uracil__dUTPase__interaction
18837522-1376	The <protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</protein-id> binding pocket is highly specific for <compound-id="1174">uracil</compound-id>.	uracil__dUTPase__interaction
18837522-1377	<compound-id="1061,167704,644102">Phosphate</compound-id> chain coordination involves Mg2+ and is analogous to that of <protein-id="O27276,O29753,O33845,O57191,O59610,O64235,O70736,O71121,O72539,O72540,P00581,P03158,P03198,P03261,P03680,P04292,P04293,P04415,P04495,P05468,P05664,P06225,P06538,P06856,P06950,P07917,P07918,P08546,P09252,P09804,P09854,P10479,P10582,P18131,P19822,P19894,P20311,P20509,P21402,P24907,P27172,P28857,P28858,P28859,P30314,P30317,P30318,P30319,P30320,P30321,P33793,P41712,P42489,P43139,P48311,P52025,P52342,P52367,P56689,P61875,P61876,P74918,P77933,P87503,P87553,Q05254,Q37882,Q37989,Q38087,Q51334,Q56366,Q58295,Q5UQR0,Q64751,Q65946,Q69025,Q6S6P1,Q83948,Q84173,Q85428,Q88469,Q90162,Q9HH05,Q9HH84,Q9YUS2,Q9YUS3">DNA polymerases</protein-id>.	Phosphate__DNA polymerases__interaction
18837522-1378	In these respective pathogens, Plasmodium falciparum and Mycobacterium tuberculosis, the biosynthesis of <compound-id="9700">dTMP</compound-id> relies exclusively on <protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</protein-id> activity.	dTMP__dUTPase__interaction
18837652-1413	Furthermore, NaHS enhanced inhibitory effects of <compound-id="2214">apocynin</compound-id>, <compound-id="12035">N-acetyl-l-cysteine</compound-id> (NAC), <compound-id="124886">reduced glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), Nomega-nitro-<compound-id="550788">l-arginine methyl ester</compound-id> (L-NAME) on ROS production and redox enzymes levels induced by Met.	l-arginine methyl ester__CAT__no_interaction	N-acetyl-l-cysteine__SOD__no_interaction	apocynin__SOD__no_interaction	reduced glutathione__catalase__no_interaction	GSH__SOD__no_interaction	apocynin__catalase__no_interaction	reduced glutathione__SOD__no_interaction	apocynin__CAT__no_interaction	GSH__superoxide dismutase__no_interaction	apocynin__superoxide dismutase__no_interaction	reduced glutathione__superoxide dismutase__no_interaction	GSH__CAT__no_interaction	N-acetyl-l-cysteine__superoxide dismutase__no_interaction	N-acetyl-l-cysteine__catalase__no_interaction	reduced glutathione__CAT__no_interaction	l-arginine methyl ester__SOD__no_interaction	GSH__catalase__no_interaction	N-acetyl-l-cysteine__CAT__no_interaction	l-arginine methyl ester__catalase__no_interaction	l-arginine methyl ester__superoxide dismutase__no_interaction
18837698-1429	It controls the expression of a total of 11 genes, the <protein-id="P24716,Q02540">CopR</protein-id> regulon, in a <compound-id="23978">copper</compound-id>-dependent manner.	copper__CopR__interaction
18838074-1535	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including <protein-id="P47744">GTH</protein-id>-releasing hormones, <protein-id="P41585,P48144,P81039">pituitary adenylate cyclase-activating polypeptide</protein-id>, <compound-id="681">dopamine</compound-id>, <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id>, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	dopamine__pituitary adenylate cyclase-activating polypeptide__no_interaction	dopamine__ghrelin__no_interaction	dopamine__GTH__no_interaction
18838074-1536	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, <protein-id="P13678,Q25378">protein kinase C</protein-id>, <compound-id="444899">arachidonic acid</compound-id>, NO, <protein-id="Q05608,Q9RI12">protein kinase A</protein-id>, <protein-id="P29323">ERK</protein-id>/<protein-id="O42781,P27638,Q00859">MAPK</protein-id>, and Smads allows for integrated control by different neuroendocrine factors.	arachidonic acid__MAPK__no_interaction	arachidonic acid__ERK__no_interaction	arachidonic acid__protein kinase C__no_interaction	arachidonic acid__protein kinase A__no_interaction
18838089-1541	An enzymatic reaction between <compound-id="784">hydrogen peroxide</compound-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> produced oxygen bubbles and thus many internal pores within microsphere were naturally developed.	hydrogen peroxide__catalase__interaction
18838102-1545	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via <protein-id="P27429">gonadotropin-releasing hormone</protein-id> (<protein-id="P27429">GnRH</protein-id>), luteinizing hormone (LH) and <compound-id="6013">testosterone</compound-id>/<compound-id="5757">estradiol</compound-id> (Te/E(2)).	estradiol__GnRH__no_interaction	estradiol__gonadotropin-releasing hormone__no_interaction	testosterone__gonadotropin-releasing hormone__no_interaction	testosterone__GnRH__no_interaction
18838266-1623	We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis <protein-id="O52271,O67762,O78485,O83269,O84317,O86094,O87903,P06173,P06271,P06272,P08036,P0A680,P0A681,P0A8V2,P0A8V3,P0A8V4,P0A8V5,P0C151,P11513,P11703,P12091,P16023,P19175,P21421,P22703,P23579,P27059,P29398,P30760,P31814,P36251,P36440,P37870,P41184,P41187,P41557,P41607,P43738,P46818,P47583,P47715,P47767,P47768,P48119,P49466,P50546,P51252,P56299,P56869,P57009,P57146,P59642,P59643,P60278,P60279,P60280,P60281,P60282,P60283,P77941,P77965,P78013,Q03587,Q1XDN5,Q20EX1,Q2FJ98,Q2GCD7,Q2GD90,Q2GJ68,Q2II86,Q2JFI5,Q2JJ19,Q2JX64,Q2L2M3,Q2L8Z9,Q2LQ87,Q2MIA8,Q2MIJ5,Q2NJ15,Q2NWR6,Q2NZX8,Q2RFN9,Q2RQV3,Q2S1Q5,Q2S905,Q2ST48,Q2SU19,Q2VEI4,Q2W2I1,Q2YB05,Q2YM15,Q2YSB9,Q30TP7,Q30X05,Q318Q7,Q31IY9,Q31N17,Q31U10,Q32AF9,Q32RG0,Q32RW5,Q33C46,Q38UQ2,Q39KH5,Q39Y13,Q3A6Q4,Q3A9Q7,Q3AHX5,Q3ATP5,Q3AZA4,Q3B1H7,Q3BAP8,Q3BWZ1,Q3C1G7,Q3ILP9,Q3J5T0,Q3J8Q7,Q3JMQ3,Q3K3L2,Q3K5Y1,Q3KM47,Q3M5D0,Q3SLQ6,Q3SSY0,Q3V542,Q3YST5,Q3YUZ7,Q3Z8V4,Q3ZJ93,Q3ZX01,Q46124,Q46J22,Q46WD4,Q47JB0,Q47LI5,Q47UV9,Q48D29,Q48VR1,Q492B9,Q49L06,Q49V52,Q4A5S7,Q4A7A9,Q4A969,Q4FLL2,Q4FQH3,Q4G3A7,Q4JT32,Q4K526,Q4L3K3,Q4MY95,Q4QN33,Q4UKD4,Q4URD2,Q4VZP1,Q4ZMN7,Q50388,Q51561,Q56P13,Q57CP8,Q57H69,Q589C0,Q59191,Q59622,Q5E238,Q5F5R5,Q5FFD9,Q5FM97,Q5FTX7,Q5GWS6,Q5HC05,Q5HID3,Q5HRL0,Q5HVY9,Q5L405,Q5L5I3,Q5L897,Q5LMQ5,Q5LXV3,Q5M2F5,Q5MZ23,Q5NID2,Q5NPK5,Q5P339,Q5PBG4,Q5PK93,Q5QA72,Q5QWA5,Q5SCX8,Q5WLS0,Q5WZL9,Q5X866,Q5XE97,Q5ZYQ0,Q5ZZS1,Q60A06,Q63H98,Q63Q03,Q64NJ7,Q65PB5,Q65W41,Q661M9,Q66FQ2,Q67JT3,Q68S14,Q6A6K6,Q6ACX5,Q6AP78,Q6B8R8,Q6DAN0,Q6ENI4,Q6ENX3,Q6EW56,Q6F0L7,Q6FF90,Q6GBU5,Q6GJC6,Q6HPR6,Q6KI09,Q6L3A7,Q6LLW2,Q6MDM1,Q6MJ09,Q6MRX6,Q6N4R9,Q6YQW3,Q724F0,Q727C7,Q72HM5,Q72UA8,Q73FA4,Q73JJ7,Q73SE4,Q748Y6,Q74L95,Q7MGR8,Q7MX27,Q7N9A4,Q7NIA0,Q7NQE6,Q7U8K4,Q7URW6,Q7V006,Q7V5P1,Q7VA29,Q7VKL7,Q7VRP7,Q7W0R9,Q7W2G9,Q7WRD9,Q7YJX8,Q81J48,Q81VT8,Q822J1,Q82DQ5,Q82T75,Q82Z40,Q85BW1,Q85FM7,Q85FR7,Q85X54,Q87A32,Q87KQ4,Q889X8,Q88QP2,Q88XZ3,Q890N4,Q89B20,Q89J74,Q8A469,Q8CQ84,Q8D233,Q8DD20,Q8DL55,Q8DNF0,Q8DS46,Q8E239,Q8E7J8,Q8EK74,Q8ETY8,Q8EWX1,Q8F0S2,Q8FS97,Q8G069,Q8G514,Q8GCR3,Q8GCR4,Q8GCR5,Q8GCR6,Q8HVY5,Q8K8W3,Q8KG15,Q8KWX2,Q8KWX4,Q8MA12,Q8NT26,Q8P2Y3,Q8PC56,Q8PNT0,Q8R7U6,Q8RHI6,Q8RQE9,Q8S8X9,Q8UE08,Q8WI24,Q8XUZ8,Q8YHP8,Q8Z320,Q8ZAP5,Q92F22,Q92QH7,Q932F8,Q93GF2,Q93MK7,Q93MK8,Q93MK9,Q93R88,Q97EG9,Q97NQ7,Q98N66,Q98Q23,Q9A1U1,Q9AAU2,Q9AIU3,Q9BBS9,Q9CEN6,Q9CK91,Q9F3X8,Q9KJG4,Q9KJM5,Q9KK59,Q9KV30,Q9KW14,Q9KWU7,Q9L0L0,Q9L637,Q9MTM5,Q9MUS5,Q9PA86,Q9PQV6,Q9RH41,Q9RH43,Q9RLT9,Q9RQZ7,Q9RVV9,Q9TL06,Q9TM35,Q9X6Y1,Q9XPS7,Q9Z9A0,Q9Z9M2">rpoB</protein-id> gene during the development of <compound-id="5381226">rifampin</compound-id> (RIF) resistance using an electrochemical genosensor.	rifampin__rpoB__interaction
18838482-1670	The main source of extracellular <compound-id="60961">adenosine</compound-id> stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the <protein-id="O18956,O75355,O93295,P49961,P55772,P97687,Q9MYU4">ecto-apyrase</protein-id> (<protein-id="O18956,O93295,P49961,Q9MYU4">CD39</protein-id>) and the <protein-id="P21588,P21589,Q05927,Q61503">ecto-5'-nucleotidase</protein-id> (CD73).	adenosine__ecto-apyrase__interaction	adenosine__CD39__interaction	adenosine__ecto-5'-nucleotidase__interaction
18838483-2012	Critical role of <protein-id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</protein-id> in <compound-id="5280427,5282411,6434194">prostacyclin</compound-id> production by human endothelial cells under modification of <compound-id="784">hydroperoxide</compound-id> tone.	hydroperoxide__COX-1__no_interaction	prostacyclin__COX-1__interaction
18838483-2013	We aimed at evaluating the relative contribution of cyclooxygenase (<protein-id="P11353,P36551,P36552,Q9UTE2,Q9V3D2">COX</protein-id>)-1 and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> to the synthesis of <compound-id="5280427,5282411,6434194">prostacyclin</compound-id> in endothelial cells under static conditions in the presence or absence of exogenous <compound-id="444899">arachidonic acid</compound-id> and/or altered intracellular redox balance.	arachidonic acid__COX__no_interaction	arachidonic acid__COX-2__no_interaction	prostacyclin__COX-2__interaction	prostacyclin__COX__interaction
18838503-1683	In contrast, <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id>.24, <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id>.26, and <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id>.27 allelic isoforms all showed active drug-metabolizing activities toward both <compound-id="5284371">codeine</compound-id> and <compound-id="3008,5360696,5362449,12305042">dextromethorphan</compound-id> O-demethylation.	dextromethorphan__CYP2D6__interaction	codeine__CYP2D6__interaction
18838506-1689	Mechanism-based inactivation of <protein-id="P11712">cytochrome P450 2C9</protein-id> by <compound-id="38409">tienilic acid</compound-id> and (+/-)-<compound-id="5359">suprofen</compound-id> : a comparison of kinetics and probe substrate selection.	suprofen__cytochrome P450 2C9__interaction	tienilic acid__cytochrome P450 2C9__interaction
18838506-1690	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of <protein-id="O08469">cytochrome P450</protein-id> (P450) 2C9 by <compound-id="38409">tienilic acid</compound-id> and (+/-)-<compound-id="5359">suprofen</compound-id> using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	tienilic acid__cytochrome P450__interaction	suprofen__cytochrome P450__interaction
18838523-1691	<protein-id="P0C081,P0C082,P0C083,P0C084,P0C085,P16462,P16535,P55117,P55118,P55123,Q7BHI8,Q9ETX2,Q9EV27,Q9EV29,Q9EV30,Q9EV31,Q9EV32,Q9EV33,Q9EV34">Leukotoxin</protein-id> activity was evaluated by measuring <compound-id="271">Ca(2</compound-id>+) entry or pore formation using spectrofluorometry or flow cytometry.	Ca(2__Leukotoxin__interaction
18838739-1780	These Ca2+-independent <protein-id="O77793,P00608,P00609,P00610,P00620,P00622,P04362,P14419,P14420,P14556,P18999,P20258,P20259,P20260,P20474,P21789,P31854,P47712,P47713,P49147,P50392,P50393,P51972,P59066,P81166,P81167,P81236,P81237,P81243,P82971,P84651,P84736,Q10756,Q7M3V3,Q7M4I5,Q7M4I6,Q99289,Q9BMK4,Q9I8F8">phospholipases A2</protein-id> display remarkable specificity for the length of the sn-2 residue, but this selectivity is lost as the residue gains <compound-id="977">oxygen</compound-id> functions.	oxygen__phospholipases A2__interaction
18839053-1886	At the end of treatment, BMI, WHR, HbA1c, fasting <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id>, HOMA-IR, alanine aminotransferase values decreased in both groups.	glucose__leptin__no_interaction
18839067-1902	<protein-id="O08328,O66935,O84804,P05416,P0A6U8,P0A6U9,P0A6V0,P39125,P45179,P58395,Q21BQ1,Q221N9,Q255S3,Q28MN0,Q2A4U4,Q2G7S7,Q2IM81,Q2J308,Q2K485,Q2P9F6,Q2RH55,Q2RS50,Q2T6R2,Q2W5G0,Q2YB48,Q30Z13,Q31BS5,Q31IB5,Q31VJ4,Q32AV6,Q3A0B8,Q3AKK1,Q3APL6,Q3AVF9,Q3B6C3,Q3BYI1,Q3K1K2,Q3KD65,Q3KKP3,Q3SH79,Q3YW96,Q46LU1,Q47IJ4,Q48JG9,Q4KCP0,Q4QK70,Q4UZL8,Q4ZS46,Q57IU1,Q5DZC1,Q5FL65,Q5H6Q4,Q5L562,Q5N1P1,Q5NHN2,Q5NXZ7,Q5PM09,Q5SMC5,Q632H4,Q65FS7,Q65TI3,Q664I5,Q6CZK3,Q6HC18,Q6KHP2,Q6LKA1,Q6MAS9,Q6NCT7,Q729V4,Q72G68,Q72YJ6,Q73MC7,Q7MJ50,Q7NM37,Q7U7I2,Q7UPY2,Q7V275,Q7V8F0,Q7VBP0,Q7W6L5,Q7WIJ0,Q816G8,Q81K85,Q821W4,Q82SP3,Q83PV4,Q87QX5,Q880M9,Q88FN9,Q890I8,Q8CWX0,Q8DAR0,Q8DKU2,Q8DPS3,Q8E079,Q8E5V5,Q8ET54,Q8KAY6,Q8PDD2,Q8PQA3,Q8RF65,Q8XPA1,Q8XT73,Q8Z232,Q8ZA78,Q935Y7,Q97GX6,Q97QS5,Q985P2,Q9CHM9,Q9CN91,Q9EUT5,Q9I1V0,Q9KDX6,Q9KRB6,Q9PLC3,Q9RNH6,Q9RWS1,Q9WZZ7,Q9Z6V8">Glycogen synthase</protein-id> kinase-3 inhibition by 3-<compound-id="137550">anilino</compound-id>-4-phenylmaleimides: insights from 3D-QSAR and docking.	anilino__Glycogen synthase__interaction
18839068-1905	Among these indicators is <compound-id="445141,6323481,44147587">phosphatidylserine</compound-id> (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexinV</protein-id> (<protein-id="P08758,P17153,P81287,Q4R4H7,Q5R1W0">ANXA5</protein-id>) conjugation.	phosphatidylserine__ANXA5__interaction	phosphatidylserine__annexinV__interaction
18839150-1938	Effects of chronic inflammation and <compound-id="5288826,5479215">morphine</compound-id> tolerance on the expression of phospho-<protein-id="P21708,P27361,Q63844">ERK 1</protein-id>/2 and phospho-<protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">P38</protein-id> in the injured tissue.	morphine__P38__interaction	morphine__ERK 1__interaction
18839150-1940	The results of the present study show that <protein-id="P29323">ERKs</protein-id> phosphorylation is unaltered by inflammation or <compound-id="5288826,5479215">morphine</compound-id> tolerance, each one individually, in the plantar tissue.	morphine__ERKs__no_interaction
18839150-1941	In contrast, no significant differences in phospho-<protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</protein-id> expression were observed between nave and tolerant animals acutely injected with saline or <compound-id="5288826,5479215">morphine</compound-id> in presence of CFA inflammation.	morphine__p38__no_interaction
18839150-1942	These results suggest that <protein-id="P29323">ERK</protein-id> but not p38 could be implicated in the development of <compound-id="5288826,5479215">morphine</compound-id> tolerance during peripheral inflammation.	morphine__ERK__interaction
18839155-1946	The anterior pituitary gland contains five types of cells secreting specific hormones (<protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id>, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> (ACTH), gonadotropic hormone, <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id>, and thyroid-stimulating hormone), and the double staining results indicated that <compound-id="71080">D:-Ala</compound-id> is localized to the ACTH-secreting cells.	D: -Ala__adrenocorticotropic hormone__no_interaction	D: -Ala__prolactin__no_interaction	D: -Ala__growth hormone__no_interaction
18839173-1953	In addition to <compound-id="5381226,5388984,5458213,6243627,6842115,6913622,16043998,17753751,25141428,45356263,56947149">rifampicin</compound-id> and <compound-id="3662,441298,5288591,6426795,46835064">hyperforin</compound-id>, the anticancer drug <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> has also been shown to be an inducer of CYP3A4 via activation of the <protein-id="O54915,O75469,Q8SQ01,Q9R1A7">pregnane X receptor</protein-id> (<protein-id="O75469,Q8SQ01">PXR</protein-id>).	rifampicin__PXR__no_interaction	hyperforin__PXR__no_interaction	paclitaxel__pregnane X receptor__interaction	hyperforin__pregnane X receptor__no_interaction	rifampicin__pregnane X receptor__no_interaction	paclitaxel__PXR__interaction
18839216-1978	A comprehensive literature review of clinical studies in children evaluating s-<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id> or <protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id>-based formulas and plasma <compound-id="588">creatinine</compound-id> or <compound-id="588">creatinine</compound-id>-based formulas against an exogenous reference method using receiver operating characteristics (ROC) curves or Bland-Altman plots is presented.	creatinine__CysC__no_interaction
18839216-1979	The comparison of s-<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id> with plasma <compound-id="588">creatinine</compound-id> indicated that s-<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id> was superior to plasma <compound-id="588">creatinine</compound-id> in five of 13 studies; four studies showed no difference, and, in four studies, no statistical comparison was made.	creatinine__CysC__no_interaction
18839216-1980	S-<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id> is most likely superior to plasma <compound-id="588">creatinine</compound-id> and at least equal to <compound-id="588">creatinine</compound-id>-based formulas.	creatinine__CysC__no_interaction
18839216-1981	<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id>-based prediction equations are at least as good as <compound-id="588">creatinine</compound-id>-based formulas but cannot replace exogenous methods.	creatinine__CysC__no_interaction
18839315-2028	By combining endosperm <protein-id="Q99K67,Q9SMZ4,Q9UDR5">LKR</protein-id>/<protein-id="O34607,O34635,O86564,P09367,P20132,P21801,P21912,P21914,P33073,P33074,P38997,P38998,P42630,P43065,P56072,P66773,P66774,P71349,P80212,P80213,Q02912,Q09694,Q48838,Q6FU27,Q75BV4,Q7SFX6,Q870G1,Q8LGI2,Q99K67,Q9SMZ4,Q9SQT8,Q9UDR5,Q9ZMU7">SDH</protein-id> suppression with embryo <protein-id="Q99K67,Q9SMZ4,Q9UDR5">LKR</protein-id>/<protein-id="O34607,O34635,O86564,P09367,P20132,P21801,P21912,P21914,P33073,P33074,P38997,P38998,P42630,P43065,P56072,P66773,P66774,P71349,P80212,P80213,Q02912,Q09694,Q48838,Q6FU27,Q75BV4,Q7SFX6,Q870G1,Q8LGI2,Q99K67,Q9SMZ4,Q9SQT8,Q9UDR5,Q9ZMU7">SDH</protein-id> suppression through crosses, the <compound-id="160556">saccharopine</compound-id> level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	saccharopine__LKR__interaction	saccharopine__SDH__interaction
18839328-2042	We examined the relationship between <protein-id="Q5MK86,Q9GZV9">FGF23</protein-id> and serum calcium, <compound-id="1061,167704,644102">phosphate</compound-id>, 1,25(OH)(2)D(3), and PTH levels in haemodialysis patients.	phosphate__FGF23__interaction
18839335-2050	Resistin, an adipokine-linked obesity with type 2 diabetes, impairs <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion (GSIS) in beta-cells.	glucose__insulin__interaction
18839360-2057	Intracellular <compound-id="312">Cl</compound-id> (-) is required for the motor function of <protein-id="P58743,Q99NH7,Q9EPH0,Q9JKQ2">prestin</protein-id>, a unique plasma membrane molecular motor of these cells.	Cl__prestin__interaction
18839361-2058	<protein-id="P58743,Q99NH7,Q9EPH0,Q9JKQ2">Prestin</protein-id> was immunostained with mouse anti-FLAG primary antibody and <compound-id="18730">FITC</compound-id>-conjugated goat anti-mouse IgG secondary antibody.	FITC__Prestin__interaction
18839419-2085	Intramuscular triacylglycerol does not appear to be a ubiquitous marker of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, although specific IMCL intermediates such as long-chain fatty acyl-CoAs, ceramide, and <compound-id="6026790">diacylglycerol</compound-id> may inhibit <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> signal transduction.	diacylglycerol__insulin__interaction
18840097-2250	Light stimulates <compound-id="24316">cGMP</compound-id> hydrolysis via the G-protein <protein-id="P49177">transducin</protein-id>, which directly binds to and activates phosphodiesterase.	cGMP__transducin__interaction
18840413-2365	Inhibition of gamma-glutamyl transferase (<protein-id="P19440,P20735">GGT1</protein-id>, EC 2.3.2.2)-catalyzed extracellular GSH degradation with <compound-id="294641">acivicin</compound-id> significantly blocked GSH efflux, suggesting that GSH breakdown is a driving force for GSH export.	acivicin__GGT1__no_interaction
18840446-2377	We injected females with human chorionic gonadotropin (<protein-id="Q9NFL4">HCG</protein-id>), <compound-id="5757">estradiol</compound-id>, <compound-id="5757">estradiol</compound-id> plus <compound-id="5994">progesterone</compound-id>, saline, or <protein-id="Q9NFL4">HCG</protein-id> plus <compound-id="59693">fadrozole</compound-id> (an aromatase blocker) and tested their responses to mating calls.	fadrozole__HCG__no_interaction	estradiol__HCG__no_interaction	progesterone__HCG__no_interaction
18840462-2386	Here we use an array of flow cytometric analyses to characterize silkworm hemocytes with various molecular probes, such as <compound-id="4939">propidium iodide</compound-id>, green fluorescence protein, monoclonal antibodies, and fluorescent <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id>.	propidium iodide__lectins__no_interaction
18840470-2387	Amino acid 1092 (AA1092) in <protein-id="O39831,O40980,O40981,O40983,O56129,O72620,O90369,O90371,P03314,P03315,P03316,P03590,P03591,P03598,P03601,P03602,P03605,P03607,P03641,P03642,P04866,P05070,P05072,P05673,P05674,P07566,P07699,P07931,P08491,P08563,P08564,P08767,P08768,P09502,P09592,P10468,P11333,P11642,P13890,P13897,P14340,P14849,P15100,P15406,P15892,P16486,P16489,P16596,P16653,P17529,P17782,P18027,P19725,P21368,P22056,P22116,P22172,P22955,P23627,P24147,P24264,P24402,P27284,P27285,P27334,P27335,P28899,P29165,P31798,P36329,P36330,P36331,P36332,P37991,P37993,P54087,P54088,P54089,P54090,P54635,P62406,P62683,P62684,P62685,P62690,P63117,P63126,P63128,P63130,P63145,P69466,P69467,P69470,P69471,P87889,P89946,Q00259,Q00260,Q00261,Q00467,Q00556,Q01669,Q02106,Q04542,Q04572,Q05142,Q06934,Q074N0,Q07506,Q07626,Q1X880,Q1X881,Q306W5,Q306W7,Q38041,Q4QXJ7,Q5WQY5,Q5XXP3,Q5Y388,Q66114,Q66120,Q66135,Q66138,Q66140,Q66141,Q66143,Q66154,Q6DV88,Q6J3P1,Q6X2U1,Q6X2U3,Q7LDI9,Q80QL5,Q80S27,Q83251,Q83253,Q83269,Q83271,Q86925,Q86993,Q87012,Q87019,Q88305,Q88894,Q89277,Q8JJX0,Q8JUX5,Q8QL52,Q8QZ72,Q8V987,Q8VA10,Q98803,Q99153,Q99IE6,Q9HDB9,Q9J6K8,Q9JGK8,Q9NRZ4,Q9WIJ8,Q9YNA8,Q9YRV3,Q9Z035">capsid protein</protein-id> 1 of coxsackievirus B3 (CVB3) is located in close vicinity to the central <compound-id="123143">phenoxy</compound-id> group of capsid binders (i.e.	phenoxy__capsid protein__interaction
18840474-2388	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> is a polypeptide hormone that is present in mammals and its main function is the maintenance of adequate <compound-id="107526">blood sugar</compound-id> level.	blood sugar__Insulin__interaction
18840497-2407	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce <compound-id="5754">cortisol</compound-id> in response to intravenous <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> injection implicating <protein-id="O57525,O73853,P05093,P05185,P12394,P19100,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7">CYP17</protein-id> as the primary cause of the observed hypocortisolism.	cortisol__CYP17__interaction	cortisol__insulin__interaction
18840501-434	In addition, <protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> facilitates bi-directional flux of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> by modifying the phospholipid content of the plasma membrane.	cholesterol__SR-BI__interaction
18840501-435	Overall, <protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> is the cell surface receptor responsible for selective uptake of lipoprotein <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and its ultimate delivery to sites of hormone synthesis in steroidogenic tissues.	cholesterol__SR-BI__interaction
18840514-2413	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the <compound-id="6037">folate</compound-id> metabolic pathway, such as <protein-id="P42898,Q5I598,Q60HE5,Q9WU20">methylenetetrahydrofolate reductase</protein-id> (<protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id>).	folate__MTHFR__interaction	folate__methylenetetrahydrofolate reductase__interaction
18840516-2417	We looked at the toxicity of non-drug-containing liposomes on (3)H-<compound-id="5789">thymidine</compound-id> incorporation by <protein-id="P81460,P81461">concanavalin A</protein-id> (<protein-id="P02866,P14894,P81460,P81461">Con A</protein-id>)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	thymidine__concanavalin A__interaction	thymidine__Con A__interaction
18840548-2430	The anti-inflammatory effect of these compounds and a <compound-id="323,94381">coumarin</compound-id> control, <compound-id="5280460">scopoletin</compound-id>, on <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>), <protein-id="Q8JFG3">tumor necrosis factor</protein-id> (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>), and macrophage chemotactic protein-1 (<protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id>) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	coumarin__tumor necrosis factor__interaction	coumarin__interleukin-6__interaction	coumarin__MCP-1__interaction	scopoletin__TNF__interaction	coumarin__IL-6__interaction	scopoletin__tumor necrosis factor__interaction	scopoletin__interleukin-6__interaction	scopoletin__MCP-1__interaction	coumarin__TNF__interaction	scopoletin__IL-6__interaction
18840610-2455	We previously determined that <protein-id="P35804">BLIP</protein-id> Tyr51 is a canonical and Trp150 an anti-canonical <protein-id="P62593">TEM-1</protein-id>-contact residue, where canonical refers to the <compound-id="602,4580,5950,71080">alanine</compound-id> substitution resulting in a matched change in the hydrophobicity of binding free energy.	alanine__BLIP__interaction	alanine__TEM-1__no_interaction
18840610-2456	This explains the anti-canonical nature of the Trp150 to <compound-id="602,4580,5950,71080">alanine</compound-id> substitution, and also reveals a strong long distance coupling between Trp150 and Asp49 of <protein-id="P35804">BLIP</protein-id>, because these two residues are more than 25 angstroms apart.	alanine__BLIP__no_interaction
18840670-2486	This effect is independent of any change in neutrophil adhesion or adhesion molecule expression but is related to the ability of statins to reduce <compound-id="443295">fMLP</compound-id>-induced <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> activity in neutrophils.	fMLP__Rho__interaction
18840670-2487	This was confirmed by the ability of the <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> precursor <compound-id="447277">geranylgeranyl pyrophosphate</compound-id> to rescue the statin-mediated reduction in neutrophil transendothelial migration.	geranylgeranyl pyrophosphate__Rho__interaction
18840677-1304	Suppression of <compound-id="1388">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</compound-id>-induced <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric-oxide synthase</protein-id> 2 expression in astrocytes by a novel <compound-id="3071">diindolylmethane</compound-id> analog protects striatal neurons against apoptosis.	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine__nitric-oxide synthase__interaction	diindolylmethane__nitric-oxide synthase__interaction
18840759-2541	We hypothesized that conditioned medium from macrophages pretreated with palmitate or LPS would directly affect <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> action and <compound-id="206,5793,64689,79025">glucose</compound-id> uptake in muscle cells.	glucose__insulin__no_interaction
18840759-2542	Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-stimulated <compound-id="206,5793,64689,79025">glucose</compound-id> uptake, <protein-id="P14672,Q27994,Q9XST2,Q9XT10">GLUT4</protein-id> translocation, and <protein-id="P31750,Q8INB9">Akt</protein-id> phosphorylation without affecting stress kinases or inflammation indexes.	glucose__GLUT4__no_interaction	glucose__insulin__interaction	glucose__Akt__no_interaction
18840763-2544	The essential role of <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and the importance of distributed control of <compound-id="206,5793,64689,79025">glucose</compound-id> fluxes are highlighted in this review.	glucose__insulin__interaction	glucose__glucagon__interaction
18840765-2545	Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz[a] <compound-id="8418">anthracene</compound-id> (<compound-id="6001">DMBA</compound-id>), Tg(MMTV-Neu)202Mul/J (<protein-id="P04626">HER2</protein-id>), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	anthracene__HER2__no_interaction	DMBA__HER2__no_interaction
18840783-2553	<protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> kinase inhibition by <compound-id="3547">fasudil</compound-id> ameliorates diabetes-induced microvascular damage.	fasudil__Rho__interaction
18840783-2554	Involvement of the <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id>/<protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> kinase (ROCK) pathway in diabetic microvasculopathy and therapeutic potential of <compound-id="3547">fasudil</compound-id>, a selective ROCK inhibitor, are investigated.	fasudil__Rho__no_interaction
18840785-2556	This study investigated the acute effects of treatment with <compound-id="6918537">vildagliptin</compound-id> on <protein-id="P14740,P22411,P27487,P28843,P81425,Q9N2I7">dipeptidyl peptidase-4</protein-id> (<protein-id="P97399,Q62598,Q9NZW4">DPP</protein-id>-4) activity, <protein-id="O12956,P01272,P01273,P01274,P01275,P01278,P05110,P06883,P15438,P22890,P29794,P55095,P68259,Q8MJ25">glucagon-like peptide 1</protein-id> (<protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id>) concentration, <protein-id="P01298,P01299,P01301,P01302,P06303,P06304,P06305,P06884,P10601,P11967,P13083,P15427,P18107,P31229,P33684,P37999,P39659,P41335,P41336,P41337,P41519,P68009,P68010,P68249">pancreatic hormone</protein-id> levels, and glucose metabolism.	vildagliptin__GLP-1__interaction	vildagliptin__dipeptidyl peptidase-4__interaction	vildagliptin__pancreatic hormone__interaction	vildagliptin__glucagon-like peptide 1__interaction	vildagliptin__DPP__interaction
18840785-2557	The primary aims were to determine the effects of <protein-id="P97399,Q62598,Q9NZW4">DPP</protein-id>-4 inhibition on <protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id> clearance and on hepatic <compound-id="206,5793,64689,79025">glucose</compound-id> uptake.	glucose__DPP__interaction	glucose__GLP-1__no_interaction
18840871-2587	In the present study we determined the effect of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> on the secretome by comparing incorporation rates of (13)C-labeled <compound-id="866,5962">lysine</compound-id> in the presence and absence of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>.	lysine__insulin__no_interaction
18840995-2643	<protein-id="P33716">Chromogranin A</protein-id> as an alternative to <compound-id="1826">5-hydroxyindoleacetic acid</compound-id> in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.	5-hydroxyindoleacetic acid__Chromogranin A__interaction
18841321-2736	<protein-id="Q64279,Q922L6">Th1</protein-id> cytokine profile may be related to the risk of the vaginal erosions following placement of <compound-id="8252">polypropylene</compound-id> meshes.	polypropylene__Th1__no_interaction
18841385-2745	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitricoxide synthase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="P15984,P16147,P84714">peroxidase</protein-id>, <protein-id="O50258">superoxide dismutase</protein-id> and the concentration of <compound-id="145068">nitric oxide</compound-id>, <compound-id="54670067,54690394">ascorbic acid</compound-id> and <compound-id="124886">glutathione</compound-id> increased.	ascorbic acid__peroxidase__no_interaction	nitric oxide__peroxidase__no_interaction	ascorbic acid__catalase__no_interaction	nitric oxide__superoxide dismutase__no_interaction	nitric oxide__catalase__no_interaction	ascorbic acid__nitricoxide synthase__no_interaction	glutathione__nitricoxide synthase__no_interaction	ascorbic acid__superoxide dismutase__no_interaction	glutathione__superoxide dismutase__no_interaction	glutathione__peroxidase__no_interaction	nitric oxide__nitricoxide synthase__no_interaction	glutathione__catalase__no_interaction
18841409-2761	The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-<protein-id="O50258">superoxide dismutase</protein-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> activities, O (2) (*-) production, lipid peroxidation, and <compound-id="124886">glutathione</compound-id> levels.	glutathione__catalase__no_interaction	glutathione__superoxide dismutase__no_interaction
18841465-2774	These results suggest that <compound-id="21576577">ugonin K</compound-id> by activation of <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 and <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>/<protein-id="P31750,Q8INB9">Akt</protein-id> signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	ugonin K__PI3K__interaction	ugonin K__ERK1__interaction	ugonin K__Akt__interaction
18841468-2776	This decrease was not modified by <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> or <compound-id="40634">Trolox</compound-id>, demonstrating that <compound-id="5460609">ONOO</compound-id> (-) was responsible for the effect.	Trolox__catalase__no_interaction	ONOO__catalase__no_interaction
18841470-2778	Cell viability (MTT colorimetric determination) and transmembrane mitochondrial potential (J-C1 fluorescence) were concentration-dependently reduced 24 h after NaN (3); neither nuclear fragmentation by <compound-id="2954">DAPI</compound-id>, nor <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">Annexin V</protein-id> positivity by flow cytometry were detected, ruling out the occurrence of apoptosis.	DAPI__Annexin V__no_interaction
18841471-2779	Plasma <compound-id="1738">homovanillic acid</compound-id> and <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> in Huntington's disease.	homovanillic acid__prolactin__no_interaction
18841471-2780	We assessed plasma <compound-id="1738">homovanillic acid</compound-id> (pHVA) and plasma <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> (pPRL), two correlates of dopaminergic activity, in 116 subjects with CAG repeats expansion in the HD gene, 26 presymptomatic (18 females) and 90 with overt symptomatology (43 females).	homovanillic acid__prolactin__no_interaction
18841529-2811	Profile of serum <protein-id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</protein-id> and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> shortly after ovariectomy and <compound-id="5757">estradiol</compound-id> replacement in rats.	estradiol__IL-1beta__interaction	estradiol__IL-10__interaction
18842264-225	A low plasma <protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (HDL-c) concentration is an important risk factor for the development of atherosclerotic cardiovascular disease.	cholesterol__high-density lipoprotein__interaction
18842297-227	A hydrogel was fabricated by chemically crosslinking alpha-<protein-id="P11547">elastin</protein-id> with <compound-id="3485">glutaraldehyde</compound-id> at high pressure CO(2).	glutaraldehyde__elastin__interaction
18842335-233	We evaluated whether inhibition of <protein-id="O44001,O61998,P24724,P40292,Q18688,Q4UDU8,Q61W58,Q69QQ6">heat shock protein 90</protein-id> (<protein-id="P40292,P41887,Q90474">hsp90</protein-id>) function by <compound-id="54675769">novobiocin</compound-id> derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	novobiocin__heat shock protein 90__interaction	novobiocin__hsp90__interaction
18842348-234	The cancer cells could find an alternate pathway to make this protein that does not require progesterone secretion, or the cancer cells may actually utilize <compound-id="5994">progesterone</compound-id> and thus make <protein-id="Q8WXW3">PIBF</protein-id> in a similar fashion to normal pregnancy.	progesterone__PIBF__no_interaction
18842620-268	<protein-id="O08469">Cytochrome P450</protein-id> (<protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id>) 1A1 and <protein-id="Q16678">CYP1B1</protein-id> are inducible by <compound-id="15625">2,3,7,8-tetrachlorodibenzo-p-dioxin</compound-id> (<compound-id="15625">dioxin</compound-id>) in the human breast cancer cell line, MCF-7.	2,3,7,8-tetrachlorodibenzo-p-dioxin__CYP1B1__interaction	dioxin__CYP__interaction	dioxin__Cytochrome P450__interaction	dioxin__CYP1B1__interaction	2,3,7,8-tetrachlorodibenzo-p-dioxin__CYP__interaction	2,3,7,8-tetrachlorodibenzo-p-dioxin__Cytochrome P450__interaction
18842620-269	<compound-id="15625">Dioxin</compound-id> treatment leads to recruitment of the <protein-id="O02747">aryl hydrocarbon receptor</protein-id> to the enhancer regions but not to the proximal promoter regions of both the <protein-id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</protein-id> and <protein-id="Q16678">CYP1B1</protein-id> genes.	Dioxin__CYP1A1__no_interaction	Dioxin__CYP1B1__no_interaction	Dioxin__aryl hydrocarbon receptor__interaction
18842620-270	These results suggest that nucleosomal remodeling is less significant for <compound-id="15625">dioxin</compound-id>-mediated induction of <protein-id="Q16678">CYP1B1</protein-id> than that of <protein-id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</protein-id> and may be related to the more modest inducibility of the former.	dioxin__CYP1B1__interaction	dioxin__CYP1A1__interaction
18842620-271	These observations provide novel insights into the functional roles of the endogenous coactivators in <compound-id="15625">dioxin</compound-id> induction of the human <protein-id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</protein-id> and <protein-id="Q16678">CYP1B1</protein-id> genes in their natural chromosomal configurations.	dioxin__CYP1B1__interaction	dioxin__CYP1A1__interaction
18842703-297	Decreased oral absorption of <compound-id="2909,5280754,5284373,5497195,6435893,49867938">cyclosporine A</compound-id> after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-<protein-id="P08163">glycoprotein</protein-id> to the first-pass metabolism in intestinal epithelial cells.	cyclosporine A__glycoprotein__no_interaction
18842954-373	The different mechanisms might be explained by the different sensitivity of <protein-id="P21521">synaptotagmin</protein-id> isoforms to Ca2+, <compound-id="104798">Sr2</compound-id>+, and Ba2+.	Sr2__synaptotagmin__interaction
18842962-374	Each residue was modified with one to three <compound-id="206,439357">hexose</compound-id> units, and the most dominant <protein-id="O68901,P00446,P0A608,P0A609,P0AGD1,P0AGD2,P15453,P20379,P24702,P25841,P25842,P53636,P57005,P66826,P66827,P69049,Q12548,Q51853,Q59081,Q59448,Q59452,Q59623,Q59689,Q5ZT17,Q877B5,Q8X1S6,Q9AGW2,Q9CBI6,Q9RU48,Q9Y8D9">SodC</protein-id> glycoform was modified with nine <compound-id="206,439357">hexose</compound-id> units.	hexose__SodC__interaction
18843259-489	Following <compound-id="27991">dDAVP</compound-id> there was a time-dependent redistribution of total <protein-id="O62735,O77697,O77714,O77722,O77740,O93938,P34080,P41181,P56402,P79099,P79144,P79164,P79165,P79168,P79200,P79213,P79229,P79803">aquaporin-2</protein-id> from predominantly intracellular vesicles to the apical plasma membrane, clathrin-coated vesicles, early endosomal compartments, and lysosomes.	dDAVP__aquaporin-2__interaction
18843273-456	The relationships among obesity, metabolic syndrome, ED, sex hormone-binding globulin (<protein-id="P04278,P08689,P15196,P97497,Q62588">SHBG</protein-id>) and serum total and free <compound-id="6013">testosterone</compound-id> levels are complex and often confusing to the physician.	testosterone__SHBG__interaction
18843482-535	The transcription factors <protein-id="P12813">Nur77</protein-id> and retinoid X receptors participate in <compound-id="3007,5826,32893">amphetamine</compound-id>-induced locomotor activities.	amphetamine__Nur77__interaction
18843519-555	The molecular masses of TKU006 <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">protease</protein-id> and <protein-id="P13656,P14529,P23472,P23473,P81241,P84754">chitinase</protein-id> determined by <compound-id="8778">sodium dodecyl sulfate</compound-id> (SDS)-polyacrylamide gel electrophoresis were approximately 39 and 35 kDa, respectively.	sodium dodecyl sulfate__chitinase__interaction	sodium dodecyl sulfate__protease__interaction
18844213-796	We now show that treatment of cells with phosphomimic <protein-id="P00749,P04185,P06869,P15120,P16227,P29598,Q05589">uPA</protein-id> (uPA138E/303E, <compound-id="5951">serine</compound-id> 138 and 303 substituted with glutamic acid) strongly inhibits matrix-induced cell migration.	serine__uPA__interaction
18844219-799	When cells were subjected to hypoxia (1% <compound-id="977,5359597">O2</compound-id>), the expression of <protein-id="P12794,P22358,P22954,P50021,Q27965,Q47XI6,Q5E3A7,Q5N1J4,Q6LS31,Q7U3C4,Q7UZG3,Q7V3T5,Q7V9G2,Q826F6,Q8DI58,Q8YW74">HSP70-2</protein-id> had a significant increase in cancer cells.	O2__HSP70-2__interaction
18844235-806	We further demonstrate that loss of <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> stress fibers is due to a <compound-id="188955">cyclic adenosine monophosphate</compound-id>, <protein-id="Q05608,Q9RI12">protein kinase A</protein-id>-mediated pathway that results in <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> inhibition.	cyclic adenosine monophosphate__actin__interaction	cyclic adenosine monophosphate__protein kinase A__interaction	cyclic adenosine monophosphate__Rho__interaction
18844240-810	The nuclear NF-kappaB <protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> expression after treatment with the SFN-<compound-id="3385">5-Fu</compound-id> combination was also evaluated by western blot analysis.	5-Fu__p65__no_interaction
18844240-812	Treatment ACCs cells with SFN and <compound-id="3385">5-Fu</compound-id> in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB <protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> protein.	5-Fu__p65__interaction
18844240-813	Our results demonstrate synergism between SFN and <compound-id="3385">5-Fu</compound-id> at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB <protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> protein.	5-Fu__p65__interaction
18844290-828	In order to further analyse the protective mode of action, the <compound-id="5359597">superoxide</compound-id> anion scavenging activity of two extracts was evaluated in a <compound-id="1188">xanthine</compound-id>/<protein-id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</protein-id> system.	xanthine__xanthine oxidase__interaction	superoxide__xanthine oxidase__interaction
18844296-833	Human genetic diseases that affect N-glycosylation result from the defective synthesis of the N-linked sugar moiety (<compound-id="871">glycan</compound-id>) of <protein-id="P08163">glycoproteins</protein-id>.	glycan__glycoproteins__interaction
18844325-840	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (<protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id>, <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferase</protein-id> and <compound-id="124886">reduced glutathione</compound-id>).	reduced glutathione__superoxide dismutase__no_interaction	reduced glutathione__glutathione-S-transferase__no_interaction	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction
18844326-841	Antiobesity effect of <compound-id="9918693,12901617,44202122,45479443">ginsenoside Rg3</compound-id> involves the <protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id> and <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">PPAR-gamma</protein-id> signal pathways.	ginsenoside Rg3__AMPK__interaction	ginsenoside Rg3__PPAR-gamma__interaction
18844326-842	This inhibitory effect of <compound-id="9918693,12901617,44202122,45479443">ginsenoside Rg3</compound-id> on adipocyte differentiation was accompanied by <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">PPAR-gamma</protein-id> inhibition in rosiglitazone-treated cells.	ginsenoside Rg3__PPAR-gamma__interaction
18844326-843	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, <compound-id="9918693,12901617,44202122,45479443">ginsenoside Rg3</compound-id>, involves the <protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id> signaling pathway and <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">PPAR-gamma</protein-id> inhibition.	ginsenoside Rg3__AMPK__interaction	ginsenoside Rg3__PPAR-gamma__interaction
18845121-1115	They can be oxidized by <protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">semicarbazide-sensitive amine oxidase</protein-id> (<protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">SSAO</protein-id>), leading to the production of toxic aldehydes such as <compound-id="712">formaldehyde</compound-id> and <compound-id="880">methylglyoxal</compound-id> as well as <compound-id="784">hydrogen peroxide</compound-id> and <compound-id="222">ammonia</compound-id>.	methylglyoxal__semicarbazide-sensitive amine oxidase__interaction	hydrogen peroxide__semicarbazide-sensitive amine oxidase__interaction	ammonia__semicarbazide-sensitive amine oxidase__interaction	formaldehyde__semicarbazide-sensitive amine oxidase__interaction	hydrogen peroxide__SSAO__interaction	formaldehyde__SSAO__interaction	methylglyoxal__SSAO__interaction	ammonia__SSAO__interaction
18845132-1120	Selenocystine is taken up well by the b(0,+) rBAT system, while <compound-id="152157">selenobetaine</compound-id> is a low-affinity substrate only for <protein-id="P39980,Q9Y3P8">SIT1</protein-id> and <protein-id="P25644,P34230,P43577,Q02166,Q6L8K7,Q7Z2H8,Q92624">PAT1</protein-id>.	selenobetaine__SIT1__interaction	selenobetaine__PAT1__interaction
18845148-1121	Experiments using a classical inhibitor of phosphotyrosine <protein-id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">phosphatase</protein-id>, <compound-id="61671">sodium orthovanadate</compound-id>, also showed that the ecto-<protein-id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">phosphatase</protein-id> activity was inhibited in a dose-dependent manner.	sodium orthovanadate__phosphatase__interaction
18845237-1144	<protein-id="P54149,Q9UJ68">MSRAs</protein-id> (methionine <compound-id="8442">sulfoxide reductases</compound-id> A) are enzymes that reverse the effects of oxidative damage by reducing <compound-id="847">methionine sulfoxide</compound-id> back to methionine and recovering protein function.	methionine sulfoxide__MSRAs__interaction	sulfoxide__MSRAs__interaction
18845237-1145	Both promoters are partially regulated by <compound-id="444795">all-trans retinoic acid</compound-id> via <protein-id="P10276,P18514,Q5FBR4,Q90966,Q9W5Z3">RARA</protein-id> and other RARs.	all-trans retinoic acid__RARA__interaction
18845277-1178	Our data suggest a developmental role of <protein-id="P16257,P30535,P30536,P50637">PBRs</protein-id> in erythropoiesis in chickens, possibly via the regulation of <compound-id="4971">heme</compound-id> availability for the assembly of functional <protein-id="P15160,P17724,P73925,Q03459">hemoglobins</protein-id>.	heme__hemoglobins__interaction	heme__PBRs__interaction
18845302-1193	Circulating <compound-id="56841713">apelin</compound-id>, adiponectin, <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id>, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, hsCRP and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> levels were determined both at baseline and after TLC intervention and statin treatment.	apelin__TNF-alpha__no_interaction	apelin__insulin__no_interaction	apelin__leptin__no_interaction
18845357-1202	<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> and <compound-id="107873">8-isoprostane</compound-id> levels in exhaled breath condensate and serum of patients with lung cancer.	8-isoprostane__TNF-alpha__no_interaction	8-isoprostane__VEGF__no_interaction
18845357-1203	The aim of the present study was to evaluate the levels of <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, <compound-id="107873">8-isoprostane</compound-id> and <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	8-isoprostane__TNF-alpha__no_interaction	8-isoprostane__VEGF__no_interaction
18845357-1204	Furthermore, associations between <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, <compound-id="107873">8-isoprostane</compound-id> and <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> levels in EBC and serum with clinicopathologic factors were investigated.	8-isoprostane__TNF-alpha__no_interaction	8-isoprostane__VEGF__no_interaction
18845357-1205	<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> and <compound-id="107873">8-isoprostane</compound-id> levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA).	8-isoprostane__TNF-alpha__no_interaction	8-isoprostane__VEGF__no_interaction
18845383-1219	Currently, adreno-corticotrophic hormone (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>), steroids and <compound-id="5665">vigabatrin</compound-id> (VGB) form the mainstay of its treatment.	vigabatrin__ACTH__no_interaction
18845389-1221	The addition of <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id> kinase C (PKC) activator, <compound-id="4792,27924,122634,22833501">phorbol 12-myristate 13-acetate</compound-id>, rescued PhIP-inhibited <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> expression in LTA-stimulated cells.	phorbol 12-myristate 13-acetate__TNF-alpha__interaction	phorbol 12-myristate 13-acetate__a protein__interaction
18845486-1248	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood <compound-id="206,5793,64689,79025">glucose</compound-id> level, immuno-histology, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> content of islets and expression of the proinflammatory cytokines, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id>, <protein-id="Q16552,Q60I29,Q61453,Q62386,Q687Y7">IL-17</protein-id>, and <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> in pancreatic lymph nodes.	glucose__TNF-alpha__no_interaction	glucose__insulin__no_interaction	glucose__IL-17__no_interaction	glucose__iNOS__no_interaction	glucose__IFN-gamma__no_interaction
18845629-1303	They secreted <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> in response to <compound-id="206,5793,64689,79025">glucose</compound-id> and could correct hyperglycemia in vivo when cotransplanted with vascular cells.	glucose__insulin__interaction
18845633-1305	This action was mimicked solely by 100 nm CH-275, a selective agonist at the somatostatin type 1 receptor (<protein-id="P30872">SSTR1</protein-id>), but not by 100 nm BIM-23027, L-362855, or <compound-id="5311371">NNC-269100</compound-id> ; agonists selective for the other four SSTRs known to exist in MIN6.	NNC-269100__SSTR1__no_interaction
18845634-1306	A functional <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> system is essential for <compound-id="26052">sodium tungstate</compound-id> antiobesity action.	sodium tungstate__leptin__interaction
18845638-1311	Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates <compound-id="5757">estradiol</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> release in female mice.	estradiol__insulin__interaction
18845639-1312	The aim of this study was to assess in rats the effect of protein feeding on the: 1) distribution of endogenous <compound-id="206,5793,64689,79025">glucose</compound-id> production (EGP) among gluconeogenic organs, and 2) repercussion on the <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity of glucose metabolism.	glucose__insulin__no_interaction
18845640-1315	Transcription of <protein-id="P58864,Q9DG08">steroidogenic acute regulatory protein</protein-id> in the rodent ovary and placenta: alternative modes of <compound-id="6076">cyclic adenosine 3', 5'-monophosphate</compound-id> dependent and independent regulation.	cyclic adenosine 3', 5'-monophosphate__steroidogenic acute regulatory protein__interaction
18845640-1316	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, <compound-id="8955">pregnenolone</compound-id>, by the cholesterol side-chain cleavage <protein-id="O08469">cytochrome P450</protein-id> (<protein-id="O46515,P00189,P05108,P10612,P79153,P79202,Q07217,Q28827,Q2XV99,Q92045,Q9EPT4">CYP11A1</protein-id>) enzyme complex takes place in the inner mitochondrial membranes.	pregnenolone__CYP11A1__interaction	pregnenolone__cytochrome P450__interaction
18845643-1319	Collectively, these studies identify a novel role for <compound-id="5280453">1,25-dihydroxyvitamin D</compound-id> (3) and the <protein-id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</protein-id> in the control of adipocyte metabolism and lipid storage in vivo.	1,25-dihydroxyvitamin D__VDR__no_interaction
18845645-1323	Direct <protein-id="P08235,P22199,P79404,Q29131,Q3YC04,Q4JM28,Q8QHI2,Q8VII8,Q91573,Q9BDJ7,Q9IAC6,Q9N0W8">mineralocorticoid receptor</protein-id> (MR) activation with <compound-id="5952">deoxycorticosterone acetate</compound-id> has deleterious effects on the cerebral vasculature.	deoxycorticosterone acetate__mineralocorticoid receptor__interaction
18845645-1325	Therefore, we hypothesized that systemic <protein-id="O77667,P50168,P50233,P51661,P51976,P80365">11betaHSD2</protein-id> inhibition with <compound-id="21913,636403,5311038">carbenoxolone</compound-id> (CBX) would cause remodeling of the middle cerebral artery (MCA) and increase the damage caused by cerebral ischemia.	carbenoxolone__11betaHSD2__interaction
18845661-1336	In this study, we attempted to evaluate the effects of <compound-id="3821,182137,644025">ketamine</compound-id> on F-<protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> and microtubular cytoskeletons in human hepatoma HepG2 cells and its possible molecular mechanisms.	ketamine__actin__interaction
18845661-1337	Consequently, <compound-id="3821,182137,644025">ketamine</compound-id>-caused cytoskeletal interruption led to suppression of <protein-id="P08684">CYP3A4</protein-id> expression and its metabolizing activity.	ketamine__CYP3A4__interaction
18845662-1339	Because many drug-drug interactions may occur at the level of drug transporting proteins, we studied interactions of <compound-id="3033">diclofenac</compound-id> with apical ATP-binding cassette (ABC) <protein-id="O31855,O82855,P37340,P45272,P58163,P58164,Q55364,Q57PL1,Q5E4Y6,Q5KZL2,Q5MZD9,Q5NYX9,Q5PH16,Q5QWR6,Q62LW6,Q63DZ4,Q63S57,Q65IG9,Q65SY9,Q66A27,Q6D5W6,Q6FEY7,Q6HLG9,Q6LQ49,Q6NB79,Q71YH0,Q73BB8,Q7MKP8,Q7N1G0,Q7N3V2,Q7NXN3,Q7UAH8,Q7VMB5,Q7WAK9,Q7WJR0,Q7WTR3,Q81G28,Q81T85,Q879Z5,Q88BA2,Q88CB9,Q89AX2,Q89W72,Q8CUL5,Q8D9N8,Q8DPQ6,Q8EES3,Q8FH68,Q8G2I1,Q8P4E6,Q8PG07,Q8UDF5,Q8Y654,Q8YFD7,Q8Z6N7,Q8ZDZ8,Q8ZPP2,Q92AG2,Q92PZ0,Q97QN5,Q98D15,Q9CMZ9,Q9F5N7,Q9HTR0,Q9I3Y3,Q9JV27,Q9K015,Q9KEJ2,Q9KRU4,Q9PA34,Q9RY44,Q9WZS2">multidrug efflux transporters</protein-id>.	diclofenac__multidrug efflux transporters__interaction
18845662-1341	Furthermore, in Sf9-<protein-id="Q9UNQ0">BCRP</protein-id> membrane vesicles <compound-id="3033">diclofenac</compound-id> inhibited transport of methotrexate in a concentration-dependent manner.	diclofenac__BCRP__interaction
18845675-1354	To test this hypothesis, we measured the effect of <protein-id="P25285,P28337,P48728,Q9TSZ7">AMT</protein-id> on <protein-id="P30957,Q92736">RyR2</protein-id> channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator <compound-id="57054">Fura-2</compound-id> <compound-id="53627513">acetoxymethyl</compound-id> ester.	Fura-2__AMT__no_interaction	Fura-2__RyR2__no_interaction	acetoxymethyl__AMT__no_interaction	acetoxymethyl__RyR2__no_interaction
18845767-1393	Most cells contain methionine sulfoxide reductases, which catalyze a <protein-id="O14463,O17486,O22022,O30974,O51088,O51890,O83889,O84544,O96952,O97508,O97680,P00276,P08058,P08628,P08629,P09857,P0A0K4,P0A0K5,P0A0K6,P0A4L3,P0A4L4,P0A616,P0A617,P10472,P10473,P10599,P10639,P11232,P14930,P14949,P21609,P21610,P29429,P29451,P33791,P34723,P37395,P42115,P43785,P46843,P47370,P50254,P50338,P50413,P51225,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P82460,P96132,P99122,P99505,Q05739,Q57755,Q5HGT9,Q5HQ29,Q5R9M3,Q6GA69,Q6GHU0,Q7KQL8,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q98TX1,Q9BDJ3,Q9CM49,Q9DGI3,Q9JWM8,Q9K1N8,Q9PJK3,Q9R6P9,Q9UW02,Q9X2T1,Q9Z7P5,Q9ZEE0">thioredoxin</protein-id>-dependent reduction of <compound-id="876,6137">methionine</compound-id> sulfoxide back to <compound-id="876,6137">methionine</compound-id>.	methionine__thioredoxin__interaction
18845767-1394	The intracellular free <compound-id="876,6137">methionine</compound-id> and <compound-id="34756">S-adenosylmethionine</compound-id> pools were not altered, nor was the specific activity of the key enzyme, <protein-id="O00088,O04867,O08467,O27612,O29313,O58097,O59648,O66514,P00964,P04773,P07804,P09606,P0A039,P0A040,P0A1P6,P0A1P7,P0A9C5,P0A9C6,P0A9C7,P0A9C8,P10583,P10656,P11600,P12424,P12425,P13499,P15103,P15104,P15105,P15106,P15124,P15623,P16580,P19064,P19904,P20479,P21154,P22248,P23712,P23794,P25821,P28605,P28786,P32288,P33035,P36205,P43386,P43518,P43794,P45627,P46410,P51120,P51121,P60890,P77961,P94126,P94845,P99095,Q04831,Q05650,Q05907,Q06378,Q09179,Q12613,Q4R7U3,Q5HGC3,Q5HPN2,Q60182,Q6B4U7,Q6C3E0,Q6FMT6,Q6G9Q4,Q6GHC6,Q75BT9,Q86ZF9,Q86ZU6,Q874T6,Q8CSR8,Q8HZM5,Q8J1R3,Q8X169,Q96UG9,Q96UV5,Q96V52,Q9C2U9,Q9CDL9,Q9CLP2,Q9HH09,Q9HNI2,Q9HU65,Q9KNJ2,Q9QY94,Q9UUN6,Q9UY99,Q9ZLW5">glutamine synthetase</protein-id>.	S-adenosylmethionine__glutamine synthetase__no_interaction	methionine__glutamine synthetase__no_interaction
18845781-1399	Activity of muscle <protein-id="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20901,P20902,P20903,P21553,P26491,P27660,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P84543,P94325,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59939,Q59977,Q9RWB2,Q9ZN37">citrate synthase</protein-id> and <protein-id="O49809,P07896,P21177,P28793,P51659,P51660,P55100,P77399,P97852,Q08426,Q0TAL0,Q1C2C4,Q1CN99,Q1Q8J9,Q1R466,Q32A21,Q39659,Q3K9D8,Q3YVC1,Q489W3,Q48GW3,Q4FQC6,Q4KFC4,Q4ZRA0,Q57HM6,Q57LW6,Q5E3U1,Q5E8X6,Q5PCX6,Q5PKQ2,Q5QXH7,Q5QXM1,Q668V1,Q66FR8,Q6D2L7,Q6DAP5,Q6FF68,Q6LTK3,Q6LW06,Q7MIS5,Q7MQH9,Q7MZ92,Q7N288,Q83PG1,Q83QQ0,Q87MM3,Q87TN9,Q87ZB2,Q88L02,Q8DB47,Q8DDK6,Q8ECP7,Q8EKR9,Q8FBI2,Q8FFG4,Q8W1L6,Q8X8I2,Q8XCP2,Q8Z3C6,Q8Z4Z0,Q8ZAN0,Q8ZD45,Q8ZNA7,Q93Q12,Q9AHY3,Q9DBM2,Q9F0Y7,Q9HZJ2,Q9KNI1,Q9KT58,Q9L6L5">3-hydroxyacyl-CoA dehydrogenase</protein-id>, as well as maximal <compound-id="977">oxygen</compound-id> uptake and 10-km performance time, remained unaltered in both groups.	oxygen__3-hydroxyacyl-CoA dehydrogenase__no_interaction	oxygen__citrate synthase__no_interaction
18845907-1434	MIN6 cells excreted insulin, <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id>, <compound-id="16129681,16129706">somatostatin</compound-id> and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id>.	somatostatin__glucagon__no_interaction	somatostatin__ghrelin__no_interaction
18845907-1435	They expressed mRNAs of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> I and II, proglucagon, <compound-id="16129681,16129706">somatostatin</compound-id>, <protein-id="P01298,P01299,P01300,P01301,P01302,P06303,P06304,P06305,P06884,P10601,P11967,P13083,P15427,P18107,P31229,P33684,P37999,P39659,P41335,P41336,P41337,P41519,P68009,P68010,P68248,P68249">pancreatic polypeptide</protein-id> (PP) and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	somatostatin__pancreatic polypeptide__no_interaction	somatostatin__ghrelin__no_interaction	somatostatin__insulin__no_interaction
18845907-1436	<protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">Glucagon</protein-id>, <compound-id="16129681,16129706">somatostatin</compound-id> and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> were detectable in the culture medium.	somatostatin__Glucagon__no_interaction	somatostatin__ghrelin__no_interaction
18846314-1555	<protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">Metallothioneins</protein-id> (MTs) are <compound-id="594,5862,5360637">cysteine</compound-id>-rich, metal-binding proteins that are useful biomarkers for monitoring pollution by heavy metals.	cysteine__Metallothioneins__interaction
18846314-1558	The deduced amino acid sequence has 18 <compound-id="594,5862,5360637">cysteine</compound-id> residues, implying that S. henanense <protein-id="Q8WSW3">CdMT</protein-id> binds six equivalents of bivalent metal ions (Cd) as opposed to the seven in its mammalian counterparts.	cysteine__CdMT__interaction
18846317-1559	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id>, <compound-id="24404,139579">phosphorus</compound-id>, HbA1C, <protein-id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</protein-id>, Mg and <compound-id="588">creatinine</compound-id> analysis.	phosphorus__alkaline phosphatase__no_interaction	creatinine__PTH__no_interaction	phosphorus__PTH__no_interaction	creatinine__alkaline phosphatase__no_interaction
18846318-1561	Treatment of Platelet Rich Plasma (PRP) with the dialyzed supernatant from the leucocyte suspension incubated with 80 microM <compound-id="2244">aspirin</compound-id> resulted in parallel syntheses of NO and <protein-id="P35849">IFN-alpha</protein-id> as determined by methemoglobin assay and enzyme linked immunosorbent assay respectively.	aspirin__IFN-alpha__interaction
18846383-1582	Muscular oxidative stress and inflammation induced by <compound-id="784">H2O2</compound-id> or MS were assessed by measurements of isoprostanes and <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> levels.	H2O2__IL-6__interaction
18846383-1583	In control rats, <compound-id="784">H2O2</compound-id>, <protein-id="O08677,P01042,P01044,P01045,P08934,P83055,P83060,P83856,P83857,P84697,P84825,P84895,Q7T3L1,Q90W88,Q90WZ1">bradykinin</protein-id> and MS significantly enhanced the HFV response.	H2O2__bradykinin__no_interaction
18846383-1584	Pre-treatment with <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> abolished the post-MS-enhanced HFV response whereas <compound-id="3033">diclofenac</compound-id> lowered the peak HFV response to MS and <compound-id="784">H2O2</compound-id>.	H2O2__SOD__no_interaction	diclofenac__SOD__no_interaction
18846383-1585	<compound-id="784">H2O2</compound-id> injection and MS elicited significant and similar increases in isoprostanes and <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>.	H2O2__IL-6__interaction
18846462-1626	The decreased level of GSH as well as <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> and GSH-Px activities in <compound-id="3559">haloperidol</compound-id>-treated mice were significantly increased by NTA pretreatment.	haloperidol__SOD__interaction
18846552-1647	In the present study, rTHS was used to stabilize penicillin <protein-id="O69768,P22984,P27765,P95896">amidase</protein-id> (PGA) in <compound-id="887,19314">methanol</compound-id>-water mixtures.	methanol__amidase__interaction
18847291-1916	In this study, fluorescence microscopy and elemental analysis were exploited to show that the 3,4-dihydroxyphenyl-L-<compound-id="602,4580,5950,71080">alanine</compound-id> (<compound-id="6047">dopa</compound-id>) residues of mussel <protein-id="Q25434,Q25460,Q27409">foot protein-1</protein-id> colocalize with Fe and Ca distributions in the cuticle of Mytilus galloprovincialis mussel byssal threads.	alanine__foot protein-1__interaction	dopa__foot protein-1__interaction
18847329-1933	We measured pain using a visual analog pain scale at five time points in 0-48 h, oxycodone use for pain, <compound-id="1983">acetaminophen</compound-id> for fever, C-reactive protein (<protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>), and total and percent gammadeltaT-cells.	acetaminophen__CRP__no_interaction
18847384-1963	Association between <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance, and hypertension in pregnancy.	glucose__insulin__interaction
18847384-1966	These results suggest that <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and relative <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance are associated with an increased risk of new-onset hypertension in pregnancy, particularly preeclampsia, and support the hypothesis that <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance may play a role in the pathogenesis of this disorder.	glucose__insulin__interaction
18848359-2685	Serotonin transporter (5-<protein-id="P31645">HTT</protein-id>) and <protein-id="P20905,P28285,P28286,Q17239,Q25190,Q25414">5-HT receptor</protein-id> (5-HTR) involved in the neurotransmission of <compound-id="5202">5-HT</compound-id> may play an important role in the development of major depression disorder (<protein-id="P32377">MDD</protein-id>).	5-HT__5-HT receptor__interaction	5-HT__HTT__interaction	5-HT__MDD__interaction
18848532-2325	These <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADHs</protein-id> are likely to perform similar functions to those reported for other mammalian <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADHs</protein-id> in the metabolism of ingested and endogenous <compound-id="702">alcohols</compound-id> and aldehydes.	alcohols__ADHs__interaction
18848584-2351	<protein-id="O04885,O49818,P0A0T2,P0A0T3,P0A1Q2,P0A1Q3,P0AC81,P0AC82,P0AC83,P16635,P44638,P46235,P46417,P50107,P84719,Q04760,Q09751,Q39366,Q42891,Q4R5F2,Q55595,Q6P7Q4,Q8H0V3,Q948T6,Q9CPU0,Q9KT93">Glyoxalase I</protein-id> and II form a ubiquitous <compound-id="124886">glutathione</compound-id>-dependent pathway for the detoxification of reactive and mutagenic ketoaldehydes.	glutathione__Glyoxalase I__interaction
18848584-2353	<compound-id="137849">S-Acetyl</compound-id>- and S-propionyltrypanothione obtained by this spontaneous reaction proved to be excellent substrates of T. brucei <protein-id="O24495,O24496,O35952,P05446,P0AC84,P0AC85,P57336,P71374,P72933,P96981,Q05584,Q08889,Q12320,Q16775,Q26547,Q28333,Q89AN4,Q99KB8,Q9C8L4,Q9SID3">glyoxalase II</protein-id>.	S-Acetyl__glyoxalase II__interaction
18848601-2359	<protein-id="P14061,P51656,P51657,Q1WNP0">17beta-Hydroxysteroid dehydrogenase type 1</protein-id> (<protein-id="P14061,P51656,P51657,Q1WNP0">17beta-HSD1</protein-id>) is responsible for the catalytic reduction of the weak estrogen <compound-id="5870">estrone</compound-id> (E1) into the highly potent <compound-id="5757">17beta-estradiol</compound-id> (E2).	estrone__17beta-HSD1__interaction	17beta-estradiol__17beta-Hydroxysteroid dehydrogenase type 1__interaction	estrone__17beta-Hydroxysteroid dehydrogenase type 1__interaction	17beta-estradiol__17beta-HSD1__interaction
18848601-2360	3-[4-(4-Hydroxyphenyl)-1H-<compound-id="67516">1,2,3-triazol</compound-id>-1-yl]phenol (3) was the most active compound discovered in this study with an IC(50) value of 840nM and a reasonable selectivity towards <protein-id="P37059,P51658,Q62730">17beta-HSD2</protein-id>.	1,2,3-triazol__17beta-HSD2__interaction
18848620-2373	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, <compound-id="5754">cortisol</compound-id>, <compound-id="951,439260">norepinephrine</compound-id>, and in vitro-stimulated <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> production.	cortisol__IL-6__no_interaction	norepinephrine__IL-6__no_interaction
18848620-2374	Higher NF-kappaB stress responses were associated with lower <compound-id="5754">cortisol</compound-id> stress responses (beta=-.37, p=.05), higher pre-stress <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> production (beta=.38, p=.043), and high chronic in combination with low acute stress, or vice versa (beta=-.61, p=.06).	cortisol__IL-6__no_interaction
18848644-2380	7-Ethoxy resorufin O-deethylase (EROD) activity is strictly related to <protein-id="Q6JZS3,Q92039,Q9YH64">CYP1A</protein-id> presence, at the same time P450-dependent oxidative metabolism leads to reactive <compound-id="977">oxygen</compound-id> species (ROS) production, thought to be an important mechanism of pollutant-mediated toxicity in aquatic organisms.	oxygen__CYP1A__no_interaction
18848646-2382	The combination of <compound-id="857,6106,439524">leucine</compound-id>-rich repeat (LRR) and immunoglobulin-like (Ig) domains is found in the domain architecture of the <protein-id="P35739,P47946,Q24155">Trk</protein-id> neurotrophin receptor protein.	leucine__Trk__interaction
18848646-2383	Given the significant biological roles of <protein-id="P35739,P47946,Q24155">Trk</protein-id> and such newly identified proteins, we have searched the public database for human proteins with LRR and Ig domains (collectively termed the <compound-id="857,6106,439524">leucine</compound-id>-rich repeat and Ig domain-containing protein, LRRIG protein, in this study), and have analyzed the mRNA expression pattern of mouse orthologs of obtained human LRRIG proteins at embryonic day 10.	leucine__Trk__no_interaction
18848727-2425	Quantum chemical studies for oxidation of <compound-id="8083">morpholine</compound-id> by <protein-id="O08469">Cytochrome P450</protein-id>.	morpholine__Cytochrome P450__interaction
18848727-2426	Since <compound-id="8083">morpholine</compound-id> oxidation has recently been shown to involve <protein-id="O08469">Cytochrome P450</protein-id>, the study on its mechanism at molecular level using quantum chemical calculations for the model of cytochrome active site is reported here.	morpholine__Cytochrome P450__interaction
18848748-2442	Pretreatment with oligonol diminished the levels of <protein-id="O01377,O02115,O16852,O82134,O82797,P04961,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00268,Q03392,Q43124,Q43266,Q6B6N4,Q9DDF1,Q9DEA3,Q9MAY3,Q9PTP1,Q9W644">proliferating cell nuclear antigen</protein-id> and expression of <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> in papillomas and carcinomas, respectively, as compared to <compound-id="6001">DMBA</compound-id> plus TPA treatment alone.	DMBA__COX-2__interaction	DMBA__proliferating cell nuclear antigen__interaction
18848782-2443	TnBP (<compound-id="31357">tri-n-butyl phosphate</compound-id>) and polysorbate 20 during the manufacture of the factor VIII/<protein-id="P04275,P80012,Q28295,Q28833,Q8CIZ8">VWF</protein-id> concentrate Optivate has been investigated.	tri-n-butyl phosphate__VWF__interaction
18848797-2450	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id>, alanine aminotransferase, <compound-id="1061,167704,644102">phosphate</compound-id>, and urine specific gravity, but higher <protein-id="Q7M4U7">lipase</protein-id> and <compound-id="588">creatinine</compound-id> concentrations than hyperthyroid cats.	creatinine__lipase__no_interaction	phosphate__lipase__no_interaction	phosphate__alkaline phosphatase__no_interaction	creatinine__alkaline phosphatase__no_interaction
18848818-2462	A role for <protein-id="P34972,P47936,Q9QZN9">CB2</protein-id> receptors in <compound-id="5281969">anandamide</compound-id> signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.	anandamide__CB2__interaction
18848825-2465	<protein-id="P16104">H2AX</protein-id> phosphorylation <compound-id="31423">pyrene</compound-id> diol epoxides.	pyrene__H2AX__interaction
18848878-2491	2-Deoxyglucose decreased NADH/<compound-id="5893">NAD</compound-id> (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell <protein-id="P15559,Q5RD31,Q8CHK7">NQO1</protein-id> activity by 74%; lactate restored NADH/<compound-id="5893">NAD</compound-id> (+), but not NADPH/NADP(+) or <protein-id="P15559,Q5RD31,Q8CHK7">NQO1</protein-id> activity.	NAD__NQO1__no_interaction
18848878-2492	The results suggest that <protein-id="P15559,Q5RD31,Q8CHK7">NQO1</protein-id> activity is more tightly coupled to the redox status of the NADPH/NADP(+) than NADH/<compound-id="5893">NAD</compound-id> (+) redox pair, and that NADPH is the endogenous <protein-id="P15559,Q5RD31,Q8CHK7">NQO1</protein-id> electron donor.	NAD__NQO1__no_interaction
18848894-880	We propose that the coordinated regulation of <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to <compound-id="271">Ca(2</compound-id>+)-induced axon growth inhibition.	Ca(2__actin__interaction
18848957-982	Cocaine stimulated <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, <compound-id="5754">cortisol</compound-id>, and LH, whereas cocaine+nalbuphine in combination produced a smaller increase in <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, and decreased <compound-id="5754">cortisol</compound-id> and LH.	cortisol__ACTH__no_interaction
18848957-983	Thus it appears that nalbuphine attenuated cocaine's effects on <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, <compound-id="5754">cortisol</compound-id>, and LH.	cortisol__ACTH__no_interaction
18848961-2547	In this work we show that in FaO rat hepatoma cells inhibition of the <protein-id="P55245">epidermal growth factor receptor</protein-id> (<protein-id="P00533,P13387,P55245">EGFR</protein-id>) with the tyrphostin <compound-id="2051">AG1478</compound-id> enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	AG1478__epidermal growth factor receptor__interaction	AG1478__EGFR__interaction
18848984-2561	Membrane inlet mass spectrometry was used to observe <compound-id="145068">nitric oxide</compound-id> in the well-studied reaction of nitrite with <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id>.	nitric oxide__hemoglobin__interaction
18849028-2571	Diminished levels of L-<compound-id="232,4367,6322">arginine</compound-id> and endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>) uncoupling through deficiency of <compound-id="44257,9816201">tetrahydrobiopterin</compound-id> (BH(4)) may contribute to endothelial dysfunction.	tetrahydrobiopterin__nitric oxide synthase__interaction	arginine__eNOS__no_interaction	tetrahydrobiopterin__eNOS__interaction	arginine__nitric oxide synthase__no_interaction
18849030-2572	Serum testosterone, <compound-id="5757">estradiol</compound-id>, sex hormone binding globulin (<protein-id="P04278,P08689,P15196,P97497,Q62588">SHBG</protein-id>), and <compound-id="5881">dehydroepiandrosterone</compound-id> levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	dehydroepiandrosterone__SHBG__no_interaction	estradiol__SHBG__no_interaction
18849030-2573	Total and bioavailable testosterone were positively associated with common cIMT independent of age, BMI, hypertension, smoking, HDL-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, LDL-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity (p=0.009 and p=0.002, respectively).	cholesterol__insulin__no_interaction
18849055-2585	In addition to lipid peroxidation, the activities of antioxidant enzymes such as <protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id>, <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> and <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> and two non-enzymatic antioxidants (<compound-id="54670067,54690394">ascorbic acid</compound-id> and <compound-id="124886">reduced glutathione</compound-id>) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione reductase__no_interaction	reduced glutathione__superoxide dismutase__no_interaction	ascorbic acid__glutathione S-transferase__no_interaction	ascorbic acid__catalase__no_interaction	ascorbic acid__glutathione reductase__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction	ascorbic acid__superoxide dismutase__no_interaction	ascorbic acid__glutathione peroxidase__no_interaction	reduced glutathione__glutathione S-transferase__no_interaction
18849055-2586	This study shows that changes in lipid peroxidation, <protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id>, <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> and <compound-id="124886">reduced glutathione</compound-id> in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	reduced glutathione__superoxide dismutase__no_interaction	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione reductase__no_interaction	reduced glutathione__glutathione S-transferase__no_interaction
18849069-2591	At the same time, both types of conduits were permeable to three compounds tested including <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7">lysozyme</protein-id> and bovine <protein-id="P21847,P83517">serum albumin</protein-id>, indicating the suitability of the conduits for free exchanges of nutrients.	glucose__serum albumin__no_interaction	glucose__lysozyme__no_interaction
18849110-2608	The inhibitory effect of <compound-id="951,439260">norepinephrine</compound-id> on the migration of ES-2 ovarian carcinoma cells involves a <protein-id="P08645,P18613,Q91VL8,Q96TL7">Rap1</protein-id>-dependent pathway.	norepinephrine__Rap1__interaction
18849110-2609	This inhibitory effect is possibly mediated by a <compound-id="6076">cAMP</compound-id>-dependent activation of the small GTPase <protein-id="P08645,P18613,Q91VL8,Q96TL7">Rap1</protein-id> via <protein-id="Q8VCC8,Q9Z1C8">Epac</protein-id>.	cAMP__Rap1__interaction	cAMP__Epac__interaction
18849120-2614	Gender differences in <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">corticotropin</protein-id> and <compound-id="5753">corticosterone</compound-id> secretion and <protein-id="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">corticotropin-releasing factor</protein-id> mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	corticosterone__corticotropin-releasing factor__no_interaction	corticosterone__corticotropin__no_interaction
18849120-2615	Although females in both proestrus and diestrus showed significant increases in plasma <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> and <compound-id="5753">corticosterone</compound-id> and <protein-id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</protein-id> mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	corticosterone__ACTH__no_interaction	corticosterone__CRF__no_interaction
18849121-2616	<protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>, <protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id>, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>), <compound-id="5754">cortisol</compound-id> and <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id> (GH) were determined at baseline on postnatal days (<protein-id="P01160">PND</protein-id>) 14, 30 and 60 by means of specific ELISA and <protein-id="P13304">RIA</protein-id> procedures.	cortisol__PND__no_interaction	cortisol__BDNF__no_interaction	cortisol__adrenocorticotropic hormone__no_interaction	cortisol__RIA__no_interaction	cortisol__NGF__no_interaction	cortisol__ACTH__no_interaction	cortisol__growth hormone__no_interaction
18849159-2635	A substrate regeneration cycle coupling <protein-id="P13006,P81156,Q92452">GOD</protein-id> with l-<compound-id="54670067,54690394">ascorbic acid</compound-id> (AsA: 0, 1.0, 3.0, 10.0 and 50.0 mmol/l; as reducing reagent system) was applied to the chemo-mechanical reaction unit in order to amplify the output signal of the tonometric biosensor.	ascorbic acid__GOD__interaction
18849171-2637	In vitro and in vivo models simulating the bee sting have been developed using live honeybees and, as the envenomation sites, pig ears and rat legs; MALDI MSI has been used to map, over time, the diffusion and distribution of three venom allergens (<compound-id="99290">Api</compound-id> m 1, <compound-id="99290">Api</compound-id> m 4, and <compound-id="99290">Api</compound-id> m 6) and two venom toxins (apamine and <protein-id="P04205,P04567">mast cell degranulating peptide</protein-id>).	Api__mast cell degranulating peptide__no_interaction
18849325-2674	The effect was lactose-inhibitable and required <protein-id="P08699,P16110,P17931,P38486,P47845,P47953">galectin-3</protein-id> affinity for <compound-id="245,439271,9800166,25203095">N-acetyllactosamine</compound-id>, a saccharide typically found on <protein-id="Q50833,Q58232">cell surface glycoproteins</protein-id>, since a mutant lacking this activity was without effect.	N-acetyllactosamine__cell surface glycoproteins__interaction	N-acetyllactosamine__galectin-3__interaction
18849352-2679	Despite widespread expression of <protein-id="P01132,P01133,P07522,Q00968,Q95ND4,Q9BEA0">epidermal growth factor</protein-id> (EGF) receptors (<protein-id="P00533,P13387,P55245">EGFRs</protein-id>) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as <compound-id="123631">gefitinib</compound-id> exhibit limited activity in this cancer.	gefitinib__epidermal growth factor__no_interaction	gefitinib__EGFRs__no_interaction
18849352-2680	It is noteworthy that <protein-id="P03969,P09038,P20003,P48798,P48799,P48800,Q60487">FGF2</protein-id> and <protein-id="P31371">FGF9</protein-id> as well as <protein-id="P11362,P21804,Q8MY86,Q91285">FGFR1</protein-id> IIIc and/or <protein-id="P18461,P21802,Q8MY85,Q91147,Q91286">FGFR2</protein-id> IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to <compound-id="123631">gefitinib</compound-id>.	gefitinib__FGFR1__interaction	gefitinib__FGF2__interaction	gefitinib__FGF9__interaction	gefitinib__FGFR2__interaction
18849389-2687	Preprandial concentrations of <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="P80303">NEFA</protein-id>, <compound-id="612">lactate</compound-id>, and <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> fluctuated over time without significant treatment effect.	lactate__NEFA__no_interaction	glucose__IGF-I__no_interaction	lactate__IGF-I__no_interaction	glucose__NEFA__no_interaction
18849389-2688	In late gestation, the postprandial increases in <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> were delayed, and smaller, after a high-fiber meal than after a control meal.	glucose__insulin__no_interaction
18849389-2689	During lactation, <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> profiles after a standard meal did not differ between sows from treatment groups.	glucose__insulin__no_interaction
18849391-1967	Effects of gram-negative bacterial <compound-id="11970143">lipopolysaccharide</compound-id> (LPS) and supplemental dietary Met on N balance, serum hormones and <protein-id="P19006">haptoglobin</protein-id>, and plasma <compound-id="1176,265993">urea</compound-id>-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	lipopolysaccharide__haptoglobin__no_interaction	urea__haptoglobin__no_interaction
18849391-1968	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of <compound-id="5754">cortisol</compound-id>, <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id>, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha, and <protein-id="P19006">haptoglobin</protein-id> 0.01).	cortisol__haptoglobin__no_interaction	cortisol__tumor necrosis factor__no_interaction	cortisol__prolactin__no_interaction
18849391-1969	Plasma <compound-id="1176,265993">urea</compound-id>-N was greater for+LPS than-LPS steers (LPS; P = 0.03), and serum <protein-id="Q95222">IGF-1</protein-id> was not affected (P &gt; or = 0.26) by LPS or Met.	urea__IGF-1__no_interaction
18849413-2041	Domain shape annealing is observed from branched to rounded shapes after <protein-id="P09599,P09978,P11889,P17627,P33377,P69502,Q2FWP1,Q5HEI1,Q9RLV9">SMase</protein-id> activity quenching by <compound-id="6049">EDTA</compound-id>, with a decay halftime of approximately 10 min.	EDTA__SMase__interaction
18849415-2702	We also found that the amino acid stretches of <protein-id="P02866,P14894,P81460,P81461">ConA</protein-id>, having high <compound-id="171147">B-factor</compound-id> values in the crystal structure, show relatively greater mobility in the simulations.	B-factor__ConA__interaction
18849420-2060	Using neighborhood approaches, we were able to assign seven novel functional partners in <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> synthesis, <compound-id="947,123329">nitrogen</compound-id> metabolism, and quorum sensing to BLUF domain-containing proteins (involved in light sensing).	nitrogen__luciferase__no_interaction
18849565-2744	Chondroitin lyases (or <protein-id="P34059">chondroitinases</protein-id>) are a family of enzymes that depolymerize <compound-id="24766,21873177">chondroitin sulfate</compound-id> (CS) and dermatan <compound-id="1117">sulfate</compound-id> (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	sulfate__chondroitinases__interaction	chondroitin sulfate__chondroitinases__interaction
18849890-22	We have assessed the impact of the functional C-1019G variant of the <protein-id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</protein-id> receptor on the response to <compound-id="5073">risperidone</compound-id> or <compound-id="3559">haloperidol</compound-id> in a prospective, randomized, double-blind study.	risperidone__5-HT1A__interaction	haloperidol__5-HT1A__interaction
18850007-61	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor <compound-id="444732">trichostatin A</compound-id> (TSA) and <compound-id="597">cytosine</compound-id> methylation inhibitor <compound-id="451668">5-aza-2-deoxycytidine</compound-id> (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in <protein-id="Q13761">RUNX3</protein-id> silencing by hypoxia.	cytosine__RUNX3__interaction	5-aza-2-deoxycytidine__RUNX3__interaction	trichostatin A__RUNX3__interaction
18850009-63	<compound-id="387447">Bortezomib</compound-id> overcomes cell-adhesion-mediated drug resistance through downregulation of <protein-id="P13612,Q00651,Q91687">VLA-4</protein-id> expression in multiple myeloma.	Bortezomib__VLA-4__interaction
18850074-89	<compound-id="31703">Doxorubicin</compound-id>-<protein-id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</protein-id> conjugate selectively overcomes multidrug resistance in leukaemia cells.	Doxorubicin__transferrin__interaction
18850074-90	The purpose of this study was to examine the distribution and action of <compound-id="31703">doxorubicin</compound-id>-<protein-id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</protein-id> conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).	doxorubicin__transferrin__interaction
18850096-105	Purification of an <protein-id="O31186,P00332,P00334,P06525,P07159,P07162,P0A9Q7,P0A9Q8,P10807,P12311,P14940,P17648,P21518,P21898,P22245,P23277,P23278,P23361,P25139,P25721,P25988,P26719,P28483,P28484,P33744,P37473,P42327,P42328,P48584,P48585,P48977,P51549,P51550,P51551,P51552,P71017,P84328,Q00669,Q00670,Q00671,Q00672,Q03384,Q05114,Q07588,Q09009,Q09010,Q24641,Q24803,Q27404,Q6LCE4,Q9GN94,Q9NAR7,Q9NG40,Q9NG42,Q9U8S9">alcohol dehydrogenase</protein-id> involved in the conversion of <compound-id="18635">methional</compound-id> to <compound-id="10448">methionol</compound-id> in Oenococcus oeni IOEB 8406.	methionol__alcohol dehydrogenase__interaction	methional__alcohol dehydrogenase__interaction
18850096-106	An <compound-id="5893">NAD</compound-id> (P)H-dependent <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id> involved in the reduction of <compound-id="18635">methional</compound-id> was then purified to homogeneity.	NAD__ADH__interaction	methional__ADH__interaction
18850096-107	Sequencing of the purified enzyme and amino acid sequence comparison with the database revealed the presence of a conserved sequence motif specific to the medium-chain zinc-containing <compound-id="5893">NAD</compound-id> (P)H-dependent <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADHs</protein-id>.	NAD__ADHs__interaction
18850096-108	The purified <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id> does not seem to be involved in the modification of buttery and lactic notes or to be involved in the specific formation of volatile <compound-id="702">alcohols</compound-id> during MLF.	alcohols__ADH__no_interaction
18850096-109	The function of the purified <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id> remains unclear, although the role of the <compound-id="402">sulfur atom</compound-id> in <compound-id="18635">methional</compound-id> molecules in the interaction between enzyme and substrate was evidenced.	methional__ADH__no_interaction	sulfur atom__ADH__no_interaction
18850241-169	All strains tested positive for <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> activity while none where capable of <compound-id="50909243">xylan</compound-id> degradation.	xylan__cellulase__no_interaction
18850267-174	In the present work we studied the effect of <protein-id="P05305,Q28469">endothelin-1</protein-id> and-3 on neuronal <compound-id="951,439260">norepinephrine</compound-id> release and the short-term regulation of tyrosine hydroxylase in the olfactory bulb.	norepinephrine__endothelin-1__interaction
18850267-175	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of <protein-id="Q05608,Q9RI12">protein kinase A</protein-id> and C, as well as <compound-id="271">Ca(2</compound-id>+)/<protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">calmodulin</protein-id>-dependent <protein-id="P00513,P25848">protein kinase</protein-id> II.	Ca(2__protein kinase A__no_interaction	Ca(2__protein kinase__no_interaction	Ca(2__calmodulin__no_interaction
18850490-228	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>) and <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), as well as the non-enzymatic antioxidants <compound-id="124886">glutathione</compound-id> (<compound-id="124886">GSH</compound-id>) and serum urate.	glutathione__CAT__no_interaction	GSH__glutathione S-transferase__no_interaction	GSH__SOD__no_interaction	glutathione__GST__no_interaction	glutathione__SOD__no_interaction	GSH__superoxide dismutase__no_interaction	glutathione__glutathione S-transferase__no_interaction	GSH__CAT__no_interaction	glutathione__superoxide dismutase__no_interaction	glutathione__glutathione reductase__no_interaction	GSH__catalase__no_interaction	GSH__glutathione reductase__no_interaction	GSH__GST__no_interaction	glutathione__catalase__no_interaction
18851707-551	<protein-id="P13900,P16604">P2X</protein-id> receptors are membrane cation channels gated by extracellular <compound-id="5957">ATP</compound-id>.	ATP__P2X__interaction
18851710-552	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers [hsCRP (high-sensitivity C-reactive protein)] and endothelial function [FMD (flow-mediated dilation), <compound-id="123831">ADMA</compound-id> (<compound-id="123831">asymmetric dimethylarginine</compound-id>), PAI-1 (plasminogen activator inhibitor-1) and vWF (<protein-id="Q62935">von Willebrand factor</protein-id>)].	asymmetric dimethylarginine__von Willebrand factor__no_interaction	ADMA__von Willebrand factor__no_interaction
18851713-556	Addition of <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> (<protein-id="O50258">superoxide dismutase</protein-id>) doubled the amount of <compound-id="83547">HOBr</compound-id> detected.	HOBr__superoxide dismutase__interaction	HOBr__SOD__interaction
18851895-635	Drug-resistant cancer cells became sensitive to <compound-id="31703">doxorubicin</compound-id> treatment when <protein-id="P06748,P07222,P13084,P16039,Q3T160,Q61937">nucleophosmin</protein-id> was expressed in cytosol.	doxorubicin__nucleophosmin__interaction
18851927-647	All the analyzed resistant mutants exhibited both increased <compound-id="3198">econazole</compound-id> efflux and increased transcription of <protein-id="P65380,P65381">mmpS5</protein-id>-<protein-id="O53784">mmpL5</protein-id> genes, encoding a hypothetical efflux system belonging to the resistance-nodulation-division (RND) family of transporters.	econazole__mmpL5__interaction	econazole__mmpS5__interaction
18851956-1598	This study investigated the effects of atorvastatin on <protein-id="P08183,P21448">ABCB1</protein-id> and <protein-id="P33527,Q5F364">ABCC1</protein-id> mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> response.	cholesterol__ABCB1__interaction	cholesterol__ABCC1__interaction
18851994-2766	While the three <protein-id="O06736,O07308,O07309,O28606,O33580,O33581,O34764,O43252,O50273,O50274,O54820,O66036,O67174,O76156,O88428,O95340,P08536,P0A951,P0A952,P0A9D4,P0A9D5,P0A9D6,P0A9D7,P13441,P13442,P21156,P21673,P23145,P23845,P28603,P28604,P29847,P32003,P43886,P52978,P52995,P56862,P56863,P56864,P56892,P56893,P57162,P57498,P57499,P59740,P65670,P65671,P65672,P65673,P67764,P67765,P67766,P71405,P72338,P72339,P74089,P74241,P77985,P78937,P84547,Q01612,Q06750,Q10600,Q12555,Q12650,Q27128,Q28999,Q3T0Q0,Q54506,Q56002,Q59967,Q5HIE6,Q5HL01,Q5HRM4,Q60967,Q60FC6,Q6GBV9,Q6GJE0,Q7MPF2,Q7MPF3,Q7N8L0,Q7NVN5,Q7UMW2,Q83JX8,Q87DG7,Q87DG8,Q87SX9,Q87SY0,Q87WW0,Q88NA9,Q89B11,Q8AAP9,Q8AXL1,Q8CR03,Q8CTU2,Q8DE72,Q8DE73,Q8EB10,Q8FEJ0,Q8FEJ1,Q8UH69,Q8X7X4,Q8X7X7,Q8Z470,Q8ZBP1,Q8ZBP2,Q8ZMF5,Q9JHW6,Q9KP19,Q9KP20,Q9PD78,Q9PD79,Q9X5U0,Q9Y872,Q9YCR4,Q9ZK14">SAT</protein-id> isotypes showed comparable Km and k(cat) for <compound-id="5951">L-serine</compound-id> and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by <compound-id="581,5862,5460838">L-cysteine</compound-id>.	L-cysteine__SAT__interaction	L-serine__SAT__interaction
18851994-2767	We propose that multiple <protein-id="O06736,O07308,O07309,O28606,O33580,O33581,O34764,O43252,O50273,O50274,O54820,O66036,O67174,O76156,O88428,O95340,P08536,P0A951,P0A952,P0A9D4,P0A9D5,P0A9D6,P0A9D7,P13441,P13442,P21156,P21673,P23145,P23845,P28603,P28604,P29847,P32003,P43886,P52978,P52995,P56862,P56863,P56864,P56892,P56893,P57162,P57498,P57499,P59740,P65670,P65671,P65672,P65673,P67764,P67765,P67766,P71405,P72338,P72339,P74089,P74241,P77985,P78937,P84547,Q01612,Q06750,Q10600,Q12555,Q12650,Q27128,Q28999,Q3T0Q0,Q54506,Q56002,Q59967,Q5HIE6,Q5HL01,Q5HRM4,Q60967,Q60FC6,Q6GBV9,Q6GJE0,Q7MPF2,Q7MPF3,Q7N8L0,Q7NVN5,Q7UMW2,Q83JX8,Q87DG7,Q87DG8,Q87SX9,Q87SY0,Q87WW0,Q88NA9,Q89B11,Q8AAP9,Q8AXL1,Q8CR03,Q8CTU2,Q8DE72,Q8DE73,Q8EB10,Q8FEJ0,Q8FEJ1,Q8UH69,Q8X7X4,Q8X7X7,Q8Z470,Q8ZBP1,Q8ZBP2,Q8ZMF5,Q9JHW6,Q9KP19,Q9KP20,Q9PD78,Q9PD79,Q9X5U0,Q9Y872,Q9YCR4,Q9ZK14">SAT</protein-id> isotypes with different properties may play complementary roles in the regulation of the <compound-id="594,5862,5360637">cysteine</compound-id> biosynthetic pathway in E. histolytica under different conditions, e.g.	cysteine__SAT__interaction
18852015-684	At 1 min before the exposure rats were treated with one of the following: intravenous <protein-id="P00974">aprotinin</protein-id>, 4.4 mg/kg; intraperitoneal (ip) <compound-id="132519">ilomastat</compound-id>, 25mg/kg; or ip <compound-id="40634">trolox</compound-id>, 500 microg/kg.	ilomastat__aprotinin__no_interaction	trolox__aprotinin__no_interaction
18852015-685	Treatment with <protein-id="P00974">aprotinin</protein-id> or <compound-id="132519">ilomastat</compound-id> eliminated these PF changes, yielding results comparable with controls for each of these parameters.	ilomastat__aprotinin__no_interaction
18852015-686	While <protein-id="P00974">aprotinin</protein-id> and <compound-id="132519">ilomastat</compound-id> both alleviated the PF perturbations, surprisingly only <protein-id="P00974">aprotinin</protein-id> reduced the observed pathology, both grossly and histologically.	ilomastat__aprotinin__no_interaction
18852015-687	These early results indicate that treatment with <protein-id="P00974">aprotinin</protein-id> and to a lesser extent <compound-id="132519">ilomastat</compound-id> reduces some of the direct inflammatory response and damage associated with SM-induced lung injury.	ilomastat__aprotinin__no_interaction
18852059-705	Thirdly, enzyme immunoassays and ovarian follicular culture were used to determine the effect of treatment with human recombinant <protein-id="P01349,P11184,P11185,P11952,P11953">relaxin</protein-id>-3 on the production of 17beta-estradiol and <compound-id="319260">17 alpha</compound-id>, 20 beta-dihydroxy-4-pregnen-3-one in killifish ovarian follicles.	17 alpha__relaxin__interaction
18852063-706	<protein-id="Q99K82,Q9NWM0">Spermine oxidase</protein-id> (<protein-id="O42224,P56726,P97698,Q99835,Q9NWM0">SMO</protein-id>) is a FAD-containing enzyme involved in animal cell polyamines (PA) homeostasis, selectively active on <compound-id="1103">spermine</compound-id> and producing H(2)O(2), spermidine, and the 3-aminopropanal.	spermine__SMO__interaction	spermine__Spermine oxidase__interaction
18852217-740	Pretreatment with DEX abrogated <protein-id="P01258,P01259,P01260,P01262,P0C234">calcitonin</protein-id> inhibition by sst (2)-preferring analogue <compound-id="383414,448601">octreotide</compound-id> in TT.	octreotide__calcitonin__interaction
18852255-2230	<compound-id="5280492">Leukotriene B4</compound-id> enhances the activity of nuclear factor-kappaB pathway through <protein-id="Q15722">BLT1</protein-id> and BLT2 receptors in atherosclerosis.	Leukotriene B4__BLT1__interaction
18853098-1027	<protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">Semicarbazide-sensitive amine oxidase</protein-id> activity and total nitrite and <compound-id="943">nitrate</compound-id> concentrations in serum: novel biochemical markers for type 2 diabetes.	nitrate__Semicarbazide-sensitive amine oxidase__no_interaction
18853098-1028	The aim of this study was to evaluate the activity of <protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">semicarbazide-sensitive amine oxidase</protein-id> (<protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">SSAO</protein-id>) and the total nitrite and <compound-id="943">nitrate</compound-id> (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	nitrate__SSAO__no_interaction	nitrate__semicarbazide-sensitive amine oxidase__no_interaction
18853099-1030	Serum lipid, <compound-id="588">creatinine</compound-id>, <compound-id="1175">uric acid</compound-id>, <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>, HbA(1C) and urinary albumin concentration were measured.	uric acid__CRP__no_interaction	creatinine__CRP__no_interaction
18853102-1107	<compound-id="82143">Cryptolepine</compound-id> activity showed highest correlations to <protein-id="O29238,O51934,O58530,O67037,O67226,P74759,P95479,Q08582,Q58907,Q6F598,Q8R979,Q8ZXT5,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9UZ86,Q9YC75,Q9YCB6">topoisomerase</protein-id> II and microtubule targeting drugs.	Cryptolepine__topoisomerase__interaction
18853145-1060	Ulcerated tissues were processed to assess ulcer area, <compound-id="10964">malondialdehyde</compound-id>, <protein-id="O01377,O02115,O16852,O82134,O82797,P04961,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00268,Q03392,Q43124,Q43266,Q6B6N4,Q9DDF1,Q9DEA3,Q9MAY3,Q9PTP1,Q9W644">proliferating cell nuclear antigen</protein-id> (<protein-id="O01377,O02115,O10308,O16852,O27367,O29912,O58398,O73947,O82134,O82797,P04961,P11038,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00265,Q00268,Q03392,Q43124,Q43266,Q57697,Q6B6N4,Q6KZF1,Q6LWJ8,Q74MV1,Q7T6Y0,Q8PX25,Q8TUF7,Q8TWK3,Q979S2,Q9DDF1,Q9DEA3,Q9HJQ0,Q9HN45,Q9M7Q7,Q9MAY3,Q9P9H8,Q9PTP1,Q9UWR9,Q9UYX8,Q9W644">PCNA</protein-id>) and cleaved caspase-3.	malondialdehyde__proliferating cell nuclear antigen__no_interaction	malondialdehyde__PCNA__no_interaction
18853166-1068	Serum NO, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> and <compound-id="124886">glutathione</compound-id> were measured.	glutathione__catalase__no_interaction
18853166-1069	Serum <compound-id="124886">glutathione</compound-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> levels were significantly lower in FM patients than controls.	glutathione__catalase__no_interaction
18853182-1073	This article discusses the physiology of proximal <compound-id="923,373840">Na</compound-id> (+)/H(+) exchange, the multiple mechanisms of <protein-id="P26432,P48764,Q28362">NHE3</protein-id> regulation, and the reciprocal relationship between <protein-id="P26432,P48764,Q28362">NHE3</protein-id> and <protein-id="Q9Y2E8">NHE8</protein-id> at the lumen of the proximal tubule.	Na__NHE3__no_interaction	Na__NHE8__no_interaction
18853185-1077	<compound-id="5754">Cortisol</compound-id> and <compound-id="12594">DHEA-sulfate</compound-id> response to rapid <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>) stimulation was inadequate.	Cortisol__ACTH__no_interaction	DHEA-sulfate__adrenocorticotropic hormone__no_interaction	DHEA-sulfate__ACTH__no_interaction	Cortisol__adrenocorticotropic hormone__no_interaction
18853207-1083	The effects of industrial storage on the changes of the cell viability and the activities of intracellular <protein-id="O31186,P00332,P00334,P06525,P07159,P07162,P0A9Q7,P0A9Q8,P10807,P12311,P14940,P17648,P21518,P21898,P22245,P23277,P23278,P23361,P25139,P25721,P25988,P26719,P28483,P28484,P33744,P37473,P42327,P42328,P48584,P48585,P48977,P51549,P51550,P51551,P51552,P71017,P84328,Q00669,Q00670,Q00671,Q00672,Q03384,Q05114,Q07588,Q09009,Q09010,Q24641,Q24803,Q27404,Q6LCE4,Q9GN94,Q9NAR7,Q9NG40,Q9NG42,Q9U8S9">alcohol dehydrogenase</protein-id> (<protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id>) and glucose-6-phosphate dehydrogenase (<protein-id="P37830,P48826">G6PDH</protein-id>) in brewer's yeast, and the corresponding capacity for the bioconversion of <compound-id="8868">ethyl-3-oxobutanoate</compound-id> (<compound-id="9547937">EOB</compound-id>) to ethyl (<compound-id="94318">S)-3-hydroxybutanoate</compound-id> ((S)-<compound-id="46942358">EHB</compound-id>), were investigated.	EOB__ADH__interaction	S)-3-hydroxybutanoate__ADH__interaction	ethyl-3-oxobutanoate__G6PDH__interaction	ethyl-3-oxobutanoate__alcohol dehydrogenase__interaction	EHB__ADH__interaction	EHB__alcohol dehydrogenase__interaction	EOB__alcohol dehydrogenase__interaction	EHB__G6PDH__interaction	S)-3-hydroxybutanoate__G6PDH__interaction	S)-3-hydroxybutanoate__alcohol dehydrogenase__interaction	EOB__G6PDH__interaction	ethyl-3-oxobutanoate__ADH__interaction
18853207-1084	The intracellular levels of <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id> and <protein-id="P37830,P48826">G6PDH</protein-id> after permeabilization of these stored cells with cetyltrimetylammonium bromide (<compound-id="2681">CTAB</compound-id>) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	CTAB__ADH__no_interaction	CTAB__G6PDH__no_interaction
18853234-1098	Streptokinase (SK), <protein-id="P81156">glucose oxidase</protein-id> (GOx) and <compound-id="1014">phosphorylcholine</compound-id> (PC) were immobilized onto PGLD to obtain a blood compatible bioconjugate with <compound-id="206,5793,64689,79025">glucose</compound-id> sensing properties.	glucose__glucose oxidase__interaction	phosphorylcholine__glucose oxidase__no_interaction
18854222-1462	Treatment of RPE cells with high <compound-id="206,64689">glucose</compound-id>-induced a significant increased of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>, accompanied by an increase in cell damage, NO and nitrotyrosine levels.	glucose__iNOS__interaction
18854222-1464	High <compound-id="206,64689">glucose</compound-id> causes increased cell damage and NO generation in RPE cells by a process of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> expression that requires the activation of <protein-id="O62618">p38MAPK</protein-id> and <protein-id="P29323">ERK</protein-id>.	glucose__iNOS__interaction	glucose__ERK__interaction	glucose__p38MAPK__interaction
18854226-1467	A crude peel extract and purified fraction of Flemingia vestita, as well as a crude rhizome extract of Stephania glabra and fractions were tested with respect to the activity of <protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id>, NO efflux and <compound-id="24316">cGMP</compound-id> concentration in the cestode Raillietina echinobothrida in order to find out the possible mode of anthelmintic action of these plant-derived components.	cGMP__NOS__no_interaction
18854307-761	Our data suggest that <protein-id="P04409,P05696,P10102,P17252,P20444">PKCalpha</protein-id> translocates to the contractile system and anchors to <protein-id="P05547,P36188,Q7M3Y3">TnI</protein-id> in a <compound-id="271">Ca(2</compound-id>+)-dependent manner in the human heart, contributing to the maintenance of contractile force.	Ca(2__PKCalpha__interaction	Ca(2__TnI__no_interaction
18854368-1518	In this study, we describe the crystal structure of yeast <protein-id="O74739,Q02890,Q4R6F3,Q503I8,Q59Q38,Q5XI55,Q5ZJM3,Q6BNI6,Q6CAX5,Q6CLZ6,Q6FRU8,Q75D29,Q7KRR5,Q96IV0,Q9JI78">PNGase</protein-id> in complex with <compound-id="439544">N,N'-diacetylchitobiose</compound-id> (<compound-id="439544">chitobiose</compound-id>).	chitobiose__PNGase__interaction	N,N'-diacetylchitobiose__PNGase__interaction
18854368-1519	Mutagenesis studies confirm the critical role of the <compound-id="439544">chitobiose</compound-id>-interacting residues in substrate binding and suggest that efficient oligosaccharide binding is required for <protein-id="O74739,Q02890,Q4R6F3,Q503I8,Q59Q38,Q5XI55,Q5ZJM3,Q6BNI6,Q6CAX5,Q6CLZ6,Q6FRU8,Q75D29,Q7KRR5,Q96IV0,Q9JI78">PNGase</protein-id> activity.	chitobiose__PNGase__interaction
18854379-1521	Prediction of the effect of <compound-id="12560">erythromycin</compound-id>, <compound-id="39186">diltiazem</compound-id>, and their metabolites, alone and in combination, on <protein-id="P08684">CYP3A4</protein-id> inhibition.	diltiazem__CYP3A4__interaction	erythromycin__CYP3A4__interaction
18854401-1524	Previous studies have suggested a regulatory relationship between serum <compound-id="24404,139579">phosphorus</compound-id>, <compound-id="5280795">vitamin D</compound-id>, and fibroblast growth factor 23 (<protein-id="Q5MK86,Q9GZV9">FGF23</protein-id>), a hormone that promotes renal excretion of phosphate.	phosphorus__FGF23__interaction	vitamin D__FGF23__interaction
18854401-1525	This condition is caused by mutations in the <protein-id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</protein-id>/<protein-id="P12272,P13085,P17251,P22858,P52211,P58073,Q9GK30,Q9GLC7,Q9GMB7">PTHrP</protein-id> receptor that result in ligand-independent <compound-id="6076">cAMP</compound-id> accumulation, thus rendering the receptor constitutively active.	cAMP__PTHrP__interaction	cAMP__PTH__interaction
18854421-1530	Adiponectin, an adipokine secreted by the white adipose tissue, plays an important role in regulating <compound-id="206,5793,64689,79025">glucose</compound-id> and lipid metabolism and controlling energy homeostasis in <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-sensitive tissues.	glucose__insulin__no_interaction
18854429-993	<protein-id="Q8VCC8,Q9Z1C8">Epac</protein-id> is involved in <compound-id="6076">cAMP</compound-id>-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	cAMP__Epac__interaction
18854429-994	Both <protein-id="Q8VCC8,Q9Z1C8">Epac</protein-id> and PKA are effectors of the second messenger <compound-id="6076">cAMP</compound-id>.	cAMP__Epac__interaction
18854435-1007	Since a polypeptide lacking the <compound-id="614,8988,145742">proline</compound-id>-rich region (P-region) of <protein-id="P42858,P42859,P51111,P51112">huntingtin</protein-id> (103Q) cannot form aggresomes, this domain serves as an aggresome-targeting signal.	proline__huntingtin__interaction
18854599-1421	Expression of <compound-id="1167,439185,23724461">UDP-N-acetyl-D-galactosamine</compound-id> : <protein-id="Q5EA41,Q8C7U7,Q8NCL4">polypeptide N-acetylgalactosaminyltransferase-6</protein-id> in gastric mucosa, intestinal metaplasia, and gastric carcinoma.	UDP-N-acetyl-D-galactosamine__polypeptide N-acetylgalactosaminyltransferase-6__interaction
18854599-1422	<compound-id="1167,439185,23724461">UDP-N-acetyl-d-galactosamine</compound-id> : <protein-id="Q5EA41,Q8C7U7,Q8NCL4">polypeptide N-acetylgalactosaminyltransferase-6</protein-id> (ppGalNAc-T6) is one of the enzymes responsible for the initial step in O-glycosylation.	UDP-N-acetyl-d-galactosamine__polypeptide N-acetylgalactosaminyltransferase-6__interaction
18854840-1661	In addition, SAH caused large increases in markers of inflammation, including <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id> and NFkappaB, and markers of cell injury or cell death, including IgG endocytosis and caspase-3 activation, with <compound-id="3488">glibenclamide</compound-id> significantly reducing these effects.	glibenclamide__TNFalpha__interaction
18854840-1662	We conclude that block of <protein-id="P33300,Q09428">SUR1</protein-id> by <compound-id="3488">glibenclamide</compound-id> may ameliorate several pathologic effects associated with inflammation that lead to cortical dysfunction after SAH.	glibenclamide__SUR1__interaction
18854981-1711	Intrinsic fluorescence of <compound-id="1148,6305,9060,5460840">tryptophan</compound-id>-214 in <protein-id="P24807,Q07490">HSA</protein-id> was monitored upon addition of the chemicals.	tryptophan__HSA__interaction
18854987-1716	The <protein-id="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2">COMT</protein-id> enzyme breaks down extracellular <compound-id="681">dopamine</compound-id> (DA) and has a particularly important role in the prefrontal cortex (PFC) where <protein-id="P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DA transporters</protein-id> are sparse.	dopamine__DA transporters__no_interaction	dopamine__COMT__interaction
18854995-1721	The 223A&gt;G polymorphism of the <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> receptor gene and lipid-lowering efficacy of <compound-id="54454,4677798">simvastatin</compound-id> in Chinese patients with coronary heart disease.	simvastatin__leptin__no_interaction
18854999-1723	CYP719A subfamily of <protein-id="O08469">cytochrome P450</protein-id> oxygenases and <compound-id="8405">isoquinoline</compound-id> alkaloid biosynthesis in Eschscholzia californica.	isoquinoline__cytochrome P450__no_interaction
18855021-1734	The metal-<compound-id="5047209">thiolate</compound-id> connectivity of recombinant Cd(7)-MT10 <protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</protein-id> from the sea mussel Mytilus galloprovincialis has been investigated for the first time by means of multinuclear, multidimensional NMR spectroscopy.	thiolate__metallothionein__interaction
18855035-1741	Radical scavenging activity of lipophilized products from <protein-id="Q7M4U7">lipase</protein-id>-catalyzed transesterification of <compound-id="5497163">triolein</compound-id> with cinnamic and ferulic acids.	triolein__lipase__interaction
18855035-1742	<protein-id="Q7M4U7">Lipase</protein-id>-catalyzed transesterification of <compound-id="5497163">triolein</compound-id> with cinnamic and ferulic acids using an immobilized <protein-id="Q7M4U7">lipase</protein-id> from Candida antarctica (E.C.	triolein__lipase__interaction	triolein__Lipase__interaction
18855107-1775	Validation of a food frequency questionnaire measurement of dietary acrylamide intake using <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> adducts of acrylamide and <compound-id="91550">glycidamide</compound-id>.	glycidamide__hemoglobin__interaction
18855190-2056	Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-mediated <compound-id="206,5793,64689,79025">glucose</compound-id> uptake in healthy obese subjects.	glucose__insulin__interaction
18855521-439	The study established that <compound-id="16069453">SPZ</compound-id> attenuated myocardial I/R injury through overexpression of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>, leading to enhancement of <compound-id="145068">nitric oxide</compound-id> bioavailability and tissue oxygenation.	nitric oxide__iNOS__interaction	SPZ__iNOS__interaction
18855522-1934	Currently, <compound-id="1051">pyridoxal-5'-phosphate</compound-id> (PLP)-dependent <protein-id="P32232,P32582,P35520,P46794,Q58H57,Q91WT9,Q9N0V7,Q9YBL2">cystathionine beta-synthase</protein-id> (CBS) is thought to be the major H(2)S-producing enzyme in the brain.	pyridoxal-5'-phosphate__cystathionine beta-synthase__interaction
18855762-2063	The present study shows that extracellular Ca2+ controls cPHB [complexed poly-(<compound-id="441,92135">R)-3-hydroxybutyrate</compound-id>] biosynthesis through the <protein-id="Q06067">AtoS</protein-id>-<protein-id="Q06065">AtoC</protein-id> two-component system.	R)-3-hydroxybutyrate__AtoC__interaction	R)-3-hydroxybutyrate__AtoS__interaction
18855911-2114	A novel approach to prepare <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-loaded poly(lactic-co-<compound-id="757">glycolic acid</compound-id>) microcapsules and the protein stability study.	glycolic acid__insulin__interaction
18855911-2115	The purpose of this study was to propose a new preparation method to fabricate <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-loaded poly(lactic-coglycolic acid) (<compound-id="36797">PLGA</compound-id>) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	PLGA__insulin__interaction
18855935-2126	A Na+/<protein-id="P00920,P27139">Ca2</protein-id>+ exchanger isoform, <protein-id="P32418,P48767">NCX1</protein-id>, is involved in retinal cell death after N-methyl-D-<compound-id="5960">aspartate</compound-id> injection and ischemia-reperfusion.	aspartate__Ca2__no_interaction	aspartate__NCX1__interaction
18855935-2127	We also examined the role of <protein-id="O43763">NCX</protein-id> in <compound-id="977">oxygen</compound-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> deprivation (OGD) stress with a retinal ganglion cell line (RGC-5) cell culture in vitro.	glucose__NCX__interaction	oxygen__NCX__interaction
18855936-2128	This injury induces central sensitization leading to tactile allodynia and is mediated by activation of <compound-id="271">Ca(2</compound-id>+) permeable AMPA/kainate receptors through <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> and PKA.	Ca(2__PKC__interaction
18855942-2132	Stimulation of choline <protein-id="P16966">acetyltransferase</protein-id> by <compound-id="216416">C3d</compound-id>, a neural cell adhesion molecule ligand.	C3d__acetyltransferase__interaction
18855943-2134	Transport properties of PIs by the drug efflux transporters P-gp and <protein-id="P06795,P08183,P16875,P21448,P33449,P34712,P43245,Q06034,Q9ZR72">multidrug resistance protein 1</protein-id> (MRP1) were assessed by measuring the cellular uptake of (3)H-<compound-id="148192">atazanavir</compound-id> or (3)H-<compound-id="392622">ritonavir</compound-id> in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	atazanavir__multidrug resistance protein 1__interaction	ritonavir__multidrug resistance protein 1__interaction
18922131-2288	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-stimulated <protein-id="P31749,P31750,P47196,Q01314,Q8INB9">PKB</protein-id> activation and <compound-id="206,5793,64689,79025">glucose</compound-id> uptake.	glucose__insulin__no_interaction	glucose__PKB__no_interaction
18922514-2447	This is the first <protein-id="O30565,P04830,P05618,P08704,P09121,P14014,P17692,P26827,P27036,P30920,P30921,P31746,P31747,P31797,P31835,P43379">cyclodextrin glycosyltransferase</protein-id> with a known primary structure and a <compound-id="738,5961">glutamine</compound-id> instead of <compound-id="750">glycine</compound-id> residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	glycine__cyclodextrin glycosyltransferase__no_interaction	glutamine__cyclodextrin glycosyltransferase__interaction
18922527-2451	Functional <protein-id="O35502,O35573,O35724,O35840,P04180,P30930,P53760,P53761,Q08758">LCAT</protein-id> is not required for macrophage <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> efflux to human serum.	cholesterol__LCAT__no_interaction
18922794-2589	The AbfR/S two-component system is required to activate the expression of the suite of enzymes that remove the numerous side chains from <compound-id="50909243">xylan</compound-id>, but not the <protein-id="O43097,O59859,O60206,P07529,P09850,P17137,P23360,P23557,P29417,P40943,P45703,P48793,P56588,P81536,Q53317">xylanases</protein-id> that hydrolyze the beta1,4-linked xylose polymeric backbone of this polysaccharide.	xylan__xylanases__no_interaction
18922879-2629	In agreement with molecular modeling predictions, the inhibitory action of pPTME and PTME toward intracellular <protein-id="O22616,P00860,P07805,P08432,P09057,P11926,P14019,P27116,P27117,P27118,P27119,P27121,P40807,P40808,P41931,P43099,P49725,P50134,P78599,Q5RFB7,Q8S3N2,Q92445,Q9BQT8,Q9UQW9">ODC</protein-id> of LN229 cells exceeded that of the previous designed lead compound <compound-id="9543438">POB</compound-id>.	POB__ODC__interaction
18922958-2662	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood <compound-id="206,5793,64689,79025">glucose</compound-id>, or plasma concentrations of catecholamines, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, and <compound-id="5754">cortisol</compound-id>.	glucose__ACTH__no_interaction	cortisol__ACTH__no_interaction
18922958-2663	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, and <compound-id="5754">cortisol</compound-id>.	cortisol__ACTH__no_interaction
18923065-2678	The induction of <protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id> by <compound-id="5712">YC-1</compound-id> was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo[4,3-alpha]quinozalin-1-one (<compound-id="1456">ODQ</compound-id>) or by the protein kinase <compound-id="68958">pyrimidin-4-ylamine</compound-id> (<compound-id="9798973">BAY 41-2272</compound-id>).	BAY 41-2272__HO-1__interaction	YC-1__HO-1__interaction	pyrimidin-4-ylamine__HO-1__interaction	ODQ__HO-1__no_interaction
18923087-1868	The endogenous brain constituent <compound-id="10596625,53394481">N-arachidonoyl L-serine</compound-id> is an activator of large conductance <protein-id="P00920,P27139">Ca2</protein-id>+-activated K+ channels.	N-arachidonoyl L-serine__Ca2__interaction
18923087-1871	The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, <protein-id="P00513,P25848">protein kinases</protein-id>, or <compound-id="271">Ca(2</compound-id>+)-dependent processes; it was lost after patch excision or after membrane <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> depletion but was restored after <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> reconstitution.	Ca(2__protein kinases__no_interaction	cholesterol__protein kinases__no_interaction
18923147-2705	Modulation of <protein-id="P40792,P63001,Q6RUV5">Rac1</protein-id> activity by <compound-id="123831">ADMA</compound-id>/<protein-id="O94760,O95865">DDAH</protein-id> regulates pulmonary endothelial barrier function.	ADMA__DDAH__no_interaction	ADMA__Rac1__interaction
18923157-2713	Endometriosis is associated with <compound-id="5994">progesterone</compound-id> resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of <protein-id="P36718,Q12889,Q28042,Q28542,Q28990,Q60557,Q62010">oviductal glycoprotein</protein-id> 1 (<protein-id="P36718,Q12889,Q28042,Q28542,Q28990,Q60557">OVGP1</protein-id>).	progesterone__oviductal glycoprotein__interaction	progesterone__OVGP1__interaction
18923157-2714	In this study we evaluated <protein-id="P36718,Q12889,Q28042,Q28542,Q28990,Q60557">OVGP1</protein-id> and steroid receptor expression in oviducts of baboons with endometriosis during the midsecretory phase and determined whether <compound-id="5994">progesterone</compound-id> resistance associated with endometriosis also occurs in the oviduct.	progesterone__OVGP1__interaction
18923157-2715	These data imply that the normal antagonism of <compound-id="5994">progesterone</compound-id> on <protein-id="O42132,P03372,P06212,P16058,P49884,P49885,P49886,P50240,P50241,P50242,P57753,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHZ7">ESR</protein-id> and <protein-id="P36718,Q12889,Q28042,Q28542,Q28990,Q60557">OVGP1</protein-id>, which results in their downregulation during the window of implantation, is absent in animals with endometriosis.	progesterone__OVGP1__interaction	progesterone__ESR__interaction
18923162-2718	Expression of <protein-id="P13563,Q61647,Q92839">hyaluronan synthase 1</protein-id> and distribution of <compound-id="24759">hyaluronan</compound-id> during follicular atresia in pig ovaries.	hyaluronan__hyaluronan synthase 1__no_interaction
18923162-2719	In this study, we evaluated the distribution of the principal CD44 ligand <compound-id="24759">hyaluronan</compound-id> (HA) and the expressions of <protein-id="P0C0H0,P0C0H1,Q5X9A9,Q8K5G6,Q8NKX1">HA synthases</protein-id> (HAS: <protein-id="Q03532,Q0UR48,Q1EA54,Q2GMX1,Q4IEK8,Q4P6N0,Q5AK59,Q5KMN6,Q6BH93,Q6C7D2,Q6CXB7,Q6FIL3,Q74Z73,Q92839">HAS1</protein-id>, <protein-id="O57424,O97711,Q92819">HAS2</protein-id>, and <protein-id="O00219,O57425">HAS3</protein-id>) during atresia in pig ovaries.	hyaluronan__HAS1__no_interaction	hyaluronan__HA synthases__no_interaction	hyaluronan__HAS3__no_interaction	hyaluronan__HAS2__no_interaction
18923385-2036	Chronic inhibition of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> by N(omega)-nitro-<compound-id="550788">L-arginine methyl ester</compound-id> (L-NAME) causes progressive renal injury with systemic hypertension and interstitial macrophage infiltration.	L-arginine methyl ester__nitric oxide synthase__interaction
18923387-2775	Transgenic mice that overexpress rat <protein-id="P01016,P01017,P67885,P67886">angiotensinogen</protein-id> in their proximal tubule cells were given either <compound-id="2214">apocynin</compound-id>, <compound-id="107807">perindopril</compound-id>, or <compound-id="3637">hydralazine</compound-id> while untreated or <compound-id="2214">apocynin</compound-id>-treated non-transgenic littermates served as controls.	apocynin__angiotensinogen__no_interaction	perindopril__angiotensinogen__no_interaction	hydralazine__angiotensinogen__no_interaction
18923396-2782	<protein-id="P01213,P01214,Q95104">Dynorphin</protein-id> peptides and the kappa-opioid receptor are important in the rewarding properties of cocaine, <compound-id="5462328">heroin</compound-id>, and alcohol.	heroin__Dynorphin__interaction
18923397-2783	Requirement of <protein-id="O77750,P55087,Q5I4F9,Q923J4">AQP4</protein-id> for antidepressive efficiency of <compound-id="3386">fluoxetine</compound-id> : implication in adult hippocampal neurogenesis.	fluoxetine__AQP4__interaction
18923397-2785	Collectively, these findings suggest that <protein-id="O77750,P55087,Q5I4F9,Q923J4">AQP4</protein-id> is required for the antidepressive action of <compound-id="3386">fluoxetine</compound-id> via regulating adult hippocampal neurogenesis.	fluoxetine__AQP4__interaction
18923398-2787	Although no significant change in the apparent K(m) was revealed in animals that exhibited an escalation in the rate of cocaine intake, an increased <compound-id="681">dopamine</compound-id> uptake rate was found suggesting an upregulation of <protein-id="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DAT</protein-id> number in response to a history of high cocaine intake.	dopamine__DAT__interaction
18923402-2788	Previous work has shown that repeated <compound-id="2995">desipramine</compound-id> treatment causes downregulation of the <protein-id="O55192,P23975,P51143">norepinephrine transporter</protein-id> (<protein-id="O55192,P23975,P41970,P51143,P54762">NET</protein-id>) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	desipramine__NET__interaction	desipramine__norepinephrine transporter__interaction
18923402-2790	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the <protein-id="O55192,P23975,P41970,P51143,P54762">NET</protein-id> and <protein-id="P31645,Q9XT49">SERT</protein-id>, or 10 mg/kg per day <compound-id="3675">phenelzine</compound-id>, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering <protein-id="O55192,P23975,P41970,P51143,P54762">NET</protein-id> or <protein-id="P31645,Q9XT49">SERT</protein-id> expression.	phenelzine__NET__no_interaction	phenelzine__SERT__no_interaction
18923405-2791	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, <protein-id="P49773,P62958,P80912,Q5RF69">HINT1</protein-id>, <compound-id="611,23327,33032">glutamate</compound-id> transport and GluRs, <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> and <protein-id="P45522">TrkB</protein-id>, numerous <protein-id="O96436">14-3-3 protein</protein-id> family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and <compound-id="5957">ATP</compound-id> generation.	glutamate__TrkB__no_interaction	ATP__BDNF__no_interaction	glutamate__14-3-3 protein__no_interaction	ATP__TrkB__no_interaction	ATP__HINT1__no_interaction	glutamate__HINT1__no_interaction	ATP__14-3-3 protein__no_interaction	glutamate__BDNF__no_interaction
18923405-2792	Brains from persons with major depressive disorder reveal decreased expression for genes in <compound-id="611,23327,33032">glutamate</compound-id> transport and metabolism, neurotrophic signaling (eg, <protein-id="O10284,P41444">FGF</protein-id>, <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> and <protein-id="O15240,O57166,P20494,Q86607,Q9JFH4">VGF</protein-id>), and MAP kinase pathways.	glutamate__FGF__no_interaction	glutamate__BDNF__no_interaction	glutamate__VGF__no_interaction
18923439-2805	BEZ increased prostaglandin D(2) (<protein-id="P00349,P14332,P52209">PGD</protein-id> (2)) synthesis by CLL cells, and treatment with <protein-id="P00349,P14332,P52209">PGD</protein-id> (2) and its antineoplastic derivative 15dDelta(12,14,) <compound-id="5311209">PGJ(2</compound-id>) recapitulated BEZ-induced antiproliferative and proapoptotic actions.	PGJ(2__PGD__no_interaction
18923823-499	However, detection of <compound-id="104815">Cu</compound-id> and Zn in <protein-id="O50258">superoxide dismutase</protein-id> after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).	Cu__superoxide dismutase__interaction
18923827-111	Recent studies have suggested that a decrease in the specific activity of the 2-<protein-id="Q89AJ7">oxoglutarate dehydrogenase</protein-id> complex (ODHC) is important for <compound-id="611,23327,33032">glutamate</compound-id> overproduction by Corynebacterium glutamicum.	glutamate__oxoglutarate dehydrogenase__interaction
18923851-130	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (<protein-id="P47971,Q15818,Q26239,Q62443">NP1</protein-id>) as a template for protein engineering, we have replaced the native <protein-id="Q07342">axial</protein-id> heme-coordinating <compound-id="773,6274">histidine</compound-id> residue with <compound-id="750">glycine</compound-id>, <compound-id="602,4580,5950,71080">alanine</compound-id>, and <compound-id="594,5862,5360637">cysteine</compound-id>.	histidine__axial__interaction	histidine__NP1__interaction	alanine__axial__interaction	alanine__NP1__interaction	cysteine__axial__interaction	glycine__axial__interaction	glycine__NP1__interaction	cysteine__NP1__interaction
18923851-133	Two crystal structures of the H60C_ <protein-id="P47971,Q15818,Q26239,Q62443">NP1</protein-id> in complex with <compound-id="795">imidazole</compound-id> and <compound-id="774">histamine</compound-id> were solved to 1.7- and 1.96-A resolution, respectively.	imidazole__NP1__interaction	histamine__NP1__interaction
18923851-134	Both structures show that the H60C mutation is well tolerated by the protein scaffold and suggest that <compound-id="4971">heme</compound-id>-<compound-id="5047209">thiolate</compound-id> coordination in H60C_ <protein-id="P47971,Q15818,Q26239,Q62443">NP1</protein-id> requires some movement of the <compound-id="4971">heme</compound-id> within its binding cavity.	thiolate__NP1__interaction	heme__NP1__interaction
18923901-159	Anticancer effect of <compound-id="2662">celecoxib</compound-id> via <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> dependent and independent mechanisms in human gastric cancers cells.	celecoxib__COX-2__interaction
18924134-216	Real-time polymerase chain reaction analysis of hypoxic, NO-<compound-id="5352,1548885,1548887">sulindac</compound-id> treated PC-3 cells showed downregulation of <protein-id="P16636,P28300,P28301,P33072,P45845,Q05063">lysyl oxidase</protein-id> and <protein-id="Q16790,Q8VHB5">carbonic anhydrase IX</protein-id> mRNA expression.	sulindac__carbonic anhydrase IX__interaction	sulindac__lysyl oxidase__interaction
18925358-887	Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance occur in the setting of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk.	glucose__insulin__interaction
18925359-508	Despite this lack of oxidative and cytotoxic action, exposure of hepatoma cells to <compound-id="934">Ni(2</compound-id>+) resulted in a significant activation of <protein-id="P31750,Q8INB9">Akt</protein-id> that was abrogated by inhibitors of PI3K.	Ni(2__Akt__interaction
18925413-539	Gas exchange was monitored and blood samples were collected during exercise for GH, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, and blood <compound-id="206,5793,64689,79025">glucose</compound-id> and <compound-id="612">lactate</compound-id> determination.	lactate__ACTH__no_interaction	glucose__insulin__no_interaction	lactate__insulin__no_interaction	glucose__ACTH__no_interaction
18925649-643	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by <compound-id="934">nickel ions</compound-id> and <compound-id="1794427">chlorogenic acid</compound-id>, characteristics of <protein-id="P07978">PP2B</protein-id> not of <protein-id="P22198,P30366,P48487,P48488,P50391,P80074,Q61041,Q63447">PP1</protein-id>.	chlorogenic acid__PP2B__no_interaction	nickel ions__PP2B__no_interaction	nickel ions__PP1__no_interaction	chlorogenic acid__PP1__no_interaction
18925653-646	Because o-quinones are very unstable, we used an oxymetric method to characterize the kinetics of this substrate, based on measurements of the <compound-id="977">oxygen</compound-id> consumed in the <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id> reaction.	oxygen__tyrosinase__interaction
18925655-1527	Plasma levels of <compound-id="2771,146570">citalopram</compound-id>, <compound-id="5754">cortisol</compound-id>, and <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> were measured.	citalopram__prolactin__no_interaction	cortisol__prolactin__no_interaction
18925655-1528	An increase in <compound-id="5754">cortisol</compound-id> and <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> concentrations was observed from the EOI until 60 min after the EOI.	cortisol__prolactin__no_interaction
18925830-712	Different lag-time of pulse-released nerve growth factor (<protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id>) from <compound-id="23340,442424,44144320">genipin</compound-id>-crosslinked gelatin within <compound-id="10401">polycaprolactone</compound-id> (PCL) conduits was evaluated in large-gap peripheral nerve repair.	polycaprolactone__NGF__interaction	genipin__NGF__interaction
18925830-713	In this study, 10% (w/v) gelatin was mixed with <protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id>, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) <compound-id="23340,442424,44144320">genipin</compound-id>, and then sucked into the wall of PCL conduits.	genipin__NGF__interaction
18925831-716	Effect of autologous bone marrow stromal cell seeding and bone <protein-id="P07580">morphogenetic protein</protein-id>-2 delivery on ectopic bone formation in a microsphere/poly(<compound-id="8252">propylene</compound-id> <compound-id="444972">fumarate</compound-id>) composite.	fumarate__morphogenetic protein__interaction	propylene__morphogenetic protein__interaction
18925831-717	Three composites consisting of 0, 0.08, or 8 microg <protein-id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</protein-id> per mg of poly(lactic-co-<compound-id="757">glycolic acid</compound-id>) microspheres, embedded in a porous PPF scaffold, were combined with either plasma (no cells) or culture-expanded BMSCs.	glycolic acid__BMP-2__interaction
18926542-922	It was found from this group that <compound-id="54682930">4-hydroxycoumarin</compound-id> was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on <protein-id="P24807,Q07490">HSA</protein-id>.	4-hydroxycoumarin__HSA__interaction
18926547-923	Effects of <protein-id="O73810,P14416,P20288,P52702,P60026,Q6TLI9,Q9GJU1">DRD2</protein-id>/<protein-id="Q8NFD2">ANKK1</protein-id> gene variations and clinical factors on <compound-id="60795">aripiprazole</compound-id> efficacy in schizophrenic patients.	aripiprazole__DRD2__interaction	aripiprazole__ANKK1__interaction
18926641-955	The majority of patients with acute depression shows an exaggerated plasma corticotrophin (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>) and <compound-id="5754">cortisol</compound-id> response to this test that normalizes gradually during successful antidepressant therapy.	cortisol__ACTH__no_interaction
18926641-956	We examined plasma <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> and <compound-id="5754">cortisol</compound-id> responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).	cortisol__ACTH__no_interaction
18926682-975	Both extracts increased <protein-id="O24006">AMP</protein-id>-kinase phosphorylation and <protein-id="O08424,O24594,O26662,O28538,O51628,O59469,O74164,O76819,P00347,P04035,P09610,P13702,P14773,P16237,P16393,P20715,P48021,P51639,P54960,Q01237,Q01559,Q03163,Q10283,Q12577,Q12649,Q1W675,Q29512,Q58116,Q59468,Q5R6N3,Q9V1R3,Q9Y7D2,Q9YAS4">HMG-CoA reductase</protein-id> phosphorylation by 2.5-to 4-fold, but with different time courses: maximal phosphorylation with <compound-id="4630">green tea</compound-id> was evident within 30 min of treatment, whereas with black tea phosphorylation was slower to develop, with maximal phosphorylation occurring &gt; or =3 hours after treatment.	green tea__HMG-CoA reductase__interaction	green tea__AMP__interaction
18926687-978	However, the ethyl ester of commipheric acid (150 mg/kg, twice daily) lowered fasting blood <compound-id="206,5793,64689,79025">glucose</compound-id> and plasma <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, and plasma triglycerides without affecting food intake or body weight.	glucose__insulin__no_interaction
18926751-991	The sequence has also been successfully implemented for <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id> at very-low concentration in interaction with a small ligand, namely the salivary IB5 protein binding the polyphenol epigallocatechine <compound-id="370">gallate</compound-id>.	gallate__a protein__interaction
18926804-1008	This finding led the authors to propose that <protein-id="Q9BPW9">RDH-E2</protein-id> may be involved in the pathogenesis of psoriasis through its potential role in <compound-id="444795">retinoic acid</compound-id> biosynthesis and stimulation of keratinocyte proliferation.	retinoic acid__RDH-E2__interaction
18926804-1010	In this study, we began the characterization of <protein-id="Q9BPW9">RDH-E2</protein-id> protein in order to determine whether it might play a role in <compound-id="444795">retinoic acid</compound-id> biosynthesis.	retinoic acid__RDH-E2__interaction
18926804-1011	The preference for NAD(+) suggests that <protein-id="Q9BPW9">RDH-E2</protein-id> is likely to function in the oxidative direction in vivo, further supporting its potential role in the oxidation of retinol to retinaldehyde for <compound-id="444795">retinoic acid</compound-id> biosynthesis in human keratinocytes.	retinoic acid__RDH-E2__interaction
18926806-1012	Identification of Aldh1a, <protein-id="O55127,O93323,P79739">Cyp26</protein-id> and RAR orthologs in protostomes pushes back the <compound-id="444795">retinoic acid</compound-id> genetic machinery in evolutionary time to the bilaterian ancestor.	retinoic acid__Cyp26__no_interaction
18926807-1160	<protein-id="P30837,P40047,P52476">ALDH5</protein-id> (aka succinic semialdehyde dehydrogenase) is a NAD(+)-dependent <protein-id="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11">aldehyde dehydrogenase</protein-id> crucial for the proper removal of the <compound-id="119">GABA</compound-id> metabolite succinic semialdehyde (SSA).	GABA__aldehyde dehydrogenase__interaction	GABA__ALDH5__interaction
18926807-1161	As release of <compound-id="439153">NADH</compound-id> can be a rate-limiting step for <protein-id="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2">ALDH</protein-id> activity, NADH binding was evaluated for R166wt and R166H enzymes.	NADH__ALDH__interaction
18926839-1035	We also established a significant role for functionalization-dependent <compound-id="123591">fullerene</compound-id>-regulation of the caspase <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</protein-id> in the elicited responses.	fullerene__proteases__interaction
18926849-1039	<compound-id="124886">GSH</compound-id> is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferases</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>) and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidases</protein-id> (GPx).	GSH__GST__interaction	GSH__glutathione peroxidases__interaction	GSH__glutathione-S-transferases__interaction
18926859-1152	Peripheral <protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id> gastroprotection against <compound-id="702">ethanol</compound-id> : the role of exendin, NO, <protein-id="P10286,P30880,P30881,P31888,P80511">CGRP</protein-id>, prostaglandins and blood flow.	ethanol__GLP-1__interaction	ethanol__CGRP__interaction
18926859-1154	<compound-id="702">Absolute ethanol</compound-id> was administered through an orogastric cannula right after the injection of <protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id> (1, 10, 100, 1000 or 10,000 ng/kg; i.p.).	Absolute ethanol__GLP-1__interaction
18926889-1065	It inhibited Trypanosoma brucei <protein-id="O01360,O13507,O27090,O28542,O32755,O34425,O42259,O52631,O57479,O57672,O59494,O59841,O67161,O83816,O96423,P00355,P00356,P00357,P00361,P00362,P04406,P04797,P08439,P09124,P09316,P09317,P0A1P0,P0A1P1,P0C0G6,P0C0G7,P10096,P10097,P10618,P15115,P16858,P17244,P17721,P19089,P19314,P19315,P20287,P20445,P22512,P22513,P23722,P24163,P24164,P24166,P24746,P24748,P24749,P24750,P24751,P24753,P25861,P26518,P26519,P26520,P26521,P26988,P27726,P28844,P29272,P29497,P32637,P32638,P34783,P35143,P39460,P44304,P46406,P46713,P46795,P46796,P47543,P48812,P51009,P51469,P51640,P52694,P52987,P53429,P53430,P54117,P54118,P54226,P55070,P55071,P55971,P56649,P57384,P58839,P61879,P61880,P64178,P64179,P68777,P70685,P75358,P80447,P80534,P83601,P87197,P94915,Q00301,Q00584,Q00640,Q01558,Q01597,Q01651,Q01982,Q05025,Q07234,Q12552,Q1DTF9,Q27652,Q27890,Q28259,Q28554,Q2NEN0,Q3IUT3,Q46450,Q48335,Q4J940,Q4KYY3,Q58546,Q59199,Q59309,Q59800,Q59906,Q5JHB5,Q5R2J2,Q5RAB4,Q5V061,Q5XDW3,Q6BMK0,Q6CCU7,Q6L125,Q6M0E6,Q757I2,Q89AK1,Q8J1H3,Q8K8M9,Q8NK47,Q8PTD3,Q8TFJ2,Q8WZN0,Q8X1X3,Q8ZWK7,Q92211,Q92243,Q92263,Q94469,Q96US8,Q971K2,Q97BJ8,Q9HFX1,Q9HGY7,Q9HJ69,Q9HSS7,Q9N2D5,Q9N655,Q9P8C0,Q9PJN6,Q9UR38,Q9UVC0,Q9UW96,Q9V1P1,Q9Y796,Q9Y8E9,Q9YFS9,Q9Z518,Q9Z7T0,Q9ZKT0">GAPDH</protein-id> with an IC(50) value of 240 microM and has been shown to be a competitive reversible inhibitor (Ki=200+/-10 microM) of this enzyme with respect to its cofactor <compound-id="5893">NAD</compound-id> (+).	NAD__GAPDH__interaction
18926911-1076	We have also described LD between <protein-id="P17693,Q95IT1">HLA-G</protein-id> alleles and HLA class II <protein-id="Q8IUH3">DRB1</protein-id> allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-<compound-id="750">G0103</compound-id>, DRB103-G0101A and DRB103-G01B.	G0103__HLA-G__no_interaction	G0103__DRB1__no_interaction
18927146-1139	<compound-id="5476374">Morpholino</compound-id> oligonucleotide-induced expression of truncated <protein-id="O97592,P11530,P11531,P11532,P11533,Q5GN48">dystrophin</protein-id> in the brains of mdx mice, but not in the muscle, ameliorated the abnormal freezing response to restraint.	Morpholino__dystrophin__interaction
18927216-1186	It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>, resulting in <compound-id="5359597">superoxide</compound-id> generation, accounts for an impaired NO availability.	superoxide__iNOS__interaction
18927219-1190	Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance in obese mice.	glucose__insulin__no_interaction
18927219-1192	These changes were associated with an alleviation of hyperglycemia, <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance, and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance.	glucose__insulin__no_interaction
18927241-1195	Vernakalant was metabolized rapidly via 4-O-demethylation by <protein-id="O08469">cytochrome P450</protein-id> (<protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id>)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive <compound-id="5281877">glucuronide</compound-id> conjugate.	glucuronide__cytochrome P450__no_interaction	glucuronide__CYP__no_interaction
18927268-1200	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused <compound-id="22880">NMDA</compound-id>, and in response to infused <protein-id="P05305,Q28469">endothelin-1</protein-id> (<protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id>) with and without MK-801, an NMDA receptor blocker.	NMDA__ET-1__no_interaction	NMDA__endothelin-1__no_interaction
18927347-1235	Thus, CS-mediated down-regulation of <protein-id="P56519,Q92769">HDAC2</protein-id> in human macrophages and lung epithelial cells in vitro and in mouse lung in vivo involves the induction of <compound-id="5951">serine</compound-id>/<compound-id="6288">threonine</compound-id> phosphorylation and proteasomal degradation, which may have implications for steroid resistance and abnormal inflammation caused by cigarette smoke.	serine__HDAC2__no_interaction	threonine__HDAC2__no_interaction
18927433-1257	Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that <protein-id="P04275,P80012,Q28295,Q28833,Q8CIZ8">VWF</protein-id> multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with <compound-id="774">histamine</compound-id>.	histamine__VWF__interaction
18927433-1258	Soluble P-selectin reduced the number of platelet-decorated <protein-id="P04275,P80012,Q28295,Q28833,Q8CIZ8">VWF</protein-id> strings in the absence of <compound-id="271">Ca(2</compound-id>+) and Mg(2+) but had no effect in the presence of these cations.	Ca(2__VWF__interaction
18927435-1259	To examine the relationship of functional expression of <protein-id="P13612,Q00651,Q91687">VLA-4</protein-id> to prognosis in AML, we studied marrow samples from 175 adult AML patients who underwent induction chemotherapy with anthracycline and <compound-id="6253">cytarabine</compound-id> on Southwest Oncology Group trials.	cytarabine__VLA-4__no_interaction
18928402-1632	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules <protein-id="P31750,Q8INB9">Akt</protein-id> and <protein-id="O08328,O66935,O84804,P05416,P0A6U8,P0A6U9,P0A6V0,P39125,P45179,P58395,Q21BQ1,Q221N9,Q255S3,Q28MN0,Q2A4U4,Q2G7S7,Q2IM81,Q2J308,Q2K485,Q2P9F6,Q2RH55,Q2RS50,Q2T6R2,Q2W5G0,Q2YB48,Q30Z13,Q31BS5,Q31IB5,Q31VJ4,Q32AV6,Q3A0B8,Q3AKK1,Q3APL6,Q3AVF9,Q3B6C3,Q3BYI1,Q3K1K2,Q3KD65,Q3KKP3,Q3SH79,Q3YW96,Q46LU1,Q47IJ4,Q48JG9,Q4KCP0,Q4QK70,Q4UZL8,Q4ZS46,Q57IU1,Q5DZC1,Q5FL65,Q5H6Q4,Q5L562,Q5N1P1,Q5NHN2,Q5NXZ7,Q5PM09,Q5SMC5,Q632H4,Q65FS7,Q65TI3,Q664I5,Q6CZK3,Q6HC18,Q6KHP2,Q6LKA1,Q6MAS9,Q6NCT7,Q729V4,Q72G68,Q72YJ6,Q73MC7,Q7MJ50,Q7NM37,Q7U7I2,Q7UPY2,Q7V275,Q7V8F0,Q7VBP0,Q7W6L5,Q7WIJ0,Q816G8,Q81K85,Q821W4,Q82SP3,Q83PV4,Q87QX5,Q880M9,Q88FN9,Q890I8,Q8CWX0,Q8DAR0,Q8DKU2,Q8DPS3,Q8E079,Q8E5V5,Q8ET54,Q8KAY6,Q8PDD2,Q8PQA3,Q8RF65,Q8XPA1,Q8XT73,Q8Z232,Q8ZA78,Q935Y7,Q97GX6,Q97QS5,Q985P2,Q9CHM9,Q9CN91,Q9EUT5,Q9I1V0,Q9KDX6,Q9KRB6,Q9PLC3,Q9RNH6,Q9RWS1,Q9WZZ7,Q9Z6V8">glycogen synthase</protein-id> kinase-3 (<protein-id="P38615">GSK3</protein-id>) in the regulation of behavior by <compound-id="681">dopamine</compound-id> and <compound-id="5202">serotonin</compound-id> (<compound-id="5202">5-HT</compound-id>).	5-HT__GSK3__no_interaction	serotonin__Akt__no_interaction	serotonin__GSK3__no_interaction	dopamine__Akt__no_interaction	dopamine__glycogen synthase__no_interaction	serotonin__glycogen synthase__no_interaction	5-HT__glycogen synthase__no_interaction	dopamine__GSK3__no_interaction	5-HT__Akt__no_interaction
18929413-2021	Inhibition of <protein-id="P18266,P49841,Q5YJC2,Q9WV60">GSK3beta</protein-id> by <compound-id="28486,3028194">lithium</compound-id> in vivo suppressed the inflammatory response in mice infected with F. tularensis LVS and conferred a survival advantage.	lithium__GSK3beta__interaction
18929429-2031	The capacity for osmotic adjustment, <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) and ascorbate <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="P27695,Q01613,Q42564">APX</protein-id>) activities and <compound-id="614,8988,145742">proline</compound-id> content were also elevated in the transgenic Arabidopsis plants.	proline__peroxidase__no_interaction	proline__SOD__no_interaction	proline__APX__no_interaction	proline__superoxide dismutase__no_interaction
18929477-2059	To prevent the effects of interfering anionic species, such as <compound-id="1175">uric acid</compound-id> and <compound-id="54670067,54690394">ascorbic acid</compound-id>, on the sensor response, the Pt-Ir electrode was coated with <compound-id="61890">Nafion</compound-id>, and then <protein-id="P81156">glucose oxidase</protein-id> was immobilized on the coated electrode.	Nafion__glucose oxidase__no_interaction	uric acid__glucose oxidase__no_interaction	ascorbic acid__glucose oxidase__no_interaction
18929529-2083	Cleavage of the transmembrane domain away from the <protein-id="P19334,P55965,Q920J4">Trp</protein-id> leader carrier protein was performed with <compound-id="10476">cyanogen bromide</compound-id>.	cyanogen bromide__Trp__interaction
18929530-2084	We review here molecular mechanisms leading to these vast combinatorial peptide libraries, and structural and functional properties of antimicrobial peptides of the <compound-id="16130489">dermaseptin</compound-id> and <protein-id="P31393">plasticin</protein-id> families, as well as those of <compound-id="16130489">dermaseptin</compound-id> S9, an amyloidogenic peptide with antimicrobial and chemoattractant activities.	dermaseptin__plasticin__no_interaction
18929666-2130	A naturally occurring <compound-id="750">glycine</compound-id> to <compound-id="424,5960,83887">aspartic acid</compound-id> mutation at position 169 (G169D) in the putative transmembrane domain 4 (<protein-id="Q40170">TM4</protein-id>) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	aspartic acid__TM4__interaction	glycine__TM4__interaction
18930039-2213	Serum free <compound-id="10918">L-carnitine</compound-id> in association with <protein-id="O77003,P02144,P02145,P02147,P02148,P02150,P02151,P02152,P02153,P02154,P02155,P02156,P02157,P02159,P02160,P02161,P02163,P02164,P02165,P02166,P02167,P02168,P02169,P02170,P02171,P02173,P02174,P02177,P02178,P02179,P02180,P02181,P02182,P02183,P02184,P02185,P02186,P02187,P02189,P02190,P02191,P02192,P02193,P02194,P02195,P02196,P02197,P02199,P02200,P02201,P02202,P02203,P02204,P02205,P02206,P02210,P02211,P02214,P02215,P04247,P04248,P04249,P04250,P09965,P0C227,P11343,P14393,P14396,P14397,P14398,P14399,P15160,P17724,P20856,P29287,P30562,P31331,P32428,P49672,P51535,P51537,P56208,P56532,P62734,P62735,P63113,P63114,P68080,P68081,P68082,P68083,P68084,P68085,P68086,P68189,P68190,P68276,P68277,P68278,P68279,P80721,P80722,P83682,P84997,P87497,Q01966,Q03459,Q0KIY0,Q0KIY1,Q0KIY2,Q0KIY3,Q0KIY5,Q0KIY9,Q2MJN4,Q6I7B0,Q6PL31,Q6VN46,Q701N9,Q76G09,Q7LZM1,Q7LZM2,Q7LZM3,Q7LZM4,Q7LZM5,Q7M3C1,Q7M424,Q7T044,Q9DEN8,Q9DEN9,Q9DEP0,Q9DEP1,Q9DGI8,Q9DGI9,Q9DGJ0,Q9DGJ1,Q9DGJ2,Q9QZ76">myoglobin</protein-id> as a diagnostic marker of acute myocardial infarction.	L-carnitine__myoglobin__interaction
18930039-2214	The aim of this study was to monitor the level of serum free <compound-id="10918">L-carnitine</compound-id> in combination with <protein-id="O77003,P02144,P02145,P02147,P02148,P02150,P02151,P02152,P02153,P02154,P02155,P02156,P02157,P02159,P02160,P02161,P02163,P02164,P02165,P02166,P02167,P02168,P02169,P02170,P02171,P02173,P02174,P02177,P02178,P02179,P02180,P02181,P02182,P02183,P02184,P02185,P02186,P02187,P02189,P02190,P02191,P02192,P02193,P02194,P02195,P02196,P02197,P02199,P02200,P02201,P02202,P02203,P02204,P02205,P02206,P02210,P02211,P02214,P02215,P04247,P04248,P04249,P04250,P09965,P0C227,P11343,P14393,P14396,P14397,P14398,P14399,P15160,P17724,P20856,P29287,P30562,P31331,P32428,P49672,P51535,P51537,P56208,P56532,P62734,P62735,P63113,P63114,P68080,P68081,P68082,P68083,P68084,P68085,P68086,P68189,P68190,P68276,P68277,P68278,P68279,P80721,P80722,P83682,P84997,P87497,Q01966,Q03459,Q0KIY0,Q0KIY1,Q0KIY2,Q0KIY3,Q0KIY5,Q0KIY9,Q2MJN4,Q6I7B0,Q6PL31,Q6VN46,Q701N9,Q76G09,Q7LZM1,Q7LZM2,Q7LZM3,Q7LZM4,Q7LZM5,Q7M3C1,Q7M424,Q7T044,Q9DEN8,Q9DEN9,Q9DEP0,Q9DEP1,Q9DGI8,Q9DGI9,Q9DGJ0,Q9DGJ1,Q9DGJ2,Q9QZ76">myoglobin</protein-id> (Myo) and creatine kinase (total activity and CK-MB level) for usefulness as a predictor of AMI in ICU patients.	L-carnitine__myoglobin__interaction
18930076-2223	Curcuminoids inhibited <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> in the in-vitro assay with IC(50) value of 19.67, <compound-id="5315472">bisdemethoxycurcumin</compound-id> 16.84, <compound-id="5324476">demethoxycurcumin</compound-id> 33.14 and curcumin 67.69 microM.	demethoxycurcumin__AChE__interaction	bisdemethoxycurcumin__AChE__interaction
18930084-2225	L-<compound-id="25242319">penetratin</compound-id> was the most effective promoter of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> absorption compared with others CPPs.	penetratin__insulin__interaction
18930084-2226	A dose-dependent relationship of L-<compound-id="25242319">penetratin</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> bioavailability was statically significant.	penetratin__insulin__interaction
18930084-2227	There was no significant difference in the release of <protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id> in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-<compound-id="25242319">penetratin</compound-id> was present.	penetratin__LDH__no_interaction
18930085-2228	GSL-liposomes remarkably enhanced the production of <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> from splenocytes in vitro and this enhancement depended on the content of the pH-sensitive lipid dioleoyl-<compound-id="1015">phosphoethanolamine</compound-id> (DOPE) in the liposomes.	phosphoethanolamine__IFN-gamma__interaction
18930122-2233	Osteoblasts up-regulate the expression of extracellular <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</protein-id> following attachment to <compound-id="107801">Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate</compound-id>).	Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate__proteases__interaction
18930149-2366	Pharmacological stimulation of <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> channels with <compound-id="1548943">capsaicin</compound-id> (10 nM) selectively enhanced the frequency of glutamate-mediated spontaneous (sEPSCs) and miniature excitatory postsynaptic currents (mEPSCs) recorded from putative striatal medium spiny neurons.	capsaicin__TRPV1__interaction
18930149-2367	Consistently, the totality of striatal neurons responded to <compound-id="1548943">capsaicin</compound-id> (10 nM or 10 microM) after prevention of desensitization of <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> channels with the protein kinase C (PKC) activator <compound-id="4792,27924,122634,22833501">phorbol 12-myristate 13-acetate</compound-id> (<compound-id="27924,122634,22833501">PMA</compound-id>).	PMA__TRPV1__interaction	capsaicin__TRPV1__interaction	phorbol 12-myristate 13-acetate__TRPV1__interaction
18930149-2368	The effects of <compound-id="1548943">capsaicin</compound-id> and of <compound-id="27924,122634,22833501">PMA</compound-id> were absent after pharmacological or genetic inactivation of <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> channels.	PMA__TRPV1__interaction	capsaicin__TRPV1__interaction
18930149-2369	Finally, we provided evidence for <compound-id="5281969">anandamide</compound-id> as an endovanilloid substance in the striatum, since genetic inhibition of <compound-id="5281969">anandamide</compound-id> degradation resulted in a tonic activation of <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> channels modulating glutamate but not GABA release.	anandamide__TRPV1__interaction
18930474-2338	With the exception of significantly elevated serum <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> after <compound-id="146570">escitalopram</compound-id>, no effects in the secondary outcome measures were detected.	escitalopram__prolactin__interaction
18930547-2375	The cellular response to dsRNA or its synthetic analog <compound-id="32744,274740">polyinosinic-polycytidylic acid</compound-id> (<compound-id="32744,213546,274740">poly I:C</compound-id>) results in <protein-id="P70671,Q14653,Q4JF28,Q764M6,Q90643">IRF-3</protein-id>-, <protein-id="P70434,Q92985">IRF-7</protein-id>- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	polyinosinic-polycytidylic acid__IRF-7__interaction	poly I:C__IRF-3__interaction	polyinosinic-polycytidylic acid__IRF-3__interaction	poly I:C__IRF-7__interaction
18930565-2381	<compound-id="4908">Primaquine</compound-id> toxicity is aggravated in people deficient of 6-glucose phosphate dehydrogenase or <protein-id="O32463,P04425,P35667,P35668,P45480,P46413,P48637,P51855,P57612,P58578,P58579,P58580,P58581,P58582,P59495,P61396,P73493,Q08220,Q5EAC2,Q5LYY5,Q5M3J8,Q65RX0,Q6ANW2,Q71VZ1,Q7M7H8,Q7MHK1,Q7NF44,Q7NQ65,Q7TUG9,Q7TUK9,Q7TVB0,Q7U3W8,Q7VY62,Q7W910,Q7WKF5,Q82V16,Q82ZG8,Q83AL0,Q83Q91,Q87D42,Q87LK1,Q87VA4,Q88D35,Q88UW5,Q89WL0,Q8D335,Q8DCA9,Q8DKF1,Q8DW15,Q8DXM9,Q8E399,Q8EIK8,Q8FE30,Q8FXW6,Q8HXX5,Q8K931,Q8P6P1,Q8PHZ5,Q8UII5,Q8XK30,Q8Y3R3,Q8YE82,Q926X7,Q92SN3,Q98DE8,Q9ABS9,Q9CM00,Q9I697,Q9JTJ6,Q9JYJ3,Q9KUP7,Q9PC29">glutathione synthetase</protein-id>.	Primaquine__glutathione synthetase__interaction
18930648-795	Levels of <protein-id="P10145">interleukin-8</protein-id> (<protein-id="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5">IL-8</protein-id>) and <compound-id="107873">8-isoprostane</compound-id> were measured in epithelial lining fluid (ELF) from central and peripheral airways separately collected using a bronchoscopic microsampling technique.	8-isoprostane__IL-8__no_interaction	8-isoprostane__interleukin-8__no_interaction
18930650-823	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like <compound-id="80170">N-hydroxysuccinimide</compound-id> (NHS) to <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> (<protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id>) which was in turn conjugated to 2,4-D molecule.	N-hydroxysuccinimide__ALP__interaction	N-hydroxysuccinimide__alkaline phosphatase__interaction
18930705-2444	The SoxN protein is proposed to harbor the heme b of lower reduction potential and the <compound-id="5326705,5942915">heme a</compound-id> (s), and <protein-id="O54088,P58029">CbsA</protein-id> the other heme b.	heme a__CbsA__no_interaction
18930712-2448	Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (<protein-id="P31513,P32417,Q7YS44,Q8HYJ9,Q8SPQ7,Q95LA1">FMO3</protein-id>) and rat liver microsomes in the presence of <compound-id="5884">NADPH</compound-id>.	NADPH__FMO3__interaction
18930714-667	Regulatory roles for <protein-id="Q60610">Tiam1</protein-id>, a guanine nucleotide exchange factor for <protein-id="P40792,P63001,Q6RUV5">Rac1</protein-id>, in <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion in pancreatic beta-cells.	glucose__Rac1__no_interaction	glucose__insulin__interaction	glucose__Tiam1__interaction
18930714-668	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for <protein-id="P40792,P63001,Q6RUV5">Rac1</protein-id>, a <protein-id="P15153">small G-protein</protein-id>, in <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion (GSIS).	glucose__small G-protein__no_interaction	glucose__insulin__interaction	glucose__Rac1__interaction
18930714-670	<compound-id="6830">GTP</compound-id>-bound form) and membrane association of <protein-id="P40792,P63001,Q6RUV5">Rac1</protein-id> in INS 832/13 cells and rat islets.	GTP__Rac1__interaction
18930714-671	Interestingly, however, in contrast to the inhibitory effects of <compound-id="409805">NSC23766</compound-id>, <protein-id="Q60610">Tiam1</protein-id> gene depletion potentiated GSIS in these cells; such a potentiation of GSIS was sensitive to extracellular calcium.	NSC23766__Tiam1__no_interaction
18930760-2475	This vector allows the co-expression of alpha-Hb as a fusion protein with <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">Glutathione S-Transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>-alpha-Hb) and beta-Hb with an additional <compound-id="876,6137">methionine</compound-id> at the N-terminal extremity (rbeta-Hb).	methionine__Glutathione S-Transferase__no_interaction	methionine__GST__no_interaction
18930779-791	<protein-id="O50258">Superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GSH-Px) activities as well as <compound-id="2723628">thiobarbituric acid</compound-id> reactive substances (TBARSs) and <compound-id="145068">nitric oxide</compound-id> (NO) levels were analysed in erythrocyte and plasma of rats.	nitric oxide__Superoxide dismutase__no_interaction	nitric oxide__catalase__no_interaction	thiobarbituric acid__Superoxide dismutase__no_interaction	thiobarbituric acid__glutathione peroxidase__no_interaction	nitric oxide__glutathione peroxidase__no_interaction	thiobarbituric acid__catalase__no_interaction	nitric oxide__SOD__no_interaction	thiobarbituric acid__SOD__no_interaction	thiobarbituric acid__CAT__no_interaction	nitric oxide__CAT__no_interaction
18930779-793	The erythrocyte <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id> activity was higher in <compound-id="65632">erdosteine</compound-id> group and there was a statistically significant increase, when compared with the <compound-id="65632">erdosteine</compound-id> plus ischemia/reperfusion group.	erdosteine__CAT__interaction
18930802-2496	The ethidium bromide (EB) demyelinating model was associated with <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> (Vit E) and <compound-id="3194">ebselen</compound-id> (Ebs) treatment to evaluate <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (<protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	ebselen__acetylcholinesterase__interaction	ebselen__AChE__interaction	vitamin E__acetylcholinesterase__interaction	vitamin E__AChE__interaction
18930812-868	These properties appear to depend on a specific mitochondrial signaling of melatonin which is associated with a lower generation of reactive <compound-id="977">oxygen</compound-id> species and a better control of redox-sensitive components such as the antiapoptotic protein <protein-id="P10417,P49950">Bcl-2</protein-id>.	oxygen__Bcl-2__no_interaction
18930813-875	A search of publicly available microarray data reveals that expression of mitochondrial manganese <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O08460,P07895,P09224,P09671,P36606,P80733,Q00637,Q03301,Q07449,Q9UQX0">Sod2</protein-id>), responsible for the conversion of <compound-id="5359597">superoxide</compound-id> (O(2)(-)) to <compound-id="784">hydrogen peroxide</compound-id> (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	hydrogen peroxide__Sod2__interaction	hydrogen peroxide__superoxide dismutase__interaction	superoxide__superoxide dismutase__interaction	superoxide__Sod2__interaction
18930826-2517	In vivo <protein-id="O14649">TASK</protein-id> blockade by <compound-id="5281969">anandamide</compound-id> significantly increased infarct volumes at 24 h in mice undergoing 30 min of transient middle cerebral artery occlusion (tMCAO).	anandamide__TASK__interaction
18930833-2520	<protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">Glutathione S-transferases</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GSTs</protein-id>) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to <compound-id="124886">glutathione</compound-id>.	glutathione__GSTs__interaction	glutathione__Glutathione S-transferases__interaction
18930846-916	It can use a dithiol-disulfide active-site to transfer reducing equivalents from <compound-id="5884">NADPH</compound-id> to <protein-id="O14463,O17486,O22022,O30974,O51088,O51890,O83889,O84544,O96952,O97508,O97680,P00276,P08058,P08628,P08629,P09857,P0A0K4,P0A0K5,P0A0K6,P0A4L3,P0A4L4,P0A616,P0A617,P10472,P10473,P10599,P10639,P11232,P14930,P14949,P21609,P21610,P29429,P29451,P33791,P34723,P37395,P42115,P43785,P46843,P47370,P50254,P50338,P50413,P51225,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P82460,P96132,P99122,P99505,Q05739,Q57755,Q5HGT9,Q5HQ29,Q5R9M3,Q6GA69,Q6GHU0,Q7KQL8,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q98TX1,Q9BDJ3,Q9CM49,Q9DGI3,Q9JWM8,Q9K1N8,Q9PJK3,Q9R6P9,Q9UW02,Q9X2T1,Q9Z7P5,Q9ZEE0">thioredoxin</protein-id> (<protein-id="O97508,O97680,P08628,P08629,P0A4L3,P0A4L4,P0A616,P0A617,P10599,P10639,P11232,P14949,P20659,P29451,P37395,P42115,P46843,P47370,P50413,P52227,P75512,P82460,P99505,Q24742,Q57755,Q5R9M3,Q98TX1,Q9BDJ3,Q9DGI3,Q9R6P9,Q9X2T1">Trx</protein-id>), via the cofactor FAD.	NADPH__Trx__interaction	NADPH__thioredoxin__interaction
18930903-626	<protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">Hypoxia-inducible factor-1alpha</protein-id> (<protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id>) is a transcription factor that plays an essential role in <compound-id="977">oxygen</compound-id> homeostasis.	oxygen__Hypoxia-inducible factor-1alpha__interaction	oxygen__HIF-1alpha__interaction
18930948-1088	However, <protein-id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</protein-id>, <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id> with no active site <compound-id="5951">serine</compound-id>, was covalently modified in vitro by 0.5mM 10-fluoroethoxyphosphinyl-N-biotinamido pentyldecanamide, chlorpyrifos oxon, diisopropylfluorophosphate, dichlorvos, sarin, and soman.	serine__a protein__no_interaction	serine__transferrin__no_interaction
18931023-1335	Ovariectomized Wistar rats consuming a high-sodium diet received one of four treatments (n=7 per group): group 1, placebo pellets; group 2, E(2) (0 x 5 mg/pellet, 21-day release); group 3, NOS inhibitor, <compound-id="4367">N(omega)-nitro-L-arginine</compound-id>-methyl-ester (L-NAME; 40 mg/kg per day for 14 days) plus <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Ang II</protein-id> (0 x 225 mg/kg per day on days 11-14); group 4, E(2) plus L-NAME/<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Ang II</protein-id>.	N(omega)-nitro-L-arginine__Ang II__no_interaction
18931024-1924	At the peripheral level, <compound-id="5754">cortisol</compound-id> (10(-6) M), <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> (10(-7) M), and <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P41589,P61280,P61281,P68000,P68001,P87352,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">alpha-MSH</protein-id> (10(-7) M) stimulate the release of T(4) from kidney and head kidney fragments, which contain all functional thyroid follicles in carp, by two-to fourfold.	cortisol__ACTH__no_interaction	cortisol__alpha-MSH__no_interaction
18931035-2612	The mechanism of lysoPAF-mediated inhibition of neutrophils involves an elevation in the intracellular <compound-id="6076">cAMP</compound-id> level, and pharmacological blockade of <protein-id="P00936,P08678,P0A1A7,P0A1A8,P0A4Y0,P0A4Y1,P14605,P15318,P23466,P26338,P27580,P30528,P40127,P40130,P40134,P40135,P40136,P43524,P49606,P59739,Q01513,Q01631,Q03100,Q03101,Q05766,Q25263,Q26721,Q26896,Q27675,Q57506,Q59119,Q59685,Q8FBP0,Q8XAP1,Q99279,Q99280,Q99396,Q9WXC3">adenylyl cyclase</protein-id> completely reverses the inhibitory effect of lysoPAF.	cAMP__adenylyl cyclase__no_interaction
18931047-2620	Sympathetic neurogenic Ca2+ signalling in rat arteries: <compound-id="5957">ATP</compound-id>, <compound-id="951,439260">noradrenaline</compound-id> and <protein-id="P01303,P01304,P07808,P14765,P28672,P28673,P28674,P29071,P33689,P57774,P68006,P68007,P68008,P69101,P69102,P80167,Q27441,Q6RUW3,Q90WF4,Q9DGK7,Q9I8P3,Q9I9D3,Q9PTA0,Q9PW68,Q9XSW6">neuropeptide Y</protein-id>.	noradrenaline__neuropeptide Y__no_interaction	ATP__neuropeptide Y__no_interaction
18931108-2645	<protein-id="O25916,O30477,O78411,O83097,P07908,P0A1Q4,P0A1Q5,P0ACB0,P0ACB1,P45256,P46394,P47340,P49519,P51333,P57611,P59966,P71715,P75539,Q55418,Q6ABX1,Q89A52,Q8FB22,Q8K932,Q8X5V3,Q8YZA1,Q92HG8,Q9CNL6,Q9F5P4,Q9ZD08,Q9ZJM5">DnaB</protein-id> (BA) demonstrated a strong DNA <protein-id="O29238,O51934,O58530,O67037,O67226,P09395,P09498,P15095,P15402,P16342,P17779,P17965,P18458,P19751,P19811,P20951,P22168,P22591,P22657,P27327,P27328,P27407,P27409,P27410,P27411,P27920,P28726,P28897,P36286,P37987,P54634,P59641,P74759,P95479,Q04544,Q04561,Q04575,Q05002,Q06502,Q07518,Q07630,Q08582,Q3I5J6,Q58907,Q66198,Q66914,Q68772,Q69014,Q6F598,Q83017,Q86117,Q86119,Q89273,Q8B912,Q8R979,Q8V439,Q8V6W7,Q8V736,Q8ZXT5,Q91A29,Q91AV2,Q91QT2,Q96725,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9IW06,Q9PYA3,Q9UZ86,Q9WJB2,Q9YC75,Q9YCB6,Q9YN02">helicase</protein-id> activity that required <compound-id="5957">ATP</compound-id> or <compound-id="15993">dATP</compound-id>.	dATP__helicase__interaction	dATP__DnaB__interaction	ATP__DnaB__interaction	ATP__helicase__interaction
18931108-2646	Based on the ratio of DNA <protein-id="O29238,O51934,O58530,O67037,O67226,P09395,P09498,P15095,P15402,P16342,P17779,P17965,P18458,P19751,P19811,P20951,P22168,P22591,P22657,P27327,P27328,P27407,P27409,P27410,P27411,P27920,P28726,P28897,P36286,P37987,P54634,P59641,P74759,P95479,Q04544,Q04561,Q04575,Q05002,Q06502,Q07518,Q07630,Q08582,Q3I5J6,Q58907,Q66198,Q66914,Q68772,Q69014,Q6F598,Q83017,Q86117,Q86119,Q89273,Q8B912,Q8R979,Q8V439,Q8V6W7,Q8V736,Q8ZXT5,Q91A29,Q91AV2,Q91QT2,Q96725,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9IW06,Q9PYA3,Q9UZ86,Q9WJB2,Q9YC75,Q9YCB6,Q9YN02">helicase</protein-id> and ATPase activities, <protein-id="O25916,O30477,O78411,O83097,P07908,P0A1Q4,P0A1Q5,P0ACB0,P0ACB1,P45256,P46394,P47340,P49519,P51333,P57611,P59966,P71715,P75539,Q55418,Q6ABX1,Q89A52,Q8FB22,Q8K932,Q8X5V3,Q8YZA1,Q92HG8,Q9CNL6,Q9F5P4,Q9ZD08,Q9ZJM5">DnaB</protein-id> (BA) is highly efficient in DNA unwinding and its coupling to <compound-id="5957">ATP</compound-id> consumption.	ATP__DnaB__interaction	ATP__helicase__interaction
18931130-230	MerH was found to transport mercuric ions in Escherichia coli via a pair of essential <compound-id="594,5862,5360637">cysteine</compound-id> residues but only when coexpressed with the <protein-id="P00392,P08332,P08662,P0A0E4,P0A0E5,P16171,P17239,P30341,P94188,P94702,Q51772,Q52109,Q54465">mercuric reductase</protein-id>.	cysteine__mercuric reductase__no_interaction
18931136-2657	HmuY and <protein-id="Q56989">HmuR</protein-id> are <compound-id="4971">hemin</compound-id> binding proteins required for P. gingivalis growth.	hemin__HmuR__interaction
18931257-1820	The effect of <protein-id="O01673,O02389,O16127,O18416,O44119,O61379,O96764,O97162,O97192,P31816,P91958,Q02088,Q23758,Q23939,Q25145,Q25456,Q25457,Q25632,Q26503,Q26519,Q7M3Y8,Q8IT89,Q8T380,Q8T6L5,Q8WR63,Q95PU1,Q95VA8,Q9GZ69,Q9GZ70,Q9GZ71,Q9N2R3,Q9NAS5,Q9NDS0,Q9NFZ4,Q9NG56,Q9UB83">tropomyosin</protein-id> on <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> filaments was independent of ionic strength, but became stronger as the <compound-id="5462224">magnesium</compound-id> concentration increased.	magnesium__actin__interaction	magnesium__tropomyosin__interaction
18931328-2696	We showed that, compared with the untreated CF serous cells, a 24-hour pre-incubation period with 200 nM salmeterol induced an 83% increase in delF508-<protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">CFTR</protein-id>-mediated <compound-id="312">chloride</compound-id> efflux.	chloride__CFTR__interaction
18931344-2072	Activation of <protein-id="P27297,Q07813,Q63690">Bax</protein-id> and <protein-id="O08734">Bak</protein-id> was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall <compound-id="11404337,45356963">obatoclax</compound-id> exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	obatoclax__Bak__no_interaction	obatoclax__Bax__no_interaction
18931380-2724	Liver <compound-id="91550">glycidamide</compound-id> DNA adducts and <compound-id="6579">acrylamide</compound-id> and <compound-id="91550">glycidamide</compound-id> N-terminal <compound-id="6287">valine</compound-id> <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> adducts were also determined.	glycidamide__hemoglobin__no_interaction	valine__hemoglobin__interaction	acrylamide__hemoglobin__interaction
18931475-2743	The acyl <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> peptide features a unique post-translational modification of O-n-octanoylation at <compound-id="5951">serine</compound-id> 3, and is the only gastrointestinal signal that increases meal size.	serine__ghrelin__interaction
18931618-2800	Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id>, CK and CK-MB levels.	glucose__LDH__no_interaction
18931836-26	Molecular and biochemical characterization of a distinct <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id> involved in <compound-id="6325610">melanin</compound-id> production from Aeromonas media.	melanin__tyrosinase__interaction
18931836-28	<protein-id="P07023,P20692,P43901,P43902,Q02287,Q9CET9">TyrA</protein-id> had a relatively higher affinity to <compound-id="33665">diphenol</compound-id> substrate L-<compound-id="836">dihydroxyphenylalanine</compound-id> (<compound-id="6047">L-dopa</compound-id>) than many other <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinases</protein-id>.	diphenol__tyrosinases__no_interaction	L-dopa__tyrosinases__interaction	diphenol__TyrA__no_interaction	dihydroxyphenylalanine__tyrosinases__interaction	L-dopa__TyrA__interaction	dihydroxyphenylalanine__TyrA__interaction
18931836-29	EDTA or glutathione notably inhibited the enzymatic activities of <protein-id="P07023,P20692,P43901,P43902,Q02287,Q9CET9">TyrA</protein-id>, whereas <compound-id="5590">Triton X-100</compound-id> and SDS activated them.	Triton X-100__TyrA__interaction
18931836-30	These results suggest that <protein-id="P07023,P20692,P43901,P43902,Q02287,Q9CET9">TyrA</protein-id> is the first reported distinct <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id> involved in <compound-id="6325610">melanin</compound-id> production in the genus Aeromonas.	melanin__TyrA__interaction	melanin__tyrosinase__no_interaction
18931932-360	<protein-id="O80452,P15274,P50998">AMP-deaminase</protein-id> from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental <compound-id="977">oxygen</compound-id> level.	oxygen__AMP-deaminase__interaction
18931932-361	Both sodium and potassium ions activated goldfish <protein-id="O80452,Q84NP7">AMPD</protein-id> at low concentrations, with maximal activation at about 80 mM of each <compound-id="312">chloride</compound-id> salt, whereas higher concentrations became inhibitory.	chloride__AMPD__interaction
18931932-362	Magnesium and calcium ions also inhibited goldfish muscle <protein-id="O80452,Q84NP7">AMPD</protein-id>, as did <compound-id="1061,167704,644102">phosphate</compound-id> and <compound-id="28179">fluoride</compound-id> ; at a concentration of 8 mM, each anion reduced activity by about 66%.	fluoride__AMPD__interaction	phosphate__AMPD__interaction
18931933-364	Age-associated impairment of <protein-id="P31750,Q8INB9">Akt</protein-id> phosphorylation in primary rat hepatocytes is remediated by <compound-id="864,6112">alpha-lipoic acid</compound-id> through <protein-id="P42347,P42348,P54673,P54674,P54675,P54676">PI3 kinase</protein-id>, <protein-id="P60483,P60484">PTEN</protein-id>, and <protein-id="P23696,Q06009,Q9ZSE4">PP2A</protein-id>.	alpha-lipoic acid__Akt__interaction	alpha-lipoic acid__PTEN__interaction	alpha-lipoic acid__PI3 kinase__interaction	alpha-lipoic acid__PP2A__interaction
18931946-74	Unfolding and inactivation of abalone (Haliotis diversicolor) <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> during denaturation by <compound-id="3520">guanidine hydrochloride</compound-id>.	guanidine hydrochloride__alkaline phosphatase__interaction
18931946-75	Unfolding and inactivation of <protein-id="P81800">ALPase</protein-id> from abalone (Haliotis diversicolor) during denaturation by <compound-id="3520">guanidine hydrochloride</compound-id> (GuHCl) of different concentrations has first been studied.	guanidine hydrochloride__ALPase__interaction
18931948-76	We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil [N-(2-hydroxyethyl) nicotinamide nitrate ester], in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>), and <compound-id="145068">nitric oxide</compound-id> (NO).	nitric oxide__TNF-alpha__no_interaction	nitric oxide__tumor necrosis factor__no_interaction
18932012-101	Converting <compound-id="439153">NADH</compound-id> to <compound-id="5893">NAD</compound-id>+ by <protein-id="P11024,Q13423,Q61941">nicotinamide nucleotide transhydrogenase</protein-id> as a novel strategy against mitochondrial pathologies during aging.	NADH__nicotinamide nucleotide transhydrogenase__interaction	NAD__nicotinamide nucleotide transhydrogenase__interaction
18932012-102	<compound-id="439153">NADH</compound-id>/<compound-id="5893">NAD</compound-id> (+) ratio can be normalized by the activation or overexpression of <protein-id="P11024,Q13423,Q61941">nicotinamide nucleotide transhydrogenase</protein-id> (<protein-id="O93474,P11024,Q13423">NNT</protein-id>--&gt; <compound-id="5884">NADPH</compound-id>+ <compound-id="5893">NAD</compound-id> (+).	NADPH__NNT__interaction	NADPH__nicotinamide nucleotide transhydrogenase__interaction	NADH__NNT__interaction	NAD__NNT__interaction	NADH__nicotinamide nucleotide transhydrogenase__interaction	NAD__nicotinamide nucleotide transhydrogenase__interaction
18932024-913	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing <protein-id="P07850,Q9S850">sulfite oxidase</protein-id> and <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> with polyaniline <compound-id="104748">sulfonic acid</compound-id> in a layer-by-layer assembly.	sulfonic acid__cytochrome c__interaction	sulfonic acid__sulfite oxidase__interaction
18932046-599	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as <protein-id="O50258">superoxide dismutase</protein-id>, nitrite/nitrate, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> and <compound-id="10964">malondialdehyde</compound-id> were performed.	malondialdehyde__superoxide dismutase__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction
18932046-600	The levels of <compound-id="10964">malondialdehyde</compound-id> and <protein-id="O50258">superoxide dismutase</protein-id> were lower in ginkgo groups but not significantly.	malondialdehyde__superoxide dismutase__no_interaction
18932201-188	These results indicate that cloned embryos have aberrant DNA methylation in the <compound-id="6804">CpG</compound-id> sites of the PE region of <protein-id="O97552,P20263,Q01860,Q9TSV5">Oct-4</protein-id>, and this may contribute directly to abnormal expression of this gene in cloned embryos.	CpG__Oct-4__interaction
18932209-190	Xenopus follicle-enclosed oocytes are endowed with <protein-id="O15547,O54803,O70397,P34996,P35383,P41231,P41232,P47824,P47900,P48042,P49650,P49651,P49652,P49653,P49654,P51575,P51576,P51577,P51578,P51579,P56373,P59902,Q64663,Q93086,Q99571,Q99572,Q9UBL9,Q9Z1M0">purinergic receptors</protein-id> located in the follicular cell membrane ; their stimulation by <compound-id="5957">ATP</compound-id> elicits an electrical response that includes generation of a fast inward current (F(Cl)) carried by Cl(-).	ATP__purinergic receptors__no_interaction
18932227-940	Moreover, the dopaminergic and glutamatergic regulation of <protein-id="Q9Z214,Q9Z2Y3">Homer1</protein-id> gene activation by <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id> was investigated.	cocaine__Homer1__interaction
18932227-941	The acute <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id>-mediated activation of <protein-id="Q9Z214,Q9Z2Y3">Homer1</protein-id> gene was regulated by D1 but not D2 dopamine receptors.	cocaine__Homer1__interaction
18932227-942	Activation of <protein-id="Q9Z214,Q9Z2Y3">Homer1</protein-id> gene may contribute to the <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id>-mediated synaptic and behavioral plasticity.	cocaine__Homer1__interaction
18935969-1418	The reduction of WST-1 was inhibited in a concentration-dependent manner by <protein-id="O50258">superoxide dismutase</protein-id>, an enzyme that catalyzes the reduction of <compound-id="5359597">superoxide</compound-id> to <compound-id="784">peroxide</compound-id>, confirming that the reduction of WST-1 was due to the presence of <compound-id="5359597">superoxide</compound-id>.	superoxide__superoxide dismutase__interaction	peroxide__superoxide dismutase__interaction
18935970-1419	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein <compound-id="9816401">peptidoglycan</compound-id> by N-linked <protein-id="P08163">glycoproteins</protein-id>, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-<compound-id="3283,5382654">ether</compound-id> lipids of archaebacteria.	ether__glycoproteins__no_interaction	peptidoglycan__glycoproteins__no_interaction
18935973-1420	<compound-id="2828334">Necrostatin-1</compound-id>, a new inhibitor of non-apoptotic death, rescued cells from death by <protein-id="P24817,P52594,P56626,Q13546,Q2TA45,Q86UA6">RIPs</protein-id>, although the effect was also partial and temporary.	Necrostatin-1__RIPs__interaction
18935985-1424	Here we show the first direct quantitative evidence for <protein-id="O32449,O43150,O74326,O74518,O83041,O96690,P09274,P0ABF1,P0ABF2,P0ABF3,P10226,P16790,P25500,P27417,P28958,P29468,P36322,P36702,P42786,P44439,P46541,P46542,P46544,P46547,P47266,P51003,P51004,P51005,P51006,P52278,P52279,P52439,P52440,P75092,P80366,P84399,P93732,P96084,Q06141,Q09131,Q10295,Q13442,Q38924,Q3UHX2,Q51D88,Q61183,Q62785,Q7SIG6,Q87DF8,Q8Z9C3,Q8ZRQ8,Q97A76,Q97UA2,Q9D0D3,Q9JUV1,Q9JZR6,Q9NVV4,Q9PD69,Q9S2L4,Q9UT49,Q9UTN3,Q9ZWQ8">PAP</protein-id> binding to the cap analog <compound-id="444378">m(7)GTP</compound-id>.	m(7)GTP__PAP__interaction
18935985-1425	van't Hoff analysis of <compound-id="444378">m(7)GTP</compound-id>-<protein-id="O32449,O43150,O74326,O74518,O83041,O96690,P09274,P0ABF1,P0ABF2,P0ABF3,P10226,P16790,P25500,P27417,P28958,P29468,P36322,P36702,P42786,P44439,P46541,P46542,P46544,P46547,P47266,P51003,P51004,P51005,P51006,P52278,P52279,P52439,P52440,P75092,P80366,P84399,P93732,P96084,Q06141,Q09131,Q10295,Q13442,Q38924,Q3UHX2,Q51D88,Q61183,Q62785,Q7SIG6,Q87DF8,Q8Z9C3,Q8ZRQ8,Q97A76,Q97UA2,Q9D0D3,Q9JUV1,Q9JZR6,Q9NVV4,Q9PD69,Q9S2L4,Q9UT49,Q9UTN3,Q9ZWQ8">PAP</protein-id> equilibrium reveals a binding reaction that is enthalpy driven and entropy favored with TDeltaS degrees contributing 15% to the overall value of DeltaG degrees.	m(7)GTP__PAP__interaction
18935985-1426	eIFiso4G was shown to enhance the interaction of <protein-id="O32449,O43150,O74326,O74518,O83041,O96690,P09274,P0ABF1,P0ABF2,P0ABF3,P10226,P16790,P25500,P27417,P28958,P29468,P36322,P36702,P42786,P44439,P46541,P46542,P46544,P46547,P47266,P51003,P51004,P51005,P51006,P52278,P52279,P52439,P52440,P75092,P80366,P84399,P93732,P96084,Q06141,Q09131,Q10295,Q13442,Q38924,Q3UHX2,Q51D88,Q61183,Q62785,Q7SIG6,Q87DF8,Q8Z9C3,Q8ZRQ8,Q97A76,Q97UA2,Q9D0D3,Q9JUV1,Q9JZR6,Q9NVV4,Q9PD69,Q9S2L4,Q9UT49,Q9UTN3,Q9ZWQ8">PAP</protein-id> with <compound-id="444378">m(7)GTP</compound-id> cap analog by 2.4-fold.	m(7)GTP__PAP__interaction
18936037-1437	In addition to activating the <protein-id="P06186,P06401,P07812,P79373,Q00175,Q28590,Q63449,Q8AYI2,Q9GLW0">progesterone receptors</protein-id> (PRs)-B and-A, members of the superfamily of ligand-dependent transcription factors, <compound-id="5994">progesterone</compound-id> also elicits a variety of rapid signalling events independently of transcriptional or genomic regulation.	progesterone__progesterone receptors__no_interaction
18936084-1443	In granulosa-lutein cells, STAR transcript abundance was not affected by <protein-id="P22004">BMP6</protein-id>, whereas <compound-id="47936">forskolin</compound-id>-induced expression of <protein-id="O46515,P00189,P05108,P10612,P79153,P79202,Q07217,Q28827,Q2XV99,Q92045,Q9EPT4">CYP11A1</protein-id>, <protein-id="P14060,Q60555">HSD3B1</protein-id>, <protein-id="O46512,P11511,P19098,P46194,P70091,P79690,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">CYP19A1</protein-id> and <protein-id="P01175,P01176,P01177,P01178,P01179,P13389,P32005,P35454,P69043,P69044,P69056,P69057,P69058">oxytocin</protein-id> transcripts was reduced.	forskolin__CYP19A1__interaction	forskolin__CYP11A1__interaction	forskolin__HSD3B1__interaction	forskolin__BMP6__interaction	forskolin__oxytocin__interaction
18936084-1444	In both cell types, follistatin attenuated the suppressive effect of activin A and <protein-id="P22004">BMP6</protein-id> on <compound-id="47936">forskolin</compound-id>-induced P4 secretion but had no effect alone.	forskolin__BMP6__interaction
18936109-1448	<compound-id="1367">1-Aminobenzotriazole</compound-id> (1-ABT) is generally considered to be a nonselective mechanism-based inactivator of both human and non-human <protein-id="O08469">cytochrome P450</protein-id> (P450) enzymes.	1-Aminobenzotriazole__cytochrome P450__interaction
18936140-1459	<compound-id="91474">7-Ketocholesterol</compound-id> is present in lipid deposits in the primate retina: potential implication in the induction of <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> and CNV formation.	7-Ketocholesterol__VEGF__interaction
18936181-1478	ETEC infection also caused a drastic inhibition of host <protein-id="P16397,P18773">esterase</protein-id> activity, as measured by <compound-id="65079">calcein</compound-id> fluorescence.	calcein__esterase__interaction
18936191-1737	<compound-id="11561383">HCV-796</compound-id> is a nonnucleoside inhibitor of the hepatitis C virus (HCV) <protein-id="P18571,P30890">nonstructural protein</protein-id> 5B (<protein-id="O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P19711,P19712,P19741,P21530,P26660,P26661,P26662,P26663,P26664,P27958,P29846,Q00269,Q01499,Q5I2N3,Q68749,Q68798,Q68801,Q69422,Q81258,Q81487,Q81495,Q81754,Q913D4,Q96662,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">NS5B</protein-id>) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.	HCV-796__NS5B__interaction	HCV-796__nonstructural protein__interaction
18936191-1738	They also exhibited resistance to <compound-id="227">anthranilate</compound-id> nonnucleoside inhibitors of NS5B but were fully sensitive to inhibitors of different mechanisms: a pyranoindole, Hsp90 inhibitors, an NS5B nucleoside inhibitor, and pegylated interferon (Peg-<protein-id="P28172,P51526">IFN</protein-id>).	anthranilate__IFN__no_interaction
18936191-1739	Mutations known to confer resistance to <compound-id="11561383">HCV-796</compound-id> (<protein-id="O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P19711,P19712,P19741,P21530,P26660,P26661,P26662,P26663,P26664,P27958,P29846,Q00269,Q01499,Q5I2N3,Q68749,Q68798,Q68801,Q69422,Q81258,Q81487,Q81495,Q81754,Q913D4,Q96662,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">NS5B</protein-id> C316Y) and boceprevir (<protein-id="O71152,P06591,P15775,P15779,P29076,Q04854,Q90056">NS3</protein-id> V170A) were present in the combination-resistant replicons.	HCV-796__NS5B__interaction	HCV-796__NS3__interaction
18936517-1603	Here, we show that 12-O-tetradecanoyl-<compound-id="499953,54612241">phorbol-13-acetate</compound-id> (TPA)-induced stabilization of receptor mRNA requires the activity of <protein-id="P13678,Q25378">protein kinase C</protein-id> and is accompanied by activation of the major <protein-id="Q00859">mitogen activated protein kinase</protein-id> pathways.	phorbol-13-acetate__mitogen activated protein kinase__interaction	phorbol-13-acetate__protein kinase C__interaction
18936772-1665	Increased apoptosis of a human salivary gland (HSG) cell line occurred only in the presence of <compound-id="11970143">lipopolysaccharide</compound-id> (LPS-) and interferon (<protein-id="P28172,P51526">IFN</protein-id>)-gamma-stimulated human monocytic THP-1 cells, which was reversed when caspase-1 in THP-1 cells was targeted by siRNA.	lipopolysaccharide__IFN__no_interaction
18936912-1717	A role for <compound-id="60823">atorvastatin</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.	atorvastatin__insulin__no_interaction
18936912-1718	Genetic type 2 diabetic Goto-Kakizaki rats were fed with a high-fat diet to test hepatic effects of type 2 diabetes with hyperlipidemia and the effect of <compound-id="60823">atorvastatin</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, individually and in combination, in systemic and hepatic inflammatory and oxidative stress markers.	atorvastatin__insulin__no_interaction
18936912-1719	Combination of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="60823">atorvastatin</compound-id> further improved glycemic and lipid profiles and decreased circulating C-reactive protein levels and liver inflammatory and oxidative stress markers.	atorvastatin__insulin__no_interaction
18936912-1720	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> and <compound-id="60823">atorvastatin</compound-id> combination leads to better glycaemic and lipid profiles and to better protection against liver inflammation and oxidative stress, giving a superior level of liver protection in type 2 diabetic with hyperlipidemia.	atorvastatin__Insulin__no_interaction
18936931-1732	Effect of genetic polymorphisms of <protein-id="P20815">CYP3A5</protein-id> and <protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id> on <compound-id="5280754,5284373,5497195,6435893,24883466,25246316">cyclosporine</compound-id> concentration during the early stage after renal transplantation in Chinese patients co-treated with <compound-id="39186">diltiazem</compound-id>.	cyclosporine__CYP3A5__interaction	diltiazem__CYP3A5__no_interaction	diltiazem__MDR1__no_interaction	cyclosporine__MDR1__interaction
18936931-1733	The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (<protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id>) gene polymorphisms on <compound-id="2909,5280754,5284373,5497195,6435893,49867938">cyclosporine A</compound-id> (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with <compound-id="39186">diltiazem</compound-id>.	cyclosporine A__MDR1__interaction	diltiazem__MDR1__no_interaction
18936963-1743	The-417- and-593 bp promoter regions were sufficient for <protein-id="P05804">GUS</protein-id> gene activation by <compound-id="6325,21159546">ethylene</compound-id> and <compound-id="62388,5281929,5319693,5367719,6432008">methyl jasmonate</compound-id> treatments, respectively.	methyl jasmonate__GUS__interaction	ethylene__GUS__interaction
18936983-1746	Reversible two-step unfolding of <compound-id="4971">heme</compound-id>-human <protein-id="P21847,P83517">serum albumin</protein-id> : a (1)H-NMR relaxometric and circular dichroism study.	heme__serum albumin__interaction
18936983-1747	Human <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P24807,Q07490">HSA</protein-id>) participates in <compound-id="4971">heme</compound-id> scavenging, the bound <compound-id="4971">heme</compound-id> turning out to be a reactivity center and a powerful spectroscopic probe.	heme__HSA__interaction	heme__serum albumin__interaction
18936983-1748	Here, the reversible unfolding of <compound-id="4971">heme</compound-id>-<protein-id="P24807,Q07490">HSA</protein-id> has been investigated by (1)H-NMR relaxometry, circular dichroism, and absorption spectroscopy.	heme__HSA__interaction
18936994-1754	The purified enzymes were a monomer with an apparent molecular mass of 32 kDa (Chi32) and 46 kDa (Chi46), respectively, and showed <protein-id="P13656,P14529,P23472,P23473,P81241,P84754">chitinase</protein-id> activity bands with 0.01% <compound-id="174">glycol</compound-id> chitin as a substrate after SDS-PAGE.	glycol__chitinase__no_interaction
18937061-1791	The interactions between N,N'-di(2-hydroxy-3-methyoxy-phenyl-1-methylene)-o-phenyldiamine-mone Zn(II), Nd(III) <compound-id="943">nitrate</compound-id> (2LZnNd) and bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) was investigated by various spectroscopic techniques under physiological conditions.	nitrate__serum albumin__interaction	nitrate__BSA__interaction
18937066-2628	In particular, expression of genes involved in N-<compound-id="871">glycan</compound-id> synthesis or in the modeling of <compound-id="53477707">chondroitin</compound-id> and <protein-id="P16070,Q60522">heparan sulfate proteoglycans</protein-id> appeared to be modulated.	glycan__heparan sulfate proteoglycans__no_interaction	chondroitin__heparan sulfate proteoglycans__no_interaction
18937073-2436	Possible relation of <compound-id="4971">hemin</compound-id>-induced <protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id> expression to the upregulation of <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> and <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> mRNA levels in rat C6 glioma cells.	hemin__HO-1__interaction	hemin__VEGF__interaction	hemin__BDNF__interaction
18937073-2437	Based on this hypothetical idea, the direct effect of <compound-id="4971">hemin</compound-id> on the expression of genes encoding <protein-id="P06762,P09601,P14791,P14901,P32394,P72849,Q5E9F2">heme oxygenase-1</protein-id> (<protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id>), vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>), and <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id> (<protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	hemin__heme oxygenase-1__interaction	hemin__HO-1__interaction	hemin__brain-derived neurotrophic factor__interaction	hemin__VEGF__interaction	hemin__BDNF__interaction
18937079-1799	Furthermore, we study the <protein-id="P31750,Q8INB9">Akt</protein-id> activation after As(2)O(3) treatment and the HCC cells proliferation after combination of As(2)O(3) with PI3K inhibitor <compound-id="312145">Wortmannin</compound-id>.	Wortmannin__Akt__no_interaction
18937214-1831	<compound-id="2566">Carbofuran</compound-id> is a pesticide whose acute toxicity is due to inhibition of <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id>.	Carbofuran__acetylcholinesterase__interaction
18937289-1865	The interaction of <compound-id="4932">propafenone</compound-id> (<compound-id="70387">PPF</compound-id>) enantiomers with human plasma, human <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P24807,Q07490">HSA</protein-id>), alpha(1)-acid <protein-id="P08163">glycoprotein</protein-id> (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	PPF__serum albumin__interaction	propafenone__glycoprotein__interaction	PPF__glycoprotein__interaction	PPF__HSA__interaction	propafenone__HSA__interaction	propafenone__serum albumin__interaction
18937323-1876	<compound-id="6076">cAMP</compound-id>-<protein-id="Q9EQZ6,Q9Z1C7">Epac2</protein-id>-mediated activation of <protein-id="P08645,P18613,Q91VL8,Q96TL7">Rap1</protein-id> in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	cAMP__Rap1__interaction	cAMP__Epac2__interaction
18937323-1878	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a <compound-id="6076">cAMP</compound-id>/<protein-id="Q9EQZ6,Q9Z1C7">Epac2</protein-id>/<protein-id="P08645,P18613,Q91VL8,Q96TL7">Rap1</protein-id>-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	cAMP__Rap1__interaction	cAMP__Epac2__interaction
18937360-1888	Cholesterol promotes basal and <compound-id="2520">verapamil</compound-id>-induced ATPase activity of P-<protein-id="P08163">glycoprotein</protein-id> (P-gp).	verapamil__glycoprotein__interaction
18937368-1889	Elucidation of the human <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P24807,Q07490">HSA</protein-id>) binding site for the <compound-id="9552058">Cu-PTSM</compound-id> and <compound-id="6409958">Cu-ATSM</compound-id> radiopharmaceuticals.	Cu-ATSM__serum albumin__interaction	Cu-PTSM__serum albumin__interaction	Cu-PTSM__HSA__interaction	Cu-ATSM__HSA__interaction
18937368-1891	This study examines the structural basis for <protein-id="P24807,Q07490">HSA</protein-id> binding of <compound-id="9552058">Cu-PTSM</compound-id> and <compound-id="6409958">Cu-ATSM</compound-id> via competition with drugs having known albumin binding sites.	Cu-PTSM__HSA__interaction	Cu-ATSM__HSA__interaction
18937368-1892	<compound-id="6409958">Cu-ATSM</compound-id> from <protein-id="P24807,Q07490">HSA</protein-id>.	Cu-ATSM__HSA__interaction
18937368-1893	At 8:1 warfarin: <protein-id="P24807,Q07490">HSA</protein-id> <compound-id="6409958">Cu-ATSM</compound-id> levels increased 300-500%.	Cu-ATSM__HSA__interaction
18937368-1894	<compound-id="6409958">Cu-ATSM</compound-id> was observed except at high ibuprofen: <protein-id="P24807,Q07490">HSA</protein-id> ratios, where secondary ibuprofen binding to the IIA site may cause modest radiopharmaceutical displacement.	Cu-ATSM__HSA__no_interaction
18937538-664	This work also demonstrated that S-(+)-AF possesses the strongest effects in induction of intracellular reactive <compound-id="977">oxygen</compound-id> species, DNA damage, and upregulation of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> gene expression.	oxygen__p53__no_interaction
18937625-2531	0.05) in the overall <compound-id="206,5793,64689,79025">glucose</compound-id>-mediated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> response.	glucose__insulin__interaction
18937625-2532	<compound-id="206,5793,64689,79025">Glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> levels were not significantly different from controls.	Glucose__insulin__interaction
18937643-2052	The inducible form of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P35228,P60321,P79290,Q27995,Q28314,Q90703,Q92037,Q92091">NOS2</protein-id>) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate <compound-id="44268108">endotoxin</compound-id>.	endotoxin__nitric oxide synthase__interaction	endotoxin__NOS2__interaction
18937645-884	Atypical sialylated N-<compound-id="871">glycan</compound-id> structures are attached to neuronal <protein-id="P0A333,P0A334,Q9YDF8">voltage-gated potassium channels</protein-id>.	glycan__voltage-gated potassium channels__interaction
18937645-885	<compound-id="906,444885,445063">Sialic acid</compound-id> linkages were identified for <protein-id="P0A333,P0A334,Q9YDF8">voltage-gated potassium channels</protein-id>, Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4, by evaluating their electrophoretic migration patterns in adult rat brain membranes digested with various glycosidases.	Sialic acid__voltage-gated potassium channels__interaction
18937879-2138	No regional difference in <protein-id="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1">dopamine D2 receptor</protein-id> occupancy by the second-generation antipsychotic drug <compound-id="5073">risperidone</compound-id> in humans: a positron emission tomography study.	risperidone__dopamine D2 receptor__no_interaction
18937879-2139	In this study, regional distribution of <protein-id="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1">dopamine D2 receptor</protein-id> occupancy by <compound-id="5073">risperidone</compound-id> was determined in order to elucidate the limbic and cortical selectivity of second-generation antipsychotics.	risperidone__dopamine D2 receptor__interaction
18937879-2140	Striatal and extrastriatal <protein-id="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1">dopamine D2 receptor</protein-id> binding <compound-id="129497">FLB 457</compound-id>, respectively.	FLB 457__dopamine D2 receptor__interaction
18937971-2150	<protein-id="O09185,O12946,O36006,O57538,O93379,P04637,P10360,P13481,P25035,P41685,P51664,P56423,P56424,P61260,P67938,P67939,P79820,P79892,Q00366,Q29480,Q29537,Q64662,Q8SPZ3,Q92143,Q95330,Q9TTA1,Q9TUB2,Q9W678,Q9W679,Q9WUR6">TP53</protein-id>, <protein-id="Q00709">BCL-2</protein-id> and <protein-id="O02703,P55269,Q07812,Q07814,Q07815">BAX</protein-id> analysis in 199 ovarian cancer patients treated with <compound-id="108169,9548828">taxane</compound-id>-<compound-id="23939">platinum</compound-id> regimens.	taxane__BAX__interaction	platinum__BCL-2__interaction	platinum__BAX__interaction	taxane__BCL-2__interaction	platinum__TP53__interaction	taxane__TP53__interaction
18938111-2180	<protein-id="Q9HC29">NOD2</protein-id>, an intracellular sensor of bacteria-derived <compound-id="40846,451714,11620162">muramyl dipeptide</compound-id> (MDP) has been implicated as a key player in intestinal immune health and disease.	muramyl dipeptide__NOD2__interaction
18938126-2184	The end product of <protein-id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</protein-id> crosslinking: simultaneous quantitation of [Nepsilon-(gamma-glutamyl) <compound-id="866,5962">lysine</compound-id>] and <compound-id="866,5962">lysine</compound-id> by HPLC-MS3.	lysine__transglutaminase__interaction
18938128-2186	The <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>-catalyzed formation of CA-<compound-id="124886">GSH</compound-id> occurred with both CA-AMP and CA-CoA.	GSH__GST__interaction
18938142-2192	Exposure of HEK293 cells to BK produced a concentration-dependent rise in intracellular Ca(2+) (EC(50)=36.5+/-8.0 x 10(-9)M), a rapid increase in <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of <protein-id="P29323">ERK</protein-id> (EC(50)=9.8+/-0.4 x 10(-9)M), and elevation in ECAR by approximately 20%.	tyrosine__ERK__interaction
18938163-2196	<protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> expression coupled with infusion of the IGF binding protein inhibitor <compound-id="54684689">NBI-31772</compound-id> significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.	NBI-31772__IGF-I__interaction
18938187-2204	A significant decrease was observed in <compound-id="119">GABA</compound-id> (A) alpha(1), <protein-id="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20">GAD</protein-id> (67), and <protein-id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</protein-id>, but not <protein-id="P35436,Q00959,Q12879,Q5IS45">NR2A</protein-id>, mRNAs in adult rats that consumed <compound-id="702">ethanol</compound-id> in comparison to controls.	ethanol__GAD__interaction	ethanol__NR2A__no_interaction	GABA__NR2A__no_interaction	ethanol__CRF__interaction	GABA__CRF__no_interaction	GABA__GAD__no_interaction
18938240-2219	We showed previously that activation of the <protein-id="Q10757">angiotensin</protein-id> type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to <protein-id="P00523,P05480,P12931,Q9WUD9">c-Src</protein-id>-dependent <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor <protein-id="P05549,P34056,P58197,Q9N0N3">AP-2</protein-id>.	tyrosine__AP-2__interaction	tyrosine__c-Src__interaction	tyrosine__angiotensin__interaction
18939858-2823	EPL was used to incorporate d-<compound-id="602,4580,5950,71080">alanine</compound-id> and an amide-to-ester backbone modification in the selectivity filter of the <protein-id="P0A333,P0A334">KcsA</protein-id> potassium channel, providing insight into the mechanism of selectivity in ion conduction.	alanine__KcsA__interaction
18939895-2826	Genotoxic effect of 2,4,6-<compound-id="6914">trichlorophenol</compound-id> on <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> gene in zebrafish liver.	trichlorophenol__p53__interaction
18940183-691	Extensive neutrophil infiltration and chemoattractant factor <protein-id="P10145">interleukin 8</protein-id> (<protein-id="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5">IL-8</protein-id>) expression in IL-10 KO mice were observed after <compound-id="3562">halothane</compound-id> administration.	halothane__IL-8__interaction	halothane__interleukin 8__interaction
18940183-692	In addition, increased signal transducer and activator of transcription factors (<protein-id="P08457,P35610,Q7QDU4">STAT</protein-id>) 1 and <protein-id="P40763,P61635">STAT3</protein-id> were observed in <compound-id="3562">halothane</compound-id> treated IL-10 KO mice.	halothane__STAT__interaction	halothane__STAT3__interaction
18940187-471	Human <protein-id="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11">aldehyde dehydrogenase</protein-id>-catalyzed oxidation of <compound-id="174">ethylene glycol</compound-id> <compound-id="3283,5382654">ether</compound-id> aldehydes.	ethylene glycol__aldehyde dehydrogenase__interaction	ether__aldehyde dehydrogenase__interaction
18940188-92	Interaction of <protein-id="O23970,P00435,P04041,P07203,P11352,P11909,P36014,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">glutathione peroxidase-1</protein-id> and <compound-id="6326970">selenium</compound-id> in endemic dilated cardiomyopathy.	selenium__glutathione peroxidase-1__interaction
18940188-93	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood <compound-id="6326970">selenium</compound-id> and polymorphisms in <protein-id="O23970,P00435,P04041,P07203,P11352,P11909,P36014,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">glutathione peroxidase-1</protein-id> (<protein-id="P00435,P04041,P07203,P11352,P11909,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">GPx-1</protein-id>) gene.	selenium__glutathione peroxidase-1__interaction	selenium__GPx-1__interaction
18940204-495	However, under the pressure of a death stimulus such as <compound-id="1393">edelfosine</compound-id> treatment, L. infantum <protein-id="O08600,P38447,Q14249,Q95NM6">EndoG</protein-id> is released from the single mitochondrion and translocates to the nucleus, where it is thought to participate in the process of DNA degradation that is associated with programmed cell death.	edelfosine__EndoG__interaction
18940228-124	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of <compound-id="124886">glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), activity of <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> and glucose-6-phosphate dehydrogenase.	GSH__SOD__no_interaction	glutathione__SOD__no_interaction	GSH__superoxide dismutase__no_interaction	glutathione__superoxide dismutase__no_interaction	GSH__catalase__no_interaction	glutathione__catalase__no_interaction
18940247-147	However, these events were blocked by treatment with the antioxidant, <compound-id="581">N-acetyl-cysteine</compound-id> (NAC), as well as <protein-id="P35557,Q12851,Q61161">GCK</protein-id> overexpression.	N-acetyl-cysteine__GCK__no_interaction
18940248-149	Consistently, immunoprecipitation followed by immunodetection with anti-<compound-id="68841">phosphoserine</compound-id> antibody suggest that <protein-id="Q9JL10,Q9UHV2">TRIP-Br1</protein-id> exists in a <compound-id="5951">serine</compound-id>-phosphorylated form.	phosphoserine__TRIP-Br1__interaction	serine__TRIP-Br1__interaction
18940267-156	It decreased TG levels in tyloxapol-induced hyperlipidemia and increased <protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (HDL-C) and reduced atherogenic index in normotensive rats.	cholesterol__high-density lipoprotein__interaction
18940894-262	This analysis reveals <protein-id="P25170">TRPCs</protein-id> as major and unsuspected gates of <compound-id="271">Ca(2</compound-id>+) entry that contribute, depending on context, to activation of transcription factors, apoptosis, vascular contractility, platelet activation, and cardiac hypertrophy, as well as to normal and abnormal cell proliferation.	Ca(2__TRPCs__interaction
18940938-278	A single bout of exercise increases <compound-id="206,5793,64689,79025">glucose</compound-id> uptake and fatty acid oxidation in skeletal muscle, with a corresponding activation of AMP-activated <protein-id="P00513,P25848">protein kinase</protein-id> (<protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id>).	glucose__protein kinase__interaction	glucose__AMPK__interaction
18940938-280	Changes in <compound-id="977">oxygen</compound-id> consumption and the RQ ratio during sedentary and low-intensity exercise were not different between alpha(1)-<protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id>-DN and WT.	oxygen__AMPK__no_interaction
18941142-329	<protein-id="O95477">ABCA1</protein-id>-mediated <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.	cholesterol__ABCA1__interaction
18941467-423	<compound-id="10635">DHT</compound-id> treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</protein-id> (<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>) and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>).	DHT__cyclooxygenase-2__interaction	DHT__iNOS__interaction	DHT__nitric oxide synthase__interaction	DHT__COX-2__interaction
18941467-424	Effects of <compound-id="10635">DHT</compound-id> on <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> and <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> were attenuated by <compound-id="3397">flutamide</compound-id>.	flutamide__iNOS__interaction	DHT__iNOS__interaction	flutamide__COX-2__interaction	DHT__COX-2__interaction
18941467-426	In conclusion, activation of the NFkappaB-mediated <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>/<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> pathway by the selective androgen receptor agonist, <compound-id="10635">DHT</compound-id>, results in a state of vascular inflammation.	DHT__iNOS__interaction	DHT__COX-2__interaction
18941468-399	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-<compound-id="5988">sucrose</compound-id>, and another had <compound-id="5356750,6913958,9566058">Evans blue</compound-id> (EB) injected for fluorescent microscopy for <protein-id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">MMP-2</protein-id>, <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id>, tight junction proteins (TJPs), and in situ zymography.	sucrose__MMP-9__interaction	Evans blue__MMP-2__interaction	Evans blue__MMP-9__interaction	sucrose__MMP-2__interaction
18941714-1885	The electrons released from <compound-id="5884">NADPH</compound-id> by <protein-id="P00388,P00389,P04175,P16435,P16603,P19618,P36587,P37039,P37040,P37116,P37201,P50126,Q00141,Q05001,Q07994,Q27597,Q3SYT8,Q9EQV9,Q9HDG2,Q9JHH6">CPR</protein-id> were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	NADPH__CPR__interaction
18941758-517	<compound-id="838,5816,247704">Adrenaline</compound-id>, <compound-id="4782,6041">phenylephrine</compound-id> and <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">ang II</protein-id> (<protein-id="O25424,P06608,P54420,Q9ZLB9">Asn</protein-id> (1), Val(5)) were injected into P. borchgrevinki.	phenylephrine__ang II__no_interaction	phenylephrine__Asn__no_interaction	Adrenaline__ang II__no_interaction	Adrenaline__Asn__no_interaction
18941797-421	Effects of dissolved <compound-id="977">oxygen</compound-id> tension and agitation rate on the production of heat-shock protein <protein-id="P08163">glycoprotein</protein-id> 96 by MethA tumor cell suspension culture in stirred-tank bioreactors.	oxygen__glycoprotein__interaction
18941818-549	Goldfish scales were incubated either with 20:3n-9 or with <compound-id="445639">oleic acid</compound-id> at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> (<protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id>) and tartrate-resistant acid <protein-id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">phosphatase</protein-id>, respectively.	oleic acid__ALP__no_interaction	oleic acid__alkaline phosphatase__no_interaction	oleic acid__phosphatase__no_interaction
18941818-550	MC3T3-E1 cells (an osteoblast cell line derived from the mouse) were incubated with 20:3n-9 or <compound-id="445639">oleic acid</compound-id> at 37 degrees C for 6 and 18 h. <protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id> activity in cell lysate was measured.	oleic acid__ALP__interaction
18941890-590	Reactive oxygen species induce phosphorylation of <compound-id="5951">serine</compound-id> 118 and 167 on <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> alpha.	serine__estrogen receptor__interaction
18941890-591	Both kinases have been implicated in the phosphorylation of <compound-id="5951">serine</compound-id> 118 and <compound-id="5951">serine</compound-id> 167 on <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id>, respectively.	serine__ERalpha__interaction
18941890-592	Our data show for the first time that ROS can induce post-translational modifications of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> at <compound-id="5951">serine</compound-id> 118 and <compound-id="5951">serine</compound-id> 167, and may lead to <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> down-regulation in human breast cancer cells.	serine__ERalpha__interaction
18942092-662	Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by <protein-id="P00533,P13387,P55245">EGFR</protein-id> inhibition or <compound-id="148124">docetaxel</compound-id> chemotherapy.	docetaxel__EGFR__no_interaction
18942097-665	Expression of the <protein-id="O22582,O49118,O97484,P02280,P02283,P14001,P17271,P19374,P21897,P23754,P27326,P27795,P27893,P30757,P35067,P37210,P40284,P48557,P59781,P59782,P69069,P69070,P78567,P82887,P83837,P83863,P93354,Q27442,Q2HH38,Q2U5A9,Q4HTT2,Q4PEF8,Q4WWC5,Q5G577,Q5KMT4,Q6C4I7,Q75VN4,Q76FD7,Q76FE5,Q76FE9,Q76FF3,Q7M400,Q7M4G7,Q7Z9J4,Q875B7,Q8I1N0,Q8J1K2,Q8SRE2,Q99285">histone H2B</protein-id>-<protein-id="P42212">GFP</protein-id> fusion protein was observed exclusively upon <compound-id="54671203">doxycycline</compound-id> induction and was uniformly distributed throughout the intestinal epithelium.	doxycycline__GFP__interaction	doxycycline__histone H2B__interaction
18942140-690	On <compound-id="12332">hexanoamide</compound-id> the <protein-id="O69768,P22984,P27765,P95896">amidase</protein-id> exhibited a K(m) value of 5.5 mM compared to 0.07 mM for <compound-id="7691">p-nitroacetanilide</compound-id>.	p-nitroacetanilide__amidase__interaction	hexanoamide__amidase__interaction
18942727-207	<protein-id="P21457,P34057,P35243">Recoverin</protein-id> is an important neuronal calcium sensor (<protein-id="P0A3R9,P0A3S0">NCS</protein-id>) protein, which have been implicated in a wide range of <compound-id="271">Ca(2</compound-id>+) signaling events in neurons and photoreceptors.	Ca(2__Recoverin__interaction	Ca(2__NCS__no_interaction
18942747-891	Activation of <protein-id="P13900,P16604">P2X</protein-id> (7)R in OPCs in response to 3'-O-(4-benzoyl) benzoyl-<compound-id="5957">ATP</compound-id> (BzATP) led to an increased mobilization of intracellular calcium [Ca(2+)]i, formation of large pores and cell death.	ATP__P2X__interaction
18942747-893	A decrease in <protein-id="P13900,P16604">P2X</protein-id> (7)R expression was observed in cultured OPCs after exposure to <compound-id="977">oxygen</compound-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> deprivation (OGD) for 2 h in vitro.	oxygen__P2X__interaction	glucose__P2X__interaction
18945212-1760	Reactivity of <compound-id="145068">nitric oxide</compound-id> with the [<compound-id="6398953">4Fe-4S] cluster</compound-id> of <protein-id="O06069,O27498,O29248,O51887,O67009,O69198,P05791,P31874,P31959,P40810,P44851,P51785,P55186,P57656,P57957,P59426,P65154,P65155,P65156,P65157,P65158,P65159,P65160,P74689,Q02139,Q317H9,Q31UL3,Q329V0,Q3A3A5,Q3AER0,Q3APB9,Q3BYS5,Q3IMV2,Q3IXP4,Q3J9N3,Q3JV12,Q3K559,Q3SW60,Q3YVJ3,Q3Z888,Q3ZXH9,Q46AU2,Q46LF6,Q47JC0,Q47MS7,Q47UN7,Q48PA6,Q491Z0,Q4FM19,Q4FS54,Q4J860,Q4JUN3,Q4K498,Q4L7T6,Q4QMF8,Q4UZT2,Q4ZZ83,Q57FS2,Q57HU7,Q58672,Q5E1P2,Q5F8G6,Q5FN26,Q5GUY8,Q5HEE8,Q5HMG3,Q5HXE4,Q5KYA5,Q5L9I8,Q5LN98,Q5LYH1,Q5M334,Q5N3N2,Q5NH32,Q5NLJ4,Q5PK00,Q5SIY0,Q5V545,Q5WEM9,Q606D6,Q62LG7,Q63CV3,Q63WB9,Q64PS6,Q65IB0,Q65QD4,Q66G45,Q67KX6,Q6AEN9,Q6CZC7,Q6G543,Q6G7Q4,Q6GF19,Q6HKA0,Q6KZ30,Q6LLH7,Q6M0F3,Q6N9S5,Q6NHN6,Q71Y38,Q725Q1,Q72JA8,Q72TC0,Q73TT7,Q74BW7,Q7MAN4,Q7MGI8,Q7MYJ5,Q7NGK1,Q7NYJ7,Q7TV16,Q7U763,Q7UJ69,Q7V1T1,Q7VC95,Q7VHW3,Q7VRL8,Q81F26,Q81S26,Q82E99,Q82XY7,Q83GP9,Q83HI6,Q83PI6,Q87F63,Q87KB6,Q87V83,Q88CQ2,Q8A608,Q8CNL6,Q8DDG1,Q8DK13,Q8DRT7,Q8E9D9,Q8EN63,Q8F219,Q8FBR5,Q8G353,Q8G3H2,Q8KER4,Q8KTS9,Q8NQZ9,Q8PDJ3,Q8PQI0,Q8Q078,Q8RDJ9,Q8TW40,Q8U297,Q8UE43,Q8XAV1,Q8XWR1,Q8Y5S2,Q8YEN0,Q8YTE6,Q8Z377,Q8ZAB3,Q8ZYU6,Q92A32,Q92M28,Q96YK0,Q97EE3,Q97UB2,Q9I6E0,Q9JS61,Q9JUE0,Q9K8E4,Q9KVW0,Q9PH47,Q9PJ98,Q9RQ48,Q9RQ52,Q9RQ56,Q9RV97,Q9UZ03,Q9WZ21,Q9XBI3,Q9YG88">dihydroxyacid dehydratase</protein-id> from Escherichia coli.	nitric oxide__dihydroxyacid dehydratase__interaction	4Fe-4S] cluster__dihydroxyacid dehydratase__interaction
18945212-1763	The rate constant for the initial reaction between NO and the <protein-id="O06069,O27498,O29248,O51887,O67009,O69198,P05791,P31874,P31959,P40810,P44851,P51785,P55186,P57656,P57957,P59426,P65154,P65155,P65156,P65157,P65158,P65159,P65160,P74689,Q02139,Q317H9,Q31UL3,Q329V0,Q3A3A5,Q3AER0,Q3APB9,Q3BYS5,Q3IMV2,Q3IXP4,Q3J9N3,Q3JV12,Q3K559,Q3SW60,Q3YVJ3,Q3Z888,Q3ZXH9,Q46AU2,Q46LF6,Q47JC0,Q47MS7,Q47UN7,Q48PA6,Q491Z0,Q4FM19,Q4FS54,Q4J860,Q4JUN3,Q4K498,Q4L7T6,Q4QMF8,Q4UZT2,Q4ZZ83,Q57FS2,Q57HU7,Q58672,Q5E1P2,Q5F8G6,Q5FN26,Q5GUY8,Q5HEE8,Q5HMG3,Q5HXE4,Q5KYA5,Q5L9I8,Q5LN98,Q5LYH1,Q5M334,Q5N3N2,Q5NH32,Q5NLJ4,Q5PK00,Q5SIY0,Q5V545,Q5WEM9,Q606D6,Q62LG7,Q63CV3,Q63WB9,Q64PS6,Q65IB0,Q65QD4,Q66G45,Q67KX6,Q6AEN9,Q6CZC7,Q6G543,Q6G7Q4,Q6GF19,Q6HKA0,Q6KZ30,Q6LLH7,Q6M0F3,Q6N9S5,Q6NHN6,Q71Y38,Q725Q1,Q72JA8,Q72TC0,Q73TT7,Q74BW7,Q7MAN4,Q7MGI8,Q7MYJ5,Q7NGK1,Q7NYJ7,Q7TV16,Q7U763,Q7UJ69,Q7V1T1,Q7VC95,Q7VHW3,Q7VRL8,Q81F26,Q81S26,Q82E99,Q82XY7,Q83GP9,Q83HI6,Q83PI6,Q87F63,Q87KB6,Q87V83,Q88CQ2,Q8A608,Q8CNL6,Q8DDG1,Q8DK13,Q8DRT7,Q8E9D9,Q8EN63,Q8F219,Q8FBR5,Q8FPX6,Q8G353,Q8G3H2,Q8KER4,Q8KTS9,Q8NQZ9,Q8PDJ3,Q8PQI0,Q8Q078,Q8RDJ9,Q8TW40,Q8U297,Q8UE43,Q8XAV1,Q8XWR1,Q8Y5S2,Q8YEN0,Q8YTE6,Q8Z377,Q8ZAB3,Q8ZYU6,Q92A32,Q92M28,Q96YK0,Q97EE3,Q97UB2,Q98BZ8,Q9I6E0,Q9JUE0,Q9K8E4,Q9KVW0,Q9PH47,Q9PJ98,Q9RQ48,Q9RQ52,Q9RQ56,Q9RV97,Q9UZ03,Q9WZ21,Q9XBI3,Q9YG88">IlvD</protein-id> [<compound-id="6398953">4Fe-4S] cluster</compound-id> is estimated to be (7.0+/-2.0)x10(6) M(-2) x s(-1) at 25 degrees C, which is approx.	4Fe-4S] cluster__IlvD__interaction
18945212-1766	The results suggest that the iron-<compound-id="402">sulfur</compound-id> clusters in proteins such as <protein-id="O06069,O27498,O29248,O51887,O67009,O69198,P05791,P31874,P31959,P40810,P44851,P51785,P55186,P57656,P57957,P59426,P65154,P65155,P65156,P65157,P65158,P65159,P65160,P74689,Q02139,Q317H9,Q31UL3,Q329V0,Q3A3A5,Q3AER0,Q3APB9,Q3BYS5,Q3IMV2,Q3IXP4,Q3J9N3,Q3JV12,Q3K559,Q3SW60,Q3YVJ3,Q3Z888,Q3ZXH9,Q46AU2,Q46LF6,Q47JC0,Q47MS7,Q47UN7,Q48PA6,Q491Z0,Q4FM19,Q4FS54,Q4J860,Q4JUN3,Q4K498,Q4L7T6,Q4QMF8,Q4UZT2,Q4ZZ83,Q57FS2,Q57HU7,Q58672,Q5E1P2,Q5F8G6,Q5FN26,Q5GUY8,Q5HEE8,Q5HMG3,Q5HXE4,Q5KYA5,Q5L9I8,Q5LN98,Q5LYH1,Q5M334,Q5N3N2,Q5NH32,Q5NLJ4,Q5PK00,Q5SIY0,Q5V545,Q5WEM9,Q606D6,Q62LG7,Q63CV3,Q63WB9,Q64PS6,Q65IB0,Q65QD4,Q66G45,Q67KX6,Q6AEN9,Q6CZC7,Q6G543,Q6G7Q4,Q6GF19,Q6HKA0,Q6KZ30,Q6LLH7,Q6M0F3,Q6N9S5,Q6NHN6,Q71Y38,Q725Q1,Q72JA8,Q72TC0,Q73TT7,Q74BW7,Q7MAN4,Q7MGI8,Q7MYJ5,Q7NGK1,Q7NYJ7,Q7TV16,Q7U763,Q7UJ69,Q7V1T1,Q7VC95,Q7VHW3,Q7VRL8,Q81F26,Q81S26,Q82E99,Q82XY7,Q83GP9,Q83HI6,Q83PI6,Q87F63,Q87KB6,Q87V83,Q88CQ2,Q8A608,Q8CNL6,Q8DDG1,Q8DK13,Q8DRT7,Q8E9D9,Q8EN63,Q8F219,Q8FBR5,Q8FPX6,Q8G353,Q8G3H2,Q8KER4,Q8KTS9,Q8NQZ9,Q8PDJ3,Q8PQI0,Q8Q078,Q8RDJ9,Q8TW40,Q8U297,Q8UE43,Q8XAV1,Q8XWR1,Q8Y5S2,Q8YEN0,Q8YTE6,Q8Z377,Q8ZAB3,Q8ZYU6,Q92A32,Q92M28,Q96YK0,Q97EE3,Q97UB2,Q98BZ8,Q9I6E0,Q9JUE0,Q9K8E4,Q9KVW0,Q9PH47,Q9PJ98,Q9RQ48,Q9RQ52,Q9RQ56,Q9RV97,Q9UZ03,Q9WZ21,Q9XBI3,Q9YG88">IlvD</protein-id> and <protein-id="O04916,O08451,O13966,P09339,P16276,P19414,P20004,P21399,P28271,P34455,P37032,P49608,P49609,P63433,P63434,P70920,P82611,P99148,Q01059,Q23500,Q2A1K3,Q42669,Q59938,Q5HG69,Q5HPJ0,Q63270,Q6G9K9,Q6GH55,Q6YZX6,Q8CPC2,Q90875,Q92G90,Q99798,Q99KI0,Q9ER34,Q9ZCF4">aconitase</protein-id> B may constitute the primary targets of the NO cytotoxicity under both aerobic and anaerobic conditions.	sulfur__aconitase__interaction	sulfur__IlvD__interaction
18945214-2009	Moreover, following size-exclusion separation of <compound-id="5590">Triton X-100</compound-id>-extracted <protein-id="P16629,P24266,P28991,Q04565,Q07252">membrane proteins</protein-id>, <protein-id="P48025,Q64725">Syk</protein-id> was found only in the high-molecular-mass fraction containing oligomerized/phosphorylated band 3.	Triton X-100__membrane proteins__interaction	Triton X-100__Syk__interaction
18945215-1768	Acylcarnitines have been suggested to play a role in <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, as well as other <compound-id="284">long-chain fatty acid</compound-id> metabolites.	long-chain fatty acid__insulin__interaction
18945215-1769	In the present study we investigated whether muscle long-chain acylcarnitines increase during fasting and we investigated their relationship with <compound-id="206,5793,64689,79025">glucose</compound-id>/fat oxidation and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity in lean healthy humans.	glucose__insulin__no_interaction
18945217-1773	<compound-id="702">Ethanol</compound-id> attenuates the HFS-induced, <protein-id="P29323">ERK</protein-id>-mediated LTP in a dose-dependent manner in rat striatum.	Ethanol__ERK__interaction
18945429-1846	These results suggest that <protein-id="O46689,P49675,P51557,P58864,P70114,P79245,P97826,Q28918,Q28996,Q9DE06,Q9DEB4,Q9DG08,Q9DG09,Q9DG10">StAR</protein-id> delivers <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> to mitochondria where regulatory oxysterols are generated.	cholesterol__StAR__interaction
18945563-2825	<protein-id="P14061,P51656,P51657,Q1WNP0">17beta-Hydroxysteroid dehydrogenase type 1</protein-id> (<protein-id="P14061,Q1WNP0">HSD17B1</protein-id>) is a key enzyme of <compound-id="5757">17beta-estradiol</compound-id> biosynthesis, which might play an important role in follicular development of the ovary.	17beta-estradiol__HSD17B1__interaction	17beta-estradiol__17beta-Hydroxysteroid dehydrogenase type 1__interaction
18945608-1920	A prototype chronoamperometric biosensor for the determination of total cholesterol was developed that consists of a homemade potentiostat and disposable strips immobilized with <compound-id="29936">Fe(3</compound-id>)O(4), cholesterol oxidase (ChOx), and <protein-id="P07882,P19835,P30122,P32947,Q64285">cholesterol esterase</protein-id> (ChE).	Fe(3__cholesterol esterase__no_interaction
18945611-1922	<protein-id="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8">MGMT</protein-id> promoter hypermethylation correlates with a survival benefit from <compound-id="5394">temozolomide</compound-id> in patients with recurrent anaplastic astrocytoma but not glioblastoma.	temozolomide__MGMT__interaction
18945611-1923	To investigate the correlation between O(6)-methylguanine-DNA-<protein-id="O40976,P03588,P03589,P06011,P17769,P20122,P27752,P28726,P28931,Q00020,Q66121,Q83264,Q83270">methyltransferase</protein-id> (<protein-id="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8">MGMT</protein-id>) promoter methylation and benefit from <compound-id="5394">temozolomide</compound-id> in patients with recurrent high-grade glioma.	temozolomide__methyltransferase__interaction	temozolomide__MGMT__interaction
18945624-1926	<compound-id="64971">Betulinic acid</compound-id> binding to human <protein-id="P21847,P83517">serum albumin</protein-id> : a study of protein conformation and binding affinity.	Betulinic acid__serum albumin__interaction
18945756-2007	Adenosine nucleotide translocase (<protein-id="P02723,P25083,P27080,P27081,P31691,P31692,P49382,Q09188,Q26365,Q38914">ANT</protein-id>) translocates ADP/<compound-id="5957">ATP</compound-id> across the inner mitochondrial membrane.	ATP__ANT__interaction
18945757-720	This review will focus on recent evidence that <compound-id="145068">nitric oxide</compound-id>, <protein-id="P28374">natriuretic peptides</protein-id> and <protein-id="P01303,P01304,P07808,P14765,P28672,P28673,P28674,P29071,P33689,P57774,P68006,P68007,P68008,P69101,P69102,P80167,Q27441,Q6RUW3,Q90WF4,Q9DGK7,Q9I8P3,Q9I9D3,Q9PTA0,Q9PW68,Q9XSW6">neuropeptide Y</protein-id> act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	nitric oxide__natriuretic peptides__no_interaction	nitric oxide__neuropeptide Y__no_interaction
18945783-756	Deletion of the first <compound-id="594,5862,5360637">cysteine</compound-id>-rich region of the varicella-zoster virus <protein-id="P18345">glycoprotein E</protein-id> ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.	cysteine__glycoprotein E__interaction
18945810-2026	Glucocorticoid-activated GR repressed <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> gene induction by <compound-id="11970143">lipopolysaccharide</compound-id> (LPS).	lipopolysaccharide__COX-2__interaction
18945821-2039	Inhibition of P-<protein-id="P08163">glycoprotein</protein-id>-mediated <compound-id="4666,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> resistance by reversibly linked quinine homodimers.	paclitaxel__glycoprotein__interaction
18945824-860	The data provide the first demonstration for the presence of <protein-id="O77808,P30518">V2R</protein-id> in primary cilia of renal epithelial cells, and a functional <compound-id="6076">cAMP</compound-id>-signaling pathway, which targets ciliary channel function and may help control the sensory function of the primary cilium.	cAMP__V2R__no_interaction
18945826-2045	The endothelial [<compound-id="271">Ca(2</compound-id>+)](<compound-id="597">CYT</compound-id>) response to <protein-id="O08677,P01042,P01044,P01045,P08934,P83055,P83060,P83856,P83857,P84697,P84825,P84895,Q7T3L1,Q90W88,Q90WZ1">bradykinin</protein-id> (100 nM) was significantly attenuated.	CYT__bradykinin__interaction	Ca(2__bradykinin__interaction
18945930-874	The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor [phenylephrine (PHE)] into nasal formulations containing therapeutic <protein-id="P21259">neuropeptides</protein-id> [<protein-id="O43612,O55232,O55241,O77668,P56717,Q9GLF6">hypocretin-1</protein-id> (HC) or the dipeptide L-Tyr-D-Arg (D-<compound-id="446833">KTP</compound-id>)].	KTP__neuropeptides__no_interaction	KTP__hypocretin-1__no_interaction
18945988-1510	<compound-id="6804">CpG</compound-id> dinucleotides identified in <protein-id="O35185,O35780">Bhlhb2</protein-id>, <protein-id="O88275,P37234,P37238">Pparg</protein-id>, <protein-id="Q27368">E2f</protein-id>, and <protein-id="P08046,P08154,P26632">Egr1</protein-id> binding sites at the <protein-id="P09216,P16054">Prkce</protein-id> gene promoter were densely methylated in males and females and were unaffected by cocaine exposure.	CpG__E2f__interaction	CpG__Pparg__interaction	CpG__Prkce__interaction	CpG__Bhlhb2__interaction	CpG__Egr1__interaction
